data_2vxe_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2vxe _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 N--CA 1.501 2.094 0 CA-C-O 121.003 0.43 . . . . 1.5700000000000001 110.836 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.61 -1.95 84.25 Favored Glycine 0 N--CA 1.497 2.706 0 C-N-CA 120.708 -0.758 . . . . 0.54000000000000004 111.798 176.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.3 m -63.29 145.11 56.23 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.039 -1.271 . . . . 0.83999999999999997 110.445 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.9 pttt -82.18 125.15 30.57 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.73 -0.606 . . . . 2.1200000000000001 110.269 176.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 87.1 mt -120.97 143.42 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.499 -0.751 . . . . 1.05 110.059 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.9 t -102.5 137.22 41.02 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.35 -0.611 . . . . 0.85999999999999999 109.35 174.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 13.9 tp -133.8 127.1 31.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.673 -0.642 . . . . 1.03 110.268 -169.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.6 mt -107.05 118.19 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.55 -0.719 . . . . 1.02 109.732 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m -93.08 157.82 16.1 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.022 0.439 . . . . 0.63 111.212 -177.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -53.76 -13.91 0.81 Allowed 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 112.839 0.681 . . . . 2.9900000000000002 112.839 -171.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.15 20.78 4.11 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.154 -0.966 . . . . 1.05 110.416 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 53.93 34.28 19.18 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.54 -0.725 . . . . 0.80000000000000004 109.886 -174.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.4 mt -102.59 141.88 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 109.128 -0.693 . . . . 1.0800000000000001 109.128 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -104.74 119.87 40.02 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.999 -0.68 . . . . 2.96 109.927 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -114.28 149.53 35.79 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.086 -0.709 . . . . 0.81999999999999995 109.086 174.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -140.52 140.53 35.26 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.498 -0.751 . . . . 1.54 109.628 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.68 173.37 43.3 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 119.801 -1.19 . . . . 0.070000000000000007 110.541 -175.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -84.89 137.26 33.24 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.906 -0.761 . . . . 2.5 110.543 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 14.9 tp -66.09 117.66 8.73 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.589 -0.695 . . . . 1.0900000000000001 110.6 175.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -100.05 -50.08 4.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.621 -0.675 . . . . 0.93000000000000005 110.562 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.8 p -154.44 156.95 37.71 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.696 -0.628 . . . . 1.04 110.293 -177.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.7 p -142.27 146.32 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.755 -0.591 . . . . 1.05 110.085 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -128.12 100.95 22.92 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.716 -0.615 . . . . 0.91000000000000003 109.507 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.31 -42.02 30.75 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 O-C-N 123.652 1.343 . . . . 0.84999999999999998 110.734 -174.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -80.77 -23.88 39.03 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.379 -0.825 . . . . 2.7599999999999998 110.148 -171.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -87.33 1.11 54.26 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.525 -0.734 . . . . 1.5900000000000001 111.294 173.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 37.2 m 49.78 38.52 15.82 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.079 -1.013 . . . . 1.24 111.195 -176.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.0 p -135.77 155.44 50.36 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.405 -0.81 . . . . 0.96999999999999997 110.399 -174.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.7 pt -142.1 162.0 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.715 -0.616 . . . . 0.98999999999999999 110.06 177.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.14 128.42 30.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.61 -0.681 . . . . 0.92000000000000004 109.722 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 84.2 mt -109.81 146.35 35.18 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.579 -0.526 . . . . 1.05 109.579 -178.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.3 p -118.29 152.54 35.57 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.12 -0.696 . . . . 0.68999999999999995 109.12 -177.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.6 p 45.65 84.08 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 121.489 0.662 . . . . 0.81000000000000005 110.238 -171.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.0 p -134.63 150.46 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 109.774 -0.454 . . . . 1.03 109.774 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -135.72 153.23 51.65 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.697 -0.627 . . . . 3.0499999999999998 109.967 178.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.8 p -106.57 139.21 41.38 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.686 -0.634 . . . . 0.71999999999999997 109.788 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -82.74 -38.36 23.38 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.591 -0.693 . . . . 0.67000000000000004 110.871 -173.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.63 170.48 32.48 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 120.024 -1.084 . . . . 0.51000000000000001 110.447 177.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.4 p -118.08 6.58 12.09 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.952 -0.734 . . . . 1.29 110.737 174.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -48.94 -25.96 2.23 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.635 -0.666 . . . . 2.6899999999999999 112.584 -166.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -64.87 -59.29 4.36 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.201 -0.937 . . . . 2.1400000000000001 110.629 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 58.1 mtp85 -94.43 10.26 35.14 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.64 -0.662 . . . . 5.5300000000000002 111.38 176.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -59.74 174.02 0.51 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.237 -0.914 . . . . 2.1400000000000001 111.466 -169.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.1 m -78.95 164.42 24.43 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.647 -0.501 . . . . 3.5 109.647 173.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -77.44 3.45 13.33 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.653 -0.654 . . . . 4.3700000000000001 111.344 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -97.5 154.21 17.65 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.203 -0.936 . . . . 4.3600000000000003 109.691 171.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -68.08 137.34 54.91 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.582 -0.699 . . . . 3.8900000000000001 110.607 -175.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.9 mt -117.1 136.56 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.638 -0.664 . . . . 2.7400000000000002 109.507 176.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.35 138.89 36.15 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.693 -0.629 . . . . 2.98 110.124 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -63.09 149.13 92.39 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 O-C-N 123.362 1.19 . . . . 2.2599999999999998 110.543 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -96.49 115.0 26.71 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.641 -0.662 . . . . 3.1600000000000001 110.097 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.9 m -85.66 -33.27 21.61 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.687 -0.633 . . . . 2.4100000000000001 110.331 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -62.56 141.76 58.3 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.679 -0.638 . . . . 3.1299999999999999 110.66 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.3 mm -96.86 147.36 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.761 -0.587 . . . . 1.2 109.719 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -93.93 114.98 27.3 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.614 -0.679 . . . . 1.21 110.192 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -51.12 -42.18 60.53 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.865 -0.522 . . . . 1.8600000000000001 111.678 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -152.58 129.19 10.77 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.606 -0.684 . . . . 0.76000000000000001 110.272 -174.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 78.3 mt -128.58 128.74 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.662 -0.649 . . . . 1.04 109.823 172.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.1 tp -90.79 137.08 32.64 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.893 -0.504 . . . . 1.04 109.932 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.456 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 3.2 m-85 -136.29 130.12 32.47 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.557 -0.714 . . . . 0.33000000000000002 110.605 -175.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.7 mtm-85 -91.07 147.88 22.77 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.678 -0.639 . . . . 3.1299999999999999 110.258 173.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.03 -26.46 61.02 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 110.558 -1.017 . . . . 0.14999999999999999 110.558 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.3 m -65.7 -39.79 91.62 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.464 -1.021 . . . . 1.52 110.989 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.68 -32.95 31.52 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.395 -0.816 . . . . 1.0900000000000001 110.859 -174.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.456 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 8.4 mt -103.07 139.35 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.472 -0.768 . . . . 1.0800000000000001 110.101 177.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.5 tttp -106.26 -20.05 13.51 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 120.571 -0.452 . . . . 2.5800000000000001 111.676 -166.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -150.92 136.38 17.84 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 118.996 -1.082 . . . . 1.03 111.342 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.5 tt -133.6 143.42 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.829 -0.434 . . . . 1.1100000000000001 109.829 177.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -146.71 136.93 23.6 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.624 -0.672 . . . . 3.5299999999999998 110.297 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.0 t -87.46 144.4 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.562 -0.711 . . . . 2.2000000000000002 109.777 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.4 t . . . . . 0 N--CA 1.497 1.893 0 O-C-N 121.672 -0.643 . . . . 1.6399999999999999 109.74 -179.903 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 N--CA 1.501 2.094 0 CA-C-O 121.003 0.43 . . . . 1.5700000000000001 110.836 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.61 -1.95 84.25 Favored Glycine 0 N--CA 1.497 2.706 0 C-N-CA 120.708 -0.758 . . . . 0.54000000000000004 111.798 176.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.3 m -63.29 145.11 56.23 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.039 -1.271 . . . . 0.83999999999999997 110.445 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.9 pttt -82.18 125.15 30.57 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.73 -0.606 . . . . 2.1200000000000001 110.269 176.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 87.1 mt -120.97 143.42 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.499 -0.751 . . . . 1.05 110.059 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.9 t -102.5 137.22 41.02 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.35 -0.611 . . . . 0.85999999999999999 109.35 174.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 13.9 tp -133.8 127.1 31.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.673 -0.642 . . . . 1.03 110.268 -169.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.6 mt -107.05 118.19 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.55 -0.719 . . . . 1.02 109.732 -178.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m -93.08 157.82 16.1 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.022 0.439 . . . . 0.63 111.212 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -53.76 -13.91 0.81 Allowed 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 112.839 0.681 . . . . 2.9900000000000002 112.839 -171.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.15 20.78 4.11 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.154 -0.966 . . . . 1.05 110.416 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 53.93 34.28 19.18 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.54 -0.725 . . . . 0.80000000000000004 109.886 -174.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.4 mt -102.59 141.88 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 109.128 -0.693 . . . . 1.0800000000000001 109.128 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -104.74 119.87 40.02 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.999 -0.68 . . . . 2.96 109.927 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -114.28 149.53 35.79 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.086 -0.709 . . . . 0.81999999999999995 109.086 174.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -140.52 140.53 35.26 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.498 -0.751 . . . . 1.54 109.628 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.68 173.37 43.3 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 119.801 -1.19 . . . . 0.070000000000000007 110.541 -175.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -84.89 137.26 33.24 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.906 -0.761 . . . . 2.5 110.543 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 14.9 tp -66.09 117.66 8.73 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.589 -0.695 . . . . 1.0900000000000001 110.6 175.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -100.05 -50.08 4.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.621 -0.675 . . . . 0.93000000000000005 110.562 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.8 p -154.44 156.95 37.71 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.696 -0.628 . . . . 1.04 110.293 -177.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.7 p -142.27 146.32 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.755 -0.591 . . . . 1.05 110.085 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -128.12 100.95 22.92 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.716 -0.615 . . . . 0.91000000000000003 109.507 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.31 -42.02 30.75 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 O-C-N 123.652 1.343 . . . . 0.84999999999999998 110.734 -174.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -80.77 -23.88 39.03 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.379 -0.825 . . . . 2.7599999999999998 110.148 -171.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -87.33 1.11 54.26 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.525 -0.734 . . . . 1.5900000000000001 111.294 173.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 37.2 m 49.78 38.52 15.82 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.079 -1.013 . . . . 1.24 111.195 -176.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.0 p -135.77 155.44 50.36 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.405 -0.81 . . . . 0.96999999999999997 110.399 -174.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.7 pt -142.1 162.0 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.715 -0.616 . . . . 0.98999999999999999 110.06 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.14 128.42 30.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.61 -0.681 . . . . 0.92000000000000004 109.722 176.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 84.2 mt -109.81 146.35 35.18 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.579 -0.526 . . . . 1.05 109.579 -178.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.3 p -118.29 152.54 35.57 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.12 -0.696 . . . . 0.68999999999999995 109.12 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.6 p 45.65 84.08 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 121.489 0.662 . . . . 0.81000000000000005 110.238 -171.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.0 p -134.63 150.46 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 109.774 -0.454 . . . . 1.03 109.774 -178.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -135.72 153.23 51.65 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.697 -0.627 . . . . 3.0499999999999998 109.967 178.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.8 p -106.57 139.21 41.38 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.686 -0.634 . . . . 0.71999999999999997 109.788 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -82.74 -38.36 23.38 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.591 -0.693 . . . . 0.67000000000000004 110.871 -173.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.63 170.48 32.48 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 120.024 -1.084 . . . . 0.51000000000000001 110.447 177.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.4 p -118.08 6.58 12.09 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.952 -0.734 . . . . 1.29 110.737 174.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -48.94 -25.96 2.23 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.635 -0.666 . . . . 2.6899999999999999 112.584 -166.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -64.87 -59.29 4.36 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.201 -0.937 . . . . 2.1400000000000001 110.629 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 58.1 mtp85 -94.43 10.26 35.14 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.64 -0.662 . . . . 5.5300000000000002 111.38 176.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -59.74 174.02 0.51 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.237 -0.914 . . . . 2.1400000000000001 111.466 -169.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.1 m -78.95 164.42 24.43 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.647 -0.501 . . . . 3.5 109.647 173.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -77.44 3.45 13.33 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.653 -0.654 . . . . 4.3700000000000001 111.344 -178.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -97.5 154.21 17.65 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.203 -0.936 . . . . 4.3600000000000003 109.691 171.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -68.08 137.34 54.91 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.582 -0.699 . . . . 3.8900000000000001 110.607 -175.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.9 mt -117.1 136.56 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.638 -0.664 . . . . 2.7400000000000002 109.507 176.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.35 138.89 36.15 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.693 -0.629 . . . . 2.98 110.124 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -63.09 149.13 92.39 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 O-C-N 123.362 1.19 . . . . 2.2599999999999998 110.543 178.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -96.49 115.0 26.71 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.641 -0.662 . . . . 3.1600000000000001 110.097 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.9 m -85.66 -33.27 21.61 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.687 -0.633 . . . . 2.4100000000000001 110.331 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -62.56 141.76 58.3 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.679 -0.638 . . . . 3.1299999999999999 110.66 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.3 mm -96.86 147.36 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.761 -0.587 . . . . 1.2 109.719 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -93.93 114.98 27.3 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.614 -0.679 . . . . 1.21 110.192 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -51.12 -42.18 60.53 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.865 -0.522 . . . . 1.8600000000000001 111.678 178.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -152.58 129.19 10.77 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.606 -0.684 . . . . 0.76000000000000001 110.272 -174.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 78.3 mt -128.58 128.74 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.662 -0.649 . . . . 1.04 109.823 172.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.1 tp -90.79 137.08 32.64 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.893 -0.504 . . . . 1.04 109.932 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.456 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 3.2 m-85 -136.29 130.12 32.47 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.557 -0.714 . . . . 0.33000000000000002 110.605 -175.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.7 mtm-85 -91.07 147.88 22.77 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.678 -0.639 . . . . 3.1299999999999999 110.258 173.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.03 -26.46 61.02 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 110.558 -1.017 . . . . 0.14999999999999999 110.558 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.3 m -65.7 -39.79 91.62 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.464 -1.021 . . . . 1.52 110.989 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.68 -32.95 31.52 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.395 -0.816 . . . . 1.0900000000000001 110.859 -174.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.456 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 8.4 mt -103.07 139.35 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.472 -0.768 . . . . 1.0800000000000001 110.101 177.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.5 tttp -106.26 -20.05 13.51 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 120.571 -0.452 . . . . 2.5800000000000001 111.676 -166.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -150.92 136.38 17.84 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 118.996 -1.082 . . . . 1.03 111.342 -177.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.5 tt -133.6 143.42 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.829 -0.434 . . . . 1.1100000000000001 109.829 177.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -146.71 136.93 23.6 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.624 -0.672 . . . . 3.5299999999999998 110.297 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.0 t -87.46 144.4 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.562 -0.711 . . . . 2.2000000000000002 109.777 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.4 t . . . . . 0 N--CA 1.497 1.893 0 O-C-N 121.672 -0.643 . . . . 1.6399999999999999 109.74 -179.903 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.2 mt . . . . . 0 N--CA 1.501 2.109 0 CA-C-O 120.95 0.405 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.76 -1.85 84.96 Favored Glycine 0 N--CA 1.496 2.66 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.722 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.8 m -61.38 143.21 56.18 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.101 -1.235 . . . . 0.0 110.413 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -82.2 128.95 34.67 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.692 -0.63 . . . . 0.0 110.494 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 86.1 mt -122.0 142.92 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.581 -0.699 . . . . 0.0 110.076 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.5 t -103.15 137.23 41.59 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 174.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 13.7 tp -134.78 125.4 26.84 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.673 -0.642 . . . . 0.0 110.301 -169.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 81.5 mt -107.09 117.97 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.538 -0.727 . . . . 0.0 109.696 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.2 m -92.65 157.77 16.3 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.059 0.457 . . . . 0.0 111.267 -177.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -54.07 -13.66 0.87 Allowed 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -171.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.1 20.73 4.12 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.163 -0.961 . . . . 0.0 110.416 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 54.13 34.28 19.73 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.481 -0.762 . . . . 0.0 109.836 -174.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.0 mt -102.94 141.3 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 55.1 ttt85 -104.61 119.84 39.92 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.997 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -114.79 149.65 36.64 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -140.42 140.49 35.45 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.556 -0.715 . . . . 0.0 109.478 175.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.3 172.01 41.48 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.688 -1.244 . . . . 0.0 110.681 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.3 mmt85 -84.85 138.51 32.51 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.919 -0.753 . . . . 0.0 110.522 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.8 tp -66.16 118.27 9.65 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.565 -0.709 . . . . 0.0 110.669 175.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -100.51 -50.14 4.0 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.623 -0.673 . . . . 0.0 110.385 176.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.8 p -154.3 153.58 31.91 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.741 -0.599 . . . . 0.0 110.263 -178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.4 p -142.3 145.45 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.729 -0.607 . . . . 0.0 110.052 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -128.94 100.9 20.3 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.669 -0.644 . . . . 0.0 109.554 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.51 -39.44 45.2 Favored 'Trans proline' 0 N--CA 1.489 1.24 0 O-C-N 123.533 1.281 . . . . 0.0 110.796 -175.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -80.6 -25.74 38.27 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.369 -0.832 . . . . 0.0 110.066 -171.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -87.41 1.49 53.23 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.555 -0.715 . . . . 0.0 111.22 173.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 38.6 m 49.61 38.68 15.49 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.091 -1.006 . . . . 0.0 111.343 -176.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.9 p -136.3 153.36 51.19 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.348 -0.845 . . . . 0.0 110.286 -174.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.9 pt -142.74 162.0 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.676 -0.64 . . . . 0.0 110.252 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.46 127.61 28.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.657 -0.652 . . . . 0.0 109.704 175.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 83.2 mt -109.94 146.77 34.64 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -177.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 96.0 p -118.13 153.42 33.83 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.7 p 45.65 85.01 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 121.476 0.655 . . . . 0.0 110.364 -172.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.5 p -134.53 150.41 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.95 -0.469 . . . . 0.0 109.753 -178.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -135.21 153.18 52.03 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.634 -0.666 . . . . 0.0 109.952 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 82.5 p -108.19 138.83 43.79 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.656 -0.652 . . . . 0.0 109.866 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -83.02 -38.29 22.79 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.654 -0.654 . . . . 0.0 110.859 -174.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.64 168.1 29.29 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.6 p -118.15 6.6 12.03 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.925 -0.75 . . . . 0.0 110.908 175.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -49.87 -25.27 3.01 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.563 -0.711 . . . . 0.0 112.781 -166.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -64.92 -59.34 4.29 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.134 -0.978 . . . . 0.0 110.671 -177.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.1 mtp180 -94.45 10.16 35.59 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.502 -0.749 . . . . 0.0 111.524 176.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.5 p-10 -58.63 174.06 0.36 Allowed 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.204 -0.935 . . . . 0.0 111.448 -170.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.0 m -78.85 164.42 24.5 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.935 -0.478 . . . . 0.0 109.759 175.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -77.55 4.89 10.13 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.642 -0.661 . . . . 0.0 111.289 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -95.84 166.03 12.0 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.226 -0.921 . . . . 0.0 109.591 168.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -80.74 132.1 35.5 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.607 -0.683 . . . . 0.0 110.488 -175.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.5 mt -114.27 134.35 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.715 -0.615 . . . . 0.0 109.443 176.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.38 146.01 38.88 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.629 -0.669 . . . . 0.0 110.154 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -63.07 149.37 91.72 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 O-C-N 123.399 1.21 . . . . 0.0 110.539 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -96.28 121.62 38.26 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.647 -0.658 . . . . 0.0 110.107 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.0 t -91.66 -32.55 15.42 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.708 -0.62 . . . . 0.0 110.356 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -62.59 140.49 58.66 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.641 -0.662 . . . . 0.0 110.569 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.9 mm -96.89 148.12 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.744 -0.597 . . . . 0.0 109.683 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -94.2 114.27 26.35 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.62 -0.675 . . . . 0.0 110.195 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -51.38 -42.42 61.37 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.754 -0.591 . . . . 0.0 111.585 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -152.87 129.88 11.06 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.665 -0.647 . . . . 0.0 110.219 -174.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.8 mt -128.87 129.06 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.701 -0.625 . . . . 0.0 109.87 172.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.0 tp -90.34 137.05 32.66 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.802 -0.561 . . . . 0.0 109.84 176.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.466 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 2.8 m-85 -134.55 128.2 32.82 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.699 -0.626 . . . . 0.0 110.563 -175.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -91.61 146.81 23.47 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.686 -0.634 . . . . 0.0 110.213 172.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.81 -26.55 60.57 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.1 t -65.36 -40.11 93.15 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.467 -1.019 . . . . 0.0 111.004 -177.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -81.55 -32.31 32.3 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.431 -0.793 . . . . 0.0 110.857 -174.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.466 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 6.9 mt -101.15 140.48 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.456 -0.778 . . . . 0.0 110.149 177.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -104.63 -20.34 13.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.938 -0.476 . . . . 0.0 111.492 -168.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -151.56 133.69 15.17 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.034 -1.041 . . . . 0.0 111.233 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.0 tt -131.87 143.81 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.908 -0.495 . . . . 0.0 109.756 176.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -145.76 130.16 17.74 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.597 -0.689 . . . . 0.0 110.257 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 51.4 t -88.36 143.55 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.684 -0.635 . . . . 0.0 109.781 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.9 t . . . . . 0 N--CA 1.497 1.901 0 O-C-N 121.567 -0.708 . . . . 0.0 109.674 179.471 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.0 mt . . . . . 0 N--CA 1.502 2.129 0 CA-C-O 120.985 0.421 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.6 -1.85 84.54 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.871 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 75.0 m -61.44 146.08 49.62 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.07 -1.253 . . . . 0.0 110.479 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.1 pttt -81.97 126.41 31.91 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.718 -0.613 . . . . 0.0 110.485 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 88.5 mt -123.91 143.96 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.605 -0.684 . . . . 0.0 110.177 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.6 t -102.65 137.26 41.11 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 175.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 13.8 tp -133.23 128.4 35.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.708 -0.62 . . . . 0.0 110.318 -170.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.1 mt -108.22 119.61 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.464 -0.772 . . . . 0.0 109.698 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.1 m -93.9 157.61 16.04 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.114 0.483 . . . . 0.0 111.222 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -54.12 -13.56 0.86 Allowed 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -172.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.84 20.41 4.16 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.148 -0.97 . . . . 0.0 110.485 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 53.91 34.04 18.6 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.38 -0.825 . . . . 0.0 109.804 -174.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 67.3 mt -102.2 141.82 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -105.37 119.85 40.11 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.007 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -114.74 148.72 37.94 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 174.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -140.09 140.51 36.1 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.476 -0.765 . . . . 0.0 109.603 175.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.92 173.52 42.22 Favored Glycine 0 N--CA 1.495 2.597 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.48 -175.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -84.73 136.5 33.69 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.889 -0.771 . . . . 0.0 110.501 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.7 tp -66.14 116.33 7.1 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.548 -0.72 . . . . 0.0 110.537 175.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -99.14 -49.99 4.3 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.677 -0.639 . . . . 0.0 110.364 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.1 p -152.97 154.87 35.86 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.655 -0.653 . . . . 0.0 110.25 -178.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.6 p -142.23 145.61 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.686 -0.634 . . . . 0.0 110.104 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -127.83 101.54 23.26 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.627 -0.671 . . . . 0.0 109.506 177.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.44 -41.82 30.94 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 O-C-N 123.626 1.329 . . . . 0.0 110.868 -174.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -80.59 -24.55 39.08 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.301 -0.874 . . . . 0.0 110.214 -171.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -87.42 1.13 54.29 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.412 -0.805 . . . . 0.0 111.235 173.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 39.6 m 49.75 39.26 17.43 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.153 -0.967 . . . . 0.0 111.243 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.8 p -135.82 153.79 51.4 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.407 -0.808 . . . . 0.0 110.38 -174.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.9 pt -142.62 162.02 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.708 -0.62 . . . . 0.0 110.193 177.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.61 129.54 33.02 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.63 -0.669 . . . . 0.0 109.82 175.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 50.6 mt -109.84 144.23 38.59 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -178.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 99.9 p -116.24 151.41 35.83 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.8 p 46.1 87.43 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 CA-C-O 121.462 0.648 . . . . 0.0 110.267 -172.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.3 p -134.62 147.79 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.968 -0.458 . . . . 0.0 109.837 -178.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -127.33 153.08 46.63 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.821 -0.549 . . . . 0.0 109.703 178.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.8 p -109.39 136.74 48.33 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.697 -0.627 . . . . 0.0 109.824 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -82.93 -38.19 23.13 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.624 -0.672 . . . . 0.0 110.847 -174.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.58 167.13 27.8 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 176.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 p -118.16 6.6 12.03 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.976 -0.72 . . . . 0.0 110.977 175.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -48.99 -25.46 1.98 Allowed 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.498 -0.752 . . . . 0.0 112.417 -169.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -64.4 -59.2 4.63 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.225 -0.922 . . . . 0.0 110.622 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -94.34 10.23 35.07 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.628 -0.67 . . . . 0.0 111.373 177.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -61.08 174.02 0.72 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.241 -0.912 . . . . 0.0 111.279 -170.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 39.9 p -78.88 164.5 24.41 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.914 -0.491 . . . . 0.0 109.917 175.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -77.52 3.89 12.47 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.004 176.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -97.34 165.28 12.1 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.181 -0.95 . . . . 0.0 109.621 167.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -68.51 142.47 55.26 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.524 -0.735 . . . . 0.0 110.388 -177.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 49.9 mm -112.67 134.95 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.704 -0.622 . . . . 0.0 109.675 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -97.96 109.91 53.48 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.731 -0.606 . . . . 0.0 110.201 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -67.49 147.16 76.54 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 O-C-N 123.379 1.199 . . . . 0.0 110.409 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -96.54 119.77 35.63 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.721 -0.612 . . . . 0.0 110.222 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.6 p -68.26 -30.65 69.74 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.707 -0.62 . . . . 0.0 110.422 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -62.4 145.78 53.07 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.551 -0.718 . . . . 0.0 110.595 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.87 154.71 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.745 -0.597 . . . . 0.0 109.699 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -94.13 113.68 25.68 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.667 -0.645 . . . . 0.0 110.17 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -51.54 -40.52 59.83 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.753 -0.592 . . . . 0.0 111.765 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -153.38 130.84 11.37 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.669 -0.644 . . . . 0.0 110.177 -175.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 76.2 mt -129.75 128.22 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.725 -0.609 . . . . 0.0 109.791 172.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.6 tp -90.46 136.99 32.71 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.851 -0.53 . . . . 0.0 109.805 176.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.466 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 3.3 m-85 -135.81 130.62 34.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.661 -0.649 . . . . 0.0 110.58 -175.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -91.68 149.66 21.52 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.678 -0.639 . . . . 0.0 110.343 173.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.05 -24.55 60.86 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.0 t -66.81 -42.14 86.39 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.481 -1.011 . . . . 0.0 111.056 -175.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -82.77 -33.04 27.49 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.396 -0.815 . . . . 0.0 110.879 -175.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.466 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 13.8 mt -100.72 138.4 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.423 -0.798 . . . . 0.0 110.143 177.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 50.3 tptt -108.0 -19.12 13.61 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.789 -166.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -149.71 135.86 18.89 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 118.935 -1.106 . . . . 0.0 111.319 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.2 tt -134.08 144.47 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.868 -0.52 . . . . 0.0 109.886 177.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -146.1 133.28 20.47 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.608 -0.682 . . . . 0.0 110.288 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 51.2 t -87.67 145.35 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.681 -0.637 . . . . 0.0 109.736 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.1 t . . . . . 0 N--CA 1.498 1.952 0 O-C-N 121.641 -0.662 . . . . 0.0 109.748 -179.423 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.9 mt . . . . . 0 N--CA 1.501 2.121 0 CA-C-O 120.948 0.404 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.63 -1.79 84.83 Favored Glycine 0 N--CA 1.496 2.685 0 C-N-CA 120.49 -0.862 . . . . 0.0 111.73 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 58.5 m -60.88 153.66 24.18 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.119 -1.224 . . . . 0.0 110.541 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -81.56 123.58 28.78 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.715 -0.616 . . . . 0.0 110.583 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 89.0 mt -120.81 145.27 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.508 -0.745 . . . . 0.0 110.066 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.0 t -102.54 137.31 40.94 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 175.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 13.8 tp -131.71 125.6 32.44 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.707 -0.621 . . . . 0.0 110.146 -170.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.3 mt -106.03 119.05 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.552 -0.718 . . . . 0.0 109.632 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.3 m -94.33 157.72 15.9 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.068 0.461 . . . . 0.0 111.227 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -53.43 -14.73 0.84 Allowed 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -172.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.32 20.3 3.89 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.097 -1.002 . . . . 0.0 110.463 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 54.0 34.08 18.93 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.478 -0.764 . . . . 0.0 109.796 -174.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.5 mt -102.0 141.41 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 63.8 ttt-85 -105.5 119.81 40.05 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.887 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -114.15 150.01 34.81 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -140.68 140.46 34.95 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.42 -0.8 . . . . 0.0 109.647 175.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.6 172.97 43.23 Favored Glycine 0 N--CA 1.495 2.611 0 C-N-CA 119.716 -1.231 . . . . 0.0 110.538 -175.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -84.96 135.53 34.0 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.893 -0.769 . . . . 0.0 110.576 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.0 tp -66.1 117.93 9.13 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.542 -0.724 . . . . 0.0 110.595 175.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -99.52 -50.13 4.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.573 -0.704 . . . . 0.0 110.481 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.0 p -153.93 156.48 37.59 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.734 -0.604 . . . . 0.0 110.32 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.3 p -142.32 145.86 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.708 -0.62 . . . . 0.0 110.034 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -128.25 99.14 24.97 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.659 -0.651 . . . . 0.0 109.55 177.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -59.5 -40.86 62.54 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 O-C-N 123.553 1.291 . . . . 0.0 110.937 -175.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -80.58 -25.76 38.3 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.338 -0.852 . . . . 0.0 110.181 -171.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -87.43 1.87 52.14 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.538 -0.726 . . . . 0.0 111.167 173.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.3 m 49.54 38.41 14.61 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.079 -1.013 . . . . 0.0 111.197 -176.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.5 p -135.71 154.76 51.16 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.415 -0.803 . . . . 0.0 110.438 -174.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.4 pt -142.26 162.02 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.732 -0.605 . . . . 0.0 110.131 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.82 128.28 30.46 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.592 -0.693 . . . . 0.0 109.765 176.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.3 mt -109.86 146.37 35.2 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.9 p -117.68 151.58 36.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.623 -0.673 . . . . 0.0 109.234 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 46.8 p 45.98 86.71 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 121.472 0.653 . . . . 0.0 110.291 -172.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.8 p -134.58 147.76 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.939 -0.476 . . . . 0.0 109.873 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -126.19 153.06 45.17 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.732 -0.605 . . . . 0.0 109.798 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.3 p -108.79 134.39 51.55 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.665 -0.647 . . . . 0.0 109.794 177.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -83.02 -38.28 22.8 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.623 -0.673 . . . . 0.0 111.011 -173.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.66 168.74 30.25 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.993 -1.099 . . . . 0.0 110.54 176.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.14 6.61 12.04 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 122.008 -0.701 . . . . 0.0 110.997 175.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.3 tp10 -48.95 -25.95 2.23 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.546 -0.721 . . . . 0.0 112.455 -168.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -65.76 -59.21 4.13 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.335 -0.853 . . . . 0.0 110.421 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.9 mmp_? -94.19 10.14 35.09 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.68 -0.638 . . . . 0.0 111.319 177.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.9 p-10 -59.47 166.18 2.49 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.243 -0.91 . . . . 0.0 111.418 -170.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.0 m -78.95 164.44 24.42 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.949 -0.47 . . . . 0.0 109.765 174.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -77.56 4.12 12.01 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.616 -0.678 . . . . 0.0 111.268 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -96.81 158.35 15.47 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.174 -0.954 . . . . 0.0 109.632 167.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -70.77 140.15 51.23 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.489 -0.757 . . . . 0.0 110.375 -176.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 81.1 mt -115.28 134.9 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.664 -0.647 . . . . 0.0 109.616 177.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.05 109.92 53.69 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.736 -0.603 . . . . 0.0 110.133 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -66.61 146.54 79.63 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 O-C-N 123.343 1.18 . . . . 0.0 110.379 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -95.59 124.01 39.42 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.667 -0.645 . . . . 0.0 110.232 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.5 p -67.67 -29.35 68.61 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.675 -0.641 . . . . 0.0 110.492 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -62.02 145.93 51.67 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.55 -0.719 . . . . 0.0 110.538 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.91 156.24 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.749 -0.594 . . . . 0.0 109.747 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -93.65 115.14 27.58 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.669 -0.644 . . . . 0.0 110.087 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -51.25 -42.98 61.4 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.767 -0.583 . . . . 0.0 111.697 178.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -152.73 129.1 10.59 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.624 -0.673 . . . . 0.0 110.244 -174.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 75.4 mt -128.0 129.24 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.665 -0.647 . . . . 0.0 109.871 172.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.0 tp -90.32 137.04 32.67 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.802 -0.562 . . . . 0.0 109.797 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.464 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 2.8 m-85 -135.19 130.33 35.15 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.647 -0.658 . . . . 0.0 110.544 -175.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.1 mtm-85 -91.47 148.26 22.43 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.713 -0.617 . . . . 0.0 110.322 173.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.69 -24.03 59.37 Favored Glycine 0 N--CA 1.498 2.816 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 178.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.0 p -67.82 -42.11 82.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.361 -1.082 . . . . 0.0 111.089 -175.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -82.49 -32.41 28.8 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.398 -0.814 . . . . 0.0 110.894 -175.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.464 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 14.8 mt -99.56 141.48 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.333 -0.854 . . . . 0.0 110.18 176.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -106.15 -24.61 12.3 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 120.554 -0.459 . . . . 0.0 111.447 -166.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -150.8 136.19 17.84 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 119.037 -1.065 . . . . 0.0 111.471 -176.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.4 tt -131.83 137.77 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -143.94 143.33 31.2 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.634 -0.666 . . . . 0.0 110.191 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.4 m -84.87 147.02 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.638 -0.664 . . . . 0.0 110.246 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.5 t . . . . . 0 N--CA 1.497 1.89 0 O-C-N 121.569 -0.707 . . . . 0.0 109.89 -178.97 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 80.6 mt . . . . . 0 N--CA 1.501 2.079 0 CA-C-O 120.999 0.428 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.62 -1.83 84.66 Favored Glycine 0 N--CA 1.497 2.708 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.679 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 58.2 m -60.86 155.5 19.48 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.074 -1.251 . . . . 0.0 110.579 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.19 122.25 27.66 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.805 -0.559 . . . . 0.0 110.366 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 90.3 mt -119.96 144.38 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.515 -0.741 . . . . 0.0 110.114 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.7 t -102.83 137.24 41.3 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 175.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 14.2 tp -133.33 125.47 29.28 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.789 -0.569 . . . . 0.0 110.183 -169.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.1 mt -106.52 117.97 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.561 -0.712 . . . . 0.0 109.654 -178.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m -93.35 157.74 16.08 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.078 0.466 . . . . 0.0 111.239 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -53.89 -13.95 0.87 Allowed 'General case' 0 N--CA 1.507 2.392 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -171.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.18 20.91 4.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.169 -0.957 . . . . 0.0 110.444 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 54.15 34.42 20.08 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.486 -0.759 . . . . 0.0 109.882 -174.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.1 mt -102.86 141.24 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -104.85 119.73 39.71 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.905 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -114.47 148.29 38.04 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 174.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -139.05 140.51 38.1 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.573 -0.704 . . . . 0.0 109.592 175.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.54 173.11 43.21 Favored Glycine 0 N--CA 1.496 2.659 0 C-N-CA 119.794 -1.193 . . . . 0.0 110.386 -175.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 -85.95 136.16 33.38 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.814 -0.815 . . . . 0.0 110.604 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.3 tp -66.13 119.5 11.55 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.62 -0.675 . . . . 0.0 110.675 176.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -100.11 -50.01 4.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.693 -0.629 . . . . 0.0 110.446 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.5 p -153.77 154.36 33.88 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.622 -0.674 . . . . 0.0 110.384 -178.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.4 p -142.28 146.1 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.696 -0.627 . . . . 0.0 110.09 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -129.03 101.26 19.76 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.61 -0.681 . . . . 0.0 109.574 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.42 -41.08 35.27 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 O-C-N 123.628 1.33 . . . . 0.0 110.785 -174.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -80.61 -23.98 39.42 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.396 -0.815 . . . . 0.0 110.187 -172.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -87.37 0.88 54.8 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.492 -0.755 . . . . 0.0 111.14 173.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.3 m 49.81 38.14 15.02 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.139 -0.976 . . . . 0.0 111.205 -176.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.5 p -136.68 152.94 50.95 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.352 -0.842 . . . . 0.0 110.405 -174.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.8 pt -142.75 162.02 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.714 -0.616 . . . . 0.0 110.164 178.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.22 128.34 29.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.593 -0.692 . . . . 0.0 109.786 175.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.7 mt -109.96 148.13 32.18 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 95.1 p -120.26 152.8 37.26 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.628 -0.67 . . . . 0.0 109.214 -177.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 53.0 p 44.94 87.34 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 CA-C-O 121.392 0.615 . . . . 0.0 110.385 -172.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.2 p -134.59 145.18 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 CA-C-O 121.155 0.503 . . . . 0.0 110.005 -177.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -120.46 153.11 37.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.688 -0.633 . . . . 0.0 109.755 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 86.3 p -111.27 133.44 53.6 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.629 -0.669 . . . . 0.0 109.856 177.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -83.05 -38.49 22.48 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.052 -173.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.53 171.98 34.14 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.993 -1.099 . . . . 0.0 110.445 177.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.2 p -117.97 6.48 12.18 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.797 -0.826 . . . . 0.0 110.915 173.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -51.06 -24.1 3.61 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.507 -0.746 . . . . 0.0 112.795 -167.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.08 -59.44 4.13 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.193 -0.942 . . . . 0.0 110.706 -176.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -94.5 10.21 35.49 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.575 -0.703 . . . . 0.0 111.444 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 40.2 p-10 -58.76 174.04 0.37 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.189 -0.944 . . . . 0.0 111.419 -170.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.0 m -78.92 164.48 24.4 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.957 -0.464 . . . . 0.0 109.774 175.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -77.5 4.71 10.48 Favored 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.277 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -95.98 166.07 11.95 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.176 -0.952 . . . . 0.0 109.622 168.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -80.6 133.19 35.72 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.594 -0.691 . . . . 0.0 110.399 -175.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.6 mt -113.9 135.35 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.625 -0.672 . . . . 0.0 109.54 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.88 146.11 38.09 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.642 -0.661 . . . . 0.0 110.138 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -68.78 149.37 72.86 Favored 'Trans proline' 0 N--CA 1.487 1.104 0 O-C-N 123.55 1.289 . . . . 0.0 110.307 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -92.71 107.4 19.19 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.631 -0.668 . . . . 0.0 110.074 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.9 m -68.01 -35.72 78.77 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.699 -0.625 . . . . 0.0 110.345 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -60.99 133.47 56.13 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.658 -0.651 . . . . 0.0 110.809 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.7 mm -96.97 153.73 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.659 -0.651 . . . . 0.0 109.606 178.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -96.76 112.47 24.21 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.598 -0.689 . . . . 0.0 110.446 -175.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -51.67 -41.02 61.09 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.678 -0.639 . . . . 0.0 111.496 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -153.02 130.31 11.28 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.604 -0.685 . . . . 0.0 110.124 -175.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 77.4 mt -127.96 128.34 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.644 -0.66 . . . . 0.0 109.804 172.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.2 tp -90.29 137.04 32.67 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.867 -0.52 . . . . 0.0 109.753 175.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.456 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 3.0 m-85 -137.03 130.54 31.54 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.663 -0.648 . . . . 0.0 110.6 -174.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -91.57 147.81 22.74 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.705 -0.622 . . . . 0.0 110.301 173.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.11 -26.8 61.66 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.4 m -65.56 -39.39 91.62 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.453 -1.028 . . . . 0.0 110.944 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.69 -32.54 31.67 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.445 -0.785 . . . . 0.0 110.807 -174.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.456 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 8.1 mt -102.97 140.23 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.422 -0.799 . . . . 0.0 110.157 177.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -106.34 -19.7 13.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.961 -0.462 . . . . 0.0 111.647 -167.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -150.41 133.61 16.25 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 119.008 -1.077 . . . . 0.0 111.379 -178.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.3 tt -132.44 138.77 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.931 -0.48 . . . . 0.0 109.799 176.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.1 mtm180 -147.07 145.95 29.81 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.598 -0.688 . . . . 0.0 110.422 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.8 m -84.83 147.1 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.664 -0.647 . . . . 0.0 110.328 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.499 1.996 0 O-C-N 121.559 -0.713 . . . . 0.0 110.172 -178.358 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.0 mt . . . . . 0 N--CA 1.501 2.114 0 CA-C-O 120.993 0.425 . . . . 0.0 110.602 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.72 -1.94 84.58 Favored Glycine 0 N--CA 1.496 2.659 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.793 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 74.1 m -61.13 148.1 41.74 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.097 -1.237 . . . . 0.0 110.46 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -81.59 125.18 30.22 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.716 -0.615 . . . . 0.0 110.536 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 90.0 mt -120.91 145.05 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.555 -0.716 . . . . 0.0 110.014 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.6 t -102.93 137.19 41.45 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 13.5 tp -133.12 124.86 28.32 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.875 -0.515 . . . . 0.0 110.211 -169.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.3 mt -105.75 118.49 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.633 -0.667 . . . . 0.0 109.661 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.1 m -93.1 157.8 16.1 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.112 0.482 . . . . 0.0 111.235 -176.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -53.8 -14.2 0.89 Allowed 'General case' 0 N--CA 1.51 2.525 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -171.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.63 20.08 4.23 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.207 -0.933 . . . . 0.0 110.412 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 54.38 35.07 22.18 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.448 -0.782 . . . . 0.0 109.817 -175.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.2 mt -103.23 144.27 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 59.5 ttm-85 -105.06 119.87 40.09 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.073 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -114.2 150.12 34.75 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 174.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -141.48 140.52 33.55 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.484 -0.76 . . . . 0.0 109.648 175.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -169.28 172.86 43.6 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 119.607 -1.282 . . . . 0.0 110.575 -175.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -85.23 136.28 33.58 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.878 -0.778 . . . . 0.0 110.609 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.0 tp -66.3 119.53 11.71 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.634 -0.666 . . . . 0.0 110.694 175.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -100.13 -50.18 4.05 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.549 -0.719 . . . . 0.0 110.419 178.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.5 p -154.4 156.01 36.04 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.636 -0.665 . . . . 0.0 110.283 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.6 p -142.26 145.63 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.612 -0.68 . . . . 0.0 110.068 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -127.5 98.74 28.24 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.627 -0.671 . . . . 0.0 109.565 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -59.38 -42.05 52.58 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 O-C-N 123.597 1.314 . . . . 0.0 111.044 -175.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -80.74 -24.59 38.6 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.372 -0.83 . . . . 0.0 110.169 -171.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -87.12 1.15 53.9 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.509 -0.745 . . . . 0.0 111.245 173.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.4 m 49.82 37.91 14.53 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.122 -0.986 . . . . 0.0 111.203 -176.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.9 p -136.13 154.38 51.0 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.405 -0.809 . . . . 0.0 110.368 -174.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.9 pt -142.51 162.09 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.706 -0.621 . . . . 0.0 110.166 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.54 128.07 28.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.698 -0.627 . . . . 0.0 109.752 175.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 90.6 mt -109.92 148.95 30.63 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 96.6 p -119.65 152.18 37.52 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.6 p 45.58 83.46 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.226 0 CA-C-O 121.54 0.686 . . . . 0.0 110.382 -172.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.9 p -134.59 150.48 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -136.07 153.21 51.4 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.598 -0.689 . . . . 0.0 110.063 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 81.7 p -107.25 137.52 45.15 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.74 -0.6 . . . . 0.0 109.56 177.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -82.76 -38.47 23.18 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.92 -172.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.38 167.37 27.96 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 175.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.3 p -118.28 6.24 11.92 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.807 -0.819 . . . . 0.0 110.913 172.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -52.71 -26.22 13.36 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.49 -0.756 . . . . 0.0 112.095 -167.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -66.22 -59.16 4.0 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.393 -0.817 . . . . 0.0 110.273 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -94.28 10.18 35.15 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.736 -0.602 . . . . 0.0 111.342 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 52.9 p-10 -57.68 174.06 0.26 Allowed 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.29 -0.881 . . . . 0.0 111.499 -171.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.5 m -79.0 164.55 24.29 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -77.44 3.24 13.84 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.584 -0.698 . . . . 0.0 111.227 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -100.46 165.99 11.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.225 -0.922 . . . . 0.0 109.567 169.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -66.98 136.83 55.93 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.579 -0.7 . . . . 0.0 110.515 -175.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.2 mm -113.52 137.26 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.679 -0.638 . . . . 0.0 109.604 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -96.83 109.94 51.13 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.664 -0.648 . . . . 0.0 110.21 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -67.49 145.06 69.48 Favored 'Trans proline' 0 N--CA 1.488 1.16 0 O-C-N 123.395 1.208 . . . . 0.0 110.288 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -97.36 114.42 26.22 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.648 -0.657 . . . . 0.0 110.265 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 87.3 p -77.51 -29.18 52.34 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.655 -0.653 . . . . 0.0 110.478 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -62.13 151.24 36.31 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.601 -0.687 . . . . 0.0 110.669 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.5 mm -96.75 144.92 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.751 -0.593 . . . . 0.0 109.747 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -94.32 114.59 26.68 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.56 -0.712 . . . . 0.0 110.218 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -50.95 -40.51 57.64 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.824 -0.547 . . . . 0.0 111.812 178.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -152.57 130.12 11.47 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.714 -0.616 . . . . 0.0 110.289 -174.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 76.3 mt -130.09 129.53 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.641 -0.662 . . . . 0.0 109.793 172.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.2 tp -90.27 137.02 32.69 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.814 -0.554 . . . . 0.0 109.864 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.462 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 2.5 m-85 -135.17 129.28 33.56 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.658 -0.651 . . . . 0.0 110.562 -175.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 71.2 mtp85 -91.26 146.77 23.54 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.703 -0.623 . . . . 0.0 110.249 173.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.8 -26.52 60.49 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 110.539 -1.025 . . . . 0.0 110.539 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.2 m -65.84 -39.4 90.76 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.527 -0.984 . . . . 0.0 110.953 -177.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.67 -31.71 32.12 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.533 -0.73 . . . . 0.0 110.824 -174.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.462 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 7.9 mt -102.32 142.42 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.443 -0.786 . . . . 0.0 110.191 177.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -104.46 -23.67 13.13 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.378 -167.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -151.99 135.34 15.98 Favored 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 119.146 -1.022 . . . . 0.0 111.446 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.6 tt -131.81 140.8 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.906 -0.496 . . . . 0.0 109.775 176.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -146.91 141.56 26.66 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.519 -0.738 . . . . 0.0 110.349 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.5 t -86.85 145.75 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.679 -0.638 . . . . 0.0 109.711 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.3 t . . . . . 0 N--CA 1.497 1.904 0 O-C-N 121.583 -0.698 . . . . 0.0 109.758 -178.676 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.1 mt . . . . . 0 N--CA 1.5 2.068 0 CA-C-O 120.972 0.415 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.68 -1.92 84.55 Favored Glycine 0 N--CA 1.497 2.753 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.788 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 63.8 m -62.0 155.27 24.26 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.168 -1.195 . . . . 0.0 110.4 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.8 pttt -81.21 127.98 33.28 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 120.191 -0.604 . . . . 0.0 110.384 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 87.7 mt -121.62 142.95 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.563 -0.711 . . . . 0.0 110.03 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.0 t -102.99 137.29 41.38 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 175.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 13.9 tp -134.33 123.88 24.9 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.736 -0.602 . . . . 0.0 110.164 -169.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.5 mt -106.33 118.16 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.574 -0.704 . . . . 0.0 109.609 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 62.3 m -92.47 157.81 16.37 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 120.963 0.411 . . . . 0.0 111.245 -176.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -53.56 -13.98 0.75 Allowed 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 -172.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.96 20.58 4.13 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.115 -0.991 . . . . 0.0 110.412 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 53.43 34.37 18.02 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.395 -0.816 . . . . 0.0 109.813 -174.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.1 mt -101.24 141.99 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -104.68 119.86 39.98 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.958 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -115.0 149.28 37.67 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 174.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -140.95 140.52 34.44 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.377 -0.827 . . . . 0.0 109.706 174.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.35 172.17 41.56 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 119.814 -1.184 . . . . 0.0 110.559 -175.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -84.7 139.41 32.03 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.933 -0.745 . . . . 0.0 110.611 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.0 tp -66.11 117.9 9.09 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.718 -0.614 . . . . 0.0 110.7 175.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -100.11 -50.06 4.1 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.561 -0.712 . . . . 0.0 110.333 177.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.9 p -153.81 156.05 36.94 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.684 -0.635 . . . . 0.0 110.271 -178.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.5 p -142.24 145.28 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.74 -0.6 . . . . 0.0 110.18 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -129.03 101.88 19.38 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.675 -0.641 . . . . 0.0 109.434 176.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.83 -41.78 28.35 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 O-C-N 123.562 1.296 . . . . 0.0 110.919 -173.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -80.66 -24.97 38.57 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.332 -0.855 . . . . 0.0 110.227 -170.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -87.79 1.75 53.07 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.484 -0.76 . . . . 0.0 111.293 173.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 40.3 m 49.87 41.1 22.14 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.125 -0.984 . . . . 0.0 111.218 -176.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.5 p -135.5 153.45 51.73 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.327 -0.858 . . . . 0.0 110.53 -174.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.4 pt -141.74 162.0 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.66 -0.65 . . . . 0.0 110.117 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.01 127.87 29.31 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.719 -0.613 . . . . 0.0 109.669 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.5 mt -109.87 145.07 37.44 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 -177.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 99.2 p -116.47 151.82 35.3 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.8 p 45.92 85.47 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 121.5 0.667 . . . . 0.0 110.356 -171.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.9 p -134.65 149.1 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -131.68 153.01 50.44 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.623 -0.673 . . . . 0.0 109.891 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 96.9 p -112.01 140.64 46.52 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.741 -0.599 . . . . 0.0 109.891 177.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -83.06 -38.5 22.44 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.613 -0.679 . . . . 0.0 111.175 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.58 171.91 34.1 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.993 -1.098 . . . . 0.0 110.417 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.16 6.5 12.02 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.829 -0.807 . . . . 0.0 110.884 173.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -50.3 -25.53 3.85 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.508 -0.745 . . . . 0.0 112.446 -168.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -66.06 -59.26 3.97 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.365 -0.834 . . . . 0.0 110.382 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -94.31 10.19 35.16 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.618 -0.676 . . . . 0.0 111.391 177.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 50.5 p-10 -58.15 171.98 0.49 Allowed 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.212 -0.93 . . . . 0.0 111.362 -171.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.7 m -78.98 164.41 24.41 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.908 -0.495 . . . . 0.0 109.873 176.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -77.6 4.22 11.88 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.662 -0.649 . . . . 0.0 111.198 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -95.54 164.75 12.66 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.25 -0.906 . . . . 0.0 109.608 167.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -68.55 135.38 51.44 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.507 -0.746 . . . . 0.0 110.453 -176.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.6 mm -114.17 134.39 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.734 -0.604 . . . . 0.0 109.615 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -96.22 109.88 49.49 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.703 -0.623 . . . . 0.0 110.181 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -67.33 135.02 35.34 Favored 'Trans proline' 0 N--CA 1.488 1.154 0 O-C-N 123.414 1.218 . . . . 0.0 110.308 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 18.8 mp0 -111.63 135.07 52.71 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.671 -0.643 . . . . 0.0 110.168 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 83.1 p -91.48 6.87 43.87 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.655 -0.653 . . . . 0.0 111.2 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -63.1 141.04 58.91 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.217 -0.927 . . . . 0.0 110.438 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.8 mm -96.86 137.7 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.655 -0.653 . . . . 0.0 109.844 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -94.14 119.03 32.39 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.715 -0.616 . . . . 0.0 110.177 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -51.35 -42.61 61.43 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.789 -0.569 . . . . 0.0 111.745 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -152.27 130.3 11.84 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.587 -0.695 . . . . 0.0 110.293 -174.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 75.2 mt -130.26 130.3 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.728 -0.608 . . . . 0.0 109.877 171.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 19.0 tp -90.25 137.01 32.69 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.823 -0.548 . . . . 0.0 109.934 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.47 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 2.3 m-85 -133.4 127.09 32.68 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.627 -0.67 . . . . 0.0 110.477 -176.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -92.12 145.98 24.08 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.592 -0.692 . . . . 0.0 110.31 173.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.88 -26.67 60.92 Favored Glycine 0 N--CA 1.499 2.843 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.2 m -65.02 -39.94 94.14 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.408 -1.054 . . . . 0.0 110.977 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.77 -32.24 31.51 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.445 -0.784 . . . . 0.0 110.826 -175.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.47 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 6.6 mt -99.34 141.75 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.53 -0.731 . . . . 0.0 110.264 177.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -104.35 -20.78 13.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.938 -0.476 . . . . 0.0 111.377 -169.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -151.79 131.95 13.56 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.238 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.1 tt -130.91 140.48 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.872 -0.517 . . . . 0.0 109.737 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -146.47 130.28 17.12 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.62 -0.675 . . . . 0.0 110.306 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.5 p -87.74 146.29 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.613 -0.679 . . . . 0.0 110.27 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.6 t . . . . . 0 N--CA 1.497 1.882 0 O-C-N 121.572 -0.705 . . . . 0.0 109.738 179.433 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 N--CA 1.501 2.114 0 CA-C-O 120.945 0.402 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.68 -1.92 84.53 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.841 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.6 m -61.72 142.22 57.37 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.113 -1.228 . . . . 0.0 110.457 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -82.36 123.38 29.04 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.748 -0.595 . . . . 0.0 110.559 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 91.0 mt -120.25 144.18 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.472 -0.768 . . . . 0.0 110.199 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.4 t -103.11 137.27 41.5 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 174.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 13.1 tp -133.49 127.84 34.11 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.712 -0.618 . . . . 0.0 110.339 -169.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.0 mt -107.59 119.98 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.593 -0.692 . . . . 0.0 109.738 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.3 m -94.35 157.81 15.86 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.049 0.452 . . . . 0.0 111.248 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.0 tptp -53.51 -15.18 1.0 Allowed 'General case' 0 N--CA 1.509 2.5 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -172.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.75 21.32 3.59 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.13 -0.982 . . . . 0.0 110.436 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 54.16 33.98 19.14 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.44 -0.788 . . . . 0.0 109.795 -174.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.2 mt -101.81 142.72 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 36.7 ttp85 -105.19 119.8 39.94 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.941 -0.704 . . . . 0.0 109.887 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -113.79 149.24 35.21 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -140.61 140.53 35.09 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.546 -0.721 . . . . 0.0 109.696 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -169.13 173.24 43.57 Favored Glycine 0 N--CA 1.495 2.603 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.463 -175.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -85.11 136.44 33.55 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.881 -0.776 . . . . 0.0 110.495 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.3 tp -66.12 119.04 10.74 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.57 -0.706 . . . . 0.0 110.693 175.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -99.4 -50.09 4.22 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.666 -0.646 . . . . 0.0 110.292 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.2 p -153.9 153.29 31.79 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.78 -0.575 . . . . 0.0 110.255 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.5 p -142.31 144.86 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.643 -0.661 . . . . 0.0 110.102 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -128.99 101.53 19.68 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.531 -0.73 . . . . 0.0 109.528 177.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.68 -40.25 38.33 Favored 'Trans proline' 0 N--CA 1.489 1.243 0 O-C-N 123.515 1.271 . . . . 0.0 110.719 -175.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -80.68 -25.18 38.39 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.306 -0.871 . . . . 0.0 110.174 -171.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -87.44 1.46 53.36 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.516 -0.74 . . . . 0.0 111.256 173.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.0 m 49.84 39.51 18.38 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.105 -0.997 . . . . 0.0 111.284 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.7 p -136.65 151.98 49.9 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.365 -0.834 . . . . 0.0 110.368 -175.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.7 pt -142.6 161.47 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.695 -0.628 . . . . 0.0 110.179 177.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.86 127.91 27.75 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.628 -0.67 . . . . 0.0 109.678 175.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 85.6 mt -109.87 146.98 34.19 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -177.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 96.7 p -118.7 153.06 34.99 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -177.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.7 p 45.75 85.9 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 121.452 0.644 . . . . 0.0 110.318 -172.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.3 p -134.51 148.61 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.952 -0.468 . . . . 0.0 109.909 -177.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -126.41 153.12 45.43 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.699 -0.626 . . . . 0.0 109.829 177.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 96.6 p -108.24 134.93 50.39 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.703 -0.623 . . . . 0.0 109.726 175.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -83.01 -38.37 22.7 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.57 -0.706 . . . . 0.0 111.045 -173.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.61 169.29 30.96 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 120.027 -1.083 . . . . 0.0 110.602 176.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.19 6.58 12.0 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.97 -0.724 . . . . 0.0 110.837 174.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -49.16 -25.64 2.32 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.6 -0.688 . . . . 0.0 112.62 -168.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -65.04 -59.22 4.37 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.321 -0.862 . . . . 0.0 110.587 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -94.31 10.14 35.35 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.569 -0.707 . . . . 0.0 111.381 177.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.9 p-10 -59.44 165.86 2.61 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.251 -0.906 . . . . 0.0 111.438 -170.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.3 m -78.98 164.46 24.38 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.925 -0.484 . . . . 0.0 109.748 174.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -77.55 4.22 11.76 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.607 -0.683 . . . . 0.0 111.263 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -96.78 155.32 16.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.156 -0.965 . . . . 0.0 109.623 167.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -68.77 139.8 55.31 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.649 -0.657 . . . . 0.0 110.387 -175.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 81.5 mt -116.38 138.41 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.674 -0.641 . . . . 0.0 109.612 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -97.98 109.98 53.81 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.733 -0.605 . . . . 0.0 110.223 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -66.14 149.64 85.51 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 O-C-N 123.357 1.188 . . . . 0.0 110.335 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -93.22 112.64 24.64 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.667 -0.646 . . . . 0.0 110.301 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.7 t -67.18 -29.4 69.07 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.668 -0.645 . . . . 0.0 110.463 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -60.98 159.29 11.73 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.544 -0.723 . . . . 0.0 110.759 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.81 146.72 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.843 -0.536 . . . . 0.0 109.748 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -91.72 111.85 23.54 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.659 -0.651 . . . . 0.0 109.894 176.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -52.35 -43.21 64.5 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.786 -0.571 . . . . 0.0 111.707 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -154.55 130.28 10.02 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.742 -0.599 . . . . 0.0 110.264 -174.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 82.9 mt -129.07 127.44 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.663 -0.648 . . . . 0.0 109.989 171.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 24.0 tp -90.79 137.03 32.68 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.867 -0.521 . . . . 0.0 109.859 175.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.44 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 4.5 m-85 -136.95 131.59 33.22 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.685 -0.634 . . . . 0.0 110.65 -175.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -91.78 151.57 20.55 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.736 -0.602 . . . . 0.0 110.452 174.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.96 -23.98 59.94 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.2 p -67.52 -41.99 83.51 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.45 -1.03 . . . . 0.0 111.032 -176.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -83.13 -32.87 26.45 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.354 -0.842 . . . . 0.0 110.914 -175.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.44 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 22.2 mt -105.94 136.25 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.459 -0.775 . . . . 0.0 110.013 177.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 59.4 tttt -109.1 -14.34 14.54 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 120.417 -0.513 . . . . 0.0 112.008 -165.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -147.88 131.41 16.75 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 118.901 -1.12 . . . . 0.0 111.433 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 15.8 tt -132.38 137.48 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.936 -0.478 . . . . 0.0 109.77 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.0 mtm180 -147.04 147.1 30.31 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.606 -0.684 . . . . 0.0 110.387 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.9 t -85.96 145.04 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.679 -0.638 . . . . 0.0 109.601 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.2 t . . . . . 0 N--CA 1.497 1.922 0 O-C-N 121.601 -0.687 . . . . 0.0 109.898 -177.194 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.5 mt . . . . . 0 N--CA 1.502 2.133 0 CA-C-O 120.999 0.428 . . . . 0.0 110.71 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.65 -1.97 84.29 Favored Glycine 0 N--CA 1.497 2.713 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.837 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.9 m -62.06 148.21 44.85 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.125 -1.221 . . . . 0.0 110.49 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -81.87 124.53 29.79 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.662 -0.649 . . . . 0.0 110.401 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 88.8 mt -120.64 144.54 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.565 -0.71 . . . . 0.0 110.122 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.6 t -102.91 137.33 41.25 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 13.6 tp -132.79 125.64 30.55 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.711 -0.618 . . . . 0.0 110.219 -169.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.0 mt -106.94 118.6 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.447 -0.783 . . . . 0.0 109.661 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.9 m -93.77 157.65 16.05 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 120.997 0.427 . . . . 0.0 111.3 -177.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -55.68 -11.17 0.85 Allowed 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -172.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.72 18.48 4.67 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.196 -0.94 . . . . 0.0 110.439 176.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 55.64 36.06 26.46 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.442 -0.786 . . . . 0.0 109.918 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 57.6 mt -106.96 145.0 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -105.62 119.81 40.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.618 -0.676 . . . . 0.0 110.123 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -113.81 152.12 31.09 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -142.27 140.57 32.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.429 -0.795 . . . . 0.0 109.672 175.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.87 172.21 42.55 Favored Glycine 0 N--CA 1.496 2.634 0 C-N-CA 119.713 -1.232 . . . . 0.0 110.558 -175.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -85.08 136.16 33.68 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.864 -0.786 . . . . 0.0 110.517 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.1 tp -66.16 117.8 8.98 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.623 -0.673 . . . . 0.0 110.664 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -99.95 -50.1 4.11 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.657 -0.652 . . . . 0.0 110.455 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.1 p -154.35 156.06 36.2 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.736 -0.603 . . . . 0.0 110.348 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.3 p -142.31 146.25 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.771 -0.58 . . . . 0.0 110.007 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -128.48 100.8 21.97 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.582 -0.699 . . . . 0.0 109.536 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.59 -40.16 39.67 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 O-C-N 123.558 1.294 . . . . 0.0 110.71 -174.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -80.63 -25.27 38.47 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.365 -0.834 . . . . 0.0 110.202 -171.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -87.47 1.3 53.85 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.498 -0.751 . . . . 0.0 111.258 173.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 45.2 m 49.6 39.19 16.66 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.089 -1.007 . . . . 0.0 111.303 -176.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.0 p -136.07 155.35 50.34 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.393 -0.817 . . . . 0.0 110.315 -174.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.8 pt -142.27 162.03 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.616 -0.677 . . . . 0.0 110.17 177.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.4 127.68 28.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.669 -0.644 . . . . 0.0 109.692 175.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 87.2 mt -109.87 147.12 33.94 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 96.8 p -118.22 152.43 35.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.674 -0.642 . . . . 0.0 109.27 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.3 p 45.5 84.79 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 CA-C-O 121.476 0.655 . . . . 0.0 110.358 -172.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.7 p -134.54 149.02 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.905 -0.497 . . . . 0.0 109.853 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.4 ttm180 -131.71 153.05 50.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.68 -0.637 . . . . 0.0 109.799 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 85.1 p -107.93 133.89 51.63 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.741 -0.599 . . . . 0.0 109.476 175.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -82.68 -38.63 23.15 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.039 -171.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.23 167.08 27.38 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 175.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.0 p -118.23 -11.2 10.13 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.963 -0.728 . . . . 0.0 110.83 170.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -52.74 -24.99 9.81 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.462 -0.774 . . . . 0.0 112.492 -166.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -79.12 -59.3 2.83 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.261 -0.899 . . . . 0.0 110.894 -176.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -94.42 9.93 36.41 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.596 -0.69 . . . . 0.0 112.006 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -90.16 174.56 7.55 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.085 -1.009 . . . . 0.0 111.126 -175.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.0 m -78.43 164.66 24.58 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 122.016 -0.428 . . . . 0.0 109.854 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -77.45 12.07 1.72 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.726 -0.609 . . . . 0.0 111.616 -173.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -92.49 140.54 29.46 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.241 -0.912 . . . . 0.0 109.62 169.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -65.97 141.03 58.34 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.713 -0.617 . . . . 0.0 110.919 -170.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 82.5 mt -118.83 138.81 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.731 -0.606 . . . . 0.0 109.399 176.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.62 113.43 14.23 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.617 -0.677 . . . . 0.0 110.125 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -64.18 142.65 81.15 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 O-C-N 123.305 1.161 . . . . 0.0 110.465 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -104.02 107.11 17.85 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.713 -0.617 . . . . 0.0 110.27 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.6 p -93.4 -32.72 14.13 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.685 -0.634 . . . . 0.0 110.327 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -62.8 152.64 35.4 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.619 -0.675 . . . . 0.0 110.655 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.4 mm -96.8 141.08 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.705 -0.622 . . . . 0.0 109.592 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -96.36 113.16 24.72 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.64 -0.663 . . . . 0.0 110.37 -177.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -51.19 -39.93 57.55 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.738 -0.601 . . . . 0.0 111.416 175.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -152.73 129.19 10.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.627 -0.671 . . . . 0.0 110.201 -175.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.6 mt -127.55 129.14 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.566 -0.709 . . . . 0.0 109.798 172.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.9 tp -90.18 137.05 32.67 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.859 -0.526 . . . . 0.0 109.808 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.46 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 2.6 m-85 -135.56 129.21 32.62 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.751 -0.593 . . . . 0.0 110.559 -175.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -91.07 146.62 23.69 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.715 -0.615 . . . . 0.0 110.176 173.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.58 -25.86 58.94 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.1 p -67.75 -37.61 82.38 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.459 -1.024 . . . . 0.0 110.875 -177.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -82.46 -30.5 29.94 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.454 -0.779 . . . . 0.0 110.934 -175.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.46 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 8.6 mt -103.95 142.87 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.426 -0.796 . . . . 0.0 110.278 176.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -104.63 -24.73 12.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.932 -0.48 . . . . 0.0 111.381 -167.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -151.88 136.24 16.79 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.048 -1.033 . . . . 0.0 111.465 -177.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.7 tt -131.79 140.51 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.963 -0.461 . . . . 0.0 109.828 176.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -146.87 140.77 25.96 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.544 -0.723 . . . . 0.0 110.335 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.0 p -86.04 147.05 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.669 -0.644 . . . . 0.0 110.107 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.0 t . . . . . 0 N--CA 1.497 1.907 0 O-C-N 121.578 -0.701 . . . . 0.0 109.868 -178.79 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.6 mt . . . . . 0 N--CA 1.501 2.087 0 CA-C-O 121.001 0.429 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.57 -1.9 84.31 Favored Glycine 0 N--CA 1.496 2.663 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.85 176.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.4 m -62.71 138.94 58.63 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.126 -1.22 . . . . 0.0 110.355 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -82.13 126.98 32.67 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.624 -0.673 . . . . 0.0 110.415 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 86.5 mt -120.97 143.36 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.614 -0.679 . . . . 0.0 110.142 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.0 t -103.18 137.32 41.49 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 14.0 tp -134.8 125.9 27.8 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.687 -0.633 . . . . 0.0 110.337 -168.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.3 mt -106.85 118.11 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.614 -0.679 . . . . 0.0 109.665 -178.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.6 m -92.86 157.89 16.14 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 120.97 0.414 . . . . 0.0 111.303 -176.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -53.75 -14.43 0.93 Allowed 'General case' 0 N--CA 1.508 2.453 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -171.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.14 20.22 3.82 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.169 -0.957 . . . . 0.0 110.519 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 56.03 36.08 26.72 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.463 -0.773 . . . . 0.0 109.916 -177.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 53.6 mt -107.05 146.58 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -105.39 119.81 40.03 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.13 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -113.41 152.39 30.11 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -142.36 140.45 32.08 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.491 -0.756 . . . . 0.0 109.583 175.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.95 171.41 41.77 Favored Glycine 0 N--CA 1.496 2.66 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.602 -175.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -85.45 137.27 33.02 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.836 -0.803 . . . . 0.0 110.607 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.2 tp -66.2 118.81 10.45 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.648 -0.657 . . . . 0.0 110.723 175.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -100.36 -50.06 4.05 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.611 -0.681 . . . . 0.0 110.351 176.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.2 p -153.55 153.59 32.68 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.741 -0.599 . . . . 0.0 110.18 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.5 p -142.3 145.04 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.593 -0.692 . . . . 0.0 110.102 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -128.5 100.51 22.26 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.623 -0.673 . . . . 0.0 109.566 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.41 -39.69 44.47 Favored 'Trans proline' 0 N--CA 1.489 1.244 0 O-C-N 123.578 1.304 . . . . 0.0 110.726 -175.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -80.49 -25.83 38.56 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.406 -0.809 . . . . 0.0 110.157 -172.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -87.35 1.83 52.14 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.501 -0.75 . . . . 0.0 111.195 173.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 75.5 m 49.58 38.3 14.51 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.116 -0.99 . . . . 0.0 111.291 -176.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.5 p -136.26 153.73 51.11 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.399 -0.813 . . . . 0.0 110.26 -174.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.9 pt -142.73 162.02 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.703 -0.623 . . . . 0.0 110.249 178.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.69 127.29 27.01 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.669 -0.644 . . . . 0.0 109.665 175.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 83.8 mt -109.94 146.99 34.27 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -177.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 95.7 p -118.07 152.68 35.09 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.5 p 45.58 84.0 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 121.492 0.663 . . . . 0.0 110.336 -172.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.9 p -134.53 150.55 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.947 -0.47 . . . . 0.0 109.774 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -136.4 153.09 51.19 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.64 -0.663 . . . . 0.0 110.168 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.5 p -107.2 133.03 52.39 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.71 -0.619 . . . . 0.0 109.506 176.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -83.09 -38.62 22.22 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.726 -0.79 . . . . 0.0 111.087 -170.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.27 171.73 33.65 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 176.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.6 p -118.22 6.1 11.95 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.789 -0.83 . . . . 0.0 110.467 169.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -57.26 -31.41 65.54 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.545 -0.722 . . . . 0.0 112.427 -161.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -66.69 -59.34 3.67 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.239 -0.913 . . . . 0.0 110.486 -174.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.0 mtt-85 -94.51 10.3 35.15 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.677 -0.639 . . . . 0.0 111.612 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.2 p30 -54.63 172.15 0.11 Allowed 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.166 -0.959 . . . . 0.0 111.894 -171.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.0 m -78.94 164.6 24.29 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 173.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -77.32 3.75 12.33 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.567 -0.708 . . . . 0.0 111.214 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -98.28 153.34 18.58 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.215 -0.928 . . . . 0.0 109.619 169.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -67.82 138.59 56.25 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.578 -0.701 . . . . 0.0 110.597 -174.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 79.2 mt -117.43 141.2 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.661 -0.65 . . . . 0.0 109.511 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -97.66 109.86 52.59 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.612 -0.68 . . . . 0.0 110.215 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -68.6 147.65 70.64 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 O-C-N 123.44 1.232 . . . . 0.0 110.325 178.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -101.38 121.44 41.93 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.64 -0.662 . . . . 0.0 110.206 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 86.6 p -81.25 -26.81 35.53 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.724 -0.61 . . . . 0.0 110.686 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -61.67 148.35 42.93 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.471 -0.768 . . . . 0.0 110.623 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.1 mm -96.85 145.64 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.712 -0.618 . . . . 0.0 109.747 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -95.75 114.34 26.06 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.659 -0.651 . . . . 0.0 110.347 -178.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -51.04 -41.09 59.64 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.709 -0.62 . . . . 0.0 111.527 176.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -152.63 129.51 10.97 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.727 -0.608 . . . . 0.0 110.226 -174.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 73.7 mt -128.23 128.34 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.683 -0.635 . . . . 0.0 109.794 172.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.8 tp -90.13 137.06 32.65 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.889 -0.507 . . . . 0.0 109.838 176.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.462 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 3.0 m-85 -135.35 128.84 32.43 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.572 -0.705 . . . . 0.0 110.603 -175.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -91.27 147.03 23.33 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.653 -0.654 . . . . 0.0 110.177 172.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.63 -25.62 58.76 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.2 p -67.83 -37.85 82.45 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.427 -1.043 . . . . 0.0 110.917 -177.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -82.43 -30.79 29.86 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.504 -0.748 . . . . 0.0 110.9 -175.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.462 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 8.5 mt -104.31 138.78 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.492 -0.755 . . . . 0.0 110.104 176.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -105.04 -18.07 14.28 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.92 -0.487 . . . . 0.0 111.58 -167.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -151.03 132.03 14.27 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 119.115 -1.034 . . . . 0.0 111.249 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 16.8 tt -132.2 141.97 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.887 -0.508 . . . . 0.0 109.806 176.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -146.4 135.13 22.28 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.659 -0.65 . . . . 0.0 110.361 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 52.4 t -87.59 143.74 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.682 -0.636 . . . . 0.0 109.775 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 N--CA 1.497 1.895 0 O-C-N 121.59 -0.694 . . . . 0.0 109.745 -179.777 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.3 mt . . . . . 0 N--CA 1.501 2.101 0 CA-C-O 121.01 0.433 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.68 -1.79 84.95 Favored Glycine 0 N--CA 1.497 2.707 0 C-N-CA 120.453 -0.879 . . . . 0.0 111.742 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.4 m -60.39 151.7 27.33 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.078 -1.248 . . . . 0.0 110.482 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.5 pttt -81.95 126.54 32.06 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.66 -0.65 . . . . 0.0 110.551 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 89.5 mt -120.8 143.76 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.57 -0.706 . . . . 0.0 109.988 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.4 t -102.42 137.27 40.89 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 175.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 14.7 tp -133.11 125.06 28.7 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.763 -0.586 . . . . 0.0 110.227 -169.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 81.7 mt -106.75 118.85 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.548 -0.72 . . . . 0.0 109.629 -178.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.7 m -93.69 157.66 16.06 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.064 0.459 . . . . 0.0 111.148 -178.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -54.21 -13.24 0.8 Allowed 'General case' 0 N--CA 1.507 2.416 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -172.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.0 20.4 4.27 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.142 -0.974 . . . . 0.0 110.475 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 53.96 33.98 18.6 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.485 -0.76 . . . . 0.0 109.749 -173.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.8 mt -102.22 140.89 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -104.9 119.81 39.92 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.922 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -114.36 147.55 38.98 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 173.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -139.31 140.43 37.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.436 -0.79 . . . . 0.0 109.627 175.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.11 173.22 42.34 Favored Glycine 0 N--CA 1.496 2.678 0 C-N-CA 119.737 -1.22 . . . . 0.0 110.58 -175.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -84.28 137.57 33.39 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.907 -0.761 . . . . 0.0 110.546 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.0 tp -66.15 116.88 7.7 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.727 -0.608 . . . . 0.0 110.655 175.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -99.68 -50.18 4.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.659 -0.651 . . . . 0.0 110.421 178.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.1 p -153.97 153.64 32.36 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.705 -0.622 . . . . 0.0 110.269 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.7 p -142.24 145.19 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.696 -0.627 . . . . 0.0 110.092 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -127.88 98.73 27.01 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.631 -0.668 . . . . 0.0 109.611 177.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -59.44 -42.06 52.07 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 O-C-N 123.577 1.304 . . . . 0.0 110.984 -175.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -80.73 -24.82 38.49 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.413 -0.804 . . . . 0.0 110.181 -171.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -87.02 1.26 53.43 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.536 -0.728 . . . . 0.0 111.177 173.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 96.5 m 49.8 38.17 15.05 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.053 -1.029 . . . . 0.0 111.249 -176.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.6 p -136.12 153.09 51.4 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.431 -0.793 . . . . 0.0 110.43 -174.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.9 pt -142.77 162.04 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.703 -0.623 . . . . 0.0 110.22 177.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.79 128.1 28.19 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.67 -0.644 . . . . 0.0 109.686 175.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 83.6 mt -109.89 145.83 36.17 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -178.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.4 p -116.92 153.0 33.34 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -178.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 44.6 p 45.93 87.05 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 121.516 0.674 . . . . 0.0 110.317 -172.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.4 p -134.59 147.19 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.897 -0.502 . . . . 0.0 109.929 -177.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -123.84 153.17 41.45 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.767 -0.583 . . . . 0.0 109.881 177.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.3 p -108.54 136.69 47.72 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.716 -0.615 . . . . 0.0 109.707 176.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -82.93 -38.39 22.87 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.528 -0.733 . . . . 0.0 110.968 -174.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.57 167.62 28.51 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 120.024 -1.084 . . . . 0.0 110.578 176.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.09 6.55 12.08 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.974 -0.721 . . . . 0.0 110.899 174.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -49.45 -25.16 2.39 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.544 -0.723 . . . . 0.0 112.624 -168.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -64.5 -59.22 4.57 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.191 -0.943 . . . . 0.0 110.607 -178.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 35.5 mtp180 -94.35 10.14 35.43 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.558 -0.714 . . . . 0.0 111.472 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 40.0 p-10 -60.27 173.97 0.6 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.3 -0.875 . . . . 0.0 111.297 -170.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.0 m -78.99 164.34 24.47 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.93 -0.481 . . . . 0.0 109.737 175.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -77.55 3.56 13.32 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.601 -0.687 . . . . 0.0 111.291 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -96.54 166.01 11.89 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.219 -0.926 . . . . 0.0 109.656 168.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -68.61 139.29 55.51 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.606 -0.684 . . . . 0.0 110.364 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 49.5 mm -114.18 134.76 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.745 -0.597 . . . . 0.0 109.697 178.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.01 109.94 53.68 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.649 -0.657 . . . . 0.0 110.236 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -66.86 146.57 78.48 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 O-C-N 123.331 1.174 . . . . 0.0 110.305 178.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -97.44 121.12 38.98 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.653 -0.654 . . . . 0.0 110.299 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 86.4 p -75.79 -22.07 56.74 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.705 -0.622 . . . . 0.0 110.828 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -61.16 156.59 17.96 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.376 -0.828 . . . . 0.0 110.693 -178.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.5 mm -96.87 145.9 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.754 -0.591 . . . . 0.0 109.853 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -92.1 111.87 23.58 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.553 -0.717 . . . . 0.0 109.87 175.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -52.35 -43.11 64.45 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.746 -0.596 . . . . 0.0 111.769 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -154.62 130.15 9.87 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.588 -0.695 . . . . 0.0 110.238 -174.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 80.4 mt -128.77 127.42 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.618 -0.676 . . . . 0.0 109.916 171.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 24.8 tp -90.32 137.09 32.63 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.779 -0.576 . . . . 0.0 109.755 175.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.465 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 3.5 m-85 -136.08 130.77 33.93 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.649 -0.657 . . . . 0.0 110.664 -175.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -91.6 149.57 21.59 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.663 -0.648 . . . . 0.0 110.339 173.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.31 -24.51 61.41 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 177.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.7 m -66.53 -42.04 87.83 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.366 -1.079 . . . . 0.0 111.077 -176.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -82.96 -33.41 26.69 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.423 -0.798 . . . . 0.0 110.919 -175.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.465 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 14.2 mt -101.02 138.15 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.404 -0.81 . . . . 0.0 110.11 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.0 tptp -107.32 -18.25 13.92 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 120.501 -0.479 . . . . 0.0 111.758 -166.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -148.93 131.14 15.49 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.897 -1.127 . . . . 0.0 111.354 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.0 tt -132.55 138.51 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.895 -0.503 . . . . 0.0 109.866 176.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.1 mtp180 -147.02 138.67 24.25 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.496 -0.753 . . . . 0.0 110.39 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.3 p -86.61 146.63 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.589 -0.694 . . . . 0.0 110.186 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 N--CA 1.497 1.887 0 O-C-N 121.647 -0.658 . . . . 0.0 109.907 -179.056 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.0 mt . . . . . 0 N--CA 1.501 2.088 0 CA-C-O 121.087 0.47 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.62 -1.91 84.42 Favored Glycine 0 N--CA 1.497 2.707 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.759 177.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.3 m -62.55 140.59 58.64 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.094 -1.239 . . . . 0.0 110.372 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -81.97 123.14 28.62 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.67 -0.644 . . . . 0.0 110.473 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 91.8 mt -121.17 145.35 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.492 -0.755 . . . . 0.0 110.222 -178.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.0 t -103.21 137.24 41.62 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 175.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 14.3 tp -132.02 126.14 33.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.741 -0.599 . . . . 0.0 110.261 -169.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 81.4 mt -107.04 119.03 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.594 -0.691 . . . . 0.0 109.622 -178.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.9 m -93.56 157.73 16.05 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.081 0.467 . . . . 0.0 111.187 -177.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.0 tptp -53.67 -14.78 0.97 Allowed 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -172.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.85 21.23 3.68 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.183 -0.948 . . . . 0.0 110.469 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 53.99 34.31 19.4 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.509 -0.745 . . . . 0.0 109.886 -174.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 67.3 mt -102.1 141.55 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 54.0 ttt85 -104.51 119.84 39.89 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.891 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -113.86 149.24 35.36 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 174.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -140.69 140.49 34.94 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.499 -0.751 . . . . 0.0 109.494 175.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.64 173.09 43.27 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.666 -175.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -85.05 134.61 34.2 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.963 -0.728 . . . . 0.0 110.465 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.1 tp -66.2 119.87 12.24 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.61 -0.681 . . . . 0.0 110.735 176.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -99.43 -50.09 4.22 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.639 -0.663 . . . . 0.0 110.338 178.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.4 p -153.83 154.29 33.69 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.693 -0.63 . . . . 0.0 110.229 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.4 p -142.2 145.51 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.697 -0.627 . . . . 0.0 110.099 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -129.04 98.25 24.37 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.583 -0.698 . . . . 0.0 109.502 177.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -59.45 -40.16 69.43 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 O-C-N 123.606 1.319 . . . . 0.0 111.037 -175.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -80.51 -27.12 37.77 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.319 -0.863 . . . . 0.0 110.21 -170.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -87.59 3.34 47.98 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.524 -0.735 . . . . 0.0 111.212 173.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 42.4 m 49.61 39.66 17.77 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.13 -0.981 . . . . 0.0 111.351 -177.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.8 p -136.18 151.9 50.22 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.379 -0.826 . . . . 0.0 110.357 -175.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.0 pt -142.68 162.1 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.628 -0.67 . . . . 0.0 110.121 178.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.06 127.63 26.87 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.662 -0.648 . . . . 0.0 109.634 175.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 88.6 mt -109.9 148.67 31.14 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -177.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.8 p -119.55 152.24 37.31 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.9 p 45.63 83.71 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 CA-C-O 121.457 0.646 . . . . 0.0 110.355 -172.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.6 p -134.54 150.33 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -178.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -136.07 153.19 51.41 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.658 -0.651 . . . . 0.0 110.043 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.9 p -108.41 139.89 42.5 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.753 -0.592 . . . . 0.0 109.839 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -83.0 -38.39 22.7 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.669 -0.644 . . . . 0.0 111.035 -173.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.62 171.93 34.15 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 177.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.3 p -118.09 6.51 12.08 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.925 -0.75 . . . . 0.0 110.986 174.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -50.99 -24.43 3.69 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.555 -0.716 . . . . 0.0 112.749 -167.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -65.95 -59.35 3.92 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.191 -0.943 . . . . 0.0 110.583 -177.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 -94.5 10.24 35.36 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.567 -0.708 . . . . 0.0 111.474 176.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 41.4 p-10 -58.22 174.08 0.31 Allowed 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.168 -0.958 . . . . 0.0 111.283 -171.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.0 m -79.03 164.37 24.41 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.905 -0.497 . . . . 0.0 109.794 176.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -77.53 4.09 12.02 Favored 'General case' 0 N--CA 1.502 2.135 0 C-N-CA 120.046 -0.662 . . . . 0.0 111.235 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -96.2 164.91 12.47 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.169 -0.957 . . . . 0.0 109.597 168.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -68.81 137.0 53.61 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.62 -0.675 . . . . 0.0 110.47 -176.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.3 mm -114.43 135.96 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.705 -0.622 . . . . 0.0 109.591 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -96.1 109.85 49.09 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.621 -0.675 . . . . 0.0 110.195 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -69.29 140.74 45.21 Favored 'Trans proline' 0 N--CA 1.487 1.091 0 O-C-N 123.469 1.247 . . . . 0.0 110.269 177.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -115.21 136.35 53.2 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.626 -0.671 . . . . 0.0 110.174 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.5 m -91.45 11.86 22.58 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.693 -0.63 . . . . 0.0 111.234 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -63.38 138.52 58.55 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.279 -0.888 . . . . 0.0 110.449 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.0 mm -96.92 135.35 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.715 -0.616 . . . . 0.0 109.758 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -95.28 117.72 30.79 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.605 -0.684 . . . . 0.0 110.191 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -51.02 -42.41 60.43 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.817 -0.552 . . . . 0.0 111.634 177.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -152.68 130.38 11.58 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.614 -0.679 . . . . 0.0 110.3 -174.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 77.0 mt -129.4 128.43 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.664 -0.647 . . . . 0.0 109.854 172.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.2 tp -90.47 137.1 32.62 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.821 -0.549 . . . . 0.0 109.817 176.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.465 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 3.4 m-85 -136.53 130.81 33.01 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.636 -0.665 . . . . 0.0 110.606 -175.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.9 mtm-85 -92.21 150.68 20.76 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.725 -0.609 . . . . 0.0 110.367 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.31 -23.99 60.74 Favored Glycine 0 N--CA 1.498 2.804 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.3 p -67.11 -42.04 85.19 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.408 -1.054 . . . . 0.0 110.979 -176.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -82.92 -33.22 26.87 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.471 -0.768 . . . . 0.0 110.942 -175.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.465 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 14.9 mt -102.32 138.26 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.393 -0.817 . . . . 0.0 110.142 177.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -107.22 -18.45 13.88 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.797 -166.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -149.64 131.31 14.97 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 118.936 -1.106 . . . . 0.0 111.231 -178.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.1 tt -132.01 138.27 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.937 -0.477 . . . . 0.0 109.783 176.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -146.92 144.12 29.0 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.584 -0.698 . . . . 0.0 110.429 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.5 m -84.87 147.0 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.585 -0.697 . . . . 0.0 110.203 178.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.6 t . . . . . 0 N--CA 1.496 1.866 0 O-C-N 121.636 -0.665 . . . . 0.0 109.868 -178.727 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.5 mt . . . . . 0 N--CA 1.501 2.122 0 CA-C-O 120.961 0.41 . . . . 0.0 110.673 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.62 -1.88 84.5 Favored Glycine 0 N--CA 1.497 2.728 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.783 177.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.6 m -62.17 147.37 47.91 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.047 -1.266 . . . . 0.0 110.446 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.6 pttt -81.77 126.0 31.31 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.716 -0.615 . . . . 0.0 110.371 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 89.1 mt -122.49 144.15 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.543 -0.723 . . . . 0.0 110.107 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.3 t -102.68 137.3 41.08 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 13.4 tp -135.41 128.33 31.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.742 -0.599 . . . . 0.0 110.28 -169.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.3 mt -108.38 121.88 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.558 -0.714 . . . . 0.0 109.668 -178.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.1 m -93.2 157.85 16.06 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.042 0.449 . . . . 0.0 111.151 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -53.95 -13.78 0.85 Allowed 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -172.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.52 20.07 4.17 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.2 -0.938 . . . . 0.0 110.394 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 54.16 34.81 20.98 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.411 -0.806 . . . . 0.0 109.829 -175.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.4 mt -102.35 143.44 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -104.31 119.67 39.48 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.058 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -114.22 149.28 36.04 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -141.13 140.5 34.12 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.417 -0.802 . . . . 0.0 109.7 175.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.27 173.23 43.04 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 119.721 -1.228 . . . . 0.0 110.527 -175.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -85.29 136.81 33.34 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.872 -0.781 . . . . 0.0 110.581 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.5 tp -66.23 119.22 11.12 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.57 -0.706 . . . . 0.0 110.66 175.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -100.07 -50.16 4.07 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.641 -0.662 . . . . 0.0 110.445 178.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.6 p -153.94 156.18 37.01 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.708 -0.62 . . . . 0.0 110.34 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.6 p -142.18 145.37 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.758 -0.589 . . . . 0.0 110.093 -178.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -128.83 98.46 24.52 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.678 -0.639 . . . . 0.0 109.539 177.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -59.4 -43.29 41.45 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 O-C-N 123.595 1.313 . . . . 0.0 110.993 -175.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -80.88 -23.88 38.7 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.335 -0.853 . . . . 0.0 110.237 -171.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -87.18 0.99 54.46 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.473 -0.767 . . . . 0.0 111.188 173.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.0 m 50.03 39.8 19.84 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.101 -0.999 . . . . 0.0 111.172 -176.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.1 p -136.06 154.36 51.05 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.452 -0.78 . . . . 0.0 110.476 -174.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.3 pt -141.66 160.61 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.816 -0.553 . . . . 0.0 110.031 177.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.52 126.94 26.71 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.698 -0.626 . . . . 0.0 109.648 175.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 88.0 mt -109.89 146.6 34.86 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -178.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 99.9 p -117.65 152.24 35.6 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.1 p 45.65 83.62 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 121.491 0.662 . . . . 0.0 110.311 -172.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.9 p -134.58 151.06 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.938 -0.476 . . . . 0.0 109.733 -179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -136.6 153.19 51.03 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.596 -0.69 . . . . 0.0 110.137 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.3 p -109.6 137.7 47.04 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.806 -0.559 . . . . 0.0 109.664 177.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -83.06 -38.57 22.34 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.194 -172.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.31 169.4 30.83 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 175.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.0 p -118.17 6.21 12.0 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.865 -0.785 . . . . 0.0 110.818 170.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -54.29 -24.3 18.48 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.48 -0.762 . . . . 0.0 112.257 -167.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -65.79 -59.21 4.12 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.281 -0.887 . . . . 0.0 110.387 -177.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 82.0 mmt-85 -94.52 10.26 35.34 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.619 -0.676 . . . . 0.0 111.417 177.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.2 p-10 -57.42 170.02 0.57 Allowed 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.211 -0.93 . . . . 0.0 111.52 -170.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.7 m -79.01 164.54 24.29 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 175.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -77.42 4.21 11.48 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.092 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -97.53 148.16 23.53 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.312 -0.867 . . . . 0.0 109.394 166.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -65.98 142.2 57.93 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.578 -0.701 . . . . 0.0 110.81 -174.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 79.8 mt -115.75 135.7 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.678 -0.639 . . . . 0.0 109.439 177.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.35 132.52 89.66 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.626 -0.671 . . . . 0.0 110.025 -178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -69.48 144.07 54.28 Favored 'Trans proline' 0 N--CA 1.487 1.117 0 O-C-N 123.389 1.205 . . . . 0.0 110.253 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -98.93 110.1 22.76 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.668 -0.645 . . . . 0.0 110.111 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.4 t -99.18 -33.17 10.88 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.748 -0.595 . . . . 0.0 110.364 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -62.52 148.64 45.24 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.592 -0.692 . . . . 0.0 110.668 -179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.4 mm -96.83 143.75 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.681 -0.637 . . . . 0.0 109.667 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -94.75 114.77 26.72 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.711 -0.618 . . . . 0.0 110.322 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.19 -41.39 60.18 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 121.812 -0.555 . . . . 0.0 111.56 177.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -152.59 130.6 11.82 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.632 -0.668 . . . . 0.0 110.262 -175.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 76.2 mt -129.34 127.27 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.586 -0.696 . . . . 0.0 109.792 171.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.2 tp -90.58 137.07 32.64 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.833 -0.542 . . . . 0.0 109.858 176.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.435 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 3.9 m-85 -137.93 131.89 31.57 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.685 -0.634 . . . . 0.0 110.67 -175.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -91.59 151.91 20.51 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.752 -0.592 . . . . 0.0 110.313 174.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.93 -24.75 60.82 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.6 t -66.83 -42.15 86.27 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.451 -1.029 . . . . 0.0 111.066 -176.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -82.89 -33.17 27.02 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.527 -0.733 . . . . 0.0 110.93 -175.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.435 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 24.5 mt -105.17 135.1 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.336 -0.853 . . . . 0.0 109.962 176.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -110.18 -12.59 14.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.941 -0.474 . . . . 0.0 112.111 -165.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -147.4 130.65 16.52 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.809 -1.182 . . . . 0.0 111.298 -178.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.6 tt -132.27 141.25 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.92 -0.488 . . . . 0.0 109.87 176.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -145.96 134.4 21.95 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.498 -0.751 . . . . 0.0 110.307 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.3 t -87.14 144.45 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.612 -0.68 . . . . 0.0 109.611 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.8 t . . . . . 0 N--CA 1.497 1.905 0 O-C-N 121.603 -0.686 . . . . 0.0 109.749 -179.614 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.5 mt . . . . . 0 N--CA 1.501 2.083 0 CA-C-O 120.932 0.396 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.66 -1.75 85.01 Favored Glycine 0 N--CA 1.497 2.721 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.608 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 42.6 m -60.01 159.54 9.22 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.151 -1.206 . . . . 0.0 110.437 -177.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -81.27 126.58 31.72 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.747 -0.596 . . . . 0.0 110.534 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 88.1 mt -120.83 144.66 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.555 -0.716 . . . . 0.0 109.907 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.8 t -102.97 137.27 41.39 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 175.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.9 tp -134.15 123.88 25.12 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.723 -0.611 . . . . 0.0 110.057 -170.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.0 mt -103.99 119.45 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.528 -0.732 . . . . 0.0 109.643 -177.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.7 m -94.96 157.89 15.7 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.166 0.507 . . . . 0.0 111.59 -175.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -53.64 -15.19 1.08 Allowed 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -171.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.6 21.15 3.58 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.157 -0.964 . . . . 0.0 110.449 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 56.69 35.57 26.37 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.49 -0.756 . . . . 0.0 110.031 -178.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 53.1 mt -107.05 148.79 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.0 ttt-85 -106.66 119.83 40.36 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.167 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -112.87 152.37 29.34 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 175.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -141.88 140.55 32.89 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.452 -0.78 . . . . 0.0 109.68 175.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.57 171.8 41.61 Favored Glycine 0 N--CA 1.496 2.65 0 C-N-CA 119.753 -1.213 . . . . 0.0 110.464 -176.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 43.1 mmm-85 -84.35 138.97 32.59 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.843 -0.798 . . . . 0.0 110.538 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.5 tp -66.17 116.5 7.31 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.605 -0.684 . . . . 0.0 110.618 175.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -100.35 -50.13 4.03 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.609 -0.682 . . . . 0.0 110.553 178.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.5 p -154.58 155.33 34.56 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.718 -0.614 . . . . 0.0 110.359 -177.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.4 p -142.23 145.94 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.746 -0.597 . . . . 0.0 110.062 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -128.5 99.01 24.27 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.579 -0.7 . . . . 0.0 109.649 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -59.61 -41.67 54.17 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 O-C-N 123.654 1.344 . . . . 0.0 111.038 -175.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -80.59 -25.51 38.43 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.384 -0.823 . . . . 0.0 110.252 -170.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -87.58 1.97 52.12 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.437 -0.79 . . . . 0.0 111.236 173.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 97.7 m 49.66 39.97 18.7 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.093 -1.004 . . . . 0.0 111.199 -176.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.0 p -135.86 154.32 51.2 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.415 -0.803 . . . . 0.0 110.379 -175.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.9 pt -142.0 160.94 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.675 -0.641 . . . . 0.0 109.969 176.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.06 128.99 29.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.572 -0.705 . . . . 0.0 109.828 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 84.1 mt -109.87 144.82 37.8 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -178.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 97.6 p -114.95 152.66 31.97 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.1 p 45.55 84.94 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 121.454 0.645 . . . . 0.0 110.214 -171.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.1 p -134.55 149.97 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.967 -0.458 . . . . 0.0 109.766 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -136.07 153.2 51.4 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.635 -0.665 . . . . 0.0 110.068 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.2 p -105.61 129.79 53.78 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.757 -0.589 . . . . 0.0 109.463 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -83.07 -38.49 22.44 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.112 -170.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.22 175.45 37.25 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 178.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 65.3 p -118.11 2.68 12.05 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.81 -0.817 . . . . 0.0 110.489 169.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -57.33 -33.83 68.12 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.541 -0.725 . . . . 0.0 112.134 -163.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -63.36 -59.06 5.19 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.332 -0.855 . . . . 0.0 110.435 -175.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -94.32 10.49 34.01 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.753 -0.592 . . . . 0.0 111.289 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 51.2 p30 -49.82 157.78 0.55 Allowed 'General case' 0 N--CA 1.51 2.556 0 O-C-N 121.413 -0.804 . . . . 0.0 112.41 -169.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.1 m -79.2 164.49 24.16 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 172.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -77.51 4.53 10.92 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.236 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -96.83 166.05 11.82 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.236 -0.915 . . . . 0.0 109.645 167.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -76.58 133.98 39.52 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.544 -0.722 . . . . 0.0 110.52 -176.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 69.8 mt -119.35 139.48 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.805 -0.56 . . . . 0.0 109.531 177.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.04 109.89 53.56 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.613 -0.679 . . . . 0.0 110.249 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -68.77 152.06 74.17 Favored 'Trans proline' 0 N--CA 1.488 1.153 0 O-C-N 123.414 1.218 . . . . 0.0 110.387 178.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -99.0 127.8 45.0 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.755 -0.59 . . . . 0.0 110.187 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.2 m -94.63 -31.63 13.76 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.721 -0.612 . . . . 0.0 110.468 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -61.76 151.45 34.04 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.633 -0.667 . . . . 0.0 110.613 -178.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.2 mm -96.81 140.01 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.67 -0.643 . . . . 0.0 109.758 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -97.3 116.19 29.05 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.603 -0.686 . . . . 0.0 110.297 -177.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -50.96 -40.35 57.34 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.701 -0.625 . . . . 0.0 111.562 176.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -152.97 129.76 10.9 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.656 -0.652 . . . . 0.0 110.217 -174.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 71.2 mt -128.32 126.68 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.713 -0.617 . . . . 0.0 109.893 171.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.4 tp -91.42 137.12 32.62 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.87 -0.519 . . . . 0.0 109.9 176.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.413 ' CD1' HD12 ' A' ' 72' ' ' ILE . 7.3 m-85 -135.47 130.85 35.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.642 -0.661 . . . . 0.0 110.429 -176.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -89.56 151.38 21.97 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.716 -0.615 . . . . 0.0 110.076 174.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.4 -24.49 45.96 Favored Glycine 0 N--CA 1.5 2.929 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 86.5 p -76.82 -39.06 52.61 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.411 -1.052 . . . . 0.0 111.047 -177.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -82.04 -21.3 37.02 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.391 -0.818 . . . . 0.0 111.309 -173.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.413 HD12 ' CD1' ' A' ' 67' ' ' PHE . 45.1 mt -116.03 141.22 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.256 -0.902 . . . . 0.0 109.694 168.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -105.88 -14.3 15.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.86 -0.525 . . . . 0.0 111.87 -167.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -150.29 134.22 16.86 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 118.993 -1.083 . . . . 0.0 111.438 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 15.7 tt -132.04 140.63 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.94 -0.475 . . . . 0.0 109.826 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -147.05 138.04 23.85 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.624 -0.673 . . . . 0.0 110.344 178.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.9 t -87.2 146.1 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.573 -0.704 . . . . 0.0 109.656 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.3 t . . . . . 0 N--CA 1.498 1.932 0 O-C-N 121.52 -0.737 . . . . 0.0 109.788 -178.638 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.6 mt . . . . . 0 N--CA 1.501 2.085 0 CA-C-O 121.041 0.448 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.67 -1.96 84.36 Favored Glycine 0 N--CA 1.497 2.72 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.794 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.0 m -62.18 139.86 58.46 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.079 -1.247 . . . . 0.0 110.445 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.8 pttt -81.87 127.27 32.83 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.71 -0.619 . . . . 0.0 110.35 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 92.8 mt -124.94 145.13 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.597 -0.689 . . . . 0.0 110.223 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.2 t -102.84 137.25 41.29 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 13.8 tp -131.88 125.69 32.35 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.814 -0.554 . . . . 0.0 110.198 -170.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 80.9 mt -107.5 118.65 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.522 -0.736 . . . . 0.0 109.692 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.9 m -93.57 157.72 16.05 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.039 0.447 . . . . 0.0 111.293 -177.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -53.29 -15.02 0.82 Allowed 'General case' 0 N--CA 1.508 2.473 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -172.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.29 20.55 3.73 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.099 -1.001 . . . . 0.0 110.405 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 54.35 33.51 18.63 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.435 -0.791 . . . . 0.0 109.874 -174.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.7 mt -101.5 141.31 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -104.66 119.79 39.82 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.941 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -113.99 148.96 36.06 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 174.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -140.08 140.48 36.1 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.471 -0.768 . . . . 0.0 109.498 175.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.43 173.02 43.14 Favored Glycine 0 N--CA 1.496 2.683 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.665 -175.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 72.0 mtp85 -85.54 135.47 33.81 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.881 -0.776 . . . . 0.0 110.59 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.4 tp -66.16 119.53 11.63 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.668 -0.645 . . . . 0.0 110.679 176.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -99.57 -50.06 4.2 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.677 -0.64 . . . . 0.0 110.296 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.5 p -153.79 154.97 34.99 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.671 -0.643 . . . . 0.0 110.295 -178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.6 p -142.26 145.7 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.648 -0.657 . . . . 0.0 110.11 -178.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -128.64 98.3 25.51 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.591 -0.693 . . . . 0.0 109.554 177.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -59.42 -41.1 61.04 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 O-C-N 123.507 1.267 . . . . 0.0 110.924 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -80.66 -25.52 38.22 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.388 -0.82 . . . . 0.0 110.156 -171.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -87.46 2.19 51.28 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.463 -0.773 . . . . 0.0 111.254 173.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.8 m 49.73 38.79 16.23 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.122 -0.986 . . . . 0.0 111.254 -176.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.3 p -136.6 152.71 50.76 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.336 -0.852 . . . . 0.0 110.391 -174.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.0 pt -142.38 162.03 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.687 -0.633 . . . . 0.0 110.167 177.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.3 127.81 28.67 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.571 -0.706 . . . . 0.0 109.666 175.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 85.9 mt -109.9 148.03 32.31 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -177.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 96.8 p -119.41 152.8 36.23 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -178.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.8 p 45.65 84.38 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 CA-C-O 121.565 0.698 . . . . 0.0 110.301 -172.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.6 p -134.55 149.86 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.914 -0.491 . . . . 0.0 109.786 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -135.11 153.13 52.12 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.679 -0.638 . . . . 0.0 109.941 177.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.9 p -109.43 141.93 41.14 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.736 -0.603 . . . . 0.0 109.911 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -82.55 -38.36 23.84 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.591 -0.693 . . . . 0.0 110.678 -175.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.64 167.37 28.2 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 176.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.3 p -118.29 6.51 11.91 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.944 -0.739 . . . . 0.0 111.015 175.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -48.94 -25.89 2.19 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.582 -0.699 . . . . 0.0 112.784 -167.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -66.82 -59.21 3.74 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.287 -0.883 . . . . 0.0 110.417 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -94.39 10.21 35.24 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.633 -0.667 . . . . 0.0 111.225 176.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -58.32 174.07 0.32 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.232 -0.918 . . . . 0.0 111.552 -170.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.1 p -78.83 164.64 24.33 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 122.0 -0.438 . . . . 0.0 109.94 174.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -77.33 2.76 14.83 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.996 -0.681 . . . . 0.0 111.103 177.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -101.7 151.91 21.48 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.31 -0.869 . . . . 0.0 109.527 169.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -66.49 138.93 57.87 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.501 -0.749 . . . . 0.0 110.56 -174.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.7 mt -109.97 135.22 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.704 -0.622 . . . . 0.0 109.459 177.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -83.84 146.06 48.4 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.762 -0.587 . . . . 0.0 110.176 -178.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -68.44 156.96 63.79 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 O-C-N 123.522 1.275 . . . . 0.0 110.269 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -79.64 132.58 36.28 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.683 -0.636 . . . . 0.0 110.041 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.9 m -98.98 30.29 3.46 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.749 -0.594 . . . . 0.0 110.541 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -175.65 160.85 2.52 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.634 -0.666 . . . . 0.0 109.78 -177.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.0 mm -96.74 157.4 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.703 -0.623 . . . . 0.0 109.725 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -93.0 114.08 26.54 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.556 -0.715 . . . . 0.0 110.177 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -51.23 -42.34 60.94 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.9 -0.5 . . . . 0.0 111.711 178.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -152.72 129.95 11.23 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.685 -0.635 . . . . 0.0 110.292 -174.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 76.2 mt -129.6 129.14 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.652 -0.655 . . . . 0.0 109.85 172.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 24.8 tp -90.65 137.0 32.7 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.774 -0.579 . . . . 0.0 109.918 176.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.467 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 3.7 m-85 -135.59 129.44 32.91 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.67 -0.644 . . . . 0.0 110.635 -175.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 73.5 mtt85 -92.1 150.06 21.16 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.797 -0.565 . . . . 0.0 110.352 173.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.18 -24.43 61.0 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.9 m -66.57 -42.09 87.58 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.493 -1.004 . . . . 0.0 111.034 -176.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -83.16 -32.75 26.46 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.445 -0.785 . . . . 0.0 110.969 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.467 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 14.7 mt -101.38 138.61 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.395 -0.816 . . . . 0.0 110.174 177.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -106.37 -18.54 13.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.892 -0.505 . . . . 0.0 111.736 -167.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -150.0 131.25 14.56 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 119.001 -1.08 . . . . 0.0 111.242 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.6 tt -132.14 139.83 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 176.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -146.29 133.22 20.2 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.521 -0.737 . . . . 0.0 110.411 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.3 p -87.62 147.1 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.722 -0.611 . . . . 0.0 110.29 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.6 t . . . . . 0 N--CA 1.497 1.895 0 O-C-N 121.56 -0.712 . . . . 0.0 109.759 -179.638 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.4 mt . . . . . 0 N--CA 1.501 2.118 0 CA-C-O 120.915 0.388 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.79 -1.73 85.4 Favored Glycine 0 N--CA 1.498 2.78 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.561 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 45.8 m -59.36 155.58 14.43 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.129 -1.218 . . . . 0.0 110.484 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -81.35 124.49 29.41 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.734 -0.604 . . . . 0.0 110.794 -177.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 91.5 mt -121.92 146.16 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.661 -0.649 . . . . 0.0 110.017 178.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.6 t -103.19 137.26 41.58 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 176.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 13.9 tp -132.47 126.31 32.71 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.75 -0.594 . . . . 0.0 110.252 -170.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.1 mt -107.05 118.79 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.515 -0.741 . . . . 0.0 109.66 -178.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.0 m -93.59 157.71 16.05 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.039 0.447 . . . . 0.0 111.301 -177.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.5 tttm -53.99 -13.63 0.83 Allowed 'General case' 0 N--CA 1.508 2.441 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -172.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.9 20.37 4.23 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.107 -0.996 . . . . 0.0 110.426 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 53.86 34.45 19.36 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.521 -0.737 . . . . 0.0 109.865 -173.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 72.2 mt -102.27 140.96 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -104.67 119.8 39.85 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.009 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -113.84 150.3 33.75 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 175.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -141.45 140.54 33.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.423 -0.798 . . . . 0.0 109.796 174.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.53 173.1 43.2 Favored Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.764 -1.207 . . . . 0.0 110.377 -176.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -85.04 135.83 33.84 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.849 -0.795 . . . . 0.0 110.588 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.7 tp -66.08 120.02 12.43 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.583 -0.698 . . . . 0.0 110.716 175.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -99.78 -50.11 4.14 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.655 -0.653 . . . . 0.0 110.394 178.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.7 p -153.96 155.84 36.35 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.67 -0.644 . . . . 0.0 110.305 -178.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.4 p -142.22 145.81 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.697 -0.627 . . . . 0.0 110.081 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -128.66 101.78 20.51 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.629 -0.669 . . . . 0.0 109.54 177.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.44 -41.93 30.35 Favored 'Trans proline' 0 N--CA 1.49 1.276 0 O-C-N 123.553 1.291 . . . . 0.0 110.746 -174.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -80.76 -23.56 39.28 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.384 -0.822 . . . . 0.0 110.212 -172.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -87.26 0.75 54.89 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.476 -0.765 . . . . 0.0 111.178 173.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.3 m 49.91 38.14 15.41 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.157 -0.964 . . . . 0.0 111.255 -176.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.2 p -136.71 153.34 50.9 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.402 -0.811 . . . . 0.0 110.403 -174.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.9 pt -142.31 162.0 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.719 -0.613 . . . . 0.0 110.081 177.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.87 127.95 29.75 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.61 -0.681 . . . . 0.0 109.722 176.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.1 mt -109.88 147.73 32.84 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -177.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 95.7 p -118.51 151.42 37.87 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -178.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.7 p 45.8 84.05 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 CA-C-O 121.517 0.675 . . . . 0.0 110.341 -172.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.3 p -134.56 150.92 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.935 -0.478 . . . . 0.0 109.717 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -135.8 153.19 51.6 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.602 -0.686 . . . . 0.0 110.087 178.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.4 p -108.19 139.66 42.54 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.733 -0.604 . . . . 0.0 109.834 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -82.94 -38.33 22.93 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.657 -0.652 . . . . 0.0 111.056 -173.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.67 172.22 34.52 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 119.975 -1.107 . . . . 0.0 110.522 177.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.01 6.58 12.15 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.928 -0.748 . . . . 0.0 110.739 174.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -48.99 -25.2 1.84 Allowed 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.618 -0.676 . . . . 0.0 112.528 -169.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -64.42 -59.19 4.64 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.291 -0.881 . . . . 0.0 110.574 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -94.29 10.22 35.0 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.612 -0.68 . . . . 0.0 111.408 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.5 p-10 -61.4 174.19 0.77 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.279 -0.888 . . . . 0.0 111.244 -171.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.8 p -78.91 164.59 24.32 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.922 -0.486 . . . . 0.0 109.876 174.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -77.46 2.57 15.78 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.081 177.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -97.86 166.05 11.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.126 -0.984 . . . . 0.0 109.513 169.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -65.97 140.54 58.32 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.543 -0.723 . . . . 0.0 110.451 -175.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.9 mp -111.95 141.91 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.702 -0.624 . . . . 0.0 109.705 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -92.06 109.87 40.34 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.65 -0.656 . . . . 0.0 110.178 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -66.79 146.96 80.18 Favored 'Trans proline' 0 N--CA 1.489 1.258 0 O-C-N 123.373 1.196 . . . . 0.0 110.428 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -96.81 117.24 30.63 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.678 -0.639 . . . . 0.0 110.165 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 86.8 p -88.29 -28.73 20.89 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.732 -0.605 . . . . 0.0 110.609 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -62.13 146.86 49.33 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.539 -0.726 . . . . 0.0 110.693 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.3 mm -96.77 144.72 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.695 -0.628 . . . . 0.0 109.708 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -94.97 114.54 26.37 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.586 -0.696 . . . . 0.0 110.285 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -51.08 -40.22 57.87 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.781 -0.575 . . . . 0.0 111.728 177.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -152.97 129.92 11.02 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.637 -0.664 . . . . 0.0 110.257 -174.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 74.3 mt -129.33 129.35 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.678 -0.639 . . . . 0.0 109.798 171.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.0 tp -90.38 137.06 32.66 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.87 -0.519 . . . . 0.0 109.865 176.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.466 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 3.2 m-85 -135.75 129.75 33.07 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.604 -0.685 . . . . 0.0 110.579 -175.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -92.08 150.18 21.1 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.748 -0.595 . . . . 0.0 110.325 173.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.29 -24.49 61.33 Favored Glycine 0 N--CA 1.498 2.818 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 177.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.5 m -66.59 -42.12 87.42 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.472 -1.016 . . . . 0.0 111.115 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -83.0 -32.94 26.68 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.415 -0.803 . . . . 0.0 110.905 -175.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.466 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 13.9 mt -100.77 139.89 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.418 -0.802 . . . . 0.0 110.124 177.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.0 tptm -106.27 -21.28 13.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.937 -0.477 . . . . 0.0 111.606 -166.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -150.63 135.28 17.32 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 119.037 -1.065 . . . . 0.0 111.353 -177.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.3 tt -133.2 142.13 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -146.44 139.02 25.24 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.535 -0.728 . . . . 0.0 110.411 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.0 t -87.2 144.48 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.621 -0.674 . . . . 0.0 109.638 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.8 t . . . . . 0 N--CA 1.496 1.863 0 O-C-N 121.492 -0.755 . . . . 0.0 109.831 -178.391 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.4 mt . . . . . 0 N--CA 1.501 2.096 0 CA-C-O 121.031 0.443 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.73 -1.87 84.83 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.763 177.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 67.0 m -61.39 137.64 58.24 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.138 -1.213 . . . . 0.0 110.411 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -82.15 124.36 29.8 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.72 -0.612 . . . . 0.0 110.611 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 88.1 mt -121.16 145.12 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.644 -0.66 . . . . 0.0 110.17 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.8 t -103.44 137.27 41.77 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 175.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 13.8 tp -133.04 125.96 30.83 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.68 -0.638 . . . . 0.0 110.259 -169.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.0 mt -106.68 117.84 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.47 -0.769 . . . . 0.0 109.683 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.0 m -93.04 157.83 16.1 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.06 0.457 . . . . 0.0 111.254 -177.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -54.03 -13.9 0.92 Allowed 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -171.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.09 20.6 4.19 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.094 -1.004 . . . . 0.0 110.408 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 54.37 34.16 20.11 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.512 -0.743 . . . . 0.0 109.788 -174.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.8 mt -102.47 141.82 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 36.8 ttp180 -104.85 119.86 40.01 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.973 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -114.0 150.3 34.08 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 174.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -140.7 140.47 34.92 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.535 -0.728 . . . . 0.0 109.515 175.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.58 172.69 43.13 Favored Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.657 -175.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -85.08 136.15 33.69 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.908 -0.76 . . . . 0.0 110.532 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.5 tp -66.14 118.83 10.44 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.62 -0.675 . . . . 0.0 110.716 175.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -100.03 -50.13 4.09 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.662 -0.649 . . . . 0.0 110.376 177.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.8 p -154.09 153.74 32.41 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.701 -0.625 . . . . 0.0 110.284 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.3 p -142.19 145.24 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.656 -0.652 . . . . 0.0 110.033 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -128.22 100.48 23.26 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.625 -0.672 . . . . 0.0 109.457 176.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.34 -42.79 26.09 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 O-C-N 123.496 1.261 . . . . 0.0 110.792 -174.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -80.2 -27.33 38.87 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.295 -0.878 . . . . 0.0 109.95 -172.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -89.24 12.04 17.12 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.62 -0.675 . . . . 0.0 111.268 172.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 6.3 p 47.48 33.62 2.94 Favored 'General case' 0 N--CA 1.507 2.411 0 O-C-N 121.783 -0.573 . . . . 0.0 112.034 173.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.1 p -136.56 154.73 50.62 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.458 -0.776 . . . . 0.0 110.432 -173.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.0 pt -142.45 162.03 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.704 -0.622 . . . . 0.0 110.158 177.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.01 127.76 27.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.678 -0.639 . . . . 0.0 109.735 175.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 87.4 mt -109.91 148.04 32.29 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -177.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 95.8 p -119.44 152.93 36.05 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.5 p 45.79 84.29 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 CA-C-O 121.494 0.664 . . . . 0.0 110.271 -172.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.9 p -134.52 151.26 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -135.97 153.2 51.48 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.629 -0.669 . . . . 0.0 109.947 177.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 84.5 p -107.61 139.34 42.3 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.703 -0.623 . . . . 0.0 109.763 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -82.49 -38.36 23.99 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.626 -0.671 . . . . 0.0 110.941 -173.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.56 169.95 31.75 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 120.032 -1.08 . . . . 0.0 110.417 176.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 p -118.08 6.6 12.09 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.906 -0.761 . . . . 0.0 110.886 174.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -48.99 -26.03 2.3 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.649 -0.657 . . . . 0.0 112.504 -167.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -64.98 -59.23 4.39 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.267 -0.896 . . . . 0.0 110.555 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 82.5 mmt-85 -94.35 10.25 35.0 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.655 -0.653 . . . . 0.0 111.335 177.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.8 p-10 -60.15 173.46 0.64 Allowed 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.224 -0.923 . . . . 0.0 111.518 -169.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.3 m -78.92 164.45 24.42 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 173.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -77.33 3.34 13.31 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.596 -0.69 . . . . 0.0 111.309 -178.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -102.12 154.92 18.55 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.242 -0.911 . . . . 0.0 109.637 170.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -67.21 141.09 57.42 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.557 -0.714 . . . . 0.0 110.605 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 81.3 mt -114.91 137.04 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.658 -0.651 . . . . 0.0 109.596 177.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.07 109.97 53.98 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.746 -0.597 . . . . 0.0 110.143 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -67.14 151.19 81.84 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 O-C-N 123.355 1.187 . . . . 0.0 110.345 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -94.03 123.95 37.73 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.691 -0.63 . . . . 0.0 110.245 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.0 m -66.29 -31.5 72.35 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.741 -0.6 . . . . 0.0 110.519 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -61.69 148.49 42.54 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.561 -0.712 . . . . 0.0 110.687 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.2 mm -96.83 156.57 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.743 -0.598 . . . . 0.0 109.767 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -93.45 112.44 24.35 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.677 -0.64 . . . . 0.0 110.171 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -51.17 -43.03 61.2 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.807 -0.558 . . . . 0.0 111.669 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -152.88 130.27 11.35 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.659 -0.65 . . . . 0.0 110.284 -174.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 74.9 mt -128.93 128.6 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.66 -0.65 . . . . 0.0 109.859 172.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.0 tp -90.42 137.05 32.66 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.902 -0.498 . . . . 0.0 109.862 176.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.458 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 2.9 m-85 -135.45 129.65 33.54 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.645 -0.66 . . . . 0.0 110.546 -175.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -91.26 147.39 23.08 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.684 -0.635 . . . . 0.0 110.239 173.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.89 -26.38 60.56 Favored Glycine 0 N--CA 1.498 2.818 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.0 m -65.87 -39.65 90.91 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.476 -1.014 . . . . 0.0 110.947 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.68 -32.54 31.7 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.462 -0.774 . . . . 0.0 110.858 -174.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.458 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 8.1 mt -102.83 140.85 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.382 -0.824 . . . . 0.0 110.156 177.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -105.04 -21.82 13.21 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.522 -167.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -151.39 134.27 15.75 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 119.068 -1.053 . . . . 0.0 111.368 -177.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.6 tt -131.5 140.09 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.882 -0.511 . . . . 0.0 109.739 176.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -146.83 142.83 28.1 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.548 -0.72 . . . . 0.0 110.4 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.4 m -85.03 147.03 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.653 -0.654 . . . . 0.0 110.183 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.9 t . . . . . 0 N--CA 1.497 1.904 0 O-C-N 121.587 -0.695 . . . . 0.0 109.771 -179.586 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.5 mt . . . . . 0 N--CA 1.501 2.109 0 CA-C-O 120.961 0.41 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.72 -1.8 85.02 Favored Glycine 0 N--CA 1.497 2.755 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.727 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.5 m -60.25 152.99 23.46 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.118 -1.225 . . . . 0.0 110.45 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.9 pttt -81.13 125.99 30.92 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.738 -0.601 . . . . 0.0 110.387 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 90.2 mt -124.3 143.79 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.547 -0.721 . . . . 0.0 110.129 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.5 t -101.66 137.25 40.22 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 174.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 15.2 tp -133.9 127.72 33.09 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.694 -0.629 . . . . 0.0 110.282 -169.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 81.9 mt -108.51 121.06 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.455 -0.778 . . . . 0.0 109.683 -178.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.3 m -94.51 157.62 15.92 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 120.981 0.42 . . . . 0.0 111.171 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -55.43 -11.5 0.85 Allowed 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -173.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.2 20.54 4.31 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.097 -1.002 . . . . 0.0 110.453 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 54.16 34.2 19.63 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.505 -0.747 . . . . 0.0 109.795 -174.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.2 mt -102.6 141.91 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -105.84 119.83 40.16 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.007 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -114.4 148.82 37.12 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 173.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -140.09 140.5 36.1 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.37 -0.831 . . . . 0.0 109.504 175.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.53 173.5 43.22 Favored Glycine 0 N--CA 1.496 2.651 0 C-N-CA 119.636 -1.269 . . . . 0.0 110.617 -175.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 39.6 mmm-85 -84.83 134.19 34.3 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.926 -0.75 . . . . 0.0 110.439 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.7 tp -66.21 118.62 10.18 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.605 -0.684 . . . . 0.0 110.61 175.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -99.43 -50.19 4.18 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.567 -0.708 . . . . 0.0 110.413 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.3 p -154.12 154.97 34.53 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.704 -0.622 . . . . 0.0 110.326 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.2 p -142.34 144.95 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.737 -0.602 . . . . 0.0 110.055 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -129.05 102.14 19.18 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.58 -0.7 . . . . 0.0 109.496 177.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.93 -38.04 50.08 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 O-C-N 123.652 1.343 . . . . 0.0 110.814 -174.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -80.42 -27.37 38.05 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.296 -0.878 . . . . 0.0 110.137 -170.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -87.85 2.51 51.26 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.512 -0.742 . . . . 0.0 111.28 173.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 55.5 m 49.3 40.02 17.33 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.077 -1.014 . . . . 0.0 111.326 -176.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.6 p -135.92 153.13 51.53 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.357 -0.839 . . . . 0.0 110.411 -174.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.4 pt -142.63 162.01 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.685 -0.634 . . . . 0.0 110.082 178.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.42 128.22 29.15 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.655 -0.653 . . . . 0.0 109.741 175.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 88.7 mt -109.92 147.36 33.55 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 99.7 p -117.99 151.77 36.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.619 -0.676 . . . . 0.0 109.24 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.3 p 45.94 85.17 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 CA-C-O 121.574 0.702 . . . . 0.0 110.352 -172.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.3 p -134.66 150.55 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -178.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -133.38 153.09 51.89 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.6 -0.688 . . . . 0.0 109.941 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 84.0 p -110.14 140.01 44.68 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.656 -0.653 . . . . 0.0 109.875 178.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -82.89 -38.46 22.86 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.6 -0.688 . . . . 0.0 110.893 -174.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.59 168.65 30.05 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 176.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.13 6.48 12.04 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.863 -0.786 . . . . 0.0 111.03 174.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -49.06 -26.49 2.68 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.556 -0.715 . . . . 0.0 112.314 -168.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -66.34 -59.22 3.91 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.348 -0.845 . . . . 0.0 110.35 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -94.25 10.22 34.9 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.66 -0.65 . . . . 0.0 111.354 177.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 49.9 p-10 -58.71 172.91 0.46 Allowed 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.252 -0.905 . . . . 0.0 111.261 -170.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.8 m -78.99 164.44 24.39 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.942 -0.474 . . . . 0.0 109.743 175.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -77.39 2.89 14.61 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.646 -0.659 . . . . 0.0 111.246 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -98.58 165.08 11.98 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.332 -0.855 . . . . 0.0 109.551 170.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -67.88 135.52 52.62 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.51 -0.744 . . . . 0.0 110.439 -175.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 45.5 mm -114.1 132.82 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.726 -0.609 . . . . 0.0 109.58 177.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.03 137.28 29.69 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.717 -0.615 . . . . 0.0 110.136 -178.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -69.81 145.95 58.38 Favored 'Trans proline' 0 N--CA 1.488 1.155 0 O-C-N 123.463 1.244 . . . . 0.0 110.244 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -100.6 115.15 29.5 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.681 -0.637 . . . . 0.0 110.198 178.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 28.6 m -85.24 -33.01 22.3 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.7 -0.625 . . . . 0.0 110.329 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -62.37 143.93 56.4 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.687 -0.633 . . . . 0.0 110.567 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.4 mm -96.76 149.96 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.649 -0.657 . . . . 0.0 109.814 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -94.37 115.66 27.9 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.644 -0.66 . . . . 0.0 110.208 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -51.31 -40.97 60.16 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.769 -0.582 . . . . 0.0 111.804 178.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -153.38 130.51 11.13 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.686 -0.634 . . . . 0.0 110.316 -174.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 78.3 mt -129.88 129.61 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.659 -0.65 . . . . 0.0 109.895 172.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 24.5 tp -90.42 137.06 32.65 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.862 -0.524 . . . . 0.0 109.898 176.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.451 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 2.9 m-85 -135.53 130.29 34.36 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.701 -0.624 . . . . 0.0 110.45 -175.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -91.17 147.53 22.99 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.762 -0.586 . . . . 0.0 110.272 173.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.08 -25.63 60.03 Favored Glycine 0 N--CA 1.499 2.865 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.8 m -65.92 -39.36 90.48 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.46 -1.024 . . . . 0.0 110.898 -178.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -82.36 -32.5 29.23 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.541 -0.725 . . . . 0.0 111.055 -175.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.451 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 10.1 mt -104.84 141.35 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.412 -0.805 . . . . 0.0 110.209 177.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -106.98 -24.19 12.08 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.891 -0.505 . . . . 0.0 111.659 -166.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -150.62 139.15 20.55 Favored 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 119.013 -1.075 . . . . 0.0 111.359 -176.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.2 tt -134.16 143.85 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.996 -0.44 . . . . 0.0 110.023 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -143.03 127.19 17.52 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.65 -0.656 . . . . 0.0 110.052 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.5 p -87.7 145.77 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.56 -0.713 . . . . 0.0 110.434 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.9 t . . . . . 0 N--CA 1.497 1.898 0 O-C-N 121.629 -0.669 . . . . 0.0 109.78 179.502 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.9 mt . . . . . 0 N--CA 1.5 2.055 0 CA-C-O 120.948 0.404 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.65 -1.88 84.59 Favored Glycine 0 N--CA 1.497 2.73 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.808 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.9 m -60.81 153.01 25.6 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 120.997 -1.296 . . . . 0.0 110.445 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.5 pttt -82.05 126.92 32.56 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.714 -0.616 . . . . 0.0 110.67 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 86.3 mt -118.6 142.39 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.581 -0.699 . . . . 0.0 109.941 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.6 t -103.67 137.34 41.85 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 175.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 13.7 tp -135.96 127.89 29.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.665 -0.647 . . . . 0.0 110.487 -169.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 79.5 mt -107.17 120.56 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.507 -0.746 . . . . 0.0 109.609 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.0 m -95.15 157.58 15.83 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.027 0.441 . . . . 0.0 111.134 -177.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -56.43 -11.44 1.26 Allowed 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -173.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.77 22.01 3.29 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.124 -0.985 . . . . 0.0 110.348 177.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 57.55 34.48 24.62 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.56 -0.713 . . . . 0.0 110.12 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.8 mt -107.27 148.97 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.713 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -107.83 119.71 40.22 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.07 175.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -113.41 154.07 27.56 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 175.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -142.83 140.47 31.31 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.596 -0.69 . . . . 0.0 109.521 173.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -164.17 169.77 39.15 Favored Glycine 0 N--CA 1.496 2.657 0 C-N-CA 119.648 -1.263 . . . . 0.0 110.619 -176.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -84.61 137.43 33.29 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.911 -0.758 . . . . 0.0 110.525 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.8 tp -66.14 117.55 8.62 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.629 -0.669 . . . . 0.0 110.645 175.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -99.88 -50.15 4.11 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.585 -0.697 . . . . 0.0 110.309 177.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.2 p -153.7 153.61 32.56 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.709 -0.619 . . . . 0.0 110.233 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.3 p -142.26 145.1 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.709 -0.619 . . . . 0.0 110.096 -178.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -129.04 102.2 19.16 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.669 -0.644 . . . . 0.0 109.477 176.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.71 -39.42 43.28 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 O-C-N 123.575 1.303 . . . . 0.0 110.863 -174.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -80.49 -26.4 38.23 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.339 -0.851 . . . . 0.0 110.152 -170.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -87.6 2.13 51.75 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.532 -0.73 . . . . 0.0 111.292 173.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.3 m 49.65 40.16 19.09 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 120.996 -1.065 . . . . 0.0 111.229 -176.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.3 p -136.54 151.84 49.84 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.383 -0.823 . . . . 0.0 110.397 -174.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.1 pt -142.65 161.97 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.637 -0.664 . . . . 0.0 110.226 177.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.46 127.51 29.75 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.629 -0.669 . . . . 0.0 109.695 175.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 83.9 mt -109.99 145.23 37.32 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -177.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.8 p -116.73 152.36 34.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.625 -0.672 . . . . 0.0 109.195 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 44.9 p 45.81 86.43 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.225 0 CA-C-O 121.502 0.668 . . . . 0.0 110.288 -172.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.9 p -134.65 147.73 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -129.1 153.03 48.05 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.748 -0.595 . . . . 0.0 109.754 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.5 p -107.51 121.81 45.37 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -83.09 -38.53 22.36 Favored 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.964 -169.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.4 -177.51 41.86 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.5 p -118.12 -2.41 11.22 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.794 -0.827 . . . . 0.0 110.645 172.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -54.41 -24.92 21.85 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.379 -0.825 . . . . 0.0 112.528 -162.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -77.07 -59.47 2.77 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.252 -0.905 . . . . 0.0 110.928 -174.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 70.7 mtp85 -94.51 6.15 49.66 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.631 -0.668 . . . . 0.0 112.098 -175.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.8 p-10 -89.32 174.45 7.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.092 -1.005 . . . . 0.0 111.295 -172.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.8 m -78.76 164.47 24.53 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.056 0.455 . . . . 0.0 110.013 178.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -77.66 9.24 3.55 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.743 -0.598 . . . . 0.0 111.71 -176.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -87.98 155.18 19.96 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.098 -1.001 . . . . 0.0 109.948 172.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -67.15 129.94 41.51 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.698 -0.627 . . . . 0.0 110.827 -172.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 82.4 mt -129.0 140.63 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.737 -0.602 . . . . 0.0 109.444 175.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.0 109.84 53.27 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.547 -0.72 . . . . 0.0 110.371 -178.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -77.63 157.07 32.03 Favored 'Trans proline' 0 N--CA 1.486 1.066 0 O-C-N 123.449 1.237 . . . . 0.0 110.432 176.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -114.67 131.22 56.81 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.656 -0.652 . . . . 0.0 110.14 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.6 m -97.06 12.41 32.71 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.69 -0.631 . . . . 0.0 111.333 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -63.62 145.07 56.42 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.308 -0.87 . . . . 0.0 110.564 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.81 128.94 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.613 -0.68 . . . . 0.0 109.863 178.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -98.99 119.53 37.92 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.689 -0.632 . . . . 0.0 110.376 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -51.75 -41.22 61.43 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.715 -0.615 . . . . 0.0 111.252 173.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -153.98 128.82 9.46 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.686 -0.634 . . . . 0.0 110.103 -175.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 67.4 mt -126.31 130.33 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.639 -0.663 . . . . 0.0 109.879 172.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.5 tp -89.94 137.06 32.65 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.838 -0.539 . . . . 0.0 109.686 175.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.463 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 3.3 m-85 -133.8 126.5 30.71 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.706 -0.621 . . . . 0.0 110.55 -175.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -92.71 149.95 20.99 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.689 -0.632 . . . . 0.0 110.305 172.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.83 -24.01 57.02 Favored Glycine 0 N--CA 1.498 2.821 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 177.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.0 p -68.32 -42.05 79.94 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.409 -1.053 . . . . 0.0 111.115 -176.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -82.98 -29.38 29.04 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.331 -0.856 . . . . 0.0 111.028 -175.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.463 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 15.4 mt -103.74 140.7 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.416 -0.802 . . . . 0.0 110.255 176.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -105.74 -19.83 13.64 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.912 -0.492 . . . . 0.0 111.552 -168.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -149.98 131.55 14.86 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 119.046 -1.062 . . . . 0.0 111.319 -178.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.7 tt -129.88 138.81 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.979 -0.451 . . . . 0.0 109.809 176.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 90.6 mtt-85 -146.89 137.94 23.99 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.543 -0.723 . . . . 0.0 110.421 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.6 t -87.17 143.76 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.658 -0.652 . . . . 0.0 109.693 178.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.9 t . . . . . 0 N--CA 1.496 1.872 0 O-C-N 121.541 -0.724 . . . . 0.0 109.885 -178.5 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.1 mt . . . . . 0 N--CA 1.502 2.159 0 CA-C-O 121.05 0.452 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.57 -2.37 82.78 Favored Glycine 0 N--CA 1.497 2.765 0 C-N-CA 120.699 -0.763 . . . . 0.0 111.944 175.196 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.1 m -64.29 150.62 45.71 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.168 -1.195 . . . . 0.0 110.389 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -81.42 127.84 33.22 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.623 -0.673 . . . . 0.0 110.052 175.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 88.4 mt -125.12 143.92 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.435 -0.791 . . . . 0.0 110.299 -178.317 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.6 t -102.19 137.28 40.66 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 173.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 12.6 tp -134.66 130.6 36.61 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.675 -0.641 . . . . 0.0 110.292 -170.183 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.2 mt -107.12 121.49 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.508 -0.745 . . . . 0.0 109.743 -178.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.6 m -93.95 157.86 15.91 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.033 0.444 . . . . 0.0 111.23 -178.129 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -53.35 -15.41 0.99 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -171.045 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.17 20.65 4.21 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.148 -0.97 . . . . 0.0 110.433 -179.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 54.1 34.98 21.2 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.446 -0.784 . . . . 0.0 109.805 -174.511 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.8 mt -102.89 143.1 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.21 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -103.77 119.83 39.72 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.159 -178.614 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -113.7 149.7 34.36 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 175.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -141.17 140.6 34.08 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.418 -0.801 . . . . 0.0 109.815 175.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.35 172.84 43.04 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 119.716 -1.231 . . . . 0.0 110.529 -175.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 80.8 mtt85 -86.0 135.91 33.46 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.888 -0.772 . . . . 0.0 110.62 179.05 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.6 tp -66.17 118.0 9.27 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.605 -0.684 . . . . 0.0 110.663 176.6 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -100.24 -50.14 4.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.627 -0.67 . . . . 0.0 110.55 179.093 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.7 p -154.63 155.61 34.99 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.603 -0.686 . . . . 0.0 110.382 -178.024 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.2 p -142.31 145.92 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.744 -0.597 . . . . 0.0 110.009 -179.425 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -128.92 100.26 21.2 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.603 -0.686 . . . . 0.0 109.503 177.581 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.58 -37.16 60.09 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 O-C-N 123.599 1.315 . . . . 0.0 110.793 -175.17 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -80.07 -27.98 39.26 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.379 -0.826 . . . . 0.0 110.061 -171.251 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -88.23 2.6 51.92 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.545 -0.722 . . . . 0.0 111.235 174.011 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 39.0 m 49.44 40.66 19.41 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.007 -1.058 . . . . 0.0 111.198 -175.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.2 p -135.73 154.49 51.23 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.436 -0.79 . . . . 0.0 110.381 -175.166 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.0 pt -141.94 162.03 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.718 -0.614 . . . . 0.0 110.142 177.675 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.9 128.37 28.43 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.695 -0.628 . . . . 0.0 109.802 175.482 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 85.0 mt -109.81 147.01 34.06 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -178.536 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 87.6 p -115.71 150.12 37.33 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -177.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 52.5 p 45.73 85.36 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 121.504 0.668 . . . . 0.0 110.29 -172.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.0 p -134.64 152.33 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -178.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -136.39 153.09 51.2 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.503 -0.748 . . . . 0.0 110.236 179.037 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.6 p -109.69 136.3 49.25 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.764 -0.585 . . . . 0.0 109.637 176.576 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -83.04 -38.59 22.36 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.537 -0.727 . . . . 0.0 111.19 -172.533 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.4 174.94 36.93 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.912 -1.137 . . . . 0.0 110.515 176.195 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.4 p -116.75 6.53 13.26 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.834 -0.804 . . . . 0.0 110.528 169.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -52.35 -24.56 7.82 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.615 -0.678 . . . . 0.0 112.597 -166.451 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -64.14 -59.43 4.45 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.154 -0.966 . . . . 0.0 110.604 -176.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 39.6 mtp85 -94.54 10.2 35.61 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.55 -0.719 . . . . 0.0 111.393 176.512 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.5 p-10 -58.91 172.29 0.57 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.234 -0.916 . . . . 0.0 111.552 -169.161 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.8 m -85.0 164.49 18.23 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 174.717 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -77.47 3.81 12.55 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.642 -0.661 . . . . 0.0 111.287 -179.364 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -95.17 157.48 15.88 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.247 -0.908 . . . . 0.0 109.683 168.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -70.52 139.25 51.54 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.645 -0.659 . . . . 0.0 110.538 -176.004 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.7 mt -115.36 136.23 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.725 -0.61 . . . . 0.0 109.556 176.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.11 113.08 12.87 Favored Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 121.707 -0.621 . . . . 0.0 110.138 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -66.93 143.76 67.67 Favored 'Trans proline' 0 N--CA 1.488 1.188 0 O-C-N 123.389 1.205 . . . . 0.0 110.392 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -97.82 114.7 26.8 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.72 -0.612 . . . . 0.0 110.216 -179.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.6 t -101.54 -32.95 10.13 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.721 -0.612 . . . . 0.0 110.306 179.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -62.24 151.49 36.13 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.627 -0.671 . . . . 0.0 110.634 -178.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.2 mm -96.81 142.71 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.808 -0.557 . . . . 0.0 109.79 179.672 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -94.82 118.09 31.2 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.613 -0.679 . . . . 0.0 110.137 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -51.14 -42.36 60.7 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.859 -0.525 . . . . 0.0 111.732 178.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -152.7 130.88 11.95 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.609 -0.682 . . . . 0.0 110.182 -174.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 75.5 mt -129.73 127.45 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.625 -0.672 . . . . 0.0 109.859 172.148 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 23.9 tp -90.2 137.1 32.62 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.817 -0.552 . . . . 0.0 109.741 175.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.425 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 3.6 m-85 -136.57 131.16 33.43 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.629 -0.67 . . . . 0.0 110.6 -175.691 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -90.71 149.18 22.15 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.781 -0.575 . . . . 0.0 110.187 174.741 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.26 -25.06 59.69 Favored Glycine 0 N--CA 1.5 2.912 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 178.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.9 m -65.91 -40.55 91.6 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.412 -1.052 . . . . 0.0 110.885 -178.432 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.95 -34.42 29.8 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.631 -0.668 . . . . 0.0 110.929 -174.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.425 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 13.9 mt -105.94 140.26 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.429 -0.794 . . . . 0.0 110.11 177.617 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 47.8 tttm -107.27 -24.62 11.82 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.839 -164.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -149.12 140.78 23.5 Favored 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.548 -174.414 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 15.4 tt -134.09 147.81 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.939 -0.475 . . . . 0.0 110.106 179.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -147.02 129.75 16.1 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.597 -0.69 . . . . 0.0 110.287 176.59 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 51.4 t -87.4 146.05 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.657 -0.652 . . . . 0.0 109.83 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 50.2 t . . . . . 0 N--CA 1.498 1.957 0 O-C-N 121.573 -0.704 . . . . 0.0 109.711 179.99 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.5 mt . . . . . 0 N--CA 1.5 2.064 0 CA-C-O 121.002 0.43 . . . . 0.0 110.675 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.7 -1.96 84.46 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.826 177.287 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.7 m -61.99 136.34 57.92 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.13 -1.218 . . . . 0.0 110.405 179.283 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.3 pttt -81.83 126.4 31.82 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.655 -0.653 . . . . 0.0 110.475 179.761 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 92.7 mt -124.84 145.07 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.523 -0.736 . . . . 0.0 110.203 179.501 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.8 t -102.8 137.26 41.25 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.582 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 17.3 tp -134.9 126.76 29.36 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.788 -0.57 . . . . 0.0 110.282 -168.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 81.3 mt -108.74 120.91 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.557 -0.714 . . . . 0.0 109.697 -178.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.2 m -93.54 157.78 16.03 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.146 0.498 . . . . 0.0 111.216 -176.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -54.27 -13.77 0.97 Allowed 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -172.159 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.19 20.03 3.96 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.147 -0.97 . . . . 0.0 110.436 179.081 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 55.64 35.78 25.9 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.503 -0.748 . . . . 0.0 109.821 -176.241 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 60.6 mt -105.81 145.63 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -105.4 119.82 40.05 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.25 -179.313 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -114.53 151.04 33.98 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 174.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -142.29 140.64 32.25 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.35 -0.844 . . . . 0.0 109.818 174.354 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.22 173.08 43.01 Favored Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.526 -175.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 56.4 mtm180 -85.71 136.03 33.52 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.867 -0.784 . . . . 0.0 110.573 179.164 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 28.0 tp -66.17 119.99 12.43 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.62 -0.675 . . . . 0.0 110.738 175.343 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -99.68 -50.03 4.19 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.764 -0.585 . . . . 0.0 110.347 177.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.2 p -153.98 155.58 35.85 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.642 -0.661 . . . . 0.0 110.233 -178.39 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.5 p -142.31 145.56 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.654 -0.654 . . . . 0.0 110.093 -178.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -127.33 98.62 29.04 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.65 -0.656 . . . . 0.0 109.602 177.645 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -59.3 -42.39 50.01 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 O-C-N 123.636 1.335 . . . . 0.0 111.03 -175.763 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -80.63 -25.14 38.55 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.405 -0.809 . . . . 0.0 110.199 -171.13 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -87.33 1.67 52.57 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.438 -0.789 . . . . 0.0 111.18 173.605 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 38.7 m 49.87 38.55 16.25 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 121.13 -0.981 . . . . 0.0 111.226 -177.009 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.6 p -135.77 154.28 51.27 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.394 -0.816 . . . . 0.0 110.407 -175.128 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.9 pt -143.1 161.87 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.638 -0.664 . . . . 0.0 110.204 178.634 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.9 127.93 27.69 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.652 -0.655 . . . . 0.0 109.692 175.524 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 87.4 mt -109.91 147.78 32.79 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -177.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 91.8 p -118.33 151.43 37.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.641 -0.662 . . . . 0.0 109.226 -177.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 44.1 p 45.63 83.66 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 121.543 0.687 . . . . 0.0 110.376 -172.197 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.3 p -134.63 150.53 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.406 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -136.36 153.19 51.19 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.638 -0.663 . . . . 0.0 110.128 178.554 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.0 p -108.4 137.16 46.83 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.736 -0.602 . . . . 0.0 109.546 177.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -83.01 -38.57 22.44 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 119.833 -0.747 . . . . 0.0 111.063 -172.017 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.32 167.55 28.16 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 175.614 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.2 p -118.3 -13.84 9.83 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.875 -0.779 . . . . 0.0 110.84 171.289 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -52.52 -24.59 8.38 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.398 -0.814 . . . . 0.0 112.482 -165.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -78.22 -59.36 2.81 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.287 -0.883 . . . . 0.0 110.836 -176.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -94.55 10.12 35.91 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.52 -0.738 . . . . 0.0 111.956 -174.668 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.9 p-10 -93.18 174.6 7.14 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.056 -1.028 . . . . 0.0 111.19 -174.584 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.4 m -78.48 164.58 24.62 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.967 -0.458 . . . . 0.0 109.783 177.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -77.49 11.78 1.87 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.662 -0.649 . . . . 0.0 111.671 -174.015 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -91.32 143.36 26.72 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.121 -0.987 . . . . 0.0 109.73 170.07 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -66.04 140.21 58.25 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.712 -0.618 . . . . 0.0 110.953 -171.013 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 83.9 mt -120.88 142.02 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 176.417 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.3 112.81 10.15 Favored Pre-proline 0 N--CA 1.501 2.084 0 O-C-N 121.628 -0.67 . . . . 0.0 110.204 -179.492 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -63.8 141.89 80.4 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 O-C-N 123.345 1.181 . . . . 0.0 110.614 -179.271 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -107.9 107.16 17.75 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.655 -0.653 . . . . 0.0 110.199 179.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.2 t -103.36 -34.87 8.6 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.713 -0.617 . . . . 0.0 110.2 179.47 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -62.84 157.45 21.37 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.674 -0.641 . . . . 0.0 110.611 -179.479 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.8 mm -96.75 136.98 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.698 -0.626 . . . . 0.0 109.686 179.071 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -96.05 117.2 30.21 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.62 -0.675 . . . . 0.0 110.356 -178.2 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -51.23 -40.46 58.84 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.827 -0.546 . . . . 0.0 111.629 177.229 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -152.33 130.2 11.71 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.615 -0.678 . . . . 0.0 110.35 -174.471 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 77.2 mt -129.66 126.68 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.671 -0.643 . . . . 0.0 109.798 171.527 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 19.2 tp -90.57 137.13 32.6 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.77 -0.581 . . . . 0.0 109.841 176.226 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.453 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 4.6 m-85 -137.07 132.58 34.35 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.653 -0.655 . . . . 0.0 110.585 -175.281 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -90.69 148.13 22.81 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.71 -0.619 . . . . 0.0 110.269 173.579 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.21 -25.65 60.35 Favored Glycine 0 N--CA 1.499 2.854 0 N-CA-C 110.521 -1.031 . . . . 0.0 110.521 179.363 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.4 p -67.41 -38.26 84.36 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.419 -1.048 . . . . 0.0 110.842 -177.45 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -82.48 -32.57 28.79 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.432 -0.792 . . . . 0.0 110.841 -175.394 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.453 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 10.6 mt -106.41 134.19 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.496 -0.752 . . . . 0.0 109.923 176.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.4 tttp -108.75 -10.98 15.11 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 120.485 -0.486 . . . . 0.0 112.077 -166.68 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -147.8 129.63 15.22 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.876 -1.14 . . . . 0.0 111.155 -179.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.1 tt -137.96 139.48 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.958 -0.464 . . . . 0.0 110.017 178.197 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 82.5 mtm-85 -147.12 136.86 23.04 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.54 -0.725 . . . . 0.0 110.51 176.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.3 p -87.13 147.04 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.688 -0.632 . . . . 0.0 110.1 177.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.4 t . . . . . 0 N--CA 1.498 1.953 0 O-C-N 121.624 -0.673 . . . . 0.0 109.772 -178.835 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.3 mt . . . . . 0 N--CA 1.502 2.14 0 CA-C-O 121.055 0.455 . . . . 0.0 110.683 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.71 -1.96 84.49 Favored Glycine 0 N--CA 1.496 2.682 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.809 177.712 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 74.8 m -62.38 142.73 57.68 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.09 -1.241 . . . . 0.0 110.477 179.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -82.03 126.81 32.42 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.693 -0.63 . . . . 0.0 110.386 178.289 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 90.5 mt -123.97 145.02 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.584 -0.697 . . . . 0.0 110.148 -179.725 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.6 t -103.33 137.29 41.65 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 176.12 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 14.5 tp -133.23 123.18 25.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.776 -0.578 . . . . 0.0 110.263 -169.662 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 79.8 mt -106.31 116.87 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.427 -0.796 . . . . 0.0 109.711 -178.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.5 m -92.83 157.71 16.25 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 120.955 0.407 . . . . 0.0 111.231 -177.101 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -54.61 -11.81 0.63 Allowed 'General case' 0 N--CA 1.509 2.49 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -171.608 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.22 20.0 4.69 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.083 -1.01 . . . . 0.0 110.45 179.386 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 54.66 33.52 19.49 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.52 -0.738 . . . . 0.0 109.853 -174.285 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.7 mt -102.52 140.93 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.441 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -104.83 119.77 39.8 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.994 -0.683 . . . . 0.0 109.939 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -114.25 149.43 35.87 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 174.403 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -140.34 140.46 35.6 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.584 -0.698 . . . . 0.0 109.54 175.154 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.4 172.65 42.4 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.624 -175.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -85.38 135.61 33.81 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.956 -0.732 . . . . 0.0 110.504 179.097 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.8 tp -66.14 120.82 13.87 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.597 -0.689 . . . . 0.0 110.663 176.13 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -99.19 -49.96 4.3 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.666 -0.646 . . . . 0.0 110.257 178.194 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.0 p -153.38 156.77 38.9 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.742 -0.599 . . . . 0.0 110.068 -179.162 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.6 p -142.25 145.9 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.658 -0.651 . . . . 0.0 110.227 -177.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -128.26 101.49 21.96 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.609 -0.682 . . . . 0.0 109.507 177.022 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.38 -41.2 34.89 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 O-C-N 123.579 1.305 . . . . 0.0 110.839 -174.459 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -80.7 -24.57 38.75 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.283 -0.886 . . . . 0.0 110.203 -171.732 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -87.31 1.31 53.63 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.474 -0.767 . . . . 0.0 111.262 173.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.9 m 49.86 38.14 15.21 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.042 -1.036 . . . . 0.0 111.276 -176.698 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.6 p -136.45 153.52 51.03 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.477 -0.764 . . . . 0.0 110.377 -174.27 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.8 pt -142.34 162.06 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.711 -0.618 . . . . 0.0 110.182 177.707 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.68 127.7 33.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.659 -0.651 . . . . 0.0 109.62 176.011 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 88.7 mt -109.94 149.45 29.9 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -176.481 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 91.8 p -123.1 154.33 38.73 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.134 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.5 p 45.41 83.76 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 121.492 0.663 . . . . 0.0 110.375 -171.805 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.4 p -134.55 149.74 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -178.537 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -134.84 153.21 52.13 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.622 -0.674 . . . . 0.0 109.982 178.766 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.2 p -107.32 138.55 43.3 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.671 -0.643 . . . . 0.0 109.894 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -83.07 -38.28 22.73 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.648 -0.658 . . . . 0.0 110.905 -174.282 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.74 170.32 32.37 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 178.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.8 p -118.03 6.75 12.14 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.909 -0.759 . . . . 0.0 111.173 177.451 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -48.89 -23.87 1.26 Allowed 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.471 -0.768 . . . . 0.0 112.694 -169.552 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -54.3 -45.56 72.59 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.235 -0.915 . . . . 0.0 111.344 -179.396 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 75.4 mtp180 -94.14 -58.08 2.34 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.432 -0.792 . . . . 0.0 110.766 -179.788 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -67.35 174.88 3.01 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.727 -0.608 . . . . 0.0 110.378 -178.67 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.7 p -78.13 164.41 25.0 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.694 -0.629 . . . . 0.0 110.664 -170.664 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -77.52 1.68 18.65 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.413 -177.746 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -72.53 161.17 31.14 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.171 -0.956 . . . . 0.0 109.811 176.4 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -65.94 130.24 42.58 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.625 -0.672 . . . . 0.0 111.017 -168.179 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 82.2 mt -114.92 136.67 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 173.521 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.03 112.49 7.59 Favored Pre-proline 0 N--CA 1.501 2.122 0 O-C-N 121.581 -0.7 . . . . 0.0 110.54 -174.628 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -79.67 151.25 22.02 Favored 'Trans proline' 0 N--CA 1.485 1.021 0 O-C-N 123.403 1.212 . . . . 0.0 110.261 179.171 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -101.75 114.19 28.04 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.662 -0.649 . . . . 0.0 110.053 177.435 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.2 m -66.38 -32.65 74.17 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.698 -0.626 . . . . 0.0 110.492 -178.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -62.15 143.29 56.93 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.602 -0.686 . . . . 0.0 110.724 -178.238 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.9 mm -96.76 158.9 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.798 -0.564 . . . . 0.0 109.703 179.008 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -93.4 112.5 24.42 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.598 -0.689 . . . . 0.0 110.138 -178.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -51.57 -42.32 61.78 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.78 -0.575 . . . . 0.0 111.629 177.199 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -153.09 128.78 10.11 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.594 -0.691 . . . . 0.0 110.365 -174.018 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 71.1 mt -128.34 133.48 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.693 -0.63 . . . . 0.0 109.939 172.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 27.1 tp -90.35 137.06 32.66 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.866 -0.521 . . . . 0.0 109.971 176.107 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.458 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 2.2 m-85 -133.61 124.43 26.82 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.686 -0.634 . . . . 0.0 110.673 -176.622 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 73.6 mtt85 -92.96 145.98 23.97 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.696 -0.628 . . . . 0.0 110.358 172.358 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.73 -24.69 62.6 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 179.532 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.6 m -67.9 -42.24 81.47 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.413 -1.051 . . . . 0.0 111.199 -173.799 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -85.46 -24.19 27.52 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.328 -0.858 . . . . 0.0 111.128 -175.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.458 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 86.7 mt -96.65 143.03 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.236 -0.915 . . . . 0.0 110.165 173.556 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -104.02 -20.85 13.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.984 -0.447 . . . . 0.0 111.304 -170.412 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -152.87 131.88 12.59 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 119.147 -1.021 . . . . 0.0 111.297 -179.414 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.5 tt -131.53 138.53 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 175.292 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -146.81 131.28 17.68 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.663 -0.648 . . . . 0.0 110.423 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.2 p -87.99 147.08 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.61 -0.681 . . . . 0.0 110.171 177.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.2 t . . . . . 0 N--CA 1.497 1.906 0 O-C-N 121.57 -0.706 . . . . 0.0 109.737 -179.703 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.8 mt . . . . . 0 N--CA 1.501 2.102 0 CA-C-O 121.035 0.445 . . . . 0.0 110.529 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.58 -1.88 84.4 Favored Glycine 0 N--CA 1.497 2.741 0 C-N-CA 120.453 -0.88 . . . . 0.0 111.815 177.653 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 71.5 m -61.35 148.58 40.93 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.155 -1.203 . . . . 0.0 110.44 -179.086 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -82.21 127.45 33.19 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.491 179.588 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 89.1 mt -121.78 144.5 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.588 -0.695 . . . . 0.0 109.944 179.01 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.0 t -103.05 137.32 41.38 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 175.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.5 tp -133.32 123.3 25.2 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.792 -0.568 . . . . 0.0 110.002 -171.246 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.2 mt -103.98 119.17 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.522 -0.736 . . . . 0.0 109.683 -177.707 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.1 m -94.32 157.93 15.81 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.137 0.494 . . . . 0.0 111.46 -175.525 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -53.72 -14.6 0.95 Allowed 'General case' 0 N--CA 1.507 2.385 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -171.363 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.68 20.39 4.07 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.221 -0.924 . . . . 0.0 110.459 179.475 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 55.53 35.42 25.11 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.486 -0.759 . . . . 0.0 109.93 -176.137 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 60.9 mt -105.31 145.3 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 55.5 ttt85 -105.73 119.8 40.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.624 -0.673 . . . . 0.0 110.15 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -113.68 150.68 32.89 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.682 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -141.36 140.55 33.76 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.437 -0.79 . . . . 0.0 109.776 174.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.61 172.49 41.12 Favored Glycine 0 N--CA 1.495 2.623 0 C-N-CA 119.875 -1.155 . . . . 0.0 110.451 -175.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -84.3 138.75 32.74 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.919 -0.753 . . . . 0.0 110.545 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 17.0 tp -66.15 117.68 8.8 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.628 -0.67 . . . . 0.0 110.685 175.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -100.09 -50.08 4.09 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.596 -0.69 . . . . 0.0 110.437 177.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.2 p -154.19 154.83 34.18 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.648 -0.658 . . . . 0.0 110.317 -178.185 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.5 p -142.19 145.6 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.707 -0.62 . . . . 0.0 110.054 -179.347 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -129.02 98.19 24.56 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.643 -0.661 . . . . 0.0 109.504 177.355 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -59.64 -40.34 65.99 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 O-C-N 123.64 1.337 . . . . 0.0 110.973 -176.118 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -80.32 -27.39 38.42 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.308 -0.87 . . . . 0.0 110.118 -170.675 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -87.76 2.89 50.06 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.529 -0.732 . . . . 0.0 111.252 173.707 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 40.1 m 50.02 40.34 21.1 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.141 -0.974 . . . . 0.0 111.425 -177.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 39.6 p -136.0 154.34 51.1 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.372 -0.83 . . . . 0.0 110.481 -176.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.0 pt -142.06 161.5 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.672 -0.643 . . . . 0.0 109.991 176.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.72 128.6 29.21 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.688 -0.633 . . . . 0.0 109.724 176.262 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 83.8 mt -109.76 144.57 37.98 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -178.3 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.4 p -115.3 153.11 31.54 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -178.038 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.0 p 45.31 84.69 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 CA-C-O 121.506 0.669 . . . . 0.0 110.271 -171.672 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.6 p -134.64 149.52 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -178.314 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -134.92 153.09 52.19 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.612 -0.68 . . . . 0.0 110.136 179.061 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.8 p -107.91 136.7 47.18 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.747 -0.596 . . . . 0.0 109.639 177.644 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -82.77 -38.45 23.18 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 119.864 -0.735 . . . . 0.0 111.115 -172.339 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.47 166.47 26.6 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 175.783 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 45.7 p -118.2 -19.77 8.87 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.846 -0.796 . . . . 0.0 110.909 172.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -53.3 -26.48 18.77 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.511 -0.743 . . . . 0.0 112.249 -167.54 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -70.49 -59.31 2.92 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.359 -0.838 . . . . 0.0 110.733 -176.025 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 63.1 mtp85 -94.42 -16.34 23.51 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.606 -0.684 . . . . 0.0 111.741 -175.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -63.7 174.57 1.34 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.239 -0.913 . . . . 0.0 111.245 -172.639 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.1 m -78.68 164.63 24.44 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 177.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -77.5 11.46 2.01 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.676 -0.64 . . . . 0.0 111.565 -174.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -92.93 164.48 13.29 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.2 -0.938 . . . . 0.0 109.683 169.519 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -66.05 138.17 57.58 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.584 -0.697 . . . . 0.0 110.726 -172.623 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.3 mm -118.39 139.54 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.773 -0.579 . . . . 0.0 109.595 177.383 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.58 113.63 18.48 Favored Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 121.69 -0.631 . . . . 0.0 110.288 -178.827 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -68.54 153.18 74.21 Favored 'Trans proline' 0 N--CA 1.487 1.123 0 O-C-N 123.365 1.192 . . . . 0.0 110.4 179.006 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -132.92 65.73 1.58 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.649 -0.657 . . . . 0.0 110.127 179.526 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.1 m -65.98 -33.4 75.72 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.515 -0.741 . . . . 0.0 110.401 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -62.0 155.35 24.05 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.616 -0.678 . . . . 0.0 110.621 -178.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.2 mm -96.71 138.34 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.656 -0.652 . . . . 0.0 109.741 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -97.85 118.8 35.24 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.664 -0.647 . . . . 0.0 110.471 -177.324 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -51.3 -39.95 57.95 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.721 -0.612 . . . . 0.0 111.428 175.27 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -152.95 130.4 11.4 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.75 -0.593 . . . . 0.0 110.254 -174.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.9 mt -128.97 127.33 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.65 -0.656 . . . . 0.0 109.901 171.445 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 24.0 tp -91.03 137.14 32.59 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.929 -0.482 . . . . 0.0 109.917 176.317 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.442 ' CD1' HD12 ' A' ' 72' ' ' ILE . 5.9 m-85 -137.18 128.61 28.29 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.65 -0.656 . . . . 0.0 110.531 -176.483 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -91.1 154.93 19.02 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.658 -0.651 . . . . 0.0 110.278 173.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.07 -23.96 57.87 Favored Glycine 0 N--CA 1.498 2.824 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 177.691 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.8 m -72.72 -42.09 64.52 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.46 -1.023 . . . . 0.0 111.28 -175.074 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -84.55 -26.63 27.89 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.345 -0.847 . . . . 0.0 111.144 -174.015 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.442 HD12 ' CD1' ' A' ' 67' ' ' PHE . 32.8 mt -106.27 140.73 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.316 -0.865 . . . . 0.0 109.91 171.089 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -105.19 -16.67 14.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.921 -0.487 . . . . 0.0 111.687 -167.691 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -149.94 133.45 16.61 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.92 -1.113 . . . . 0.0 111.409 -178.689 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 16.2 tt -131.13 137.92 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.048 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -144.89 135.18 24.16 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.613 -0.679 . . . . 0.0 110.164 179.633 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.2 p -86.85 147.04 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.589 -0.694 . . . . 0.0 110.163 178.546 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.4 t . . . . . 0 N--CA 1.499 2.003 0 O-C-N 121.572 -0.705 . . . . 0.0 109.79 -179.175 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.391 0 N-CA-C 109.476 -1.45 . . . . 17.02 109.476 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -67.28 -33.19 74.79 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.653 -0.91 . . . . 14.75 110.342 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 74.2 mtm -99.14 138.57 36.06 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.717 -0.614 . . . . 13.83 110.263 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -68.19 -33.65 74.82 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.701 -0.624 . . . . 11.609999999999999 110.259 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.2 mmt -120.83 151.91 39.03 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.69 -0.631 . . . . 10.460000000000001 110.267 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.7 p -131.31 155.9 46.39 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.677 -0.64 . . . . 8.1999999999999993 110.127 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -126.93 -46.86 0.2 Allowed Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.511 -1.436 . . . . 6.25 109.511 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -67.85 -45.28 75.54 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.756 -1.338 . . . . 4.7699999999999996 109.756 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 11.7 tp -81.98 114.83 53.51 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.721 -0.87 . . . . 5.5300000000000002 110.291 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -67.11 138.26 46.85 Favored 'Trans proline' 0 N--CA 1.488 1.161 0 O-C-N 123.339 1.178 . . . . 3.29 110.292 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -64.87 131.72 47.48 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.682 -0.636 . . . . 2.6699999999999999 110.437 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.9 mt -64.75 142.89 58.27 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.686 -0.633 . . . . 1.5700000000000001 110.836 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.61 -1.95 84.25 Favored Glycine 0 N--CA 1.497 2.706 0 C-N-CA 120.708 -0.758 . . . . 0.54000000000000004 111.798 176.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.3 m -63.29 145.11 56.23 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.039 -1.271 . . . . 0.83999999999999997 110.445 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.9 pttt -82.18 125.15 30.57 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.73 -0.606 . . . . 2.1200000000000001 110.269 176.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 87.1 mt -120.97 143.42 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.499 -0.751 . . . . 1.05 110.059 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.9 t -102.5 137.22 41.02 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.35 -0.611 . . . . 0.85999999999999999 109.35 174.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 13.9 tp -133.8 127.1 31.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.673 -0.642 . . . . 1.03 110.268 -169.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.6 mt -107.05 118.19 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.55 -0.719 . . . . 1.02 109.732 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m -93.08 157.82 16.1 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.022 0.439 . . . . 0.63 111.212 -177.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -53.76 -13.91 0.81 Allowed 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 112.839 0.681 . . . . 2.9900000000000002 112.839 -171.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.15 20.78 4.11 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.154 -0.966 . . . . 1.05 110.416 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 53.93 34.28 19.18 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.54 -0.725 . . . . 0.80000000000000004 109.886 -174.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.4 mt -102.59 141.88 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 109.128 -0.693 . . . . 1.0800000000000001 109.128 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -104.74 119.87 40.02 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.999 -0.68 . . . . 2.96 109.927 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -114.28 149.53 35.79 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.086 -0.709 . . . . 0.81999999999999995 109.086 174.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -140.52 140.53 35.26 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.498 -0.751 . . . . 1.54 109.628 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.68 173.37 43.3 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 119.801 -1.19 . . . . 0.070000000000000007 110.541 -175.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -84.89 137.26 33.24 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.906 -0.761 . . . . 2.5 110.543 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 14.9 tp -66.09 117.66 8.73 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.589 -0.695 . . . . 1.0900000000000001 110.6 175.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -100.05 -50.08 4.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.621 -0.675 . . . . 0.93000000000000005 110.562 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.8 p -154.44 156.95 37.71 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.696 -0.628 . . . . 1.04 110.293 -177.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.7 p -142.27 146.32 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.755 -0.591 . . . . 1.05 110.085 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -128.12 100.95 22.92 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.716 -0.615 . . . . 0.91000000000000003 109.507 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.31 -42.02 30.75 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 O-C-N 123.652 1.343 . . . . 0.84999999999999998 110.734 -174.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -80.77 -23.88 39.03 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.379 -0.825 . . . . 2.7599999999999998 110.148 -171.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -87.33 1.11 54.26 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.525 -0.734 . . . . 1.5900000000000001 111.294 173.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 37.2 m 49.78 38.52 15.82 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.079 -1.013 . . . . 1.24 111.195 -176.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.0 p -135.77 155.44 50.36 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.405 -0.81 . . . . 0.96999999999999997 110.399 -174.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.7 pt -142.1 162.0 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.715 -0.616 . . . . 0.98999999999999999 110.06 177.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.14 128.42 30.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.61 -0.681 . . . . 0.92000000000000004 109.722 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 84.2 mt -109.81 146.35 35.18 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.579 -0.526 . . . . 1.05 109.579 -178.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.3 p -118.29 152.54 35.57 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.12 -0.696 . . . . 0.68999999999999995 109.12 -177.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.6 p 45.65 84.08 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 121.489 0.662 . . . . 0.81000000000000005 110.238 -171.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.0 p -134.63 150.46 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 109.774 -0.454 . . . . 1.03 109.774 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -135.72 153.23 51.65 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.697 -0.627 . . . . 3.0499999999999998 109.967 178.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.8 p -106.57 139.21 41.38 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.686 -0.634 . . . . 0.71999999999999997 109.788 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -82.74 -38.36 23.38 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.591 -0.693 . . . . 0.67000000000000004 110.871 -173.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.63 170.48 32.48 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 120.024 -1.084 . . . . 0.51000000000000001 110.447 177.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.4 p -118.08 6.58 12.09 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.952 -0.734 . . . . 1.29 110.737 174.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -48.94 -25.96 2.23 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.635 -0.666 . . . . 2.6899999999999999 112.584 -166.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -64.87 -59.29 4.36 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.201 -0.937 . . . . 2.1400000000000001 110.629 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 58.1 mtp85 -94.43 10.26 35.14 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.64 -0.662 . . . . 5.5300000000000002 111.38 176.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -59.74 174.02 0.51 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.237 -0.914 . . . . 2.1400000000000001 111.466 -169.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.1 m -78.95 164.42 24.43 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.647 -0.501 . . . . 3.5 109.647 173.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -77.44 3.45 13.33 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.653 -0.654 . . . . 4.3700000000000001 111.344 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -97.5 154.21 17.65 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.203 -0.936 . . . . 4.3600000000000003 109.691 171.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -68.08 137.34 54.91 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.582 -0.699 . . . . 3.8900000000000001 110.607 -175.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.9 mt -117.1 136.56 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.638 -0.664 . . . . 2.7400000000000002 109.507 176.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.35 138.89 36.15 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.693 -0.629 . . . . 2.98 110.124 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -63.09 149.13 92.39 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 O-C-N 123.362 1.19 . . . . 2.2599999999999998 110.543 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -96.49 115.0 26.71 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.641 -0.662 . . . . 3.1600000000000001 110.097 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.9 m -85.66 -33.27 21.61 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.687 -0.633 . . . . 2.4100000000000001 110.331 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -62.56 141.76 58.3 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.679 -0.638 . . . . 3.1299999999999999 110.66 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.3 mm -96.86 147.36 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.761 -0.587 . . . . 1.2 109.719 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -93.93 114.98 27.3 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.614 -0.679 . . . . 1.21 110.192 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -51.12 -42.18 60.53 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.865 -0.522 . . . . 1.8600000000000001 111.678 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -152.58 129.19 10.77 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.606 -0.684 . . . . 0.76000000000000001 110.272 -174.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 78.3 mt -128.58 128.74 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.662 -0.649 . . . . 1.04 109.823 172.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.1 tp -90.79 137.08 32.64 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.893 -0.504 . . . . 1.04 109.932 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.456 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 3.2 m-85 -136.29 130.12 32.47 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.557 -0.714 . . . . 0.33000000000000002 110.605 -175.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.7 mtm-85 -91.07 147.88 22.77 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.678 -0.639 . . . . 3.1299999999999999 110.258 173.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.03 -26.46 61.02 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 110.558 -1.017 . . . . 0.14999999999999999 110.558 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.3 m -65.7 -39.79 91.62 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.464 -1.021 . . . . 1.52 110.989 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.68 -32.95 31.52 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.395 -0.816 . . . . 1.0900000000000001 110.859 -174.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.456 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 8.4 mt -103.07 139.35 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.472 -0.768 . . . . 1.0800000000000001 110.101 177.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.5 tttp -106.26 -20.05 13.51 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 120.571 -0.452 . . . . 2.5800000000000001 111.676 -166.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -150.92 136.38 17.84 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 118.996 -1.082 . . . . 1.03 111.342 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.5 tt -133.6 143.42 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.829 -0.434 . . . . 1.1100000000000001 109.829 177.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -146.71 136.93 23.6 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.624 -0.672 . . . . 3.5299999999999998 110.297 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.0 t -87.46 144.4 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.562 -0.711 . . . . 2.2000000000000002 109.777 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.4 t -93.99 133.89 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.672 -0.643 . . . . 1.6399999999999999 109.74 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -107.41 121.82 45.37 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.755 -0.591 . . . . 3.3700000000000001 110.318 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -116.19 104.12 11.21 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.644 -0.66 . . . . 4.8099999999999996 110.116 178.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -136.56 171.95 13.73 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.609 -0.682 . . . . 7.3499999999999996 110.228 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.2 p -116.44 162.42 17.58 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.657 -0.652 . . . . 6.8200000000000003 110.171 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.5 mt -117.19 164.21 20.0 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.703 -0.623 . . . . 10.42 110.165 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo . . . . . 0 N--CA 1.486 1.083 0 O-C-N 123.686 1.361 . . . . 12.369999999999999 110.362 179.906 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.391 0 N-CA-C 109.476 -1.45 . . . . 17.02 109.476 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -67.28 -33.19 74.79 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.653 -0.91 . . . . 14.75 110.342 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 74.2 mtm -99.14 138.57 36.06 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.717 -0.614 . . . . 13.83 110.263 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -68.19 -33.65 74.82 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.701 -0.624 . . . . 11.609999999999999 110.259 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.2 mmt -120.83 151.91 39.03 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.69 -0.631 . . . . 10.460000000000001 110.267 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.7 p -131.31 155.9 46.39 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.677 -0.64 . . . . 8.1999999999999993 110.127 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -126.93 -46.86 0.2 Allowed Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.511 -1.436 . . . . 6.25 109.511 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -67.85 -45.28 75.54 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.756 -1.338 . . . . 4.7699999999999996 109.756 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 11.7 tp -81.98 114.83 53.51 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.721 -0.87 . . . . 5.5300000000000002 110.291 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -67.11 138.26 46.85 Favored 'Trans proline' 0 N--CA 1.488 1.161 0 O-C-N 123.339 1.178 . . . . 3.29 110.292 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -64.87 131.72 47.48 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.682 -0.636 . . . . 2.6699999999999999 110.437 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.9 mt -64.75 142.89 58.27 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.686 -0.633 . . . . 1.5700000000000001 110.836 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.61 -1.95 84.25 Favored Glycine 0 N--CA 1.497 2.706 0 C-N-CA 120.708 -0.758 . . . . 0.54000000000000004 111.798 176.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.3 m -63.29 145.11 56.23 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.039 -1.271 . . . . 0.83999999999999997 110.445 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.9 pttt -82.18 125.15 30.57 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.73 -0.606 . . . . 2.1200000000000001 110.269 176.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 87.1 mt -120.97 143.42 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.499 -0.751 . . . . 1.05 110.059 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.9 t -102.5 137.22 41.02 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.35 -0.611 . . . . 0.85999999999999999 109.35 174.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 13.9 tp -133.8 127.1 31.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.673 -0.642 . . . . 1.03 110.268 -169.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.6 mt -107.05 118.19 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.55 -0.719 . . . . 1.02 109.732 -178.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m -93.08 157.82 16.1 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.022 0.439 . . . . 0.63 111.212 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -53.76 -13.91 0.81 Allowed 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 112.839 0.681 . . . . 2.9900000000000002 112.839 -171.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.15 20.78 4.11 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.154 -0.966 . . . . 1.05 110.416 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 53.93 34.28 19.18 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.54 -0.725 . . . . 0.80000000000000004 109.886 -174.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.4 mt -102.59 141.88 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 109.128 -0.693 . . . . 1.0800000000000001 109.128 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -104.74 119.87 40.02 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.999 -0.68 . . . . 2.96 109.927 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -114.28 149.53 35.79 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.086 -0.709 . . . . 0.81999999999999995 109.086 174.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -140.52 140.53 35.26 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.498 -0.751 . . . . 1.54 109.628 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.68 173.37 43.3 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 119.801 -1.19 . . . . 0.070000000000000007 110.541 -175.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -84.89 137.26 33.24 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.906 -0.761 . . . . 2.5 110.543 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 14.9 tp -66.09 117.66 8.73 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.589 -0.695 . . . . 1.0900000000000001 110.6 175.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -100.05 -50.08 4.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.621 -0.675 . . . . 0.93000000000000005 110.562 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.8 p -154.44 156.95 37.71 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.696 -0.628 . . . . 1.04 110.293 -177.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.7 p -142.27 146.32 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.755 -0.591 . . . . 1.05 110.085 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -128.12 100.95 22.92 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.716 -0.615 . . . . 0.91000000000000003 109.507 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.31 -42.02 30.75 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 O-C-N 123.652 1.343 . . . . 0.84999999999999998 110.734 -174.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -80.77 -23.88 39.03 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.379 -0.825 . . . . 2.7599999999999998 110.148 -171.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -87.33 1.11 54.26 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.525 -0.734 . . . . 1.5900000000000001 111.294 173.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 37.2 m 49.78 38.52 15.82 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.079 -1.013 . . . . 1.24 111.195 -176.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.0 p -135.77 155.44 50.36 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.405 -0.81 . . . . 0.96999999999999997 110.399 -174.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.7 pt -142.1 162.0 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.715 -0.616 . . . . 0.98999999999999999 110.06 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.14 128.42 30.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.61 -0.681 . . . . 0.92000000000000004 109.722 176.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 84.2 mt -109.81 146.35 35.18 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.579 -0.526 . . . . 1.05 109.579 -178.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.3 p -118.29 152.54 35.57 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.12 -0.696 . . . . 0.68999999999999995 109.12 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.6 p 45.65 84.08 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 121.489 0.662 . . . . 0.81000000000000005 110.238 -171.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.0 p -134.63 150.46 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 109.774 -0.454 . . . . 1.03 109.774 -178.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -135.72 153.23 51.65 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.697 -0.627 . . . . 3.0499999999999998 109.967 178.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.8 p -106.57 139.21 41.38 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.686 -0.634 . . . . 0.71999999999999997 109.788 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -82.74 -38.36 23.38 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.591 -0.693 . . . . 0.67000000000000004 110.871 -173.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.63 170.48 32.48 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 120.024 -1.084 . . . . 0.51000000000000001 110.447 177.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.4 p -118.08 6.58 12.09 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.952 -0.734 . . . . 1.29 110.737 174.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -48.94 -25.96 2.23 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.635 -0.666 . . . . 2.6899999999999999 112.584 -166.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -64.87 -59.29 4.36 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.201 -0.937 . . . . 2.1400000000000001 110.629 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 58.1 mtp85 -94.43 10.26 35.14 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.64 -0.662 . . . . 5.5300000000000002 111.38 176.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -59.74 174.02 0.51 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.237 -0.914 . . . . 2.1400000000000001 111.466 -169.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.1 m -78.95 164.42 24.43 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.647 -0.501 . . . . 3.5 109.647 173.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -77.44 3.45 13.33 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.653 -0.654 . . . . 4.3700000000000001 111.344 -178.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -97.5 154.21 17.65 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.203 -0.936 . . . . 4.3600000000000003 109.691 171.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -68.08 137.34 54.91 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.582 -0.699 . . . . 3.8900000000000001 110.607 -175.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.9 mt -117.1 136.56 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.638 -0.664 . . . . 2.7400000000000002 109.507 176.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.35 138.89 36.15 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.693 -0.629 . . . . 2.98 110.124 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -63.09 149.13 92.39 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 O-C-N 123.362 1.19 . . . . 2.2599999999999998 110.543 178.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -96.49 115.0 26.71 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.641 -0.662 . . . . 3.1600000000000001 110.097 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.9 m -85.66 -33.27 21.61 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.687 -0.633 . . . . 2.4100000000000001 110.331 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -62.56 141.76 58.3 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.679 -0.638 . . . . 3.1299999999999999 110.66 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.3 mm -96.86 147.36 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.761 -0.587 . . . . 1.2 109.719 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -93.93 114.98 27.3 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.614 -0.679 . . . . 1.21 110.192 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -51.12 -42.18 60.53 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.865 -0.522 . . . . 1.8600000000000001 111.678 178.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -152.58 129.19 10.77 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.606 -0.684 . . . . 0.76000000000000001 110.272 -174.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 78.3 mt -128.58 128.74 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.662 -0.649 . . . . 1.04 109.823 172.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.1 tp -90.79 137.08 32.64 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.893 -0.504 . . . . 1.04 109.932 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.456 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 3.2 m-85 -136.29 130.12 32.47 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.557 -0.714 . . . . 0.33000000000000002 110.605 -175.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.7 mtm-85 -91.07 147.88 22.77 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.678 -0.639 . . . . 3.1299999999999999 110.258 173.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.03 -26.46 61.02 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 110.558 -1.017 . . . . 0.14999999999999999 110.558 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.3 m -65.7 -39.79 91.62 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.464 -1.021 . . . . 1.52 110.989 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.68 -32.95 31.52 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.395 -0.816 . . . . 1.0900000000000001 110.859 -174.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.456 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 8.4 mt -103.07 139.35 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.472 -0.768 . . . . 1.0800000000000001 110.101 177.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.5 tttp -106.26 -20.05 13.51 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 120.571 -0.452 . . . . 2.5800000000000001 111.676 -166.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -150.92 136.38 17.84 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 118.996 -1.082 . . . . 1.03 111.342 -177.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.5 tt -133.6 143.42 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.829 -0.434 . . . . 1.1100000000000001 109.829 177.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -146.71 136.93 23.6 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.624 -0.672 . . . . 3.5299999999999998 110.297 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.0 t -87.46 144.4 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.562 -0.711 . . . . 2.2000000000000002 109.777 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.4 t -93.99 133.89 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.672 -0.643 . . . . 1.6399999999999999 109.74 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -107.41 121.82 45.37 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.755 -0.591 . . . . 3.3700000000000001 110.318 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -116.19 104.12 11.21 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.644 -0.66 . . . . 4.8099999999999996 110.116 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -136.56 171.95 13.73 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.609 -0.682 . . . . 7.3499999999999996 110.228 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.2 p -116.44 162.42 17.58 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.657 -0.652 . . . . 6.8200000000000003 110.171 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.5 mt -117.19 164.21 20.0 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.703 -0.623 . . . . 10.42 110.165 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo . . . . . 0 N--CA 1.486 1.083 0 O-C-N 123.686 1.361 . . . . 12.369999999999999 110.362 179.906 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -144.53 156.7 44.28 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.761 -0.846 . . . . 0.0 110.206 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 89.1 mmm -96.91 138.31 34.64 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.698 -0.626 . . . . 0.0 110.171 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -67.89 -33.46 74.77 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.739 -0.601 . . . . 0.0 110.289 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt -118.22 151.63 37.26 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.628 -0.67 . . . . 0.0 110.213 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.4 m -65.2 -35.19 80.3 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.661 -0.649 . . . . 0.0 110.36 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -148.04 173.39 28.09 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.61 178.09 47.14 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.5 tp -155.43 87.8 3.15 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.74 -0.859 . . . . 0.0 109.953 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -67.52 106.55 1.27 Allowed 'Trans proline' 0 N--CA 1.488 1.183 0 O-C-N 123.509 1.268 . . . . 0.0 110.343 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -64.86 139.26 58.74 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.686 -0.634 . . . . 0.0 110.544 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.2 mt -64.76 -172.67 0.09 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.674 -0.642 . . . . 0.0 110.498 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.76 -1.85 84.96 Favored Glycine 0 N--CA 1.496 2.66 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.722 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.8 m -61.38 143.21 56.18 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.101 -1.235 . . . . 0.0 110.413 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -82.2 128.95 34.67 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.692 -0.63 . . . . 0.0 110.494 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 86.1 mt -122.0 142.92 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.581 -0.699 . . . . 0.0 110.076 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.5 t -103.15 137.23 41.59 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 174.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 13.7 tp -134.78 125.4 26.84 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.673 -0.642 . . . . 0.0 110.301 -169.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 81.5 mt -107.09 117.97 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.538 -0.727 . . . . 0.0 109.696 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.2 m -92.65 157.77 16.3 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.059 0.457 . . . . 0.0 111.267 -177.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -54.07 -13.66 0.87 Allowed 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -171.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.1 20.73 4.12 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.163 -0.961 . . . . 0.0 110.416 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 54.13 34.28 19.73 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.481 -0.762 . . . . 0.0 109.836 -174.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.0 mt -102.94 141.3 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 55.1 ttt85 -104.61 119.84 39.92 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.997 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -114.79 149.65 36.64 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -140.42 140.49 35.45 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.556 -0.715 . . . . 0.0 109.478 175.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.3 172.01 41.48 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.688 -1.244 . . . . 0.0 110.681 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.3 mmt85 -84.85 138.51 32.51 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.919 -0.753 . . . . 0.0 110.522 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.8 tp -66.16 118.27 9.65 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.565 -0.709 . . . . 0.0 110.669 175.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -100.51 -50.14 4.0 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.623 -0.673 . . . . 0.0 110.385 176.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.8 p -154.3 153.58 31.91 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.741 -0.599 . . . . 0.0 110.263 -178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.4 p -142.3 145.45 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.729 -0.607 . . . . 0.0 110.052 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -128.94 100.9 20.3 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.669 -0.644 . . . . 0.0 109.554 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.51 -39.44 45.2 Favored 'Trans proline' 0 N--CA 1.489 1.24 0 O-C-N 123.533 1.281 . . . . 0.0 110.796 -175.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -80.6 -25.74 38.27 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.369 -0.832 . . . . 0.0 110.066 -171.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -87.41 1.49 53.23 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.555 -0.715 . . . . 0.0 111.22 173.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 38.6 m 49.61 38.68 15.49 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.091 -1.006 . . . . 0.0 111.343 -176.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.9 p -136.3 153.36 51.19 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.348 -0.845 . . . . 0.0 110.286 -174.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.9 pt -142.74 162.0 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.676 -0.64 . . . . 0.0 110.252 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.46 127.61 28.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.657 -0.652 . . . . 0.0 109.704 175.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 83.2 mt -109.94 146.77 34.64 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -177.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 96.0 p -118.13 153.42 33.83 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.7 p 45.65 85.01 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 121.476 0.655 . . . . 0.0 110.364 -172.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.5 p -134.53 150.41 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.95 -0.469 . . . . 0.0 109.753 -178.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -135.21 153.18 52.03 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.634 -0.666 . . . . 0.0 109.952 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 82.5 p -108.19 138.83 43.79 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.656 -0.652 . . . . 0.0 109.866 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -83.02 -38.29 22.79 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.654 -0.654 . . . . 0.0 110.859 -174.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.64 168.1 29.29 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.6 p -118.15 6.6 12.03 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.925 -0.75 . . . . 0.0 110.908 175.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -49.87 -25.27 3.01 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.563 -0.711 . . . . 0.0 112.781 -166.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -64.92 -59.34 4.29 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.134 -0.978 . . . . 0.0 110.671 -177.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.1 mtp180 -94.45 10.16 35.59 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.502 -0.749 . . . . 0.0 111.524 176.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.5 p-10 -58.63 174.06 0.36 Allowed 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.204 -0.935 . . . . 0.0 111.448 -170.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.0 m -78.85 164.42 24.5 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.935 -0.478 . . . . 0.0 109.759 175.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -77.55 4.89 10.13 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.642 -0.661 . . . . 0.0 111.289 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -95.84 166.03 12.0 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.226 -0.921 . . . . 0.0 109.591 168.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -80.74 132.1 35.5 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.607 -0.683 . . . . 0.0 110.488 -175.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.5 mt -114.27 134.35 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.715 -0.615 . . . . 0.0 109.443 176.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.38 146.01 38.88 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.629 -0.669 . . . . 0.0 110.154 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -63.07 149.37 91.72 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 O-C-N 123.399 1.21 . . . . 0.0 110.539 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -96.28 121.62 38.26 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.647 -0.658 . . . . 0.0 110.107 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.0 t -91.66 -32.55 15.42 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.708 -0.62 . . . . 0.0 110.356 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -62.59 140.49 58.66 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.641 -0.662 . . . . 0.0 110.569 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.9 mm -96.89 148.12 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.744 -0.597 . . . . 0.0 109.683 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -94.2 114.27 26.35 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.62 -0.675 . . . . 0.0 110.195 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -51.38 -42.42 61.37 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.754 -0.591 . . . . 0.0 111.585 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -152.87 129.88 11.06 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.665 -0.647 . . . . 0.0 110.219 -174.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.8 mt -128.87 129.06 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.701 -0.625 . . . . 0.0 109.87 172.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.0 tp -90.34 137.05 32.66 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.802 -0.561 . . . . 0.0 109.84 176.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.466 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 2.8 m-85 -134.55 128.2 32.82 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.699 -0.626 . . . . 0.0 110.563 -175.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -91.61 146.81 23.47 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.686 -0.634 . . . . 0.0 110.213 172.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.81 -26.55 60.57 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.1 t -65.36 -40.11 93.15 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.467 -1.019 . . . . 0.0 111.004 -177.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -81.55 -32.31 32.3 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.431 -0.793 . . . . 0.0 110.857 -174.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.466 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 6.9 mt -101.15 140.48 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.456 -0.778 . . . . 0.0 110.149 177.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -104.63 -20.34 13.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.938 -0.476 . . . . 0.0 111.492 -168.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -151.56 133.69 15.17 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.034 -1.041 . . . . 0.0 111.233 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.0 tt -131.87 143.81 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.908 -0.495 . . . . 0.0 109.756 176.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -145.76 130.16 17.74 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.597 -0.689 . . . . 0.0 110.257 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 51.4 t -88.36 143.55 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.684 -0.635 . . . . 0.0 109.781 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.9 t -93.7 129.87 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.567 -0.708 . . . . 0.0 109.674 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -117.5 140.25 49.86 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.667 -0.646 . . . . 0.0 110.259 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -106.11 131.88 52.84 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.677 -0.64 . . . . 0.0 110.125 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -119.77 140.34 50.89 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.672 -0.643 . . . . 0.0 110.215 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.7 m -122.27 138.74 54.39 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.666 -0.646 . . . . 0.0 110.127 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.0 tt -111.49 109.93 55.79 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.716 -0.615 . . . . 0.0 110.167 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo . . . . . 0 N--CA 1.49 1.279 0 O-C-N 123.369 1.194 . . . . 0.0 110.451 179.073 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -95.16 127.8 41.49 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.745 -0.856 . . . . 0.0 110.173 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.36 -34.38 70.41 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.699 -0.626 . . . . 0.0 110.234 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -90.9 115.35 27.87 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.636 -0.665 . . . . 0.0 110.169 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.9 mtp -67.26 -34.4 77.35 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.74 -0.6 . . . . 0.0 110.326 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.4 t -112.48 146.95 37.55 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.724 -0.61 . . . . 0.0 110.376 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -133.32 177.59 18.86 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -142.95 173.31 24.15 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -155.33 157.06 31.62 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.594 -0.945 . . . . 0.0 110.135 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -67.55 111.69 2.41 Favored 'Trans proline' 0 N--CA 1.488 1.149 0 O-C-N 123.612 1.322 . . . . 0.0 110.369 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.79 130.29 42.96 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.712 -0.617 . . . . 0.0 110.609 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.0 mt -64.83 149.67 49.01 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.714 -0.616 . . . . 0.0 110.626 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.6 -1.85 84.54 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.871 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 75.0 m -61.44 146.08 49.62 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.07 -1.253 . . . . 0.0 110.479 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.1 pttt -81.97 126.41 31.91 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.718 -0.613 . . . . 0.0 110.485 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 88.5 mt -123.91 143.96 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.605 -0.684 . . . . 0.0 110.177 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.6 t -102.65 137.26 41.11 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 175.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 13.8 tp -133.23 128.4 35.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.708 -0.62 . . . . 0.0 110.318 -170.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.1 mt -108.22 119.61 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.464 -0.772 . . . . 0.0 109.698 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.1 m -93.9 157.61 16.04 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.114 0.483 . . . . 0.0 111.222 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -54.12 -13.56 0.86 Allowed 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -172.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.84 20.41 4.16 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.148 -0.97 . . . . 0.0 110.485 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 53.91 34.04 18.6 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.38 -0.825 . . . . 0.0 109.804 -174.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 67.3 mt -102.2 141.82 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -105.37 119.85 40.11 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.007 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -114.74 148.72 37.94 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 174.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -140.09 140.51 36.1 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.476 -0.765 . . . . 0.0 109.603 175.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.92 173.52 42.22 Favored Glycine 0 N--CA 1.495 2.597 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.48 -175.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -84.73 136.5 33.69 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.889 -0.771 . . . . 0.0 110.501 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.7 tp -66.14 116.33 7.1 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.548 -0.72 . . . . 0.0 110.537 175.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -99.14 -49.99 4.3 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.677 -0.639 . . . . 0.0 110.364 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.1 p -152.97 154.87 35.86 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.655 -0.653 . . . . 0.0 110.25 -178.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.6 p -142.23 145.61 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.686 -0.634 . . . . 0.0 110.104 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -127.83 101.54 23.26 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.627 -0.671 . . . . 0.0 109.506 177.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.44 -41.82 30.94 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 O-C-N 123.626 1.329 . . . . 0.0 110.868 -174.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -80.59 -24.55 39.08 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.301 -0.874 . . . . 0.0 110.214 -171.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -87.42 1.13 54.29 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.412 -0.805 . . . . 0.0 111.235 173.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 39.6 m 49.75 39.26 17.43 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.153 -0.967 . . . . 0.0 111.243 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.8 p -135.82 153.79 51.4 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.407 -0.808 . . . . 0.0 110.38 -174.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.9 pt -142.62 162.02 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.708 -0.62 . . . . 0.0 110.193 177.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.61 129.54 33.02 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.63 -0.669 . . . . 0.0 109.82 175.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 50.6 mt -109.84 144.23 38.59 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -178.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 99.9 p -116.24 151.41 35.83 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.8 p 46.1 87.43 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 CA-C-O 121.462 0.648 . . . . 0.0 110.267 -172.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.3 p -134.62 147.79 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.968 -0.458 . . . . 0.0 109.837 -178.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -127.33 153.08 46.63 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.821 -0.549 . . . . 0.0 109.703 178.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.8 p -109.39 136.74 48.33 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.697 -0.627 . . . . 0.0 109.824 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -82.93 -38.19 23.13 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.624 -0.672 . . . . 0.0 110.847 -174.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.58 167.13 27.8 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 176.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 p -118.16 6.6 12.03 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.976 -0.72 . . . . 0.0 110.977 175.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -48.99 -25.46 1.98 Allowed 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.498 -0.752 . . . . 0.0 112.417 -169.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -64.4 -59.2 4.63 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.225 -0.922 . . . . 0.0 110.622 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -94.34 10.23 35.07 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.628 -0.67 . . . . 0.0 111.373 177.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -61.08 174.02 0.72 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.241 -0.912 . . . . 0.0 111.279 -170.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 39.9 p -78.88 164.5 24.41 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.914 -0.491 . . . . 0.0 109.917 175.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -77.52 3.89 12.47 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.004 176.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -97.34 165.28 12.1 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.181 -0.95 . . . . 0.0 109.621 167.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -68.51 142.47 55.26 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.524 -0.735 . . . . 0.0 110.388 -177.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 49.9 mm -112.67 134.95 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.704 -0.622 . . . . 0.0 109.675 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -97.96 109.91 53.48 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.731 -0.606 . . . . 0.0 110.201 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -67.49 147.16 76.54 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 O-C-N 123.379 1.199 . . . . 0.0 110.409 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -96.54 119.77 35.63 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.721 -0.612 . . . . 0.0 110.222 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.6 p -68.26 -30.65 69.74 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.707 -0.62 . . . . 0.0 110.422 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -62.4 145.78 53.07 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.551 -0.718 . . . . 0.0 110.595 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.87 154.71 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.745 -0.597 . . . . 0.0 109.699 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -94.13 113.68 25.68 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.667 -0.645 . . . . 0.0 110.17 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -51.54 -40.52 59.83 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.753 -0.592 . . . . 0.0 111.765 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -153.38 130.84 11.37 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.669 -0.644 . . . . 0.0 110.177 -175.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 76.2 mt -129.75 128.22 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.725 -0.609 . . . . 0.0 109.791 172.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.6 tp -90.46 136.99 32.71 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.851 -0.53 . . . . 0.0 109.805 176.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.466 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 3.3 m-85 -135.81 130.62 34.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.661 -0.649 . . . . 0.0 110.58 -175.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -91.68 149.66 21.52 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.678 -0.639 . . . . 0.0 110.343 173.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.05 -24.55 60.86 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.0 t -66.81 -42.14 86.39 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.481 -1.011 . . . . 0.0 111.056 -175.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -82.77 -33.04 27.49 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.396 -0.815 . . . . 0.0 110.879 -175.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.466 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 13.8 mt -100.72 138.4 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.423 -0.798 . . . . 0.0 110.143 177.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 50.3 tptt -108.0 -19.12 13.61 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.789 -166.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -149.71 135.86 18.89 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 118.935 -1.106 . . . . 0.0 111.319 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.2 tt -134.08 144.47 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.868 -0.52 . . . . 0.0 109.886 177.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -146.1 133.28 20.47 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.608 -0.682 . . . . 0.0 110.288 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 51.2 t -87.67 145.35 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.681 -0.637 . . . . 0.0 109.736 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.1 t -93.74 135.27 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.641 -0.662 . . . . 0.0 109.748 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -123.41 173.52 7.94 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.716 -0.615 . . . . 0.0 110.201 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -75.77 168.43 20.04 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.672 -0.642 . . . . 0.0 110.117 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -65.09 -34.82 79.31 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.724 -0.61 . . . . 0.0 110.335 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.6 m -121.23 141.09 51.2 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.674 -0.641 . . . . 0.0 110.097 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.5 mp -109.47 161.84 22.48 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.758 -0.589 . . . . 0.0 110.241 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo . . . . . 0 N--CA 1.488 1.178 0 O-C-N 123.689 1.362 . . . . 0.0 110.324 -179.868 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -143.83 155.43 44.12 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.684 -0.892 . . . . 0.0 110.255 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 89.0 mmm -120.41 153.98 35.79 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.711 -0.618 . . . . 0.0 110.157 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -145.62 155.47 43.05 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.689 -0.632 . . . . 0.0 110.225 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.1 mtp -108.11 146.68 32.3 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.796 -0.565 . . . . 0.0 110.203 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 94.4 p -131.69 155.88 46.86 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.667 -0.646 . . . . 0.0 110.223 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -148.3 37.62 1.06 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -129.84 44.02 1.25 Allowed Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 15.6 tp -79.94 138.9 53.37 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.682 -0.893 . . . . 0.0 109.946 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -68.31 108.99 1.9 Allowed 'Trans proline' 0 N--CA 1.488 1.18 0 O-C-N 123.35 1.184 . . . . 0.0 110.324 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -64.93 137.78 57.96 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.711 -0.618 . . . . 0.0 110.491 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.9 mt -64.84 152.17 43.56 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.675 -0.641 . . . . 0.0 110.559 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.63 -1.79 84.83 Favored Glycine 0 N--CA 1.496 2.685 0 C-N-CA 120.49 -0.862 . . . . 0.0 111.73 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 58.5 m -60.88 153.66 24.18 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.119 -1.224 . . . . 0.0 110.541 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -81.56 123.58 28.78 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.715 -0.616 . . . . 0.0 110.583 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 89.0 mt -120.81 145.27 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.508 -0.745 . . . . 0.0 110.066 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.0 t -102.54 137.31 40.94 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 175.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 13.8 tp -131.71 125.6 32.44 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.707 -0.621 . . . . 0.0 110.146 -170.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.3 mt -106.03 119.05 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.552 -0.718 . . . . 0.0 109.632 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.3 m -94.33 157.72 15.9 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.068 0.461 . . . . 0.0 111.227 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -53.43 -14.73 0.84 Allowed 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -172.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.32 20.3 3.89 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.097 -1.002 . . . . 0.0 110.463 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 54.0 34.08 18.93 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.478 -0.764 . . . . 0.0 109.796 -174.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.5 mt -102.0 141.41 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 63.8 ttt-85 -105.5 119.81 40.05 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.887 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -114.15 150.01 34.81 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -140.68 140.46 34.95 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.42 -0.8 . . . . 0.0 109.647 175.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.6 172.97 43.23 Favored Glycine 0 N--CA 1.495 2.611 0 C-N-CA 119.716 -1.231 . . . . 0.0 110.538 -175.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -84.96 135.53 34.0 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.893 -0.769 . . . . 0.0 110.576 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.0 tp -66.1 117.93 9.13 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.542 -0.724 . . . . 0.0 110.595 175.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -99.52 -50.13 4.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.573 -0.704 . . . . 0.0 110.481 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.0 p -153.93 156.48 37.59 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.734 -0.604 . . . . 0.0 110.32 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.3 p -142.32 145.86 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.708 -0.62 . . . . 0.0 110.034 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -128.25 99.14 24.97 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.659 -0.651 . . . . 0.0 109.55 177.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -59.5 -40.86 62.54 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 O-C-N 123.553 1.291 . . . . 0.0 110.937 -175.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -80.58 -25.76 38.3 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.338 -0.852 . . . . 0.0 110.181 -171.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -87.43 1.87 52.14 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.538 -0.726 . . . . 0.0 111.167 173.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.3 m 49.54 38.41 14.61 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.079 -1.013 . . . . 0.0 111.197 -176.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.5 p -135.71 154.76 51.16 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.415 -0.803 . . . . 0.0 110.438 -174.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.4 pt -142.26 162.02 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.732 -0.605 . . . . 0.0 110.131 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.82 128.28 30.46 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.592 -0.693 . . . . 0.0 109.765 176.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.3 mt -109.86 146.37 35.2 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.9 p -117.68 151.58 36.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.623 -0.673 . . . . 0.0 109.234 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 46.8 p 45.98 86.71 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 121.472 0.653 . . . . 0.0 110.291 -172.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.8 p -134.58 147.76 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.939 -0.476 . . . . 0.0 109.873 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -126.19 153.06 45.17 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.732 -0.605 . . . . 0.0 109.798 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.3 p -108.79 134.39 51.55 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.665 -0.647 . . . . 0.0 109.794 177.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -83.02 -38.28 22.8 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.623 -0.673 . . . . 0.0 111.011 -173.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.66 168.74 30.25 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.993 -1.099 . . . . 0.0 110.54 176.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.14 6.61 12.04 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 122.008 -0.701 . . . . 0.0 110.997 175.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.3 tp10 -48.95 -25.95 2.23 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.546 -0.721 . . . . 0.0 112.455 -168.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -65.76 -59.21 4.13 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.335 -0.853 . . . . 0.0 110.421 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.9 mmp_? -94.19 10.14 35.09 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.68 -0.638 . . . . 0.0 111.319 177.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.9 p-10 -59.47 166.18 2.49 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.243 -0.91 . . . . 0.0 111.418 -170.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.0 m -78.95 164.44 24.42 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.949 -0.47 . . . . 0.0 109.765 174.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -77.56 4.12 12.01 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.616 -0.678 . . . . 0.0 111.268 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -96.81 158.35 15.47 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.174 -0.954 . . . . 0.0 109.632 167.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -70.77 140.15 51.23 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.489 -0.757 . . . . 0.0 110.375 -176.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 81.1 mt -115.28 134.9 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.664 -0.647 . . . . 0.0 109.616 177.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.05 109.92 53.69 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.736 -0.603 . . . . 0.0 110.133 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -66.61 146.54 79.63 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 O-C-N 123.343 1.18 . . . . 0.0 110.379 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -95.59 124.01 39.42 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.667 -0.645 . . . . 0.0 110.232 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.5 p -67.67 -29.35 68.61 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.675 -0.641 . . . . 0.0 110.492 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -62.02 145.93 51.67 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.55 -0.719 . . . . 0.0 110.538 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.91 156.24 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.749 -0.594 . . . . 0.0 109.747 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -93.65 115.14 27.58 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.669 -0.644 . . . . 0.0 110.087 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -51.25 -42.98 61.4 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.767 -0.583 . . . . 0.0 111.697 178.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -152.73 129.1 10.59 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.624 -0.673 . . . . 0.0 110.244 -174.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 75.4 mt -128.0 129.24 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.665 -0.647 . . . . 0.0 109.871 172.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.0 tp -90.32 137.04 32.67 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.802 -0.562 . . . . 0.0 109.797 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.464 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 2.8 m-85 -135.19 130.33 35.15 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.647 -0.658 . . . . 0.0 110.544 -175.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.1 mtm-85 -91.47 148.26 22.43 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.713 -0.617 . . . . 0.0 110.322 173.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.69 -24.03 59.37 Favored Glycine 0 N--CA 1.498 2.816 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 178.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.0 p -67.82 -42.11 82.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.361 -1.082 . . . . 0.0 111.089 -175.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -82.49 -32.41 28.8 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.398 -0.814 . . . . 0.0 110.894 -175.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.464 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 14.8 mt -99.56 141.48 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.333 -0.854 . . . . 0.0 110.18 176.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -106.15 -24.61 12.3 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 120.554 -0.459 . . . . 0.0 111.447 -166.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -150.8 136.19 17.84 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 119.037 -1.065 . . . . 0.0 111.471 -176.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.4 tt -131.83 137.77 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -143.94 143.33 31.2 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.634 -0.666 . . . . 0.0 110.191 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.4 m -84.87 147.02 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.638 -0.664 . . . . 0.0 110.246 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.5 t -96.91 132.74 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.569 -0.707 . . . . 0.0 109.89 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -114.67 122.41 46.36 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.729 -0.607 . . . . 0.0 110.135 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -132.4 -46.47 0.9 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.714 -0.616 . . . . 0.0 110.325 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -124.73 141.25 52.24 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.704 -0.622 . . . . 0.0 110.183 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 25.1 m -119.42 141.65 48.93 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.658 -0.651 . . . . 0.0 110.105 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.1 tp -102.7 109.87 61.94 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.691 -0.63 . . . . 0.0 110.24 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo . . . . . 0 N--CA 1.488 1.199 0 O-C-N 123.328 1.172 . . . . 0.0 110.509 179.094 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -67.79 -33.69 75.31 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.702 -0.881 . . . . 0.0 110.407 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 89.4 mtp -65.86 -36.59 83.88 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.669 -0.644 . . . . 0.0 110.549 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -107.67 155.96 19.59 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.646 -0.659 . . . . 0.0 110.306 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.4 mtm -86.84 120.75 28.45 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.644 -0.66 . . . . 0.0 110.085 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -66.24 -35.42 80.37 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.69 -0.631 . . . . 0.0 110.366 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -101.34 34.26 5.79 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.74 -60.13 0.66 Allowed Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.7 mp -81.35 152.23 70.22 Favored Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 121.69 -0.888 . . . . 0.0 110.115 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -68.61 129.56 19.1 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 O-C-N 123.659 1.347 . . . . 0.0 110.309 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -64.88 129.51 40.01 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.62 -0.675 . . . . 0.0 110.441 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 80.6 mt -64.81 145.25 56.53 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.778 -0.576 . . . . 0.0 110.614 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.62 -1.83 84.66 Favored Glycine 0 N--CA 1.497 2.708 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.679 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 58.2 m -60.86 155.5 19.48 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.074 -1.251 . . . . 0.0 110.579 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.19 122.25 27.66 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.805 -0.559 . . . . 0.0 110.366 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 90.3 mt -119.96 144.38 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.515 -0.741 . . . . 0.0 110.114 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.7 t -102.83 137.24 41.3 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 175.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 14.2 tp -133.33 125.47 29.28 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.789 -0.569 . . . . 0.0 110.183 -169.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.1 mt -106.52 117.97 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.561 -0.712 . . . . 0.0 109.654 -178.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m -93.35 157.74 16.08 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.078 0.466 . . . . 0.0 111.239 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -53.89 -13.95 0.87 Allowed 'General case' 0 N--CA 1.507 2.392 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -171.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.18 20.91 4.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.169 -0.957 . . . . 0.0 110.444 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 54.15 34.42 20.08 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.486 -0.759 . . . . 0.0 109.882 -174.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.1 mt -102.86 141.24 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -104.85 119.73 39.71 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.905 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -114.47 148.29 38.04 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 174.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -139.05 140.51 38.1 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.573 -0.704 . . . . 0.0 109.592 175.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.54 173.11 43.21 Favored Glycine 0 N--CA 1.496 2.659 0 C-N-CA 119.794 -1.193 . . . . 0.0 110.386 -175.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 -85.95 136.16 33.38 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.814 -0.815 . . . . 0.0 110.604 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.3 tp -66.13 119.5 11.55 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.62 -0.675 . . . . 0.0 110.675 176.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -100.11 -50.01 4.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.693 -0.629 . . . . 0.0 110.446 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.5 p -153.77 154.36 33.88 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.622 -0.674 . . . . 0.0 110.384 -178.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.4 p -142.28 146.1 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.696 -0.627 . . . . 0.0 110.09 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -129.03 101.26 19.76 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.61 -0.681 . . . . 0.0 109.574 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.42 -41.08 35.27 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 O-C-N 123.628 1.33 . . . . 0.0 110.785 -174.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -80.61 -23.98 39.42 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.396 -0.815 . . . . 0.0 110.187 -172.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -87.37 0.88 54.8 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.492 -0.755 . . . . 0.0 111.14 173.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.3 m 49.81 38.14 15.02 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.139 -0.976 . . . . 0.0 111.205 -176.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.5 p -136.68 152.94 50.95 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.352 -0.842 . . . . 0.0 110.405 -174.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.8 pt -142.75 162.02 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.714 -0.616 . . . . 0.0 110.164 178.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.22 128.34 29.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.593 -0.692 . . . . 0.0 109.786 175.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.7 mt -109.96 148.13 32.18 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 95.1 p -120.26 152.8 37.26 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.628 -0.67 . . . . 0.0 109.214 -177.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 53.0 p 44.94 87.34 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 CA-C-O 121.392 0.615 . . . . 0.0 110.385 -172.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.2 p -134.59 145.18 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 CA-C-O 121.155 0.503 . . . . 0.0 110.005 -177.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -120.46 153.11 37.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.688 -0.633 . . . . 0.0 109.755 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 86.3 p -111.27 133.44 53.6 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.629 -0.669 . . . . 0.0 109.856 177.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -83.05 -38.49 22.48 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.052 -173.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.53 171.98 34.14 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.993 -1.099 . . . . 0.0 110.445 177.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.2 p -117.97 6.48 12.18 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.797 -0.826 . . . . 0.0 110.915 173.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -51.06 -24.1 3.61 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.507 -0.746 . . . . 0.0 112.795 -167.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.08 -59.44 4.13 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.193 -0.942 . . . . 0.0 110.706 -176.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -94.5 10.21 35.49 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.575 -0.703 . . . . 0.0 111.444 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 40.2 p-10 -58.76 174.04 0.37 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.189 -0.944 . . . . 0.0 111.419 -170.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.0 m -78.92 164.48 24.4 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.957 -0.464 . . . . 0.0 109.774 175.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -77.5 4.71 10.48 Favored 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.277 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -95.98 166.07 11.95 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.176 -0.952 . . . . 0.0 109.622 168.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -80.6 133.19 35.72 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.594 -0.691 . . . . 0.0 110.399 -175.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.6 mt -113.9 135.35 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.625 -0.672 . . . . 0.0 109.54 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.88 146.11 38.09 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.642 -0.661 . . . . 0.0 110.138 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -68.78 149.37 72.86 Favored 'Trans proline' 0 N--CA 1.487 1.104 0 O-C-N 123.55 1.289 . . . . 0.0 110.307 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -92.71 107.4 19.19 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.631 -0.668 . . . . 0.0 110.074 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.9 m -68.01 -35.72 78.77 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.699 -0.625 . . . . 0.0 110.345 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -60.99 133.47 56.13 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.658 -0.651 . . . . 0.0 110.809 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.7 mm -96.97 153.73 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.659 -0.651 . . . . 0.0 109.606 178.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -96.76 112.47 24.21 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.598 -0.689 . . . . 0.0 110.446 -175.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -51.67 -41.02 61.09 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.678 -0.639 . . . . 0.0 111.496 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -153.02 130.31 11.28 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.604 -0.685 . . . . 0.0 110.124 -175.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 77.4 mt -127.96 128.34 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.644 -0.66 . . . . 0.0 109.804 172.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.2 tp -90.29 137.04 32.67 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.867 -0.52 . . . . 0.0 109.753 175.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.456 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 3.0 m-85 -137.03 130.54 31.54 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.663 -0.648 . . . . 0.0 110.6 -174.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -91.57 147.81 22.74 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.705 -0.622 . . . . 0.0 110.301 173.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.11 -26.8 61.66 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.4 m -65.56 -39.39 91.62 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.453 -1.028 . . . . 0.0 110.944 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.69 -32.54 31.67 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.445 -0.785 . . . . 0.0 110.807 -174.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.456 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 8.1 mt -102.97 140.23 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.422 -0.799 . . . . 0.0 110.157 177.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -106.34 -19.7 13.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.961 -0.462 . . . . 0.0 111.647 -167.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -150.41 133.61 16.25 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 119.008 -1.077 . . . . 0.0 111.379 -178.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.3 tt -132.44 138.77 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.931 -0.48 . . . . 0.0 109.799 176.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.1 mtm180 -147.07 145.95 29.81 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.598 -0.688 . . . . 0.0 110.422 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.8 m -84.83 147.1 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.664 -0.647 . . . . 0.0 110.328 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.7 m -139.15 147.09 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.559 -0.713 . . . . 0.0 110.172 -178.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -101.63 147.08 26.84 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.697 -0.627 . . . . 0.0 110.164 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -64.94 -31.79 73.19 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.618 -0.676 . . . . 0.0 110.531 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -95.11 109.22 21.31 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.68 -0.638 . . . . 0.0 110.127 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 39.3 p -131.85 166.47 21.53 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.743 -0.598 . . . . 0.0 110.194 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.3 mp -71.56 155.26 92.75 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 121.669 -0.645 . . . . 0.0 110.129 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo . . . . . 0 N--CA 1.487 1.137 0 O-C-N 123.699 1.368 . . . . 0.0 110.365 -179.636 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -102.31 141.59 34.9 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.659 -0.907 . . . . 0.0 110.192 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 90.2 mtp -65.98 -37.65 86.5 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.712 -0.617 . . . . 0.0 110.322 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -154.98 150.08 26.97 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.771 -0.581 . . . . 0.0 110.238 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.9 ttm -119.95 123.03 42.53 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.658 -0.651 . . . . 0.0 110.16 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.8 m -125.52 142.93 51.24 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.701 -0.625 . . . . 0.0 110.155 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -155.05 110.29 0.44 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.87 -60.1 0.89 Allowed Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.6 mp -80.76 156.37 72.77 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.64 -0.918 . . . . 0.0 110.158 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -66.98 132.92 29.48 Favored 'Trans proline' 0 N--CA 1.488 1.151 0 O-C-N 123.659 1.347 . . . . 0.0 110.329 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -64.91 127.49 31.79 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.626 -0.671 . . . . 0.0 110.525 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.0 mt -64.89 150.52 47.63 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.765 -0.584 . . . . 0.0 110.602 178.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.72 -1.94 84.58 Favored Glycine 0 N--CA 1.496 2.659 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.793 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 74.1 m -61.13 148.1 41.74 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.097 -1.237 . . . . 0.0 110.46 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -81.59 125.18 30.22 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.716 -0.615 . . . . 0.0 110.536 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 90.0 mt -120.91 145.05 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.555 -0.716 . . . . 0.0 110.014 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.6 t -102.93 137.19 41.45 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 13.5 tp -133.12 124.86 28.32 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.875 -0.515 . . . . 0.0 110.211 -169.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.3 mt -105.75 118.49 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.633 -0.667 . . . . 0.0 109.661 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.1 m -93.1 157.8 16.1 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.112 0.482 . . . . 0.0 111.235 -176.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -53.8 -14.2 0.89 Allowed 'General case' 0 N--CA 1.51 2.525 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -171.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.63 20.08 4.23 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.207 -0.933 . . . . 0.0 110.412 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 54.38 35.07 22.18 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.448 -0.782 . . . . 0.0 109.817 -175.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.2 mt -103.23 144.27 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 59.5 ttm-85 -105.06 119.87 40.09 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.073 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -114.2 150.12 34.75 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 174.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -141.48 140.52 33.55 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.484 -0.76 . . . . 0.0 109.648 175.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -169.28 172.86 43.6 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 119.607 -1.282 . . . . 0.0 110.575 -175.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -85.23 136.28 33.58 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.878 -0.778 . . . . 0.0 110.609 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.0 tp -66.3 119.53 11.71 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.634 -0.666 . . . . 0.0 110.694 175.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -100.13 -50.18 4.05 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.549 -0.719 . . . . 0.0 110.419 178.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.5 p -154.4 156.01 36.04 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.636 -0.665 . . . . 0.0 110.283 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.6 p -142.26 145.63 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.612 -0.68 . . . . 0.0 110.068 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -127.5 98.74 28.24 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.627 -0.671 . . . . 0.0 109.565 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -59.38 -42.05 52.58 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 O-C-N 123.597 1.314 . . . . 0.0 111.044 -175.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -80.74 -24.59 38.6 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.372 -0.83 . . . . 0.0 110.169 -171.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -87.12 1.15 53.9 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.509 -0.745 . . . . 0.0 111.245 173.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.4 m 49.82 37.91 14.53 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.122 -0.986 . . . . 0.0 111.203 -176.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.9 p -136.13 154.38 51.0 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.405 -0.809 . . . . 0.0 110.368 -174.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.9 pt -142.51 162.09 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.706 -0.621 . . . . 0.0 110.166 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.54 128.07 28.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.698 -0.627 . . . . 0.0 109.752 175.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 90.6 mt -109.92 148.95 30.63 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 96.6 p -119.65 152.18 37.52 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.6 p 45.58 83.46 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.226 0 CA-C-O 121.54 0.686 . . . . 0.0 110.382 -172.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.9 p -134.59 150.48 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -136.07 153.21 51.4 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.598 -0.689 . . . . 0.0 110.063 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 81.7 p -107.25 137.52 45.15 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.74 -0.6 . . . . 0.0 109.56 177.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -82.76 -38.47 23.18 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.92 -172.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.38 167.37 27.96 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 175.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.3 p -118.28 6.24 11.92 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.807 -0.819 . . . . 0.0 110.913 172.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -52.71 -26.22 13.36 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.49 -0.756 . . . . 0.0 112.095 -167.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -66.22 -59.16 4.0 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.393 -0.817 . . . . 0.0 110.273 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -94.28 10.18 35.15 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.736 -0.602 . . . . 0.0 111.342 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 52.9 p-10 -57.68 174.06 0.26 Allowed 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.29 -0.881 . . . . 0.0 111.499 -171.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.5 m -79.0 164.55 24.29 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -77.44 3.24 13.84 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.584 -0.698 . . . . 0.0 111.227 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -100.46 165.99 11.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.225 -0.922 . . . . 0.0 109.567 169.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -66.98 136.83 55.93 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.579 -0.7 . . . . 0.0 110.515 -175.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.2 mm -113.52 137.26 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.679 -0.638 . . . . 0.0 109.604 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -96.83 109.94 51.13 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.664 -0.648 . . . . 0.0 110.21 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -67.49 145.06 69.48 Favored 'Trans proline' 0 N--CA 1.488 1.16 0 O-C-N 123.395 1.208 . . . . 0.0 110.288 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -97.36 114.42 26.22 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.648 -0.657 . . . . 0.0 110.265 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 87.3 p -77.51 -29.18 52.34 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.655 -0.653 . . . . 0.0 110.478 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -62.13 151.24 36.31 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.601 -0.687 . . . . 0.0 110.669 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.5 mm -96.75 144.92 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.751 -0.593 . . . . 0.0 109.747 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -94.32 114.59 26.68 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.56 -0.712 . . . . 0.0 110.218 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -50.95 -40.51 57.64 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.824 -0.547 . . . . 0.0 111.812 178.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -152.57 130.12 11.47 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.714 -0.616 . . . . 0.0 110.289 -174.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 76.3 mt -130.09 129.53 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.641 -0.662 . . . . 0.0 109.793 172.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.2 tp -90.27 137.02 32.69 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.814 -0.554 . . . . 0.0 109.864 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.462 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 2.5 m-85 -135.17 129.28 33.56 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.658 -0.651 . . . . 0.0 110.562 -175.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 71.2 mtp85 -91.26 146.77 23.54 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.703 -0.623 . . . . 0.0 110.249 173.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.8 -26.52 60.49 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 110.539 -1.025 . . . . 0.0 110.539 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.2 m -65.84 -39.4 90.76 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.527 -0.984 . . . . 0.0 110.953 -177.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.67 -31.71 32.12 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.533 -0.73 . . . . 0.0 110.824 -174.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.462 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 7.9 mt -102.32 142.42 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.443 -0.786 . . . . 0.0 110.191 177.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -104.46 -23.67 13.13 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.378 -167.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -151.99 135.34 15.98 Favored 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 119.146 -1.022 . . . . 0.0 111.446 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.6 tt -131.81 140.8 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.906 -0.496 . . . . 0.0 109.775 176.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -146.91 141.56 26.66 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.519 -0.738 . . . . 0.0 110.349 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.5 t -86.85 145.75 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.679 -0.638 . . . . 0.0 109.711 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.3 t -139.2 135.92 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.583 -0.698 . . . . 0.0 109.758 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -142.35 100.36 3.69 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.65 -0.656 . . . . 0.0 110.167 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -125.0 105.87 9.52 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.708 -0.62 . . . . 0.0 110.255 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -110.59 -26.29 9.53 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.658 -0.651 . . . . 0.0 110.677 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 56.4 p -77.09 161.46 28.25 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.446 -0.784 . . . . 0.0 110.097 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.2 tp -109.1 109.91 60.71 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.65 -0.656 . . . . 0.0 110.128 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo . . . . . 0 N--CA 1.488 1.182 0 O-C-N 123.394 1.207 . . . . 0.0 110.295 179.178 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -103.82 144.76 31.07 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.613 -0.934 . . . . 0.0 110.196 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 88.8 mmm -119.01 148.34 43.11 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.734 -0.604 . . . . 0.0 110.148 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -95.18 111.38 23.23 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.684 -0.635 . . . . 0.0 110.147 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.6 mtp -134.71 158.27 44.54 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.666 -0.646 . . . . 0.0 110.241 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.3 t -120.81 141.24 50.72 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.695 -0.628 . . . . 0.0 110.142 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -127.66 104.72 0.7 Allowed Glycine 0 N--CA 1.496 2.691 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.24 -179.58 48.39 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.91 -56.81 1.04 Allowed Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.643 -0.916 . . . . 0.0 110.591 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -71.93 137.43 29.39 Favored 'Trans proline' 0 N--CA 1.487 1.104 0 O-C-N 123.244 1.128 . . . . 0.0 110.377 -178.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -64.79 141.03 58.92 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.707 -0.621 . . . . 0.0 110.499 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.1 mt -64.76 152.05 43.63 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.623 -0.673 . . . . 0.0 110.622 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.68 -1.92 84.55 Favored Glycine 0 N--CA 1.497 2.753 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.788 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 63.8 m -62.0 155.27 24.26 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.168 -1.195 . . . . 0.0 110.4 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.8 pttt -81.21 127.98 33.28 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 120.191 -0.604 . . . . 0.0 110.384 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 87.7 mt -121.62 142.95 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.563 -0.711 . . . . 0.0 110.03 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.0 t -102.99 137.29 41.38 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 175.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 13.9 tp -134.33 123.88 24.9 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.736 -0.602 . . . . 0.0 110.164 -169.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.5 mt -106.33 118.16 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.574 -0.704 . . . . 0.0 109.609 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 62.3 m -92.47 157.81 16.37 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 120.963 0.411 . . . . 0.0 111.245 -176.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -53.56 -13.98 0.75 Allowed 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 -172.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.96 20.58 4.13 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.115 -0.991 . . . . 0.0 110.412 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 53.43 34.37 18.02 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.395 -0.816 . . . . 0.0 109.813 -174.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.1 mt -101.24 141.99 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -104.68 119.86 39.98 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.958 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -115.0 149.28 37.67 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 174.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -140.95 140.52 34.44 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.377 -0.827 . . . . 0.0 109.706 174.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.35 172.17 41.56 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 119.814 -1.184 . . . . 0.0 110.559 -175.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -84.7 139.41 32.03 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.933 -0.745 . . . . 0.0 110.611 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.0 tp -66.11 117.9 9.09 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.718 -0.614 . . . . 0.0 110.7 175.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -100.11 -50.06 4.1 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.561 -0.712 . . . . 0.0 110.333 177.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.9 p -153.81 156.05 36.94 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.684 -0.635 . . . . 0.0 110.271 -178.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.5 p -142.24 145.28 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.74 -0.6 . . . . 0.0 110.18 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -129.03 101.88 19.38 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.675 -0.641 . . . . 0.0 109.434 176.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.83 -41.78 28.35 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 O-C-N 123.562 1.296 . . . . 0.0 110.919 -173.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -80.66 -24.97 38.57 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.332 -0.855 . . . . 0.0 110.227 -170.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -87.79 1.75 53.07 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.484 -0.76 . . . . 0.0 111.293 173.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 40.3 m 49.87 41.1 22.14 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.125 -0.984 . . . . 0.0 111.218 -176.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.5 p -135.5 153.45 51.73 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.327 -0.858 . . . . 0.0 110.53 -174.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.4 pt -141.74 162.0 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.66 -0.65 . . . . 0.0 110.117 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.01 127.87 29.31 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.719 -0.613 . . . . 0.0 109.669 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.5 mt -109.87 145.07 37.44 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 -177.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 99.2 p -116.47 151.82 35.3 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.8 p 45.92 85.47 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 121.5 0.667 . . . . 0.0 110.356 -171.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.9 p -134.65 149.1 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -131.68 153.01 50.44 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.623 -0.673 . . . . 0.0 109.891 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 96.9 p -112.01 140.64 46.52 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.741 -0.599 . . . . 0.0 109.891 177.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -83.06 -38.5 22.44 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.613 -0.679 . . . . 0.0 111.175 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.58 171.91 34.1 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.993 -1.098 . . . . 0.0 110.417 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.16 6.5 12.02 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.829 -0.807 . . . . 0.0 110.884 173.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -50.3 -25.53 3.85 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.508 -0.745 . . . . 0.0 112.446 -168.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -66.06 -59.26 3.97 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.365 -0.834 . . . . 0.0 110.382 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -94.31 10.19 35.16 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.618 -0.676 . . . . 0.0 111.391 177.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 50.5 p-10 -58.15 171.98 0.49 Allowed 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.212 -0.93 . . . . 0.0 111.362 -171.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.7 m -78.98 164.41 24.41 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.908 -0.495 . . . . 0.0 109.873 176.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -77.6 4.22 11.88 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.662 -0.649 . . . . 0.0 111.198 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -95.54 164.75 12.66 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.25 -0.906 . . . . 0.0 109.608 167.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -68.55 135.38 51.44 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.507 -0.746 . . . . 0.0 110.453 -176.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.6 mm -114.17 134.39 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.734 -0.604 . . . . 0.0 109.615 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -96.22 109.88 49.49 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.703 -0.623 . . . . 0.0 110.181 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -67.33 135.02 35.34 Favored 'Trans proline' 0 N--CA 1.488 1.154 0 O-C-N 123.414 1.218 . . . . 0.0 110.308 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 18.8 mp0 -111.63 135.07 52.71 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.671 -0.643 . . . . 0.0 110.168 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 83.1 p -91.48 6.87 43.87 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.655 -0.653 . . . . 0.0 111.2 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -63.1 141.04 58.91 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.217 -0.927 . . . . 0.0 110.438 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.8 mm -96.86 137.7 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.655 -0.653 . . . . 0.0 109.844 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -94.14 119.03 32.39 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.715 -0.616 . . . . 0.0 110.177 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -51.35 -42.61 61.43 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.789 -0.569 . . . . 0.0 111.745 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -152.27 130.3 11.84 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.587 -0.695 . . . . 0.0 110.293 -174.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 75.2 mt -130.26 130.3 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.728 -0.608 . . . . 0.0 109.877 171.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 19.0 tp -90.25 137.01 32.69 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.823 -0.548 . . . . 0.0 109.934 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.47 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 2.3 m-85 -133.4 127.09 32.68 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.627 -0.67 . . . . 0.0 110.477 -176.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -92.12 145.98 24.08 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.592 -0.692 . . . . 0.0 110.31 173.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.88 -26.67 60.92 Favored Glycine 0 N--CA 1.499 2.843 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.2 m -65.02 -39.94 94.14 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.408 -1.054 . . . . 0.0 110.977 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.77 -32.24 31.51 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.445 -0.784 . . . . 0.0 110.826 -175.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.47 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 6.6 mt -99.34 141.75 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.53 -0.731 . . . . 0.0 110.264 177.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -104.35 -20.78 13.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.938 -0.476 . . . . 0.0 111.377 -169.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -151.79 131.95 13.56 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.238 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.1 tt -130.91 140.48 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.872 -0.517 . . . . 0.0 109.737 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -146.47 130.28 17.12 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.62 -0.675 . . . . 0.0 110.306 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.5 p -87.74 146.29 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.613 -0.679 . . . . 0.0 110.27 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.6 t -96.05 133.48 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.572 -0.705 . . . . 0.0 109.738 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -125.42 -60.06 1.35 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.619 -0.676 . . . . 0.0 110.155 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -114.69 117.71 31.59 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.7 -0.625 . . . . 0.0 110.169 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -121.66 120.13 33.85 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.64 -0.662 . . . . 0.0 110.155 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.0 t -138.78 160.52 39.49 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.582 -0.699 . . . . 0.0 110.352 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.1 mp -113.36 165.19 13.85 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.614 -0.679 . . . . 0.0 110.19 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo . . . . . 0 N--CA 1.489 1.235 0 O-C-N 123.664 1.349 . . . . 0.0 110.481 179.964 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -144.74 156.65 44.17 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.662 -0.905 . . . . 0.0 110.203 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 74.4 mtm -118.52 159.0 24.3 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.81 -0.556 . . . . 0.0 110.151 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -141.3 156.74 45.83 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.763 -0.586 . . . . 0.0 110.147 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.6 mtm -110.39 151.71 27.14 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.729 -0.607 . . . . 0.0 110.209 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.6 t -117.36 143.87 45.52 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.687 -0.633 . . . . 0.0 110.225 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.33 -34.84 89.16 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -146.3 83.73 0.19 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 14.9 tp -80.26 139.63 52.45 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.724 -0.868 . . . . 0.0 110.032 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -66.28 153.18 79.03 Favored 'Trans proline' 0 N--CA 1.489 1.224 0 O-C-N 123.392 1.206 . . . . 0.0 110.415 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -64.91 96.05 0.18 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.67 -0.644 . . . . 0.0 110.473 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.0 mt -64.81 174.09 2.0 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.693 -0.629 . . . . 0.0 110.722 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.68 -1.92 84.53 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.841 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.6 m -61.72 142.22 57.37 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.113 -1.228 . . . . 0.0 110.457 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -82.36 123.38 29.04 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.748 -0.595 . . . . 0.0 110.559 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 91.0 mt -120.25 144.18 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.472 -0.768 . . . . 0.0 110.199 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.4 t -103.11 137.27 41.5 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 174.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 13.1 tp -133.49 127.84 34.11 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.712 -0.618 . . . . 0.0 110.339 -169.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.0 mt -107.59 119.98 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.593 -0.692 . . . . 0.0 109.738 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.3 m -94.35 157.81 15.86 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.049 0.452 . . . . 0.0 111.248 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.0 tptp -53.51 -15.18 1.0 Allowed 'General case' 0 N--CA 1.509 2.5 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -172.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.75 21.32 3.59 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.13 -0.982 . . . . 0.0 110.436 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 54.16 33.98 19.14 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.44 -0.788 . . . . 0.0 109.795 -174.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.2 mt -101.81 142.72 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 36.7 ttp85 -105.19 119.8 39.94 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.941 -0.704 . . . . 0.0 109.887 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -113.79 149.24 35.21 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -140.61 140.53 35.09 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.546 -0.721 . . . . 0.0 109.696 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -169.13 173.24 43.57 Favored Glycine 0 N--CA 1.495 2.603 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.463 -175.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -85.11 136.44 33.55 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.881 -0.776 . . . . 0.0 110.495 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.3 tp -66.12 119.04 10.74 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.57 -0.706 . . . . 0.0 110.693 175.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -99.4 -50.09 4.22 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.666 -0.646 . . . . 0.0 110.292 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.2 p -153.9 153.29 31.79 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.78 -0.575 . . . . 0.0 110.255 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.5 p -142.31 144.86 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.643 -0.661 . . . . 0.0 110.102 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -128.99 101.53 19.68 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.531 -0.73 . . . . 0.0 109.528 177.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.68 -40.25 38.33 Favored 'Trans proline' 0 N--CA 1.489 1.243 0 O-C-N 123.515 1.271 . . . . 0.0 110.719 -175.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -80.68 -25.18 38.39 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.306 -0.871 . . . . 0.0 110.174 -171.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -87.44 1.46 53.36 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.516 -0.74 . . . . 0.0 111.256 173.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.0 m 49.84 39.51 18.38 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.105 -0.997 . . . . 0.0 111.284 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.7 p -136.65 151.98 49.9 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.365 -0.834 . . . . 0.0 110.368 -175.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.7 pt -142.6 161.47 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.695 -0.628 . . . . 0.0 110.179 177.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.86 127.91 27.75 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.628 -0.67 . . . . 0.0 109.678 175.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 85.6 mt -109.87 146.98 34.19 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -177.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 96.7 p -118.7 153.06 34.99 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -177.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.7 p 45.75 85.9 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 121.452 0.644 . . . . 0.0 110.318 -172.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.3 p -134.51 148.61 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.952 -0.468 . . . . 0.0 109.909 -177.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -126.41 153.12 45.43 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.699 -0.626 . . . . 0.0 109.829 177.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 96.6 p -108.24 134.93 50.39 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.703 -0.623 . . . . 0.0 109.726 175.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -83.01 -38.37 22.7 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.57 -0.706 . . . . 0.0 111.045 -173.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.61 169.29 30.96 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 120.027 -1.083 . . . . 0.0 110.602 176.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.19 6.58 12.0 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.97 -0.724 . . . . 0.0 110.837 174.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -49.16 -25.64 2.32 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.6 -0.688 . . . . 0.0 112.62 -168.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -65.04 -59.22 4.37 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.321 -0.862 . . . . 0.0 110.587 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -94.31 10.14 35.35 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.569 -0.707 . . . . 0.0 111.381 177.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.9 p-10 -59.44 165.86 2.61 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.251 -0.906 . . . . 0.0 111.438 -170.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.3 m -78.98 164.46 24.38 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.925 -0.484 . . . . 0.0 109.748 174.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -77.55 4.22 11.76 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.607 -0.683 . . . . 0.0 111.263 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -96.78 155.32 16.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.156 -0.965 . . . . 0.0 109.623 167.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -68.77 139.8 55.31 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.649 -0.657 . . . . 0.0 110.387 -175.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 81.5 mt -116.38 138.41 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.674 -0.641 . . . . 0.0 109.612 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -97.98 109.98 53.81 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.733 -0.605 . . . . 0.0 110.223 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -66.14 149.64 85.51 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 O-C-N 123.357 1.188 . . . . 0.0 110.335 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -93.22 112.64 24.64 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.667 -0.646 . . . . 0.0 110.301 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.7 t -67.18 -29.4 69.07 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.668 -0.645 . . . . 0.0 110.463 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -60.98 159.29 11.73 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.544 -0.723 . . . . 0.0 110.759 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.81 146.72 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.843 -0.536 . . . . 0.0 109.748 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -91.72 111.85 23.54 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.659 -0.651 . . . . 0.0 109.894 176.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -52.35 -43.21 64.5 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.786 -0.571 . . . . 0.0 111.707 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -154.55 130.28 10.02 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.742 -0.599 . . . . 0.0 110.264 -174.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 82.9 mt -129.07 127.44 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.663 -0.648 . . . . 0.0 109.989 171.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 24.0 tp -90.79 137.03 32.68 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.867 -0.521 . . . . 0.0 109.859 175.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.44 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 4.5 m-85 -136.95 131.59 33.22 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.685 -0.634 . . . . 0.0 110.65 -175.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -91.78 151.57 20.55 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.736 -0.602 . . . . 0.0 110.452 174.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.96 -23.98 59.94 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.2 p -67.52 -41.99 83.51 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.45 -1.03 . . . . 0.0 111.032 -176.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -83.13 -32.87 26.45 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.354 -0.842 . . . . 0.0 110.914 -175.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.44 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 22.2 mt -105.94 136.25 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.459 -0.775 . . . . 0.0 110.013 177.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 59.4 tttt -109.1 -14.34 14.54 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 120.417 -0.513 . . . . 0.0 112.008 -165.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -147.88 131.41 16.75 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 118.901 -1.12 . . . . 0.0 111.433 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 15.8 tt -132.38 137.48 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.936 -0.478 . . . . 0.0 109.77 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.0 mtm180 -147.04 147.1 30.31 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.606 -0.684 . . . . 0.0 110.387 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.9 t -85.96 145.04 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.679 -0.638 . . . . 0.0 109.601 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.2 t -94.68 134.89 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.601 -0.687 . . . . 0.0 109.898 -177.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -105.14 126.27 51.9 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.704 -0.623 . . . . 0.0 110.096 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -99.96 150.24 22.62 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.683 -0.636 . . . . 0.0 110.263 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -121.74 163.58 18.84 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.74 -0.6 . . . . 0.0 110.104 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.8 p -87.5 160.49 18.24 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.717 -0.615 . . . . 0.0 110.214 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.7 mt -126.35 163.56 39.53 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.682 -0.636 . . . . 0.0 110.112 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo . . . . . 0 N--CA 1.487 1.11 0 O-C-N 123.728 1.383 . . . . 0.0 110.323 179.932 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.361 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -102.96 144.81 30.76 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.678 -0.895 . . . . 0.0 110.27 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 9.3 tpt -66.48 -35.59 80.65 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.651 -0.656 . . . . 0.0 110.263 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -140.1 -59.78 0.54 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.765 -0.584 . . . . 0.0 110.176 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.5 mtp -109.64 134.8 51.53 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.673 -0.642 . . . . 0.0 110.115 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 86.4 p -108.35 28.77 7.99 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.67 -0.644 . . . . 0.0 110.585 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -153.31 37.34 0.74 Allowed Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.89 -60.06 1.16 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 27.5 mt -80.29 152.95 74.01 Favored Pre-proline 0 N--CA 1.497 1.919 0 O-C-N 121.63 -0.924 . . . . 0.0 110.262 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -69.16 155.76 66.94 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 O-C-N 123.685 1.361 . . . . 0.0 110.279 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -64.82 103.87 0.77 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.644 -0.66 . . . . 0.0 110.407 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.5 mt -64.8 149.95 48.41 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.736 -0.603 . . . . 0.0 110.71 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.65 -1.97 84.29 Favored Glycine 0 N--CA 1.497 2.713 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.837 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.9 m -62.06 148.21 44.85 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.125 -1.221 . . . . 0.0 110.49 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -81.87 124.53 29.79 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.662 -0.649 . . . . 0.0 110.401 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 88.8 mt -120.64 144.54 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.565 -0.71 . . . . 0.0 110.122 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.6 t -102.91 137.33 41.25 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 13.6 tp -132.79 125.64 30.55 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.711 -0.618 . . . . 0.0 110.219 -169.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.0 mt -106.94 118.6 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.447 -0.783 . . . . 0.0 109.661 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.9 m -93.77 157.65 16.05 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 120.997 0.427 . . . . 0.0 111.3 -177.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -55.68 -11.17 0.85 Allowed 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -172.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.72 18.48 4.67 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.196 -0.94 . . . . 0.0 110.439 176.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 55.64 36.06 26.46 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.442 -0.786 . . . . 0.0 109.918 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 57.6 mt -106.96 145.0 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -105.62 119.81 40.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.618 -0.676 . . . . 0.0 110.123 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -113.81 152.12 31.09 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -142.27 140.57 32.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.429 -0.795 . . . . 0.0 109.672 175.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.87 172.21 42.55 Favored Glycine 0 N--CA 1.496 2.634 0 C-N-CA 119.713 -1.232 . . . . 0.0 110.558 -175.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -85.08 136.16 33.68 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.864 -0.786 . . . . 0.0 110.517 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.1 tp -66.16 117.8 8.98 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.623 -0.673 . . . . 0.0 110.664 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -99.95 -50.1 4.11 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.657 -0.652 . . . . 0.0 110.455 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.1 p -154.35 156.06 36.2 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.736 -0.603 . . . . 0.0 110.348 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.3 p -142.31 146.25 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.771 -0.58 . . . . 0.0 110.007 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -128.48 100.8 21.97 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.582 -0.699 . . . . 0.0 109.536 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.59 -40.16 39.67 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 O-C-N 123.558 1.294 . . . . 0.0 110.71 -174.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -80.63 -25.27 38.47 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.365 -0.834 . . . . 0.0 110.202 -171.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -87.47 1.3 53.85 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.498 -0.751 . . . . 0.0 111.258 173.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 45.2 m 49.6 39.19 16.66 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.089 -1.007 . . . . 0.0 111.303 -176.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.0 p -136.07 155.35 50.34 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.393 -0.817 . . . . 0.0 110.315 -174.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.8 pt -142.27 162.03 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.616 -0.677 . . . . 0.0 110.17 177.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.4 127.68 28.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.669 -0.644 . . . . 0.0 109.692 175.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 87.2 mt -109.87 147.12 33.94 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 96.8 p -118.22 152.43 35.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.674 -0.642 . . . . 0.0 109.27 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.3 p 45.5 84.79 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 CA-C-O 121.476 0.655 . . . . 0.0 110.358 -172.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.7 p -134.54 149.02 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.905 -0.497 . . . . 0.0 109.853 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.4 ttm180 -131.71 153.05 50.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.68 -0.637 . . . . 0.0 109.799 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 85.1 p -107.93 133.89 51.63 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.741 -0.599 . . . . 0.0 109.476 175.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -82.68 -38.63 23.15 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.039 -171.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.23 167.08 27.38 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 175.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.0 p -118.23 -11.2 10.13 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.963 -0.728 . . . . 0.0 110.83 170.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -52.74 -24.99 9.81 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.462 -0.774 . . . . 0.0 112.492 -166.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -79.12 -59.3 2.83 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.261 -0.899 . . . . 0.0 110.894 -176.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -94.42 9.93 36.41 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.596 -0.69 . . . . 0.0 112.006 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -90.16 174.56 7.55 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.085 -1.009 . . . . 0.0 111.126 -175.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.0 m -78.43 164.66 24.58 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 122.016 -0.428 . . . . 0.0 109.854 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -77.45 12.07 1.72 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.726 -0.609 . . . . 0.0 111.616 -173.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -92.49 140.54 29.46 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.241 -0.912 . . . . 0.0 109.62 169.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -65.97 141.03 58.34 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.713 -0.617 . . . . 0.0 110.919 -170.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 82.5 mt -118.83 138.81 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.731 -0.606 . . . . 0.0 109.399 176.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.62 113.43 14.23 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.617 -0.677 . . . . 0.0 110.125 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -64.18 142.65 81.15 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 O-C-N 123.305 1.161 . . . . 0.0 110.465 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -104.02 107.11 17.85 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.713 -0.617 . . . . 0.0 110.27 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.6 p -93.4 -32.72 14.13 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.685 -0.634 . . . . 0.0 110.327 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -62.8 152.64 35.4 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.619 -0.675 . . . . 0.0 110.655 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.4 mm -96.8 141.08 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.705 -0.622 . . . . 0.0 109.592 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -96.36 113.16 24.72 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.64 -0.663 . . . . 0.0 110.37 -177.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -51.19 -39.93 57.55 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.738 -0.601 . . . . 0.0 111.416 175.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -152.73 129.19 10.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.627 -0.671 . . . . 0.0 110.201 -175.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.6 mt -127.55 129.14 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.566 -0.709 . . . . 0.0 109.798 172.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.9 tp -90.18 137.05 32.67 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.859 -0.526 . . . . 0.0 109.808 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.46 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 2.6 m-85 -135.56 129.21 32.62 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.751 -0.593 . . . . 0.0 110.559 -175.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -91.07 146.62 23.69 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.715 -0.615 . . . . 0.0 110.176 173.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.58 -25.86 58.94 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.1 p -67.75 -37.61 82.38 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.459 -1.024 . . . . 0.0 110.875 -177.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -82.46 -30.5 29.94 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.454 -0.779 . . . . 0.0 110.934 -175.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.46 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 8.6 mt -103.95 142.87 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.426 -0.796 . . . . 0.0 110.278 176.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -104.63 -24.73 12.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.932 -0.48 . . . . 0.0 111.381 -167.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -151.88 136.24 16.79 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.048 -1.033 . . . . 0.0 111.465 -177.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.7 tt -131.79 140.51 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.963 -0.461 . . . . 0.0 109.828 176.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -146.87 140.77 25.96 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.544 -0.723 . . . . 0.0 110.335 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.0 p -86.04 147.05 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.669 -0.644 . . . . 0.0 110.107 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.0 t -93.98 134.76 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.578 -0.701 . . . . 0.0 109.868 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -120.82 157.31 30.03 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.712 -0.617 . . . . 0.0 110.195 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -98.81 134.2 42.03 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.707 -0.621 . . . . 0.0 110.111 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -116.85 139.49 50.56 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.656 -0.652 . . . . 0.0 110.184 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.8 t -133.46 156.96 46.77 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.705 -0.622 . . . . 0.0 110.397 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.1 tp -145.06 139.74 15.44 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.719 -0.613 . . . . 0.0 110.059 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo . . . . . 0 N--CA 1.488 1.193 0 O-C-N 123.346 1.182 . . . . 0.0 110.295 179.534 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -143.76 151.32 39.84 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.663 -0.904 . . . . 0.0 110.219 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 66.0 mtt -104.24 29.33 6.08 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.668 -0.645 . . . . 0.0 110.406 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -69.06 -34.68 75.56 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.577 -0.702 . . . . 0.0 110.254 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.7 mtp -129.18 165.47 21.26 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.667 -0.645 . . . . 0.0 110.313 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.5 m -117.41 151.9 36.08 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.715 -0.615 . . . . 0.0 110.102 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.35 34.53 5.47 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -115.44 37.51 3.44 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.0 pp -77.64 152.59 80.75 Favored Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 121.687 -0.89 . . . . 0.0 110.499 -179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -68.52 155.4 69.16 Favored 'Trans proline' 0 N--CA 1.487 1.127 0 O-C-N 123.624 1.328 . . . . 0.0 110.382 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -64.82 127.0 29.73 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.652 -0.655 . . . . 0.0 110.445 -178.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.6 mt -64.85 145.82 55.74 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.748 -0.595 . . . . 0.0 110.737 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.57 -1.9 84.31 Favored Glycine 0 N--CA 1.496 2.663 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.85 176.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.4 m -62.71 138.94 58.63 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.126 -1.22 . . . . 0.0 110.355 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -82.13 126.98 32.67 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.624 -0.673 . . . . 0.0 110.415 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 86.5 mt -120.97 143.36 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.614 -0.679 . . . . 0.0 110.142 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.0 t -103.18 137.32 41.49 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 14.0 tp -134.8 125.9 27.8 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.687 -0.633 . . . . 0.0 110.337 -168.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.3 mt -106.85 118.11 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.614 -0.679 . . . . 0.0 109.665 -178.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.6 m -92.86 157.89 16.14 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 120.97 0.414 . . . . 0.0 111.303 -176.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -53.75 -14.43 0.93 Allowed 'General case' 0 N--CA 1.508 2.453 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -171.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.14 20.22 3.82 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.169 -0.957 . . . . 0.0 110.519 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 56.03 36.08 26.72 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.463 -0.773 . . . . 0.0 109.916 -177.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 53.6 mt -107.05 146.58 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -105.39 119.81 40.03 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.13 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -113.41 152.39 30.11 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -142.36 140.45 32.08 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.491 -0.756 . . . . 0.0 109.583 175.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.95 171.41 41.77 Favored Glycine 0 N--CA 1.496 2.66 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.602 -175.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -85.45 137.27 33.02 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.836 -0.803 . . . . 0.0 110.607 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.2 tp -66.2 118.81 10.45 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.648 -0.657 . . . . 0.0 110.723 175.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -100.36 -50.06 4.05 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.611 -0.681 . . . . 0.0 110.351 176.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.2 p -153.55 153.59 32.68 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.741 -0.599 . . . . 0.0 110.18 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.5 p -142.3 145.04 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.593 -0.692 . . . . 0.0 110.102 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -128.5 100.51 22.26 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.623 -0.673 . . . . 0.0 109.566 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.41 -39.69 44.47 Favored 'Trans proline' 0 N--CA 1.489 1.244 0 O-C-N 123.578 1.304 . . . . 0.0 110.726 -175.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -80.49 -25.83 38.56 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.406 -0.809 . . . . 0.0 110.157 -172.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -87.35 1.83 52.14 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.501 -0.75 . . . . 0.0 111.195 173.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 75.5 m 49.58 38.3 14.51 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.116 -0.99 . . . . 0.0 111.291 -176.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.5 p -136.26 153.73 51.11 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.399 -0.813 . . . . 0.0 110.26 -174.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.9 pt -142.73 162.02 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.703 -0.623 . . . . 0.0 110.249 178.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.69 127.29 27.01 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.669 -0.644 . . . . 0.0 109.665 175.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 83.8 mt -109.94 146.99 34.27 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -177.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 95.7 p -118.07 152.68 35.09 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.5 p 45.58 84.0 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 121.492 0.663 . . . . 0.0 110.336 -172.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.9 p -134.53 150.55 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.947 -0.47 . . . . 0.0 109.774 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -136.4 153.09 51.19 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.64 -0.663 . . . . 0.0 110.168 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.5 p -107.2 133.03 52.39 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.71 -0.619 . . . . 0.0 109.506 176.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -83.09 -38.62 22.22 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.726 -0.79 . . . . 0.0 111.087 -170.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.27 171.73 33.65 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 176.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.6 p -118.22 6.1 11.95 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.789 -0.83 . . . . 0.0 110.467 169.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -57.26 -31.41 65.54 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.545 -0.722 . . . . 0.0 112.427 -161.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -66.69 -59.34 3.67 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.239 -0.913 . . . . 0.0 110.486 -174.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.0 mtt-85 -94.51 10.3 35.15 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.677 -0.639 . . . . 0.0 111.612 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.2 p30 -54.63 172.15 0.11 Allowed 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.166 -0.959 . . . . 0.0 111.894 -171.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.0 m -78.94 164.6 24.29 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 173.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -77.32 3.75 12.33 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.567 -0.708 . . . . 0.0 111.214 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -98.28 153.34 18.58 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.215 -0.928 . . . . 0.0 109.619 169.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -67.82 138.59 56.25 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.578 -0.701 . . . . 0.0 110.597 -174.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 79.2 mt -117.43 141.2 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.661 -0.65 . . . . 0.0 109.511 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -97.66 109.86 52.59 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.612 -0.68 . . . . 0.0 110.215 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -68.6 147.65 70.64 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 O-C-N 123.44 1.232 . . . . 0.0 110.325 178.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -101.38 121.44 41.93 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.64 -0.662 . . . . 0.0 110.206 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 86.6 p -81.25 -26.81 35.53 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.724 -0.61 . . . . 0.0 110.686 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -61.67 148.35 42.93 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.471 -0.768 . . . . 0.0 110.623 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.1 mm -96.85 145.64 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.712 -0.618 . . . . 0.0 109.747 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -95.75 114.34 26.06 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.659 -0.651 . . . . 0.0 110.347 -178.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -51.04 -41.09 59.64 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.709 -0.62 . . . . 0.0 111.527 176.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -152.63 129.51 10.97 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.727 -0.608 . . . . 0.0 110.226 -174.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 73.7 mt -128.23 128.34 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.683 -0.635 . . . . 0.0 109.794 172.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.8 tp -90.13 137.06 32.65 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.889 -0.507 . . . . 0.0 109.838 176.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.462 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 3.0 m-85 -135.35 128.84 32.43 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.572 -0.705 . . . . 0.0 110.603 -175.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -91.27 147.03 23.33 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.653 -0.654 . . . . 0.0 110.177 172.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.63 -25.62 58.76 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.2 p -67.83 -37.85 82.45 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.427 -1.043 . . . . 0.0 110.917 -177.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -82.43 -30.79 29.86 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.504 -0.748 . . . . 0.0 110.9 -175.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.462 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 8.5 mt -104.31 138.78 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.492 -0.755 . . . . 0.0 110.104 176.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -105.04 -18.07 14.28 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.92 -0.487 . . . . 0.0 111.58 -167.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -151.03 132.03 14.27 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 119.115 -1.034 . . . . 0.0 111.249 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 16.8 tt -132.2 141.97 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.887 -0.508 . . . . 0.0 109.806 176.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -146.4 135.13 22.28 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.659 -0.65 . . . . 0.0 110.361 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 52.4 t -87.59 143.74 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.682 -0.636 . . . . 0.0 109.775 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.3 t -93.82 134.81 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.59 -0.694 . . . . 0.0 109.745 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -113.28 165.46 12.4 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.736 -0.603 . . . . 0.0 110.227 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -90.35 132.1 35.77 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.763 -0.586 . . . . 0.0 110.107 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -118.9 160.32 22.16 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.599 -0.688 . . . . 0.0 110.203 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.6 m -113.18 142.39 45.84 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.706 -0.621 . . . . 0.0 110.135 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.33 162.22 63.04 Favored Pre-proline 0 N--CA 1.5 2.049 0 O-C-N 121.646 -0.659 . . . . 0.0 110.244 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo . . . . . 0 N--CA 1.488 1.175 0 O-C-N 123.561 1.296 . . . . 0.0 110.47 179.796 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -103.83 31.7 4.33 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.686 -0.89 . . . . 0.0 110.376 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 22.5 ttt -111.71 138.67 47.97 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.607 -0.683 . . . . 0.0 110.174 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -102.06 141.68 34.52 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.791 -0.568 . . . . 0.0 110.216 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.88 -35.36 79.85 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.703 -0.623 . . . . 0.0 110.301 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.2 t -124.25 140.62 52.78 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.706 -0.622 . . . . 0.0 110.217 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -106.25 -50.08 0.89 Allowed Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.32 137.66 23.13 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 11.6 tp -81.28 112.03 29.75 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.665 -0.903 . . . . 0.0 110.111 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -65.82 136.59 46.03 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 O-C-N 123.349 1.184 . . . . 0.0 110.383 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -64.83 131.56 47.09 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.653 -0.654 . . . . 0.0 110.583 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.3 mt -64.76 165.56 10.29 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.664 -0.647 . . . . 0.0 110.469 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.68 -1.79 84.95 Favored Glycine 0 N--CA 1.497 2.707 0 C-N-CA 120.453 -0.879 . . . . 0.0 111.742 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.4 m -60.39 151.7 27.33 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.078 -1.248 . . . . 0.0 110.482 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.5 pttt -81.95 126.54 32.06 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.66 -0.65 . . . . 0.0 110.551 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 89.5 mt -120.8 143.76 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.57 -0.706 . . . . 0.0 109.988 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.4 t -102.42 137.27 40.89 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 175.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 14.7 tp -133.11 125.06 28.7 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.763 -0.586 . . . . 0.0 110.227 -169.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 81.7 mt -106.75 118.85 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.548 -0.72 . . . . 0.0 109.629 -178.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.7 m -93.69 157.66 16.06 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.064 0.459 . . . . 0.0 111.148 -178.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -54.21 -13.24 0.8 Allowed 'General case' 0 N--CA 1.507 2.416 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -172.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.0 20.4 4.27 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.142 -0.974 . . . . 0.0 110.475 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 53.96 33.98 18.6 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.485 -0.76 . . . . 0.0 109.749 -173.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.8 mt -102.22 140.89 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -104.9 119.81 39.92 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.922 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -114.36 147.55 38.98 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 173.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -139.31 140.43 37.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.436 -0.79 . . . . 0.0 109.627 175.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.11 173.22 42.34 Favored Glycine 0 N--CA 1.496 2.678 0 C-N-CA 119.737 -1.22 . . . . 0.0 110.58 -175.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -84.28 137.57 33.39 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.907 -0.761 . . . . 0.0 110.546 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.0 tp -66.15 116.88 7.7 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.727 -0.608 . . . . 0.0 110.655 175.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -99.68 -50.18 4.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.659 -0.651 . . . . 0.0 110.421 178.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.1 p -153.97 153.64 32.36 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.705 -0.622 . . . . 0.0 110.269 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.7 p -142.24 145.19 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.696 -0.627 . . . . 0.0 110.092 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -127.88 98.73 27.01 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.631 -0.668 . . . . 0.0 109.611 177.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -59.44 -42.06 52.07 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 O-C-N 123.577 1.304 . . . . 0.0 110.984 -175.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -80.73 -24.82 38.49 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.413 -0.804 . . . . 0.0 110.181 -171.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -87.02 1.26 53.43 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.536 -0.728 . . . . 0.0 111.177 173.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 96.5 m 49.8 38.17 15.05 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.053 -1.029 . . . . 0.0 111.249 -176.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.6 p -136.12 153.09 51.4 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.431 -0.793 . . . . 0.0 110.43 -174.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.9 pt -142.77 162.04 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.703 -0.623 . . . . 0.0 110.22 177.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.79 128.1 28.19 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.67 -0.644 . . . . 0.0 109.686 175.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 83.6 mt -109.89 145.83 36.17 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -178.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.4 p -116.92 153.0 33.34 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -178.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 44.6 p 45.93 87.05 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 121.516 0.674 . . . . 0.0 110.317 -172.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.4 p -134.59 147.19 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.897 -0.502 . . . . 0.0 109.929 -177.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -123.84 153.17 41.45 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.767 -0.583 . . . . 0.0 109.881 177.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.3 p -108.54 136.69 47.72 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.716 -0.615 . . . . 0.0 109.707 176.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -82.93 -38.39 22.87 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.528 -0.733 . . . . 0.0 110.968 -174.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.57 167.62 28.51 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 120.024 -1.084 . . . . 0.0 110.578 176.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.09 6.55 12.08 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.974 -0.721 . . . . 0.0 110.899 174.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -49.45 -25.16 2.39 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.544 -0.723 . . . . 0.0 112.624 -168.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -64.5 -59.22 4.57 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.191 -0.943 . . . . 0.0 110.607 -178.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 35.5 mtp180 -94.35 10.14 35.43 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.558 -0.714 . . . . 0.0 111.472 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 40.0 p-10 -60.27 173.97 0.6 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.3 -0.875 . . . . 0.0 111.297 -170.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.0 m -78.99 164.34 24.47 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.93 -0.481 . . . . 0.0 109.737 175.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -77.55 3.56 13.32 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.601 -0.687 . . . . 0.0 111.291 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -96.54 166.01 11.89 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.219 -0.926 . . . . 0.0 109.656 168.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -68.61 139.29 55.51 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.606 -0.684 . . . . 0.0 110.364 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 49.5 mm -114.18 134.76 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.745 -0.597 . . . . 0.0 109.697 178.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.01 109.94 53.68 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.649 -0.657 . . . . 0.0 110.236 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -66.86 146.57 78.48 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 O-C-N 123.331 1.174 . . . . 0.0 110.305 178.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -97.44 121.12 38.98 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.653 -0.654 . . . . 0.0 110.299 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 86.4 p -75.79 -22.07 56.74 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.705 -0.622 . . . . 0.0 110.828 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -61.16 156.59 17.96 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.376 -0.828 . . . . 0.0 110.693 -178.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.5 mm -96.87 145.9 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.754 -0.591 . . . . 0.0 109.853 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -92.1 111.87 23.58 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.553 -0.717 . . . . 0.0 109.87 175.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -52.35 -43.11 64.45 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.746 -0.596 . . . . 0.0 111.769 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -154.62 130.15 9.87 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.588 -0.695 . . . . 0.0 110.238 -174.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 80.4 mt -128.77 127.42 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.618 -0.676 . . . . 0.0 109.916 171.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 24.8 tp -90.32 137.09 32.63 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.779 -0.576 . . . . 0.0 109.755 175.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.465 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 3.5 m-85 -136.08 130.77 33.93 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.649 -0.657 . . . . 0.0 110.664 -175.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -91.6 149.57 21.59 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.663 -0.648 . . . . 0.0 110.339 173.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.31 -24.51 61.41 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 177.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.7 m -66.53 -42.04 87.83 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.366 -1.079 . . . . 0.0 111.077 -176.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -82.96 -33.41 26.69 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.423 -0.798 . . . . 0.0 110.919 -175.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.465 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 14.2 mt -101.02 138.15 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.404 -0.81 . . . . 0.0 110.11 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.0 tptp -107.32 -18.25 13.92 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 120.501 -0.479 . . . . 0.0 111.758 -166.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -148.93 131.14 15.49 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.897 -1.127 . . . . 0.0 111.354 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.0 tt -132.55 138.51 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.895 -0.503 . . . . 0.0 109.866 176.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.1 mtp180 -147.02 138.67 24.25 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.496 -0.753 . . . . 0.0 110.39 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.3 p -86.61 146.63 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.589 -0.694 . . . . 0.0 110.186 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.1 t -97.31 133.95 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.647 -0.658 . . . . 0.0 109.907 -179.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -120.84 93.89 4.18 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.724 -0.61 . . . . 0.0 110.158 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -97.3 -60.0 1.67 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.679 -0.638 . . . . 0.0 110.331 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -139.42 157.69 45.42 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.706 -0.621 . . . . 0.0 110.239 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.1 t -133.69 156.84 47.2 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.66 -0.65 . . . . 0.0 110.317 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -146.86 159.63 42.9 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.622 -0.674 . . . . 0.0 110.406 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo . . . . . 0 N--CA 1.488 1.198 0 O-C-N 123.662 1.348 . . . . 0.0 110.342 179.972 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -143.59 153.22 42.32 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.654 -0.909 . . . . 0.0 110.203 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 89.5 mtp -125.72 150.63 47.53 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.711 -0.618 . . . . 0.0 110.154 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -154.98 -47.1 0.08 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.705 -0.622 . . . . 0.0 110.232 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.5 mtp -128.88 167.79 16.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.66 -0.65 . . . . 0.0 110.194 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.1 m -113.36 147.92 36.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.653 -0.655 . . . . 0.0 110.205 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -113.25 -49.62 0.56 Allowed Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -119.22 -44.52 0.48 Allowed Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 41.8 mt -79.43 154.39 76.59 Favored Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.635 -0.921 . . . . 0.0 110.319 -178.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -68.4 160.12 50.48 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 O-C-N 123.718 1.378 . . . . 0.0 110.327 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -64.76 108.3 1.69 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.724 -0.61 . . . . 0.0 110.407 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.0 mt -64.89 143.19 58.11 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.718 -0.614 . . . . 0.0 110.663 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.62 -1.91 84.42 Favored Glycine 0 N--CA 1.497 2.707 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.759 177.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.3 m -62.55 140.59 58.64 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.094 -1.239 . . . . 0.0 110.372 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -81.97 123.14 28.62 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.67 -0.644 . . . . 0.0 110.473 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 91.8 mt -121.17 145.35 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.492 -0.755 . . . . 0.0 110.222 -178.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.0 t -103.21 137.24 41.62 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 175.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 14.3 tp -132.02 126.14 33.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.741 -0.599 . . . . 0.0 110.261 -169.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 81.4 mt -107.04 119.03 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.594 -0.691 . . . . 0.0 109.622 -178.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.9 m -93.56 157.73 16.05 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.081 0.467 . . . . 0.0 111.187 -177.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.0 tptp -53.67 -14.78 0.97 Allowed 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -172.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.85 21.23 3.68 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.183 -0.948 . . . . 0.0 110.469 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 53.99 34.31 19.4 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.509 -0.745 . . . . 0.0 109.886 -174.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 67.3 mt -102.1 141.55 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 54.0 ttt85 -104.51 119.84 39.89 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.891 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -113.86 149.24 35.36 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 174.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -140.69 140.49 34.94 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.499 -0.751 . . . . 0.0 109.494 175.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.64 173.09 43.27 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.666 -175.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -85.05 134.61 34.2 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.963 -0.728 . . . . 0.0 110.465 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.1 tp -66.2 119.87 12.24 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.61 -0.681 . . . . 0.0 110.735 176.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -99.43 -50.09 4.22 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.639 -0.663 . . . . 0.0 110.338 178.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.4 p -153.83 154.29 33.69 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.693 -0.63 . . . . 0.0 110.229 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.4 p -142.2 145.51 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.697 -0.627 . . . . 0.0 110.099 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -129.04 98.25 24.37 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.583 -0.698 . . . . 0.0 109.502 177.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -59.45 -40.16 69.43 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 O-C-N 123.606 1.319 . . . . 0.0 111.037 -175.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -80.51 -27.12 37.77 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.319 -0.863 . . . . 0.0 110.21 -170.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -87.59 3.34 47.98 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.524 -0.735 . . . . 0.0 111.212 173.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 42.4 m 49.61 39.66 17.77 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.13 -0.981 . . . . 0.0 111.351 -177.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.8 p -136.18 151.9 50.22 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.379 -0.826 . . . . 0.0 110.357 -175.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.0 pt -142.68 162.1 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.628 -0.67 . . . . 0.0 110.121 178.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.06 127.63 26.87 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.662 -0.648 . . . . 0.0 109.634 175.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 88.6 mt -109.9 148.67 31.14 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -177.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.8 p -119.55 152.24 37.31 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.9 p 45.63 83.71 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 CA-C-O 121.457 0.646 . . . . 0.0 110.355 -172.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.6 p -134.54 150.33 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -178.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -136.07 153.19 51.41 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.658 -0.651 . . . . 0.0 110.043 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.9 p -108.41 139.89 42.5 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.753 -0.592 . . . . 0.0 109.839 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -83.0 -38.39 22.7 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.669 -0.644 . . . . 0.0 111.035 -173.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.62 171.93 34.15 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 177.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.3 p -118.09 6.51 12.08 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.925 -0.75 . . . . 0.0 110.986 174.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -50.99 -24.43 3.69 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.555 -0.716 . . . . 0.0 112.749 -167.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -65.95 -59.35 3.92 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.191 -0.943 . . . . 0.0 110.583 -177.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 -94.5 10.24 35.36 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.567 -0.708 . . . . 0.0 111.474 176.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 41.4 p-10 -58.22 174.08 0.31 Allowed 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.168 -0.958 . . . . 0.0 111.283 -171.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.0 m -79.03 164.37 24.41 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.905 -0.497 . . . . 0.0 109.794 176.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -77.53 4.09 12.02 Favored 'General case' 0 N--CA 1.502 2.135 0 C-N-CA 120.046 -0.662 . . . . 0.0 111.235 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -96.2 164.91 12.47 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.169 -0.957 . . . . 0.0 109.597 168.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -68.81 137.0 53.61 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.62 -0.675 . . . . 0.0 110.47 -176.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.3 mm -114.43 135.96 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.705 -0.622 . . . . 0.0 109.591 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -96.1 109.85 49.09 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.621 -0.675 . . . . 0.0 110.195 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -69.29 140.74 45.21 Favored 'Trans proline' 0 N--CA 1.487 1.091 0 O-C-N 123.469 1.247 . . . . 0.0 110.269 177.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -115.21 136.35 53.2 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.626 -0.671 . . . . 0.0 110.174 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.5 m -91.45 11.86 22.58 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.693 -0.63 . . . . 0.0 111.234 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -63.38 138.52 58.55 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.279 -0.888 . . . . 0.0 110.449 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.0 mm -96.92 135.35 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.715 -0.616 . . . . 0.0 109.758 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -95.28 117.72 30.79 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.605 -0.684 . . . . 0.0 110.191 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -51.02 -42.41 60.43 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.817 -0.552 . . . . 0.0 111.634 177.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -152.68 130.38 11.58 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.614 -0.679 . . . . 0.0 110.3 -174.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 77.0 mt -129.4 128.43 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.664 -0.647 . . . . 0.0 109.854 172.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.2 tp -90.47 137.1 32.62 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.821 -0.549 . . . . 0.0 109.817 176.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.465 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 3.4 m-85 -136.53 130.81 33.01 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.636 -0.665 . . . . 0.0 110.606 -175.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.9 mtm-85 -92.21 150.68 20.76 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.725 -0.609 . . . . 0.0 110.367 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.31 -23.99 60.74 Favored Glycine 0 N--CA 1.498 2.804 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.3 p -67.11 -42.04 85.19 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.408 -1.054 . . . . 0.0 110.979 -176.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -82.92 -33.22 26.87 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.471 -0.768 . . . . 0.0 110.942 -175.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.465 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 14.9 mt -102.32 138.26 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.393 -0.817 . . . . 0.0 110.142 177.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -107.22 -18.45 13.88 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.797 -166.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -149.64 131.31 14.97 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 118.936 -1.106 . . . . 0.0 111.231 -178.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.1 tt -132.01 138.27 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.937 -0.477 . . . . 0.0 109.783 176.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -146.92 144.12 29.0 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.584 -0.698 . . . . 0.0 110.429 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.5 m -84.87 147.0 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.585 -0.697 . . . . 0.0 110.203 178.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.6 t -96.12 129.03 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.636 -0.665 . . . . 0.0 109.868 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -107.09 -36.06 6.69 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.747 -0.596 . . . . 0.0 110.194 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -104.68 136.79 43.55 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.687 -0.633 . . . . 0.0 110.238 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -111.27 138.69 47.41 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.759 -0.588 . . . . 0.0 110.159 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.1 m -109.62 141.23 42.45 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.702 -0.624 . . . . 0.0 110.157 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.6 mt -115.06 161.72 27.9 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.679 -0.638 . . . . 0.0 110.181 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo . . . . . 0 N--CA 1.487 1.141 0 O-C-N 123.707 1.372 . . . . 0.0 110.302 179.987 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -102.16 144.31 30.88 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.718 -0.872 . . . . 0.0 110.18 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 8.5 tpt -101.09 129.47 46.97 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.755 -0.59 . . . . 0.0 110.187 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -154.66 32.74 0.41 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.742 -0.599 . . . . 0.0 110.285 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.5 mtm -126.31 148.62 49.5 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.638 -0.664 . . . . 0.0 110.169 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 86.2 p -108.54 29.54 7.31 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.697 -0.627 . . . . 0.0 110.595 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -142.72 39.85 1.31 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.69 -50.2 1.21 Allowed Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.5 mp -80.11 158.66 72.0 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.737 -0.86 . . . . 0.0 110.202 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -64.91 147.61 89.38 Favored 'Trans proline' 0 N--CA 1.489 1.261 0 O-C-N 123.605 1.318 . . . . 0.0 110.383 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -64.86 132.09 48.49 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.71 -0.619 . . . . 0.0 110.463 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.5 mt -64.84 148.62 50.96 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.646 -0.659 . . . . 0.0 110.673 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.62 -1.88 84.5 Favored Glycine 0 N--CA 1.497 2.728 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.783 177.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.6 m -62.17 147.37 47.91 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.047 -1.266 . . . . 0.0 110.446 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.6 pttt -81.77 126.0 31.31 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.716 -0.615 . . . . 0.0 110.371 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 89.1 mt -122.49 144.15 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.543 -0.723 . . . . 0.0 110.107 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.3 t -102.68 137.3 41.08 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 13.4 tp -135.41 128.33 31.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.742 -0.599 . . . . 0.0 110.28 -169.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.3 mt -108.38 121.88 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.558 -0.714 . . . . 0.0 109.668 -178.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.1 m -93.2 157.85 16.06 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.042 0.449 . . . . 0.0 111.151 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -53.95 -13.78 0.85 Allowed 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -172.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.52 20.07 4.17 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.2 -0.938 . . . . 0.0 110.394 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 54.16 34.81 20.98 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.411 -0.806 . . . . 0.0 109.829 -175.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.4 mt -102.35 143.44 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -104.31 119.67 39.48 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.058 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -114.22 149.28 36.04 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -141.13 140.5 34.12 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.417 -0.802 . . . . 0.0 109.7 175.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.27 173.23 43.04 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 119.721 -1.228 . . . . 0.0 110.527 -175.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -85.29 136.81 33.34 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.872 -0.781 . . . . 0.0 110.581 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.5 tp -66.23 119.22 11.12 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.57 -0.706 . . . . 0.0 110.66 175.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -100.07 -50.16 4.07 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.641 -0.662 . . . . 0.0 110.445 178.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.6 p -153.94 156.18 37.01 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.708 -0.62 . . . . 0.0 110.34 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.6 p -142.18 145.37 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.758 -0.589 . . . . 0.0 110.093 -178.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -128.83 98.46 24.52 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.678 -0.639 . . . . 0.0 109.539 177.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -59.4 -43.29 41.45 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 O-C-N 123.595 1.313 . . . . 0.0 110.993 -175.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -80.88 -23.88 38.7 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.335 -0.853 . . . . 0.0 110.237 -171.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -87.18 0.99 54.46 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.473 -0.767 . . . . 0.0 111.188 173.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.0 m 50.03 39.8 19.84 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.101 -0.999 . . . . 0.0 111.172 -176.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.1 p -136.06 154.36 51.05 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.452 -0.78 . . . . 0.0 110.476 -174.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.3 pt -141.66 160.61 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.816 -0.553 . . . . 0.0 110.031 177.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.52 126.94 26.71 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.698 -0.626 . . . . 0.0 109.648 175.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 88.0 mt -109.89 146.6 34.86 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -178.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 99.9 p -117.65 152.24 35.6 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.1 p 45.65 83.62 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 121.491 0.662 . . . . 0.0 110.311 -172.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.9 p -134.58 151.06 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.938 -0.476 . . . . 0.0 109.733 -179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -136.6 153.19 51.03 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.596 -0.69 . . . . 0.0 110.137 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.3 p -109.6 137.7 47.04 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.806 -0.559 . . . . 0.0 109.664 177.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -83.06 -38.57 22.34 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.194 -172.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.31 169.4 30.83 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 175.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.0 p -118.17 6.21 12.0 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.865 -0.785 . . . . 0.0 110.818 170.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -54.29 -24.3 18.48 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.48 -0.762 . . . . 0.0 112.257 -167.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -65.79 -59.21 4.12 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.281 -0.887 . . . . 0.0 110.387 -177.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 82.0 mmt-85 -94.52 10.26 35.34 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.619 -0.676 . . . . 0.0 111.417 177.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.2 p-10 -57.42 170.02 0.57 Allowed 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.211 -0.93 . . . . 0.0 111.52 -170.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.7 m -79.01 164.54 24.29 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 175.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -77.42 4.21 11.48 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.092 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -97.53 148.16 23.53 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.312 -0.867 . . . . 0.0 109.394 166.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -65.98 142.2 57.93 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.578 -0.701 . . . . 0.0 110.81 -174.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 79.8 mt -115.75 135.7 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.678 -0.639 . . . . 0.0 109.439 177.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.35 132.52 89.66 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.626 -0.671 . . . . 0.0 110.025 -178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -69.48 144.07 54.28 Favored 'Trans proline' 0 N--CA 1.487 1.117 0 O-C-N 123.389 1.205 . . . . 0.0 110.253 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -98.93 110.1 22.76 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.668 -0.645 . . . . 0.0 110.111 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.4 t -99.18 -33.17 10.88 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.748 -0.595 . . . . 0.0 110.364 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -62.52 148.64 45.24 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.592 -0.692 . . . . 0.0 110.668 -179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.4 mm -96.83 143.75 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.681 -0.637 . . . . 0.0 109.667 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -94.75 114.77 26.72 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.711 -0.618 . . . . 0.0 110.322 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.19 -41.39 60.18 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 121.812 -0.555 . . . . 0.0 111.56 177.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -152.59 130.6 11.82 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.632 -0.668 . . . . 0.0 110.262 -175.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 76.2 mt -129.34 127.27 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.586 -0.696 . . . . 0.0 109.792 171.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.2 tp -90.58 137.07 32.64 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.833 -0.542 . . . . 0.0 109.858 176.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.435 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 3.9 m-85 -137.93 131.89 31.57 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.685 -0.634 . . . . 0.0 110.67 -175.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -91.59 151.91 20.51 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.752 -0.592 . . . . 0.0 110.313 174.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.93 -24.75 60.82 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.6 t -66.83 -42.15 86.27 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.451 -1.029 . . . . 0.0 111.066 -176.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -82.89 -33.17 27.02 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.527 -0.733 . . . . 0.0 110.93 -175.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.435 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 24.5 mt -105.17 135.1 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.336 -0.853 . . . . 0.0 109.962 176.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -110.18 -12.59 14.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.941 -0.474 . . . . 0.0 112.111 -165.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -147.4 130.65 16.52 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.809 -1.182 . . . . 0.0 111.298 -178.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.6 tt -132.27 141.25 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.92 -0.488 . . . . 0.0 109.87 176.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -145.96 134.4 21.95 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.498 -0.751 . . . . 0.0 110.307 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.3 t -87.14 144.45 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.612 -0.68 . . . . 0.0 109.611 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.8 t -93.71 127.09 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.603 -0.686 . . . . 0.0 109.749 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -149.55 -176.4 5.39 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.863 -0.523 . . . . 0.0 110.186 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -87.0 172.35 10.06 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.69 -0.631 . . . . 0.0 110.112 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -98.42 132.35 43.95 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.671 -0.643 . . . . 0.0 110.269 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.8 t -138.46 164.76 28.55 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.74 -0.6 . . . . 0.0 110.286 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.0 tt -97.32 109.87 51.9 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.666 -0.646 . . . . 0.0 110.147 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo . . . . . 0 N--CA 1.489 1.234 0 O-C-N 123.422 1.222 . . . . 0.0 110.411 179.102 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -67.56 -33.66 75.48 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.69 -0.888 . . . . 0.0 110.319 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 65.7 mtt -122.22 148.41 45.01 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.659 -0.65 . . . . 0.0 110.198 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -113.36 32.92 5.43 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.715 -0.616 . . . . 0.0 110.269 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.1 mmm -95.88 135.89 37.02 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.631 -0.668 . . . . 0.0 110.175 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 89.3 p -67.83 -31.85 71.98 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.692 -0.63 . . . . 0.0 110.424 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -144.05 174.2 24.49 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.59 -41.76 1.31 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 29.1 mt -79.9 160.17 69.51 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.63 -0.924 . . . . 0.0 110.14 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -64.98 131.09 27.67 Favored 'Trans proline' 0 N--CA 1.489 1.246 0 O-C-N 123.652 1.343 . . . . 0.0 110.456 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -64.89 143.0 58.24 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.697 -0.627 . . . . 0.0 110.503 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.5 mt -64.64 174.38 1.8 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.635 -0.666 . . . . 0.0 110.496 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.66 -1.75 85.01 Favored Glycine 0 N--CA 1.497 2.721 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.608 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 42.6 m -60.01 159.54 9.22 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.151 -1.206 . . . . 0.0 110.437 -177.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -81.27 126.58 31.72 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.747 -0.596 . . . . 0.0 110.534 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 88.1 mt -120.83 144.66 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.555 -0.716 . . . . 0.0 109.907 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.8 t -102.97 137.27 41.39 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 175.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.9 tp -134.15 123.88 25.12 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.723 -0.611 . . . . 0.0 110.057 -170.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.0 mt -103.99 119.45 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.528 -0.732 . . . . 0.0 109.643 -177.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.7 m -94.96 157.89 15.7 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.166 0.507 . . . . 0.0 111.59 -175.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -53.64 -15.19 1.08 Allowed 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -171.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.6 21.15 3.58 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.157 -0.964 . . . . 0.0 110.449 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 56.69 35.57 26.37 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.49 -0.756 . . . . 0.0 110.031 -178.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 53.1 mt -107.05 148.79 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.0 ttt-85 -106.66 119.83 40.36 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.167 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -112.87 152.37 29.34 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 175.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -141.88 140.55 32.89 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.452 -0.78 . . . . 0.0 109.68 175.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.57 171.8 41.61 Favored Glycine 0 N--CA 1.496 2.65 0 C-N-CA 119.753 -1.213 . . . . 0.0 110.464 -176.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 43.1 mmm-85 -84.35 138.97 32.59 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.843 -0.798 . . . . 0.0 110.538 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.5 tp -66.17 116.5 7.31 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.605 -0.684 . . . . 0.0 110.618 175.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -100.35 -50.13 4.03 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.609 -0.682 . . . . 0.0 110.553 178.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.5 p -154.58 155.33 34.56 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.718 -0.614 . . . . 0.0 110.359 -177.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.4 p -142.23 145.94 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.746 -0.597 . . . . 0.0 110.062 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -128.5 99.01 24.27 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.579 -0.7 . . . . 0.0 109.649 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -59.61 -41.67 54.17 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 O-C-N 123.654 1.344 . . . . 0.0 111.038 -175.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -80.59 -25.51 38.43 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.384 -0.823 . . . . 0.0 110.252 -170.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -87.58 1.97 52.12 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.437 -0.79 . . . . 0.0 111.236 173.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 97.7 m 49.66 39.97 18.7 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.093 -1.004 . . . . 0.0 111.199 -176.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.0 p -135.86 154.32 51.2 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.415 -0.803 . . . . 0.0 110.379 -175.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.9 pt -142.0 160.94 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.675 -0.641 . . . . 0.0 109.969 176.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.06 128.99 29.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.572 -0.705 . . . . 0.0 109.828 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 84.1 mt -109.87 144.82 37.8 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -178.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 97.6 p -114.95 152.66 31.97 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.1 p 45.55 84.94 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 121.454 0.645 . . . . 0.0 110.214 -171.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.1 p -134.55 149.97 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.967 -0.458 . . . . 0.0 109.766 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -136.07 153.2 51.4 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.635 -0.665 . . . . 0.0 110.068 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.2 p -105.61 129.79 53.78 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.757 -0.589 . . . . 0.0 109.463 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -83.07 -38.49 22.44 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.112 -170.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.22 175.45 37.25 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 178.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 65.3 p -118.11 2.68 12.05 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.81 -0.817 . . . . 0.0 110.489 169.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -57.33 -33.83 68.12 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.541 -0.725 . . . . 0.0 112.134 -163.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -63.36 -59.06 5.19 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.332 -0.855 . . . . 0.0 110.435 -175.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -94.32 10.49 34.01 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.753 -0.592 . . . . 0.0 111.289 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 51.2 p30 -49.82 157.78 0.55 Allowed 'General case' 0 N--CA 1.51 2.556 0 O-C-N 121.413 -0.804 . . . . 0.0 112.41 -169.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.1 m -79.2 164.49 24.16 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 172.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -77.51 4.53 10.92 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.236 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -96.83 166.05 11.82 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.236 -0.915 . . . . 0.0 109.645 167.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -76.58 133.98 39.52 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.544 -0.722 . . . . 0.0 110.52 -176.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 69.8 mt -119.35 139.48 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.805 -0.56 . . . . 0.0 109.531 177.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.04 109.89 53.56 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.613 -0.679 . . . . 0.0 110.249 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -68.77 152.06 74.17 Favored 'Trans proline' 0 N--CA 1.488 1.153 0 O-C-N 123.414 1.218 . . . . 0.0 110.387 178.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -99.0 127.8 45.0 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.755 -0.59 . . . . 0.0 110.187 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.2 m -94.63 -31.63 13.76 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.721 -0.612 . . . . 0.0 110.468 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -61.76 151.45 34.04 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.633 -0.667 . . . . 0.0 110.613 -178.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.2 mm -96.81 140.01 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.67 -0.643 . . . . 0.0 109.758 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -97.3 116.19 29.05 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.603 -0.686 . . . . 0.0 110.297 -177.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -50.96 -40.35 57.34 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.701 -0.625 . . . . 0.0 111.562 176.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -152.97 129.76 10.9 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.656 -0.652 . . . . 0.0 110.217 -174.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 71.2 mt -128.32 126.68 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.713 -0.617 . . . . 0.0 109.893 171.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.4 tp -91.42 137.12 32.62 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.87 -0.519 . . . . 0.0 109.9 176.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.413 ' CD1' HD12 ' A' ' 72' ' ' ILE . 7.3 m-85 -135.47 130.85 35.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.642 -0.661 . . . . 0.0 110.429 -176.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -89.56 151.38 21.97 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.716 -0.615 . . . . 0.0 110.076 174.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.4 -24.49 45.96 Favored Glycine 0 N--CA 1.5 2.929 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 86.5 p -76.82 -39.06 52.61 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.411 -1.052 . . . . 0.0 111.047 -177.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -82.04 -21.3 37.02 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.391 -0.818 . . . . 0.0 111.309 -173.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.413 HD12 ' CD1' ' A' ' 67' ' ' PHE . 45.1 mt -116.03 141.22 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.256 -0.902 . . . . 0.0 109.694 168.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -105.88 -14.3 15.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.86 -0.525 . . . . 0.0 111.87 -167.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -150.29 134.22 16.86 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 118.993 -1.083 . . . . 0.0 111.438 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 15.7 tt -132.04 140.63 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.94 -0.475 . . . . 0.0 109.826 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -147.05 138.04 23.85 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.624 -0.673 . . . . 0.0 110.344 178.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.9 t -87.2 146.1 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.573 -0.704 . . . . 0.0 109.656 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.3 t -93.63 132.71 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.52 -0.737 . . . . 0.0 109.788 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -118.63 144.99 45.79 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.774 -0.578 . . . . 0.0 110.035 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -94.46 109.79 21.63 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.713 -0.617 . . . . 0.0 110.213 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 47.4 p-80 -111.0 32.44 5.28 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.633 -0.667 . . . . 0.0 110.331 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.0 m -101.77 140.79 35.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.692 -0.63 . . . . 0.0 110.175 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 24.2 mt -110.72 162.63 19.83 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.649 -0.657 . . . . 0.0 110.204 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo . . . . . 0 N--CA 1.487 1.111 0 O-C-N 123.692 1.364 . . . . 0.0 110.373 179.97 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -104.49 144.76 31.23 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.685 -0.891 . . . . 0.0 110.118 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 88.2 mmm -96.51 97.93 9.81 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.679 -0.638 . . . . 0.0 110.219 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -105.9 135.46 47.3 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.678 -0.639 . . . . 0.0 110.067 178.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.3 mmm -131.44 153.35 49.81 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.666 -0.646 . . . . 0.0 110.231 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.6 t -121.73 143.47 49.35 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.619 -0.675 . . . . 0.0 110.054 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -136.63 -48.19 0.08 OUTLIER Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.55 -46.54 75.89 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 16.4 mt -80.96 145.93 58.18 Favored Pre-proline 0 N--CA 1.497 1.9 0 O-C-N 121.618 -0.93 . . . . 0.0 110.151 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -71.05 154.72 62.5 Favored 'Trans proline' 0 N--CA 1.486 1.055 0 O-C-N 123.551 1.29 . . . . 0.0 110.157 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -64.79 130.85 45.05 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.657 -0.652 . . . . 0.0 110.481 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.6 mt -64.79 145.96 55.51 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.681 -0.637 . . . . 0.0 110.652 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.67 -1.96 84.36 Favored Glycine 0 N--CA 1.497 2.72 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.794 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.0 m -62.18 139.86 58.46 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.079 -1.247 . . . . 0.0 110.445 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.8 pttt -81.87 127.27 32.83 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.71 -0.619 . . . . 0.0 110.35 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 92.8 mt -124.94 145.13 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.597 -0.689 . . . . 0.0 110.223 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.2 t -102.84 137.25 41.29 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 13.8 tp -131.88 125.69 32.35 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.814 -0.554 . . . . 0.0 110.198 -170.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 80.9 mt -107.5 118.65 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.522 -0.736 . . . . 0.0 109.692 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.9 m -93.57 157.72 16.05 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.039 0.447 . . . . 0.0 111.293 -177.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -53.29 -15.02 0.82 Allowed 'General case' 0 N--CA 1.508 2.473 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -172.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.29 20.55 3.73 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.099 -1.001 . . . . 0.0 110.405 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 54.35 33.51 18.63 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.435 -0.791 . . . . 0.0 109.874 -174.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.7 mt -101.5 141.31 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -104.66 119.79 39.82 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.941 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -113.99 148.96 36.06 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 174.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -140.08 140.48 36.1 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.471 -0.768 . . . . 0.0 109.498 175.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.43 173.02 43.14 Favored Glycine 0 N--CA 1.496 2.683 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.665 -175.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 72.0 mtp85 -85.54 135.47 33.81 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.881 -0.776 . . . . 0.0 110.59 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.4 tp -66.16 119.53 11.63 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.668 -0.645 . . . . 0.0 110.679 176.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -99.57 -50.06 4.2 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.677 -0.64 . . . . 0.0 110.296 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.5 p -153.79 154.97 34.99 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.671 -0.643 . . . . 0.0 110.295 -178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.6 p -142.26 145.7 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.648 -0.657 . . . . 0.0 110.11 -178.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -128.64 98.3 25.51 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.591 -0.693 . . . . 0.0 109.554 177.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -59.42 -41.1 61.04 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 O-C-N 123.507 1.267 . . . . 0.0 110.924 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -80.66 -25.52 38.22 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.388 -0.82 . . . . 0.0 110.156 -171.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -87.46 2.19 51.28 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.463 -0.773 . . . . 0.0 111.254 173.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.8 m 49.73 38.79 16.23 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.122 -0.986 . . . . 0.0 111.254 -176.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.3 p -136.6 152.71 50.76 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.336 -0.852 . . . . 0.0 110.391 -174.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.0 pt -142.38 162.03 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.687 -0.633 . . . . 0.0 110.167 177.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.3 127.81 28.67 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.571 -0.706 . . . . 0.0 109.666 175.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 85.9 mt -109.9 148.03 32.31 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -177.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 96.8 p -119.41 152.8 36.23 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -178.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.8 p 45.65 84.38 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 CA-C-O 121.565 0.698 . . . . 0.0 110.301 -172.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.6 p -134.55 149.86 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.914 -0.491 . . . . 0.0 109.786 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -135.11 153.13 52.12 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.679 -0.638 . . . . 0.0 109.941 177.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.9 p -109.43 141.93 41.14 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.736 -0.603 . . . . 0.0 109.911 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -82.55 -38.36 23.84 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.591 -0.693 . . . . 0.0 110.678 -175.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.64 167.37 28.2 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 176.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.3 p -118.29 6.51 11.91 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.944 -0.739 . . . . 0.0 111.015 175.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -48.94 -25.89 2.19 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.582 -0.699 . . . . 0.0 112.784 -167.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -66.82 -59.21 3.74 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.287 -0.883 . . . . 0.0 110.417 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -94.39 10.21 35.24 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.633 -0.667 . . . . 0.0 111.225 176.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -58.32 174.07 0.32 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.232 -0.918 . . . . 0.0 111.552 -170.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.1 p -78.83 164.64 24.33 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 122.0 -0.438 . . . . 0.0 109.94 174.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -77.33 2.76 14.83 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.996 -0.681 . . . . 0.0 111.103 177.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -101.7 151.91 21.48 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.31 -0.869 . . . . 0.0 109.527 169.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -66.49 138.93 57.87 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.501 -0.749 . . . . 0.0 110.56 -174.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.7 mt -109.97 135.22 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.704 -0.622 . . . . 0.0 109.459 177.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -83.84 146.06 48.4 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.762 -0.587 . . . . 0.0 110.176 -178.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -68.44 156.96 63.79 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 O-C-N 123.522 1.275 . . . . 0.0 110.269 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -79.64 132.58 36.28 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.683 -0.636 . . . . 0.0 110.041 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.9 m -98.98 30.29 3.46 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.749 -0.594 . . . . 0.0 110.541 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -175.65 160.85 2.52 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.634 -0.666 . . . . 0.0 109.78 -177.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.0 mm -96.74 157.4 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.703 -0.623 . . . . 0.0 109.725 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -93.0 114.08 26.54 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.556 -0.715 . . . . 0.0 110.177 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -51.23 -42.34 60.94 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.9 -0.5 . . . . 0.0 111.711 178.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -152.72 129.95 11.23 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.685 -0.635 . . . . 0.0 110.292 -174.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 76.2 mt -129.6 129.14 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.652 -0.655 . . . . 0.0 109.85 172.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 24.8 tp -90.65 137.0 32.7 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.774 -0.579 . . . . 0.0 109.918 176.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.467 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 3.7 m-85 -135.59 129.44 32.91 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.67 -0.644 . . . . 0.0 110.635 -175.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 73.5 mtt85 -92.1 150.06 21.16 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.797 -0.565 . . . . 0.0 110.352 173.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.18 -24.43 61.0 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.9 m -66.57 -42.09 87.58 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.493 -1.004 . . . . 0.0 111.034 -176.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -83.16 -32.75 26.46 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.445 -0.785 . . . . 0.0 110.969 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.467 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 14.7 mt -101.38 138.61 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.395 -0.816 . . . . 0.0 110.174 177.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -106.37 -18.54 13.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.892 -0.505 . . . . 0.0 111.736 -167.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -150.0 131.25 14.56 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 119.001 -1.08 . . . . 0.0 111.242 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.6 tt -132.14 139.83 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 176.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -146.29 133.22 20.2 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.521 -0.737 . . . . 0.0 110.411 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.3 p -87.62 147.1 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.722 -0.611 . . . . 0.0 110.29 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.6 t -94.88 129.54 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.56 -0.712 . . . . 0.0 109.759 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -142.41 142.29 32.37 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.76 -0.588 . . . . 0.0 110.154 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -64.95 -33.97 77.29 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.659 -0.651 . . . . 0.0 110.3 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 46.7 p-80 -129.13 148.26 51.06 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.717 -0.614 . . . . 0.0 110.188 179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.3 p -122.38 161.49 23.34 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.682 -0.636 . . . . 0.0 110.182 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.7 mp -115.95 164.64 17.0 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.756 -0.59 . . . . 0.0 110.184 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo . . . . . 0 N--CA 1.488 1.195 0 O-C-N 123.596 1.314 . . . . 0.0 110.421 179.777 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -102.95 144.08 31.7 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.716 -0.873 . . . . 0.0 110.205 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 49.1 ttm -106.94 72.98 0.91 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.64 -0.663 . . . . 0.0 110.165 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -155.08 152.16 29.21 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.553 -0.717 . . . . 0.0 110.16 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.3 mtm -106.19 130.4 54.07 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.738 -0.601 . . . . 0.0 110.23 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 64.4 m -97.3 23.39 7.55 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.691 -0.631 . . . . 0.0 110.824 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -143.8 -56.96 0.03 OUTLIER Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.17 134.86 12.35 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -155.46 68.0 5.1 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.628 -0.925 . . . . 0.0 110.063 178.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -64.97 122.31 10.07 Favored 'Trans proline' 0 N--CA 1.489 1.24 0 O-C-N 123.387 1.204 . . . . 0.0 110.52 -178.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -64.84 152.03 43.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.718 -0.614 . . . . 0.0 110.445 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.4 mt -64.71 173.28 2.29 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.698 -0.626 . . . . 0.0 110.411 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.79 -1.73 85.4 Favored Glycine 0 N--CA 1.498 2.78 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.561 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 45.8 m -59.36 155.58 14.43 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.129 -1.218 . . . . 0.0 110.484 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -81.35 124.49 29.41 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.734 -0.604 . . . . 0.0 110.794 -177.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 91.5 mt -121.92 146.16 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.661 -0.649 . . . . 0.0 110.017 178.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.6 t -103.19 137.26 41.58 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 176.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 13.9 tp -132.47 126.31 32.71 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.75 -0.594 . . . . 0.0 110.252 -170.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.1 mt -107.05 118.79 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.515 -0.741 . . . . 0.0 109.66 -178.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.0 m -93.59 157.71 16.05 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.039 0.447 . . . . 0.0 111.301 -177.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.5 tttm -53.99 -13.63 0.83 Allowed 'General case' 0 N--CA 1.508 2.441 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -172.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.9 20.37 4.23 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.107 -0.996 . . . . 0.0 110.426 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 53.86 34.45 19.36 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.521 -0.737 . . . . 0.0 109.865 -173.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 72.2 mt -102.27 140.96 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -104.67 119.8 39.85 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.009 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -113.84 150.3 33.75 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 175.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -141.45 140.54 33.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.423 -0.798 . . . . 0.0 109.796 174.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.53 173.1 43.2 Favored Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.764 -1.207 . . . . 0.0 110.377 -176.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -85.04 135.83 33.84 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.849 -0.795 . . . . 0.0 110.588 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.7 tp -66.08 120.02 12.43 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.583 -0.698 . . . . 0.0 110.716 175.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -99.78 -50.11 4.14 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.655 -0.653 . . . . 0.0 110.394 178.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.7 p -153.96 155.84 36.35 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.67 -0.644 . . . . 0.0 110.305 -178.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.4 p -142.22 145.81 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.697 -0.627 . . . . 0.0 110.081 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -128.66 101.78 20.51 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.629 -0.669 . . . . 0.0 109.54 177.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.44 -41.93 30.35 Favored 'Trans proline' 0 N--CA 1.49 1.276 0 O-C-N 123.553 1.291 . . . . 0.0 110.746 -174.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -80.76 -23.56 39.28 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.384 -0.822 . . . . 0.0 110.212 -172.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -87.26 0.75 54.89 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.476 -0.765 . . . . 0.0 111.178 173.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.3 m 49.91 38.14 15.41 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.157 -0.964 . . . . 0.0 111.255 -176.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.2 p -136.71 153.34 50.9 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.402 -0.811 . . . . 0.0 110.403 -174.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.9 pt -142.31 162.0 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.719 -0.613 . . . . 0.0 110.081 177.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.87 127.95 29.75 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.61 -0.681 . . . . 0.0 109.722 176.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.1 mt -109.88 147.73 32.84 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -177.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 95.7 p -118.51 151.42 37.87 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -178.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.7 p 45.8 84.05 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 CA-C-O 121.517 0.675 . . . . 0.0 110.341 -172.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.3 p -134.56 150.92 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.935 -0.478 . . . . 0.0 109.717 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -135.8 153.19 51.6 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.602 -0.686 . . . . 0.0 110.087 178.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.4 p -108.19 139.66 42.54 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.733 -0.604 . . . . 0.0 109.834 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -82.94 -38.33 22.93 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.657 -0.652 . . . . 0.0 111.056 -173.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.67 172.22 34.52 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 119.975 -1.107 . . . . 0.0 110.522 177.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.01 6.58 12.15 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.928 -0.748 . . . . 0.0 110.739 174.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -48.99 -25.2 1.84 Allowed 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.618 -0.676 . . . . 0.0 112.528 -169.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -64.42 -59.19 4.64 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.291 -0.881 . . . . 0.0 110.574 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -94.29 10.22 35.0 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.612 -0.68 . . . . 0.0 111.408 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.5 p-10 -61.4 174.19 0.77 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.279 -0.888 . . . . 0.0 111.244 -171.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.8 p -78.91 164.59 24.32 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.922 -0.486 . . . . 0.0 109.876 174.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -77.46 2.57 15.78 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.081 177.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -97.86 166.05 11.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.126 -0.984 . . . . 0.0 109.513 169.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -65.97 140.54 58.32 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.543 -0.723 . . . . 0.0 110.451 -175.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.9 mp -111.95 141.91 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.702 -0.624 . . . . 0.0 109.705 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -92.06 109.87 40.34 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.65 -0.656 . . . . 0.0 110.178 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -66.79 146.96 80.18 Favored 'Trans proline' 0 N--CA 1.489 1.258 0 O-C-N 123.373 1.196 . . . . 0.0 110.428 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -96.81 117.24 30.63 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.678 -0.639 . . . . 0.0 110.165 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 86.8 p -88.29 -28.73 20.89 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.732 -0.605 . . . . 0.0 110.609 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -62.13 146.86 49.33 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.539 -0.726 . . . . 0.0 110.693 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.3 mm -96.77 144.72 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.695 -0.628 . . . . 0.0 109.708 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -94.97 114.54 26.37 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.586 -0.696 . . . . 0.0 110.285 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -51.08 -40.22 57.87 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.781 -0.575 . . . . 0.0 111.728 177.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -152.97 129.92 11.02 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.637 -0.664 . . . . 0.0 110.257 -174.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 74.3 mt -129.33 129.35 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.678 -0.639 . . . . 0.0 109.798 171.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.0 tp -90.38 137.06 32.66 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.87 -0.519 . . . . 0.0 109.865 176.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.466 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 3.2 m-85 -135.75 129.75 33.07 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.604 -0.685 . . . . 0.0 110.579 -175.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -92.08 150.18 21.1 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.748 -0.595 . . . . 0.0 110.325 173.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.29 -24.49 61.33 Favored Glycine 0 N--CA 1.498 2.818 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 177.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.5 m -66.59 -42.12 87.42 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.472 -1.016 . . . . 0.0 111.115 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -83.0 -32.94 26.68 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.415 -0.803 . . . . 0.0 110.905 -175.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.466 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 13.9 mt -100.77 139.89 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.418 -0.802 . . . . 0.0 110.124 177.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.0 tptm -106.27 -21.28 13.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.937 -0.477 . . . . 0.0 111.606 -166.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -150.63 135.28 17.32 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 119.037 -1.065 . . . . 0.0 111.353 -177.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.3 tt -133.2 142.13 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -146.44 139.02 25.24 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.535 -0.728 . . . . 0.0 110.411 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.0 t -87.2 144.48 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.621 -0.674 . . . . 0.0 109.638 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.8 t -95.5 132.32 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.492 -0.755 . . . . 0.0 109.831 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -148.62 38.38 0.85 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.761 -0.587 . . . . 0.0 110.155 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -97.28 133.27 42.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.596 -0.69 . . . . 0.0 110.272 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -124.54 146.21 49.13 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.704 -0.623 . . . . 0.0 110.214 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.5 m -119.6 138.79 53.0 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.633 -0.667 . . . . 0.0 110.128 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.9 mt -111.03 109.87 56.98 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.705 -0.622 . . . . 0.0 110.207 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo . . . . . 0 N--CA 1.49 1.272 0 O-C-N 123.398 1.209 . . . . 0.0 110.447 179.152 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -144.14 154.5 43.23 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.774 -0.839 . . . . 0.0 110.171 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 74.4 mtm -125.03 155.36 39.84 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.725 -0.61 . . . . 0.0 110.203 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -105.19 145.58 30.42 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.693 -0.629 . . . . 0.0 110.259 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.3 mtm -113.53 144.0 43.59 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.677 -0.639 . . . . 0.0 110.226 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.6 p -67.66 -31.9 72.21 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.744 -0.598 . . . . 0.0 110.348 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.56 62.46 0.29 Allowed Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.94 177.15 53.92 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 24.7 tp -80.44 145.25 58.91 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.717 -0.873 . . . . 0.0 109.985 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -64.92 153.88 75.91 Favored 'Trans proline' 0 N--CA 1.489 1.264 0 O-C-N 123.281 1.148 . . . . 0.0 110.343 177.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -64.81 123.35 19.15 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.727 -0.608 . . . . 0.0 110.55 -178.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.4 mt -64.85 160.12 21.09 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.711 -0.618 . . . . 0.0 110.594 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.73 -1.87 84.83 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.763 177.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 67.0 m -61.39 137.64 58.24 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.138 -1.213 . . . . 0.0 110.411 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -82.15 124.36 29.8 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.72 -0.612 . . . . 0.0 110.611 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 88.1 mt -121.16 145.12 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.644 -0.66 . . . . 0.0 110.17 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.8 t -103.44 137.27 41.77 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 175.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 13.8 tp -133.04 125.96 30.83 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.68 -0.638 . . . . 0.0 110.259 -169.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.0 mt -106.68 117.84 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.47 -0.769 . . . . 0.0 109.683 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.0 m -93.04 157.83 16.1 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.06 0.457 . . . . 0.0 111.254 -177.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -54.03 -13.9 0.92 Allowed 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -171.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.09 20.6 4.19 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.094 -1.004 . . . . 0.0 110.408 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 54.37 34.16 20.11 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.512 -0.743 . . . . 0.0 109.788 -174.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.8 mt -102.47 141.82 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 36.8 ttp180 -104.85 119.86 40.01 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.973 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -114.0 150.3 34.08 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 174.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -140.7 140.47 34.92 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.535 -0.728 . . . . 0.0 109.515 175.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.58 172.69 43.13 Favored Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.657 -175.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -85.08 136.15 33.69 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.908 -0.76 . . . . 0.0 110.532 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.5 tp -66.14 118.83 10.44 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.62 -0.675 . . . . 0.0 110.716 175.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -100.03 -50.13 4.09 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.662 -0.649 . . . . 0.0 110.376 177.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.8 p -154.09 153.74 32.41 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.701 -0.625 . . . . 0.0 110.284 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.3 p -142.19 145.24 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.656 -0.652 . . . . 0.0 110.033 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -128.22 100.48 23.26 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.625 -0.672 . . . . 0.0 109.457 176.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.34 -42.79 26.09 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 O-C-N 123.496 1.261 . . . . 0.0 110.792 -174.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -80.2 -27.33 38.87 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.295 -0.878 . . . . 0.0 109.95 -172.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -89.24 12.04 17.12 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.62 -0.675 . . . . 0.0 111.268 172.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 6.3 p 47.48 33.62 2.94 Favored 'General case' 0 N--CA 1.507 2.411 0 O-C-N 121.783 -0.573 . . . . 0.0 112.034 173.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.1 p -136.56 154.73 50.62 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.458 -0.776 . . . . 0.0 110.432 -173.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.0 pt -142.45 162.03 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.704 -0.622 . . . . 0.0 110.158 177.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.01 127.76 27.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.678 -0.639 . . . . 0.0 109.735 175.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 87.4 mt -109.91 148.04 32.29 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -177.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 95.8 p -119.44 152.93 36.05 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.5 p 45.79 84.29 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 CA-C-O 121.494 0.664 . . . . 0.0 110.271 -172.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.9 p -134.52 151.26 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -135.97 153.2 51.48 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.629 -0.669 . . . . 0.0 109.947 177.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 84.5 p -107.61 139.34 42.3 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.703 -0.623 . . . . 0.0 109.763 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -82.49 -38.36 23.99 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.626 -0.671 . . . . 0.0 110.941 -173.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.56 169.95 31.75 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 120.032 -1.08 . . . . 0.0 110.417 176.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 p -118.08 6.6 12.09 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.906 -0.761 . . . . 0.0 110.886 174.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -48.99 -26.03 2.3 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.649 -0.657 . . . . 0.0 112.504 -167.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -64.98 -59.23 4.39 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.267 -0.896 . . . . 0.0 110.555 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 82.5 mmt-85 -94.35 10.25 35.0 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.655 -0.653 . . . . 0.0 111.335 177.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.8 p-10 -60.15 173.46 0.64 Allowed 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.224 -0.923 . . . . 0.0 111.518 -169.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.3 m -78.92 164.45 24.42 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 173.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -77.33 3.34 13.31 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.596 -0.69 . . . . 0.0 111.309 -178.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -102.12 154.92 18.55 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.242 -0.911 . . . . 0.0 109.637 170.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -67.21 141.09 57.42 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.557 -0.714 . . . . 0.0 110.605 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 81.3 mt -114.91 137.04 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.658 -0.651 . . . . 0.0 109.596 177.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.07 109.97 53.98 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.746 -0.597 . . . . 0.0 110.143 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -67.14 151.19 81.84 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 O-C-N 123.355 1.187 . . . . 0.0 110.345 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -94.03 123.95 37.73 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.691 -0.63 . . . . 0.0 110.245 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.0 m -66.29 -31.5 72.35 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.741 -0.6 . . . . 0.0 110.519 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -61.69 148.49 42.54 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.561 -0.712 . . . . 0.0 110.687 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.2 mm -96.83 156.57 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.743 -0.598 . . . . 0.0 109.767 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -93.45 112.44 24.35 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.677 -0.64 . . . . 0.0 110.171 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -51.17 -43.03 61.2 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.807 -0.558 . . . . 0.0 111.669 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -152.88 130.27 11.35 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.659 -0.65 . . . . 0.0 110.284 -174.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 74.9 mt -128.93 128.6 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.66 -0.65 . . . . 0.0 109.859 172.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.0 tp -90.42 137.05 32.66 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.902 -0.498 . . . . 0.0 109.862 176.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.458 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 2.9 m-85 -135.45 129.65 33.54 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.645 -0.66 . . . . 0.0 110.546 -175.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -91.26 147.39 23.08 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.684 -0.635 . . . . 0.0 110.239 173.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.89 -26.38 60.56 Favored Glycine 0 N--CA 1.498 2.818 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.0 m -65.87 -39.65 90.91 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.476 -1.014 . . . . 0.0 110.947 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.68 -32.54 31.7 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.462 -0.774 . . . . 0.0 110.858 -174.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.458 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 8.1 mt -102.83 140.85 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.382 -0.824 . . . . 0.0 110.156 177.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -105.04 -21.82 13.21 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.522 -167.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -151.39 134.27 15.75 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 119.068 -1.053 . . . . 0.0 111.368 -177.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.6 tt -131.5 140.09 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.882 -0.511 . . . . 0.0 109.739 176.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -146.83 142.83 28.1 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.548 -0.72 . . . . 0.0 110.4 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.4 m -85.03 147.03 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.653 -0.654 . . . . 0.0 110.183 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.9 t -94.95 131.55 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.587 -0.695 . . . . 0.0 109.771 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -122.64 125.12 44.97 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.764 -0.585 . . . . 0.0 110.14 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -99.52 128.83 45.65 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.648 -0.658 . . . . 0.0 110.2 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -120.96 152.86 38.03 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.691 -0.631 . . . . 0.0 110.262 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.7 m -120.87 142.79 49.34 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.695 -0.628 . . . . 0.0 110.14 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.7 tt -99.93 110.0 57.86 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.751 -0.593 . . . . 0.0 110.124 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo . . . . . 0 N--CA 1.487 1.112 0 O-C-N 123.393 1.207 . . . . 0.0 110.343 179.081 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -107.0 149.91 27.04 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.673 -0.898 . . . . 0.0 110.247 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 90.7 mtp -99.03 165.63 11.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.67 -0.643 . . . . 0.0 110.142 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -99.23 30.11 3.63 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.645 -0.66 . . . . 0.0 110.516 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -117.56 99.5 7.02 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.547 -0.72 . . . . 0.0 110.009 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 t -155.06 33.8 0.39 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.634 -0.666 . . . . 0.0 110.262 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -143.91 112.86 0.71 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.03 -48.32 0.95 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -79.72 151.68 74.26 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.714 -0.874 . . . . 0.0 109.813 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -67.34 138.97 48.24 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 O-C-N 123.454 1.239 . . . . 0.0 110.361 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -64.88 113.51 3.88 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.695 -0.628 . . . . 0.0 110.503 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.5 mt -64.84 162.34 16.41 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.654 -0.654 . . . . 0.0 110.542 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.72 -1.8 85.02 Favored Glycine 0 N--CA 1.497 2.755 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.727 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.5 m -60.25 152.99 23.46 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.118 -1.225 . . . . 0.0 110.45 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.9 pttt -81.13 125.99 30.92 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.738 -0.601 . . . . 0.0 110.387 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 90.2 mt -124.3 143.79 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.547 -0.721 . . . . 0.0 110.129 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.5 t -101.66 137.25 40.22 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 174.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 15.2 tp -133.9 127.72 33.09 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.694 -0.629 . . . . 0.0 110.282 -169.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 81.9 mt -108.51 121.06 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.455 -0.778 . . . . 0.0 109.683 -178.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.3 m -94.51 157.62 15.92 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 120.981 0.42 . . . . 0.0 111.171 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -55.43 -11.5 0.85 Allowed 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -173.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.2 20.54 4.31 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.097 -1.002 . . . . 0.0 110.453 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 54.16 34.2 19.63 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.505 -0.747 . . . . 0.0 109.795 -174.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.2 mt -102.6 141.91 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -105.84 119.83 40.16 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.007 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -114.4 148.82 37.12 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 173.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -140.09 140.5 36.1 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.37 -0.831 . . . . 0.0 109.504 175.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.53 173.5 43.22 Favored Glycine 0 N--CA 1.496 2.651 0 C-N-CA 119.636 -1.269 . . . . 0.0 110.617 -175.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 39.6 mmm-85 -84.83 134.19 34.3 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.926 -0.75 . . . . 0.0 110.439 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.7 tp -66.21 118.62 10.18 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.605 -0.684 . . . . 0.0 110.61 175.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -99.43 -50.19 4.18 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.567 -0.708 . . . . 0.0 110.413 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.3 p -154.12 154.97 34.53 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.704 -0.622 . . . . 0.0 110.326 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.2 p -142.34 144.95 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.737 -0.602 . . . . 0.0 110.055 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -129.05 102.14 19.18 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.58 -0.7 . . . . 0.0 109.496 177.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.93 -38.04 50.08 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 O-C-N 123.652 1.343 . . . . 0.0 110.814 -174.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -80.42 -27.37 38.05 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.296 -0.878 . . . . 0.0 110.137 -170.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -87.85 2.51 51.26 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.512 -0.742 . . . . 0.0 111.28 173.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 55.5 m 49.3 40.02 17.33 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.077 -1.014 . . . . 0.0 111.326 -176.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.6 p -135.92 153.13 51.53 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.357 -0.839 . . . . 0.0 110.411 -174.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.4 pt -142.63 162.01 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.685 -0.634 . . . . 0.0 110.082 178.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.42 128.22 29.15 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.655 -0.653 . . . . 0.0 109.741 175.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 88.7 mt -109.92 147.36 33.55 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 99.7 p -117.99 151.77 36.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.619 -0.676 . . . . 0.0 109.24 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.3 p 45.94 85.17 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 CA-C-O 121.574 0.702 . . . . 0.0 110.352 -172.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.3 p -134.66 150.55 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -178.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -133.38 153.09 51.89 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.6 -0.688 . . . . 0.0 109.941 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 84.0 p -110.14 140.01 44.68 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.656 -0.653 . . . . 0.0 109.875 178.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -82.89 -38.46 22.86 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.6 -0.688 . . . . 0.0 110.893 -174.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.59 168.65 30.05 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 176.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.13 6.48 12.04 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.863 -0.786 . . . . 0.0 111.03 174.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -49.06 -26.49 2.68 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.556 -0.715 . . . . 0.0 112.314 -168.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -66.34 -59.22 3.91 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.348 -0.845 . . . . 0.0 110.35 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -94.25 10.22 34.9 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.66 -0.65 . . . . 0.0 111.354 177.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 49.9 p-10 -58.71 172.91 0.46 Allowed 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.252 -0.905 . . . . 0.0 111.261 -170.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.8 m -78.99 164.44 24.39 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.942 -0.474 . . . . 0.0 109.743 175.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -77.39 2.89 14.61 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.646 -0.659 . . . . 0.0 111.246 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -98.58 165.08 11.98 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.332 -0.855 . . . . 0.0 109.551 170.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -67.88 135.52 52.62 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.51 -0.744 . . . . 0.0 110.439 -175.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 45.5 mm -114.1 132.82 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.726 -0.609 . . . . 0.0 109.58 177.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.03 137.28 29.69 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.717 -0.615 . . . . 0.0 110.136 -178.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -69.81 145.95 58.38 Favored 'Trans proline' 0 N--CA 1.488 1.155 0 O-C-N 123.463 1.244 . . . . 0.0 110.244 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -100.6 115.15 29.5 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.681 -0.637 . . . . 0.0 110.198 178.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 28.6 m -85.24 -33.01 22.3 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.7 -0.625 . . . . 0.0 110.329 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -62.37 143.93 56.4 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.687 -0.633 . . . . 0.0 110.567 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.4 mm -96.76 149.96 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.649 -0.657 . . . . 0.0 109.814 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -94.37 115.66 27.9 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.644 -0.66 . . . . 0.0 110.208 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -51.31 -40.97 60.16 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.769 -0.582 . . . . 0.0 111.804 178.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -153.38 130.51 11.13 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.686 -0.634 . . . . 0.0 110.316 -174.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 78.3 mt -129.88 129.61 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.659 -0.65 . . . . 0.0 109.895 172.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 24.5 tp -90.42 137.06 32.65 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.862 -0.524 . . . . 0.0 109.898 176.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.451 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 2.9 m-85 -135.53 130.29 34.36 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.701 -0.624 . . . . 0.0 110.45 -175.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -91.17 147.53 22.99 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.762 -0.586 . . . . 0.0 110.272 173.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.08 -25.63 60.03 Favored Glycine 0 N--CA 1.499 2.865 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.8 m -65.92 -39.36 90.48 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.46 -1.024 . . . . 0.0 110.898 -178.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -82.36 -32.5 29.23 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.541 -0.725 . . . . 0.0 111.055 -175.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.451 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 10.1 mt -104.84 141.35 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.412 -0.805 . . . . 0.0 110.209 177.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -106.98 -24.19 12.08 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.891 -0.505 . . . . 0.0 111.659 -166.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -150.62 139.15 20.55 Favored 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 119.013 -1.075 . . . . 0.0 111.359 -176.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.2 tt -134.16 143.85 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.996 -0.44 . . . . 0.0 110.023 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -143.03 127.19 17.52 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.65 -0.656 . . . . 0.0 110.052 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.5 p -87.7 145.77 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.56 -0.713 . . . . 0.0 110.434 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.9 t -97.43 133.45 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.629 -0.669 . . . . 0.0 109.78 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -123.4 122.67 38.86 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.622 -0.674 . . . . 0.0 110.203 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -65.49 -36.83 85.04 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.701 -0.624 . . . . 0.0 110.309 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -113.81 130.9 56.41 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.776 -0.578 . . . . 0.0 110.09 178.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.8 m -126.59 138.58 53.47 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.652 -0.655 . . . . 0.0 110.129 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 40.9 mt -127.78 159.53 65.8 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.724 -0.61 . . . . 0.0 110.199 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo . . . . . 0 N--CA 1.488 1.157 0 O-C-N 123.642 1.338 . . . . 0.0 110.303 179.835 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -67.51 -33.67 75.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.678 -0.896 . . . . 0.0 110.304 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 23.5 ttt -98.6 118.62 35.72 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.657 -0.652 . . . . 0.0 110.265 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -155.08 -60.04 0.11 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.683 -0.636 . . . . 0.0 110.148 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.2 ttp -135.7 152.18 50.91 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.708 -0.62 . . . . 0.0 110.156 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.2 t -109.55 130.0 55.54 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.664 -0.648 . . . . 0.0 110.202 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -155.09 -60.01 0.01 OUTLIER Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.21 36.62 4.2 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 11.9 tp -155.41 87.92 3.14 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.626 -0.926 . . . . 0.0 109.886 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -67.79 95.86 0.42 Allowed 'Trans proline' 0 N--CA 1.487 1.133 0 O-C-N 123.575 1.303 . . . . 0.0 110.407 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -64.81 146.8 54.33 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.552 -0.717 . . . . 0.0 110.473 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.9 mt -64.61 160.26 20.08 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.58 -0.7 . . . . 0.0 110.523 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.65 -1.88 84.59 Favored Glycine 0 N--CA 1.497 2.73 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.808 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.9 m -60.81 153.01 25.6 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 120.997 -1.296 . . . . 0.0 110.445 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.5 pttt -82.05 126.92 32.56 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.714 -0.616 . . . . 0.0 110.67 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 86.3 mt -118.6 142.39 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.581 -0.699 . . . . 0.0 109.941 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.6 t -103.67 137.34 41.85 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 175.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 13.7 tp -135.96 127.89 29.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.665 -0.647 . . . . 0.0 110.487 -169.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 79.5 mt -107.17 120.56 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.507 -0.746 . . . . 0.0 109.609 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.0 m -95.15 157.58 15.83 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.027 0.441 . . . . 0.0 111.134 -177.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -56.43 -11.44 1.26 Allowed 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -173.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.77 22.01 3.29 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.124 -0.985 . . . . 0.0 110.348 177.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 57.55 34.48 24.62 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.56 -0.713 . . . . 0.0 110.12 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.8 mt -107.27 148.97 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.713 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -107.83 119.71 40.22 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.07 175.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -113.41 154.07 27.56 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 175.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -142.83 140.47 31.31 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.596 -0.69 . . . . 0.0 109.521 173.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -164.17 169.77 39.15 Favored Glycine 0 N--CA 1.496 2.657 0 C-N-CA 119.648 -1.263 . . . . 0.0 110.619 -176.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -84.61 137.43 33.29 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.911 -0.758 . . . . 0.0 110.525 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.8 tp -66.14 117.55 8.62 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.629 -0.669 . . . . 0.0 110.645 175.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -99.88 -50.15 4.11 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.585 -0.697 . . . . 0.0 110.309 177.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.2 p -153.7 153.61 32.56 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.709 -0.619 . . . . 0.0 110.233 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.3 p -142.26 145.1 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.709 -0.619 . . . . 0.0 110.096 -178.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -129.04 102.2 19.16 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.669 -0.644 . . . . 0.0 109.477 176.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.71 -39.42 43.28 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 O-C-N 123.575 1.303 . . . . 0.0 110.863 -174.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -80.49 -26.4 38.23 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.339 -0.851 . . . . 0.0 110.152 -170.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -87.6 2.13 51.75 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.532 -0.73 . . . . 0.0 111.292 173.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.3 m 49.65 40.16 19.09 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 120.996 -1.065 . . . . 0.0 111.229 -176.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.3 p -136.54 151.84 49.84 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.383 -0.823 . . . . 0.0 110.397 -174.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.1 pt -142.65 161.97 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.637 -0.664 . . . . 0.0 110.226 177.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.46 127.51 29.75 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.629 -0.669 . . . . 0.0 109.695 175.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 83.9 mt -109.99 145.23 37.32 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -177.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.8 p -116.73 152.36 34.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.625 -0.672 . . . . 0.0 109.195 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 44.9 p 45.81 86.43 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.225 0 CA-C-O 121.502 0.668 . . . . 0.0 110.288 -172.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.9 p -134.65 147.73 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -129.1 153.03 48.05 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.748 -0.595 . . . . 0.0 109.754 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.5 p -107.51 121.81 45.37 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -83.09 -38.53 22.36 Favored 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.964 -169.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.4 -177.51 41.86 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.5 p -118.12 -2.41 11.22 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.794 -0.827 . . . . 0.0 110.645 172.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -54.41 -24.92 21.85 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.379 -0.825 . . . . 0.0 112.528 -162.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -77.07 -59.47 2.77 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.252 -0.905 . . . . 0.0 110.928 -174.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 70.7 mtp85 -94.51 6.15 49.66 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.631 -0.668 . . . . 0.0 112.098 -175.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.8 p-10 -89.32 174.45 7.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.092 -1.005 . . . . 0.0 111.295 -172.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.8 m -78.76 164.47 24.53 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.056 0.455 . . . . 0.0 110.013 178.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -77.66 9.24 3.55 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.743 -0.598 . . . . 0.0 111.71 -176.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -87.98 155.18 19.96 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.098 -1.001 . . . . 0.0 109.948 172.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -67.15 129.94 41.51 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.698 -0.627 . . . . 0.0 110.827 -172.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 82.4 mt -129.0 140.63 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.737 -0.602 . . . . 0.0 109.444 175.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.0 109.84 53.27 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.547 -0.72 . . . . 0.0 110.371 -178.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -77.63 157.07 32.03 Favored 'Trans proline' 0 N--CA 1.486 1.066 0 O-C-N 123.449 1.237 . . . . 0.0 110.432 176.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -114.67 131.22 56.81 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.656 -0.652 . . . . 0.0 110.14 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.6 m -97.06 12.41 32.71 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.69 -0.631 . . . . 0.0 111.333 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -63.62 145.07 56.42 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.308 -0.87 . . . . 0.0 110.564 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.81 128.94 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.613 -0.68 . . . . 0.0 109.863 178.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -98.99 119.53 37.92 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.689 -0.632 . . . . 0.0 110.376 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -51.75 -41.22 61.43 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.715 -0.615 . . . . 0.0 111.252 173.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -153.98 128.82 9.46 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.686 -0.634 . . . . 0.0 110.103 -175.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 67.4 mt -126.31 130.33 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.639 -0.663 . . . . 0.0 109.879 172.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.5 tp -89.94 137.06 32.65 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.838 -0.539 . . . . 0.0 109.686 175.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.463 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 3.3 m-85 -133.8 126.5 30.71 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.706 -0.621 . . . . 0.0 110.55 -175.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -92.71 149.95 20.99 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.689 -0.632 . . . . 0.0 110.305 172.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.83 -24.01 57.02 Favored Glycine 0 N--CA 1.498 2.821 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 177.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.0 p -68.32 -42.05 79.94 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.409 -1.053 . . . . 0.0 111.115 -176.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -82.98 -29.38 29.04 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.331 -0.856 . . . . 0.0 111.028 -175.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.463 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 15.4 mt -103.74 140.7 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.416 -0.802 . . . . 0.0 110.255 176.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -105.74 -19.83 13.64 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.912 -0.492 . . . . 0.0 111.552 -168.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -149.98 131.55 14.86 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 119.046 -1.062 . . . . 0.0 111.319 -178.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.7 tt -129.88 138.81 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.979 -0.451 . . . . 0.0 109.809 176.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 90.6 mtt-85 -146.89 137.94 23.99 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.543 -0.723 . . . . 0.0 110.421 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.6 t -87.17 143.76 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.658 -0.652 . . . . 0.0 109.693 178.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.9 t -94.63 134.61 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.541 -0.724 . . . . 0.0 109.885 -178.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -121.16 156.94 31.27 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.706 -0.621 . . . . 0.0 110.134 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -96.75 135.42 38.72 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.733 -0.604 . . . . 0.0 110.225 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -124.92 148.2 48.46 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.695 -0.628 . . . . 0.0 110.191 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.2 p -121.23 161.18 22.36 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.671 -0.643 . . . . 0.0 110.271 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -146.41 159.81 43.88 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.695 -0.628 . . . . 0.0 110.351 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo . . . . . 0 N--CA 1.488 1.177 0 O-C-N 123.623 1.328 . . . . 0.0 110.299 179.883 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -134.08 150.36 51.17 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.754 -0.851 . . . . 0.0 110.172 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 65.4 mtt -128.62 158.38 38.66 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.661 -0.649 . . . . 0.0 110.224 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -95.29 125.91 40.24 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.635 -0.666 . . . . 0.0 110.109 178.579 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 ttp -146.32 36.65 1.0 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.611 -0.681 . . . . 0.0 110.097 -179.359 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 97.8 p -112.95 151.97 29.91 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.625 -0.672 . . . . 0.0 110.201 -179.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -102.56 -48.22 1.32 Allowed Glycine 0 N--CA 1.495 2.586 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.678 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -131.42 158.68 22.86 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -78.6 -57.49 0.84 Allowed Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.674 -0.898 . . . . 0.0 110.695 -179.588 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -71.44 136.48 28.74 Favored 'Trans proline' 0 N--CA 1.488 1.161 0 O-C-N 123.23 1.121 . . . . 0.0 110.367 -176.329 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -64.78 126.31 27.54 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.676 -0.64 . . . . 0.0 110.519 179.174 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.78 136.48 56.95 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.689 -0.632 . . . . 0.0 110.902 -178.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.57 -2.37 82.78 Favored Glycine 0 N--CA 1.497 2.765 0 C-N-CA 120.699 -0.763 . . . . 0.0 111.944 175.196 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.1 m -64.29 150.62 45.71 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.168 -1.195 . . . . 0.0 110.389 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -81.42 127.84 33.22 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.623 -0.673 . . . . 0.0 110.052 175.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 88.4 mt -125.12 143.92 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.435 -0.791 . . . . 0.0 110.299 -178.317 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.6 t -102.19 137.28 40.66 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 173.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 12.6 tp -134.66 130.6 36.61 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.675 -0.641 . . . . 0.0 110.292 -170.183 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.2 mt -107.12 121.49 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.508 -0.745 . . . . 0.0 109.743 -178.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.6 m -93.95 157.86 15.91 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.033 0.444 . . . . 0.0 111.23 -178.129 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -53.35 -15.41 0.99 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -171.045 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.17 20.65 4.21 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.148 -0.97 . . . . 0.0 110.433 -179.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 54.1 34.98 21.2 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.446 -0.784 . . . . 0.0 109.805 -174.511 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.8 mt -102.89 143.1 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.21 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -103.77 119.83 39.72 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.159 -178.614 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -113.7 149.7 34.36 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 175.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -141.17 140.6 34.08 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.418 -0.801 . . . . 0.0 109.815 175.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.35 172.84 43.04 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 119.716 -1.231 . . . . 0.0 110.529 -175.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 80.8 mtt85 -86.0 135.91 33.46 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.888 -0.772 . . . . 0.0 110.62 179.05 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.6 tp -66.17 118.0 9.27 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.605 -0.684 . . . . 0.0 110.663 176.6 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -100.24 -50.14 4.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.627 -0.67 . . . . 0.0 110.55 179.093 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.7 p -154.63 155.61 34.99 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.603 -0.686 . . . . 0.0 110.382 -178.024 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.2 p -142.31 145.92 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.744 -0.597 . . . . 0.0 110.009 -179.425 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -128.92 100.26 21.2 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.603 -0.686 . . . . 0.0 109.503 177.581 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.58 -37.16 60.09 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 O-C-N 123.599 1.315 . . . . 0.0 110.793 -175.17 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -80.07 -27.98 39.26 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.379 -0.826 . . . . 0.0 110.061 -171.251 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -88.23 2.6 51.92 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.545 -0.722 . . . . 0.0 111.235 174.011 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 39.0 m 49.44 40.66 19.41 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.007 -1.058 . . . . 0.0 111.198 -175.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.2 p -135.73 154.49 51.23 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.436 -0.79 . . . . 0.0 110.381 -175.166 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.0 pt -141.94 162.03 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.718 -0.614 . . . . 0.0 110.142 177.675 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.9 128.37 28.43 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.695 -0.628 . . . . 0.0 109.802 175.482 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 85.0 mt -109.81 147.01 34.06 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -178.536 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 87.6 p -115.71 150.12 37.33 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -177.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 52.5 p 45.73 85.36 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 121.504 0.668 . . . . 0.0 110.29 -172.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.0 p -134.64 152.33 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -178.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -136.39 153.09 51.2 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.503 -0.748 . . . . 0.0 110.236 179.037 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.6 p -109.69 136.3 49.25 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.764 -0.585 . . . . 0.0 109.637 176.576 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -83.04 -38.59 22.36 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.537 -0.727 . . . . 0.0 111.19 -172.533 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.4 174.94 36.93 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.912 -1.137 . . . . 0.0 110.515 176.195 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.4 p -116.75 6.53 13.26 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.834 -0.804 . . . . 0.0 110.528 169.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -52.35 -24.56 7.82 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.615 -0.678 . . . . 0.0 112.597 -166.451 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -64.14 -59.43 4.45 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.154 -0.966 . . . . 0.0 110.604 -176.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 39.6 mtp85 -94.54 10.2 35.61 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.55 -0.719 . . . . 0.0 111.393 176.512 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.5 p-10 -58.91 172.29 0.57 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.234 -0.916 . . . . 0.0 111.552 -169.161 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.8 m -85.0 164.49 18.23 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 174.717 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -77.47 3.81 12.55 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.642 -0.661 . . . . 0.0 111.287 -179.364 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -95.17 157.48 15.88 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.247 -0.908 . . . . 0.0 109.683 168.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -70.52 139.25 51.54 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.645 -0.659 . . . . 0.0 110.538 -176.004 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.7 mt -115.36 136.23 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.725 -0.61 . . . . 0.0 109.556 176.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.11 113.08 12.87 Favored Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 121.707 -0.621 . . . . 0.0 110.138 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -66.93 143.76 67.67 Favored 'Trans proline' 0 N--CA 1.488 1.188 0 O-C-N 123.389 1.205 . . . . 0.0 110.392 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -97.82 114.7 26.8 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.72 -0.612 . . . . 0.0 110.216 -179.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.6 t -101.54 -32.95 10.13 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.721 -0.612 . . . . 0.0 110.306 179.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -62.24 151.49 36.13 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.627 -0.671 . . . . 0.0 110.634 -178.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.2 mm -96.81 142.71 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.808 -0.557 . . . . 0.0 109.79 179.672 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -94.82 118.09 31.2 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.613 -0.679 . . . . 0.0 110.137 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -51.14 -42.36 60.7 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.859 -0.525 . . . . 0.0 111.732 178.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -152.7 130.88 11.95 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.609 -0.682 . . . . 0.0 110.182 -174.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 75.5 mt -129.73 127.45 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.625 -0.672 . . . . 0.0 109.859 172.148 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 23.9 tp -90.2 137.1 32.62 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.817 -0.552 . . . . 0.0 109.741 175.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.425 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 3.6 m-85 -136.57 131.16 33.43 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.629 -0.67 . . . . 0.0 110.6 -175.691 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -90.71 149.18 22.15 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.781 -0.575 . . . . 0.0 110.187 174.741 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.26 -25.06 59.69 Favored Glycine 0 N--CA 1.5 2.912 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 178.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.9 m -65.91 -40.55 91.6 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.412 -1.052 . . . . 0.0 110.885 -178.432 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.95 -34.42 29.8 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.631 -0.668 . . . . 0.0 110.929 -174.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.425 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 13.9 mt -105.94 140.26 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.429 -0.794 . . . . 0.0 110.11 177.617 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 47.8 tttm -107.27 -24.62 11.82 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.839 -164.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -149.12 140.78 23.5 Favored 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.548 -174.414 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 15.4 tt -134.09 147.81 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.939 -0.475 . . . . 0.0 110.106 179.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -147.02 129.75 16.1 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.597 -0.69 . . . . 0.0 110.287 176.59 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 51.4 t -87.4 146.05 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.657 -0.652 . . . . 0.0 109.83 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 50.2 t -93.4 125.38 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.573 -0.704 . . . . 0.0 109.711 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -154.96 -179.75 8.35 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.682 -0.636 . . . . 0.0 110.345 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -142.95 175.15 10.06 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.706 -0.621 . . . . 0.0 110.287 179.149 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 31.7 t60 -116.02 129.48 56.38 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.653 -0.654 . . . . 0.0 110.099 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.5 p -100.79 158.95 15.58 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.719 -0.613 . . . . 0.0 110.323 -178.531 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.9 tt -153.81 109.95 2.52 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.696 -0.627 . . . . 0.0 110.158 179.453 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo . . . . . 0 N--CA 1.487 1.117 0 O-C-N 123.445 1.234 . . . . 0.0 110.309 179.144 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -104.63 145.67 30.0 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.73 -0.865 . . . . 0.0 110.19 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 57.3 ttp -96.98 123.52 40.72 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.738 -0.601 . . . . 0.0 110.213 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -150.65 159.22 44.66 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.695 -0.628 . . . . 0.0 110.256 -179.652 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptm -125.15 159.23 31.99 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.675 -0.641 . . . . 0.0 110.222 179.6 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.4 t -111.63 139.79 46.78 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.682 -0.637 . . . . 0.0 110.223 -179.537 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -89.18 -176.22 46.31 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -147.33 59.26 0.47 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 28.7 mt -79.75 156.92 74.9 Favored Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 121.661 -0.905 . . . . 0.0 110.268 -179.499 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -66.95 155.69 69.68 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.711 1.374 . . . . 0.0 110.39 179.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -64.83 98.26 0.27 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.661 -0.649 . . . . 0.0 110.452 -179.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.5 mt -64.79 155.53 33.58 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.749 -0.594 . . . . 0.0 110.675 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.7 -1.96 84.46 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.826 177.287 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.7 m -61.99 136.34 57.92 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.13 -1.218 . . . . 0.0 110.405 179.283 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.3 pttt -81.83 126.4 31.82 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.655 -0.653 . . . . 0.0 110.475 179.761 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 92.7 mt -124.84 145.07 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.523 -0.736 . . . . 0.0 110.203 179.501 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.8 t -102.8 137.26 41.25 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.582 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 17.3 tp -134.9 126.76 29.36 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.788 -0.57 . . . . 0.0 110.282 -168.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 81.3 mt -108.74 120.91 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.557 -0.714 . . . . 0.0 109.697 -178.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.2 m -93.54 157.78 16.03 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.146 0.498 . . . . 0.0 111.216 -176.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -54.27 -13.77 0.97 Allowed 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -172.159 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.19 20.03 3.96 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.147 -0.97 . . . . 0.0 110.436 179.081 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 55.64 35.78 25.9 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.503 -0.748 . . . . 0.0 109.821 -176.241 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 60.6 mt -105.81 145.63 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -105.4 119.82 40.05 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.25 -179.313 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -114.53 151.04 33.98 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 174.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -142.29 140.64 32.25 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.35 -0.844 . . . . 0.0 109.818 174.354 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.22 173.08 43.01 Favored Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.526 -175.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 56.4 mtm180 -85.71 136.03 33.52 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.867 -0.784 . . . . 0.0 110.573 179.164 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 28.0 tp -66.17 119.99 12.43 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.62 -0.675 . . . . 0.0 110.738 175.343 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -99.68 -50.03 4.19 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.764 -0.585 . . . . 0.0 110.347 177.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.2 p -153.98 155.58 35.85 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.642 -0.661 . . . . 0.0 110.233 -178.39 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.5 p -142.31 145.56 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.654 -0.654 . . . . 0.0 110.093 -178.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -127.33 98.62 29.04 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.65 -0.656 . . . . 0.0 109.602 177.645 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -59.3 -42.39 50.01 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 O-C-N 123.636 1.335 . . . . 0.0 111.03 -175.763 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -80.63 -25.14 38.55 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.405 -0.809 . . . . 0.0 110.199 -171.13 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -87.33 1.67 52.57 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.438 -0.789 . . . . 0.0 111.18 173.605 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 38.7 m 49.87 38.55 16.25 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 121.13 -0.981 . . . . 0.0 111.226 -177.009 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.6 p -135.77 154.28 51.27 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.394 -0.816 . . . . 0.0 110.407 -175.128 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.9 pt -143.1 161.87 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.638 -0.664 . . . . 0.0 110.204 178.634 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.9 127.93 27.69 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.652 -0.655 . . . . 0.0 109.692 175.524 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 87.4 mt -109.91 147.78 32.79 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -177.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 91.8 p -118.33 151.43 37.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.641 -0.662 . . . . 0.0 109.226 -177.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 44.1 p 45.63 83.66 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 121.543 0.687 . . . . 0.0 110.376 -172.197 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.3 p -134.63 150.53 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.406 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -136.36 153.19 51.19 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.638 -0.663 . . . . 0.0 110.128 178.554 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.0 p -108.4 137.16 46.83 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.736 -0.602 . . . . 0.0 109.546 177.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -83.01 -38.57 22.44 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 119.833 -0.747 . . . . 0.0 111.063 -172.017 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.32 167.55 28.16 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 175.614 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.2 p -118.3 -13.84 9.83 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.875 -0.779 . . . . 0.0 110.84 171.289 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -52.52 -24.59 8.38 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.398 -0.814 . . . . 0.0 112.482 -165.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -78.22 -59.36 2.81 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.287 -0.883 . . . . 0.0 110.836 -176.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -94.55 10.12 35.91 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.52 -0.738 . . . . 0.0 111.956 -174.668 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.9 p-10 -93.18 174.6 7.14 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.056 -1.028 . . . . 0.0 111.19 -174.584 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.4 m -78.48 164.58 24.62 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.967 -0.458 . . . . 0.0 109.783 177.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -77.49 11.78 1.87 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.662 -0.649 . . . . 0.0 111.671 -174.015 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -91.32 143.36 26.72 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.121 -0.987 . . . . 0.0 109.73 170.07 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -66.04 140.21 58.25 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.712 -0.618 . . . . 0.0 110.953 -171.013 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 83.9 mt -120.88 142.02 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 176.417 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.3 112.81 10.15 Favored Pre-proline 0 N--CA 1.501 2.084 0 O-C-N 121.628 -0.67 . . . . 0.0 110.204 -179.492 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -63.8 141.89 80.4 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 O-C-N 123.345 1.181 . . . . 0.0 110.614 -179.271 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -107.9 107.16 17.75 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.655 -0.653 . . . . 0.0 110.199 179.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.2 t -103.36 -34.87 8.6 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.713 -0.617 . . . . 0.0 110.2 179.47 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -62.84 157.45 21.37 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.674 -0.641 . . . . 0.0 110.611 -179.479 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.8 mm -96.75 136.98 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.698 -0.626 . . . . 0.0 109.686 179.071 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -96.05 117.2 30.21 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.62 -0.675 . . . . 0.0 110.356 -178.2 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -51.23 -40.46 58.84 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.827 -0.546 . . . . 0.0 111.629 177.229 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -152.33 130.2 11.71 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.615 -0.678 . . . . 0.0 110.35 -174.471 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 77.2 mt -129.66 126.68 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.671 -0.643 . . . . 0.0 109.798 171.527 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 19.2 tp -90.57 137.13 32.6 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.77 -0.581 . . . . 0.0 109.841 176.226 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.453 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 4.6 m-85 -137.07 132.58 34.35 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.653 -0.655 . . . . 0.0 110.585 -175.281 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -90.69 148.13 22.81 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.71 -0.619 . . . . 0.0 110.269 173.579 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.21 -25.65 60.35 Favored Glycine 0 N--CA 1.499 2.854 0 N-CA-C 110.521 -1.031 . . . . 0.0 110.521 179.363 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.4 p -67.41 -38.26 84.36 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.419 -1.048 . . . . 0.0 110.842 -177.45 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -82.48 -32.57 28.79 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.432 -0.792 . . . . 0.0 110.841 -175.394 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.453 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 10.6 mt -106.41 134.19 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.496 -0.752 . . . . 0.0 109.923 176.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.4 tttp -108.75 -10.98 15.11 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 120.485 -0.486 . . . . 0.0 112.077 -166.68 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -147.8 129.63 15.22 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.876 -1.14 . . . . 0.0 111.155 -179.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.1 tt -137.96 139.48 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.958 -0.464 . . . . 0.0 110.017 178.197 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 82.5 mtm-85 -147.12 136.86 23.04 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.54 -0.725 . . . . 0.0 110.51 176.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.3 p -87.13 147.04 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.688 -0.632 . . . . 0.0 110.1 177.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.4 t -94.76 131.69 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.624 -0.673 . . . . 0.0 109.772 -178.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -143.61 106.82 4.54 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.675 -0.641 . . . . 0.0 110.214 179.695 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -103.3 106.56 17.11 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.684 -0.635 . . . . 0.0 110.187 179.413 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -67.97 -47.94 67.21 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.699 -0.626 . . . . 0.0 110.239 -179.676 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.9 t -142.03 160.46 40.17 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.678 -0.639 . . . . 0.0 110.44 -179.486 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.2 tp -97.06 139.49 21.55 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.681 -0.637 . . . . 0.0 110.005 179.341 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo . . . . . 0 N--CA 1.489 1.236 0 O-C-N 123.452 1.238 . . . . 0.0 110.362 179.848 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -67.38 -34.46 77.32 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.642 -0.917 . . . . 0.0 110.298 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 57.7 ttp -101.3 114.78 29.07 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.776 -0.577 . . . . 0.0 110.205 179.737 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -109.12 139.29 44.21 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.617 -0.677 . . . . 0.0 110.204 179.574 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.2 mtm -110.94 28.78 8.38 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.733 -0.605 . . . . 0.0 110.514 179.594 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.3 m -105.44 29.62 6.35 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.487 -0.758 . . . . 0.0 110.57 -179.259 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -143.08 165.87 26.85 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.472 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -154.96 -178.78 29.59 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.617 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 35.4 mt -79.86 151.22 73.4 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.694 -0.886 . . . . 0.0 110.067 179.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -68.57 135.26 32.9 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 O-C-N 123.583 1.307 . . . . 0.0 110.345 -179.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -64.9 114.0 4.23 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.592 -0.693 . . . . 0.0 110.465 179.28 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.3 mt -64.82 144.46 57.24 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.644 -0.66 . . . . 0.0 110.683 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.71 -1.96 84.49 Favored Glycine 0 N--CA 1.496 2.682 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.809 177.712 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 74.8 m -62.38 142.73 57.68 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.09 -1.241 . . . . 0.0 110.477 179.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -82.03 126.81 32.42 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.693 -0.63 . . . . 0.0 110.386 178.289 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 90.5 mt -123.97 145.02 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.584 -0.697 . . . . 0.0 110.148 -179.725 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.6 t -103.33 137.29 41.65 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 176.12 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 14.5 tp -133.23 123.18 25.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.776 -0.578 . . . . 0.0 110.263 -169.662 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 79.8 mt -106.31 116.87 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.427 -0.796 . . . . 0.0 109.711 -178.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.5 m -92.83 157.71 16.25 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 120.955 0.407 . . . . 0.0 111.231 -177.101 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -54.61 -11.81 0.63 Allowed 'General case' 0 N--CA 1.509 2.49 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -171.608 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.22 20.0 4.69 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.083 -1.01 . . . . 0.0 110.45 179.386 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 54.66 33.52 19.49 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.52 -0.738 . . . . 0.0 109.853 -174.285 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.7 mt -102.52 140.93 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.441 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -104.83 119.77 39.8 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.994 -0.683 . . . . 0.0 109.939 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -114.25 149.43 35.87 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 174.403 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -140.34 140.46 35.6 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.584 -0.698 . . . . 0.0 109.54 175.154 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.4 172.65 42.4 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.624 -175.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -85.38 135.61 33.81 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.956 -0.732 . . . . 0.0 110.504 179.097 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.8 tp -66.14 120.82 13.87 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.597 -0.689 . . . . 0.0 110.663 176.13 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -99.19 -49.96 4.3 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.666 -0.646 . . . . 0.0 110.257 178.194 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.0 p -153.38 156.77 38.9 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.742 -0.599 . . . . 0.0 110.068 -179.162 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.6 p -142.25 145.9 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.658 -0.651 . . . . 0.0 110.227 -177.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -128.26 101.49 21.96 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.609 -0.682 . . . . 0.0 109.507 177.022 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.38 -41.2 34.89 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 O-C-N 123.579 1.305 . . . . 0.0 110.839 -174.459 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -80.7 -24.57 38.75 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.283 -0.886 . . . . 0.0 110.203 -171.732 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -87.31 1.31 53.63 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.474 -0.767 . . . . 0.0 111.262 173.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.9 m 49.86 38.14 15.21 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.042 -1.036 . . . . 0.0 111.276 -176.698 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.6 p -136.45 153.52 51.03 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.477 -0.764 . . . . 0.0 110.377 -174.27 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.8 pt -142.34 162.06 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.711 -0.618 . . . . 0.0 110.182 177.707 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.68 127.7 33.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.659 -0.651 . . . . 0.0 109.62 176.011 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 88.7 mt -109.94 149.45 29.9 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -176.481 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 91.8 p -123.1 154.33 38.73 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.134 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.5 p 45.41 83.76 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 121.492 0.663 . . . . 0.0 110.375 -171.805 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.4 p -134.55 149.74 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -178.537 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -134.84 153.21 52.13 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.622 -0.674 . . . . 0.0 109.982 178.766 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.2 p -107.32 138.55 43.3 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.671 -0.643 . . . . 0.0 109.894 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -83.07 -38.28 22.73 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.648 -0.658 . . . . 0.0 110.905 -174.282 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.74 170.32 32.37 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 178.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.8 p -118.03 6.75 12.14 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.909 -0.759 . . . . 0.0 111.173 177.451 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -48.89 -23.87 1.26 Allowed 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.471 -0.768 . . . . 0.0 112.694 -169.552 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -54.3 -45.56 72.59 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.235 -0.915 . . . . 0.0 111.344 -179.396 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 75.4 mtp180 -94.14 -58.08 2.34 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.432 -0.792 . . . . 0.0 110.766 -179.788 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -67.35 174.88 3.01 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.727 -0.608 . . . . 0.0 110.378 -178.67 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.7 p -78.13 164.41 25.0 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.694 -0.629 . . . . 0.0 110.664 -170.664 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -77.52 1.68 18.65 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.413 -177.746 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -72.53 161.17 31.14 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.171 -0.956 . . . . 0.0 109.811 176.4 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -65.94 130.24 42.58 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.625 -0.672 . . . . 0.0 111.017 -168.179 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 82.2 mt -114.92 136.67 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 173.521 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.03 112.49 7.59 Favored Pre-proline 0 N--CA 1.501 2.122 0 O-C-N 121.581 -0.7 . . . . 0.0 110.54 -174.628 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -79.67 151.25 22.02 Favored 'Trans proline' 0 N--CA 1.485 1.021 0 O-C-N 123.403 1.212 . . . . 0.0 110.261 179.171 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -101.75 114.19 28.04 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.662 -0.649 . . . . 0.0 110.053 177.435 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.2 m -66.38 -32.65 74.17 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.698 -0.626 . . . . 0.0 110.492 -178.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -62.15 143.29 56.93 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.602 -0.686 . . . . 0.0 110.724 -178.238 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.9 mm -96.76 158.9 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.798 -0.564 . . . . 0.0 109.703 179.008 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -93.4 112.5 24.42 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.598 -0.689 . . . . 0.0 110.138 -178.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -51.57 -42.32 61.78 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.78 -0.575 . . . . 0.0 111.629 177.199 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -153.09 128.78 10.11 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.594 -0.691 . . . . 0.0 110.365 -174.018 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 71.1 mt -128.34 133.48 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.693 -0.63 . . . . 0.0 109.939 172.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 27.1 tp -90.35 137.06 32.66 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.866 -0.521 . . . . 0.0 109.971 176.107 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.458 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 2.2 m-85 -133.61 124.43 26.82 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.686 -0.634 . . . . 0.0 110.673 -176.622 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 73.6 mtt85 -92.96 145.98 23.97 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.696 -0.628 . . . . 0.0 110.358 172.358 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.73 -24.69 62.6 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 179.532 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.6 m -67.9 -42.24 81.47 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.413 -1.051 . . . . 0.0 111.199 -173.799 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -85.46 -24.19 27.52 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.328 -0.858 . . . . 0.0 111.128 -175.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.458 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 86.7 mt -96.65 143.03 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.236 -0.915 . . . . 0.0 110.165 173.556 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -104.02 -20.85 13.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.984 -0.447 . . . . 0.0 111.304 -170.412 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -152.87 131.88 12.59 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 119.147 -1.021 . . . . 0.0 111.297 -179.414 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.5 tt -131.53 138.53 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 175.292 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -146.81 131.28 17.68 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.663 -0.648 . . . . 0.0 110.423 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.2 p -87.99 147.08 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.61 -0.681 . . . . 0.0 110.171 177.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.2 t -94.84 133.85 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.57 -0.706 . . . . 0.0 109.737 -179.703 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -139.48 -41.75 0.45 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.658 -0.652 . . . . 0.0 111.0 -179.458 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -134.7 30.29 3.45 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.408 -0.808 . . . . 0.0 110.622 -178.249 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -153.16 157.06 39.75 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.592 -0.693 . . . . 0.0 110.311 179.099 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.4 p -125.03 163.17 22.94 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.608 -0.683 . . . . 0.0 110.223 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.3 tt -107.55 109.9 62.66 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.704 -0.622 . . . . 0.0 110.144 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo . . . . . 0 N--CA 1.489 1.222 0 O-C-N 123.405 1.213 . . . . 0.0 110.361 179.159 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -92.91 118.67 31.4 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.704 -0.88 . . . . 0.0 110.209 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 90.3 mtp -66.75 -37.77 85.3 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.586 -0.696 . . . . 0.0 110.266 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -154.5 155.71 35.37 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.711 -0.618 . . . . 0.0 110.241 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.2 ttp -147.71 -57.64 0.25 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.741 -0.6 . . . . 0.0 110.192 179.449 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.5 m -66.16 -34.27 77.67 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.705 -0.622 . . . . 0.0 110.347 -179.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.06 -40.85 93.12 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.215 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.18 152.1 20.75 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.847 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 12.0 tp -155.39 58.16 1.82 Allowed Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.709 -0.877 . . . . 0.0 110.035 179.682 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -68.77 127.83 16.0 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 O-C-N 123.477 1.251 . . . . 0.0 110.27 179.374 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -64.89 112.99 3.53 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.669 -0.645 . . . . 0.0 110.503 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.8 mt -64.87 147.35 53.47 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.628 -0.67 . . . . 0.0 110.529 178.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.58 -1.88 84.4 Favored Glycine 0 N--CA 1.497 2.741 0 C-N-CA 120.453 -0.88 . . . . 0.0 111.815 177.653 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 71.5 m -61.35 148.58 40.93 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.155 -1.203 . . . . 0.0 110.44 -179.086 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -82.21 127.45 33.19 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.491 179.588 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 89.1 mt -121.78 144.5 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.588 -0.695 . . . . 0.0 109.944 179.01 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.0 t -103.05 137.32 41.38 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 175.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.5 tp -133.32 123.3 25.2 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.792 -0.568 . . . . 0.0 110.002 -171.246 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.2 mt -103.98 119.17 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.522 -0.736 . . . . 0.0 109.683 -177.707 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.1 m -94.32 157.93 15.81 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.137 0.494 . . . . 0.0 111.46 -175.525 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -53.72 -14.6 0.95 Allowed 'General case' 0 N--CA 1.507 2.385 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -171.363 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.68 20.39 4.07 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.221 -0.924 . . . . 0.0 110.459 179.475 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 55.53 35.42 25.11 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.486 -0.759 . . . . 0.0 109.93 -176.137 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 60.9 mt -105.31 145.3 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 55.5 ttt85 -105.73 119.8 40.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.624 -0.673 . . . . 0.0 110.15 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -113.68 150.68 32.89 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.682 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -141.36 140.55 33.76 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.437 -0.79 . . . . 0.0 109.776 174.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.61 172.49 41.12 Favored Glycine 0 N--CA 1.495 2.623 0 C-N-CA 119.875 -1.155 . . . . 0.0 110.451 -175.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -84.3 138.75 32.74 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.919 -0.753 . . . . 0.0 110.545 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 17.0 tp -66.15 117.68 8.8 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.628 -0.67 . . . . 0.0 110.685 175.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -100.09 -50.08 4.09 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.596 -0.69 . . . . 0.0 110.437 177.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.2 p -154.19 154.83 34.18 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.648 -0.658 . . . . 0.0 110.317 -178.185 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.5 p -142.19 145.6 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.707 -0.62 . . . . 0.0 110.054 -179.347 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -129.02 98.19 24.56 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.643 -0.661 . . . . 0.0 109.504 177.355 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -59.64 -40.34 65.99 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 O-C-N 123.64 1.337 . . . . 0.0 110.973 -176.118 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -80.32 -27.39 38.42 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.308 -0.87 . . . . 0.0 110.118 -170.675 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -87.76 2.89 50.06 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.529 -0.732 . . . . 0.0 111.252 173.707 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 40.1 m 50.02 40.34 21.1 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.141 -0.974 . . . . 0.0 111.425 -177.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 39.6 p -136.0 154.34 51.1 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.372 -0.83 . . . . 0.0 110.481 -176.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.0 pt -142.06 161.5 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.672 -0.643 . . . . 0.0 109.991 176.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.72 128.6 29.21 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.688 -0.633 . . . . 0.0 109.724 176.262 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 83.8 mt -109.76 144.57 37.98 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -178.3 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.4 p -115.3 153.11 31.54 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -178.038 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.0 p 45.31 84.69 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 CA-C-O 121.506 0.669 . . . . 0.0 110.271 -171.672 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.6 p -134.64 149.52 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -178.314 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -134.92 153.09 52.19 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.612 -0.68 . . . . 0.0 110.136 179.061 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.8 p -107.91 136.7 47.18 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.747 -0.596 . . . . 0.0 109.639 177.644 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -82.77 -38.45 23.18 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 119.864 -0.735 . . . . 0.0 111.115 -172.339 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.47 166.47 26.6 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 175.783 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 45.7 p -118.2 -19.77 8.87 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.846 -0.796 . . . . 0.0 110.909 172.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -53.3 -26.48 18.77 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.511 -0.743 . . . . 0.0 112.249 -167.54 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -70.49 -59.31 2.92 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.359 -0.838 . . . . 0.0 110.733 -176.025 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 63.1 mtp85 -94.42 -16.34 23.51 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.606 -0.684 . . . . 0.0 111.741 -175.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -63.7 174.57 1.34 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.239 -0.913 . . . . 0.0 111.245 -172.639 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.1 m -78.68 164.63 24.44 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 177.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -77.5 11.46 2.01 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.676 -0.64 . . . . 0.0 111.565 -174.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -92.93 164.48 13.29 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.2 -0.938 . . . . 0.0 109.683 169.519 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -66.05 138.17 57.58 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.584 -0.697 . . . . 0.0 110.726 -172.623 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.3 mm -118.39 139.54 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.773 -0.579 . . . . 0.0 109.595 177.383 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.58 113.63 18.48 Favored Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 121.69 -0.631 . . . . 0.0 110.288 -178.827 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -68.54 153.18 74.21 Favored 'Trans proline' 0 N--CA 1.487 1.123 0 O-C-N 123.365 1.192 . . . . 0.0 110.4 179.006 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -132.92 65.73 1.58 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.649 -0.657 . . . . 0.0 110.127 179.526 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.1 m -65.98 -33.4 75.72 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.515 -0.741 . . . . 0.0 110.401 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -62.0 155.35 24.05 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.616 -0.678 . . . . 0.0 110.621 -178.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.2 mm -96.71 138.34 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.656 -0.652 . . . . 0.0 109.741 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -97.85 118.8 35.24 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.664 -0.647 . . . . 0.0 110.471 -177.324 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -51.3 -39.95 57.95 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.721 -0.612 . . . . 0.0 111.428 175.27 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -152.95 130.4 11.4 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.75 -0.593 . . . . 0.0 110.254 -174.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.9 mt -128.97 127.33 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.65 -0.656 . . . . 0.0 109.901 171.445 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 24.0 tp -91.03 137.14 32.59 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.929 -0.482 . . . . 0.0 109.917 176.317 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.442 ' CD1' HD12 ' A' ' 72' ' ' ILE . 5.9 m-85 -137.18 128.61 28.29 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.65 -0.656 . . . . 0.0 110.531 -176.483 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -91.1 154.93 19.02 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.658 -0.651 . . . . 0.0 110.278 173.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.07 -23.96 57.87 Favored Glycine 0 N--CA 1.498 2.824 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 177.691 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.8 m -72.72 -42.09 64.52 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.46 -1.023 . . . . 0.0 111.28 -175.074 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -84.55 -26.63 27.89 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.345 -0.847 . . . . 0.0 111.144 -174.015 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.442 HD12 ' CD1' ' A' ' 67' ' ' PHE . 32.8 mt -106.27 140.73 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.316 -0.865 . . . . 0.0 109.91 171.089 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -105.19 -16.67 14.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.921 -0.487 . . . . 0.0 111.687 -167.691 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -149.94 133.45 16.61 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.92 -1.113 . . . . 0.0 111.409 -178.689 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 16.2 tt -131.13 137.92 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.048 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -144.89 135.18 24.16 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.613 -0.679 . . . . 0.0 110.164 179.633 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.2 p -86.85 147.04 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.589 -0.694 . . . . 0.0 110.163 178.546 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.4 t -93.87 136.96 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.572 -0.705 . . . . 0.0 109.79 -179.175 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 36.0 p-10 -100.42 165.71 11.31 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.706 -0.621 . . . . 0.0 110.389 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -103.92 32.54 3.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.725 -0.609 . . . . 0.0 110.298 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -112.4 134.3 54.02 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.57 -0.706 . . . . 0.0 110.173 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.7 m -120.1 141.98 49.31 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.712 -0.617 . . . . 0.0 110.109 -179.708 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.8 mp -95.56 158.29 34.74 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.753 -0.592 . . . . 0.0 110.209 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo . . . . . 0 N--CA 1.487 1.11 0 O-C-N 123.684 1.36 . . . . 0.0 110.34 -179.985 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 N--CA 1.501 2.094 0 CA-C-O 121.003 0.43 . . . . 1.08 110.836 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.61 -1.95 84.25 Favored Glycine 0 N--CA 1.497 2.706 0 C-N-CA 120.708 -0.758 . . . . 0.45 111.798 176.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.3 m -63.29 145.11 56.23 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.039 -1.271 . . . . 0.35 110.445 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.46 ' HE3' HG11 ' A' ' 78' ' ' VAL . 30.9 pttt -82.18 125.15 30.57 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.73 -0.606 . . . . 1.62 110.269 176.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.619 ' CD1' HD13 ' A' ' 26' ' ' LEU . 87.1 mt -120.97 143.42 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.499 -0.751 . . . . 0.18 110.059 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.9 t -102.5 137.22 41.02 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.35 -0.611 . . . . 0.12 109.35 174.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.613 HD21 HD13 ' A' ' 72' ' ' ILE . 13.9 tp -133.8 127.1 31.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.673 -0.642 . . . . 0.17 110.268 -169.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.6 mt -107.05 118.19 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.55 -0.719 . . . . 0.13 109.732 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m -93.08 157.82 16.1 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.022 0.439 . . . . 0.12 111.212 -177.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -53.76 -13.91 0.81 Allowed 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 112.839 0.681 . . . . 2.52 112.839 -171.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.51 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -90.15 20.78 4.11 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.154 -0.966 . . . . 0.16 110.416 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 53.93 34.28 19.18 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.54 -0.725 . . . . 0.8 109.886 -174.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.833 HG12 HG22 ' A' ' 46' ' ' THR . 68.4 mt -102.59 141.88 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 109.128 -0.693 . . . . 0.23 109.128 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -104.74 119.87 40.02 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.999 -0.68 . . . . 2.34 109.927 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -114.28 149.53 35.79 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.086 -0.709 . . . . 0.15 109.086 174.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.651 ' O ' HG23 ' A' ' 41' ' ' VAL . 45.7 tt0 -140.52 140.53 35.26 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.498 -0.751 . . . . 1.44 109.628 175.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.68 173.37 43.3 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 119.801 -1.19 . . . . 0.06 110.541 -175.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -84.89 137.26 33.24 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.906 -0.761 . . . . 2.07 110.543 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.619 HD13 ' CD1' ' A' ' 12' ' ' ILE . 14.9 tp -66.09 117.66 8.73 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.589 -0.695 . . . . 0.24 110.6 175.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.454 ' O ' HG23 ' A' ' 28' ' ' THR . 31.1 t80 -100.05 -50.08 4.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.621 -0.675 . . . . 0.18 110.562 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 27' ' ' TYR . 14.8 p -154.44 156.95 37.71 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.696 -0.628 . . . . 0.1 110.293 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.813 HG23 HG22 ' A' ' 36' ' ' ILE . 13.7 p -142.27 146.32 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.755 -0.591 . . . . 0.15 110.085 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -128.12 100.95 22.92 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.716 -0.615 . . . . 0.91 109.507 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.31 -42.02 30.75 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 O-C-N 123.652 1.343 . . . . 0.48 110.734 -174.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -80.77 -23.88 39.03 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.379 -0.825 . . . . 2.16 110.148 -171.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.68 ' O ' HG23 ' A' ' 35' ' ' THR . 74.9 mm-40 -87.33 1.11 54.26 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.525 -0.734 . . . . 1.59 111.294 173.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 37.2 m 49.78 38.52 15.82 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.079 -1.013 . . . . 0.74 111.195 -176.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.68 HG23 ' O ' ' A' ' 33' ' ' GLU . 17.0 p -135.77 155.44 50.36 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.405 -0.81 . . . . 0.14 110.399 -174.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.813 HG22 HG23 ' A' ' 29' ' ' VAL . 39.7 pt -142.1 162.0 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.715 -0.616 . . . . 0.15 110.06 177.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.516 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.14 128.42 30.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.61 -0.681 . . . . 0.09 109.722 176.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 26' ' ' LEU . 84.2 mt -109.81 146.35 35.18 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.579 -0.526 . . . . 0.14 109.579 -178.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.3 p -118.29 152.54 35.57 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.12 -0.696 . . . . 0.08 109.12 -177.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.6 p 45.65 84.08 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 121.489 0.662 . . . . 0.07 110.238 -171.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.687 HG11 HD12 ' A' ' 65' ' ' ILE . 15.0 p -134.63 150.46 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 109.774 -0.454 . . . . 0.1 109.774 -178.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -135.72 153.23 51.65 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.697 -0.627 . . . . 2.7 109.967 178.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.8 p -106.57 139.21 41.38 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.686 -0.634 . . . . 0.24 109.788 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -82.74 -38.36 23.38 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.591 -0.693 . . . . 0.59 110.871 -173.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.63 170.48 32.48 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 120.024 -1.084 . . . . 0.51 110.447 177.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.833 HG22 HG12 ' A' ' 20' ' ' ILE . 1.4 p -118.08 6.58 12.09 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.952 -0.734 . . . . 1.13 110.737 174.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -48.94 -25.96 2.23 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.635 -0.666 . . . . 2.69 112.584 -166.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -64.87 -59.29 4.36 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.201 -0.937 . . . . 1.96 110.629 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 58.1 mtp85 -94.43 10.26 35.14 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.64 -0.662 . . . . 4.87 111.38 176.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.445 ' HB2' HD12 ' A' ' 55' ' ' ILE . 38.8 p-10 -59.74 174.02 0.51 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.237 -0.914 . . . . 2.14 111.466 -169.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.1 m -78.95 164.42 24.43 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.647 -0.501 . . . . 3.23 109.647 173.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -77.44 3.45 13.33 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.653 -0.654 . . . . 4.1 111.344 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -97.5 154.21 17.65 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.203 -0.936 . . . . 4.1 109.691 171.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -68.08 137.34 54.91 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.582 -0.699 . . . . 3.57 110.607 -175.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.445 HD12 ' HB2' ' A' ' 50' ' ' ASP . 78.9 mt -117.1 136.56 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.638 -0.664 . . . . 2.27 109.507 176.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . . . -85.35 138.89 36.15 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.693 -0.629 . . . . 2.49 110.124 -178.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 56' ' ' ALA . 17.3 Cg_exo -63.09 149.13 92.39 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 O-C-N 123.362 1.19 . . . . 2.03 110.543 178.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -96.49 115.0 26.71 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.641 -0.662 . . . . 2.72 110.097 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.9 m -85.66 -33.27 21.61 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.687 -0.633 . . . . 2.17 110.331 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -62.56 141.76 58.3 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.679 -0.638 . . . . 2.7 110.66 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.3 mm -96.86 147.36 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.761 -0.587 . . . . 0.5 109.719 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -93.93 114.98 27.3 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.614 -0.679 . . . . 0.73 110.192 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -51.12 -42.18 60.53 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.865 -0.522 . . . . 1.86 111.678 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.516 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.0 t80 -152.58 129.19 10.77 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.606 -0.684 . . . . 0.1 110.272 -174.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.687 HD12 HG11 ' A' ' 41' ' ' VAL . 78.3 mt -128.58 128.74 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.662 -0.649 . . . . 0.11 109.823 172.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.1 tp -90.79 137.08 32.64 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.893 -0.504 . . . . 0.17 109.932 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.538 ' CD1' HD11 ' A' ' 72' ' ' ILE . 3.2 m-85 -136.29 130.12 32.47 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.557 -0.714 . . . . 0.29 110.605 -175.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.7 mtm-85 -91.07 147.88 22.77 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.678 -0.639 . . . . 2.52 110.258 173.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.03 -26.46 61.02 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 110.558 -1.017 . . . . 0.13 110.558 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.3 m -65.7 -39.79 91.62 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.464 -1.021 . . . . 1.29 110.989 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.68 -32.95 31.52 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.395 -0.816 . . . . 1.09 110.859 -174.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.613 HD13 HD21 ' A' ' 14' ' ' LEU . 8.4 mt -103.07 139.35 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.472 -0.768 . . . . 0.27 110.101 177.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.5 tttp -106.26 -20.05 13.51 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 120.571 -0.452 . . . . 2.11 111.676 -166.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -150.92 136.38 17.84 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 118.996 -1.082 . . . . 1.03 111.342 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.525 HD12 ' CD1' ' A' ' 14' ' ' LEU . 17.5 tt -133.6 143.42 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.829 -0.434 . . . . 0.26 109.829 177.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -146.71 136.93 23.6 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.624 -0.672 . . . . 2.91 110.297 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.0 t -87.46 144.4 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.562 -0.711 . . . . 1.54 109.777 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.46 HG11 ' HE3' ' A' ' 11' ' ' LYS . 55.4 t . . . . . 0 N--CA 1.497 1.893 0 O-C-N 121.672 -0.643 . . . . 0.98 109.74 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 N--CA 1.501 2.094 0 CA-C-O 121.003 0.43 . . . . 1.08 110.836 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.61 -1.95 84.25 Favored Glycine 0 N--CA 1.497 2.706 0 C-N-CA 120.708 -0.758 . . . . 0.45 111.798 176.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.3 m -63.29 145.11 56.23 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.039 -1.271 . . . . 0.35 110.445 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.46 ' HE3' HG11 ' A' ' 78' ' ' VAL . 30.9 pttt -82.18 125.15 30.57 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.73 -0.606 . . . . 1.62 110.269 176.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.619 ' CD1' HD13 ' A' ' 26' ' ' LEU . 87.1 mt -120.97 143.42 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.499 -0.751 . . . . 0.18 110.059 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.9 t -102.5 137.22 41.02 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.35 -0.611 . . . . 0.12 109.35 174.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.613 HD21 HD13 ' A' ' 72' ' ' ILE . 13.9 tp -133.8 127.1 31.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.673 -0.642 . . . . 0.17 110.268 -169.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.6 mt -107.05 118.19 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.55 -0.719 . . . . 0.13 109.732 -178.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m -93.08 157.82 16.1 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.022 0.439 . . . . 0.12 111.212 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -53.76 -13.91 0.81 Allowed 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 112.839 0.681 . . . . 2.52 112.839 -171.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.51 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -90.15 20.78 4.11 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.154 -0.966 . . . . 0.16 110.416 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 53.93 34.28 19.18 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.54 -0.725 . . . . 0.8 109.886 -174.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.833 HG12 HG22 ' A' ' 46' ' ' THR . 68.4 mt -102.59 141.88 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 109.128 -0.693 . . . . 0.23 109.128 178.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -104.74 119.87 40.02 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.999 -0.68 . . . . 2.34 109.927 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -114.28 149.53 35.79 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.086 -0.709 . . . . 0.15 109.086 174.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.651 ' O ' HG23 ' A' ' 41' ' ' VAL . 45.7 tt0 -140.52 140.53 35.26 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.498 -0.751 . . . . 1.44 109.628 175.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.68 173.37 43.3 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 119.801 -1.19 . . . . 0.06 110.541 -175.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -84.89 137.26 33.24 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.906 -0.761 . . . . 2.07 110.543 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.619 HD13 ' CD1' ' A' ' 12' ' ' ILE . 14.9 tp -66.09 117.66 8.73 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.589 -0.695 . . . . 0.24 110.6 175.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.454 ' O ' HG23 ' A' ' 28' ' ' THR . 31.1 t80 -100.05 -50.08 4.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.621 -0.675 . . . . 0.18 110.562 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 27' ' ' TYR . 14.8 p -154.44 156.95 37.71 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.696 -0.628 . . . . 0.1 110.293 -177.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.813 HG23 HG22 ' A' ' 36' ' ' ILE . 13.7 p -142.27 146.32 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.755 -0.591 . . . . 0.15 110.085 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -128.12 100.95 22.92 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.716 -0.615 . . . . 0.91 109.507 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.31 -42.02 30.75 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 O-C-N 123.652 1.343 . . . . 0.48 110.734 -174.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -80.77 -23.88 39.03 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.379 -0.825 . . . . 2.16 110.148 -171.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.68 ' O ' HG23 ' A' ' 35' ' ' THR . 74.9 mm-40 -87.33 1.11 54.26 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.525 -0.734 . . . . 1.59 111.294 173.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 37.2 m 49.78 38.52 15.82 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.079 -1.013 . . . . 0.74 111.195 -176.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.68 HG23 ' O ' ' A' ' 33' ' ' GLU . 17.0 p -135.77 155.44 50.36 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.405 -0.81 . . . . 0.14 110.399 -174.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.813 HG22 HG23 ' A' ' 29' ' ' VAL . 39.7 pt -142.1 162.0 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.715 -0.616 . . . . 0.15 110.06 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.516 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.14 128.42 30.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.61 -0.681 . . . . 0.09 109.722 176.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 26' ' ' LEU . 84.2 mt -109.81 146.35 35.18 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.579 -0.526 . . . . 0.14 109.579 -178.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.3 p -118.29 152.54 35.57 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.12 -0.696 . . . . 0.08 109.12 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.6 p 45.65 84.08 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 121.489 0.662 . . . . 0.07 110.238 -171.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.687 HG11 HD12 ' A' ' 65' ' ' ILE . 15.0 p -134.63 150.46 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 109.774 -0.454 . . . . 0.1 109.774 -178.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -135.72 153.23 51.65 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.697 -0.627 . . . . 2.7 109.967 178.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.8 p -106.57 139.21 41.38 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.686 -0.634 . . . . 0.24 109.788 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -82.74 -38.36 23.38 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.591 -0.693 . . . . 0.59 110.871 -173.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.63 170.48 32.48 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 120.024 -1.084 . . . . 0.51 110.447 177.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.833 HG22 HG12 ' A' ' 20' ' ' ILE . 1.4 p -118.08 6.58 12.09 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.952 -0.734 . . . . 1.13 110.737 174.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -48.94 -25.96 2.23 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.635 -0.666 . . . . 2.69 112.584 -166.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -64.87 -59.29 4.36 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.201 -0.937 . . . . 1.96 110.629 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 58.1 mtp85 -94.43 10.26 35.14 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.64 -0.662 . . . . 4.87 111.38 176.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.445 ' HB2' HD12 ' A' ' 55' ' ' ILE . 38.8 p-10 -59.74 174.02 0.51 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.237 -0.914 . . . . 2.14 111.466 -169.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.1 m -78.95 164.42 24.43 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.647 -0.501 . . . . 3.23 109.647 173.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -77.44 3.45 13.33 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.653 -0.654 . . . . 4.1 111.344 -178.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -97.5 154.21 17.65 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.203 -0.936 . . . . 4.1 109.691 171.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -68.08 137.34 54.91 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.582 -0.699 . . . . 3.57 110.607 -175.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.445 HD12 ' HB2' ' A' ' 50' ' ' ASP . 78.9 mt -117.1 136.56 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.638 -0.664 . . . . 2.27 109.507 176.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . . . -85.35 138.89 36.15 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.693 -0.629 . . . . 2.49 110.124 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 56' ' ' ALA . 17.3 Cg_exo -63.09 149.13 92.39 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 O-C-N 123.362 1.19 . . . . 2.03 110.543 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -96.49 115.0 26.71 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.641 -0.662 . . . . 2.72 110.097 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.9 m -85.66 -33.27 21.61 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.687 -0.633 . . . . 2.17 110.331 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -62.56 141.76 58.3 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.679 -0.638 . . . . 2.7 110.66 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.3 mm -96.86 147.36 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.761 -0.587 . . . . 0.5 109.719 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -93.93 114.98 27.3 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.614 -0.679 . . . . 0.73 110.192 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -51.12 -42.18 60.53 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.865 -0.522 . . . . 1.86 111.678 178.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.516 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.0 t80 -152.58 129.19 10.77 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.606 -0.684 . . . . 0.1 110.272 -174.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.687 HD12 HG11 ' A' ' 41' ' ' VAL . 78.3 mt -128.58 128.74 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.662 -0.649 . . . . 0.11 109.823 172.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.1 tp -90.79 137.08 32.64 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.893 -0.504 . . . . 0.17 109.932 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.538 ' CD1' HD11 ' A' ' 72' ' ' ILE . 3.2 m-85 -136.29 130.12 32.47 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.557 -0.714 . . . . 0.29 110.605 -175.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.7 mtm-85 -91.07 147.88 22.77 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.678 -0.639 . . . . 2.52 110.258 173.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.03 -26.46 61.02 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 110.558 -1.017 . . . . 0.13 110.558 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.3 m -65.7 -39.79 91.62 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.464 -1.021 . . . . 1.29 110.989 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.68 -32.95 31.52 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.395 -0.816 . . . . 1.09 110.859 -174.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.613 HD13 HD21 ' A' ' 14' ' ' LEU . 8.4 mt -103.07 139.35 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.472 -0.768 . . . . 0.27 110.101 177.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.5 tttp -106.26 -20.05 13.51 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 120.571 -0.452 . . . . 2.11 111.676 -166.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -150.92 136.38 17.84 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 118.996 -1.082 . . . . 1.03 111.342 -177.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.525 HD12 ' CD1' ' A' ' 14' ' ' LEU . 17.5 tt -133.6 143.42 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.829 -0.434 . . . . 0.26 109.829 177.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -146.71 136.93 23.6 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.624 -0.672 . . . . 2.91 110.297 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.0 t -87.46 144.4 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.562 -0.711 . . . . 1.54 109.777 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.46 HG11 ' HE3' ' A' ' 11' ' ' LYS . 55.4 t . . . . . 0 N--CA 1.497 1.893 0 O-C-N 121.672 -0.643 . . . . 0.98 109.74 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.2 mt . . . . . 0 N--CA 1.501 2.109 0 CA-C-O 120.95 0.405 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.76 -1.85 84.96 Favored Glycine 0 N--CA 1.496 2.66 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.722 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.8 m -61.38 143.21 56.18 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.101 -1.235 . . . . 0.0 110.413 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -82.2 128.95 34.67 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.692 -0.63 . . . . 0.0 110.494 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.716 ' CD1' HD13 ' A' ' 26' ' ' LEU . 86.1 mt -122.0 142.92 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.581 -0.699 . . . . 0.0 110.076 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.5 t -103.15 137.23 41.59 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 174.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.77 HD21 HD13 ' A' ' 72' ' ' ILE . 13.7 tp -134.78 125.4 26.84 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.673 -0.642 . . . . 0.0 110.301 -169.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 81.5 mt -107.09 117.97 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.538 -0.727 . . . . 0.0 109.696 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.2 m -92.65 157.77 16.3 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.059 0.457 . . . . 0.0 111.267 -177.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -54.07 -13.66 0.87 Allowed 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -171.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.53 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -90.1 20.73 4.12 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.163 -0.961 . . . . 0.0 110.416 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 54.13 34.28 19.73 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.481 -0.762 . . . . 0.0 109.836 -174.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.844 HG12 HG22 ' A' ' 46' ' ' THR . 65.0 mt -102.94 141.3 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 55.1 ttt85 -104.61 119.84 39.92 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.997 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -114.79 149.65 36.64 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.666 ' O ' HG23 ' A' ' 41' ' ' VAL . 42.1 tt0 -140.42 140.49 35.45 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.556 -0.715 . . . . 0.0 109.478 175.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.3 172.01 41.48 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.688 -1.244 . . . . 0.0 110.681 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.3 mmt85 -84.85 138.51 32.51 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.919 -0.753 . . . . 0.0 110.522 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.716 HD13 ' CD1' ' A' ' 12' ' ' ILE . 16.8 tp -66.16 118.27 9.65 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.565 -0.709 . . . . 0.0 110.669 175.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.463 ' O ' HG23 ' A' ' 28' ' ' THR . 23.9 t80 -100.51 -50.14 4.0 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.623 -0.673 . . . . 0.0 110.385 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 27' ' ' TYR . 12.8 p -154.3 153.58 31.91 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.741 -0.599 . . . . 0.0 110.263 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.885 HG23 HG22 ' A' ' 36' ' ' ILE . 13.4 p -142.3 145.45 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.729 -0.607 . . . . 0.0 110.052 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -128.94 100.9 20.3 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.669 -0.644 . . . . 0.0 109.554 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.51 -39.44 45.2 Favored 'Trans proline' 0 N--CA 1.489 1.24 0 O-C-N 123.533 1.281 . . . . 0.0 110.796 -175.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -80.6 -25.74 38.27 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.369 -0.832 . . . . 0.0 110.066 -171.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.562 ' O ' HG23 ' A' ' 35' ' ' THR . 79.1 mt-10 -87.41 1.49 53.23 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.555 -0.715 . . . . 0.0 111.22 173.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 38.6 m 49.61 38.68 15.49 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.091 -1.006 . . . . 0.0 111.343 -176.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 33' ' ' GLU . 9.9 p -136.3 153.36 51.19 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.348 -0.845 . . . . 0.0 110.286 -174.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.885 HG22 HG23 ' A' ' 29' ' ' VAL . 39.9 pt -142.74 162.0 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.676 -0.64 . . . . 0.0 110.252 178.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.52 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.46 127.61 28.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.657 -0.652 . . . . 0.0 109.704 175.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 26' ' ' LEU . 83.2 mt -109.94 146.77 34.64 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -177.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 96.0 p -118.13 153.42 33.83 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.7 p 45.65 85.01 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 121.476 0.655 . . . . 0.0 110.364 -172.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.711 HG11 HD12 ' A' ' 65' ' ' ILE . 14.5 p -134.53 150.41 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.95 -0.469 . . . . 0.0 109.753 -178.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -135.21 153.18 52.03 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.634 -0.666 . . . . 0.0 109.952 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 82.5 p -108.19 138.83 43.79 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.656 -0.652 . . . . 0.0 109.866 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -83.02 -38.29 22.79 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.654 -0.654 . . . . 0.0 110.859 -174.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.64 168.1 29.29 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.844 HG22 HG12 ' A' ' 20' ' ' ILE . 17.6 p -118.15 6.6 12.03 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.925 -0.75 . . . . 0.0 110.908 175.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -49.87 -25.27 3.01 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.563 -0.711 . . . . 0.0 112.781 -166.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -64.92 -59.34 4.29 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.134 -0.978 . . . . 0.0 110.671 -177.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.1 mtp180 -94.45 10.16 35.59 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.502 -0.749 . . . . 0.0 111.524 176.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.593 ' HB2' HD12 ' A' ' 55' ' ' ILE . 39.5 p-10 -58.63 174.06 0.36 Allowed 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.204 -0.935 . . . . 0.0 111.448 -170.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.0 m -78.85 164.42 24.5 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.935 -0.478 . . . . 0.0 109.759 175.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -77.55 4.89 10.13 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.642 -0.661 . . . . 0.0 111.289 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -95.84 166.03 12.0 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.226 -0.921 . . . . 0.0 109.591 168.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -80.74 132.1 35.5 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.607 -0.683 . . . . 0.0 110.488 -175.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.593 HD12 ' HB2' ' A' ' 50' ' ' ASP . 78.5 mt -114.27 134.35 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.715 -0.615 . . . . 0.0 109.443 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.38 146.01 38.88 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.629 -0.669 . . . . 0.0 110.154 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -63.07 149.37 91.72 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 O-C-N 123.399 1.21 . . . . 0.0 110.539 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -96.28 121.62 38.26 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.647 -0.658 . . . . 0.0 110.107 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.0 t -91.66 -32.55 15.42 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.708 -0.62 . . . . 0.0 110.356 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -62.59 140.49 58.66 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.641 -0.662 . . . . 0.0 110.569 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.9 mm -96.89 148.12 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.744 -0.597 . . . . 0.0 109.683 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -94.2 114.27 26.35 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.62 -0.675 . . . . 0.0 110.195 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -51.38 -42.42 61.37 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.754 -0.591 . . . . 0.0 111.585 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.52 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.8 t80 -152.87 129.88 11.06 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.665 -0.647 . . . . 0.0 110.219 -174.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.711 HD12 HG11 ' A' ' 41' ' ' VAL . 72.8 mt -128.87 129.06 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.701 -0.625 . . . . 0.0 109.87 172.184 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.0 tp -90.34 137.05 32.66 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.802 -0.561 . . . . 0.0 109.84 176.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.609 ' CD1' HD11 ' A' ' 72' ' ' ILE . 2.8 m-85 -134.55 128.2 32.82 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.699 -0.626 . . . . 0.0 110.563 -175.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -91.61 146.81 23.47 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.686 -0.634 . . . . 0.0 110.213 172.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.81 -26.55 60.57 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.1 t -65.36 -40.11 93.15 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.467 -1.019 . . . . 0.0 111.004 -177.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -81.55 -32.31 32.3 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.431 -0.793 . . . . 0.0 110.857 -174.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.77 HD13 HD21 ' A' ' 14' ' ' LEU . 6.9 mt -101.15 140.48 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.456 -0.778 . . . . 0.0 110.149 177.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -104.63 -20.34 13.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.938 -0.476 . . . . 0.0 111.492 -168.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -151.56 133.69 15.17 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.034 -1.041 . . . . 0.0 111.233 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.539 HD12 ' CD1' ' A' ' 14' ' ' LEU . 17.0 tt -131.87 143.81 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.908 -0.495 . . . . 0.0 109.756 176.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -145.76 130.16 17.74 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.597 -0.689 . . . . 0.0 110.257 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.45 HG22 HG12 ' A' ' 12' ' ' ILE . 51.4 t -88.36 143.55 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.684 -0.635 . . . . 0.0 109.781 179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.9 t . . . . . 0 N--CA 1.497 1.901 0 O-C-N 121.567 -0.708 . . . . 0.0 109.674 179.471 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.0 mt . . . . . 0 N--CA 1.502 2.129 0 CA-C-O 120.985 0.421 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.6 -1.85 84.54 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.871 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 75.0 m -61.44 146.08 49.62 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.07 -1.253 . . . . 0.0 110.479 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.602 ' HE3' HG11 ' A' ' 78' ' ' VAL . 28.1 pttt -81.97 126.41 31.91 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.718 -0.613 . . . . 0.0 110.485 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.418 HG12 HG22 ' A' ' 77' ' ' VAL . 88.5 mt -123.91 143.96 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.605 -0.684 . . . . 0.0 110.177 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.6 t -102.65 137.26 41.11 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 175.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.629 HD21 HD13 ' A' ' 72' ' ' ILE . 13.8 tp -133.23 128.4 35.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.708 -0.62 . . . . 0.0 110.318 -170.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.1 mt -108.22 119.61 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.464 -0.772 . . . . 0.0 109.698 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.1 m -93.9 157.61 16.04 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.114 0.483 . . . . 0.0 111.222 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -54.12 -13.56 0.86 Allowed 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -172.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.552 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.84 20.41 4.16 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.148 -0.97 . . . . 0.0 110.485 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 53.91 34.04 18.6 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.38 -0.825 . . . . 0.0 109.804 -174.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.781 HG12 HG22 ' A' ' 46' ' ' THR . 67.3 mt -102.2 141.82 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -105.37 119.85 40.11 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.007 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -114.74 148.72 37.94 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 174.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.672 ' O ' HG23 ' A' ' 41' ' ' VAL . 41.9 tt0 -140.09 140.51 36.1 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.476 -0.765 . . . . 0.0 109.603 175.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.92 173.52 42.22 Favored Glycine 0 N--CA 1.495 2.597 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.48 -175.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -84.73 136.5 33.69 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.889 -0.771 . . . . 0.0 110.501 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' A' ' 38' ' ' LEU . 27.7 tp -66.14 116.33 7.1 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.548 -0.72 . . . . 0.0 110.537 175.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.413 ' C ' HG23 ' A' ' 28' ' ' THR . 25.8 t80 -99.14 -49.99 4.3 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.677 -0.639 . . . . 0.0 110.364 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.413 HG23 ' C ' ' A' ' 27' ' ' TYR . 25.1 p -152.97 154.87 35.86 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.655 -0.653 . . . . 0.0 110.25 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.829 HG23 HG22 ' A' ' 36' ' ' ILE . 13.6 p -142.23 145.61 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.686 -0.634 . . . . 0.0 110.104 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -127.83 101.54 23.26 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.627 -0.671 . . . . 0.0 109.506 177.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.44 -41.82 30.94 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 O-C-N 123.626 1.329 . . . . 0.0 110.868 -174.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -80.59 -24.55 39.08 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.301 -0.874 . . . . 0.0 110.214 -171.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.609 ' O ' HG23 ' A' ' 35' ' ' THR . 54.6 mt-10 -87.42 1.13 54.29 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.412 -0.805 . . . . 0.0 111.235 173.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 39.6 m 49.75 39.26 17.43 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.153 -0.967 . . . . 0.0 111.243 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.609 HG23 ' O ' ' A' ' 33' ' ' GLU . 11.8 p -135.82 153.79 51.4 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.407 -0.808 . . . . 0.0 110.38 -174.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.829 HG22 HG23 ' A' ' 29' ' ' VAL . 39.9 pt -142.62 162.02 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.708 -0.62 . . . . 0.0 110.193 177.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.51 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -135.61 129.54 33.02 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.63 -0.669 . . . . 0.0 109.82 175.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 26' ' ' LEU . 50.6 mt -109.84 144.23 38.59 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -178.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 99.9 p -116.24 151.41 35.83 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.8 p 46.1 87.43 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 CA-C-O 121.462 0.648 . . . . 0.0 110.267 -172.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.76 HG11 HD12 ' A' ' 65' ' ' ILE . 12.3 p -134.62 147.79 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.968 -0.458 . . . . 0.0 109.837 -178.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -127.33 153.08 46.63 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.821 -0.549 . . . . 0.0 109.703 178.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.8 p -109.39 136.74 48.33 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.697 -0.627 . . . . 0.0 109.824 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -82.93 -38.19 23.13 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.624 -0.672 . . . . 0.0 110.847 -174.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.58 167.13 27.8 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 176.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.781 HG22 HG12 ' A' ' 20' ' ' ILE . 6.9 p -118.16 6.6 12.03 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.976 -0.72 . . . . 0.0 110.977 175.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -48.99 -25.46 1.98 Allowed 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.498 -0.752 . . . . 0.0 112.417 -169.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -64.4 -59.2 4.63 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.225 -0.922 . . . . 0.0 110.622 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -94.34 10.23 35.07 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.628 -0.67 . . . . 0.0 111.373 177.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -61.08 174.02 0.72 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.241 -0.912 . . . . 0.0 111.279 -170.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.715 ' OG1' HD11 ' A' ' 55' ' ' ILE . 39.9 p -78.88 164.5 24.41 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.914 -0.491 . . . . 0.0 109.917 175.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -77.52 3.89 12.47 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.004 176.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -97.34 165.28 12.1 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.181 -0.95 . . . . 0.0 109.621 167.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -68.51 142.47 55.26 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.524 -0.735 . . . . 0.0 110.388 -177.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.715 HD11 ' OG1' ' A' ' 51' ' ' THR . 49.9 mm -112.67 134.95 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.704 -0.622 . . . . 0.0 109.675 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -97.96 109.91 53.48 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.731 -0.606 . . . . 0.0 110.201 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -67.49 147.16 76.54 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 O-C-N 123.379 1.199 . . . . 0.0 110.409 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -96.54 119.77 35.63 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.721 -0.612 . . . . 0.0 110.222 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.6 p -68.26 -30.65 69.74 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.707 -0.62 . . . . 0.0 110.422 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -62.4 145.78 53.07 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.551 -0.718 . . . . 0.0 110.595 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.87 154.71 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.745 -0.597 . . . . 0.0 109.699 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -94.13 113.68 25.68 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.667 -0.645 . . . . 0.0 110.17 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -51.54 -40.52 59.83 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.753 -0.592 . . . . 0.0 111.765 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.51 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.4 t80 -153.38 130.84 11.37 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.669 -0.644 . . . . 0.0 110.177 -175.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.76 HD12 HG11 ' A' ' 41' ' ' VAL . 76.2 mt -129.75 128.22 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.725 -0.609 . . . . 0.0 109.791 172.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.6 tp -90.46 136.99 32.71 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.851 -0.53 . . . . 0.0 109.805 176.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.589 ' CD1' HD11 ' A' ' 72' ' ' ILE . 3.3 m-85 -135.81 130.62 34.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.661 -0.649 . . . . 0.0 110.58 -175.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -91.68 149.66 21.52 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.678 -0.639 . . . . 0.0 110.343 173.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.05 -24.55 60.86 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.0 t -66.81 -42.14 86.39 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.481 -1.011 . . . . 0.0 111.056 -175.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -82.77 -33.04 27.49 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.396 -0.815 . . . . 0.0 110.879 -175.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.629 HD13 HD21 ' A' ' 14' ' ' LEU . 13.8 mt -100.72 138.4 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.423 -0.798 . . . . 0.0 110.143 177.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 50.3 tptt -108.0 -19.12 13.61 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.789 -166.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -149.71 135.86 18.89 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 118.935 -1.106 . . . . 0.0 111.319 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.5 HD12 ' CD1' ' A' ' 14' ' ' LEU . 18.2 tt -134.08 144.47 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.868 -0.52 . . . . 0.0 109.886 177.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -146.1 133.28 20.47 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.608 -0.682 . . . . 0.0 110.288 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.418 HG22 HG12 ' A' ' 12' ' ' ILE . 51.2 t -87.67 145.35 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.681 -0.637 . . . . 0.0 109.736 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.602 HG11 ' HE3' ' A' ' 11' ' ' LYS . 56.1 t . . . . . 0 N--CA 1.498 1.952 0 O-C-N 121.641 -0.662 . . . . 0.0 109.748 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.9 mt . . . . . 0 N--CA 1.501 2.121 0 CA-C-O 120.948 0.404 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.63 -1.79 84.83 Favored Glycine 0 N--CA 1.496 2.685 0 C-N-CA 120.49 -0.862 . . . . 0.0 111.73 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 58.5 m -60.88 153.66 24.18 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.119 -1.224 . . . . 0.0 110.541 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -81.56 123.58 28.78 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.715 -0.616 . . . . 0.0 110.583 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 89.0 mt -120.81 145.27 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.508 -0.745 . . . . 0.0 110.066 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.0 t -102.54 137.31 40.94 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 175.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.707 HD21 HD13 ' A' ' 72' ' ' ILE . 13.8 tp -131.71 125.6 32.44 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.707 -0.621 . . . . 0.0 110.146 -170.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.3 mt -106.03 119.05 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.552 -0.718 . . . . 0.0 109.632 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.3 m -94.33 157.72 15.9 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.068 0.461 . . . . 0.0 111.227 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -53.43 -14.73 0.84 Allowed 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -172.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.551 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.32 20.3 3.89 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.097 -1.002 . . . . 0.0 110.463 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 54.0 34.08 18.93 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.478 -0.764 . . . . 0.0 109.796 -174.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.794 HG12 HG22 ' A' ' 46' ' ' THR . 68.5 mt -102.0 141.41 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 63.8 ttt-85 -105.5 119.81 40.05 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.887 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -114.15 150.01 34.81 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.665 ' O ' HG23 ' A' ' 41' ' ' VAL . 34.4 tt0 -140.68 140.46 34.95 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.42 -0.8 . . . . 0.0 109.647 175.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.6 172.97 43.23 Favored Glycine 0 N--CA 1.495 2.611 0 C-N-CA 119.716 -1.231 . . . . 0.0 110.538 -175.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -84.96 135.53 34.0 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.893 -0.769 . . . . 0.0 110.576 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.461 ' HA ' HD23 ' A' ' 38' ' ' LEU . 25.0 tp -66.1 117.93 9.13 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.542 -0.724 . . . . 0.0 110.595 175.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.443 ' O ' HG23 ' A' ' 28' ' ' THR . 25.9 t80 -99.52 -50.13 4.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.573 -0.704 . . . . 0.0 110.481 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 27' ' ' TYR . 16.0 p -153.93 156.48 37.59 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.734 -0.604 . . . . 0.0 110.32 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.846 HG23 HG22 ' A' ' 36' ' ' ILE . 13.3 p -142.32 145.86 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.708 -0.62 . . . . 0.0 110.034 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -128.25 99.14 24.97 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.659 -0.651 . . . . 0.0 109.55 177.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -59.5 -40.86 62.54 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 O-C-N 123.553 1.291 . . . . 0.0 110.937 -175.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -80.58 -25.76 38.3 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.338 -0.852 . . . . 0.0 110.181 -171.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.626 ' O ' HG23 ' A' ' 35' ' ' THR . 79.4 mt-10 -87.43 1.87 52.14 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.538 -0.726 . . . . 0.0 111.167 173.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.3 m 49.54 38.41 14.61 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.079 -1.013 . . . . 0.0 111.197 -176.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.626 HG23 ' O ' ' A' ' 33' ' ' GLU . 11.5 p -135.71 154.76 51.16 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.415 -0.803 . . . . 0.0 110.438 -174.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.846 HG22 HG23 ' A' ' 29' ' ' VAL . 40.4 pt -142.26 162.02 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.732 -0.605 . . . . 0.0 110.131 177.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.515 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -135.82 128.28 30.46 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.592 -0.693 . . . . 0.0 109.765 176.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 26' ' ' LEU . 86.3 mt -109.86 146.37 35.2 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -178.047 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.9 p -117.68 151.58 36.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.623 -0.673 . . . . 0.0 109.234 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 46.8 p 45.98 86.71 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 121.472 0.653 . . . . 0.0 110.291 -172.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.745 HG11 HD12 ' A' ' 65' ' ' ILE . 12.8 p -134.58 147.76 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.939 -0.476 . . . . 0.0 109.873 -178.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -126.19 153.06 45.17 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.732 -0.605 . . . . 0.0 109.798 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.3 p -108.79 134.39 51.55 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.665 -0.647 . . . . 0.0 109.794 177.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -83.02 -38.28 22.8 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.623 -0.673 . . . . 0.0 111.011 -173.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.66 168.74 30.25 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.993 -1.099 . . . . 0.0 110.54 176.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.794 HG22 HG12 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -118.14 6.61 12.04 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 122.008 -0.701 . . . . 0.0 110.997 175.021 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.3 tp10 -48.95 -25.95 2.23 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.546 -0.721 . . . . 0.0 112.455 -168.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -65.76 -59.21 4.13 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.335 -0.853 . . . . 0.0 110.421 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.9 mmp_? -94.19 10.14 35.09 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.68 -0.638 . . . . 0.0 111.319 177.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.413 ' HB2' HD12 ' A' ' 55' ' ' ILE . 39.9 p-10 -59.47 166.18 2.49 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.243 -0.91 . . . . 0.0 111.418 -170.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.0 m -78.95 164.44 24.42 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.949 -0.47 . . . . 0.0 109.765 174.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -77.56 4.12 12.01 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.616 -0.678 . . . . 0.0 111.268 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -96.81 158.35 15.47 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.174 -0.954 . . . . 0.0 109.632 167.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -70.77 140.15 51.23 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.489 -0.757 . . . . 0.0 110.375 -176.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.413 HD12 ' HB2' ' A' ' 50' ' ' ASP . 81.1 mt -115.28 134.9 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.664 -0.647 . . . . 0.0 109.616 177.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.05 109.92 53.69 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.736 -0.603 . . . . 0.0 110.133 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -66.61 146.54 79.63 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 O-C-N 123.343 1.18 . . . . 0.0 110.379 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -95.59 124.01 39.42 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.667 -0.645 . . . . 0.0 110.232 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.5 p -67.67 -29.35 68.61 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.675 -0.641 . . . . 0.0 110.492 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -62.02 145.93 51.67 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.55 -0.719 . . . . 0.0 110.538 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.91 156.24 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.749 -0.594 . . . . 0.0 109.747 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -93.65 115.14 27.58 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.669 -0.644 . . . . 0.0 110.087 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -51.25 -42.98 61.4 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.767 -0.583 . . . . 0.0 111.697 178.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.515 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.8 t80 -152.73 129.1 10.59 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.624 -0.673 . . . . 0.0 110.244 -174.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.745 HD12 HG11 ' A' ' 41' ' ' VAL . 75.4 mt -128.0 129.24 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.665 -0.647 . . . . 0.0 109.871 172.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.0 tp -90.32 137.04 32.67 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.802 -0.562 . . . . 0.0 109.797 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.614 ' CD1' HD11 ' A' ' 72' ' ' ILE . 2.8 m-85 -135.19 130.33 35.15 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.647 -0.658 . . . . 0.0 110.544 -175.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.1 mtm-85 -91.47 148.26 22.43 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.713 -0.617 . . . . 0.0 110.322 173.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.69 -24.03 59.37 Favored Glycine 0 N--CA 1.498 2.816 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 178.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.0 p -67.82 -42.11 82.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.361 -1.082 . . . . 0.0 111.089 -175.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -82.49 -32.41 28.8 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.398 -0.814 . . . . 0.0 110.894 -175.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.707 HD13 HD21 ' A' ' 14' ' ' LEU . 14.8 mt -99.56 141.48 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.333 -0.854 . . . . 0.0 110.18 176.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -106.15 -24.61 12.3 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 120.554 -0.459 . . . . 0.0 111.447 -166.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -150.8 136.19 17.84 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 119.037 -1.065 . . . . 0.0 111.471 -176.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.49 HD12 ' CD1' ' A' ' 14' ' ' LEU . 18.4 tt -131.83 137.77 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 176.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -143.94 143.33 31.2 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.634 -0.666 . . . . 0.0 110.191 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.4 m -84.87 147.02 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.638 -0.664 . . . . 0.0 110.246 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.5 t . . . . . 0 N--CA 1.497 1.89 0 O-C-N 121.569 -0.707 . . . . 0.0 109.89 -178.97 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 80.6 mt . . . . . 0 N--CA 1.501 2.079 0 CA-C-O 120.999 0.428 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.62 -1.83 84.66 Favored Glycine 0 N--CA 1.497 2.708 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.679 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 58.2 m -60.86 155.5 19.48 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.074 -1.251 . . . . 0.0 110.579 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.19 122.25 27.66 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.805 -0.559 . . . . 0.0 110.366 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 90.3 mt -119.96 144.38 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.515 -0.741 . . . . 0.0 110.114 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.7 t -102.83 137.24 41.3 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 175.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.675 HD21 HD13 ' A' ' 72' ' ' ILE . 14.2 tp -133.33 125.47 29.28 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.789 -0.569 . . . . 0.0 110.183 -169.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.1 mt -106.52 117.97 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.561 -0.712 . . . . 0.0 109.654 -178.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m -93.35 157.74 16.08 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.078 0.466 . . . . 0.0 111.239 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -53.89 -13.95 0.87 Allowed 'General case' 0 N--CA 1.507 2.392 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -171.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.519 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -90.18 20.91 4.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.169 -0.957 . . . . 0.0 110.444 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 54.15 34.42 20.08 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.486 -0.759 . . . . 0.0 109.882 -174.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.834 HG12 HG22 ' A' ' 46' ' ' THR . 66.1 mt -102.86 141.24 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -104.85 119.73 39.71 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.905 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -114.47 148.29 38.04 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 174.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.66 ' O ' HG23 ' A' ' 41' ' ' VAL . 41.0 tt0 -139.05 140.51 38.1 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.573 -0.704 . . . . 0.0 109.592 175.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.54 173.11 43.21 Favored Glycine 0 N--CA 1.496 2.659 0 C-N-CA 119.794 -1.193 . . . . 0.0 110.386 -175.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 -85.95 136.16 33.38 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.814 -0.815 . . . . 0.0 110.604 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.466 ' HA ' HD23 ' A' ' 38' ' ' LEU . 25.3 tp -66.13 119.5 11.55 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.62 -0.675 . . . . 0.0 110.675 176.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.437 ' O ' HG23 ' A' ' 28' ' ' THR . 22.6 t80 -100.11 -50.01 4.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.693 -0.629 . . . . 0.0 110.446 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 27' ' ' TYR . 16.5 p -153.77 154.36 33.88 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.622 -0.674 . . . . 0.0 110.384 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.895 HG23 HG22 ' A' ' 36' ' ' ILE . 13.4 p -142.28 146.1 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.696 -0.627 . . . . 0.0 110.09 -178.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -129.03 101.26 19.76 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.61 -0.681 . . . . 0.0 109.574 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.42 -41.08 35.27 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 O-C-N 123.628 1.33 . . . . 0.0 110.785 -174.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -80.61 -23.98 39.42 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.396 -0.815 . . . . 0.0 110.187 -172.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.73 ' O ' HG23 ' A' ' 35' ' ' THR . 13.3 mm-40 -87.37 0.88 54.8 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.492 -0.755 . . . . 0.0 111.14 173.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.3 m 49.81 38.14 15.02 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.139 -0.976 . . . . 0.0 111.205 -176.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.73 HG23 ' O ' ' A' ' 33' ' ' GLU . 21.5 p -136.68 152.94 50.95 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.352 -0.842 . . . . 0.0 110.405 -174.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.895 HG22 HG23 ' A' ' 29' ' ' VAL . 39.8 pt -142.75 162.02 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.714 -0.616 . . . . 0.0 110.164 178.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.519 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.22 128.34 29.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.593 -0.692 . . . . 0.0 109.786 175.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 26' ' ' LEU . 86.7 mt -109.96 148.13 32.18 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 95.1 p -120.26 152.8 37.26 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.628 -0.67 . . . . 0.0 109.214 -177.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 53.0 p 44.94 87.34 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 CA-C-O 121.392 0.615 . . . . 0.0 110.385 -172.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.742 HG11 HD12 ' A' ' 65' ' ' ILE . 11.2 p -134.59 145.18 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 CA-C-O 121.155 0.503 . . . . 0.0 110.005 -177.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.837 ' HG2' HD12 ' A' ' 61' ' ' ILE . 90.8 mtt180 -120.46 153.11 37.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.688 -0.633 . . . . 0.0 109.755 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 86.3 p -111.27 133.44 53.6 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.629 -0.669 . . . . 0.0 109.856 177.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -83.05 -38.49 22.48 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.052 -173.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.53 171.98 34.14 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.993 -1.099 . . . . 0.0 110.445 177.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.834 HG22 HG12 ' A' ' 20' ' ' ILE . 2.2 p -117.97 6.48 12.18 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.797 -0.826 . . . . 0.0 110.915 173.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -51.06 -24.1 3.61 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.507 -0.746 . . . . 0.0 112.795 -167.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.08 -59.44 4.13 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.193 -0.942 . . . . 0.0 110.706 -176.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -94.5 10.21 35.49 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.575 -0.703 . . . . 0.0 111.444 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.559 ' HB2' HD12 ' A' ' 55' ' ' ILE . 40.2 p-10 -58.76 174.04 0.37 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.189 -0.944 . . . . 0.0 111.419 -170.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.0 m -78.92 164.48 24.4 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.957 -0.464 . . . . 0.0 109.774 175.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -77.5 4.71 10.48 Favored 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.277 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -95.98 166.07 11.95 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.176 -0.952 . . . . 0.0 109.622 168.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -80.6 133.19 35.72 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.594 -0.691 . . . . 0.0 110.399 -175.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.559 HD12 ' HB2' ' A' ' 50' ' ' ASP . 78.6 mt -113.9 135.35 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.625 -0.672 . . . . 0.0 109.54 177.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.88 146.11 38.09 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.642 -0.661 . . . . 0.0 110.138 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -68.78 149.37 72.86 Favored 'Trans proline' 0 N--CA 1.487 1.104 0 O-C-N 123.55 1.289 . . . . 0.0 110.307 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -92.71 107.4 19.19 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.631 -0.668 . . . . 0.0 110.074 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.9 m -68.01 -35.72 78.77 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.699 -0.625 . . . . 0.0 110.345 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -60.99 133.47 56.13 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.658 -0.651 . . . . 0.0 110.809 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.837 HD12 ' HG2' ' A' ' 42' ' ' ARG . 45.7 mm -96.97 153.73 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.659 -0.651 . . . . 0.0 109.606 178.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -96.76 112.47 24.21 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.598 -0.689 . . . . 0.0 110.446 -175.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -51.67 -41.02 61.09 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.678 -0.639 . . . . 0.0 111.496 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.519 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.7 t80 -153.02 130.31 11.28 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.604 -0.685 . . . . 0.0 110.124 -175.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.742 HD12 HG11 ' A' ' 41' ' ' VAL . 77.4 mt -127.96 128.34 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.644 -0.66 . . . . 0.0 109.804 172.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.2 tp -90.29 137.04 32.67 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.867 -0.52 . . . . 0.0 109.753 175.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.551 ' CD1' HD11 ' A' ' 72' ' ' ILE . 3.0 m-85 -137.03 130.54 31.54 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.663 -0.648 . . . . 0.0 110.6 -174.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -91.57 147.81 22.74 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.705 -0.622 . . . . 0.0 110.301 173.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.11 -26.8 61.66 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.4 m -65.56 -39.39 91.62 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.453 -1.028 . . . . 0.0 110.944 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.69 -32.54 31.67 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.445 -0.785 . . . . 0.0 110.807 -174.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.675 HD13 HD21 ' A' ' 14' ' ' LEU . 8.1 mt -102.97 140.23 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.422 -0.799 . . . . 0.0 110.157 177.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -106.34 -19.7 13.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.961 -0.462 . . . . 0.0 111.647 -167.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -150.41 133.61 16.25 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 119.008 -1.077 . . . . 0.0 111.379 -178.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.525 HD12 ' CD1' ' A' ' 14' ' ' LEU . 17.3 tt -132.44 138.77 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.931 -0.48 . . . . 0.0 109.799 176.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.1 mtm180 -147.07 145.95 29.81 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.598 -0.688 . . . . 0.0 110.422 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.8 m -84.83 147.1 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.664 -0.647 . . . . 0.0 110.328 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.499 1.996 0 O-C-N 121.559 -0.713 . . . . 0.0 110.172 -178.358 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.0 mt . . . . . 0 N--CA 1.501 2.114 0 CA-C-O 120.993 0.425 . . . . 0.0 110.602 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.72 -1.94 84.58 Favored Glycine 0 N--CA 1.496 2.659 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.793 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 74.1 m -61.13 148.1 41.74 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.097 -1.237 . . . . 0.0 110.46 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -81.59 125.18 30.22 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.716 -0.615 . . . . 0.0 110.536 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.61 ' CD1' HD13 ' A' ' 26' ' ' LEU . 90.0 mt -120.91 145.05 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.555 -0.716 . . . . 0.0 110.014 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.6 t -102.93 137.19 41.45 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.778 HD21 HD13 ' A' ' 72' ' ' ILE . 13.5 tp -133.12 124.86 28.32 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.875 -0.515 . . . . 0.0 110.211 -169.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.3 mt -105.75 118.49 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.633 -0.667 . . . . 0.0 109.661 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.1 m -93.1 157.8 16.1 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.112 0.482 . . . . 0.0 111.235 -176.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -53.8 -14.2 0.89 Allowed 'General case' 0 N--CA 1.51 2.525 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -171.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.516 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.63 20.08 4.23 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.207 -0.933 . . . . 0.0 110.412 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 54.38 35.07 22.18 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.448 -0.782 . . . . 0.0 109.817 -175.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.838 HG12 HG22 ' A' ' 46' ' ' THR . 65.2 mt -103.23 144.27 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 59.5 ttm-85 -105.06 119.87 40.09 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.073 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -114.2 150.12 34.75 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 174.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.647 ' O ' HG23 ' A' ' 41' ' ' VAL . 41.8 tt0 -141.48 140.52 33.55 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.484 -0.76 . . . . 0.0 109.648 175.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -169.28 172.86 43.6 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 119.607 -1.282 . . . . 0.0 110.575 -175.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -85.23 136.28 33.58 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.878 -0.778 . . . . 0.0 110.609 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.61 HD13 ' CD1' ' A' ' 12' ' ' ILE . 15.0 tp -66.3 119.53 11.71 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.634 -0.666 . . . . 0.0 110.694 175.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.453 ' O ' HG23 ' A' ' 28' ' ' THR . 26.2 t80 -100.13 -50.18 4.05 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.549 -0.719 . . . . 0.0 110.419 178.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 27' ' ' TYR . 13.5 p -154.4 156.01 36.04 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.636 -0.665 . . . . 0.0 110.283 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.874 HG23 HG22 ' A' ' 36' ' ' ILE . 13.6 p -142.26 145.63 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.612 -0.68 . . . . 0.0 110.068 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -127.5 98.74 28.24 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.627 -0.671 . . . . 0.0 109.565 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -59.38 -42.05 52.58 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 O-C-N 123.597 1.314 . . . . 0.0 111.044 -175.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -80.74 -24.59 38.6 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.372 -0.83 . . . . 0.0 110.169 -171.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.57 ' O ' HG23 ' A' ' 35' ' ' THR . 74.8 mm-40 -87.12 1.15 53.9 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.509 -0.745 . . . . 0.0 111.245 173.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.4 m 49.82 37.91 14.53 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.122 -0.986 . . . . 0.0 111.203 -176.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 33' ' ' GLU . 9.9 p -136.13 154.38 51.0 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.405 -0.809 . . . . 0.0 110.368 -174.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.874 HG22 HG23 ' A' ' 29' ' ' VAL . 39.9 pt -142.51 162.09 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.706 -0.621 . . . . 0.0 110.166 178.036 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.516 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.54 128.07 28.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.698 -0.627 . . . . 0.0 109.752 175.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.477 HD23 ' HA ' ' A' ' 26' ' ' LEU . 90.6 mt -109.92 148.95 30.63 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -177.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 96.6 p -119.65 152.18 37.52 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.6 p 45.58 83.46 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.226 0 CA-C-O 121.54 0.686 . . . . 0.0 110.382 -172.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.702 ' CG1' HD12 ' A' ' 65' ' ' ILE . 14.9 p -134.59 150.48 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -136.07 153.21 51.4 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.598 -0.689 . . . . 0.0 110.063 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 81.7 p -107.25 137.52 45.15 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.74 -0.6 . . . . 0.0 109.56 177.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -82.76 -38.47 23.18 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.92 -172.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.38 167.37 27.96 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 175.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.838 HG22 HG12 ' A' ' 20' ' ' ILE . 38.3 p -118.28 6.24 11.92 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.807 -0.819 . . . . 0.0 110.913 172.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -52.71 -26.22 13.36 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.49 -0.756 . . . . 0.0 112.095 -167.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -66.22 -59.16 4.0 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.393 -0.817 . . . . 0.0 110.273 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -94.28 10.18 35.15 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.736 -0.602 . . . . 0.0 111.342 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 52.9 p-10 -57.68 174.06 0.26 Allowed 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.29 -0.881 . . . . 0.0 111.499 -171.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.5 m -79.0 164.55 24.29 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -77.44 3.24 13.84 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.584 -0.698 . . . . 0.0 111.227 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -100.46 165.99 11.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.225 -0.922 . . . . 0.0 109.567 169.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -66.98 136.83 55.93 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.579 -0.7 . . . . 0.0 110.515 -175.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.2 mm -113.52 137.26 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.679 -0.638 . . . . 0.0 109.604 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -96.83 109.94 51.13 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.664 -0.648 . . . . 0.0 110.21 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -67.49 145.06 69.48 Favored 'Trans proline' 0 N--CA 1.488 1.16 0 O-C-N 123.395 1.208 . . . . 0.0 110.288 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -97.36 114.42 26.22 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.648 -0.657 . . . . 0.0 110.265 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 87.3 p -77.51 -29.18 52.34 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.655 -0.653 . . . . 0.0 110.478 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -62.13 151.24 36.31 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.601 -0.687 . . . . 0.0 110.669 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.5 mm -96.75 144.92 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.751 -0.593 . . . . 0.0 109.747 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -94.32 114.59 26.68 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.56 -0.712 . . . . 0.0 110.218 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -50.95 -40.51 57.64 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.824 -0.547 . . . . 0.0 111.812 178.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.516 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.8 t80 -152.57 130.12 11.47 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.714 -0.616 . . . . 0.0 110.289 -174.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.702 HD12 ' CG1' ' A' ' 41' ' ' VAL . 76.3 mt -130.09 129.53 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.641 -0.662 . . . . 0.0 109.793 172.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.2 tp -90.27 137.02 32.69 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.814 -0.554 . . . . 0.0 109.864 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.592 ' CD1' HD11 ' A' ' 72' ' ' ILE . 2.5 m-85 -135.17 129.28 33.56 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.658 -0.651 . . . . 0.0 110.562 -175.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 71.2 mtp85 -91.26 146.77 23.54 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.703 -0.623 . . . . 0.0 110.249 173.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.8 -26.52 60.49 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 110.539 -1.025 . . . . 0.0 110.539 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.2 m -65.84 -39.4 90.76 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.527 -0.984 . . . . 0.0 110.953 -177.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.67 -31.71 32.12 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.533 -0.73 . . . . 0.0 110.824 -174.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.778 HD13 HD21 ' A' ' 14' ' ' LEU . 7.9 mt -102.32 142.42 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.443 -0.786 . . . . 0.0 110.191 177.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -104.46 -23.67 13.13 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.378 -167.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -151.99 135.34 15.98 Favored 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 119.146 -1.022 . . . . 0.0 111.446 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.538 HD12 ' CD1' ' A' ' 14' ' ' LEU . 17.6 tt -131.81 140.8 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.906 -0.496 . . . . 0.0 109.775 176.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -146.91 141.56 26.66 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.519 -0.738 . . . . 0.0 110.349 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.5 t -86.85 145.75 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.679 -0.638 . . . . 0.0 109.711 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.3 t . . . . . 0 N--CA 1.497 1.904 0 O-C-N 121.583 -0.698 . . . . 0.0 109.758 -178.676 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.1 mt . . . . . 0 N--CA 1.5 2.068 0 CA-C-O 120.972 0.415 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.68 -1.92 84.55 Favored Glycine 0 N--CA 1.497 2.753 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.788 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 63.8 m -62.0 155.27 24.26 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.168 -1.195 . . . . 0.0 110.4 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.547 ' HE3' HG11 ' A' ' 78' ' ' VAL . 35.8 pttt -81.21 127.98 33.28 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 120.191 -0.604 . . . . 0.0 110.384 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.686 ' CD1' HD13 ' A' ' 26' ' ' LEU . 87.7 mt -121.62 142.95 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.563 -0.711 . . . . 0.0 110.03 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.0 t -102.99 137.29 41.38 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 175.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.885 HD21 HD13 ' A' ' 72' ' ' ILE . 13.9 tp -134.33 123.88 24.9 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.736 -0.602 . . . . 0.0 110.164 -169.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.5 mt -106.33 118.16 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.574 -0.704 . . . . 0.0 109.609 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 62.3 m -92.47 157.81 16.37 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 120.963 0.411 . . . . 0.0 111.245 -176.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -53.56 -13.98 0.75 Allowed 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 -172.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.571 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.96 20.58 4.13 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.115 -0.991 . . . . 0.0 110.412 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 53.43 34.37 18.02 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.395 -0.816 . . . . 0.0 109.813 -174.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.778 HG12 HG22 ' A' ' 46' ' ' THR . 73.1 mt -101.24 141.99 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -104.68 119.86 39.98 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.958 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -115.0 149.28 37.67 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 174.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.664 ' O ' HG23 ' A' ' 41' ' ' VAL . 71.2 mt-10 -140.95 140.52 34.44 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.377 -0.827 . . . . 0.0 109.706 174.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.35 172.17 41.56 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 119.814 -1.184 . . . . 0.0 110.559 -175.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -84.7 139.41 32.03 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.933 -0.745 . . . . 0.0 110.611 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.686 HD13 ' CD1' ' A' ' 12' ' ' ILE . 16.0 tp -66.11 117.9 9.09 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.718 -0.614 . . . . 0.0 110.7 175.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.446 ' O ' HG23 ' A' ' 28' ' ' THR . 21.8 t80 -100.11 -50.06 4.1 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.561 -0.712 . . . . 0.0 110.333 177.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 27' ' ' TYR . 16.9 p -153.81 156.05 36.94 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.684 -0.635 . . . . 0.0 110.271 -178.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.593 HG23 HG22 ' A' ' 36' ' ' ILE . 10.5 p -142.24 145.28 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.74 -0.6 . . . . 0.0 110.18 -178.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -129.03 101.88 19.38 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.675 -0.641 . . . . 0.0 109.434 176.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.83 -41.78 28.35 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 O-C-N 123.562 1.296 . . . . 0.0 110.919 -173.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -80.66 -24.97 38.57 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.332 -0.855 . . . . 0.0 110.227 -170.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.756 ' O ' HG23 ' A' ' 35' ' ' THR . 56.7 mt-10 -87.79 1.75 53.07 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.484 -0.76 . . . . 0.0 111.293 173.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 40.3 m 49.87 41.1 22.14 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.125 -0.984 . . . . 0.0 111.218 -176.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.756 HG23 ' O ' ' A' ' 33' ' ' GLU . 23.5 p -135.5 153.45 51.73 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.327 -0.858 . . . . 0.0 110.53 -174.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.593 HG22 HG23 ' A' ' 29' ' ' VAL . 40.4 pt -141.74 162.0 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.66 -0.65 . . . . 0.0 110.117 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.509 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.01 127.87 29.31 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.719 -0.613 . . . . 0.0 109.669 175.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 26' ' ' LEU . 51.5 mt -109.87 145.07 37.44 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 99.2 p -116.47 151.82 35.3 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.8 p 45.92 85.47 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 121.5 0.667 . . . . 0.0 110.356 -171.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.687 HG11 HD12 ' A' ' 65' ' ' ILE . 12.9 p -134.65 149.1 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -131.68 153.01 50.44 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.623 -0.673 . . . . 0.0 109.891 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 96.9 p -112.01 140.64 46.52 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.741 -0.599 . . . . 0.0 109.891 177.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -83.06 -38.5 22.44 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.613 -0.679 . . . . 0.0 111.175 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.58 171.91 34.1 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.993 -1.098 . . . . 0.0 110.417 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.778 HG22 HG12 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -118.16 6.5 12.02 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.829 -0.807 . . . . 0.0 110.884 173.56 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -50.3 -25.53 3.85 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.508 -0.745 . . . . 0.0 112.446 -168.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -66.06 -59.26 3.97 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.365 -0.834 . . . . 0.0 110.382 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -94.31 10.19 35.16 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.618 -0.676 . . . . 0.0 111.391 177.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 50.5 p-10 -58.15 171.98 0.49 Allowed 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.212 -0.93 . . . . 0.0 111.362 -171.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.7 m -78.98 164.41 24.41 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.908 -0.495 . . . . 0.0 109.873 176.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -77.6 4.22 11.88 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.662 -0.649 . . . . 0.0 111.198 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -95.54 164.75 12.66 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.25 -0.906 . . . . 0.0 109.608 167.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -68.55 135.38 51.44 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.507 -0.746 . . . . 0.0 110.453 -176.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.6 mm -114.17 134.39 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.734 -0.604 . . . . 0.0 109.615 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -96.22 109.88 49.49 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.703 -0.623 . . . . 0.0 110.181 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -67.33 135.02 35.34 Favored 'Trans proline' 0 N--CA 1.488 1.154 0 O-C-N 123.414 1.218 . . . . 0.0 110.308 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 18.8 mp0 -111.63 135.07 52.71 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.671 -0.643 . . . . 0.0 110.168 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 83.1 p -91.48 6.87 43.87 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.655 -0.653 . . . . 0.0 111.2 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -63.1 141.04 58.91 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.217 -0.927 . . . . 0.0 110.438 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.8 mm -96.86 137.7 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.655 -0.653 . . . . 0.0 109.844 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -94.14 119.03 32.39 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.715 -0.616 . . . . 0.0 110.177 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -51.35 -42.61 61.43 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.789 -0.569 . . . . 0.0 111.745 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.509 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.1 t80 -152.27 130.3 11.84 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.587 -0.695 . . . . 0.0 110.293 -174.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.687 HD12 HG11 ' A' ' 41' ' ' VAL . 75.2 mt -130.26 130.3 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.728 -0.608 . . . . 0.0 109.877 171.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 19.0 tp -90.25 137.01 32.69 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.823 -0.548 . . . . 0.0 109.934 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.647 ' CD1' HD11 ' A' ' 72' ' ' ILE . 2.3 m-85 -133.4 127.09 32.68 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.627 -0.67 . . . . 0.0 110.477 -176.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -92.12 145.98 24.08 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.592 -0.692 . . . . 0.0 110.31 173.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.88 -26.67 60.92 Favored Glycine 0 N--CA 1.499 2.843 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.2 m -65.02 -39.94 94.14 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.408 -1.054 . . . . 0.0 110.977 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.77 -32.24 31.51 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.445 -0.784 . . . . 0.0 110.826 -175.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.885 HD13 HD21 ' A' ' 14' ' ' LEU . 6.6 mt -99.34 141.75 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.53 -0.731 . . . . 0.0 110.264 177.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -104.35 -20.78 13.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.938 -0.476 . . . . 0.0 111.377 -169.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -151.79 131.95 13.56 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.238 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.536 HD12 ' CD1' ' A' ' 14' ' ' LEU . 17.1 tt -130.91 140.48 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.872 -0.517 . . . . 0.0 109.737 176.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -146.47 130.28 17.12 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.62 -0.675 . . . . 0.0 110.306 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.5 p -87.74 146.29 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.613 -0.679 . . . . 0.0 110.27 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.547 HG11 ' HE3' ' A' ' 11' ' ' LYS . 61.6 t . . . . . 0 N--CA 1.497 1.882 0 O-C-N 121.572 -0.705 . . . . 0.0 109.738 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 N--CA 1.501 2.114 0 CA-C-O 120.945 0.402 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.68 -1.92 84.53 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.841 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.6 m -61.72 142.22 57.37 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.113 -1.228 . . . . 0.0 110.457 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -82.36 123.38 29.04 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.748 -0.595 . . . . 0.0 110.559 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.621 ' CD1' HD13 ' A' ' 26' ' ' LEU . 91.0 mt -120.25 144.18 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.472 -0.768 . . . . 0.0 110.199 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.4 t -103.11 137.27 41.5 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 174.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.475 ' CD1' HD12 ' A' ' 75' ' ' ILE . 13.1 tp -133.49 127.84 34.11 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.712 -0.618 . . . . 0.0 110.339 -169.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.0 mt -107.59 119.98 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.593 -0.692 . . . . 0.0 109.738 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.3 m -94.35 157.81 15.86 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.049 0.452 . . . . 0.0 111.248 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.0 tptp -53.51 -15.18 1.0 Allowed 'General case' 0 N--CA 1.509 2.5 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -172.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.534 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.75 21.32 3.59 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.13 -0.982 . . . . 0.0 110.436 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 54.16 33.98 19.14 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.44 -0.788 . . . . 0.0 109.795 -174.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.804 HG12 HG22 ' A' ' 46' ' ' THR . 69.2 mt -101.81 142.72 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 36.7 ttp85 -105.19 119.8 39.94 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.941 -0.704 . . . . 0.0 109.887 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -113.79 149.24 35.21 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.662 ' O ' HG23 ' A' ' 41' ' ' VAL . 42.6 tt0 -140.61 140.53 35.09 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.546 -0.721 . . . . 0.0 109.696 176.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -169.13 173.24 43.57 Favored Glycine 0 N--CA 1.495 2.603 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.463 -175.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -85.11 136.44 33.55 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.881 -0.776 . . . . 0.0 110.495 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.621 HD13 ' CD1' ' A' ' 12' ' ' ILE . 15.3 tp -66.12 119.04 10.74 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.57 -0.706 . . . . 0.0 110.693 175.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.448 ' O ' HG23 ' A' ' 28' ' ' THR . 25.9 t80 -99.4 -50.09 4.22 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.666 -0.646 . . . . 0.0 110.292 178.05 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 27' ' ' TYR . 15.2 p -153.9 153.29 31.79 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.78 -0.575 . . . . 0.0 110.255 -178.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.882 HG23 HG22 ' A' ' 36' ' ' ILE . 13.5 p -142.31 144.86 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.643 -0.661 . . . . 0.0 110.102 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -128.99 101.53 19.68 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.531 -0.73 . . . . 0.0 109.528 177.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.68 -40.25 38.33 Favored 'Trans proline' 0 N--CA 1.489 1.243 0 O-C-N 123.515 1.271 . . . . 0.0 110.719 -175.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -80.68 -25.18 38.39 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.306 -0.871 . . . . 0.0 110.174 -171.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.723 ' O ' HG23 ' A' ' 35' ' ' THR . 79.2 mt-10 -87.44 1.46 53.36 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.516 -0.74 . . . . 0.0 111.256 173.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.0 m 49.84 39.51 18.38 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.105 -0.997 . . . . 0.0 111.284 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.723 HG23 ' O ' ' A' ' 33' ' ' GLU . 22.7 p -136.65 151.98 49.9 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.365 -0.834 . . . . 0.0 110.368 -175.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.882 HG22 HG23 ' A' ' 29' ' ' VAL . 39.7 pt -142.6 161.47 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.695 -0.628 . . . . 0.0 110.179 177.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.508 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.86 127.91 27.75 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.628 -0.67 . . . . 0.0 109.678 175.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 26' ' ' LEU . 85.6 mt -109.87 146.98 34.19 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -177.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 96.7 p -118.7 153.06 34.99 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -177.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.7 p 45.75 85.9 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 121.452 0.644 . . . . 0.0 110.318 -172.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.783 HG11 HD12 ' A' ' 65' ' ' ILE . 13.3 p -134.51 148.61 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.952 -0.468 . . . . 0.0 109.909 -177.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -126.41 153.12 45.43 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.699 -0.626 . . . . 0.0 109.829 177.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 96.6 p -108.24 134.93 50.39 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.703 -0.623 . . . . 0.0 109.726 175.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -83.01 -38.37 22.7 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.57 -0.706 . . . . 0.0 111.045 -173.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.61 169.29 30.96 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 120.027 -1.083 . . . . 0.0 110.602 176.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.804 HG22 HG12 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -118.19 6.58 12.0 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.97 -0.724 . . . . 0.0 110.837 174.309 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -49.16 -25.64 2.32 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.6 -0.688 . . . . 0.0 112.62 -168.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -65.04 -59.22 4.37 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.321 -0.862 . . . . 0.0 110.587 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -94.31 10.14 35.35 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.569 -0.707 . . . . 0.0 111.381 177.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.46 ' HB2' HD12 ' A' ' 55' ' ' ILE . 39.9 p-10 -59.44 165.86 2.61 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.251 -0.906 . . . . 0.0 111.438 -170.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.3 m -78.98 164.46 24.38 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.925 -0.484 . . . . 0.0 109.748 174.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -77.55 4.22 11.76 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.607 -0.683 . . . . 0.0 111.263 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -96.78 155.32 16.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.156 -0.965 . . . . 0.0 109.623 167.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -68.77 139.8 55.31 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.649 -0.657 . . . . 0.0 110.387 -175.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.46 HD12 ' HB2' ' A' ' 50' ' ' ASP . 81.5 mt -116.38 138.41 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.674 -0.641 . . . . 0.0 109.612 177.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -97.98 109.98 53.81 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.733 -0.605 . . . . 0.0 110.223 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -66.14 149.64 85.51 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 O-C-N 123.357 1.188 . . . . 0.0 110.335 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -93.22 112.64 24.64 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.667 -0.646 . . . . 0.0 110.301 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.7 t -67.18 -29.4 69.07 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.668 -0.645 . . . . 0.0 110.463 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -60.98 159.29 11.73 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.544 -0.723 . . . . 0.0 110.759 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.81 146.72 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.843 -0.536 . . . . 0.0 109.748 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -91.72 111.85 23.54 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.659 -0.651 . . . . 0.0 109.894 176.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -52.35 -43.21 64.5 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.786 -0.571 . . . . 0.0 111.707 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.508 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.7 t80 -154.55 130.28 10.02 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.742 -0.599 . . . . 0.0 110.264 -174.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.783 HD12 HG11 ' A' ' 41' ' ' VAL . 82.9 mt -129.07 127.44 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.663 -0.648 . . . . 0.0 109.989 171.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 24.0 tp -90.79 137.03 32.68 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.867 -0.521 . . . . 0.0 109.859 175.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.515 ' CZ ' HG21 ' A' ' 65' ' ' ILE . 4.5 m-85 -136.95 131.59 33.22 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.685 -0.634 . . . . 0.0 110.65 -175.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -91.78 151.57 20.55 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.736 -0.602 . . . . 0.0 110.452 174.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.96 -23.98 59.94 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.2 p -67.52 -41.99 83.51 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.45 -1.03 . . . . 0.0 111.032 -176.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -83.13 -32.87 26.45 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.354 -0.842 . . . . 0.0 110.914 -175.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.44 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 22.2 mt -105.94 136.25 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.459 -0.775 . . . . 0.0 110.013 177.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 59.4 tttt -109.1 -14.34 14.54 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 120.417 -0.513 . . . . 0.0 112.008 -165.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -147.88 131.41 16.75 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 118.901 -1.12 . . . . 0.0 111.433 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.475 HD12 ' CD1' ' A' ' 14' ' ' LEU . 15.8 tt -132.38 137.48 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.936 -0.478 . . . . 0.0 109.77 176.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.0 mtm180 -147.04 147.1 30.31 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.606 -0.684 . . . . 0.0 110.387 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.9 t -85.96 145.04 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.679 -0.638 . . . . 0.0 109.601 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.2 t . . . . . 0 N--CA 1.497 1.922 0 O-C-N 121.601 -0.687 . . . . 0.0 109.898 -177.194 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.5 mt . . . . . 0 N--CA 1.502 2.133 0 CA-C-O 120.999 0.428 . . . . 0.0 110.71 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.65 -1.97 84.29 Favored Glycine 0 N--CA 1.497 2.713 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.837 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.9 m -62.06 148.21 44.85 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.125 -1.221 . . . . 0.0 110.49 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -81.87 124.53 29.79 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.662 -0.649 . . . . 0.0 110.401 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.609 ' CD1' HD13 ' A' ' 26' ' ' LEU . 88.8 mt -120.64 144.54 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.565 -0.71 . . . . 0.0 110.122 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.6 t -102.91 137.33 41.25 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.766 HD21 HD13 ' A' ' 72' ' ' ILE . 13.6 tp -132.79 125.64 30.55 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.711 -0.618 . . . . 0.0 110.219 -169.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.0 mt -106.94 118.6 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.447 -0.783 . . . . 0.0 109.661 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.9 m -93.77 157.65 16.05 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 120.997 0.427 . . . . 0.0 111.3 -177.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -55.68 -11.17 0.85 Allowed 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -172.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.72 18.48 4.67 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.196 -0.94 . . . . 0.0 110.439 176.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 55.64 36.06 26.46 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.442 -0.786 . . . . 0.0 109.918 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.812 HG12 HG22 ' A' ' 46' ' ' THR . 57.6 mt -106.96 145.0 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -105.62 119.81 40.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.618 -0.676 . . . . 0.0 110.123 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -113.81 152.12 31.09 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.659 ' O ' HG23 ' A' ' 41' ' ' VAL . 46.4 tt0 -142.27 140.57 32.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.429 -0.795 . . . . 0.0 109.672 175.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.87 172.21 42.55 Favored Glycine 0 N--CA 1.496 2.634 0 C-N-CA 119.713 -1.232 . . . . 0.0 110.558 -175.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -85.08 136.16 33.68 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.864 -0.786 . . . . 0.0 110.517 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.609 HD13 ' CD1' ' A' ' 12' ' ' ILE . 15.1 tp -66.16 117.8 8.98 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.623 -0.673 . . . . 0.0 110.664 175.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.454 ' O ' HG23 ' A' ' 28' ' ' THR . 25.9 t80 -99.95 -50.1 4.11 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.657 -0.652 . . . . 0.0 110.455 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 27' ' ' TYR . 14.1 p -154.35 156.06 36.2 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.736 -0.603 . . . . 0.0 110.348 -178.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.828 HG23 HG22 ' A' ' 36' ' ' ILE . 13.3 p -142.31 146.25 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.771 -0.58 . . . . 0.0 110.007 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -128.48 100.8 21.97 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.582 -0.699 . . . . 0.0 109.536 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.59 -40.16 39.67 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 O-C-N 123.558 1.294 . . . . 0.0 110.71 -174.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -80.63 -25.27 38.47 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.365 -0.834 . . . . 0.0 110.202 -171.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.566 ' O ' HG23 ' A' ' 35' ' ' THR . 78.7 mt-10 -87.47 1.3 53.85 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.498 -0.751 . . . . 0.0 111.258 173.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 45.2 m 49.6 39.19 16.66 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.089 -1.007 . . . . 0.0 111.303 -176.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 33' ' ' GLU . 10.0 p -136.07 155.35 50.34 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.393 -0.817 . . . . 0.0 110.315 -174.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.828 HG22 HG23 ' A' ' 29' ' ' VAL . 39.8 pt -142.27 162.03 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.616 -0.677 . . . . 0.0 110.17 177.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.525 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.4 127.68 28.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.669 -0.644 . . . . 0.0 109.692 175.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' A' ' 26' ' ' LEU . 87.2 mt -109.87 147.12 33.94 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -178.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 96.8 p -118.22 152.43 35.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.674 -0.642 . . . . 0.0 109.27 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.3 p 45.5 84.79 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 CA-C-O 121.476 0.655 . . . . 0.0 110.358 -172.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.664 HG11 HD12 ' A' ' 65' ' ' ILE . 13.7 p -134.54 149.02 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.905 -0.497 . . . . 0.0 109.853 -178.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.4 ttm180 -131.71 153.05 50.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.68 -0.637 . . . . 0.0 109.799 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 85.1 p -107.93 133.89 51.63 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.741 -0.599 . . . . 0.0 109.476 175.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -82.68 -38.63 23.15 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.039 -171.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.23 167.08 27.38 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 175.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.812 HG22 HG12 ' A' ' 20' ' ' ILE . 53.0 p -118.23 -11.2 10.13 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.963 -0.728 . . . . 0.0 110.83 170.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -52.74 -24.99 9.81 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.462 -0.774 . . . . 0.0 112.492 -166.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -79.12 -59.3 2.83 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.261 -0.899 . . . . 0.0 110.894 -176.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -94.42 9.93 36.41 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.596 -0.69 . . . . 0.0 112.006 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -90.16 174.56 7.55 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.085 -1.009 . . . . 0.0 111.126 -175.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.0 m -78.43 164.66 24.58 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 122.016 -0.428 . . . . 0.0 109.854 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -77.45 12.07 1.72 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.726 -0.609 . . . . 0.0 111.616 -173.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -92.49 140.54 29.46 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.241 -0.912 . . . . 0.0 109.62 169.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -65.97 141.03 58.34 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.713 -0.617 . . . . 0.0 110.919 -170.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 82.5 mt -118.83 138.81 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.731 -0.606 . . . . 0.0 109.399 176.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.62 113.43 14.23 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.617 -0.677 . . . . 0.0 110.125 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -64.18 142.65 81.15 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 O-C-N 123.305 1.161 . . . . 0.0 110.465 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -104.02 107.11 17.85 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.713 -0.617 . . . . 0.0 110.27 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.6 p -93.4 -32.72 14.13 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.685 -0.634 . . . . 0.0 110.327 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -62.8 152.64 35.4 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.619 -0.675 . . . . 0.0 110.655 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.4 mm -96.8 141.08 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.705 -0.622 . . . . 0.0 109.592 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -96.36 113.16 24.72 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.64 -0.663 . . . . 0.0 110.37 -177.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -51.19 -39.93 57.55 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.738 -0.601 . . . . 0.0 111.416 175.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.525 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.7 t80 -152.73 129.19 10.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.627 -0.671 . . . . 0.0 110.201 -175.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.664 HD12 HG11 ' A' ' 41' ' ' VAL . 72.6 mt -127.55 129.14 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.566 -0.709 . . . . 0.0 109.798 172.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.9 tp -90.18 137.05 32.67 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.859 -0.526 . . . . 0.0 109.808 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.589 ' CD1' HD11 ' A' ' 72' ' ' ILE . 2.6 m-85 -135.56 129.21 32.62 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.751 -0.593 . . . . 0.0 110.559 -175.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -91.07 146.62 23.69 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.715 -0.615 . . . . 0.0 110.176 173.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.58 -25.86 58.94 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.1 p -67.75 -37.61 82.38 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.459 -1.024 . . . . 0.0 110.875 -177.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -82.46 -30.5 29.94 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.454 -0.779 . . . . 0.0 110.934 -175.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.766 HD13 HD21 ' A' ' 14' ' ' LEU . 8.6 mt -103.95 142.87 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.426 -0.796 . . . . 0.0 110.278 176.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -104.63 -24.73 12.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.932 -0.48 . . . . 0.0 111.381 -167.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -151.88 136.24 16.79 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.048 -1.033 . . . . 0.0 111.465 -177.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.53 HD12 ' CD1' ' A' ' 14' ' ' LEU . 17.7 tt -131.79 140.51 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.963 -0.461 . . . . 0.0 109.828 176.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -146.87 140.77 25.96 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.544 -0.723 . . . . 0.0 110.335 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.0 p -86.04 147.05 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.669 -0.644 . . . . 0.0 110.107 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.0 t . . . . . 0 N--CA 1.497 1.907 0 O-C-N 121.578 -0.701 . . . . 0.0 109.868 -178.79 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.6 mt . . . . . 0 N--CA 1.501 2.087 0 CA-C-O 121.001 0.429 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.57 -1.9 84.31 Favored Glycine 0 N--CA 1.496 2.663 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.85 176.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.4 m -62.71 138.94 58.63 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.126 -1.22 . . . . 0.0 110.355 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -82.13 126.98 32.67 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.624 -0.673 . . . . 0.0 110.415 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.679 ' CD1' HD13 ' A' ' 26' ' ' LEU . 86.5 mt -120.97 143.36 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.614 -0.679 . . . . 0.0 110.142 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.0 t -103.18 137.32 41.49 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.762 HD21 HD13 ' A' ' 72' ' ' ILE . 14.0 tp -134.8 125.9 27.8 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.687 -0.633 . . . . 0.0 110.337 -168.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.3 mt -106.85 118.11 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.614 -0.679 . . . . 0.0 109.665 -178.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.6 m -92.86 157.89 16.14 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 120.97 0.414 . . . . 0.0 111.303 -176.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -53.75 -14.43 0.93 Allowed 'General case' 0 N--CA 1.508 2.453 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -171.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.14 20.22 3.82 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.169 -0.957 . . . . 0.0 110.519 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 56.03 36.08 26.72 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.463 -0.773 . . . . 0.0 109.916 -177.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.788 HG12 HG22 ' A' ' 46' ' ' THR . 53.6 mt -107.05 146.58 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -105.39 119.81 40.03 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.13 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -113.41 152.39 30.11 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.656 ' O ' HG23 ' A' ' 41' ' ' VAL . 42.6 tt0 -142.36 140.45 32.08 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.491 -0.756 . . . . 0.0 109.583 175.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.95 171.41 41.77 Favored Glycine 0 N--CA 1.496 2.66 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.602 -175.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -85.45 137.27 33.02 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.836 -0.803 . . . . 0.0 110.607 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.679 HD13 ' CD1' ' A' ' 12' ' ' ILE . 16.2 tp -66.2 118.81 10.45 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.648 -0.657 . . . . 0.0 110.723 175.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.416 ' O ' HG23 ' A' ' 28' ' ' THR . 25.4 t80 -100.36 -50.06 4.05 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.611 -0.681 . . . . 0.0 110.351 176.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 27' ' ' TYR . 23.2 p -153.55 153.59 32.68 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.741 -0.599 . . . . 0.0 110.18 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.882 HG23 HG22 ' A' ' 36' ' ' ILE . 13.5 p -142.3 145.04 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.593 -0.692 . . . . 0.0 110.102 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -128.5 100.51 22.26 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.623 -0.673 . . . . 0.0 109.566 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.41 -39.69 44.47 Favored 'Trans proline' 0 N--CA 1.489 1.244 0 O-C-N 123.578 1.304 . . . . 0.0 110.726 -175.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -80.49 -25.83 38.56 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.406 -0.809 . . . . 0.0 110.157 -172.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.572 ' O ' HG23 ' A' ' 35' ' ' THR . 54.9 mt-10 -87.35 1.83 52.14 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.501 -0.75 . . . . 0.0 111.195 173.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 75.5 m 49.58 38.3 14.51 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.116 -0.99 . . . . 0.0 111.291 -176.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 33' ' ' GLU . 10.5 p -136.26 153.73 51.11 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.399 -0.813 . . . . 0.0 110.26 -174.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.882 HG22 HG23 ' A' ' 29' ' ' VAL . 39.9 pt -142.73 162.02 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.703 -0.623 . . . . 0.0 110.249 178.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.523 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.69 127.29 27.01 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.669 -0.644 . . . . 0.0 109.665 175.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 26' ' ' LEU . 83.8 mt -109.94 146.99 34.27 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -177.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 95.7 p -118.07 152.68 35.09 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.5 p 45.58 84.0 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 121.492 0.663 . . . . 0.0 110.336 -172.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.669 ' CG1' HD12 ' A' ' 65' ' ' ILE . 14.9 p -134.53 150.55 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.947 -0.47 . . . . 0.0 109.774 -178.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -136.4 153.09 51.19 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.64 -0.663 . . . . 0.0 110.168 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.5 p -107.2 133.03 52.39 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.71 -0.619 . . . . 0.0 109.506 176.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -83.09 -38.62 22.22 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.726 -0.79 . . . . 0.0 111.087 -170.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.27 171.73 33.65 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 176.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.788 HG22 HG12 ' A' ' 20' ' ' ILE . 69.6 p -118.22 6.1 11.95 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.789 -0.83 . . . . 0.0 110.467 169.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -57.26 -31.41 65.54 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.545 -0.722 . . . . 0.0 112.427 -161.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -66.69 -59.34 3.67 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.239 -0.913 . . . . 0.0 110.486 -174.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.0 mtt-85 -94.51 10.3 35.15 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.677 -0.639 . . . . 0.0 111.612 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.474 ' HB2' HD12 ' A' ' 55' ' ' ILE . 38.2 p30 -54.63 172.15 0.11 Allowed 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.166 -0.959 . . . . 0.0 111.894 -171.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.0 m -78.94 164.6 24.29 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 173.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -77.32 3.75 12.33 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.567 -0.708 . . . . 0.0 111.214 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -98.28 153.34 18.58 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.215 -0.928 . . . . 0.0 109.619 169.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -67.82 138.59 56.25 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.578 -0.701 . . . . 0.0 110.597 -174.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.474 HD12 ' HB2' ' A' ' 50' ' ' ASP . 79.2 mt -117.43 141.2 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.661 -0.65 . . . . 0.0 109.511 177.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -97.66 109.86 52.59 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.612 -0.68 . . . . 0.0 110.215 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -68.6 147.65 70.64 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 O-C-N 123.44 1.232 . . . . 0.0 110.325 178.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -101.38 121.44 41.93 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.64 -0.662 . . . . 0.0 110.206 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 86.6 p -81.25 -26.81 35.53 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.724 -0.61 . . . . 0.0 110.686 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -61.67 148.35 42.93 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.471 -0.768 . . . . 0.0 110.623 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.1 mm -96.85 145.64 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.712 -0.618 . . . . 0.0 109.747 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -95.75 114.34 26.06 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.659 -0.651 . . . . 0.0 110.347 -178.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -51.04 -41.09 59.64 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.709 -0.62 . . . . 0.0 111.527 176.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.523 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.7 t80 -152.63 129.51 10.97 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.727 -0.608 . . . . 0.0 110.226 -174.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.669 HD12 ' CG1' ' A' ' 41' ' ' VAL . 73.7 mt -128.23 128.34 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.683 -0.635 . . . . 0.0 109.794 172.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.8 tp -90.13 137.06 32.65 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.889 -0.507 . . . . 0.0 109.838 176.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.583 ' CD1' HD11 ' A' ' 72' ' ' ILE . 3.0 m-85 -135.35 128.84 32.43 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.572 -0.705 . . . . 0.0 110.603 -175.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -91.27 147.03 23.33 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.653 -0.654 . . . . 0.0 110.177 172.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.63 -25.62 58.76 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.2 p -67.83 -37.85 82.45 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.427 -1.043 . . . . 0.0 110.917 -177.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -82.43 -30.79 29.86 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.504 -0.748 . . . . 0.0 110.9 -175.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.762 HD13 HD21 ' A' ' 14' ' ' LEU . 8.5 mt -104.31 138.78 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.492 -0.755 . . . . 0.0 110.104 176.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -105.04 -18.07 14.28 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.92 -0.487 . . . . 0.0 111.58 -167.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -151.03 132.03 14.27 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 119.115 -1.034 . . . . 0.0 111.249 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.541 HD12 ' CD1' ' A' ' 14' ' ' LEU . 16.8 tt -132.2 141.97 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.887 -0.508 . . . . 0.0 109.806 176.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -146.4 135.13 22.28 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.659 -0.65 . . . . 0.0 110.361 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.406 HG22 HG12 ' A' ' 12' ' ' ILE . 52.4 t -87.59 143.74 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.682 -0.636 . . . . 0.0 109.775 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 N--CA 1.497 1.895 0 O-C-N 121.59 -0.694 . . . . 0.0 109.745 -179.777 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.3 mt . . . . . 0 N--CA 1.501 2.101 0 CA-C-O 121.01 0.433 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.68 -1.79 84.95 Favored Glycine 0 N--CA 1.497 2.707 0 C-N-CA 120.453 -0.879 . . . . 0.0 111.742 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.4 m -60.39 151.7 27.33 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.078 -1.248 . . . . 0.0 110.482 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.434 ' HE3' HG11 ' A' ' 78' ' ' VAL . 30.5 pttt -81.95 126.54 32.06 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.66 -0.65 . . . . 0.0 110.551 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.652 ' CD1' HD13 ' A' ' 26' ' ' LEU . 89.5 mt -120.8 143.76 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.57 -0.706 . . . . 0.0 109.988 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.4 t -102.42 137.27 40.89 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 175.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.668 HD21 HD13 ' A' ' 72' ' ' ILE . 14.7 tp -133.11 125.06 28.7 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.763 -0.586 . . . . 0.0 110.227 -169.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 81.7 mt -106.75 118.85 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.548 -0.72 . . . . 0.0 109.629 -178.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.7 m -93.69 157.66 16.06 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.064 0.459 . . . . 0.0 111.148 -178.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -54.21 -13.24 0.8 Allowed 'General case' 0 N--CA 1.507 2.416 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -172.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.556 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -90.0 20.4 4.27 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.142 -0.974 . . . . 0.0 110.475 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 53.96 33.98 18.6 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.485 -0.76 . . . . 0.0 109.749 -173.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.779 HG12 HG22 ' A' ' 46' ' ' THR . 68.8 mt -102.22 140.89 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.168 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -104.9 119.81 39.92 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.922 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -114.36 147.55 38.98 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 173.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.671 ' O ' HG23 ' A' ' 41' ' ' VAL . 41.5 tt0 -139.31 140.43 37.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.436 -0.79 . . . . 0.0 109.627 175.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.11 173.22 42.34 Favored Glycine 0 N--CA 1.496 2.678 0 C-N-CA 119.737 -1.22 . . . . 0.0 110.58 -175.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -84.28 137.57 33.39 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.907 -0.761 . . . . 0.0 110.546 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.652 HD13 ' CD1' ' A' ' 12' ' ' ILE . 16.0 tp -66.15 116.88 7.7 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.727 -0.608 . . . . 0.0 110.655 175.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.453 ' O ' HG23 ' A' ' 28' ' ' THR . 24.9 t80 -99.68 -50.18 4.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.659 -0.651 . . . . 0.0 110.421 178.168 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 27' ' ' TYR . 15.1 p -153.97 153.64 32.36 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.705 -0.622 . . . . 0.0 110.269 -178.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.885 HG23 HG22 ' A' ' 36' ' ' ILE . 13.7 p -142.24 145.19 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.696 -0.627 . . . . 0.0 110.092 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -127.88 98.73 27.01 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.631 -0.668 . . . . 0.0 109.611 177.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -59.44 -42.06 52.07 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 O-C-N 123.577 1.304 . . . . 0.0 110.984 -175.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -80.73 -24.82 38.49 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.413 -0.804 . . . . 0.0 110.181 -171.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.561 ' O ' HG23 ' A' ' 35' ' ' THR . 74.7 mm-40 -87.02 1.26 53.43 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.536 -0.728 . . . . 0.0 111.177 173.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 96.5 m 49.8 38.17 15.05 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.053 -1.029 . . . . 0.0 111.249 -176.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 33' ' ' GLU . 10.6 p -136.12 153.09 51.4 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.431 -0.793 . . . . 0.0 110.43 -174.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.885 HG22 HG23 ' A' ' 29' ' ' VAL . 39.9 pt -142.77 162.04 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.703 -0.623 . . . . 0.0 110.22 177.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.515 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.79 128.1 28.19 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.67 -0.644 . . . . 0.0 109.686 175.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 26' ' ' LEU . 83.6 mt -109.89 145.83 36.17 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -178.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.4 p -116.92 153.0 33.34 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -178.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 44.6 p 45.93 87.05 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 121.516 0.674 . . . . 0.0 110.317 -172.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.798 HG11 HD12 ' A' ' 65' ' ' ILE . 12.4 p -134.59 147.19 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.897 -0.502 . . . . 0.0 109.929 -177.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -123.84 153.17 41.45 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.767 -0.583 . . . . 0.0 109.881 177.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.3 p -108.54 136.69 47.72 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.716 -0.615 . . . . 0.0 109.707 176.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -82.93 -38.39 22.87 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.528 -0.733 . . . . 0.0 110.968 -174.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.57 167.62 28.51 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 120.024 -1.084 . . . . 0.0 110.578 176.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.779 HG22 HG12 ' A' ' 20' ' ' ILE . 0.8 OUTLIER -118.09 6.55 12.08 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.974 -0.721 . . . . 0.0 110.899 174.14 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -49.45 -25.16 2.39 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.544 -0.723 . . . . 0.0 112.624 -168.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -64.5 -59.22 4.57 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.191 -0.943 . . . . 0.0 110.607 -178.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 35.5 mtp180 -94.35 10.14 35.43 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.558 -0.714 . . . . 0.0 111.472 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 40.0 p-10 -60.27 173.97 0.6 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.3 -0.875 . . . . 0.0 111.297 -170.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.0 m -78.99 164.34 24.47 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.93 -0.481 . . . . 0.0 109.737 175.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -77.55 3.56 13.32 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.601 -0.687 . . . . 0.0 111.291 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -96.54 166.01 11.89 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.219 -0.926 . . . . 0.0 109.656 168.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -68.61 139.29 55.51 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.606 -0.684 . . . . 0.0 110.364 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 49.5 mm -114.18 134.76 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.745 -0.597 . . . . 0.0 109.697 178.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.01 109.94 53.68 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.649 -0.657 . . . . 0.0 110.236 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -66.86 146.57 78.48 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 O-C-N 123.331 1.174 . . . . 0.0 110.305 178.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -97.44 121.12 38.98 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.653 -0.654 . . . . 0.0 110.299 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 86.4 p -75.79 -22.07 56.74 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.705 -0.622 . . . . 0.0 110.828 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -61.16 156.59 17.96 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.376 -0.828 . . . . 0.0 110.693 -178.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.5 mm -96.87 145.9 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.754 -0.591 . . . . 0.0 109.853 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -92.1 111.87 23.58 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.553 -0.717 . . . . 0.0 109.87 175.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -52.35 -43.11 64.45 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.746 -0.596 . . . . 0.0 111.769 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.515 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.0 t80 -154.62 130.15 9.87 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.588 -0.695 . . . . 0.0 110.238 -174.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.798 HD12 HG11 ' A' ' 41' ' ' VAL . 80.4 mt -128.77 127.42 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.618 -0.676 . . . . 0.0 109.916 171.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 24.8 tp -90.32 137.09 32.63 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.779 -0.576 . . . . 0.0 109.755 175.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.57 ' CD1' HD11 ' A' ' 72' ' ' ILE . 3.5 m-85 -136.08 130.77 33.93 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.649 -0.657 . . . . 0.0 110.664 -175.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -91.6 149.57 21.59 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.663 -0.648 . . . . 0.0 110.339 173.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.31 -24.51 61.41 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 177.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.7 m -66.53 -42.04 87.83 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.366 -1.079 . . . . 0.0 111.077 -176.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -82.96 -33.41 26.69 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.423 -0.798 . . . . 0.0 110.919 -175.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.668 HD13 HD21 ' A' ' 14' ' ' LEU . 14.2 mt -101.02 138.15 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.404 -0.81 . . . . 0.0 110.11 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.0 tptp -107.32 -18.25 13.92 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 120.501 -0.479 . . . . 0.0 111.758 -166.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -148.93 131.14 15.49 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.897 -1.127 . . . . 0.0 111.354 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.499 HD12 ' CD1' ' A' ' 14' ' ' LEU . 18.0 tt -132.55 138.51 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.895 -0.503 . . . . 0.0 109.866 176.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.1 mtp180 -147.02 138.67 24.25 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.496 -0.753 . . . . 0.0 110.39 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.3 p -86.61 146.63 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.589 -0.694 . . . . 0.0 110.186 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.434 HG11 ' HE3' ' A' ' 11' ' ' LYS . 60.1 t . . . . . 0 N--CA 1.497 1.887 0 O-C-N 121.647 -0.658 . . . . 0.0 109.907 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.0 mt . . . . . 0 N--CA 1.501 2.088 0 CA-C-O 121.087 0.47 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.62 -1.91 84.42 Favored Glycine 0 N--CA 1.497 2.707 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.759 177.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.3 m -62.55 140.59 58.64 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.094 -1.239 . . . . 0.0 110.372 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -81.97 123.14 28.62 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.67 -0.644 . . . . 0.0 110.473 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.595 ' CD1' HD13 ' A' ' 26' ' ' LEU . 91.8 mt -121.17 145.35 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.492 -0.755 . . . . 0.0 110.222 -178.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.0 t -103.21 137.24 41.62 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 175.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.683 HD21 HD13 ' A' ' 72' ' ' ILE . 14.3 tp -132.02 126.14 33.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.741 -0.599 . . . . 0.0 110.261 -169.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 81.4 mt -107.04 119.03 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.594 -0.691 . . . . 0.0 109.622 -178.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.9 m -93.56 157.73 16.05 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.081 0.467 . . . . 0.0 111.187 -177.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.0 tptp -53.67 -14.78 0.97 Allowed 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -172.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.553 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.85 21.23 3.68 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.183 -0.948 . . . . 0.0 110.469 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 53.99 34.31 19.4 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.509 -0.745 . . . . 0.0 109.886 -174.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.836 HG12 HG22 ' A' ' 46' ' ' THR . 67.3 mt -102.1 141.55 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 54.0 ttt85 -104.51 119.84 39.89 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.891 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -113.86 149.24 35.36 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 174.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.653 ' O ' HG23 ' A' ' 41' ' ' VAL . 42.1 tt0 -140.69 140.49 34.94 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.499 -0.751 . . . . 0.0 109.494 175.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.64 173.09 43.27 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.666 -175.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -85.05 134.61 34.2 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.963 -0.728 . . . . 0.0 110.465 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.595 HD13 ' CD1' ' A' ' 12' ' ' ILE . 15.1 tp -66.2 119.87 12.24 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.61 -0.681 . . . . 0.0 110.735 176.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.443 ' O ' HG23 ' A' ' 28' ' ' THR . 24.0 t80 -99.43 -50.09 4.22 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.639 -0.663 . . . . 0.0 110.338 178.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 27' ' ' TYR . 15.4 p -153.83 154.29 33.69 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.693 -0.63 . . . . 0.0 110.229 -178.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.893 HG23 HG22 ' A' ' 36' ' ' ILE . 13.4 p -142.2 145.51 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.697 -0.627 . . . . 0.0 110.099 -178.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -129.04 98.25 24.37 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.583 -0.698 . . . . 0.0 109.502 177.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -59.45 -40.16 69.43 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 O-C-N 123.606 1.319 . . . . 0.0 111.037 -175.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -80.51 -27.12 37.77 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.319 -0.863 . . . . 0.0 110.21 -170.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.693 ' O ' HG23 ' A' ' 35' ' ' THR . 80.0 mt-10 -87.59 3.34 47.98 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.524 -0.735 . . . . 0.0 111.212 173.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 42.4 m 49.61 39.66 17.77 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.13 -0.981 . . . . 0.0 111.351 -177.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.693 HG23 ' O ' ' A' ' 33' ' ' GLU . 19.8 p -136.18 151.9 50.22 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.379 -0.826 . . . . 0.0 110.357 -175.162 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.893 HG22 HG23 ' A' ' 29' ' ' VAL . 40.0 pt -142.68 162.1 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.628 -0.67 . . . . 0.0 110.121 178.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.518 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -137.06 127.63 26.87 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.662 -0.648 . . . . 0.0 109.634 175.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 26' ' ' LEU . 88.6 mt -109.9 148.67 31.14 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -177.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.8 p -119.55 152.24 37.31 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.9 p 45.63 83.71 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 CA-C-O 121.457 0.646 . . . . 0.0 110.355 -172.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.674 ' CG1' HD12 ' A' ' 65' ' ' ILE . 14.6 p -134.54 150.33 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -178.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -136.07 153.19 51.41 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.658 -0.651 . . . . 0.0 110.043 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.9 p -108.41 139.89 42.5 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.753 -0.592 . . . . 0.0 109.839 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -83.0 -38.39 22.7 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.669 -0.644 . . . . 0.0 111.035 -173.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.62 171.93 34.15 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 177.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.836 HG22 HG12 ' A' ' 20' ' ' ILE . 2.3 p -118.09 6.51 12.08 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.925 -0.75 . . . . 0.0 110.986 174.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -50.99 -24.43 3.69 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.555 -0.716 . . . . 0.0 112.749 -167.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -65.95 -59.35 3.92 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.191 -0.943 . . . . 0.0 110.583 -177.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 -94.5 10.24 35.36 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.567 -0.708 . . . . 0.0 111.474 176.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 41.4 p-10 -58.22 174.08 0.31 Allowed 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.168 -0.958 . . . . 0.0 111.283 -171.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.0 m -79.03 164.37 24.41 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.905 -0.497 . . . . 0.0 109.794 176.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -77.53 4.09 12.02 Favored 'General case' 0 N--CA 1.502 2.135 0 C-N-CA 120.046 -0.662 . . . . 0.0 111.235 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -96.2 164.91 12.47 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.169 -0.957 . . . . 0.0 109.597 168.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -68.81 137.0 53.61 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.62 -0.675 . . . . 0.0 110.47 -176.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.3 mm -114.43 135.96 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.705 -0.622 . . . . 0.0 109.591 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -96.1 109.85 49.09 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.621 -0.675 . . . . 0.0 110.195 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -69.29 140.74 45.21 Favored 'Trans proline' 0 N--CA 1.487 1.091 0 O-C-N 123.469 1.247 . . . . 0.0 110.269 177.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -115.21 136.35 53.2 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.626 -0.671 . . . . 0.0 110.174 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.5 m -91.45 11.86 22.58 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.693 -0.63 . . . . 0.0 111.234 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -63.38 138.52 58.55 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.279 -0.888 . . . . 0.0 110.449 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.0 mm -96.92 135.35 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.715 -0.616 . . . . 0.0 109.758 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -95.28 117.72 30.79 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.605 -0.684 . . . . 0.0 110.191 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -51.02 -42.41 60.43 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.817 -0.552 . . . . 0.0 111.634 177.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.518 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.6 t80 -152.68 130.38 11.58 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.614 -0.679 . . . . 0.0 110.3 -174.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.674 HD12 ' CG1' ' A' ' 41' ' ' VAL . 77.0 mt -129.4 128.43 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.664 -0.647 . . . . 0.0 109.854 172.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.2 tp -90.47 137.1 32.62 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.821 -0.549 . . . . 0.0 109.817 176.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.57 ' CD1' HD11 ' A' ' 72' ' ' ILE . 3.4 m-85 -136.53 130.81 33.01 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.636 -0.665 . . . . 0.0 110.606 -175.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.9 mtm-85 -92.21 150.68 20.76 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.725 -0.609 . . . . 0.0 110.367 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.31 -23.99 60.74 Favored Glycine 0 N--CA 1.498 2.804 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.3 p -67.11 -42.04 85.19 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.408 -1.054 . . . . 0.0 110.979 -176.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -82.92 -33.22 26.87 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.471 -0.768 . . . . 0.0 110.942 -175.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.683 HD13 HD21 ' A' ' 14' ' ' LEU . 14.9 mt -102.32 138.26 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.393 -0.817 . . . . 0.0 110.142 177.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -107.22 -18.45 13.88 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.797 -166.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -149.64 131.31 14.97 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 118.936 -1.106 . . . . 0.0 111.231 -178.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.509 HD12 ' CD1' ' A' ' 14' ' ' LEU . 18.1 tt -132.01 138.27 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.937 -0.477 . . . . 0.0 109.783 176.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -146.92 144.12 29.0 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.584 -0.698 . . . . 0.0 110.429 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.465 HG12 HG12 ' A' ' 12' ' ' ILE . 35.5 m -84.87 147.0 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.585 -0.697 . . . . 0.0 110.203 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.6 t . . . . . 0 N--CA 1.496 1.866 0 O-C-N 121.636 -0.665 . . . . 0.0 109.868 -178.727 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.5 mt . . . . . 0 N--CA 1.501 2.122 0 CA-C-O 120.961 0.41 . . . . 0.0 110.673 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.62 -1.88 84.5 Favored Glycine 0 N--CA 1.497 2.728 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.783 177.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.6 m -62.17 147.37 47.91 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.047 -1.266 . . . . 0.0 110.446 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.562 ' HE3' HG11 ' A' ' 78' ' ' VAL . 28.6 pttt -81.77 126.0 31.31 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.716 -0.615 . . . . 0.0 110.371 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.628 ' CD1' HD13 ' A' ' 26' ' ' LEU . 89.1 mt -122.49 144.15 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.543 -0.723 . . . . 0.0 110.107 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.3 t -102.68 137.3 41.08 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.476 ' CD1' HD12 ' A' ' 75' ' ' ILE . 13.4 tp -135.41 128.33 31.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.742 -0.599 . . . . 0.0 110.28 -169.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.3 mt -108.38 121.88 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.558 -0.714 . . . . 0.0 109.668 -178.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.1 m -93.2 157.85 16.06 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.042 0.449 . . . . 0.0 111.151 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -53.95 -13.78 0.85 Allowed 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -172.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.515 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.52 20.07 4.17 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.2 -0.938 . . . . 0.0 110.394 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 54.16 34.81 20.98 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.411 -0.806 . . . . 0.0 109.829 -175.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.828 HG12 HG22 ' A' ' 46' ' ' THR . 64.4 mt -102.35 143.44 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -104.31 119.67 39.48 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.058 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -114.22 149.28 36.04 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.649 ' O ' HG23 ' A' ' 41' ' ' VAL . 63.4 mt-10 -141.13 140.5 34.12 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.417 -0.802 . . . . 0.0 109.7 175.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.27 173.23 43.04 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 119.721 -1.228 . . . . 0.0 110.527 -175.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -85.29 136.81 33.34 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.872 -0.781 . . . . 0.0 110.581 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.628 HD13 ' CD1' ' A' ' 12' ' ' ILE . 15.5 tp -66.23 119.22 11.12 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.57 -0.706 . . . . 0.0 110.66 175.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.443 ' O ' HG23 ' A' ' 28' ' ' THR . 25.2 t80 -100.07 -50.16 4.07 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.641 -0.662 . . . . 0.0 110.445 178.219 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 27' ' ' TYR . 16.6 p -153.94 156.18 37.01 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.708 -0.62 . . . . 0.0 110.34 -177.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.598 HG23 HG22 ' A' ' 36' ' ' ILE . 10.6 p -142.18 145.37 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.758 -0.589 . . . . 0.0 110.093 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -128.83 98.46 24.52 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.678 -0.639 . . . . 0.0 109.539 177.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -59.4 -43.29 41.45 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 O-C-N 123.595 1.313 . . . . 0.0 110.993 -175.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -80.88 -23.88 38.7 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.335 -0.853 . . . . 0.0 110.237 -171.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.74 ' O ' HG23 ' A' ' 35' ' ' THR . 74.7 mm-40 -87.18 0.99 54.46 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.473 -0.767 . . . . 0.0 111.188 173.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.0 m 50.03 39.8 19.84 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.101 -0.999 . . . . 0.0 111.172 -176.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.74 HG23 ' O ' ' A' ' 33' ' ' GLU . 23.1 p -136.06 154.36 51.05 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.452 -0.78 . . . . 0.0 110.476 -174.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.598 HG22 HG23 ' A' ' 29' ' ' VAL . 40.3 pt -141.66 160.61 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.816 -0.553 . . . . 0.0 110.031 177.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.512 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.52 126.94 26.71 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.698 -0.626 . . . . 0.0 109.648 175.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 26' ' ' LEU . 88.0 mt -109.89 146.6 34.86 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -178.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 99.9 p -117.65 152.24 35.6 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.1 p 45.65 83.62 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 121.491 0.662 . . . . 0.0 110.311 -172.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.666 ' CG1' HD12 ' A' ' 65' ' ' ILE . 14.9 p -134.58 151.06 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.938 -0.476 . . . . 0.0 109.733 -179.01 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -136.6 153.19 51.03 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.596 -0.69 . . . . 0.0 110.137 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.3 p -109.6 137.7 47.04 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.806 -0.559 . . . . 0.0 109.664 177.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -83.06 -38.57 22.34 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.194 -172.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.31 169.4 30.83 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 175.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.828 HG22 HG12 ' A' ' 20' ' ' ILE . 41.0 p -118.17 6.21 12.0 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.865 -0.785 . . . . 0.0 110.818 170.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -54.29 -24.3 18.48 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.48 -0.762 . . . . 0.0 112.257 -167.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -65.79 -59.21 4.12 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.281 -0.887 . . . . 0.0 110.387 -177.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 82.0 mmt-85 -94.52 10.26 35.34 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.619 -0.676 . . . . 0.0 111.417 177.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.448 ' HB2' HD12 ' A' ' 55' ' ' ILE . 53.2 p-10 -57.42 170.02 0.57 Allowed 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.211 -0.93 . . . . 0.0 111.52 -170.187 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.7 m -79.01 164.54 24.29 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 175.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -77.42 4.21 11.48 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.092 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -97.53 148.16 23.53 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.312 -0.867 . . . . 0.0 109.394 166.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -65.98 142.2 57.93 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.578 -0.701 . . . . 0.0 110.81 -174.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.448 HD12 ' HB2' ' A' ' 50' ' ' ASP . 79.8 mt -115.75 135.7 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.678 -0.639 . . . . 0.0 109.439 177.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.35 132.52 89.66 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.626 -0.671 . . . . 0.0 110.025 -178.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -69.48 144.07 54.28 Favored 'Trans proline' 0 N--CA 1.487 1.117 0 O-C-N 123.389 1.205 . . . . 0.0 110.253 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -98.93 110.1 22.76 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.668 -0.645 . . . . 0.0 110.111 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.4 t -99.18 -33.17 10.88 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.748 -0.595 . . . . 0.0 110.364 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -62.52 148.64 45.24 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.592 -0.692 . . . . 0.0 110.668 -179.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.4 mm -96.83 143.75 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.681 -0.637 . . . . 0.0 109.667 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -94.75 114.77 26.72 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.711 -0.618 . . . . 0.0 110.322 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.19 -41.39 60.18 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 121.812 -0.555 . . . . 0.0 111.56 177.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.512 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.0 t80 -152.59 130.6 11.82 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.632 -0.668 . . . . 0.0 110.262 -175.303 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.666 HD12 ' CG1' ' A' ' 41' ' ' VAL . 76.2 mt -129.34 127.27 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.586 -0.696 . . . . 0.0 109.792 171.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.2 tp -90.58 137.07 32.64 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.833 -0.542 . . . . 0.0 109.858 176.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.457 ' CZ ' HG21 ' A' ' 65' ' ' ILE . 3.9 m-85 -137.93 131.89 31.57 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.685 -0.634 . . . . 0.0 110.67 -175.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -91.59 151.91 20.51 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.752 -0.592 . . . . 0.0 110.313 174.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.93 -24.75 60.82 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.6 t -66.83 -42.15 86.27 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.451 -1.029 . . . . 0.0 111.066 -176.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -82.89 -33.17 27.02 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.527 -0.733 . . . . 0.0 110.93 -175.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.435 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 24.5 mt -105.17 135.1 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.336 -0.853 . . . . 0.0 109.962 176.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -110.18 -12.59 14.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.941 -0.474 . . . . 0.0 112.111 -165.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -147.4 130.65 16.52 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.809 -1.182 . . . . 0.0 111.298 -178.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.476 HD12 ' CD1' ' A' ' 14' ' ' LEU . 14.6 tt -132.27 141.25 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.92 -0.488 . . . . 0.0 109.87 176.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -145.96 134.4 21.95 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.498 -0.751 . . . . 0.0 110.307 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.3 t -87.14 144.45 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.612 -0.68 . . . . 0.0 109.611 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.562 HG11 ' HE3' ' A' ' 11' ' ' LYS . 57.8 t . . . . . 0 N--CA 1.497 1.905 0 O-C-N 121.603 -0.686 . . . . 0.0 109.749 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.5 mt . . . . . 0 N--CA 1.501 2.083 0 CA-C-O 120.932 0.396 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.66 -1.75 85.01 Favored Glycine 0 N--CA 1.497 2.721 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.608 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 42.6 m -60.01 159.54 9.22 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.151 -1.206 . . . . 0.0 110.437 -177.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -81.27 126.58 31.72 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.747 -0.596 . . . . 0.0 110.534 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.686 ' CD1' HD13 ' A' ' 26' ' ' LEU . 88.1 mt -120.83 144.66 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.555 -0.716 . . . . 0.0 109.907 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.8 t -102.97 137.27 41.39 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 175.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.788 ' HG ' HG21 ' A' ' 72' ' ' ILE . 11.9 tp -134.15 123.88 25.12 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.723 -0.611 . . . . 0.0 110.057 -170.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.721 ' O ' HG23 ' A' ' 72' ' ' ILE . 82.0 mt -103.99 119.45 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.528 -0.732 . . . . 0.0 109.643 -177.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.7 m -94.96 157.89 15.7 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.166 0.507 . . . . 0.0 111.59 -175.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -53.64 -15.19 1.08 Allowed 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -171.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.6 21.15 3.58 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.157 -0.964 . . . . 0.0 110.449 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 56.69 35.57 26.37 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.49 -0.756 . . . . 0.0 110.031 -178.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.747 HG12 HG22 ' A' ' 46' ' ' THR . 53.1 mt -107.05 148.79 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.073 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.0 ttt-85 -106.66 119.83 40.36 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.167 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -112.87 152.37 29.34 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 175.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.655 ' O ' HG23 ' A' ' 41' ' ' VAL . 42.3 tt0 -141.88 140.55 32.89 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.452 -0.78 . . . . 0.0 109.68 175.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.57 171.8 41.61 Favored Glycine 0 N--CA 1.496 2.65 0 C-N-CA 119.753 -1.213 . . . . 0.0 110.464 -176.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 43.1 mmm-85 -84.35 138.97 32.59 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.843 -0.798 . . . . 0.0 110.538 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.686 HD13 ' CD1' ' A' ' 12' ' ' ILE . 16.5 tp -66.17 116.5 7.31 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.605 -0.684 . . . . 0.0 110.618 175.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.461 ' O ' HG23 ' A' ' 28' ' ' THR . 32.1 t80 -100.35 -50.13 4.03 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.609 -0.682 . . . . 0.0 110.553 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 27' ' ' TYR . 14.5 p -154.58 155.33 34.56 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.718 -0.614 . . . . 0.0 110.359 -177.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.836 HG23 HG22 ' A' ' 36' ' ' ILE . 13.4 p -142.23 145.94 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.746 -0.597 . . . . 0.0 110.062 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -128.5 99.01 24.27 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.579 -0.7 . . . . 0.0 109.649 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -59.61 -41.67 54.17 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 O-C-N 123.654 1.344 . . . . 0.0 111.038 -175.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -80.59 -25.51 38.43 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.384 -0.823 . . . . 0.0 110.252 -170.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.581 ' O ' HG23 ' A' ' 35' ' ' THR . 79.3 mt-10 -87.58 1.97 52.12 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.437 -0.79 . . . . 0.0 111.236 173.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 97.7 m 49.66 39.97 18.7 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.093 -1.004 . . . . 0.0 111.199 -176.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 33' ' ' GLU . 11.0 p -135.86 154.32 51.2 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.415 -0.803 . . . . 0.0 110.379 -175.127 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.836 HG22 HG23 ' A' ' 29' ' ' VAL . 39.9 pt -142.0 160.94 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.675 -0.641 . . . . 0.0 109.969 176.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.505 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -137.06 128.99 29.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.572 -0.705 . . . . 0.0 109.828 176.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 26' ' ' LEU . 84.1 mt -109.87 144.82 37.8 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -178.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 97.6 p -114.95 152.66 31.97 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.1 p 45.55 84.94 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 121.454 0.645 . . . . 0.0 110.214 -171.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.1 p -134.55 149.97 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.967 -0.458 . . . . 0.0 109.766 -178.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -136.07 153.2 51.4 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.635 -0.665 . . . . 0.0 110.068 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.2 p -105.61 129.79 53.78 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.757 -0.589 . . . . 0.0 109.463 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -83.07 -38.49 22.44 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.112 -170.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.22 175.45 37.25 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 178.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.747 HG22 HG12 ' A' ' 20' ' ' ILE . 65.3 p -118.11 2.68 12.05 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.81 -0.817 . . . . 0.0 110.489 169.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -57.33 -33.83 68.12 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.541 -0.725 . . . . 0.0 112.134 -163.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -63.36 -59.06 5.19 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.332 -0.855 . . . . 0.0 110.435 -175.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -94.32 10.49 34.01 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.753 -0.592 . . . . 0.0 111.289 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 51.2 p30 -49.82 157.78 0.55 Allowed 'General case' 0 N--CA 1.51 2.556 0 O-C-N 121.413 -0.804 . . . . 0.0 112.41 -169.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.421 ' H ' HD11 ' A' ' 55' ' ' ILE . 21.1 m -79.2 164.49 24.16 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 172.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -77.51 4.53 10.92 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.236 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -96.83 166.05 11.82 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.236 -0.915 . . . . 0.0 109.645 167.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -76.58 133.98 39.52 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.544 -0.722 . . . . 0.0 110.52 -176.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.421 HD11 ' H ' ' A' ' 51' ' ' THR . 69.8 mt -119.35 139.48 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.805 -0.56 . . . . 0.0 109.531 177.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.04 109.89 53.56 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.613 -0.679 . . . . 0.0 110.249 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -68.77 152.06 74.17 Favored 'Trans proline' 0 N--CA 1.488 1.153 0 O-C-N 123.414 1.218 . . . . 0.0 110.387 178.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -99.0 127.8 45.0 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.755 -0.59 . . . . 0.0 110.187 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.2 m -94.63 -31.63 13.76 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.721 -0.612 . . . . 0.0 110.468 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -61.76 151.45 34.04 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.633 -0.667 . . . . 0.0 110.613 -178.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.2 mm -96.81 140.01 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.67 -0.643 . . . . 0.0 109.758 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -97.3 116.19 29.05 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.603 -0.686 . . . . 0.0 110.297 -177.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -50.96 -40.35 57.34 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.701 -0.625 . . . . 0.0 111.562 176.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.505 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.3 t80 -152.97 129.76 10.9 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.656 -0.652 . . . . 0.0 110.217 -174.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.651 HD12 ' CG1' ' A' ' 41' ' ' VAL . 71.2 mt -128.32 126.68 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.713 -0.617 . . . . 0.0 109.893 171.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.4 HD12 ' HB2' ' A' ' 37' ' ' ALA . 22.4 tp -91.42 137.12 32.62 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.87 -0.519 . . . . 0.0 109.9 176.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.469 ' CD1' HD11 ' A' ' 72' ' ' ILE . 7.3 m-85 -135.47 130.85 35.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.642 -0.661 . . . . 0.0 110.429 -176.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -89.56 151.38 21.97 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.716 -0.615 . . . . 0.0 110.076 174.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.4 -24.49 45.96 Favored Glycine 0 N--CA 1.5 2.929 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 86.5 p -76.82 -39.06 52.61 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.411 -1.052 . . . . 0.0 111.047 -177.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -82.04 -21.3 37.02 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.391 -0.818 . . . . 0.0 111.309 -173.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.788 HG21 ' HG ' ' A' ' 14' ' ' LEU . 45.1 mt -116.03 141.22 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.256 -0.902 . . . . 0.0 109.694 168.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -105.88 -14.3 15.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.86 -0.525 . . . . 0.0 111.87 -167.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -150.29 134.22 16.86 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 118.993 -1.083 . . . . 0.0 111.438 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.425 HD12 ' CD1' ' A' ' 14' ' ' LEU . 15.7 tt -132.04 140.63 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.94 -0.475 . . . . 0.0 109.826 176.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -147.05 138.04 23.85 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.624 -0.673 . . . . 0.0 110.344 178.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.9 t -87.2 146.1 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.573 -0.704 . . . . 0.0 109.656 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.3 t . . . . . 0 N--CA 1.498 1.932 0 O-C-N 121.52 -0.737 . . . . 0.0 109.788 -178.638 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.6 mt . . . . . 0 N--CA 1.501 2.085 0 CA-C-O 121.041 0.448 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.67 -1.96 84.36 Favored Glycine 0 N--CA 1.497 2.72 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.794 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.0 m -62.18 139.86 58.46 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.079 -1.247 . . . . 0.0 110.445 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.572 ' HE3' HG11 ' A' ' 78' ' ' VAL . 35.8 pttt -81.87 127.27 32.83 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.71 -0.619 . . . . 0.0 110.35 179.015 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.404 HD12 ' HB2' ' A' ' 26' ' ' LEU . 92.8 mt -124.94 145.13 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.597 -0.689 . . . . 0.0 110.223 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.2 t -102.84 137.25 41.29 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.735 HD21 HD13 ' A' ' 72' ' ' ILE . 13.8 tp -131.88 125.69 32.35 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.814 -0.554 . . . . 0.0 110.198 -170.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 80.9 mt -107.5 118.65 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.522 -0.736 . . . . 0.0 109.692 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.9 m -93.57 157.72 16.05 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.039 0.447 . . . . 0.0 111.293 -177.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -53.29 -15.02 0.82 Allowed 'General case' 0 N--CA 1.508 2.473 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -172.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.568 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.29 20.55 3.73 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.099 -1.001 . . . . 0.0 110.405 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 54.35 33.51 18.63 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.435 -0.791 . . . . 0.0 109.874 -174.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.662 HG12 HG22 ' A' ' 46' ' ' THR . 65.7 mt -101.5 141.31 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -104.66 119.79 39.82 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.941 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -113.99 148.96 36.06 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 174.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.66 ' O ' HG23 ' A' ' 41' ' ' VAL . 42.8 tt0 -140.08 140.48 36.1 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.471 -0.768 . . . . 0.0 109.498 175.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.43 173.02 43.14 Favored Glycine 0 N--CA 1.496 2.683 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.665 -175.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 72.0 mtp85 -85.54 135.47 33.81 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.881 -0.776 . . . . 0.0 110.59 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.483 ' HA ' HD23 ' A' ' 38' ' ' LEU . 29.4 tp -66.16 119.53 11.63 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.668 -0.645 . . . . 0.0 110.679 176.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.44 ' O ' HG23 ' A' ' 28' ' ' THR . 26.4 t80 -99.57 -50.06 4.2 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.677 -0.64 . . . . 0.0 110.296 178.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 27' ' ' TYR . 16.5 p -153.79 154.97 34.99 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.671 -0.643 . . . . 0.0 110.295 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.895 HG23 HG22 ' A' ' 36' ' ' ILE . 13.6 p -142.26 145.7 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.648 -0.657 . . . . 0.0 110.11 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -128.64 98.3 25.51 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.591 -0.693 . . . . 0.0 109.554 177.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -59.42 -41.1 61.04 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 O-C-N 123.507 1.267 . . . . 0.0 110.924 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -80.66 -25.52 38.22 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.388 -0.82 . . . . 0.0 110.156 -171.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.728 ' O ' HG23 ' A' ' 35' ' ' THR . 54.6 mt-10 -87.46 2.19 51.28 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.463 -0.773 . . . . 0.0 111.254 173.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.8 m 49.73 38.79 16.23 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.122 -0.986 . . . . 0.0 111.254 -176.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.728 HG23 ' O ' ' A' ' 33' ' ' GLU . 22.3 p -136.6 152.71 50.76 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.336 -0.852 . . . . 0.0 110.391 -174.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.895 HG22 HG23 ' A' ' 29' ' ' VAL . 40.0 pt -142.38 162.03 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.687 -0.633 . . . . 0.0 110.167 177.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.518 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.3 127.81 28.67 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.571 -0.706 . . . . 0.0 109.666 175.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.483 HD23 ' HA ' ' A' ' 26' ' ' LEU . 85.9 mt -109.9 148.03 32.31 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -177.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 96.8 p -119.41 152.8 36.23 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -178.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.8 p 45.65 84.38 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 CA-C-O 121.565 0.698 . . . . 0.0 110.301 -172.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.695 HG11 HD12 ' A' ' 65' ' ' ILE . 14.6 p -134.55 149.86 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.914 -0.491 . . . . 0.0 109.786 -178.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.582 ' HB3' HD12 ' A' ' 61' ' ' ILE . 32.1 ptt180 -135.11 153.13 52.12 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.679 -0.638 . . . . 0.0 109.941 177.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.9 p -109.43 141.93 41.14 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.736 -0.603 . . . . 0.0 109.911 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -82.55 -38.36 23.84 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.591 -0.693 . . . . 0.0 110.678 -175.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.64 167.37 28.2 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 176.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.662 HG22 HG12 ' A' ' 20' ' ' ILE . 16.3 p -118.29 6.51 11.91 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.944 -0.739 . . . . 0.0 111.015 175.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -48.94 -25.89 2.19 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.582 -0.699 . . . . 0.0 112.784 -167.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -66.82 -59.21 3.74 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.287 -0.883 . . . . 0.0 110.417 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -94.39 10.21 35.24 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.633 -0.667 . . . . 0.0 111.225 176.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -58.32 174.07 0.32 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.232 -0.918 . . . . 0.0 111.552 -170.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.1 p -78.83 164.64 24.33 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 122.0 -0.438 . . . . 0.0 109.94 174.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -77.33 2.76 14.83 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.996 -0.681 . . . . 0.0 111.103 177.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -101.7 151.91 21.48 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.31 -0.869 . . . . 0.0 109.527 169.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -66.49 138.93 57.87 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.501 -0.749 . . . . 0.0 110.56 -174.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.7 mt -109.97 135.22 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.704 -0.622 . . . . 0.0 109.459 177.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -83.84 146.06 48.4 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.762 -0.587 . . . . 0.0 110.176 -178.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -68.44 156.96 63.79 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 O-C-N 123.522 1.275 . . . . 0.0 110.269 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -79.64 132.58 36.28 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.683 -0.636 . . . . 0.0 110.041 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.9 m -98.98 30.29 3.46 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.749 -0.594 . . . . 0.0 110.541 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -175.65 160.85 2.52 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.634 -0.666 . . . . 0.0 109.78 -177.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.582 HD12 ' HB3' ' A' ' 42' ' ' ARG . 51.0 mm -96.74 157.4 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.703 -0.623 . . . . 0.0 109.725 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -93.0 114.08 26.54 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.556 -0.715 . . . . 0.0 110.177 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -51.23 -42.34 60.94 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.9 -0.5 . . . . 0.0 111.711 178.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.518 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.9 t80 -152.72 129.95 11.23 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.685 -0.635 . . . . 0.0 110.292 -174.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.695 HD12 HG11 ' A' ' 41' ' ' VAL . 76.2 mt -129.6 129.14 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.652 -0.655 . . . . 0.0 109.85 172.249 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 24.8 tp -90.65 137.0 32.7 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.774 -0.579 . . . . 0.0 109.918 176.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.601 ' CD1' HD11 ' A' ' 72' ' ' ILE . 3.7 m-85 -135.59 129.44 32.91 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.67 -0.644 . . . . 0.0 110.635 -175.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 73.5 mtt85 -92.1 150.06 21.16 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.797 -0.565 . . . . 0.0 110.352 173.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.18 -24.43 61.0 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.9 m -66.57 -42.09 87.58 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.493 -1.004 . . . . 0.0 111.034 -176.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -83.16 -32.75 26.46 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.445 -0.785 . . . . 0.0 110.969 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.735 HD13 HD21 ' A' ' 14' ' ' LEU . 14.7 mt -101.38 138.61 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.395 -0.816 . . . . 0.0 110.174 177.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -106.37 -18.54 13.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.892 -0.505 . . . . 0.0 111.736 -167.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -150.0 131.25 14.56 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 119.001 -1.08 . . . . 0.0 111.242 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.538 HD12 ' CD1' ' A' ' 14' ' ' LEU . 17.6 tt -132.14 139.83 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 176.161 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -146.29 133.22 20.2 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.521 -0.737 . . . . 0.0 110.411 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.3 p -87.62 147.1 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.722 -0.611 . . . . 0.0 110.29 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.572 HG11 ' HE3' ' A' ' 11' ' ' LYS . 60.6 t . . . . . 0 N--CA 1.497 1.895 0 O-C-N 121.56 -0.712 . . . . 0.0 109.759 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.4 mt . . . . . 0 N--CA 1.501 2.118 0 CA-C-O 120.915 0.388 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.79 -1.73 85.4 Favored Glycine 0 N--CA 1.498 2.78 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.561 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 45.8 m -59.36 155.58 14.43 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.129 -1.218 . . . . 0.0 110.484 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -81.35 124.49 29.41 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.734 -0.604 . . . . 0.0 110.794 -177.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.417 HD12 ' HB2' ' A' ' 26' ' ' LEU . 91.5 mt -121.92 146.16 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.661 -0.649 . . . . 0.0 110.017 178.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.6 t -103.19 137.26 41.58 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 176.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.694 HD21 HD13 ' A' ' 72' ' ' ILE . 13.9 tp -132.47 126.31 32.71 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.75 -0.594 . . . . 0.0 110.252 -170.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.1 mt -107.05 118.79 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.515 -0.741 . . . . 0.0 109.66 -178.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.0 m -93.59 157.71 16.05 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.039 0.447 . . . . 0.0 111.301 -177.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.5 tttm -53.99 -13.63 0.83 Allowed 'General case' 0 N--CA 1.508 2.441 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -172.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.532 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.9 20.37 4.23 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.107 -0.996 . . . . 0.0 110.426 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 53.86 34.45 19.36 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.521 -0.737 . . . . 0.0 109.865 -173.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.791 HG12 HG22 ' A' ' 46' ' ' THR . 72.2 mt -102.27 140.96 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -104.67 119.8 39.85 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.009 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -113.84 150.3 33.75 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 175.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.653 ' O ' HG23 ' A' ' 41' ' ' VAL . 58.3 mt-10 -141.45 140.54 33.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.423 -0.798 . . . . 0.0 109.796 174.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.53 173.1 43.2 Favored Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.764 -1.207 . . . . 0.0 110.377 -176.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -85.04 135.83 33.84 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.849 -0.795 . . . . 0.0 110.588 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.479 ' HA ' HD23 ' A' ' 38' ' ' LEU . 24.7 tp -66.08 120.02 12.43 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.583 -0.698 . . . . 0.0 110.716 175.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.44 ' O ' HG23 ' A' ' 28' ' ' THR . 24.2 t80 -99.78 -50.11 4.14 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.655 -0.653 . . . . 0.0 110.394 178.074 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 27' ' ' TYR . 15.7 p -153.96 155.84 36.35 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.67 -0.644 . . . . 0.0 110.305 -178.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.894 HG23 HG22 ' A' ' 36' ' ' ILE . 13.4 p -142.22 145.81 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.697 -0.627 . . . . 0.0 110.081 -179.069 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -128.66 101.78 20.51 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.629 -0.669 . . . . 0.0 109.54 177.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.44 -41.93 30.35 Favored 'Trans proline' 0 N--CA 1.49 1.276 0 O-C-N 123.553 1.291 . . . . 0.0 110.746 -174.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -80.76 -23.56 39.28 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.384 -0.822 . . . . 0.0 110.212 -172.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.667 ' O ' HG23 ' A' ' 35' ' ' THR . 74.9 mm-40 -87.26 0.75 54.89 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.476 -0.765 . . . . 0.0 111.178 173.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.3 m 49.91 38.14 15.41 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.157 -0.964 . . . . 0.0 111.255 -176.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.667 HG23 ' O ' ' A' ' 33' ' ' GLU . 17.2 p -136.71 153.34 50.9 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.402 -0.811 . . . . 0.0 110.403 -174.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.894 HG22 HG23 ' A' ' 29' ' ' VAL . 39.9 pt -142.31 162.0 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.719 -0.613 . . . . 0.0 110.081 177.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.513 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -135.87 127.95 29.75 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.61 -0.681 . . . . 0.0 109.722 176.121 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.479 HD23 ' HA ' ' A' ' 26' ' ' LEU . 86.1 mt -109.88 147.73 32.84 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -177.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 95.7 p -118.51 151.42 37.87 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -178.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.7 p 45.8 84.05 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 CA-C-O 121.517 0.675 . . . . 0.0 110.341 -172.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.673 ' CG1' HD12 ' A' ' 65' ' ' ILE . 14.3 p -134.56 150.92 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.935 -0.478 . . . . 0.0 109.717 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -135.8 153.19 51.6 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.602 -0.686 . . . . 0.0 110.087 178.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.4 p -108.19 139.66 42.54 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.733 -0.604 . . . . 0.0 109.834 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -82.94 -38.33 22.93 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.657 -0.652 . . . . 0.0 111.056 -173.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.67 172.22 34.52 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 119.975 -1.107 . . . . 0.0 110.522 177.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.791 HG22 HG12 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -118.01 6.58 12.15 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.928 -0.748 . . . . 0.0 110.739 174.1 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -48.99 -25.2 1.84 Allowed 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.618 -0.676 . . . . 0.0 112.528 -169.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -64.42 -59.19 4.64 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.291 -0.881 . . . . 0.0 110.574 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -94.29 10.22 35.0 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.612 -0.68 . . . . 0.0 111.408 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.5 p-10 -61.4 174.19 0.77 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.279 -0.888 . . . . 0.0 111.244 -171.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.8 p -78.91 164.59 24.32 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.922 -0.486 . . . . 0.0 109.876 174.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -77.46 2.57 15.78 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.081 177.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -97.86 166.05 11.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.126 -0.984 . . . . 0.0 109.513 169.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -65.97 140.54 58.32 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.543 -0.723 . . . . 0.0 110.451 -175.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.466 ' N ' HD12 ' A' ' 55' ' ' ILE . 4.9 mp -111.95 141.91 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.702 -0.624 . . . . 0.0 109.705 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -92.06 109.87 40.34 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.65 -0.656 . . . . 0.0 110.178 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -66.79 146.96 80.18 Favored 'Trans proline' 0 N--CA 1.489 1.258 0 O-C-N 123.373 1.196 . . . . 0.0 110.428 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -96.81 117.24 30.63 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.678 -0.639 . . . . 0.0 110.165 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 86.8 p -88.29 -28.73 20.89 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.732 -0.605 . . . . 0.0 110.609 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -62.13 146.86 49.33 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.539 -0.726 . . . . 0.0 110.693 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.3 mm -96.77 144.72 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.695 -0.628 . . . . 0.0 109.708 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -94.97 114.54 26.37 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.586 -0.696 . . . . 0.0 110.285 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -51.08 -40.22 57.87 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.781 -0.575 . . . . 0.0 111.728 177.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.513 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.6 t80 -152.97 129.92 11.02 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.637 -0.664 . . . . 0.0 110.257 -174.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.673 HD12 ' CG1' ' A' ' 41' ' ' VAL . 74.3 mt -129.33 129.35 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.678 -0.639 . . . . 0.0 109.798 171.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.0 tp -90.38 137.06 32.66 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.87 -0.519 . . . . 0.0 109.865 176.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.602 ' CD1' HD11 ' A' ' 72' ' ' ILE . 3.2 m-85 -135.75 129.75 33.07 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.604 -0.685 . . . . 0.0 110.579 -175.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -92.08 150.18 21.1 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.748 -0.595 . . . . 0.0 110.325 173.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.29 -24.49 61.33 Favored Glycine 0 N--CA 1.498 2.818 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 177.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.5 m -66.59 -42.12 87.42 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.472 -1.016 . . . . 0.0 111.115 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -83.0 -32.94 26.68 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.415 -0.803 . . . . 0.0 110.905 -175.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.694 HD13 HD21 ' A' ' 14' ' ' LEU . 13.9 mt -100.77 139.89 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.418 -0.802 . . . . 0.0 110.124 177.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.0 tptm -106.27 -21.28 13.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.937 -0.477 . . . . 0.0 111.606 -166.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -150.63 135.28 17.32 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 119.037 -1.065 . . . . 0.0 111.353 -177.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.517 HD12 ' CD1' ' A' ' 14' ' ' LEU . 18.3 tt -133.2 142.13 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -146.44 139.02 25.24 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.535 -0.728 . . . . 0.0 110.411 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.0 t -87.2 144.48 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.621 -0.674 . . . . 0.0 109.638 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.8 t . . . . . 0 N--CA 1.496 1.863 0 O-C-N 121.492 -0.755 . . . . 0.0 109.831 -178.391 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.4 mt . . . . . 0 N--CA 1.501 2.096 0 CA-C-O 121.031 0.443 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.73 -1.87 84.83 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.763 177.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 67.0 m -61.39 137.64 58.24 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.138 -1.213 . . . . 0.0 110.411 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -82.15 124.36 29.8 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.72 -0.612 . . . . 0.0 110.611 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.62 ' CD1' HD13 ' A' ' 26' ' ' LEU . 88.1 mt -121.16 145.12 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.644 -0.66 . . . . 0.0 110.17 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.8 t -103.44 137.27 41.77 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 175.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.709 HD21 HD13 ' A' ' 72' ' ' ILE . 13.8 tp -133.04 125.96 30.83 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.68 -0.638 . . . . 0.0 110.259 -169.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.0 mt -106.68 117.84 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.47 -0.769 . . . . 0.0 109.683 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.0 m -93.04 157.83 16.1 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.06 0.457 . . . . 0.0 111.254 -177.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -54.03 -13.9 0.92 Allowed 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -171.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.54 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -90.09 20.6 4.19 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.094 -1.004 . . . . 0.0 110.408 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 54.37 34.16 20.11 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.512 -0.743 . . . . 0.0 109.788 -174.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.808 HG12 HG22 ' A' ' 46' ' ' THR . 69.8 mt -102.47 141.82 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 36.8 ttp180 -104.85 119.86 40.01 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.973 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -114.0 150.3 34.08 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 174.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.655 ' O ' HG23 ' A' ' 41' ' ' VAL . 42.1 tt0 -140.7 140.47 34.92 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.535 -0.728 . . . . 0.0 109.515 175.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.58 172.69 43.13 Favored Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.657 -175.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -85.08 136.15 33.69 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.908 -0.76 . . . . 0.0 110.532 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.62 HD13 ' CD1' ' A' ' 12' ' ' ILE . 15.5 tp -66.14 118.83 10.44 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.62 -0.675 . . . . 0.0 110.716 175.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.449 ' O ' HG23 ' A' ' 28' ' ' THR . 24.9 t80 -100.03 -50.13 4.09 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.662 -0.649 . . . . 0.0 110.376 177.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 27' ' ' TYR . 14.8 p -154.09 153.74 32.41 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.701 -0.625 . . . . 0.0 110.284 -178.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.892 HG23 HG22 ' A' ' 36' ' ' ILE . 13.3 p -142.19 145.24 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.656 -0.652 . . . . 0.0 110.033 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -128.22 100.48 23.26 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.625 -0.672 . . . . 0.0 109.457 176.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.34 -42.79 26.09 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 O-C-N 123.496 1.261 . . . . 0.0 110.792 -174.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -80.2 -27.33 38.87 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.295 -0.878 . . . . 0.0 109.95 -172.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.597 ' O ' HG23 ' A' ' 35' ' ' THR . 74.9 mm-40 -89.24 12.04 17.12 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.62 -0.675 . . . . 0.0 111.268 172.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 6.3 p 47.48 33.62 2.94 Favored 'General case' 0 N--CA 1.507 2.411 0 O-C-N 121.783 -0.573 . . . . 0.0 112.034 173.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.597 HG23 ' O ' ' A' ' 33' ' ' GLU . 9.1 p -136.56 154.73 50.62 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.458 -0.776 . . . . 0.0 110.432 -173.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.892 HG22 HG23 ' A' ' 29' ' ' VAL . 40.0 pt -142.45 162.03 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.704 -0.622 . . . . 0.0 110.158 177.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.521 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -137.01 127.76 27.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.678 -0.639 . . . . 0.0 109.735 175.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.46 HD23 ' HA ' ' A' ' 26' ' ' LEU . 87.4 mt -109.91 148.04 32.29 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -177.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 95.8 p -119.44 152.93 36.05 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.5 p 45.79 84.29 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 CA-C-O 121.494 0.664 . . . . 0.0 110.271 -172.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.694 HG11 HD12 ' A' ' 65' ' ' ILE . 14.9 p -134.52 151.26 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -178.273 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -135.97 153.2 51.48 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.629 -0.669 . . . . 0.0 109.947 177.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 84.5 p -107.61 139.34 42.3 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.703 -0.623 . . . . 0.0 109.763 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -82.49 -38.36 23.99 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.626 -0.671 . . . . 0.0 110.941 -173.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.56 169.95 31.75 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 120.032 -1.08 . . . . 0.0 110.417 176.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.808 HG22 HG12 ' A' ' 20' ' ' ILE . 1.1 p -118.08 6.6 12.09 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.906 -0.761 . . . . 0.0 110.886 174.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -48.99 -26.03 2.3 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.649 -0.657 . . . . 0.0 112.504 -167.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -64.98 -59.23 4.39 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.267 -0.896 . . . . 0.0 110.555 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 82.5 mmt-85 -94.35 10.25 35.0 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.655 -0.653 . . . . 0.0 111.335 177.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.8 p-10 -60.15 173.46 0.64 Allowed 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.224 -0.923 . . . . 0.0 111.518 -169.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.3 m -78.92 164.45 24.42 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 173.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -77.33 3.34 13.31 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.596 -0.69 . . . . 0.0 111.309 -178.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -102.12 154.92 18.55 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.242 -0.911 . . . . 0.0 109.637 170.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -67.21 141.09 57.42 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.557 -0.714 . . . . 0.0 110.605 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 81.3 mt -114.91 137.04 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.658 -0.651 . . . . 0.0 109.596 177.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.07 109.97 53.98 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.746 -0.597 . . . . 0.0 110.143 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -67.14 151.19 81.84 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 O-C-N 123.355 1.187 . . . . 0.0 110.345 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -94.03 123.95 37.73 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.691 -0.63 . . . . 0.0 110.245 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.0 m -66.29 -31.5 72.35 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.741 -0.6 . . . . 0.0 110.519 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -61.69 148.49 42.54 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.561 -0.712 . . . . 0.0 110.687 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.2 mm -96.83 156.57 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.743 -0.598 . . . . 0.0 109.767 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -93.45 112.44 24.35 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.677 -0.64 . . . . 0.0 110.171 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -51.17 -43.03 61.2 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.807 -0.558 . . . . 0.0 111.669 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.521 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.7 t80 -152.88 130.27 11.35 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.659 -0.65 . . . . 0.0 110.284 -174.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.694 HD12 HG11 ' A' ' 41' ' ' VAL . 74.9 mt -128.93 128.6 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.66 -0.65 . . . . 0.0 109.859 172.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.0 tp -90.42 137.05 32.66 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.902 -0.498 . . . . 0.0 109.862 176.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.558 ' CD1' HD11 ' A' ' 72' ' ' ILE . 2.9 m-85 -135.45 129.65 33.54 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.645 -0.66 . . . . 0.0 110.546 -175.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -91.26 147.39 23.08 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.684 -0.635 . . . . 0.0 110.239 173.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.89 -26.38 60.56 Favored Glycine 0 N--CA 1.498 2.818 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.0 m -65.87 -39.65 90.91 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.476 -1.014 . . . . 0.0 110.947 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.68 -32.54 31.7 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.462 -0.774 . . . . 0.0 110.858 -174.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.709 HD13 HD21 ' A' ' 14' ' ' LEU . 8.1 mt -102.83 140.85 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.382 -0.824 . . . . 0.0 110.156 177.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -105.04 -21.82 13.21 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.522 -167.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -151.39 134.27 15.75 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 119.068 -1.053 . . . . 0.0 111.368 -177.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.536 HD12 ' CD1' ' A' ' 14' ' ' LEU . 17.6 tt -131.5 140.09 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.882 -0.511 . . . . 0.0 109.739 176.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -146.83 142.83 28.1 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.548 -0.72 . . . . 0.0 110.4 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.4 m -85.03 147.03 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.653 -0.654 . . . . 0.0 110.183 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.9 t . . . . . 0 N--CA 1.497 1.904 0 O-C-N 121.587 -0.695 . . . . 0.0 109.771 -179.586 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.5 mt . . . . . 0 N--CA 1.501 2.109 0 CA-C-O 120.961 0.41 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.72 -1.8 85.02 Favored Glycine 0 N--CA 1.497 2.755 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.727 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.5 m -60.25 152.99 23.46 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.118 -1.225 . . . . 0.0 110.45 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.526 ' HE3' HG11 ' A' ' 78' ' ' VAL . 29.9 pttt -81.13 125.99 30.92 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.738 -0.601 . . . . 0.0 110.387 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.402 HD12 ' HB2' ' A' ' 26' ' ' LEU . 90.2 mt -124.3 143.79 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.547 -0.721 . . . . 0.0 110.129 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.5 t -101.66 137.25 40.22 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 174.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.64 HD21 HD13 ' A' ' 72' ' ' ILE . 15.2 tp -133.9 127.72 33.09 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.694 -0.629 . . . . 0.0 110.282 -169.005 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 81.9 mt -108.51 121.06 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.455 -0.778 . . . . 0.0 109.683 -178.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 18.3 m -94.51 157.62 15.92 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 120.981 0.42 . . . . 0.0 111.171 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -55.43 -11.5 0.85 Allowed 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -173.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.566 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -90.2 20.54 4.31 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.097 -1.002 . . . . 0.0 110.453 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 54.16 34.2 19.63 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.505 -0.747 . . . . 0.0 109.795 -174.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.803 HG12 HG22 ' A' ' 46' ' ' THR . 66.2 mt -102.6 141.91 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -105.84 119.83 40.16 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.007 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -114.4 148.82 37.12 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 173.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.648 ' O ' HG23 ' A' ' 41' ' ' VAL . 41.4 tt0 -140.09 140.5 36.1 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.37 -0.831 . . . . 0.0 109.504 175.05 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.53 173.5 43.22 Favored Glycine 0 N--CA 1.496 2.651 0 C-N-CA 119.636 -1.269 . . . . 0.0 110.617 -175.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 39.6 mmm-85 -84.83 134.19 34.3 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.926 -0.75 . . . . 0.0 110.439 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.481 ' HA ' HD23 ' A' ' 38' ' ' LEU . 25.7 tp -66.21 118.62 10.18 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.605 -0.684 . . . . 0.0 110.61 175.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.452 ' O ' HG23 ' A' ' 28' ' ' THR . 23.5 t80 -99.43 -50.19 4.18 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.567 -0.708 . . . . 0.0 110.413 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 27' ' ' TYR . 13.3 p -154.12 154.97 34.53 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.704 -0.622 . . . . 0.0 110.326 -178.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.893 HG23 HG22 ' A' ' 36' ' ' ILE . 13.2 p -142.34 144.95 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.737 -0.602 . . . . 0.0 110.055 -179.01 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -129.05 102.14 19.18 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.58 -0.7 . . . . 0.0 109.496 177.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.93 -38.04 50.08 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 O-C-N 123.652 1.343 . . . . 0.0 110.814 -174.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -80.42 -27.37 38.05 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.296 -0.878 . . . . 0.0 110.137 -170.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.577 ' O ' HG23 ' A' ' 35' ' ' THR . 49.5 mt-10 -87.85 2.51 51.26 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.512 -0.742 . . . . 0.0 111.28 173.275 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 55.5 m 49.3 40.02 17.33 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.077 -1.014 . . . . 0.0 111.326 -176.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.577 HG23 ' O ' ' A' ' 33' ' ' GLU . 9.6 p -135.92 153.13 51.53 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.357 -0.839 . . . . 0.0 110.411 -174.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.893 HG22 HG23 ' A' ' 29' ' ' VAL . 40.4 pt -142.63 162.01 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.685 -0.634 . . . . 0.0 110.082 178.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.518 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.42 128.22 29.15 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.655 -0.653 . . . . 0.0 109.741 175.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.481 HD23 ' HA ' ' A' ' 26' ' ' LEU . 88.7 mt -109.92 147.36 33.55 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 99.7 p -117.99 151.77 36.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.619 -0.676 . . . . 0.0 109.24 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.3 p 45.94 85.17 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 CA-C-O 121.574 0.702 . . . . 0.0 110.352 -172.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.697 HG11 HD12 ' A' ' 65' ' ' ILE . 14.3 p -134.66 150.55 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -178.266 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.508 ' HB3' HD12 ' A' ' 61' ' ' ILE . 14.0 ptm180 -133.38 153.09 51.89 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.6 -0.688 . . . . 0.0 109.941 178.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 84.0 p -110.14 140.01 44.68 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.656 -0.653 . . . . 0.0 109.875 178.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -82.89 -38.46 22.86 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.6 -0.688 . . . . 0.0 110.893 -174.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.59 168.65 30.05 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 176.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.803 HG22 HG12 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -118.13 6.48 12.04 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.863 -0.786 . . . . 0.0 111.03 174.687 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -49.06 -26.49 2.68 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.556 -0.715 . . . . 0.0 112.314 -168.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -66.34 -59.22 3.91 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.348 -0.845 . . . . 0.0 110.35 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -94.25 10.22 34.9 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.66 -0.65 . . . . 0.0 111.354 177.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 49.9 p-10 -58.71 172.91 0.46 Allowed 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.252 -0.905 . . . . 0.0 111.261 -170.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.8 m -78.99 164.44 24.39 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.942 -0.474 . . . . 0.0 109.743 175.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -77.39 2.89 14.61 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.646 -0.659 . . . . 0.0 111.246 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -98.58 165.08 11.98 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.332 -0.855 . . . . 0.0 109.551 170.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -67.88 135.52 52.62 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.51 -0.744 . . . . 0.0 110.439 -175.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 45.5 mm -114.1 132.82 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.726 -0.609 . . . . 0.0 109.58 177.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.03 137.28 29.69 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.717 -0.615 . . . . 0.0 110.136 -178.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -69.81 145.95 58.38 Favored 'Trans proline' 0 N--CA 1.488 1.155 0 O-C-N 123.463 1.244 . . . . 0.0 110.244 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -100.6 115.15 29.5 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.681 -0.637 . . . . 0.0 110.198 178.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 28.6 m -85.24 -33.01 22.3 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.7 -0.625 . . . . 0.0 110.329 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -62.37 143.93 56.4 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.687 -0.633 . . . . 0.0 110.567 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.508 HD12 ' HB3' ' A' ' 42' ' ' ARG . 49.4 mm -96.76 149.96 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.649 -0.657 . . . . 0.0 109.814 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -94.37 115.66 27.9 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.644 -0.66 . . . . 0.0 110.208 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -51.31 -40.97 60.16 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.769 -0.582 . . . . 0.0 111.804 178.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.518 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.8 t80 -153.38 130.51 11.13 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.686 -0.634 . . . . 0.0 110.316 -174.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.697 HD12 HG11 ' A' ' 41' ' ' VAL . 78.3 mt -129.88 129.61 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.659 -0.65 . . . . 0.0 109.895 172.234 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 24.5 tp -90.42 137.06 32.65 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.862 -0.524 . . . . 0.0 109.898 176.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.532 ' CD1' HD11 ' A' ' 72' ' ' ILE . 2.9 m-85 -135.53 130.29 34.36 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.701 -0.624 . . . . 0.0 110.45 -175.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -91.17 147.53 22.99 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.762 -0.586 . . . . 0.0 110.272 173.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.08 -25.63 60.03 Favored Glycine 0 N--CA 1.499 2.865 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.8 m -65.92 -39.36 90.48 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.46 -1.024 . . . . 0.0 110.898 -178.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -82.36 -32.5 29.23 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.541 -0.725 . . . . 0.0 111.055 -175.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.64 HD13 HD21 ' A' ' 14' ' ' LEU . 10.1 mt -104.84 141.35 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.412 -0.805 . . . . 0.0 110.209 177.397 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -106.98 -24.19 12.08 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.891 -0.505 . . . . 0.0 111.659 -166.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -150.62 139.15 20.55 Favored 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 119.013 -1.075 . . . . 0.0 111.359 -176.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.472 HD12 HD13 ' A' ' 14' ' ' LEU . 18.2 tt -134.16 143.85 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.996 -0.44 . . . . 0.0 110.023 178.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -143.03 127.19 17.52 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.65 -0.656 . . . . 0.0 110.052 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.5 p -87.7 145.77 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.56 -0.713 . . . . 0.0 110.434 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.526 HG11 ' HE3' ' A' ' 11' ' ' LYS . 60.9 t . . . . . 0 N--CA 1.497 1.898 0 O-C-N 121.629 -0.669 . . . . 0.0 109.78 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.9 mt . . . . . 0 N--CA 1.5 2.055 0 CA-C-O 120.948 0.404 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.65 -1.88 84.59 Favored Glycine 0 N--CA 1.497 2.73 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.808 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.9 m -60.81 153.01 25.6 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 120.997 -1.296 . . . . 0.0 110.445 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.511 ' HE3' HG11 ' A' ' 78' ' ' VAL . 28.5 pttt -82.05 126.92 32.56 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.714 -0.616 . . . . 0.0 110.67 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.688 ' CD1' HD13 ' A' ' 26' ' ' LEU . 86.3 mt -118.6 142.39 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.581 -0.699 . . . . 0.0 109.941 179.031 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.6 t -103.67 137.34 41.85 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 175.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.815 HD21 HD13 ' A' ' 72' ' ' ILE . 13.7 tp -135.96 127.89 29.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.665 -0.647 . . . . 0.0 110.487 -169.136 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 79.5 mt -107.17 120.56 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.507 -0.746 . . . . 0.0 109.609 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.0 m -95.15 157.58 15.83 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.027 0.441 . . . . 0.0 111.134 -177.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -56.43 -11.44 1.26 Allowed 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -173.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.77 22.01 3.29 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.124 -0.985 . . . . 0.0 110.348 177.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 57.55 34.48 24.62 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.56 -0.713 . . . . 0.0 110.12 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.697 HG12 HG22 ' A' ' 46' ' ' THR . 42.8 mt -107.27 148.97 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.713 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -107.83 119.71 40.22 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.07 175.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -113.41 154.07 27.56 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 175.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.67 ' O ' HG23 ' A' ' 41' ' ' VAL . 42.3 tt0 -142.83 140.47 31.31 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.596 -0.69 . . . . 0.0 109.521 173.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -164.17 169.77 39.15 Favored Glycine 0 N--CA 1.496 2.657 0 C-N-CA 119.648 -1.263 . . . . 0.0 110.619 -176.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -84.61 137.43 33.29 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.911 -0.758 . . . . 0.0 110.525 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.688 HD13 ' CD1' ' A' ' 12' ' ' ILE . 15.8 tp -66.14 117.55 8.62 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.629 -0.669 . . . . 0.0 110.645 175.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.451 ' O ' HG23 ' A' ' 28' ' ' THR . 20.2 t80 -99.88 -50.15 4.11 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.585 -0.697 . . . . 0.0 110.309 177.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 27' ' ' TYR . 15.2 p -153.7 153.61 32.56 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.709 -0.619 . . . . 0.0 110.233 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.891 HG23 HG22 ' A' ' 36' ' ' ILE . 13.3 p -142.26 145.1 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.709 -0.619 . . . . 0.0 110.096 -178.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -129.04 102.2 19.16 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.669 -0.644 . . . . 0.0 109.477 176.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.71 -39.42 43.28 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 O-C-N 123.575 1.303 . . . . 0.0 110.863 -174.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -80.49 -26.4 38.23 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.339 -0.851 . . . . 0.0 110.152 -170.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.73 ' O ' HG23 ' A' ' 35' ' ' THR . 75.0 mm-40 -87.6 2.13 51.75 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.532 -0.73 . . . . 0.0 111.292 173.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.3 m 49.65 40.16 19.09 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 120.996 -1.065 . . . . 0.0 111.229 -176.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.73 HG23 ' O ' ' A' ' 33' ' ' GLU . 22.3 p -136.54 151.84 49.84 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.383 -0.823 . . . . 0.0 110.397 -174.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.891 HG22 HG23 ' A' ' 29' ' ' VAL . 40.1 pt -142.65 161.97 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.637 -0.664 . . . . 0.0 110.226 177.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.521 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -135.46 127.51 29.75 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.629 -0.669 . . . . 0.0 109.695 175.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 26' ' ' LEU . 83.9 mt -109.99 145.23 37.32 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -177.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.8 p -116.73 152.36 34.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.625 -0.672 . . . . 0.0 109.195 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 44.9 p 45.81 86.43 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.225 0 CA-C-O 121.502 0.668 . . . . 0.0 110.288 -172.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.707 HG11 HD12 ' A' ' 65' ' ' ILE . 12.9 p -134.65 147.73 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -178.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -129.1 153.03 48.05 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.748 -0.595 . . . . 0.0 109.754 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.5 p -107.51 121.81 45.37 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -83.09 -38.53 22.36 Favored 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.964 -169.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.4 -177.51 41.86 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.697 HG22 HG12 ' A' ' 20' ' ' ILE . 66.5 p -118.12 -2.41 11.22 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.794 -0.827 . . . . 0.0 110.645 172.169 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -54.41 -24.92 21.85 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.379 -0.825 . . . . 0.0 112.528 -162.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -77.07 -59.47 2.77 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.252 -0.905 . . . . 0.0 110.928 -174.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 70.7 mtp85 -94.51 6.15 49.66 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.631 -0.668 . . . . 0.0 112.098 -175.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.8 p-10 -89.32 174.45 7.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.092 -1.005 . . . . 0.0 111.295 -172.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.8 m -78.76 164.47 24.53 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.056 0.455 . . . . 0.0 110.013 178.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -77.66 9.24 3.55 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.743 -0.598 . . . . 0.0 111.71 -176.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -87.98 155.18 19.96 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.098 -1.001 . . . . 0.0 109.948 172.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -67.15 129.94 41.51 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.698 -0.627 . . . . 0.0 110.827 -172.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 82.4 mt -129.0 140.63 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.737 -0.602 . . . . 0.0 109.444 175.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.0 109.84 53.27 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.547 -0.72 . . . . 0.0 110.371 -178.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -77.63 157.07 32.03 Favored 'Trans proline' 0 N--CA 1.486 1.066 0 O-C-N 123.449 1.237 . . . . 0.0 110.432 176.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -114.67 131.22 56.81 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.656 -0.652 . . . . 0.0 110.14 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.6 m -97.06 12.41 32.71 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.69 -0.631 . . . . 0.0 111.333 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -63.62 145.07 56.42 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.308 -0.87 . . . . 0.0 110.564 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.81 128.94 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.613 -0.68 . . . . 0.0 109.863 178.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.512 ' CG ' HD11 ' A' ' 65' ' ' ILE . 22.0 m-85 -98.99 119.53 37.92 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.689 -0.632 . . . . 0.0 110.376 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -51.75 -41.22 61.43 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.715 -0.615 . . . . 0.0 111.252 173.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.521 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.7 t80 -153.98 128.82 9.46 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.686 -0.634 . . . . 0.0 110.103 -175.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.707 HD12 HG11 ' A' ' 41' ' ' VAL . 67.4 mt -126.31 130.33 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.639 -0.663 . . . . 0.0 109.879 172.022 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.5 tp -89.94 137.06 32.65 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.838 -0.539 . . . . 0.0 109.686 175.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.648 ' CD1' HD11 ' A' ' 72' ' ' ILE . 3.3 m-85 -133.8 126.5 30.71 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.706 -0.621 . . . . 0.0 110.55 -175.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -92.71 149.95 20.99 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.689 -0.632 . . . . 0.0 110.305 172.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.83 -24.01 57.02 Favored Glycine 0 N--CA 1.498 2.821 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 177.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.0 p -68.32 -42.05 79.94 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.409 -1.053 . . . . 0.0 111.115 -176.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -82.98 -29.38 29.04 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.331 -0.856 . . . . 0.0 111.028 -175.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.815 HD13 HD21 ' A' ' 14' ' ' LEU . 15.4 mt -103.74 140.7 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.416 -0.802 . . . . 0.0 110.255 176.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -105.74 -19.83 13.64 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.912 -0.492 . . . . 0.0 111.552 -168.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -149.98 131.55 14.86 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 119.046 -1.062 . . . . 0.0 111.319 -178.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.7 tt -129.88 138.81 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.979 -0.451 . . . . 0.0 109.809 176.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 90.6 mtt-85 -146.89 137.94 23.99 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.543 -0.723 . . . . 0.0 110.421 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.6 t -87.17 143.76 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.658 -0.652 . . . . 0.0 109.693 178.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.511 HG11 ' HE3' ' A' ' 11' ' ' LYS . 55.9 t . . . . . 0 N--CA 1.496 1.872 0 O-C-N 121.541 -0.724 . . . . 0.0 109.885 -178.5 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.1 mt . . . . . 0 N--CA 1.502 2.159 0 CA-C-O 121.05 0.452 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.57 -2.37 82.78 Favored Glycine 0 N--CA 1.497 2.765 0 C-N-CA 120.699 -0.763 . . . . 0.0 111.944 175.196 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.1 m -64.29 150.62 45.71 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.168 -1.195 . . . . 0.0 110.389 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -81.42 127.84 33.22 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.623 -0.673 . . . . 0.0 110.052 175.937 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.636 ' CD1' HD13 ' A' ' 26' ' ' LEU . 88.4 mt -125.12 143.92 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.435 -0.791 . . . . 0.0 110.299 -178.317 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.6 t -102.19 137.28 40.66 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 173.983 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.467 ' CD1' HD12 ' A' ' 75' ' ' ILE . 12.6 tp -134.66 130.6 36.61 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.675 -0.641 . . . . 0.0 110.292 -170.183 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.2 mt -107.12 121.49 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.508 -0.745 . . . . 0.0 109.743 -178.699 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.6 m -93.95 157.86 15.91 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.033 0.444 . . . . 0.0 111.23 -178.129 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -53.35 -15.41 0.99 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -171.045 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.497 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -90.17 20.65 4.21 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.148 -0.97 . . . . 0.0 110.433 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 54.1 34.98 21.2 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.446 -0.784 . . . . 0.0 109.805 -174.511 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.864 HG12 HG22 ' A' ' 46' ' ' THR . 69.8 mt -102.89 143.1 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.21 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -103.77 119.83 39.72 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.159 -178.614 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -113.7 149.7 34.36 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 175.0 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.63 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.3 mt-10 -141.17 140.6 34.08 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.418 -0.801 . . . . 0.0 109.815 175.964 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.35 172.84 43.04 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 119.716 -1.231 . . . . 0.0 110.529 -175.923 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 80.8 mtt85 -86.0 135.91 33.46 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.888 -0.772 . . . . 0.0 110.62 179.05 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.636 HD13 ' CD1' ' A' ' 12' ' ' ILE . 13.6 tp -66.17 118.0 9.27 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.605 -0.684 . . . . 0.0 110.663 176.6 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.462 ' O ' HG23 ' A' ' 28' ' ' THR . 28.8 t80 -100.24 -50.14 4.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.627 -0.67 . . . . 0.0 110.55 179.093 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 27' ' ' TYR . 11.7 p -154.63 155.61 34.99 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.603 -0.686 . . . . 0.0 110.382 -178.024 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.842 HG23 HG22 ' A' ' 36' ' ' ILE . 13.2 p -142.31 145.92 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.744 -0.597 . . . . 0.0 110.009 -179.425 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -128.92 100.26 21.2 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.603 -0.686 . . . . 0.0 109.503 177.581 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.58 -37.16 60.09 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 O-C-N 123.599 1.315 . . . . 0.0 110.793 -175.17 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -80.07 -27.98 39.26 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.379 -0.826 . . . . 0.0 110.061 -171.251 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.577 ' O ' HG23 ' A' ' 35' ' ' THR . 77.8 mt-10 -88.23 2.6 51.92 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.545 -0.722 . . . . 0.0 111.235 174.011 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 39.0 m 49.44 40.66 19.41 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.007 -1.058 . . . . 0.0 111.198 -175.864 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.577 HG23 ' O ' ' A' ' 33' ' ' GLU . 11.2 p -135.73 154.49 51.23 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.436 -0.79 . . . . 0.0 110.381 -175.166 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.842 HG22 HG23 ' A' ' 29' ' ' VAL . 40.0 pt -141.94 162.03 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.718 -0.614 . . . . 0.0 110.142 177.675 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.514 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.9 128.37 28.43 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.695 -0.628 . . . . 0.0 109.802 175.482 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 26' ' ' LEU . 85.0 mt -109.81 147.01 34.06 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -178.536 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 87.6 p -115.71 150.12 37.33 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -177.957 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 52.5 p 45.73 85.36 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 121.504 0.668 . . . . 0.0 110.29 -172.657 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.709 ' CG1' HD12 ' A' ' 65' ' ' ILE . 15.0 p -134.64 152.33 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -178.787 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -136.39 153.09 51.2 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.503 -0.748 . . . . 0.0 110.236 179.037 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.6 p -109.69 136.3 49.25 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.764 -0.585 . . . . 0.0 109.637 176.576 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -83.04 -38.59 22.36 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.537 -0.727 . . . . 0.0 111.19 -172.533 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.4 174.94 36.93 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.912 -1.137 . . . . 0.0 110.515 176.195 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.864 HG22 HG12 ' A' ' 20' ' ' ILE . 7.4 p -116.75 6.53 13.26 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.834 -0.804 . . . . 0.0 110.528 169.645 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -52.35 -24.56 7.82 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.615 -0.678 . . . . 0.0 112.597 -166.451 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -64.14 -59.43 4.45 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.154 -0.966 . . . . 0.0 110.604 -176.635 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 39.6 mtp85 -94.54 10.2 35.61 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.55 -0.719 . . . . 0.0 111.393 176.512 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.5 p-10 -58.91 172.29 0.57 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.234 -0.916 . . . . 0.0 111.552 -169.161 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.8 m -85.0 164.49 18.23 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 174.717 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -77.47 3.81 12.55 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.642 -0.661 . . . . 0.0 111.287 -179.364 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -95.17 157.48 15.88 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.247 -0.908 . . . . 0.0 109.683 168.873 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -70.52 139.25 51.54 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.645 -0.659 . . . . 0.0 110.538 -176.004 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.7 mt -115.36 136.23 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.725 -0.61 . . . . 0.0 109.556 176.76 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.11 113.08 12.87 Favored Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 121.707 -0.621 . . . . 0.0 110.138 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -66.93 143.76 67.67 Favored 'Trans proline' 0 N--CA 1.488 1.188 0 O-C-N 123.389 1.205 . . . . 0.0 110.392 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -97.82 114.7 26.8 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.72 -0.612 . . . . 0.0 110.216 -179.79 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.6 t -101.54 -32.95 10.13 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.721 -0.612 . . . . 0.0 110.306 179.457 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -62.24 151.49 36.13 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.627 -0.671 . . . . 0.0 110.634 -178.807 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.2 mm -96.81 142.71 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.808 -0.557 . . . . 0.0 109.79 179.672 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -94.82 118.09 31.2 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.613 -0.679 . . . . 0.0 110.137 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -51.14 -42.36 60.7 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.859 -0.525 . . . . 0.0 111.732 178.618 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.514 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.0 t80 -152.7 130.88 11.95 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.609 -0.682 . . . . 0.0 110.182 -174.969 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.709 HD12 ' CG1' ' A' ' 41' ' ' VAL . 75.5 mt -129.73 127.45 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.625 -0.672 . . . . 0.0 109.859 172.148 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 23.9 tp -90.2 137.1 32.62 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.817 -0.552 . . . . 0.0 109.741 175.662 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.425 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 3.6 m-85 -136.57 131.16 33.43 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.629 -0.67 . . . . 0.0 110.6 -175.691 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -90.71 149.18 22.15 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.781 -0.575 . . . . 0.0 110.187 174.741 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.26 -25.06 59.69 Favored Glycine 0 N--CA 1.5 2.912 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 178.758 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.9 m -65.91 -40.55 91.6 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.412 -1.052 . . . . 0.0 110.885 -178.432 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.95 -34.42 29.8 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.631 -0.668 . . . . 0.0 110.929 -174.818 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.425 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 13.9 mt -105.94 140.26 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.429 -0.794 . . . . 0.0 110.11 177.617 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 47.8 tttm -107.27 -24.62 11.82 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.839 -164.589 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -149.12 140.78 23.5 Favored 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.548 -174.414 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.467 HD12 ' CD1' ' A' ' 14' ' ' LEU . 15.4 tt -134.09 147.81 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.939 -0.475 . . . . 0.0 110.106 179.567 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -147.02 129.75 16.1 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.597 -0.69 . . . . 0.0 110.287 176.59 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.41 HG22 HG12 ' A' ' 12' ' ' ILE . 51.4 t -87.4 146.05 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.657 -0.652 . . . . 0.0 109.83 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 50.2 t . . . . . 0 N--CA 1.498 1.957 0 O-C-N 121.573 -0.704 . . . . 0.0 109.711 179.99 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.5 mt . . . . . 0 N--CA 1.5 2.064 0 CA-C-O 121.002 0.43 . . . . 0.0 110.675 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.7 -1.96 84.46 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.826 177.287 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.7 m -61.99 136.34 57.92 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.13 -1.218 . . . . 0.0 110.405 179.283 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.485 ' HE3' HG11 ' A' ' 78' ' ' VAL . 31.3 pttt -81.83 126.4 31.82 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.655 -0.653 . . . . 0.0 110.475 179.761 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.409 HD12 ' HB2' ' A' ' 26' ' ' LEU . 92.7 mt -124.84 145.07 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.523 -0.736 . . . . 0.0 110.203 179.501 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.8 t -102.8 137.26 41.25 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.582 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.634 HD21 HD13 ' A' ' 72' ' ' ILE . 17.3 tp -134.9 126.76 29.36 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.788 -0.57 . . . . 0.0 110.282 -168.988 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 81.3 mt -108.74 120.91 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.557 -0.714 . . . . 0.0 109.697 -178.919 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.2 m -93.54 157.78 16.03 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.146 0.498 . . . . 0.0 111.216 -176.979 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -54.27 -13.77 0.97 Allowed 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -172.159 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.45 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.19 20.03 3.96 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.147 -0.97 . . . . 0.0 110.436 179.081 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 55.64 35.78 25.9 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.503 -0.748 . . . . 0.0 109.821 -176.241 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.828 HG12 HG22 ' A' ' 46' ' ' THR . 60.6 mt -105.81 145.63 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.929 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -105.4 119.82 40.05 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.25 -179.313 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -114.53 151.04 33.98 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 174.843 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.648 ' O ' HG23 ' A' ' 41' ' ' VAL . 65.1 mt-10 -142.29 140.64 32.25 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.35 -0.844 . . . . 0.0 109.818 174.354 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.22 173.08 43.01 Favored Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.526 -175.898 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 56.4 mtm180 -85.71 136.03 33.52 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.867 -0.784 . . . . 0.0 110.573 179.164 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.492 ' HA ' HD23 ' A' ' 38' ' ' LEU . 28.0 tp -66.17 119.99 12.43 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.62 -0.675 . . . . 0.0 110.738 175.343 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.439 ' O ' HG23 ' A' ' 28' ' ' THR . 27.4 t80 -99.68 -50.03 4.19 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.764 -0.585 . . . . 0.0 110.347 177.838 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 27' ' ' TYR . 16.2 p -153.98 155.58 35.85 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.642 -0.661 . . . . 0.0 110.233 -178.39 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.848 HG23 HG22 ' A' ' 36' ' ' ILE . 13.5 p -142.31 145.56 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.654 -0.654 . . . . 0.0 110.093 -178.967 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -127.33 98.62 29.04 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.65 -0.656 . . . . 0.0 109.602 177.645 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -59.3 -42.39 50.01 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 O-C-N 123.636 1.335 . . . . 0.0 111.03 -175.763 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -80.63 -25.14 38.55 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.405 -0.809 . . . . 0.0 110.199 -171.13 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.567 ' O ' HG23 ' A' ' 35' ' ' THR . 55.1 mt-10 -87.33 1.67 52.57 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.438 -0.789 . . . . 0.0 111.18 173.605 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 38.7 m 49.87 38.55 16.25 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 121.13 -0.981 . . . . 0.0 111.226 -177.009 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.567 HG23 ' O ' ' A' ' 33' ' ' GLU . 10.6 p -135.77 154.28 51.27 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.394 -0.816 . . . . 0.0 110.407 -175.128 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.848 HG22 HG23 ' A' ' 29' ' ' VAL . 39.9 pt -143.1 161.87 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.638 -0.664 . . . . 0.0 110.204 178.634 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.506 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.9 127.93 27.69 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.652 -0.655 . . . . 0.0 109.692 175.524 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 26' ' ' LEU . 87.4 mt -109.91 147.78 32.79 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -177.872 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 91.8 p -118.33 151.43 37.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.641 -0.662 . . . . 0.0 109.226 -177.888 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 44.1 p 45.63 83.66 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 121.543 0.687 . . . . 0.0 110.376 -172.197 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.692 ' CG1' HD12 ' A' ' 65' ' ' ILE . 14.3 p -134.63 150.53 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.406 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -136.36 153.19 51.19 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.638 -0.663 . . . . 0.0 110.128 178.554 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.0 p -108.4 137.16 46.83 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.736 -0.602 . . . . 0.0 109.546 177.307 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -83.01 -38.57 22.44 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 119.833 -0.747 . . . . 0.0 111.063 -172.017 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.32 167.55 28.16 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 175.614 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.828 HG22 HG12 ' A' ' 20' ' ' ILE . 50.2 p -118.3 -13.84 9.83 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.875 -0.779 . . . . 0.0 110.84 171.289 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -52.52 -24.59 8.38 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.398 -0.814 . . . . 0.0 112.482 -165.901 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -78.22 -59.36 2.81 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.287 -0.883 . . . . 0.0 110.836 -176.945 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -94.55 10.12 35.91 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.52 -0.738 . . . . 0.0 111.956 -174.668 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.9 p-10 -93.18 174.6 7.14 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.056 -1.028 . . . . 0.0 111.19 -174.584 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.4 m -78.48 164.58 24.62 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.967 -0.458 . . . . 0.0 109.783 177.948 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -77.49 11.78 1.87 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.662 -0.649 . . . . 0.0 111.671 -174.015 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -91.32 143.36 26.72 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.121 -0.987 . . . . 0.0 109.73 170.07 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -66.04 140.21 58.25 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.712 -0.618 . . . . 0.0 110.953 -171.013 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 83.9 mt -120.88 142.02 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 176.417 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.3 112.81 10.15 Favored Pre-proline 0 N--CA 1.501 2.084 0 O-C-N 121.628 -0.67 . . . . 0.0 110.204 -179.492 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -63.8 141.89 80.4 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 O-C-N 123.345 1.181 . . . . 0.0 110.614 -179.271 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -107.9 107.16 17.75 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.655 -0.653 . . . . 0.0 110.199 179.431 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.2 t -103.36 -34.87 8.6 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.713 -0.617 . . . . 0.0 110.2 179.47 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -62.84 157.45 21.37 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.674 -0.641 . . . . 0.0 110.611 -179.479 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.8 mm -96.75 136.98 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.698 -0.626 . . . . 0.0 109.686 179.071 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -96.05 117.2 30.21 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.62 -0.675 . . . . 0.0 110.356 -178.2 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -51.23 -40.46 58.84 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.827 -0.546 . . . . 0.0 111.629 177.229 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.506 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.6 t80 -152.33 130.2 11.71 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.615 -0.678 . . . . 0.0 110.35 -174.471 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.692 HD12 ' CG1' ' A' ' 41' ' ' VAL . 77.2 mt -129.66 126.68 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.671 -0.643 . . . . 0.0 109.798 171.527 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 19.2 tp -90.57 137.13 32.6 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.77 -0.581 . . . . 0.0 109.841 176.226 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.484 ' CD1' HD11 ' A' ' 72' ' ' ILE . 4.6 m-85 -137.07 132.58 34.35 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.653 -0.655 . . . . 0.0 110.585 -175.281 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -90.69 148.13 22.81 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.71 -0.619 . . . . 0.0 110.269 173.579 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.21 -25.65 60.35 Favored Glycine 0 N--CA 1.499 2.854 0 N-CA-C 110.521 -1.031 . . . . 0.0 110.521 179.363 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.4 p -67.41 -38.26 84.36 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.419 -1.048 . . . . 0.0 110.842 -177.45 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -82.48 -32.57 28.79 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.432 -0.792 . . . . 0.0 110.841 -175.394 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.634 HD13 HD21 ' A' ' 14' ' ' LEU . 10.6 mt -106.41 134.19 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.496 -0.752 . . . . 0.0 109.923 176.988 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.4 tttp -108.75 -10.98 15.11 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 120.485 -0.486 . . . . 0.0 112.077 -166.68 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -147.8 129.63 15.22 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.876 -1.14 . . . . 0.0 111.155 -179.641 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.48 HD12 ' CD1' ' A' ' 14' ' ' LEU . 18.1 tt -137.96 139.48 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.958 -0.464 . . . . 0.0 110.017 178.197 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 82.5 mtm-85 -147.12 136.86 23.04 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.54 -0.725 . . . . 0.0 110.51 176.912 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.3 p -87.13 147.04 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.688 -0.632 . . . . 0.0 110.1 177.781 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.485 HG11 ' HE3' ' A' ' 11' ' ' LYS . 61.4 t . . . . . 0 N--CA 1.498 1.953 0 O-C-N 121.624 -0.673 . . . . 0.0 109.772 -178.835 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.3 mt . . . . . 0 N--CA 1.502 2.14 0 CA-C-O 121.055 0.455 . . . . 0.0 110.683 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.71 -1.96 84.49 Favored Glycine 0 N--CA 1.496 2.682 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.809 177.712 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 74.8 m -62.38 142.73 57.68 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.09 -1.241 . . . . 0.0 110.477 179.679 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -82.03 126.81 32.42 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.693 -0.63 . . . . 0.0 110.386 178.289 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 90.5 mt -123.97 145.02 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.584 -0.697 . . . . 0.0 110.148 -179.725 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.6 t -103.33 137.29 41.65 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 176.12 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.663 HD21 HD13 ' A' ' 72' ' ' ILE . 14.5 tp -133.23 123.18 25.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.776 -0.578 . . . . 0.0 110.263 -169.662 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.604 ' O ' HG23 ' A' ' 72' ' ' ILE . 79.8 mt -106.31 116.87 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.427 -0.796 . . . . 0.0 109.711 -178.801 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.5 m -92.83 157.71 16.25 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 120.955 0.407 . . . . 0.0 111.231 -177.101 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -54.61 -11.81 0.63 Allowed 'General case' 0 N--CA 1.509 2.49 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -171.608 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.519 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -90.22 20.0 4.69 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.083 -1.01 . . . . 0.0 110.45 179.386 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 54.66 33.52 19.49 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.52 -0.738 . . . . 0.0 109.853 -174.285 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.857 HG12 HG22 ' A' ' 46' ' ' THR . 65.7 mt -102.52 140.93 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.441 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -104.83 119.77 39.8 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.994 -0.683 . . . . 0.0 109.939 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -114.25 149.43 35.87 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 174.403 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.669 ' O ' HG23 ' A' ' 41' ' ' VAL . 42.2 tt0 -140.34 140.46 35.6 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.584 -0.698 . . . . 0.0 109.54 175.154 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.4 172.65 42.4 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.624 -175.888 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -85.38 135.61 33.81 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.956 -0.732 . . . . 0.0 110.504 179.097 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.486 ' HA ' HD23 ' A' ' 38' ' ' LEU . 27.8 tp -66.14 120.82 13.87 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.597 -0.689 . . . . 0.0 110.663 176.13 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.433 ' O ' HG23 ' A' ' 28' ' ' THR . 21.6 t80 -99.19 -49.96 4.3 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.666 -0.646 . . . . 0.0 110.257 178.194 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 27' ' ' TYR . 17.0 p -153.38 156.77 38.9 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.742 -0.599 . . . . 0.0 110.068 -179.162 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.889 HG23 HG22 ' A' ' 36' ' ' ILE . 13.6 p -142.25 145.9 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.658 -0.651 . . . . 0.0 110.227 -177.795 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -128.26 101.49 21.96 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.609 -0.682 . . . . 0.0 109.507 177.022 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.38 -41.2 34.89 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 O-C-N 123.579 1.305 . . . . 0.0 110.839 -174.459 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -80.7 -24.57 38.75 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.283 -0.886 . . . . 0.0 110.203 -171.732 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.742 ' O ' HG23 ' A' ' 35' ' ' THR . 54.8 mt-10 -87.31 1.31 53.63 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.474 -0.767 . . . . 0.0 111.262 173.463 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.9 m 49.86 38.14 15.21 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.042 -1.036 . . . . 0.0 111.276 -176.698 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.742 HG23 ' O ' ' A' ' 33' ' ' GLU . 21.6 p -136.45 153.52 51.03 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.477 -0.764 . . . . 0.0 110.377 -174.27 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.889 HG22 HG23 ' A' ' 29' ' ' VAL . 39.8 pt -142.34 162.06 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.711 -0.618 . . . . 0.0 110.182 177.707 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.526 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -133.68 127.7 33.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.659 -0.651 . . . . 0.0 109.62 176.011 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 26' ' ' LEU . 88.7 mt -109.94 149.45 29.9 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -176.481 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 91.8 p -123.1 154.33 38.73 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.134 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.5 p 45.41 83.76 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 121.492 0.663 . . . . 0.0 110.375 -171.805 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.718 HG11 HD12 ' A' ' 65' ' ' ILE . 14.4 p -134.55 149.74 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -178.537 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -134.84 153.21 52.13 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.622 -0.674 . . . . 0.0 109.982 178.766 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.2 p -107.32 138.55 43.3 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.671 -0.643 . . . . 0.0 109.894 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -83.07 -38.28 22.73 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.648 -0.658 . . . . 0.0 110.905 -174.282 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.74 170.32 32.37 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 178.803 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.857 HG22 HG12 ' A' ' 20' ' ' ILE . 1.8 p -118.03 6.75 12.14 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.909 -0.759 . . . . 0.0 111.173 177.451 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -48.89 -23.87 1.26 Allowed 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.471 -0.768 . . . . 0.0 112.694 -169.552 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -54.3 -45.56 72.59 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.235 -0.915 . . . . 0.0 111.344 -179.396 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 75.4 mtp180 -94.14 -58.08 2.34 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.432 -0.792 . . . . 0.0 110.766 -179.788 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.45 ' OD1' HD11 ' A' ' 55' ' ' ILE . 2.9 p30 -67.35 174.88 3.01 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.727 -0.608 . . . . 0.0 110.378 -178.67 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.7 p -78.13 164.41 25.0 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.694 -0.629 . . . . 0.0 110.664 -170.664 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -77.52 1.68 18.65 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.413 -177.746 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -72.53 161.17 31.14 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.171 -0.956 . . . . 0.0 109.811 176.4 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -65.94 130.24 42.58 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.625 -0.672 . . . . 0.0 111.017 -168.179 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.45 HD11 ' OD1' ' A' ' 50' ' ' ASP . 82.2 mt -114.92 136.67 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 173.521 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.03 112.49 7.59 Favored Pre-proline 0 N--CA 1.501 2.122 0 O-C-N 121.581 -0.7 . . . . 0.0 110.54 -174.628 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -79.67 151.25 22.02 Favored 'Trans proline' 0 N--CA 1.485 1.021 0 O-C-N 123.403 1.212 . . . . 0.0 110.261 179.171 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -101.75 114.19 28.04 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.662 -0.649 . . . . 0.0 110.053 177.435 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.2 m -66.38 -32.65 74.17 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.698 -0.626 . . . . 0.0 110.492 -178.999 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -62.15 143.29 56.93 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.602 -0.686 . . . . 0.0 110.724 -178.238 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.9 mm -96.76 158.9 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.798 -0.564 . . . . 0.0 109.703 179.008 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -93.4 112.5 24.42 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.598 -0.689 . . . . 0.0 110.138 -178.798 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -51.57 -42.32 61.78 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.78 -0.575 . . . . 0.0 111.629 177.199 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.526 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.5 t80 -153.09 128.78 10.11 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.594 -0.691 . . . . 0.0 110.365 -174.018 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.718 HD12 HG11 ' A' ' 41' ' ' VAL . 71.1 mt -128.34 133.48 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.693 -0.63 . . . . 0.0 109.939 172.954 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 27.1 tp -90.35 137.06 32.66 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.866 -0.521 . . . . 0.0 109.971 176.107 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.919 ' CD1' HD11 ' A' ' 72' ' ' ILE . 2.2 m-85 -133.61 124.43 26.82 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.686 -0.634 . . . . 0.0 110.673 -176.622 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 73.6 mtt85 -92.96 145.98 23.97 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.696 -0.628 . . . . 0.0 110.358 172.358 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.73 -24.69 62.6 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 179.532 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.6 m -67.9 -42.24 81.47 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.413 -1.051 . . . . 0.0 111.199 -173.799 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -85.46 -24.19 27.52 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.328 -0.858 . . . . 0.0 111.128 -175.929 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.919 HD11 ' CD1' ' A' ' 67' ' ' PHE . 86.7 mt -96.65 143.03 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.236 -0.915 . . . . 0.0 110.165 173.556 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -104.02 -20.85 13.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.984 -0.447 . . . . 0.0 111.304 -170.412 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -152.87 131.88 12.59 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 119.147 -1.021 . . . . 0.0 111.297 -179.414 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.56 HD12 ' CD1' ' A' ' 14' ' ' LEU . 17.5 tt -131.53 138.53 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 175.292 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -146.81 131.28 17.68 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.663 -0.648 . . . . 0.0 110.423 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.2 p -87.99 147.08 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.61 -0.681 . . . . 0.0 110.171 177.686 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.2 t . . . . . 0 N--CA 1.497 1.906 0 O-C-N 121.57 -0.706 . . . . 0.0 109.737 -179.703 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.8 mt . . . . . 0 N--CA 1.501 2.102 0 CA-C-O 121.035 0.445 . . . . 0.0 110.529 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.58 -1.88 84.4 Favored Glycine 0 N--CA 1.497 2.741 0 C-N-CA 120.453 -0.88 . . . . 0.0 111.815 177.653 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 71.5 m -61.35 148.58 40.93 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.155 -1.203 . . . . 0.0 110.44 -179.086 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -82.21 127.45 33.19 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.491 179.588 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.683 ' CD1' HD13 ' A' ' 26' ' ' LEU . 89.1 mt -121.78 144.5 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.588 -0.695 . . . . 0.0 109.944 179.01 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.0 t -103.05 137.32 41.38 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 175.983 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.756 ' HG ' HG21 ' A' ' 72' ' ' ILE . 11.5 tp -133.32 123.3 25.2 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.792 -0.568 . . . . 0.0 110.002 -171.246 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.708 ' O ' HG23 ' A' ' 72' ' ' ILE . 82.2 mt -103.98 119.17 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.522 -0.736 . . . . 0.0 109.683 -177.707 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.1 m -94.32 157.93 15.81 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.137 0.494 . . . . 0.0 111.46 -175.525 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -53.72 -14.6 0.95 Allowed 'General case' 0 N--CA 1.507 2.385 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -171.363 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.462 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.68 20.39 4.07 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.221 -0.924 . . . . 0.0 110.459 179.475 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 55.53 35.42 25.11 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.486 -0.759 . . . . 0.0 109.93 -176.137 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.838 HG12 HG22 ' A' ' 46' ' ' THR . 60.9 mt -105.31 145.3 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.902 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 55.5 ttt85 -105.73 119.8 40.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.624 -0.673 . . . . 0.0 110.15 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -113.68 150.68 32.89 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.682 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.658 ' O ' HG23 ' A' ' 41' ' ' VAL . 36.1 mt-10 -141.36 140.55 33.76 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.437 -0.79 . . . . 0.0 109.776 174.883 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.61 172.49 41.12 Favored Glycine 0 N--CA 1.495 2.623 0 C-N-CA 119.875 -1.155 . . . . 0.0 110.451 -175.913 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -84.3 138.75 32.74 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.919 -0.753 . . . . 0.0 110.545 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.683 HD13 ' CD1' ' A' ' 12' ' ' ILE . 17.0 tp -66.15 117.68 8.8 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.628 -0.67 . . . . 0.0 110.685 175.888 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.457 ' O ' HG23 ' A' ' 28' ' ' THR . 28.7 t80 -100.09 -50.08 4.09 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.596 -0.69 . . . . 0.0 110.437 177.926 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 27' ' ' TYR . 15.2 p -154.19 154.83 34.18 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.648 -0.658 . . . . 0.0 110.317 -178.185 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.839 HG23 HG22 ' A' ' 36' ' ' ILE . 13.5 p -142.19 145.6 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.707 -0.62 . . . . 0.0 110.054 -179.347 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -129.02 98.19 24.56 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.643 -0.661 . . . . 0.0 109.504 177.355 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -59.64 -40.34 65.99 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 O-C-N 123.64 1.337 . . . . 0.0 110.973 -176.118 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -80.32 -27.39 38.42 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.308 -0.87 . . . . 0.0 110.118 -170.675 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.731 ' O ' HG23 ' A' ' 35' ' ' THR . 46.1 mt-10 -87.76 2.89 50.06 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.529 -0.732 . . . . 0.0 111.252 173.707 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 40.1 m 50.02 40.34 21.1 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.141 -0.974 . . . . 0.0 111.425 -177.768 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.731 HG23 ' O ' ' A' ' 33' ' ' GLU . 39.6 p -136.0 154.34 51.1 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.372 -0.83 . . . . 0.0 110.481 -176.81 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.839 HG22 HG23 ' A' ' 29' ' ' VAL . 40.0 pt -142.06 161.5 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.672 -0.643 . . . . 0.0 109.991 176.646 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.497 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.72 128.6 29.21 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.688 -0.633 . . . . 0.0 109.724 176.262 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 26' ' ' LEU . 83.8 mt -109.76 144.57 37.98 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -178.3 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.4 p -115.3 153.11 31.54 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -178.038 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.0 p 45.31 84.69 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 CA-C-O 121.506 0.669 . . . . 0.0 110.271 -171.672 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 23' ' ' GLU . 13.6 p -134.64 149.52 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -178.314 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.425 ' HB3' HD12 ' A' ' 61' ' ' ILE . 19.6 ptp180 -134.92 153.09 52.19 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.612 -0.68 . . . . 0.0 110.136 179.061 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.8 p -107.91 136.7 47.18 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.747 -0.596 . . . . 0.0 109.639 177.644 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -82.77 -38.45 23.18 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 119.864 -0.735 . . . . 0.0 111.115 -172.339 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.47 166.47 26.6 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 175.783 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.838 HG22 HG12 ' A' ' 20' ' ' ILE . 45.7 p -118.2 -19.77 8.87 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.846 -0.796 . . . . 0.0 110.909 172.786 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -53.3 -26.48 18.77 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.511 -0.743 . . . . 0.0 112.249 -167.54 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -70.49 -59.31 2.92 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.359 -0.838 . . . . 0.0 110.733 -176.025 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 63.1 mtp85 -94.42 -16.34 23.51 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.606 -0.684 . . . . 0.0 111.741 -175.739 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -63.7 174.57 1.34 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.239 -0.913 . . . . 0.0 111.245 -172.639 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.1 m -78.68 164.63 24.44 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 177.887 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -77.5 11.46 2.01 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.676 -0.64 . . . . 0.0 111.565 -174.805 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -92.93 164.48 13.29 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.2 -0.938 . . . . 0.0 109.683 169.519 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -66.05 138.17 57.58 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.584 -0.697 . . . . 0.0 110.726 -172.623 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.3 mm -118.39 139.54 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.773 -0.579 . . . . 0.0 109.595 177.383 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.58 113.63 18.48 Favored Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 121.69 -0.631 . . . . 0.0 110.288 -178.827 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -68.54 153.18 74.21 Favored 'Trans proline' 0 N--CA 1.487 1.123 0 O-C-N 123.365 1.192 . . . . 0.0 110.4 179.006 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -132.92 65.73 1.58 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.649 -0.657 . . . . 0.0 110.127 179.526 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.1 m -65.98 -33.4 75.72 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.515 -0.741 . . . . 0.0 110.401 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -62.0 155.35 24.05 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.616 -0.678 . . . . 0.0 110.621 -178.926 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.425 HD12 ' HB3' ' A' ' 42' ' ' ARG . 45.2 mm -96.71 138.34 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.656 -0.652 . . . . 0.0 109.741 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -97.85 118.8 35.24 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.664 -0.647 . . . . 0.0 110.471 -177.324 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -51.3 -39.95 57.95 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.721 -0.612 . . . . 0.0 111.428 175.27 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.497 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.8 t80 -152.95 130.4 11.4 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.75 -0.593 . . . . 0.0 110.254 -174.887 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.645 HD12 ' CG1' ' A' ' 41' ' ' VAL . 72.9 mt -128.97 127.33 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.65 -0.656 . . . . 0.0 109.901 171.445 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 24.0 tp -91.03 137.14 32.59 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.929 -0.482 . . . . 0.0 109.917 176.317 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.541 ' CD1' HD11 ' A' ' 72' ' ' ILE . 5.9 m-85 -137.18 128.61 28.29 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.65 -0.656 . . . . 0.0 110.531 -176.483 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -91.1 154.93 19.02 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.658 -0.651 . . . . 0.0 110.278 173.986 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.07 -23.96 57.87 Favored Glycine 0 N--CA 1.498 2.824 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 177.691 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.8 m -72.72 -42.09 64.52 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.46 -1.023 . . . . 0.0 111.28 -175.074 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -84.55 -26.63 27.89 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.345 -0.847 . . . . 0.0 111.144 -174.015 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.756 HG21 ' HG ' ' A' ' 14' ' ' LEU . 32.8 mt -106.27 140.73 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.316 -0.865 . . . . 0.0 109.91 171.089 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -105.19 -16.67 14.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.921 -0.487 . . . . 0.0 111.687 -167.691 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -149.94 133.45 16.61 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.92 -1.113 . . . . 0.0 111.409 -178.689 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.419 HD12 ' CD1' ' A' ' 14' ' ' LEU . 16.2 tt -131.13 137.92 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.048 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -144.89 135.18 24.16 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.613 -0.679 . . . . 0.0 110.164 179.633 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.2 p -86.85 147.04 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.589 -0.694 . . . . 0.0 110.163 178.546 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.4 t . . . . . 0 N--CA 1.499 2.003 0 O-C-N 121.572 -0.705 . . . . 0.0 109.79 -179.175 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.391 0 N-CA-C 109.476 -1.45 . . . . 16.81 109.476 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -67.28 -33.19 74.79 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.653 -0.91 . . . . 14.72 110.342 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 74.2 mtm -99.14 138.57 36.06 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.717 -0.614 . . . . 13.59 110.263 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -68.19 -33.65 74.82 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.701 -0.624 . . . . 11.44 110.259 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.2 mmt -120.83 151.91 39.03 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.69 -0.631 . . . . 10.45 110.267 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.7 p -131.31 155.9 46.39 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.677 -0.64 . . . . 7.87 110.127 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -126.93 -46.86 0.2 Allowed Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.511 -1.436 . . . . 6.13 109.511 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -67.85 -45.28 75.54 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.756 -1.338 . . . . 4.64 109.756 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 11.7 tp -81.98 114.83 53.51 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.721 -0.87 . . . . 5.14 110.291 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -67.11 138.26 46.85 Favored 'Trans proline' 0 N--CA 1.488 1.161 0 O-C-N 123.339 1.178 . . . . 2.91 110.292 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -64.87 131.72 47.48 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.682 -0.636 . . . . 2.67 110.437 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.9 mt -64.75 142.89 58.27 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.686 -0.633 . . . . 1.08 110.836 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.61 -1.95 84.25 Favored Glycine 0 N--CA 1.497 2.706 0 C-N-CA 120.708 -0.758 . . . . 0.45 111.798 176.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.3 m -63.29 145.11 56.23 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.039 -1.271 . . . . 0.35 110.445 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.46 ' HE3' HG11 ' A' ' 78' ' ' VAL . 30.9 pttt -82.18 125.15 30.57 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.73 -0.606 . . . . 1.62 110.269 176.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.619 ' CD1' HD13 ' A' ' 26' ' ' LEU . 87.1 mt -120.97 143.42 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.499 -0.751 . . . . 0.18 110.059 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.9 t -102.5 137.22 41.02 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.35 -0.611 . . . . 0.12 109.35 174.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.613 HD21 HD13 ' A' ' 72' ' ' ILE . 13.9 tp -133.8 127.1 31.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.673 -0.642 . . . . 0.17 110.268 -169.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.6 mt -107.05 118.19 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.55 -0.719 . . . . 0.13 109.732 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m -93.08 157.82 16.1 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.022 0.439 . . . . 0.12 111.212 -177.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -53.76 -13.91 0.81 Allowed 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 112.839 0.681 . . . . 2.52 112.839 -171.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.51 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -90.15 20.78 4.11 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.154 -0.966 . . . . 0.16 110.416 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 53.93 34.28 19.18 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.54 -0.725 . . . . 0.8 109.886 -174.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.833 HG12 HG22 ' A' ' 46' ' ' THR . 68.4 mt -102.59 141.88 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 109.128 -0.693 . . . . 0.23 109.128 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -104.74 119.87 40.02 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.999 -0.68 . . . . 2.34 109.927 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -114.28 149.53 35.79 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.086 -0.709 . . . . 0.15 109.086 174.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.651 ' O ' HG23 ' A' ' 41' ' ' VAL . 45.7 tt0 -140.52 140.53 35.26 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.498 -0.751 . . . . 1.44 109.628 175.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.68 173.37 43.3 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 119.801 -1.19 . . . . 0.06 110.541 -175.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -84.89 137.26 33.24 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.906 -0.761 . . . . 2.07 110.543 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.619 HD13 ' CD1' ' A' ' 12' ' ' ILE . 14.9 tp -66.09 117.66 8.73 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.589 -0.695 . . . . 0.24 110.6 175.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.454 ' O ' HG23 ' A' ' 28' ' ' THR . 31.1 t80 -100.05 -50.08 4.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.621 -0.675 . . . . 0.18 110.562 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 27' ' ' TYR . 14.8 p -154.44 156.95 37.71 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.696 -0.628 . . . . 0.1 110.293 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.813 HG23 HG22 ' A' ' 36' ' ' ILE . 13.7 p -142.27 146.32 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.755 -0.591 . . . . 0.15 110.085 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -128.12 100.95 22.92 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.716 -0.615 . . . . 0.91 109.507 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.31 -42.02 30.75 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 O-C-N 123.652 1.343 . . . . 0.48 110.734 -174.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -80.77 -23.88 39.03 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.379 -0.825 . . . . 2.16 110.148 -171.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.68 ' O ' HG23 ' A' ' 35' ' ' THR . 74.9 mm-40 -87.33 1.11 54.26 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.525 -0.734 . . . . 1.59 111.294 173.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 37.2 m 49.78 38.52 15.82 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.079 -1.013 . . . . 0.74 111.195 -176.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.68 HG23 ' O ' ' A' ' 33' ' ' GLU . 17.0 p -135.77 155.44 50.36 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.405 -0.81 . . . . 0.14 110.399 -174.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.813 HG22 HG23 ' A' ' 29' ' ' VAL . 39.7 pt -142.1 162.0 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.715 -0.616 . . . . 0.15 110.06 177.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.516 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.14 128.42 30.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.61 -0.681 . . . . 0.09 109.722 176.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 26' ' ' LEU . 84.2 mt -109.81 146.35 35.18 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.579 -0.526 . . . . 0.14 109.579 -178.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.3 p -118.29 152.54 35.57 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.12 -0.696 . . . . 0.08 109.12 -177.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.6 p 45.65 84.08 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 121.489 0.662 . . . . 0.07 110.238 -171.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.687 HG11 HD12 ' A' ' 65' ' ' ILE . 15.0 p -134.63 150.46 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 109.774 -0.454 . . . . 0.1 109.774 -178.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -135.72 153.23 51.65 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.697 -0.627 . . . . 2.7 109.967 178.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.8 p -106.57 139.21 41.38 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.686 -0.634 . . . . 0.24 109.788 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -82.74 -38.36 23.38 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.591 -0.693 . . . . 0.59 110.871 -173.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.63 170.48 32.48 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 120.024 -1.084 . . . . 0.51 110.447 177.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.833 HG22 HG12 ' A' ' 20' ' ' ILE . 1.4 p -118.08 6.58 12.09 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.952 -0.734 . . . . 1.13 110.737 174.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -48.94 -25.96 2.23 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.635 -0.666 . . . . 2.69 112.584 -166.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -64.87 -59.29 4.36 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.201 -0.937 . . . . 1.96 110.629 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 58.1 mtp85 -94.43 10.26 35.14 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.64 -0.662 . . . . 4.87 111.38 176.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.445 ' HB2' HD12 ' A' ' 55' ' ' ILE . 38.8 p-10 -59.74 174.02 0.51 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.237 -0.914 . . . . 2.14 111.466 -169.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.1 m -78.95 164.42 24.43 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.647 -0.501 . . . . 3.23 109.647 173.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -77.44 3.45 13.33 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.653 -0.654 . . . . 4.1 111.344 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -97.5 154.21 17.65 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.203 -0.936 . . . . 4.1 109.691 171.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -68.08 137.34 54.91 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.582 -0.699 . . . . 3.57 110.607 -175.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.445 HD12 ' HB2' ' A' ' 50' ' ' ASP . 78.9 mt -117.1 136.56 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.638 -0.664 . . . . 2.27 109.507 176.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . . . -85.35 138.89 36.15 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.693 -0.629 . . . . 2.49 110.124 -178.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 56' ' ' ALA . 17.3 Cg_exo -63.09 149.13 92.39 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 O-C-N 123.362 1.19 . . . . 2.03 110.543 178.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -96.49 115.0 26.71 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.641 -0.662 . . . . 2.72 110.097 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.9 m -85.66 -33.27 21.61 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.687 -0.633 . . . . 2.17 110.331 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -62.56 141.76 58.3 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.679 -0.638 . . . . 2.7 110.66 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.3 mm -96.86 147.36 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.761 -0.587 . . . . 0.5 109.719 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -93.93 114.98 27.3 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.614 -0.679 . . . . 0.73 110.192 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -51.12 -42.18 60.53 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.865 -0.522 . . . . 1.86 111.678 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.516 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.0 t80 -152.58 129.19 10.77 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.606 -0.684 . . . . 0.1 110.272 -174.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.687 HD12 HG11 ' A' ' 41' ' ' VAL . 78.3 mt -128.58 128.74 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.662 -0.649 . . . . 0.11 109.823 172.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.1 tp -90.79 137.08 32.64 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.893 -0.504 . . . . 0.17 109.932 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.538 ' CD1' HD11 ' A' ' 72' ' ' ILE . 3.2 m-85 -136.29 130.12 32.47 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.557 -0.714 . . . . 0.29 110.605 -175.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.7 mtm-85 -91.07 147.88 22.77 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.678 -0.639 . . . . 2.52 110.258 173.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.03 -26.46 61.02 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 110.558 -1.017 . . . . 0.13 110.558 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.3 m -65.7 -39.79 91.62 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.464 -1.021 . . . . 1.29 110.989 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.68 -32.95 31.52 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.395 -0.816 . . . . 1.09 110.859 -174.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.613 HD13 HD21 ' A' ' 14' ' ' LEU . 8.4 mt -103.07 139.35 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.472 -0.768 . . . . 0.27 110.101 177.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.5 tttp -106.26 -20.05 13.51 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 120.571 -0.452 . . . . 2.11 111.676 -166.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -150.92 136.38 17.84 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 118.996 -1.082 . . . . 1.03 111.342 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.525 HD12 ' CD1' ' A' ' 14' ' ' LEU . 17.5 tt -133.6 143.42 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.829 -0.434 . . . . 0.26 109.829 177.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -146.71 136.93 23.6 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.624 -0.672 . . . . 2.91 110.297 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.0 t -87.46 144.4 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.562 -0.711 . . . . 1.54 109.777 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.46 HG11 ' HE3' ' A' ' 11' ' ' LYS . 55.4 t -93.99 133.89 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.672 -0.643 . . . . 0.98 109.74 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -107.41 121.82 45.37 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.755 -0.591 . . . . 2.85 110.318 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -116.19 104.12 11.21 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.644 -0.66 . . . . 4.24 110.116 178.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -136.56 171.95 13.73 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.609 -0.682 . . . . 6.85 110.228 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.2 p -116.44 162.42 17.58 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.657 -0.652 . . . . 6.82 110.171 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.5 mt -117.19 164.21 20.0 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.703 -0.623 . . . . 10.11 110.165 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo . . . . . 0 N--CA 1.486 1.083 0 O-C-N 123.686 1.361 . . . . 12.05 110.362 179.906 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.391 0 N-CA-C 109.476 -1.45 . . . . 16.81 109.476 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -67.28 -33.19 74.79 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.653 -0.91 . . . . 14.72 110.342 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 74.2 mtm -99.14 138.57 36.06 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.717 -0.614 . . . . 13.59 110.263 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -68.19 -33.65 74.82 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.701 -0.624 . . . . 11.44 110.259 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.2 mmt -120.83 151.91 39.03 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.69 -0.631 . . . . 10.45 110.267 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.7 p -131.31 155.9 46.39 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.677 -0.64 . . . . 7.87 110.127 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -126.93 -46.86 0.2 Allowed Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.511 -1.436 . . . . 6.13 109.511 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -67.85 -45.28 75.54 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.756 -1.338 . . . . 4.64 109.756 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 11.7 tp -81.98 114.83 53.51 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.721 -0.87 . . . . 5.14 110.291 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -67.11 138.26 46.85 Favored 'Trans proline' 0 N--CA 1.488 1.161 0 O-C-N 123.339 1.178 . . . . 2.91 110.292 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -64.87 131.72 47.48 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.682 -0.636 . . . . 2.67 110.437 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.9 mt -64.75 142.89 58.27 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.686 -0.633 . . . . 1.08 110.836 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.61 -1.95 84.25 Favored Glycine 0 N--CA 1.497 2.706 0 C-N-CA 120.708 -0.758 . . . . 0.45 111.798 176.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.3 m -63.29 145.11 56.23 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.039 -1.271 . . . . 0.35 110.445 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.46 ' HE3' HG11 ' A' ' 78' ' ' VAL . 30.9 pttt -82.18 125.15 30.57 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.73 -0.606 . . . . 1.62 110.269 176.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.619 ' CD1' HD13 ' A' ' 26' ' ' LEU . 87.1 mt -120.97 143.42 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.499 -0.751 . . . . 0.18 110.059 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.9 t -102.5 137.22 41.02 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.35 -0.611 . . . . 0.12 109.35 174.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.613 HD21 HD13 ' A' ' 72' ' ' ILE . 13.9 tp -133.8 127.1 31.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.673 -0.642 . . . . 0.17 110.268 -169.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.6 mt -107.05 118.19 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.55 -0.719 . . . . 0.13 109.732 -178.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m -93.08 157.82 16.1 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.022 0.439 . . . . 0.12 111.212 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -53.76 -13.91 0.81 Allowed 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 112.839 0.681 . . . . 2.52 112.839 -171.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.51 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -90.15 20.78 4.11 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.154 -0.966 . . . . 0.16 110.416 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 53.93 34.28 19.18 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.54 -0.725 . . . . 0.8 109.886 -174.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.833 HG12 HG22 ' A' ' 46' ' ' THR . 68.4 mt -102.59 141.88 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 109.128 -0.693 . . . . 0.23 109.128 178.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -104.74 119.87 40.02 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.999 -0.68 . . . . 2.34 109.927 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -114.28 149.53 35.79 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.086 -0.709 . . . . 0.15 109.086 174.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.651 ' O ' HG23 ' A' ' 41' ' ' VAL . 45.7 tt0 -140.52 140.53 35.26 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.498 -0.751 . . . . 1.44 109.628 175.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.68 173.37 43.3 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 119.801 -1.19 . . . . 0.06 110.541 -175.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -84.89 137.26 33.24 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.906 -0.761 . . . . 2.07 110.543 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.619 HD13 ' CD1' ' A' ' 12' ' ' ILE . 14.9 tp -66.09 117.66 8.73 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.589 -0.695 . . . . 0.24 110.6 175.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.454 ' O ' HG23 ' A' ' 28' ' ' THR . 31.1 t80 -100.05 -50.08 4.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.621 -0.675 . . . . 0.18 110.562 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 27' ' ' TYR . 14.8 p -154.44 156.95 37.71 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.696 -0.628 . . . . 0.1 110.293 -177.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.813 HG23 HG22 ' A' ' 36' ' ' ILE . 13.7 p -142.27 146.32 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.755 -0.591 . . . . 0.15 110.085 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -128.12 100.95 22.92 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.716 -0.615 . . . . 0.91 109.507 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.31 -42.02 30.75 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 O-C-N 123.652 1.343 . . . . 0.48 110.734 -174.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -80.77 -23.88 39.03 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.379 -0.825 . . . . 2.16 110.148 -171.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.68 ' O ' HG23 ' A' ' 35' ' ' THR . 74.9 mm-40 -87.33 1.11 54.26 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.525 -0.734 . . . . 1.59 111.294 173.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 37.2 m 49.78 38.52 15.82 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.079 -1.013 . . . . 0.74 111.195 -176.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.68 HG23 ' O ' ' A' ' 33' ' ' GLU . 17.0 p -135.77 155.44 50.36 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.405 -0.81 . . . . 0.14 110.399 -174.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.813 HG22 HG23 ' A' ' 29' ' ' VAL . 39.7 pt -142.1 162.0 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.715 -0.616 . . . . 0.15 110.06 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.516 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.14 128.42 30.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.61 -0.681 . . . . 0.09 109.722 176.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 26' ' ' LEU . 84.2 mt -109.81 146.35 35.18 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.579 -0.526 . . . . 0.14 109.579 -178.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.3 p -118.29 152.54 35.57 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.12 -0.696 . . . . 0.08 109.12 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.6 p 45.65 84.08 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 121.489 0.662 . . . . 0.07 110.238 -171.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.687 HG11 HD12 ' A' ' 65' ' ' ILE . 15.0 p -134.63 150.46 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 109.774 -0.454 . . . . 0.1 109.774 -178.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -135.72 153.23 51.65 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.697 -0.627 . . . . 2.7 109.967 178.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.8 p -106.57 139.21 41.38 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.686 -0.634 . . . . 0.24 109.788 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -82.74 -38.36 23.38 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.591 -0.693 . . . . 0.59 110.871 -173.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.63 170.48 32.48 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 120.024 -1.084 . . . . 0.51 110.447 177.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.833 HG22 HG12 ' A' ' 20' ' ' ILE . 1.4 p -118.08 6.58 12.09 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.952 -0.734 . . . . 1.13 110.737 174.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -48.94 -25.96 2.23 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.635 -0.666 . . . . 2.69 112.584 -166.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -64.87 -59.29 4.36 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.201 -0.937 . . . . 1.96 110.629 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 58.1 mtp85 -94.43 10.26 35.14 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.64 -0.662 . . . . 4.87 111.38 176.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.445 ' HB2' HD12 ' A' ' 55' ' ' ILE . 38.8 p-10 -59.74 174.02 0.51 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.237 -0.914 . . . . 2.14 111.466 -169.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.1 m -78.95 164.42 24.43 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.647 -0.501 . . . . 3.23 109.647 173.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -77.44 3.45 13.33 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.653 -0.654 . . . . 4.1 111.344 -178.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -97.5 154.21 17.65 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.203 -0.936 . . . . 4.1 109.691 171.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -68.08 137.34 54.91 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.582 -0.699 . . . . 3.57 110.607 -175.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.445 HD12 ' HB2' ' A' ' 50' ' ' ASP . 78.9 mt -117.1 136.56 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.638 -0.664 . . . . 2.27 109.507 176.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . . . -85.35 138.89 36.15 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.693 -0.629 . . . . 2.49 110.124 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 56' ' ' ALA . 17.3 Cg_exo -63.09 149.13 92.39 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 O-C-N 123.362 1.19 . . . . 2.03 110.543 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -96.49 115.0 26.71 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.641 -0.662 . . . . 2.72 110.097 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.9 m -85.66 -33.27 21.61 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.687 -0.633 . . . . 2.17 110.331 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -62.56 141.76 58.3 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.679 -0.638 . . . . 2.7 110.66 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.3 mm -96.86 147.36 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.761 -0.587 . . . . 0.5 109.719 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -93.93 114.98 27.3 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.614 -0.679 . . . . 0.73 110.192 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -51.12 -42.18 60.53 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.865 -0.522 . . . . 1.86 111.678 178.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.516 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.0 t80 -152.58 129.19 10.77 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.606 -0.684 . . . . 0.1 110.272 -174.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.687 HD12 HG11 ' A' ' 41' ' ' VAL . 78.3 mt -128.58 128.74 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.662 -0.649 . . . . 0.11 109.823 172.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.1 tp -90.79 137.08 32.64 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.893 -0.504 . . . . 0.17 109.932 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.538 ' CD1' HD11 ' A' ' 72' ' ' ILE . 3.2 m-85 -136.29 130.12 32.47 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.557 -0.714 . . . . 0.29 110.605 -175.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.7 mtm-85 -91.07 147.88 22.77 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.678 -0.639 . . . . 2.52 110.258 173.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.03 -26.46 61.02 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 110.558 -1.017 . . . . 0.13 110.558 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.3 m -65.7 -39.79 91.62 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.464 -1.021 . . . . 1.29 110.989 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.68 -32.95 31.52 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.395 -0.816 . . . . 1.09 110.859 -174.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.613 HD13 HD21 ' A' ' 14' ' ' LEU . 8.4 mt -103.07 139.35 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.472 -0.768 . . . . 0.27 110.101 177.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.5 tttp -106.26 -20.05 13.51 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 120.571 -0.452 . . . . 2.11 111.676 -166.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -150.92 136.38 17.84 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 118.996 -1.082 . . . . 1.03 111.342 -177.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.525 HD12 ' CD1' ' A' ' 14' ' ' LEU . 17.5 tt -133.6 143.42 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.829 -0.434 . . . . 0.26 109.829 177.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -146.71 136.93 23.6 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.624 -0.672 . . . . 2.91 110.297 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.0 t -87.46 144.4 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.562 -0.711 . . . . 1.54 109.777 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.46 HG11 ' HE3' ' A' ' 11' ' ' LYS . 55.4 t -93.99 133.89 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.672 -0.643 . . . . 0.98 109.74 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -107.41 121.82 45.37 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.755 -0.591 . . . . 2.85 110.318 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -116.19 104.12 11.21 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.644 -0.66 . . . . 4.24 110.116 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -136.56 171.95 13.73 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.609 -0.682 . . . . 6.85 110.228 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.2 p -116.44 162.42 17.58 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.657 -0.652 . . . . 6.82 110.171 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.5 mt -117.19 164.21 20.0 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.703 -0.623 . . . . 10.11 110.165 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo . . . . . 0 N--CA 1.486 1.083 0 O-C-N 123.686 1.361 . . . . 12.05 110.362 179.906 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -144.53 156.7 44.28 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.761 -0.846 . . . . 0.0 110.206 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 89.1 mmm -96.91 138.31 34.64 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.698 -0.626 . . . . 0.0 110.171 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -67.89 -33.46 74.77 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.739 -0.601 . . . . 0.0 110.289 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt -118.22 151.63 37.26 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.628 -0.67 . . . . 0.0 110.213 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.4 m -65.2 -35.19 80.3 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.661 -0.649 . . . . 0.0 110.36 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -148.04 173.39 28.09 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.61 178.09 47.14 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.5 tp -155.43 87.8 3.15 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.74 -0.859 . . . . 0.0 109.953 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -67.52 106.55 1.27 Allowed 'Trans proline' 0 N--CA 1.488 1.183 0 O-C-N 123.509 1.268 . . . . 0.0 110.343 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -64.86 139.26 58.74 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.686 -0.634 . . . . 0.0 110.544 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.2 mt -64.76 -172.67 0.09 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.674 -0.642 . . . . 0.0 110.498 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.76 -1.85 84.96 Favored Glycine 0 N--CA 1.496 2.66 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.722 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.8 m -61.38 143.21 56.18 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.101 -1.235 . . . . 0.0 110.413 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -82.2 128.95 34.67 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.692 -0.63 . . . . 0.0 110.494 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.716 ' CD1' HD13 ' A' ' 26' ' ' LEU . 86.1 mt -122.0 142.92 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.581 -0.699 . . . . 0.0 110.076 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.5 t -103.15 137.23 41.59 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 174.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.77 HD21 HD13 ' A' ' 72' ' ' ILE . 13.7 tp -134.78 125.4 26.84 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.673 -0.642 . . . . 0.0 110.301 -169.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 81.5 mt -107.09 117.97 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.538 -0.727 . . . . 0.0 109.696 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.2 m -92.65 157.77 16.3 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.059 0.457 . . . . 0.0 111.267 -177.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -54.07 -13.66 0.87 Allowed 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -171.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.53 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -90.1 20.73 4.12 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.163 -0.961 . . . . 0.0 110.416 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 54.13 34.28 19.73 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.481 -0.762 . . . . 0.0 109.836 -174.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.844 HG12 HG22 ' A' ' 46' ' ' THR . 65.0 mt -102.94 141.3 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 55.1 ttt85 -104.61 119.84 39.92 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.997 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -114.79 149.65 36.64 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.666 ' O ' HG23 ' A' ' 41' ' ' VAL . 42.1 tt0 -140.42 140.49 35.45 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.556 -0.715 . . . . 0.0 109.478 175.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.3 172.01 41.48 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.688 -1.244 . . . . 0.0 110.681 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.3 mmt85 -84.85 138.51 32.51 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.919 -0.753 . . . . 0.0 110.522 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.716 HD13 ' CD1' ' A' ' 12' ' ' ILE . 16.8 tp -66.16 118.27 9.65 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.565 -0.709 . . . . 0.0 110.669 175.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.463 ' O ' HG23 ' A' ' 28' ' ' THR . 23.9 t80 -100.51 -50.14 4.0 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.623 -0.673 . . . . 0.0 110.385 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 27' ' ' TYR . 12.8 p -154.3 153.58 31.91 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.741 -0.599 . . . . 0.0 110.263 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.885 HG23 HG22 ' A' ' 36' ' ' ILE . 13.4 p -142.3 145.45 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.729 -0.607 . . . . 0.0 110.052 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -128.94 100.9 20.3 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.669 -0.644 . . . . 0.0 109.554 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.51 -39.44 45.2 Favored 'Trans proline' 0 N--CA 1.489 1.24 0 O-C-N 123.533 1.281 . . . . 0.0 110.796 -175.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -80.6 -25.74 38.27 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.369 -0.832 . . . . 0.0 110.066 -171.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.562 ' O ' HG23 ' A' ' 35' ' ' THR . 79.1 mt-10 -87.41 1.49 53.23 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.555 -0.715 . . . . 0.0 111.22 173.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 38.6 m 49.61 38.68 15.49 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.091 -1.006 . . . . 0.0 111.343 -176.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 33' ' ' GLU . 9.9 p -136.3 153.36 51.19 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.348 -0.845 . . . . 0.0 110.286 -174.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.885 HG22 HG23 ' A' ' 29' ' ' VAL . 39.9 pt -142.74 162.0 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.676 -0.64 . . . . 0.0 110.252 178.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.52 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.46 127.61 28.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.657 -0.652 . . . . 0.0 109.704 175.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 26' ' ' LEU . 83.2 mt -109.94 146.77 34.64 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -177.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 96.0 p -118.13 153.42 33.83 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.7 p 45.65 85.01 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 121.476 0.655 . . . . 0.0 110.364 -172.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.711 HG11 HD12 ' A' ' 65' ' ' ILE . 14.5 p -134.53 150.41 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.95 -0.469 . . . . 0.0 109.753 -178.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -135.21 153.18 52.03 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.634 -0.666 . . . . 0.0 109.952 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 82.5 p -108.19 138.83 43.79 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.656 -0.652 . . . . 0.0 109.866 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -83.02 -38.29 22.79 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.654 -0.654 . . . . 0.0 110.859 -174.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.64 168.1 29.29 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.844 HG22 HG12 ' A' ' 20' ' ' ILE . 17.6 p -118.15 6.6 12.03 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.925 -0.75 . . . . 0.0 110.908 175.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -49.87 -25.27 3.01 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.563 -0.711 . . . . 0.0 112.781 -166.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -64.92 -59.34 4.29 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.134 -0.978 . . . . 0.0 110.671 -177.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.1 mtp180 -94.45 10.16 35.59 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.502 -0.749 . . . . 0.0 111.524 176.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.593 ' HB2' HD12 ' A' ' 55' ' ' ILE . 39.5 p-10 -58.63 174.06 0.36 Allowed 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.204 -0.935 . . . . 0.0 111.448 -170.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.0 m -78.85 164.42 24.5 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.935 -0.478 . . . . 0.0 109.759 175.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -77.55 4.89 10.13 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.642 -0.661 . . . . 0.0 111.289 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -95.84 166.03 12.0 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.226 -0.921 . . . . 0.0 109.591 168.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -80.74 132.1 35.5 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.607 -0.683 . . . . 0.0 110.488 -175.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.593 HD12 ' HB2' ' A' ' 50' ' ' ASP . 78.5 mt -114.27 134.35 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.715 -0.615 . . . . 0.0 109.443 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.38 146.01 38.88 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.629 -0.669 . . . . 0.0 110.154 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -63.07 149.37 91.72 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 O-C-N 123.399 1.21 . . . . 0.0 110.539 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -96.28 121.62 38.26 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.647 -0.658 . . . . 0.0 110.107 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.0 t -91.66 -32.55 15.42 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.708 -0.62 . . . . 0.0 110.356 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -62.59 140.49 58.66 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.641 -0.662 . . . . 0.0 110.569 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.9 mm -96.89 148.12 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.744 -0.597 . . . . 0.0 109.683 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -94.2 114.27 26.35 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.62 -0.675 . . . . 0.0 110.195 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -51.38 -42.42 61.37 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.754 -0.591 . . . . 0.0 111.585 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.52 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.8 t80 -152.87 129.88 11.06 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.665 -0.647 . . . . 0.0 110.219 -174.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.711 HD12 HG11 ' A' ' 41' ' ' VAL . 72.8 mt -128.87 129.06 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.701 -0.625 . . . . 0.0 109.87 172.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.0 tp -90.34 137.05 32.66 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.802 -0.561 . . . . 0.0 109.84 176.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.609 ' CD1' HD11 ' A' ' 72' ' ' ILE . 2.8 m-85 -134.55 128.2 32.82 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.699 -0.626 . . . . 0.0 110.563 -175.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -91.61 146.81 23.47 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.686 -0.634 . . . . 0.0 110.213 172.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.81 -26.55 60.57 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.1 t -65.36 -40.11 93.15 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.467 -1.019 . . . . 0.0 111.004 -177.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -81.55 -32.31 32.3 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.431 -0.793 . . . . 0.0 110.857 -174.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.77 HD13 HD21 ' A' ' 14' ' ' LEU . 6.9 mt -101.15 140.48 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.456 -0.778 . . . . 0.0 110.149 177.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -104.63 -20.34 13.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.938 -0.476 . . . . 0.0 111.492 -168.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -151.56 133.69 15.17 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.034 -1.041 . . . . 0.0 111.233 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.539 HD12 ' CD1' ' A' ' 14' ' ' LEU . 17.0 tt -131.87 143.81 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.908 -0.495 . . . . 0.0 109.756 176.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -145.76 130.16 17.74 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.597 -0.689 . . . . 0.0 110.257 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.45 HG22 HG12 ' A' ' 12' ' ' ILE . 51.4 t -88.36 143.55 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.684 -0.635 . . . . 0.0 109.781 179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.9 t -93.7 129.87 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.567 -0.708 . . . . 0.0 109.674 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -117.5 140.25 49.86 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.667 -0.646 . . . . 0.0 110.259 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -106.11 131.88 52.84 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.677 -0.64 . . . . 0.0 110.125 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -119.77 140.34 50.89 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.672 -0.643 . . . . 0.0 110.215 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.7 m -122.27 138.74 54.39 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.666 -0.646 . . . . 0.0 110.127 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.0 tt -111.49 109.93 55.79 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.716 -0.615 . . . . 0.0 110.167 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo . . . . . 0 N--CA 1.49 1.279 0 O-C-N 123.369 1.194 . . . . 0.0 110.451 179.073 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -95.16 127.8 41.49 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.745 -0.856 . . . . 0.0 110.173 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.36 -34.38 70.41 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.699 -0.626 . . . . 0.0 110.234 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -90.9 115.35 27.87 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.636 -0.665 . . . . 0.0 110.169 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.9 mtp -67.26 -34.4 77.35 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.74 -0.6 . . . . 0.0 110.326 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.4 t -112.48 146.95 37.55 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.724 -0.61 . . . . 0.0 110.376 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -133.32 177.59 18.86 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -142.95 173.31 24.15 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.539 HD23 ' N ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -155.33 157.06 31.62 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.594 -0.945 . . . . 0.0 110.135 179.632 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -67.55 111.69 2.41 Favored 'Trans proline' 0 N--CA 1.488 1.149 0 O-C-N 123.612 1.322 . . . . 0.0 110.369 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.79 130.29 42.96 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.712 -0.617 . . . . 0.0 110.609 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.0 mt -64.83 149.67 49.01 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.714 -0.616 . . . . 0.0 110.626 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.6 -1.85 84.54 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.871 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 75.0 m -61.44 146.08 49.62 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.07 -1.253 . . . . 0.0 110.479 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.602 ' HE3' HG11 ' A' ' 78' ' ' VAL . 28.1 pttt -81.97 126.41 31.91 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.718 -0.613 . . . . 0.0 110.485 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.418 HG12 HG22 ' A' ' 77' ' ' VAL . 88.5 mt -123.91 143.96 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.605 -0.684 . . . . 0.0 110.177 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.6 t -102.65 137.26 41.11 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 175.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.629 HD21 HD13 ' A' ' 72' ' ' ILE . 13.8 tp -133.23 128.4 35.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.708 -0.62 . . . . 0.0 110.318 -170.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.1 mt -108.22 119.61 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.464 -0.772 . . . . 0.0 109.698 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.1 m -93.9 157.61 16.04 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.114 0.483 . . . . 0.0 111.222 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -54.12 -13.56 0.86 Allowed 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -172.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.552 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.84 20.41 4.16 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.148 -0.97 . . . . 0.0 110.485 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 53.91 34.04 18.6 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.38 -0.825 . . . . 0.0 109.804 -174.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.781 HG12 HG22 ' A' ' 46' ' ' THR . 67.3 mt -102.2 141.82 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -105.37 119.85 40.11 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.007 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -114.74 148.72 37.94 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 174.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.672 ' O ' HG23 ' A' ' 41' ' ' VAL . 41.9 tt0 -140.09 140.51 36.1 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.476 -0.765 . . . . 0.0 109.603 175.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.92 173.52 42.22 Favored Glycine 0 N--CA 1.495 2.597 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.48 -175.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -84.73 136.5 33.69 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.889 -0.771 . . . . 0.0 110.501 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' A' ' 38' ' ' LEU . 27.7 tp -66.14 116.33 7.1 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.548 -0.72 . . . . 0.0 110.537 175.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.413 ' C ' HG23 ' A' ' 28' ' ' THR . 25.8 t80 -99.14 -49.99 4.3 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.677 -0.639 . . . . 0.0 110.364 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.413 HG23 ' C ' ' A' ' 27' ' ' TYR . 25.1 p -152.97 154.87 35.86 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.655 -0.653 . . . . 0.0 110.25 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.829 HG23 HG22 ' A' ' 36' ' ' ILE . 13.6 p -142.23 145.61 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.686 -0.634 . . . . 0.0 110.104 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -127.83 101.54 23.26 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.627 -0.671 . . . . 0.0 109.506 177.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.44 -41.82 30.94 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 O-C-N 123.626 1.329 . . . . 0.0 110.868 -174.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -80.59 -24.55 39.08 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.301 -0.874 . . . . 0.0 110.214 -171.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.609 ' O ' HG23 ' A' ' 35' ' ' THR . 54.6 mt-10 -87.42 1.13 54.29 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.412 -0.805 . . . . 0.0 111.235 173.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 39.6 m 49.75 39.26 17.43 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.153 -0.967 . . . . 0.0 111.243 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.609 HG23 ' O ' ' A' ' 33' ' ' GLU . 11.8 p -135.82 153.79 51.4 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.407 -0.808 . . . . 0.0 110.38 -174.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.829 HG22 HG23 ' A' ' 29' ' ' VAL . 39.9 pt -142.62 162.02 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.708 -0.62 . . . . 0.0 110.193 177.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.51 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -135.61 129.54 33.02 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.63 -0.669 . . . . 0.0 109.82 175.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 26' ' ' LEU . 50.6 mt -109.84 144.23 38.59 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -178.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 99.9 p -116.24 151.41 35.83 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.8 p 46.1 87.43 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 CA-C-O 121.462 0.648 . . . . 0.0 110.267 -172.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.76 HG11 HD12 ' A' ' 65' ' ' ILE . 12.3 p -134.62 147.79 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.968 -0.458 . . . . 0.0 109.837 -178.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -127.33 153.08 46.63 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.821 -0.549 . . . . 0.0 109.703 178.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.8 p -109.39 136.74 48.33 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.697 -0.627 . . . . 0.0 109.824 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -82.93 -38.19 23.13 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.624 -0.672 . . . . 0.0 110.847 -174.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.58 167.13 27.8 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 176.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.781 HG22 HG12 ' A' ' 20' ' ' ILE . 6.9 p -118.16 6.6 12.03 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.976 -0.72 . . . . 0.0 110.977 175.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -48.99 -25.46 1.98 Allowed 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.498 -0.752 . . . . 0.0 112.417 -169.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -64.4 -59.2 4.63 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.225 -0.922 . . . . 0.0 110.622 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -94.34 10.23 35.07 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.628 -0.67 . . . . 0.0 111.373 177.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -61.08 174.02 0.72 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.241 -0.912 . . . . 0.0 111.279 -170.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.715 ' OG1' HD11 ' A' ' 55' ' ' ILE . 39.9 p -78.88 164.5 24.41 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.914 -0.491 . . . . 0.0 109.917 175.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -77.52 3.89 12.47 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.004 176.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -97.34 165.28 12.1 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.181 -0.95 . . . . 0.0 109.621 167.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -68.51 142.47 55.26 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.524 -0.735 . . . . 0.0 110.388 -177.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.715 HD11 ' OG1' ' A' ' 51' ' ' THR . 49.9 mm -112.67 134.95 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.704 -0.622 . . . . 0.0 109.675 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -97.96 109.91 53.48 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.731 -0.606 . . . . 0.0 110.201 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -67.49 147.16 76.54 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 O-C-N 123.379 1.199 . . . . 0.0 110.409 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -96.54 119.77 35.63 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.721 -0.612 . . . . 0.0 110.222 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.6 p -68.26 -30.65 69.74 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.707 -0.62 . . . . 0.0 110.422 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -62.4 145.78 53.07 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.551 -0.718 . . . . 0.0 110.595 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.87 154.71 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.745 -0.597 . . . . 0.0 109.699 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -94.13 113.68 25.68 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.667 -0.645 . . . . 0.0 110.17 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -51.54 -40.52 59.83 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.753 -0.592 . . . . 0.0 111.765 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.51 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.4 t80 -153.38 130.84 11.37 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.669 -0.644 . . . . 0.0 110.177 -175.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.76 HD12 HG11 ' A' ' 41' ' ' VAL . 76.2 mt -129.75 128.22 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.725 -0.609 . . . . 0.0 109.791 172.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.6 tp -90.46 136.99 32.71 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.851 -0.53 . . . . 0.0 109.805 176.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.589 ' CD1' HD11 ' A' ' 72' ' ' ILE . 3.3 m-85 -135.81 130.62 34.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.661 -0.649 . . . . 0.0 110.58 -175.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -91.68 149.66 21.52 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.678 -0.639 . . . . 0.0 110.343 173.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.05 -24.55 60.86 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.0 t -66.81 -42.14 86.39 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.481 -1.011 . . . . 0.0 111.056 -175.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -82.77 -33.04 27.49 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.396 -0.815 . . . . 0.0 110.879 -175.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.629 HD13 HD21 ' A' ' 14' ' ' LEU . 13.8 mt -100.72 138.4 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.423 -0.798 . . . . 0.0 110.143 177.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 50.3 tptt -108.0 -19.12 13.61 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.789 -166.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -149.71 135.86 18.89 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 118.935 -1.106 . . . . 0.0 111.319 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.5 HD12 ' CD1' ' A' ' 14' ' ' LEU . 18.2 tt -134.08 144.47 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.868 -0.52 . . . . 0.0 109.886 177.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -146.1 133.28 20.47 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.608 -0.682 . . . . 0.0 110.288 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.418 HG22 HG12 ' A' ' 12' ' ' ILE . 51.2 t -87.67 145.35 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.681 -0.637 . . . . 0.0 109.736 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.602 HG11 ' HE3' ' A' ' 11' ' ' LYS . 56.1 t -93.74 135.27 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.641 -0.662 . . . . 0.0 109.748 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -123.41 173.52 7.94 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.716 -0.615 . . . . 0.0 110.201 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -75.77 168.43 20.04 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.672 -0.642 . . . . 0.0 110.117 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -65.09 -34.82 79.31 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.724 -0.61 . . . . 0.0 110.335 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.6 m -121.23 141.09 51.2 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.674 -0.641 . . . . 0.0 110.097 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.493 ' N ' HD12 ' A' ' 83' ' ' LEU . 6.5 mp -109.47 161.84 22.48 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.758 -0.589 . . . . 0.0 110.241 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo . . . . . 0 N--CA 1.488 1.178 0 O-C-N 123.689 1.362 . . . . 0.0 110.324 -179.868 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -143.83 155.43 44.12 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.684 -0.892 . . . . 0.0 110.255 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 89.0 mmm -120.41 153.98 35.79 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.711 -0.618 . . . . 0.0 110.157 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -145.62 155.47 43.05 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.689 -0.632 . . . . 0.0 110.225 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.1 mtp -108.11 146.68 32.3 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.796 -0.565 . . . . 0.0 110.203 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 94.4 p -131.69 155.88 46.86 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.667 -0.646 . . . . 0.0 110.223 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -148.3 37.62 1.06 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -129.84 44.02 1.25 Allowed Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 15.6 tp -79.94 138.9 53.37 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.682 -0.893 . . . . 0.0 109.946 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -68.31 108.99 1.9 Allowed 'Trans proline' 0 N--CA 1.488 1.18 0 O-C-N 123.35 1.184 . . . . 0.0 110.324 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -64.93 137.78 57.96 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.711 -0.618 . . . . 0.0 110.491 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.9 mt -64.84 152.17 43.56 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.675 -0.641 . . . . 0.0 110.559 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.63 -1.79 84.83 Favored Glycine 0 N--CA 1.496 2.685 0 C-N-CA 120.49 -0.862 . . . . 0.0 111.73 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 58.5 m -60.88 153.66 24.18 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.119 -1.224 . . . . 0.0 110.541 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -81.56 123.58 28.78 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.715 -0.616 . . . . 0.0 110.583 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 89.0 mt -120.81 145.27 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.508 -0.745 . . . . 0.0 110.066 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.0 t -102.54 137.31 40.94 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 175.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.707 HD21 HD13 ' A' ' 72' ' ' ILE . 13.8 tp -131.71 125.6 32.44 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.707 -0.621 . . . . 0.0 110.146 -170.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.3 mt -106.03 119.05 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.552 -0.718 . . . . 0.0 109.632 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.3 m -94.33 157.72 15.9 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.068 0.461 . . . . 0.0 111.227 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -53.43 -14.73 0.84 Allowed 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -172.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.551 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.32 20.3 3.89 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.097 -1.002 . . . . 0.0 110.463 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 54.0 34.08 18.93 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.478 -0.764 . . . . 0.0 109.796 -174.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.794 HG12 HG22 ' A' ' 46' ' ' THR . 68.5 mt -102.0 141.41 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 63.8 ttt-85 -105.5 119.81 40.05 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.887 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -114.15 150.01 34.81 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.665 ' O ' HG23 ' A' ' 41' ' ' VAL . 34.4 tt0 -140.68 140.46 34.95 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.42 -0.8 . . . . 0.0 109.647 175.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.6 172.97 43.23 Favored Glycine 0 N--CA 1.495 2.611 0 C-N-CA 119.716 -1.231 . . . . 0.0 110.538 -175.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -84.96 135.53 34.0 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.893 -0.769 . . . . 0.0 110.576 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.461 ' HA ' HD23 ' A' ' 38' ' ' LEU . 25.0 tp -66.1 117.93 9.13 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.542 -0.724 . . . . 0.0 110.595 175.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.443 ' O ' HG23 ' A' ' 28' ' ' THR . 25.9 t80 -99.52 -50.13 4.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.573 -0.704 . . . . 0.0 110.481 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 27' ' ' TYR . 16.0 p -153.93 156.48 37.59 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.734 -0.604 . . . . 0.0 110.32 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.846 HG23 HG22 ' A' ' 36' ' ' ILE . 13.3 p -142.32 145.86 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.708 -0.62 . . . . 0.0 110.034 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -128.25 99.14 24.97 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.659 -0.651 . . . . 0.0 109.55 177.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -59.5 -40.86 62.54 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 O-C-N 123.553 1.291 . . . . 0.0 110.937 -175.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -80.58 -25.76 38.3 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.338 -0.852 . . . . 0.0 110.181 -171.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.626 ' O ' HG23 ' A' ' 35' ' ' THR . 79.4 mt-10 -87.43 1.87 52.14 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.538 -0.726 . . . . 0.0 111.167 173.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.3 m 49.54 38.41 14.61 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.079 -1.013 . . . . 0.0 111.197 -176.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.626 HG23 ' O ' ' A' ' 33' ' ' GLU . 11.5 p -135.71 154.76 51.16 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.415 -0.803 . . . . 0.0 110.438 -174.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.846 HG22 HG23 ' A' ' 29' ' ' VAL . 40.4 pt -142.26 162.02 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.732 -0.605 . . . . 0.0 110.131 177.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.515 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -135.82 128.28 30.46 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.592 -0.693 . . . . 0.0 109.765 176.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 26' ' ' LEU . 86.3 mt -109.86 146.37 35.2 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -178.047 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.9 p -117.68 151.58 36.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.623 -0.673 . . . . 0.0 109.234 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 46.8 p 45.98 86.71 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 121.472 0.653 . . . . 0.0 110.291 -172.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.745 HG11 HD12 ' A' ' 65' ' ' ILE . 12.8 p -134.58 147.76 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.939 -0.476 . . . . 0.0 109.873 -178.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -126.19 153.06 45.17 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.732 -0.605 . . . . 0.0 109.798 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.3 p -108.79 134.39 51.55 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.665 -0.647 . . . . 0.0 109.794 177.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -83.02 -38.28 22.8 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.623 -0.673 . . . . 0.0 111.011 -173.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.66 168.74 30.25 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.993 -1.099 . . . . 0.0 110.54 176.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.794 HG22 HG12 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -118.14 6.61 12.04 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 122.008 -0.701 . . . . 0.0 110.997 175.021 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.3 tp10 -48.95 -25.95 2.23 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.546 -0.721 . . . . 0.0 112.455 -168.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -65.76 -59.21 4.13 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.335 -0.853 . . . . 0.0 110.421 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.9 mmp_? -94.19 10.14 35.09 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.68 -0.638 . . . . 0.0 111.319 177.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.413 ' HB2' HD12 ' A' ' 55' ' ' ILE . 39.9 p-10 -59.47 166.18 2.49 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.243 -0.91 . . . . 0.0 111.418 -170.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.0 m -78.95 164.44 24.42 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.949 -0.47 . . . . 0.0 109.765 174.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -77.56 4.12 12.01 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.616 -0.678 . . . . 0.0 111.268 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -96.81 158.35 15.47 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.174 -0.954 . . . . 0.0 109.632 167.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -70.77 140.15 51.23 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.489 -0.757 . . . . 0.0 110.375 -176.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.413 HD12 ' HB2' ' A' ' 50' ' ' ASP . 81.1 mt -115.28 134.9 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.664 -0.647 . . . . 0.0 109.616 177.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.05 109.92 53.69 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.736 -0.603 . . . . 0.0 110.133 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -66.61 146.54 79.63 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 O-C-N 123.343 1.18 . . . . 0.0 110.379 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -95.59 124.01 39.42 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.667 -0.645 . . . . 0.0 110.232 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.5 p -67.67 -29.35 68.61 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.675 -0.641 . . . . 0.0 110.492 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -62.02 145.93 51.67 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.55 -0.719 . . . . 0.0 110.538 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.91 156.24 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.749 -0.594 . . . . 0.0 109.747 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -93.65 115.14 27.58 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.669 -0.644 . . . . 0.0 110.087 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -51.25 -42.98 61.4 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.767 -0.583 . . . . 0.0 111.697 178.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.515 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.8 t80 -152.73 129.1 10.59 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.624 -0.673 . . . . 0.0 110.244 -174.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.745 HD12 HG11 ' A' ' 41' ' ' VAL . 75.4 mt -128.0 129.24 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.665 -0.647 . . . . 0.0 109.871 172.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.0 tp -90.32 137.04 32.67 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.802 -0.562 . . . . 0.0 109.797 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.614 ' CD1' HD11 ' A' ' 72' ' ' ILE . 2.8 m-85 -135.19 130.33 35.15 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.647 -0.658 . . . . 0.0 110.544 -175.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.1 mtm-85 -91.47 148.26 22.43 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.713 -0.617 . . . . 0.0 110.322 173.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.69 -24.03 59.37 Favored Glycine 0 N--CA 1.498 2.816 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 178.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.0 p -67.82 -42.11 82.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.361 -1.082 . . . . 0.0 111.089 -175.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -82.49 -32.41 28.8 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.398 -0.814 . . . . 0.0 110.894 -175.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.707 HD13 HD21 ' A' ' 14' ' ' LEU . 14.8 mt -99.56 141.48 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.333 -0.854 . . . . 0.0 110.18 176.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -106.15 -24.61 12.3 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 120.554 -0.459 . . . . 0.0 111.447 -166.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -150.8 136.19 17.84 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 119.037 -1.065 . . . . 0.0 111.471 -176.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.49 HD12 ' CD1' ' A' ' 14' ' ' LEU . 18.4 tt -131.83 137.77 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 176.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -143.94 143.33 31.2 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.634 -0.666 . . . . 0.0 110.191 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.4 m -84.87 147.02 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.638 -0.664 . . . . 0.0 110.246 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.5 t -96.91 132.74 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.569 -0.707 . . . . 0.0 109.89 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -114.67 122.41 46.36 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.729 -0.607 . . . . 0.0 110.135 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -132.4 -46.47 0.9 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.714 -0.616 . . . . 0.0 110.325 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -124.73 141.25 52.24 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.704 -0.622 . . . . 0.0 110.183 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 25.1 m -119.42 141.65 48.93 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.658 -0.651 . . . . 0.0 110.105 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.1 tp -102.7 109.87 61.94 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.691 -0.63 . . . . 0.0 110.24 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo . . . . . 0 N--CA 1.488 1.199 0 O-C-N 123.328 1.172 . . . . 0.0 110.509 179.094 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -67.79 -33.69 75.31 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.702 -0.881 . . . . 0.0 110.407 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 89.4 mtp -65.86 -36.59 83.88 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.669 -0.644 . . . . 0.0 110.549 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -107.67 155.96 19.59 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.646 -0.659 . . . . 0.0 110.306 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.4 mtm -86.84 120.75 28.45 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.644 -0.66 . . . . 0.0 110.085 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -66.24 -35.42 80.37 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.69 -0.631 . . . . 0.0 110.366 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -101.34 34.26 5.79 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.74 -60.13 0.66 Allowed Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.509 HD12 ' N ' ' A' ' 5' ' ' LEU . 7.7 mp -81.35 152.23 70.22 Favored Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 121.69 -0.888 . . . . 0.0 110.115 178.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -68.61 129.56 19.1 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 O-C-N 123.659 1.347 . . . . 0.0 110.309 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -64.88 129.51 40.01 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.62 -0.675 . . . . 0.0 110.441 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 80.6 mt -64.81 145.25 56.53 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.778 -0.576 . . . . 0.0 110.614 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.62 -1.83 84.66 Favored Glycine 0 N--CA 1.497 2.708 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.679 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 58.2 m -60.86 155.5 19.48 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.074 -1.251 . . . . 0.0 110.579 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.19 122.25 27.66 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.805 -0.559 . . . . 0.0 110.366 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 90.3 mt -119.96 144.38 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.515 -0.741 . . . . 0.0 110.114 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.7 t -102.83 137.24 41.3 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 175.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.675 HD21 HD13 ' A' ' 72' ' ' ILE . 14.2 tp -133.33 125.47 29.28 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.789 -0.569 . . . . 0.0 110.183 -169.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.1 mt -106.52 117.97 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.561 -0.712 . . . . 0.0 109.654 -178.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m -93.35 157.74 16.08 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.078 0.466 . . . . 0.0 111.239 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -53.89 -13.95 0.87 Allowed 'General case' 0 N--CA 1.507 2.392 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -171.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.519 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -90.18 20.91 4.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.169 -0.957 . . . . 0.0 110.444 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 54.15 34.42 20.08 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.486 -0.759 . . . . 0.0 109.882 -174.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.834 HG12 HG22 ' A' ' 46' ' ' THR . 66.1 mt -102.86 141.24 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -104.85 119.73 39.71 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.905 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -114.47 148.29 38.04 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 174.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.66 ' O ' HG23 ' A' ' 41' ' ' VAL . 41.0 tt0 -139.05 140.51 38.1 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.573 -0.704 . . . . 0.0 109.592 175.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.54 173.11 43.21 Favored Glycine 0 N--CA 1.496 2.659 0 C-N-CA 119.794 -1.193 . . . . 0.0 110.386 -175.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 -85.95 136.16 33.38 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.814 -0.815 . . . . 0.0 110.604 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.466 ' HA ' HD23 ' A' ' 38' ' ' LEU . 25.3 tp -66.13 119.5 11.55 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.62 -0.675 . . . . 0.0 110.675 176.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.437 ' O ' HG23 ' A' ' 28' ' ' THR . 22.6 t80 -100.11 -50.01 4.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.693 -0.629 . . . . 0.0 110.446 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 27' ' ' TYR . 16.5 p -153.77 154.36 33.88 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.622 -0.674 . . . . 0.0 110.384 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.895 HG23 HG22 ' A' ' 36' ' ' ILE . 13.4 p -142.28 146.1 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.696 -0.627 . . . . 0.0 110.09 -178.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -129.03 101.26 19.76 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.61 -0.681 . . . . 0.0 109.574 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.42 -41.08 35.27 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 O-C-N 123.628 1.33 . . . . 0.0 110.785 -174.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -80.61 -23.98 39.42 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.396 -0.815 . . . . 0.0 110.187 -172.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.73 ' O ' HG23 ' A' ' 35' ' ' THR . 13.3 mm-40 -87.37 0.88 54.8 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.492 -0.755 . . . . 0.0 111.14 173.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.3 m 49.81 38.14 15.02 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.139 -0.976 . . . . 0.0 111.205 -176.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.73 HG23 ' O ' ' A' ' 33' ' ' GLU . 21.5 p -136.68 152.94 50.95 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.352 -0.842 . . . . 0.0 110.405 -174.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.895 HG22 HG23 ' A' ' 29' ' ' VAL . 39.8 pt -142.75 162.02 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.714 -0.616 . . . . 0.0 110.164 178.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.519 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.22 128.34 29.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.593 -0.692 . . . . 0.0 109.786 175.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 26' ' ' LEU . 86.7 mt -109.96 148.13 32.18 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 95.1 p -120.26 152.8 37.26 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.628 -0.67 . . . . 0.0 109.214 -177.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 53.0 p 44.94 87.34 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 CA-C-O 121.392 0.615 . . . . 0.0 110.385 -172.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.742 HG11 HD12 ' A' ' 65' ' ' ILE . 11.2 p -134.59 145.18 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 CA-C-O 121.155 0.503 . . . . 0.0 110.005 -177.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.837 ' HG2' HD12 ' A' ' 61' ' ' ILE . 90.8 mtt180 -120.46 153.11 37.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.688 -0.633 . . . . 0.0 109.755 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 86.3 p -111.27 133.44 53.6 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.629 -0.669 . . . . 0.0 109.856 177.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -83.05 -38.49 22.48 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.052 -173.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.53 171.98 34.14 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.993 -1.099 . . . . 0.0 110.445 177.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.834 HG22 HG12 ' A' ' 20' ' ' ILE . 2.2 p -117.97 6.48 12.18 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.797 -0.826 . . . . 0.0 110.915 173.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -51.06 -24.1 3.61 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.507 -0.746 . . . . 0.0 112.795 -167.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.08 -59.44 4.13 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.193 -0.942 . . . . 0.0 110.706 -176.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -94.5 10.21 35.49 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.575 -0.703 . . . . 0.0 111.444 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.559 ' HB2' HD12 ' A' ' 55' ' ' ILE . 40.2 p-10 -58.76 174.04 0.37 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.189 -0.944 . . . . 0.0 111.419 -170.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.0 m -78.92 164.48 24.4 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.957 -0.464 . . . . 0.0 109.774 175.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -77.5 4.71 10.48 Favored 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.277 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -95.98 166.07 11.95 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.176 -0.952 . . . . 0.0 109.622 168.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -80.6 133.19 35.72 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.594 -0.691 . . . . 0.0 110.399 -175.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.559 HD12 ' HB2' ' A' ' 50' ' ' ASP . 78.6 mt -113.9 135.35 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.625 -0.672 . . . . 0.0 109.54 177.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.88 146.11 38.09 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.642 -0.661 . . . . 0.0 110.138 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -68.78 149.37 72.86 Favored 'Trans proline' 0 N--CA 1.487 1.104 0 O-C-N 123.55 1.289 . . . . 0.0 110.307 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -92.71 107.4 19.19 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.631 -0.668 . . . . 0.0 110.074 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.9 m -68.01 -35.72 78.77 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.699 -0.625 . . . . 0.0 110.345 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -60.99 133.47 56.13 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.658 -0.651 . . . . 0.0 110.809 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.837 HD12 ' HG2' ' A' ' 42' ' ' ARG . 45.7 mm -96.97 153.73 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.659 -0.651 . . . . 0.0 109.606 178.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -96.76 112.47 24.21 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.598 -0.689 . . . . 0.0 110.446 -175.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -51.67 -41.02 61.09 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.678 -0.639 . . . . 0.0 111.496 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.519 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.7 t80 -153.02 130.31 11.28 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.604 -0.685 . . . . 0.0 110.124 -175.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.742 HD12 HG11 ' A' ' 41' ' ' VAL . 77.4 mt -127.96 128.34 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.644 -0.66 . . . . 0.0 109.804 172.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.2 tp -90.29 137.04 32.67 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.867 -0.52 . . . . 0.0 109.753 175.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.551 ' CD1' HD11 ' A' ' 72' ' ' ILE . 3.0 m-85 -137.03 130.54 31.54 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.663 -0.648 . . . . 0.0 110.6 -174.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -91.57 147.81 22.74 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.705 -0.622 . . . . 0.0 110.301 173.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.11 -26.8 61.66 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.4 m -65.56 -39.39 91.62 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.453 -1.028 . . . . 0.0 110.944 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.69 -32.54 31.67 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.445 -0.785 . . . . 0.0 110.807 -174.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.675 HD13 HD21 ' A' ' 14' ' ' LEU . 8.1 mt -102.97 140.23 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.422 -0.799 . . . . 0.0 110.157 177.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -106.34 -19.7 13.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.961 -0.462 . . . . 0.0 111.647 -167.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -150.41 133.61 16.25 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 119.008 -1.077 . . . . 0.0 111.379 -178.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.525 HD12 ' CD1' ' A' ' 14' ' ' LEU . 17.3 tt -132.44 138.77 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.931 -0.48 . . . . 0.0 109.799 176.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.1 mtm180 -147.07 145.95 29.81 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.598 -0.688 . . . . 0.0 110.422 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.8 m -84.83 147.1 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.664 -0.647 . . . . 0.0 110.328 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.7 m -139.15 147.09 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.559 -0.713 . . . . 0.0 110.172 -178.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -101.63 147.08 26.84 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.697 -0.627 . . . . 0.0 110.164 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -64.94 -31.79 73.19 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.618 -0.676 . . . . 0.0 110.531 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -95.11 109.22 21.31 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.68 -0.638 . . . . 0.0 110.127 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 39.3 p -131.85 166.47 21.53 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.743 -0.598 . . . . 0.0 110.194 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 83' ' ' LEU . 6.3 mp -71.56 155.26 92.75 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 121.669 -0.645 . . . . 0.0 110.129 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo . . . . . 0 N--CA 1.487 1.137 0 O-C-N 123.699 1.368 . . . . 0.0 110.365 -179.636 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -102.31 141.59 34.9 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.659 -0.907 . . . . 0.0 110.192 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 90.2 mtp -65.98 -37.65 86.5 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.712 -0.617 . . . . 0.0 110.322 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -154.98 150.08 26.97 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.771 -0.581 . . . . 0.0 110.238 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.9 ttm -119.95 123.03 42.53 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.658 -0.651 . . . . 0.0 110.16 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.8 m -125.52 142.93 51.24 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.701 -0.625 . . . . 0.0 110.155 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -155.05 110.29 0.44 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.87 -60.1 0.89 Allowed Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 5' ' ' LEU . 6.6 mp -80.76 156.37 72.77 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.64 -0.918 . . . . 0.0 110.158 178.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -66.98 132.92 29.48 Favored 'Trans proline' 0 N--CA 1.488 1.151 0 O-C-N 123.659 1.347 . . . . 0.0 110.329 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -64.91 127.49 31.79 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.626 -0.671 . . . . 0.0 110.525 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.0 mt -64.89 150.52 47.63 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.765 -0.584 . . . . 0.0 110.602 178.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.72 -1.94 84.58 Favored Glycine 0 N--CA 1.496 2.659 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.793 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 74.1 m -61.13 148.1 41.74 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.097 -1.237 . . . . 0.0 110.46 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -81.59 125.18 30.22 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.716 -0.615 . . . . 0.0 110.536 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.61 ' CD1' HD13 ' A' ' 26' ' ' LEU . 90.0 mt -120.91 145.05 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.555 -0.716 . . . . 0.0 110.014 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.6 t -102.93 137.19 41.45 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.778 HD21 HD13 ' A' ' 72' ' ' ILE . 13.5 tp -133.12 124.86 28.32 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.875 -0.515 . . . . 0.0 110.211 -169.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.3 mt -105.75 118.49 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.633 -0.667 . . . . 0.0 109.661 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.1 m -93.1 157.8 16.1 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.112 0.482 . . . . 0.0 111.235 -176.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -53.8 -14.2 0.89 Allowed 'General case' 0 N--CA 1.51 2.525 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -171.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.516 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.63 20.08 4.23 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.207 -0.933 . . . . 0.0 110.412 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 54.38 35.07 22.18 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.448 -0.782 . . . . 0.0 109.817 -175.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.838 HG12 HG22 ' A' ' 46' ' ' THR . 65.2 mt -103.23 144.27 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 59.5 ttm-85 -105.06 119.87 40.09 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.073 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -114.2 150.12 34.75 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 174.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.647 ' O ' HG23 ' A' ' 41' ' ' VAL . 41.8 tt0 -141.48 140.52 33.55 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.484 -0.76 . . . . 0.0 109.648 175.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -169.28 172.86 43.6 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 119.607 -1.282 . . . . 0.0 110.575 -175.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -85.23 136.28 33.58 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.878 -0.778 . . . . 0.0 110.609 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.61 HD13 ' CD1' ' A' ' 12' ' ' ILE . 15.0 tp -66.3 119.53 11.71 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.634 -0.666 . . . . 0.0 110.694 175.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.453 ' O ' HG23 ' A' ' 28' ' ' THR . 26.2 t80 -100.13 -50.18 4.05 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.549 -0.719 . . . . 0.0 110.419 178.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 27' ' ' TYR . 13.5 p -154.4 156.01 36.04 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.636 -0.665 . . . . 0.0 110.283 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.874 HG23 HG22 ' A' ' 36' ' ' ILE . 13.6 p -142.26 145.63 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.612 -0.68 . . . . 0.0 110.068 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -127.5 98.74 28.24 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.627 -0.671 . . . . 0.0 109.565 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -59.38 -42.05 52.58 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 O-C-N 123.597 1.314 . . . . 0.0 111.044 -175.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -80.74 -24.59 38.6 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.372 -0.83 . . . . 0.0 110.169 -171.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.57 ' O ' HG23 ' A' ' 35' ' ' THR . 74.8 mm-40 -87.12 1.15 53.9 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.509 -0.745 . . . . 0.0 111.245 173.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.4 m 49.82 37.91 14.53 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.122 -0.986 . . . . 0.0 111.203 -176.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 33' ' ' GLU . 9.9 p -136.13 154.38 51.0 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.405 -0.809 . . . . 0.0 110.368 -174.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.874 HG22 HG23 ' A' ' 29' ' ' VAL . 39.9 pt -142.51 162.09 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.706 -0.621 . . . . 0.0 110.166 178.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.516 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.54 128.07 28.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.698 -0.627 . . . . 0.0 109.752 175.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.477 HD23 ' HA ' ' A' ' 26' ' ' LEU . 90.6 mt -109.92 148.95 30.63 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -177.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 96.6 p -119.65 152.18 37.52 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.6 p 45.58 83.46 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.226 0 CA-C-O 121.54 0.686 . . . . 0.0 110.382 -172.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.702 ' CG1' HD12 ' A' ' 65' ' ' ILE . 14.9 p -134.59 150.48 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -136.07 153.21 51.4 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.598 -0.689 . . . . 0.0 110.063 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 81.7 p -107.25 137.52 45.15 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.74 -0.6 . . . . 0.0 109.56 177.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -82.76 -38.47 23.18 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.92 -172.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.38 167.37 27.96 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 175.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.838 HG22 HG12 ' A' ' 20' ' ' ILE . 38.3 p -118.28 6.24 11.92 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.807 -0.819 . . . . 0.0 110.913 172.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -52.71 -26.22 13.36 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.49 -0.756 . . . . 0.0 112.095 -167.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -66.22 -59.16 4.0 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.393 -0.817 . . . . 0.0 110.273 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -94.28 10.18 35.15 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.736 -0.602 . . . . 0.0 111.342 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 52.9 p-10 -57.68 174.06 0.26 Allowed 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.29 -0.881 . . . . 0.0 111.499 -171.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.5 m -79.0 164.55 24.29 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -77.44 3.24 13.84 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.584 -0.698 . . . . 0.0 111.227 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -100.46 165.99 11.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.225 -0.922 . . . . 0.0 109.567 169.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -66.98 136.83 55.93 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.579 -0.7 . . . . 0.0 110.515 -175.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.2 mm -113.52 137.26 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.679 -0.638 . . . . 0.0 109.604 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -96.83 109.94 51.13 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.664 -0.648 . . . . 0.0 110.21 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -67.49 145.06 69.48 Favored 'Trans proline' 0 N--CA 1.488 1.16 0 O-C-N 123.395 1.208 . . . . 0.0 110.288 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -97.36 114.42 26.22 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.648 -0.657 . . . . 0.0 110.265 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 87.3 p -77.51 -29.18 52.34 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.655 -0.653 . . . . 0.0 110.478 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -62.13 151.24 36.31 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.601 -0.687 . . . . 0.0 110.669 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.5 mm -96.75 144.92 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.751 -0.593 . . . . 0.0 109.747 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -94.32 114.59 26.68 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.56 -0.712 . . . . 0.0 110.218 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -50.95 -40.51 57.64 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.824 -0.547 . . . . 0.0 111.812 178.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.516 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.8 t80 -152.57 130.12 11.47 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.714 -0.616 . . . . 0.0 110.289 -174.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.702 HD12 ' CG1' ' A' ' 41' ' ' VAL . 76.3 mt -130.09 129.53 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.641 -0.662 . . . . 0.0 109.793 172.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.2 tp -90.27 137.02 32.69 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.814 -0.554 . . . . 0.0 109.864 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.592 ' CD1' HD11 ' A' ' 72' ' ' ILE . 2.5 m-85 -135.17 129.28 33.56 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.658 -0.651 . . . . 0.0 110.562 -175.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 71.2 mtp85 -91.26 146.77 23.54 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.703 -0.623 . . . . 0.0 110.249 173.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.8 -26.52 60.49 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 110.539 -1.025 . . . . 0.0 110.539 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.2 m -65.84 -39.4 90.76 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.527 -0.984 . . . . 0.0 110.953 -177.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.67 -31.71 32.12 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.533 -0.73 . . . . 0.0 110.824 -174.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.778 HD13 HD21 ' A' ' 14' ' ' LEU . 7.9 mt -102.32 142.42 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.443 -0.786 . . . . 0.0 110.191 177.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -104.46 -23.67 13.13 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.378 -167.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -151.99 135.34 15.98 Favored 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 119.146 -1.022 . . . . 0.0 111.446 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.538 HD12 ' CD1' ' A' ' 14' ' ' LEU . 17.6 tt -131.81 140.8 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.906 -0.496 . . . . 0.0 109.775 176.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -146.91 141.56 26.66 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.519 -0.738 . . . . 0.0 110.349 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.5 t -86.85 145.75 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.679 -0.638 . . . . 0.0 109.711 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.3 t -139.2 135.92 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.583 -0.698 . . . . 0.0 109.758 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -142.35 100.36 3.69 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.65 -0.656 . . . . 0.0 110.167 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -125.0 105.87 9.52 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.708 -0.62 . . . . 0.0 110.255 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -110.59 -26.29 9.53 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.658 -0.651 . . . . 0.0 110.677 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 56.4 p -77.09 161.46 28.25 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.446 -0.784 . . . . 0.0 110.097 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.2 tp -109.1 109.91 60.71 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.65 -0.656 . . . . 0.0 110.128 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo . . . . . 0 N--CA 1.488 1.182 0 O-C-N 123.394 1.207 . . . . 0.0 110.295 179.178 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -103.82 144.76 31.07 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.613 -0.934 . . . . 0.0 110.196 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 88.8 mmm -119.01 148.34 43.11 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.734 -0.604 . . . . 0.0 110.148 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -95.18 111.38 23.23 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.684 -0.635 . . . . 0.0 110.147 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.6 mtp -134.71 158.27 44.54 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.666 -0.646 . . . . 0.0 110.241 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.3 t -120.81 141.24 50.72 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.695 -0.628 . . . . 0.0 110.142 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -127.66 104.72 0.7 Allowed Glycine 0 N--CA 1.496 2.691 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.24 -179.58 48.39 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.91 -56.81 1.04 Allowed Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.643 -0.916 . . . . 0.0 110.591 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -71.93 137.43 29.39 Favored 'Trans proline' 0 N--CA 1.487 1.104 0 O-C-N 123.244 1.128 . . . . 0.0 110.377 -178.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -64.79 141.03 58.92 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.707 -0.621 . . . . 0.0 110.499 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.1 mt -64.76 152.05 43.63 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.623 -0.673 . . . . 0.0 110.622 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.68 -1.92 84.55 Favored Glycine 0 N--CA 1.497 2.753 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.788 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 63.8 m -62.0 155.27 24.26 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.168 -1.195 . . . . 0.0 110.4 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.547 ' HE3' HG11 ' A' ' 78' ' ' VAL . 35.8 pttt -81.21 127.98 33.28 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 120.191 -0.604 . . . . 0.0 110.384 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.686 ' CD1' HD13 ' A' ' 26' ' ' LEU . 87.7 mt -121.62 142.95 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.563 -0.711 . . . . 0.0 110.03 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.0 t -102.99 137.29 41.38 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 175.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.885 HD21 HD13 ' A' ' 72' ' ' ILE . 13.9 tp -134.33 123.88 24.9 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.736 -0.602 . . . . 0.0 110.164 -169.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.5 mt -106.33 118.16 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.574 -0.704 . . . . 0.0 109.609 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 62.3 m -92.47 157.81 16.37 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 120.963 0.411 . . . . 0.0 111.245 -176.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -53.56 -13.98 0.75 Allowed 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 -172.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.571 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.96 20.58 4.13 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.115 -0.991 . . . . 0.0 110.412 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 53.43 34.37 18.02 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.395 -0.816 . . . . 0.0 109.813 -174.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.778 HG12 HG22 ' A' ' 46' ' ' THR . 73.1 mt -101.24 141.99 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -104.68 119.86 39.98 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.958 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -115.0 149.28 37.67 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 174.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.664 ' O ' HG23 ' A' ' 41' ' ' VAL . 71.2 mt-10 -140.95 140.52 34.44 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.377 -0.827 . . . . 0.0 109.706 174.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.35 172.17 41.56 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 119.814 -1.184 . . . . 0.0 110.559 -175.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -84.7 139.41 32.03 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.933 -0.745 . . . . 0.0 110.611 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.686 HD13 ' CD1' ' A' ' 12' ' ' ILE . 16.0 tp -66.11 117.9 9.09 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.718 -0.614 . . . . 0.0 110.7 175.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.446 ' O ' HG23 ' A' ' 28' ' ' THR . 21.8 t80 -100.11 -50.06 4.1 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.561 -0.712 . . . . 0.0 110.333 177.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 27' ' ' TYR . 16.9 p -153.81 156.05 36.94 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.684 -0.635 . . . . 0.0 110.271 -178.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.593 HG23 HG22 ' A' ' 36' ' ' ILE . 10.5 p -142.24 145.28 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.74 -0.6 . . . . 0.0 110.18 -178.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -129.03 101.88 19.38 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.675 -0.641 . . . . 0.0 109.434 176.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.83 -41.78 28.35 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 O-C-N 123.562 1.296 . . . . 0.0 110.919 -173.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -80.66 -24.97 38.57 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.332 -0.855 . . . . 0.0 110.227 -170.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.756 ' O ' HG23 ' A' ' 35' ' ' THR . 56.7 mt-10 -87.79 1.75 53.07 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.484 -0.76 . . . . 0.0 111.293 173.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 40.3 m 49.87 41.1 22.14 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.125 -0.984 . . . . 0.0 111.218 -176.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.756 HG23 ' O ' ' A' ' 33' ' ' GLU . 23.5 p -135.5 153.45 51.73 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.327 -0.858 . . . . 0.0 110.53 -174.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.593 HG22 HG23 ' A' ' 29' ' ' VAL . 40.4 pt -141.74 162.0 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.66 -0.65 . . . . 0.0 110.117 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.509 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.01 127.87 29.31 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.719 -0.613 . . . . 0.0 109.669 175.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 26' ' ' LEU . 51.5 mt -109.87 145.07 37.44 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 99.2 p -116.47 151.82 35.3 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.8 p 45.92 85.47 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 121.5 0.667 . . . . 0.0 110.356 -171.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.687 HG11 HD12 ' A' ' 65' ' ' ILE . 12.9 p -134.65 149.1 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -131.68 153.01 50.44 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.623 -0.673 . . . . 0.0 109.891 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 96.9 p -112.01 140.64 46.52 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.741 -0.599 . . . . 0.0 109.891 177.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -83.06 -38.5 22.44 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.613 -0.679 . . . . 0.0 111.175 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.58 171.91 34.1 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.993 -1.098 . . . . 0.0 110.417 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.778 HG22 HG12 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -118.16 6.5 12.02 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.829 -0.807 . . . . 0.0 110.884 173.56 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -50.3 -25.53 3.85 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.508 -0.745 . . . . 0.0 112.446 -168.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -66.06 -59.26 3.97 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.365 -0.834 . . . . 0.0 110.382 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -94.31 10.19 35.16 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.618 -0.676 . . . . 0.0 111.391 177.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 50.5 p-10 -58.15 171.98 0.49 Allowed 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.212 -0.93 . . . . 0.0 111.362 -171.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.7 m -78.98 164.41 24.41 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.908 -0.495 . . . . 0.0 109.873 176.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -77.6 4.22 11.88 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.662 -0.649 . . . . 0.0 111.198 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -95.54 164.75 12.66 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.25 -0.906 . . . . 0.0 109.608 167.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -68.55 135.38 51.44 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.507 -0.746 . . . . 0.0 110.453 -176.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.6 mm -114.17 134.39 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.734 -0.604 . . . . 0.0 109.615 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -96.22 109.88 49.49 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.703 -0.623 . . . . 0.0 110.181 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -67.33 135.02 35.34 Favored 'Trans proline' 0 N--CA 1.488 1.154 0 O-C-N 123.414 1.218 . . . . 0.0 110.308 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 18.8 mp0 -111.63 135.07 52.71 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.671 -0.643 . . . . 0.0 110.168 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 83.1 p -91.48 6.87 43.87 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.655 -0.653 . . . . 0.0 111.2 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -63.1 141.04 58.91 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.217 -0.927 . . . . 0.0 110.438 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.8 mm -96.86 137.7 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.655 -0.653 . . . . 0.0 109.844 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -94.14 119.03 32.39 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.715 -0.616 . . . . 0.0 110.177 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -51.35 -42.61 61.43 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.789 -0.569 . . . . 0.0 111.745 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.509 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.1 t80 -152.27 130.3 11.84 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.587 -0.695 . . . . 0.0 110.293 -174.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.687 HD12 HG11 ' A' ' 41' ' ' VAL . 75.2 mt -130.26 130.3 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.728 -0.608 . . . . 0.0 109.877 171.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 19.0 tp -90.25 137.01 32.69 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.823 -0.548 . . . . 0.0 109.934 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.647 ' CD1' HD11 ' A' ' 72' ' ' ILE . 2.3 m-85 -133.4 127.09 32.68 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.627 -0.67 . . . . 0.0 110.477 -176.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -92.12 145.98 24.08 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.592 -0.692 . . . . 0.0 110.31 173.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.88 -26.67 60.92 Favored Glycine 0 N--CA 1.499 2.843 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.2 m -65.02 -39.94 94.14 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.408 -1.054 . . . . 0.0 110.977 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.77 -32.24 31.51 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.445 -0.784 . . . . 0.0 110.826 -175.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.885 HD13 HD21 ' A' ' 14' ' ' LEU . 6.6 mt -99.34 141.75 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.53 -0.731 . . . . 0.0 110.264 177.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -104.35 -20.78 13.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.938 -0.476 . . . . 0.0 111.377 -169.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -151.79 131.95 13.56 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.238 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.536 HD12 ' CD1' ' A' ' 14' ' ' LEU . 17.1 tt -130.91 140.48 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.872 -0.517 . . . . 0.0 109.737 176.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -146.47 130.28 17.12 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.62 -0.675 . . . . 0.0 110.306 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.5 p -87.74 146.29 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.613 -0.679 . . . . 0.0 110.27 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.547 HG11 ' HE3' ' A' ' 11' ' ' LYS . 61.6 t -96.05 133.48 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.572 -0.705 . . . . 0.0 109.738 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -125.42 -60.06 1.35 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.619 -0.676 . . . . 0.0 110.155 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -114.69 117.71 31.59 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.7 -0.625 . . . . 0.0 110.169 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -121.66 120.13 33.85 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.64 -0.662 . . . . 0.0 110.155 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.0 t -138.78 160.52 39.49 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.582 -0.699 . . . . 0.0 110.352 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.1 mp -113.36 165.19 13.85 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.614 -0.679 . . . . 0.0 110.19 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo . . . . . 0 N--CA 1.489 1.235 0 O-C-N 123.664 1.349 . . . . 0.0 110.481 179.964 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -144.74 156.65 44.17 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.662 -0.905 . . . . 0.0 110.203 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 74.4 mtm -118.52 159.0 24.3 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.81 -0.556 . . . . 0.0 110.151 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -141.3 156.74 45.83 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.763 -0.586 . . . . 0.0 110.147 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.6 mtm -110.39 151.71 27.14 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.729 -0.607 . . . . 0.0 110.209 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.6 t -117.36 143.87 45.52 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.687 -0.633 . . . . 0.0 110.225 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.33 -34.84 89.16 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -146.3 83.73 0.19 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.562 HD21 HD11 ' A' ' 8' ' ' LEU . 14.9 tp -80.26 139.63 52.45 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.724 -0.868 . . . . 0.0 110.032 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -66.28 153.18 79.03 Favored 'Trans proline' 0 N--CA 1.489 1.224 0 O-C-N 123.392 1.206 . . . . 0.0 110.415 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -64.91 96.05 0.18 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.67 -0.644 . . . . 0.0 110.473 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.562 HD11 HD21 ' A' ' 5' ' ' LEU . 84.0 mt -64.81 174.09 2.0 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.693 -0.629 . . . . 0.0 110.722 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.68 -1.92 84.53 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.841 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.6 m -61.72 142.22 57.37 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.113 -1.228 . . . . 0.0 110.457 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -82.36 123.38 29.04 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.748 -0.595 . . . . 0.0 110.559 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.621 ' CD1' HD13 ' A' ' 26' ' ' LEU . 91.0 mt -120.25 144.18 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.472 -0.768 . . . . 0.0 110.199 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.4 t -103.11 137.27 41.5 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 174.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.475 ' CD1' HD12 ' A' ' 75' ' ' ILE . 13.1 tp -133.49 127.84 34.11 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.712 -0.618 . . . . 0.0 110.339 -169.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.0 mt -107.59 119.98 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.593 -0.692 . . . . 0.0 109.738 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.3 m -94.35 157.81 15.86 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.049 0.452 . . . . 0.0 111.248 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.0 tptp -53.51 -15.18 1.0 Allowed 'General case' 0 N--CA 1.509 2.5 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -172.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.534 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.75 21.32 3.59 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.13 -0.982 . . . . 0.0 110.436 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 54.16 33.98 19.14 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.44 -0.788 . . . . 0.0 109.795 -174.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.804 HG12 HG22 ' A' ' 46' ' ' THR . 69.2 mt -101.81 142.72 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 36.7 ttp85 -105.19 119.8 39.94 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.941 -0.704 . . . . 0.0 109.887 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -113.79 149.24 35.21 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.662 ' O ' HG23 ' A' ' 41' ' ' VAL . 42.6 tt0 -140.61 140.53 35.09 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.546 -0.721 . . . . 0.0 109.696 176.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -169.13 173.24 43.57 Favored Glycine 0 N--CA 1.495 2.603 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.463 -175.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -85.11 136.44 33.55 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.881 -0.776 . . . . 0.0 110.495 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.621 HD13 ' CD1' ' A' ' 12' ' ' ILE . 15.3 tp -66.12 119.04 10.74 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.57 -0.706 . . . . 0.0 110.693 175.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.448 ' O ' HG23 ' A' ' 28' ' ' THR . 25.9 t80 -99.4 -50.09 4.22 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.666 -0.646 . . . . 0.0 110.292 178.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 27' ' ' TYR . 15.2 p -153.9 153.29 31.79 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.78 -0.575 . . . . 0.0 110.255 -178.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.882 HG23 HG22 ' A' ' 36' ' ' ILE . 13.5 p -142.31 144.86 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.643 -0.661 . . . . 0.0 110.102 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -128.99 101.53 19.68 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.531 -0.73 . . . . 0.0 109.528 177.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.68 -40.25 38.33 Favored 'Trans proline' 0 N--CA 1.489 1.243 0 O-C-N 123.515 1.271 . . . . 0.0 110.719 -175.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -80.68 -25.18 38.39 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.306 -0.871 . . . . 0.0 110.174 -171.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.723 ' O ' HG23 ' A' ' 35' ' ' THR . 79.2 mt-10 -87.44 1.46 53.36 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.516 -0.74 . . . . 0.0 111.256 173.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.0 m 49.84 39.51 18.38 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.105 -0.997 . . . . 0.0 111.284 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.723 HG23 ' O ' ' A' ' 33' ' ' GLU . 22.7 p -136.65 151.98 49.9 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.365 -0.834 . . . . 0.0 110.368 -175.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.882 HG22 HG23 ' A' ' 29' ' ' VAL . 39.7 pt -142.6 161.47 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.695 -0.628 . . . . 0.0 110.179 177.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.508 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.86 127.91 27.75 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.628 -0.67 . . . . 0.0 109.678 175.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 26' ' ' LEU . 85.6 mt -109.87 146.98 34.19 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -177.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 96.7 p -118.7 153.06 34.99 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -177.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.7 p 45.75 85.9 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 121.452 0.644 . . . . 0.0 110.318 -172.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.783 HG11 HD12 ' A' ' 65' ' ' ILE . 13.3 p -134.51 148.61 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.952 -0.468 . . . . 0.0 109.909 -177.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -126.41 153.12 45.43 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.699 -0.626 . . . . 0.0 109.829 177.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 96.6 p -108.24 134.93 50.39 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.703 -0.623 . . . . 0.0 109.726 175.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -83.01 -38.37 22.7 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.57 -0.706 . . . . 0.0 111.045 -173.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.61 169.29 30.96 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 120.027 -1.083 . . . . 0.0 110.602 176.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.804 HG22 HG12 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -118.19 6.58 12.0 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.97 -0.724 . . . . 0.0 110.837 174.309 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -49.16 -25.64 2.32 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.6 -0.688 . . . . 0.0 112.62 -168.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -65.04 -59.22 4.37 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.321 -0.862 . . . . 0.0 110.587 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -94.31 10.14 35.35 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.569 -0.707 . . . . 0.0 111.381 177.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.46 ' HB2' HD12 ' A' ' 55' ' ' ILE . 39.9 p-10 -59.44 165.86 2.61 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.251 -0.906 . . . . 0.0 111.438 -170.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.3 m -78.98 164.46 24.38 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.925 -0.484 . . . . 0.0 109.748 174.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -77.55 4.22 11.76 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.607 -0.683 . . . . 0.0 111.263 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -96.78 155.32 16.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.156 -0.965 . . . . 0.0 109.623 167.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -68.77 139.8 55.31 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.649 -0.657 . . . . 0.0 110.387 -175.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.46 HD12 ' HB2' ' A' ' 50' ' ' ASP . 81.5 mt -116.38 138.41 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.674 -0.641 . . . . 0.0 109.612 177.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -97.98 109.98 53.81 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.733 -0.605 . . . . 0.0 110.223 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -66.14 149.64 85.51 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 O-C-N 123.357 1.188 . . . . 0.0 110.335 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -93.22 112.64 24.64 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.667 -0.646 . . . . 0.0 110.301 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.7 t -67.18 -29.4 69.07 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.668 -0.645 . . . . 0.0 110.463 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -60.98 159.29 11.73 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.544 -0.723 . . . . 0.0 110.759 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.81 146.72 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.843 -0.536 . . . . 0.0 109.748 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -91.72 111.85 23.54 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.659 -0.651 . . . . 0.0 109.894 176.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -52.35 -43.21 64.5 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.786 -0.571 . . . . 0.0 111.707 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.508 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.7 t80 -154.55 130.28 10.02 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.742 -0.599 . . . . 0.0 110.264 -174.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.783 HD12 HG11 ' A' ' 41' ' ' VAL . 82.9 mt -129.07 127.44 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.663 -0.648 . . . . 0.0 109.989 171.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 24.0 tp -90.79 137.03 32.68 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.867 -0.521 . . . . 0.0 109.859 175.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.515 ' CZ ' HG21 ' A' ' 65' ' ' ILE . 4.5 m-85 -136.95 131.59 33.22 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.685 -0.634 . . . . 0.0 110.65 -175.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -91.78 151.57 20.55 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.736 -0.602 . . . . 0.0 110.452 174.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.96 -23.98 59.94 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.2 p -67.52 -41.99 83.51 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.45 -1.03 . . . . 0.0 111.032 -176.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -83.13 -32.87 26.45 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.354 -0.842 . . . . 0.0 110.914 -175.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.44 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 22.2 mt -105.94 136.25 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.459 -0.775 . . . . 0.0 110.013 177.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 59.4 tttt -109.1 -14.34 14.54 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 120.417 -0.513 . . . . 0.0 112.008 -165.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -147.88 131.41 16.75 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 118.901 -1.12 . . . . 0.0 111.433 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.475 HD12 ' CD1' ' A' ' 14' ' ' LEU . 15.8 tt -132.38 137.48 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.936 -0.478 . . . . 0.0 109.77 176.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.0 mtm180 -147.04 147.1 30.31 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.606 -0.684 . . . . 0.0 110.387 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.9 t -85.96 145.04 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.679 -0.638 . . . . 0.0 109.601 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.2 t -94.68 134.89 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.601 -0.687 . . . . 0.0 109.898 -177.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -105.14 126.27 51.9 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.704 -0.623 . . . . 0.0 110.096 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -99.96 150.24 22.62 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.683 -0.636 . . . . 0.0 110.263 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -121.74 163.58 18.84 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.74 -0.6 . . . . 0.0 110.104 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.8 p -87.5 160.49 18.24 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.717 -0.615 . . . . 0.0 110.214 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.7 mt -126.35 163.56 39.53 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.682 -0.636 . . . . 0.0 110.112 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo . . . . . 0 N--CA 1.487 1.11 0 O-C-N 123.728 1.383 . . . . 0.0 110.323 179.932 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.361 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -2' ' ' ALA . . . . . 0.457 ' HB1' ' O ' ' A' ' 1' ' ' MET . . . -102.96 144.81 30.76 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.678 -0.895 . . . . 0.0 110.27 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 9.3 tpt -66.48 -35.59 80.65 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.651 -0.656 . . . . 0.0 110.263 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -140.1 -59.78 0.54 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.765 -0.584 . . . . 0.0 110.176 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.457 ' O ' ' HB1' ' A' ' -2' ' ' ALA . 90.5 mtp -109.64 134.8 51.53 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.673 -0.642 . . . . 0.0 110.115 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 86.4 p -108.35 28.77 7.99 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.67 -0.644 . . . . 0.0 110.585 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -153.31 37.34 0.74 Allowed Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.89 -60.06 1.16 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 27.5 mt -80.29 152.95 74.01 Favored Pre-proline 0 N--CA 1.497 1.919 0 O-C-N 121.63 -0.924 . . . . 0.0 110.262 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -69.16 155.76 66.94 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 O-C-N 123.685 1.361 . . . . 0.0 110.279 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -64.82 103.87 0.77 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.644 -0.66 . . . . 0.0 110.407 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.5 mt -64.8 149.95 48.41 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.736 -0.603 . . . . 0.0 110.71 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.65 -1.97 84.29 Favored Glycine 0 N--CA 1.497 2.713 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.837 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.9 m -62.06 148.21 44.85 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.125 -1.221 . . . . 0.0 110.49 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -81.87 124.53 29.79 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.662 -0.649 . . . . 0.0 110.401 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.609 ' CD1' HD13 ' A' ' 26' ' ' LEU . 88.8 mt -120.64 144.54 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.565 -0.71 . . . . 0.0 110.122 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.6 t -102.91 137.33 41.25 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.766 HD21 HD13 ' A' ' 72' ' ' ILE . 13.6 tp -132.79 125.64 30.55 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.711 -0.618 . . . . 0.0 110.219 -169.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.0 mt -106.94 118.6 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.447 -0.783 . . . . 0.0 109.661 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.9 m -93.77 157.65 16.05 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 120.997 0.427 . . . . 0.0 111.3 -177.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -55.68 -11.17 0.85 Allowed 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -172.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.72 18.48 4.67 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.196 -0.94 . . . . 0.0 110.439 176.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 55.64 36.06 26.46 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.442 -0.786 . . . . 0.0 109.918 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.812 HG12 HG22 ' A' ' 46' ' ' THR . 57.6 mt -106.96 145.0 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -105.62 119.81 40.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.618 -0.676 . . . . 0.0 110.123 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -113.81 152.12 31.09 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.659 ' O ' HG23 ' A' ' 41' ' ' VAL . 46.4 tt0 -142.27 140.57 32.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.429 -0.795 . . . . 0.0 109.672 175.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.87 172.21 42.55 Favored Glycine 0 N--CA 1.496 2.634 0 C-N-CA 119.713 -1.232 . . . . 0.0 110.558 -175.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -85.08 136.16 33.68 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.864 -0.786 . . . . 0.0 110.517 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.609 HD13 ' CD1' ' A' ' 12' ' ' ILE . 15.1 tp -66.16 117.8 8.98 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.623 -0.673 . . . . 0.0 110.664 175.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.454 ' O ' HG23 ' A' ' 28' ' ' THR . 25.9 t80 -99.95 -50.1 4.11 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.657 -0.652 . . . . 0.0 110.455 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 27' ' ' TYR . 14.1 p -154.35 156.06 36.2 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.736 -0.603 . . . . 0.0 110.348 -178.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.828 HG23 HG22 ' A' ' 36' ' ' ILE . 13.3 p -142.31 146.25 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.771 -0.58 . . . . 0.0 110.007 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -128.48 100.8 21.97 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.582 -0.699 . . . . 0.0 109.536 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.59 -40.16 39.67 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 O-C-N 123.558 1.294 . . . . 0.0 110.71 -174.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -80.63 -25.27 38.47 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.365 -0.834 . . . . 0.0 110.202 -171.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.566 ' O ' HG23 ' A' ' 35' ' ' THR . 78.7 mt-10 -87.47 1.3 53.85 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.498 -0.751 . . . . 0.0 111.258 173.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 45.2 m 49.6 39.19 16.66 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.089 -1.007 . . . . 0.0 111.303 -176.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 33' ' ' GLU . 10.0 p -136.07 155.35 50.34 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.393 -0.817 . . . . 0.0 110.315 -174.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.828 HG22 HG23 ' A' ' 29' ' ' VAL . 39.8 pt -142.27 162.03 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.616 -0.677 . . . . 0.0 110.17 177.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.525 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.4 127.68 28.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.669 -0.644 . . . . 0.0 109.692 175.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' A' ' 26' ' ' LEU . 87.2 mt -109.87 147.12 33.94 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -178.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 96.8 p -118.22 152.43 35.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.674 -0.642 . . . . 0.0 109.27 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.3 p 45.5 84.79 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 CA-C-O 121.476 0.655 . . . . 0.0 110.358 -172.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.664 HG11 HD12 ' A' ' 65' ' ' ILE . 13.7 p -134.54 149.02 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.905 -0.497 . . . . 0.0 109.853 -178.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.4 ttm180 -131.71 153.05 50.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.68 -0.637 . . . . 0.0 109.799 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 85.1 p -107.93 133.89 51.63 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.741 -0.599 . . . . 0.0 109.476 175.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -82.68 -38.63 23.15 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.039 -171.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.23 167.08 27.38 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 175.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.812 HG22 HG12 ' A' ' 20' ' ' ILE . 53.0 p -118.23 -11.2 10.13 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.963 -0.728 . . . . 0.0 110.83 170.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -52.74 -24.99 9.81 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.462 -0.774 . . . . 0.0 112.492 -166.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -79.12 -59.3 2.83 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.261 -0.899 . . . . 0.0 110.894 -176.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -94.42 9.93 36.41 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.596 -0.69 . . . . 0.0 112.006 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -90.16 174.56 7.55 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.085 -1.009 . . . . 0.0 111.126 -175.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.0 m -78.43 164.66 24.58 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 122.016 -0.428 . . . . 0.0 109.854 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -77.45 12.07 1.72 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.726 -0.609 . . . . 0.0 111.616 -173.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -92.49 140.54 29.46 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.241 -0.912 . . . . 0.0 109.62 169.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -65.97 141.03 58.34 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.713 -0.617 . . . . 0.0 110.919 -170.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 82.5 mt -118.83 138.81 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.731 -0.606 . . . . 0.0 109.399 176.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.62 113.43 14.23 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.617 -0.677 . . . . 0.0 110.125 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -64.18 142.65 81.15 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 O-C-N 123.305 1.161 . . . . 0.0 110.465 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -104.02 107.11 17.85 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.713 -0.617 . . . . 0.0 110.27 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.6 p -93.4 -32.72 14.13 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.685 -0.634 . . . . 0.0 110.327 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -62.8 152.64 35.4 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.619 -0.675 . . . . 0.0 110.655 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.4 mm -96.8 141.08 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.705 -0.622 . . . . 0.0 109.592 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -96.36 113.16 24.72 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.64 -0.663 . . . . 0.0 110.37 -177.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -51.19 -39.93 57.55 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.738 -0.601 . . . . 0.0 111.416 175.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.525 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.7 t80 -152.73 129.19 10.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.627 -0.671 . . . . 0.0 110.201 -175.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.664 HD12 HG11 ' A' ' 41' ' ' VAL . 72.6 mt -127.55 129.14 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.566 -0.709 . . . . 0.0 109.798 172.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.9 tp -90.18 137.05 32.67 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.859 -0.526 . . . . 0.0 109.808 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.589 ' CD1' HD11 ' A' ' 72' ' ' ILE . 2.6 m-85 -135.56 129.21 32.62 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.751 -0.593 . . . . 0.0 110.559 -175.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -91.07 146.62 23.69 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.715 -0.615 . . . . 0.0 110.176 173.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.58 -25.86 58.94 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.1 p -67.75 -37.61 82.38 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.459 -1.024 . . . . 0.0 110.875 -177.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -82.46 -30.5 29.94 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.454 -0.779 . . . . 0.0 110.934 -175.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.766 HD13 HD21 ' A' ' 14' ' ' LEU . 8.6 mt -103.95 142.87 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.426 -0.796 . . . . 0.0 110.278 176.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -104.63 -24.73 12.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.932 -0.48 . . . . 0.0 111.381 -167.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -151.88 136.24 16.79 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.048 -1.033 . . . . 0.0 111.465 -177.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.53 HD12 ' CD1' ' A' ' 14' ' ' LEU . 17.7 tt -131.79 140.51 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.963 -0.461 . . . . 0.0 109.828 176.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -146.87 140.77 25.96 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.544 -0.723 . . . . 0.0 110.335 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.0 p -86.04 147.05 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.669 -0.644 . . . . 0.0 110.107 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.0 t -93.98 134.76 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.578 -0.701 . . . . 0.0 109.868 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -120.82 157.31 30.03 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.712 -0.617 . . . . 0.0 110.195 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -98.81 134.2 42.03 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.707 -0.621 . . . . 0.0 110.111 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -116.85 139.49 50.56 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.656 -0.652 . . . . 0.0 110.184 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.8 t -133.46 156.96 46.77 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.705 -0.622 . . . . 0.0 110.397 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.1 tp -145.06 139.74 15.44 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.719 -0.613 . . . . 0.0 110.059 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo . . . . . 0 N--CA 1.488 1.193 0 O-C-N 123.346 1.182 . . . . 0.0 110.295 179.534 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -143.76 151.32 39.84 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.663 -0.904 . . . . 0.0 110.219 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 66.0 mtt -104.24 29.33 6.08 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.668 -0.645 . . . . 0.0 110.406 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -69.06 -34.68 75.56 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.577 -0.702 . . . . 0.0 110.254 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.7 mtp -129.18 165.47 21.26 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.667 -0.645 . . . . 0.0 110.313 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.5 m -117.41 151.9 36.08 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.715 -0.615 . . . . 0.0 110.102 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.35 34.53 5.47 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -115.44 37.51 3.44 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.534 HD12 ' O ' ' A' ' 6' ' ' PRO . 4.0 pp -77.64 152.59 80.75 Favored Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 121.687 -0.89 . . . . 0.0 110.499 -179.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.534 ' O ' HD12 ' A' ' 5' ' ' LEU . 31.4 Cg_endo -68.52 155.4 69.16 Favored 'Trans proline' 0 N--CA 1.487 1.127 0 O-C-N 123.624 1.328 . . . . 0.0 110.382 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -64.82 127.0 29.73 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.652 -0.655 . . . . 0.0 110.445 -178.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.6 mt -64.85 145.82 55.74 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.748 -0.595 . . . . 0.0 110.737 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.57 -1.9 84.31 Favored Glycine 0 N--CA 1.496 2.663 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.85 176.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.4 m -62.71 138.94 58.63 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.126 -1.22 . . . . 0.0 110.355 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -82.13 126.98 32.67 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.624 -0.673 . . . . 0.0 110.415 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.679 ' CD1' HD13 ' A' ' 26' ' ' LEU . 86.5 mt -120.97 143.36 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.614 -0.679 . . . . 0.0 110.142 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.0 t -103.18 137.32 41.49 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.762 HD21 HD13 ' A' ' 72' ' ' ILE . 14.0 tp -134.8 125.9 27.8 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.687 -0.633 . . . . 0.0 110.337 -168.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.3 mt -106.85 118.11 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.614 -0.679 . . . . 0.0 109.665 -178.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.6 m -92.86 157.89 16.14 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 120.97 0.414 . . . . 0.0 111.303 -176.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -53.75 -14.43 0.93 Allowed 'General case' 0 N--CA 1.508 2.453 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -171.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.14 20.22 3.82 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.169 -0.957 . . . . 0.0 110.519 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 56.03 36.08 26.72 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.463 -0.773 . . . . 0.0 109.916 -177.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.788 HG12 HG22 ' A' ' 46' ' ' THR . 53.6 mt -107.05 146.58 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -105.39 119.81 40.03 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.13 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -113.41 152.39 30.11 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.656 ' O ' HG23 ' A' ' 41' ' ' VAL . 42.6 tt0 -142.36 140.45 32.08 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.491 -0.756 . . . . 0.0 109.583 175.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.95 171.41 41.77 Favored Glycine 0 N--CA 1.496 2.66 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.602 -175.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -85.45 137.27 33.02 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.836 -0.803 . . . . 0.0 110.607 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.679 HD13 ' CD1' ' A' ' 12' ' ' ILE . 16.2 tp -66.2 118.81 10.45 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.648 -0.657 . . . . 0.0 110.723 175.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.416 ' O ' HG23 ' A' ' 28' ' ' THR . 25.4 t80 -100.36 -50.06 4.05 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.611 -0.681 . . . . 0.0 110.351 176.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 27' ' ' TYR . 23.2 p -153.55 153.59 32.68 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.741 -0.599 . . . . 0.0 110.18 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.882 HG23 HG22 ' A' ' 36' ' ' ILE . 13.5 p -142.3 145.04 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.593 -0.692 . . . . 0.0 110.102 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -128.5 100.51 22.26 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.623 -0.673 . . . . 0.0 109.566 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.41 -39.69 44.47 Favored 'Trans proline' 0 N--CA 1.489 1.244 0 O-C-N 123.578 1.304 . . . . 0.0 110.726 -175.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -80.49 -25.83 38.56 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.406 -0.809 . . . . 0.0 110.157 -172.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.572 ' O ' HG23 ' A' ' 35' ' ' THR . 54.9 mt-10 -87.35 1.83 52.14 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.501 -0.75 . . . . 0.0 111.195 173.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 75.5 m 49.58 38.3 14.51 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.116 -0.99 . . . . 0.0 111.291 -176.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 33' ' ' GLU . 10.5 p -136.26 153.73 51.11 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.399 -0.813 . . . . 0.0 110.26 -174.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.882 HG22 HG23 ' A' ' 29' ' ' VAL . 39.9 pt -142.73 162.02 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.703 -0.623 . . . . 0.0 110.249 178.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.523 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.69 127.29 27.01 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.669 -0.644 . . . . 0.0 109.665 175.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 26' ' ' LEU . 83.8 mt -109.94 146.99 34.27 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -177.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 95.7 p -118.07 152.68 35.09 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.5 p 45.58 84.0 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 121.492 0.663 . . . . 0.0 110.336 -172.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.669 ' CG1' HD12 ' A' ' 65' ' ' ILE . 14.9 p -134.53 150.55 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.947 -0.47 . . . . 0.0 109.774 -178.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -136.4 153.09 51.19 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.64 -0.663 . . . . 0.0 110.168 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.5 p -107.2 133.03 52.39 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.71 -0.619 . . . . 0.0 109.506 176.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -83.09 -38.62 22.22 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.726 -0.79 . . . . 0.0 111.087 -170.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.27 171.73 33.65 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 176.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.788 HG22 HG12 ' A' ' 20' ' ' ILE . 69.6 p -118.22 6.1 11.95 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.789 -0.83 . . . . 0.0 110.467 169.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -57.26 -31.41 65.54 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.545 -0.722 . . . . 0.0 112.427 -161.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -66.69 -59.34 3.67 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.239 -0.913 . . . . 0.0 110.486 -174.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.0 mtt-85 -94.51 10.3 35.15 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.677 -0.639 . . . . 0.0 111.612 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.474 ' HB2' HD12 ' A' ' 55' ' ' ILE . 38.2 p30 -54.63 172.15 0.11 Allowed 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.166 -0.959 . . . . 0.0 111.894 -171.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.0 m -78.94 164.6 24.29 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 173.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -77.32 3.75 12.33 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.567 -0.708 . . . . 0.0 111.214 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -98.28 153.34 18.58 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.215 -0.928 . . . . 0.0 109.619 169.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -67.82 138.59 56.25 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.578 -0.701 . . . . 0.0 110.597 -174.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.474 HD12 ' HB2' ' A' ' 50' ' ' ASP . 79.2 mt -117.43 141.2 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.661 -0.65 . . . . 0.0 109.511 177.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -97.66 109.86 52.59 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.612 -0.68 . . . . 0.0 110.215 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -68.6 147.65 70.64 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 O-C-N 123.44 1.232 . . . . 0.0 110.325 178.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -101.38 121.44 41.93 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.64 -0.662 . . . . 0.0 110.206 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 86.6 p -81.25 -26.81 35.53 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.724 -0.61 . . . . 0.0 110.686 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -61.67 148.35 42.93 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.471 -0.768 . . . . 0.0 110.623 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.1 mm -96.85 145.64 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.712 -0.618 . . . . 0.0 109.747 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -95.75 114.34 26.06 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.659 -0.651 . . . . 0.0 110.347 -178.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -51.04 -41.09 59.64 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.709 -0.62 . . . . 0.0 111.527 176.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.523 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.7 t80 -152.63 129.51 10.97 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.727 -0.608 . . . . 0.0 110.226 -174.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.669 HD12 ' CG1' ' A' ' 41' ' ' VAL . 73.7 mt -128.23 128.34 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.683 -0.635 . . . . 0.0 109.794 172.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.8 tp -90.13 137.06 32.65 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.889 -0.507 . . . . 0.0 109.838 176.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.583 ' CD1' HD11 ' A' ' 72' ' ' ILE . 3.0 m-85 -135.35 128.84 32.43 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.572 -0.705 . . . . 0.0 110.603 -175.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -91.27 147.03 23.33 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.653 -0.654 . . . . 0.0 110.177 172.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.63 -25.62 58.76 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.2 p -67.83 -37.85 82.45 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.427 -1.043 . . . . 0.0 110.917 -177.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -82.43 -30.79 29.86 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.504 -0.748 . . . . 0.0 110.9 -175.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.762 HD13 HD21 ' A' ' 14' ' ' LEU . 8.5 mt -104.31 138.78 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.492 -0.755 . . . . 0.0 110.104 176.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -105.04 -18.07 14.28 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.92 -0.487 . . . . 0.0 111.58 -167.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -151.03 132.03 14.27 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 119.115 -1.034 . . . . 0.0 111.249 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.541 HD12 ' CD1' ' A' ' 14' ' ' LEU . 16.8 tt -132.2 141.97 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.887 -0.508 . . . . 0.0 109.806 176.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -146.4 135.13 22.28 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.659 -0.65 . . . . 0.0 110.361 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.406 HG22 HG12 ' A' ' 12' ' ' ILE . 52.4 t -87.59 143.74 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.682 -0.636 . . . . 0.0 109.775 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.3 t -93.82 134.81 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.59 -0.694 . . . . 0.0 109.745 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -113.28 165.46 12.4 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.736 -0.603 . . . . 0.0 110.227 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -90.35 132.1 35.77 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.763 -0.586 . . . . 0.0 110.107 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -118.9 160.32 22.16 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.599 -0.688 . . . . 0.0 110.203 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.6 m -113.18 142.39 45.84 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.706 -0.621 . . . . 0.0 110.135 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.33 162.22 63.04 Favored Pre-proline 0 N--CA 1.5 2.049 0 O-C-N 121.646 -0.659 . . . . 0.0 110.244 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo . . . . . 0 N--CA 1.488 1.175 0 O-C-N 123.561 1.296 . . . . 0.0 110.47 179.796 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -103.83 31.7 4.33 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.686 -0.89 . . . . 0.0 110.376 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 22.5 ttt -111.71 138.67 47.97 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.607 -0.683 . . . . 0.0 110.174 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -102.06 141.68 34.52 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.791 -0.568 . . . . 0.0 110.216 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.88 -35.36 79.85 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.703 -0.623 . . . . 0.0 110.301 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.2 t -124.25 140.62 52.78 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.706 -0.622 . . . . 0.0 110.217 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -106.25 -50.08 0.89 Allowed Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.32 137.66 23.13 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 11.6 tp -81.28 112.03 29.75 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.665 -0.903 . . . . 0.0 110.111 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -65.82 136.59 46.03 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 O-C-N 123.349 1.184 . . . . 0.0 110.383 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -64.83 131.56 47.09 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.653 -0.654 . . . . 0.0 110.583 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.3 mt -64.76 165.56 10.29 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.664 -0.647 . . . . 0.0 110.469 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.68 -1.79 84.95 Favored Glycine 0 N--CA 1.497 2.707 0 C-N-CA 120.453 -0.879 . . . . 0.0 111.742 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.4 m -60.39 151.7 27.33 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.078 -1.248 . . . . 0.0 110.482 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.434 ' HE3' HG11 ' A' ' 78' ' ' VAL . 30.5 pttt -81.95 126.54 32.06 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.66 -0.65 . . . . 0.0 110.551 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.652 ' CD1' HD13 ' A' ' 26' ' ' LEU . 89.5 mt -120.8 143.76 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.57 -0.706 . . . . 0.0 109.988 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.4 t -102.42 137.27 40.89 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 175.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.668 HD21 HD13 ' A' ' 72' ' ' ILE . 14.7 tp -133.11 125.06 28.7 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.763 -0.586 . . . . 0.0 110.227 -169.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 81.7 mt -106.75 118.85 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.548 -0.72 . . . . 0.0 109.629 -178.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.7 m -93.69 157.66 16.06 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.064 0.459 . . . . 0.0 111.148 -178.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -54.21 -13.24 0.8 Allowed 'General case' 0 N--CA 1.507 2.416 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -172.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.556 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -90.0 20.4 4.27 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.142 -0.974 . . . . 0.0 110.475 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 53.96 33.98 18.6 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.485 -0.76 . . . . 0.0 109.749 -173.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.779 HG12 HG22 ' A' ' 46' ' ' THR . 68.8 mt -102.22 140.89 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.168 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -104.9 119.81 39.92 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.922 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -114.36 147.55 38.98 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 173.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.671 ' O ' HG23 ' A' ' 41' ' ' VAL . 41.5 tt0 -139.31 140.43 37.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.436 -0.79 . . . . 0.0 109.627 175.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.11 173.22 42.34 Favored Glycine 0 N--CA 1.496 2.678 0 C-N-CA 119.737 -1.22 . . . . 0.0 110.58 -175.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -84.28 137.57 33.39 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.907 -0.761 . . . . 0.0 110.546 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.652 HD13 ' CD1' ' A' ' 12' ' ' ILE . 16.0 tp -66.15 116.88 7.7 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.727 -0.608 . . . . 0.0 110.655 175.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.453 ' O ' HG23 ' A' ' 28' ' ' THR . 24.9 t80 -99.68 -50.18 4.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.659 -0.651 . . . . 0.0 110.421 178.168 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 27' ' ' TYR . 15.1 p -153.97 153.64 32.36 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.705 -0.622 . . . . 0.0 110.269 -178.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.885 HG23 HG22 ' A' ' 36' ' ' ILE . 13.7 p -142.24 145.19 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.696 -0.627 . . . . 0.0 110.092 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -127.88 98.73 27.01 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.631 -0.668 . . . . 0.0 109.611 177.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -59.44 -42.06 52.07 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 O-C-N 123.577 1.304 . . . . 0.0 110.984 -175.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -80.73 -24.82 38.49 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.413 -0.804 . . . . 0.0 110.181 -171.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.561 ' O ' HG23 ' A' ' 35' ' ' THR . 74.7 mm-40 -87.02 1.26 53.43 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.536 -0.728 . . . . 0.0 111.177 173.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 96.5 m 49.8 38.17 15.05 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.053 -1.029 . . . . 0.0 111.249 -176.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 33' ' ' GLU . 10.6 p -136.12 153.09 51.4 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.431 -0.793 . . . . 0.0 110.43 -174.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.885 HG22 HG23 ' A' ' 29' ' ' VAL . 39.9 pt -142.77 162.04 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.703 -0.623 . . . . 0.0 110.22 177.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.515 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.79 128.1 28.19 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.67 -0.644 . . . . 0.0 109.686 175.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 26' ' ' LEU . 83.6 mt -109.89 145.83 36.17 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -178.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.4 p -116.92 153.0 33.34 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -178.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 44.6 p 45.93 87.05 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 121.516 0.674 . . . . 0.0 110.317 -172.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.798 HG11 HD12 ' A' ' 65' ' ' ILE . 12.4 p -134.59 147.19 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.897 -0.502 . . . . 0.0 109.929 -177.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -123.84 153.17 41.45 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.767 -0.583 . . . . 0.0 109.881 177.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.3 p -108.54 136.69 47.72 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.716 -0.615 . . . . 0.0 109.707 176.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -82.93 -38.39 22.87 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.528 -0.733 . . . . 0.0 110.968 -174.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.57 167.62 28.51 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 120.024 -1.084 . . . . 0.0 110.578 176.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.779 HG22 HG12 ' A' ' 20' ' ' ILE . 0.8 OUTLIER -118.09 6.55 12.08 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.974 -0.721 . . . . 0.0 110.899 174.14 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -49.45 -25.16 2.39 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.544 -0.723 . . . . 0.0 112.624 -168.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -64.5 -59.22 4.57 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.191 -0.943 . . . . 0.0 110.607 -178.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 35.5 mtp180 -94.35 10.14 35.43 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.558 -0.714 . . . . 0.0 111.472 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 40.0 p-10 -60.27 173.97 0.6 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.3 -0.875 . . . . 0.0 111.297 -170.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.0 m -78.99 164.34 24.47 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.93 -0.481 . . . . 0.0 109.737 175.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -77.55 3.56 13.32 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.601 -0.687 . . . . 0.0 111.291 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -96.54 166.01 11.89 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.219 -0.926 . . . . 0.0 109.656 168.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -68.61 139.29 55.51 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.606 -0.684 . . . . 0.0 110.364 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 49.5 mm -114.18 134.76 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.745 -0.597 . . . . 0.0 109.697 178.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.01 109.94 53.68 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.649 -0.657 . . . . 0.0 110.236 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -66.86 146.57 78.48 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 O-C-N 123.331 1.174 . . . . 0.0 110.305 178.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -97.44 121.12 38.98 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.653 -0.654 . . . . 0.0 110.299 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 86.4 p -75.79 -22.07 56.74 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.705 -0.622 . . . . 0.0 110.828 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -61.16 156.59 17.96 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.376 -0.828 . . . . 0.0 110.693 -178.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.5 mm -96.87 145.9 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.754 -0.591 . . . . 0.0 109.853 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -92.1 111.87 23.58 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.553 -0.717 . . . . 0.0 109.87 175.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -52.35 -43.11 64.45 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.746 -0.596 . . . . 0.0 111.769 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.515 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.0 t80 -154.62 130.15 9.87 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.588 -0.695 . . . . 0.0 110.238 -174.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.798 HD12 HG11 ' A' ' 41' ' ' VAL . 80.4 mt -128.77 127.42 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.618 -0.676 . . . . 0.0 109.916 171.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 24.8 tp -90.32 137.09 32.63 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.779 -0.576 . . . . 0.0 109.755 175.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.57 ' CD1' HD11 ' A' ' 72' ' ' ILE . 3.5 m-85 -136.08 130.77 33.93 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.649 -0.657 . . . . 0.0 110.664 -175.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -91.6 149.57 21.59 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.663 -0.648 . . . . 0.0 110.339 173.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.31 -24.51 61.41 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 177.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.7 m -66.53 -42.04 87.83 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.366 -1.079 . . . . 0.0 111.077 -176.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -82.96 -33.41 26.69 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.423 -0.798 . . . . 0.0 110.919 -175.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.668 HD13 HD21 ' A' ' 14' ' ' LEU . 14.2 mt -101.02 138.15 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.404 -0.81 . . . . 0.0 110.11 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.0 tptp -107.32 -18.25 13.92 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 120.501 -0.479 . . . . 0.0 111.758 -166.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -148.93 131.14 15.49 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.897 -1.127 . . . . 0.0 111.354 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.499 HD12 ' CD1' ' A' ' 14' ' ' LEU . 18.0 tt -132.55 138.51 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.895 -0.503 . . . . 0.0 109.866 176.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.1 mtp180 -147.02 138.67 24.25 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.496 -0.753 . . . . 0.0 110.39 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.3 p -86.61 146.63 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.589 -0.694 . . . . 0.0 110.186 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.434 HG11 ' HE3' ' A' ' 11' ' ' LYS . 60.1 t -97.31 133.95 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.647 -0.658 . . . . 0.0 109.907 -179.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -120.84 93.89 4.18 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.724 -0.61 . . . . 0.0 110.158 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -97.3 -60.0 1.67 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.679 -0.638 . . . . 0.0 110.331 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -139.42 157.69 45.42 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.706 -0.621 . . . . 0.0 110.239 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.1 t -133.69 156.84 47.2 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.66 -0.65 . . . . 0.0 110.317 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.532 ' N ' HD23 ' A' ' 83' ' ' LEU . 0.8 OUTLIER -146.86 159.63 42.9 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.622 -0.674 . . . . 0.0 110.406 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo . . . . . 0 N--CA 1.488 1.198 0 O-C-N 123.662 1.348 . . . . 0.0 110.342 179.972 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -143.59 153.22 42.32 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.654 -0.909 . . . . 0.0 110.203 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 89.5 mtp -125.72 150.63 47.53 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.711 -0.618 . . . . 0.0 110.154 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -154.98 -47.1 0.08 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.705 -0.622 . . . . 0.0 110.232 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.5 mtp -128.88 167.79 16.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.66 -0.65 . . . . 0.0 110.194 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.1 m -113.36 147.92 36.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.653 -0.655 . . . . 0.0 110.205 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -113.25 -49.62 0.56 Allowed Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -119.22 -44.52 0.48 Allowed Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 41.8 mt -79.43 154.39 76.59 Favored Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.635 -0.921 . . . . 0.0 110.319 -178.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -68.4 160.12 50.48 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 O-C-N 123.718 1.378 . . . . 0.0 110.327 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -64.76 108.3 1.69 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.724 -0.61 . . . . 0.0 110.407 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.0 mt -64.89 143.19 58.11 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.718 -0.614 . . . . 0.0 110.663 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.62 -1.91 84.42 Favored Glycine 0 N--CA 1.497 2.707 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.759 177.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.3 m -62.55 140.59 58.64 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.094 -1.239 . . . . 0.0 110.372 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -81.97 123.14 28.62 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.67 -0.644 . . . . 0.0 110.473 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.595 ' CD1' HD13 ' A' ' 26' ' ' LEU . 91.8 mt -121.17 145.35 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.492 -0.755 . . . . 0.0 110.222 -178.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.0 t -103.21 137.24 41.62 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 175.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.683 HD21 HD13 ' A' ' 72' ' ' ILE . 14.3 tp -132.02 126.14 33.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.741 -0.599 . . . . 0.0 110.261 -169.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 81.4 mt -107.04 119.03 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.594 -0.691 . . . . 0.0 109.622 -178.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.9 m -93.56 157.73 16.05 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.081 0.467 . . . . 0.0 111.187 -177.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.0 tptp -53.67 -14.78 0.97 Allowed 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -172.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.553 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.85 21.23 3.68 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.183 -0.948 . . . . 0.0 110.469 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 53.99 34.31 19.4 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.509 -0.745 . . . . 0.0 109.886 -174.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.836 HG12 HG22 ' A' ' 46' ' ' THR . 67.3 mt -102.1 141.55 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 54.0 ttt85 -104.51 119.84 39.89 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.891 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -113.86 149.24 35.36 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 174.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.653 ' O ' HG23 ' A' ' 41' ' ' VAL . 42.1 tt0 -140.69 140.49 34.94 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.499 -0.751 . . . . 0.0 109.494 175.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.64 173.09 43.27 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.666 -175.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -85.05 134.61 34.2 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.963 -0.728 . . . . 0.0 110.465 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.595 HD13 ' CD1' ' A' ' 12' ' ' ILE . 15.1 tp -66.2 119.87 12.24 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.61 -0.681 . . . . 0.0 110.735 176.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.443 ' O ' HG23 ' A' ' 28' ' ' THR . 24.0 t80 -99.43 -50.09 4.22 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.639 -0.663 . . . . 0.0 110.338 178.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 27' ' ' TYR . 15.4 p -153.83 154.29 33.69 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.693 -0.63 . . . . 0.0 110.229 -178.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.893 HG23 HG22 ' A' ' 36' ' ' ILE . 13.4 p -142.2 145.51 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.697 -0.627 . . . . 0.0 110.099 -178.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -129.04 98.25 24.37 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.583 -0.698 . . . . 0.0 109.502 177.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -59.45 -40.16 69.43 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 O-C-N 123.606 1.319 . . . . 0.0 111.037 -175.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -80.51 -27.12 37.77 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.319 -0.863 . . . . 0.0 110.21 -170.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.693 ' O ' HG23 ' A' ' 35' ' ' THR . 80.0 mt-10 -87.59 3.34 47.98 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.524 -0.735 . . . . 0.0 111.212 173.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 42.4 m 49.61 39.66 17.77 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.13 -0.981 . . . . 0.0 111.351 -177.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.693 HG23 ' O ' ' A' ' 33' ' ' GLU . 19.8 p -136.18 151.9 50.22 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.379 -0.826 . . . . 0.0 110.357 -175.162 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.893 HG22 HG23 ' A' ' 29' ' ' VAL . 40.0 pt -142.68 162.1 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.628 -0.67 . . . . 0.0 110.121 178.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.518 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -137.06 127.63 26.87 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.662 -0.648 . . . . 0.0 109.634 175.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 26' ' ' LEU . 88.6 mt -109.9 148.67 31.14 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -177.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.8 p -119.55 152.24 37.31 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.9 p 45.63 83.71 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 CA-C-O 121.457 0.646 . . . . 0.0 110.355 -172.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.674 ' CG1' HD12 ' A' ' 65' ' ' ILE . 14.6 p -134.54 150.33 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -178.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -136.07 153.19 51.41 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.658 -0.651 . . . . 0.0 110.043 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.9 p -108.41 139.89 42.5 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.753 -0.592 . . . . 0.0 109.839 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -83.0 -38.39 22.7 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.669 -0.644 . . . . 0.0 111.035 -173.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.62 171.93 34.15 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 177.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.836 HG22 HG12 ' A' ' 20' ' ' ILE . 2.3 p -118.09 6.51 12.08 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.925 -0.75 . . . . 0.0 110.986 174.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -50.99 -24.43 3.69 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.555 -0.716 . . . . 0.0 112.749 -167.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -65.95 -59.35 3.92 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.191 -0.943 . . . . 0.0 110.583 -177.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 -94.5 10.24 35.36 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.567 -0.708 . . . . 0.0 111.474 176.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 41.4 p-10 -58.22 174.08 0.31 Allowed 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.168 -0.958 . . . . 0.0 111.283 -171.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.0 m -79.03 164.37 24.41 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.905 -0.497 . . . . 0.0 109.794 176.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -77.53 4.09 12.02 Favored 'General case' 0 N--CA 1.502 2.135 0 C-N-CA 120.046 -0.662 . . . . 0.0 111.235 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -96.2 164.91 12.47 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.169 -0.957 . . . . 0.0 109.597 168.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -68.81 137.0 53.61 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.62 -0.675 . . . . 0.0 110.47 -176.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.3 mm -114.43 135.96 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.705 -0.622 . . . . 0.0 109.591 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -96.1 109.85 49.09 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.621 -0.675 . . . . 0.0 110.195 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -69.29 140.74 45.21 Favored 'Trans proline' 0 N--CA 1.487 1.091 0 O-C-N 123.469 1.247 . . . . 0.0 110.269 177.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -115.21 136.35 53.2 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.626 -0.671 . . . . 0.0 110.174 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.5 m -91.45 11.86 22.58 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.693 -0.63 . . . . 0.0 111.234 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -63.38 138.52 58.55 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.279 -0.888 . . . . 0.0 110.449 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.0 mm -96.92 135.35 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.715 -0.616 . . . . 0.0 109.758 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -95.28 117.72 30.79 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.605 -0.684 . . . . 0.0 110.191 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -51.02 -42.41 60.43 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.817 -0.552 . . . . 0.0 111.634 177.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.518 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.6 t80 -152.68 130.38 11.58 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.614 -0.679 . . . . 0.0 110.3 -174.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.674 HD12 ' CG1' ' A' ' 41' ' ' VAL . 77.0 mt -129.4 128.43 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.664 -0.647 . . . . 0.0 109.854 172.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.2 tp -90.47 137.1 32.62 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.821 -0.549 . . . . 0.0 109.817 176.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.57 ' CD1' HD11 ' A' ' 72' ' ' ILE . 3.4 m-85 -136.53 130.81 33.01 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.636 -0.665 . . . . 0.0 110.606 -175.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.9 mtm-85 -92.21 150.68 20.76 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.725 -0.609 . . . . 0.0 110.367 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.31 -23.99 60.74 Favored Glycine 0 N--CA 1.498 2.804 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.3 p -67.11 -42.04 85.19 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.408 -1.054 . . . . 0.0 110.979 -176.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -82.92 -33.22 26.87 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.471 -0.768 . . . . 0.0 110.942 -175.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.683 HD13 HD21 ' A' ' 14' ' ' LEU . 14.9 mt -102.32 138.26 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.393 -0.817 . . . . 0.0 110.142 177.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -107.22 -18.45 13.88 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.797 -166.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -149.64 131.31 14.97 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 118.936 -1.106 . . . . 0.0 111.231 -178.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.509 HD12 ' CD1' ' A' ' 14' ' ' LEU . 18.1 tt -132.01 138.27 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.937 -0.477 . . . . 0.0 109.783 176.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -146.92 144.12 29.0 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.584 -0.698 . . . . 0.0 110.429 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.465 HG12 HG12 ' A' ' 12' ' ' ILE . 35.5 m -84.87 147.0 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.585 -0.697 . . . . 0.0 110.203 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.6 t -96.12 129.03 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.636 -0.665 . . . . 0.0 109.868 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -107.09 -36.06 6.69 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.747 -0.596 . . . . 0.0 110.194 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -104.68 136.79 43.55 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.687 -0.633 . . . . 0.0 110.238 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -111.27 138.69 47.41 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.759 -0.588 . . . . 0.0 110.159 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.1 m -109.62 141.23 42.45 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.702 -0.624 . . . . 0.0 110.157 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.6 mt -115.06 161.72 27.9 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.679 -0.638 . . . . 0.0 110.181 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo . . . . . 0 N--CA 1.487 1.141 0 O-C-N 123.707 1.372 . . . . 0.0 110.302 179.987 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -102.16 144.31 30.88 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.718 -0.872 . . . . 0.0 110.18 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 8.5 tpt -101.09 129.47 46.97 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.755 -0.59 . . . . 0.0 110.187 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -154.66 32.74 0.41 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.742 -0.599 . . . . 0.0 110.285 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.5 mtm -126.31 148.62 49.5 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.638 -0.664 . . . . 0.0 110.169 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 86.2 p -108.54 29.54 7.31 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.697 -0.627 . . . . 0.0 110.595 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -142.72 39.85 1.31 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.69 -50.2 1.21 Allowed Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 5' ' ' LEU . 7.5 mp -80.11 158.66 72.0 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.737 -0.86 . . . . 0.0 110.202 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -64.91 147.61 89.38 Favored 'Trans proline' 0 N--CA 1.489 1.261 0 O-C-N 123.605 1.318 . . . . 0.0 110.383 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -64.86 132.09 48.49 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.71 -0.619 . . . . 0.0 110.463 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.5 mt -64.84 148.62 50.96 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.646 -0.659 . . . . 0.0 110.673 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.62 -1.88 84.5 Favored Glycine 0 N--CA 1.497 2.728 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.783 177.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.6 m -62.17 147.37 47.91 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.047 -1.266 . . . . 0.0 110.446 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.562 ' HE3' HG11 ' A' ' 78' ' ' VAL . 28.6 pttt -81.77 126.0 31.31 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.716 -0.615 . . . . 0.0 110.371 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.628 ' CD1' HD13 ' A' ' 26' ' ' LEU . 89.1 mt -122.49 144.15 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.543 -0.723 . . . . 0.0 110.107 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.3 t -102.68 137.3 41.08 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.476 ' CD1' HD12 ' A' ' 75' ' ' ILE . 13.4 tp -135.41 128.33 31.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.742 -0.599 . . . . 0.0 110.28 -169.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.3 mt -108.38 121.88 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.558 -0.714 . . . . 0.0 109.668 -178.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.1 m -93.2 157.85 16.06 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.042 0.449 . . . . 0.0 111.151 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -53.95 -13.78 0.85 Allowed 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -172.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.515 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.52 20.07 4.17 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.2 -0.938 . . . . 0.0 110.394 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 54.16 34.81 20.98 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.411 -0.806 . . . . 0.0 109.829 -175.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.828 HG12 HG22 ' A' ' 46' ' ' THR . 64.4 mt -102.35 143.44 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -104.31 119.67 39.48 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.058 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -114.22 149.28 36.04 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.649 ' O ' HG23 ' A' ' 41' ' ' VAL . 63.4 mt-10 -141.13 140.5 34.12 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.417 -0.802 . . . . 0.0 109.7 175.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.27 173.23 43.04 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 119.721 -1.228 . . . . 0.0 110.527 -175.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -85.29 136.81 33.34 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.872 -0.781 . . . . 0.0 110.581 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.628 HD13 ' CD1' ' A' ' 12' ' ' ILE . 15.5 tp -66.23 119.22 11.12 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.57 -0.706 . . . . 0.0 110.66 175.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.443 ' O ' HG23 ' A' ' 28' ' ' THR . 25.2 t80 -100.07 -50.16 4.07 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.641 -0.662 . . . . 0.0 110.445 178.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 27' ' ' TYR . 16.6 p -153.94 156.18 37.01 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.708 -0.62 . . . . 0.0 110.34 -177.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.598 HG23 HG22 ' A' ' 36' ' ' ILE . 10.6 p -142.18 145.37 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.758 -0.589 . . . . 0.0 110.093 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -128.83 98.46 24.52 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.678 -0.639 . . . . 0.0 109.539 177.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -59.4 -43.29 41.45 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 O-C-N 123.595 1.313 . . . . 0.0 110.993 -175.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -80.88 -23.88 38.7 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.335 -0.853 . . . . 0.0 110.237 -171.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.74 ' O ' HG23 ' A' ' 35' ' ' THR . 74.7 mm-40 -87.18 0.99 54.46 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.473 -0.767 . . . . 0.0 111.188 173.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.0 m 50.03 39.8 19.84 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.101 -0.999 . . . . 0.0 111.172 -176.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.74 HG23 ' O ' ' A' ' 33' ' ' GLU . 23.1 p -136.06 154.36 51.05 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.452 -0.78 . . . . 0.0 110.476 -174.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.598 HG22 HG23 ' A' ' 29' ' ' VAL . 40.3 pt -141.66 160.61 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.816 -0.553 . . . . 0.0 110.031 177.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.512 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.52 126.94 26.71 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.698 -0.626 . . . . 0.0 109.648 175.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 26' ' ' LEU . 88.0 mt -109.89 146.6 34.86 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -178.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 99.9 p -117.65 152.24 35.6 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.1 p 45.65 83.62 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 121.491 0.662 . . . . 0.0 110.311 -172.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.666 ' CG1' HD12 ' A' ' 65' ' ' ILE . 14.9 p -134.58 151.06 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.938 -0.476 . . . . 0.0 109.733 -179.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -136.6 153.19 51.03 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.596 -0.69 . . . . 0.0 110.137 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.3 p -109.6 137.7 47.04 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.806 -0.559 . . . . 0.0 109.664 177.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -83.06 -38.57 22.34 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.194 -172.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.31 169.4 30.83 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 175.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.828 HG22 HG12 ' A' ' 20' ' ' ILE . 41.0 p -118.17 6.21 12.0 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.865 -0.785 . . . . 0.0 110.818 170.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -54.29 -24.3 18.48 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.48 -0.762 . . . . 0.0 112.257 -167.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -65.79 -59.21 4.12 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.281 -0.887 . . . . 0.0 110.387 -177.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 82.0 mmt-85 -94.52 10.26 35.34 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.619 -0.676 . . . . 0.0 111.417 177.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.448 ' HB2' HD12 ' A' ' 55' ' ' ILE . 53.2 p-10 -57.42 170.02 0.57 Allowed 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.211 -0.93 . . . . 0.0 111.52 -170.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.7 m -79.01 164.54 24.29 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 175.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -77.42 4.21 11.48 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.092 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -97.53 148.16 23.53 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.312 -0.867 . . . . 0.0 109.394 166.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -65.98 142.2 57.93 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.578 -0.701 . . . . 0.0 110.81 -174.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.448 HD12 ' HB2' ' A' ' 50' ' ' ASP . 79.8 mt -115.75 135.7 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.678 -0.639 . . . . 0.0 109.439 177.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.35 132.52 89.66 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.626 -0.671 . . . . 0.0 110.025 -178.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -69.48 144.07 54.28 Favored 'Trans proline' 0 N--CA 1.487 1.117 0 O-C-N 123.389 1.205 . . . . 0.0 110.253 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -98.93 110.1 22.76 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.668 -0.645 . . . . 0.0 110.111 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.4 t -99.18 -33.17 10.88 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.748 -0.595 . . . . 0.0 110.364 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -62.52 148.64 45.24 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.592 -0.692 . . . . 0.0 110.668 -179.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.4 mm -96.83 143.75 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.681 -0.637 . . . . 0.0 109.667 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -94.75 114.77 26.72 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.711 -0.618 . . . . 0.0 110.322 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.19 -41.39 60.18 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 121.812 -0.555 . . . . 0.0 111.56 177.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.512 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.0 t80 -152.59 130.6 11.82 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.632 -0.668 . . . . 0.0 110.262 -175.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.666 HD12 ' CG1' ' A' ' 41' ' ' VAL . 76.2 mt -129.34 127.27 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.586 -0.696 . . . . 0.0 109.792 171.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.2 tp -90.58 137.07 32.64 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.833 -0.542 . . . . 0.0 109.858 176.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.457 ' CZ ' HG21 ' A' ' 65' ' ' ILE . 3.9 m-85 -137.93 131.89 31.57 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.685 -0.634 . . . . 0.0 110.67 -175.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -91.59 151.91 20.51 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.752 -0.592 . . . . 0.0 110.313 174.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.93 -24.75 60.82 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.6 t -66.83 -42.15 86.27 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.451 -1.029 . . . . 0.0 111.066 -176.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -82.89 -33.17 27.02 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.527 -0.733 . . . . 0.0 110.93 -175.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.435 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 24.5 mt -105.17 135.1 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.336 -0.853 . . . . 0.0 109.962 176.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -110.18 -12.59 14.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.941 -0.474 . . . . 0.0 112.111 -165.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -147.4 130.65 16.52 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.809 -1.182 . . . . 0.0 111.298 -178.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.476 HD12 ' CD1' ' A' ' 14' ' ' LEU . 14.6 tt -132.27 141.25 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.92 -0.488 . . . . 0.0 109.87 176.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -145.96 134.4 21.95 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.498 -0.751 . . . . 0.0 110.307 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.3 t -87.14 144.45 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.612 -0.68 . . . . 0.0 109.611 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.562 HG11 ' HE3' ' A' ' 11' ' ' LYS . 57.8 t -93.71 127.09 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.603 -0.686 . . . . 0.0 109.749 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -149.55 -176.4 5.39 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.863 -0.523 . . . . 0.0 110.186 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -87.0 172.35 10.06 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.69 -0.631 . . . . 0.0 110.112 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -98.42 132.35 43.95 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.671 -0.643 . . . . 0.0 110.269 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.8 t -138.46 164.76 28.55 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.74 -0.6 . . . . 0.0 110.286 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.434 ' C ' HD23 ' A' ' 83' ' ' LEU . 5.0 tt -97.32 109.87 51.9 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.666 -0.646 . . . . 0.0 110.147 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo . . . . . 0 N--CA 1.489 1.234 0 O-C-N 123.422 1.222 . . . . 0.0 110.411 179.102 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -67.56 -33.66 75.48 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.69 -0.888 . . . . 0.0 110.319 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 65.7 mtt -122.22 148.41 45.01 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.659 -0.65 . . . . 0.0 110.198 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -113.36 32.92 5.43 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.715 -0.616 . . . . 0.0 110.269 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.1 mmm -95.88 135.89 37.02 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.631 -0.668 . . . . 0.0 110.175 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 89.3 p -67.83 -31.85 71.98 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.692 -0.63 . . . . 0.0 110.424 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -144.05 174.2 24.49 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.59 -41.76 1.31 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 29.1 mt -79.9 160.17 69.51 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.63 -0.924 . . . . 0.0 110.14 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -64.98 131.09 27.67 Favored 'Trans proline' 0 N--CA 1.489 1.246 0 O-C-N 123.652 1.343 . . . . 0.0 110.456 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -64.89 143.0 58.24 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.697 -0.627 . . . . 0.0 110.503 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.5 mt -64.64 174.38 1.8 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.635 -0.666 . . . . 0.0 110.496 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.66 -1.75 85.01 Favored Glycine 0 N--CA 1.497 2.721 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.608 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 42.6 m -60.01 159.54 9.22 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.151 -1.206 . . . . 0.0 110.437 -177.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -81.27 126.58 31.72 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.747 -0.596 . . . . 0.0 110.534 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.686 ' CD1' HD13 ' A' ' 26' ' ' LEU . 88.1 mt -120.83 144.66 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.555 -0.716 . . . . 0.0 109.907 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.8 t -102.97 137.27 41.39 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 175.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.788 ' HG ' HG21 ' A' ' 72' ' ' ILE . 11.9 tp -134.15 123.88 25.12 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.723 -0.611 . . . . 0.0 110.057 -170.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.721 ' O ' HG23 ' A' ' 72' ' ' ILE . 82.0 mt -103.99 119.45 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.528 -0.732 . . . . 0.0 109.643 -177.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.7 m -94.96 157.89 15.7 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.166 0.507 . . . . 0.0 111.59 -175.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -53.64 -15.19 1.08 Allowed 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -171.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.6 21.15 3.58 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.157 -0.964 . . . . 0.0 110.449 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 56.69 35.57 26.37 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.49 -0.756 . . . . 0.0 110.031 -178.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.747 HG12 HG22 ' A' ' 46' ' ' THR . 53.1 mt -107.05 148.79 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.073 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.0 ttt-85 -106.66 119.83 40.36 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.167 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -112.87 152.37 29.34 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 175.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.655 ' O ' HG23 ' A' ' 41' ' ' VAL . 42.3 tt0 -141.88 140.55 32.89 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.452 -0.78 . . . . 0.0 109.68 175.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.57 171.8 41.61 Favored Glycine 0 N--CA 1.496 2.65 0 C-N-CA 119.753 -1.213 . . . . 0.0 110.464 -176.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 43.1 mmm-85 -84.35 138.97 32.59 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.843 -0.798 . . . . 0.0 110.538 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.686 HD13 ' CD1' ' A' ' 12' ' ' ILE . 16.5 tp -66.17 116.5 7.31 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.605 -0.684 . . . . 0.0 110.618 175.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.461 ' O ' HG23 ' A' ' 28' ' ' THR . 32.1 t80 -100.35 -50.13 4.03 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.609 -0.682 . . . . 0.0 110.553 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 27' ' ' TYR . 14.5 p -154.58 155.33 34.56 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.718 -0.614 . . . . 0.0 110.359 -177.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.836 HG23 HG22 ' A' ' 36' ' ' ILE . 13.4 p -142.23 145.94 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.746 -0.597 . . . . 0.0 110.062 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -128.5 99.01 24.27 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.579 -0.7 . . . . 0.0 109.649 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -59.61 -41.67 54.17 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 O-C-N 123.654 1.344 . . . . 0.0 111.038 -175.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -80.59 -25.51 38.43 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.384 -0.823 . . . . 0.0 110.252 -170.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.581 ' O ' HG23 ' A' ' 35' ' ' THR . 79.3 mt-10 -87.58 1.97 52.12 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.437 -0.79 . . . . 0.0 111.236 173.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 97.7 m 49.66 39.97 18.7 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.093 -1.004 . . . . 0.0 111.199 -176.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 33' ' ' GLU . 11.0 p -135.86 154.32 51.2 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.415 -0.803 . . . . 0.0 110.379 -175.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.836 HG22 HG23 ' A' ' 29' ' ' VAL . 39.9 pt -142.0 160.94 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.675 -0.641 . . . . 0.0 109.969 176.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.505 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -137.06 128.99 29.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.572 -0.705 . . . . 0.0 109.828 176.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 26' ' ' LEU . 84.1 mt -109.87 144.82 37.8 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -178.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 97.6 p -114.95 152.66 31.97 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.1 p 45.55 84.94 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 121.454 0.645 . . . . 0.0 110.214 -171.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.1 p -134.55 149.97 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.967 -0.458 . . . . 0.0 109.766 -178.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -136.07 153.2 51.4 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.635 -0.665 . . . . 0.0 110.068 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.2 p -105.61 129.79 53.78 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.757 -0.589 . . . . 0.0 109.463 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -83.07 -38.49 22.44 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.112 -170.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.22 175.45 37.25 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 178.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.747 HG22 HG12 ' A' ' 20' ' ' ILE . 65.3 p -118.11 2.68 12.05 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.81 -0.817 . . . . 0.0 110.489 169.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -57.33 -33.83 68.12 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.541 -0.725 . . . . 0.0 112.134 -163.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -63.36 -59.06 5.19 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.332 -0.855 . . . . 0.0 110.435 -175.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -94.32 10.49 34.01 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.753 -0.592 . . . . 0.0 111.289 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 51.2 p30 -49.82 157.78 0.55 Allowed 'General case' 0 N--CA 1.51 2.556 0 O-C-N 121.413 -0.804 . . . . 0.0 112.41 -169.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.421 ' H ' HD11 ' A' ' 55' ' ' ILE . 21.1 m -79.2 164.49 24.16 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 172.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -77.51 4.53 10.92 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.236 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -96.83 166.05 11.82 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.236 -0.915 . . . . 0.0 109.645 167.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -76.58 133.98 39.52 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.544 -0.722 . . . . 0.0 110.52 -176.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.421 HD11 ' H ' ' A' ' 51' ' ' THR . 69.8 mt -119.35 139.48 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.805 -0.56 . . . . 0.0 109.531 177.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.04 109.89 53.56 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.613 -0.679 . . . . 0.0 110.249 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -68.77 152.06 74.17 Favored 'Trans proline' 0 N--CA 1.488 1.153 0 O-C-N 123.414 1.218 . . . . 0.0 110.387 178.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -99.0 127.8 45.0 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.755 -0.59 . . . . 0.0 110.187 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.2 m -94.63 -31.63 13.76 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.721 -0.612 . . . . 0.0 110.468 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -61.76 151.45 34.04 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.633 -0.667 . . . . 0.0 110.613 -178.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.2 mm -96.81 140.01 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.67 -0.643 . . . . 0.0 109.758 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -97.3 116.19 29.05 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.603 -0.686 . . . . 0.0 110.297 -177.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -50.96 -40.35 57.34 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.701 -0.625 . . . . 0.0 111.562 176.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.505 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.3 t80 -152.97 129.76 10.9 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.656 -0.652 . . . . 0.0 110.217 -174.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.651 HD12 ' CG1' ' A' ' 41' ' ' VAL . 71.2 mt -128.32 126.68 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.713 -0.617 . . . . 0.0 109.893 171.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.4 HD12 ' HB2' ' A' ' 37' ' ' ALA . 22.4 tp -91.42 137.12 32.62 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.87 -0.519 . . . . 0.0 109.9 176.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.469 ' CD1' HD11 ' A' ' 72' ' ' ILE . 7.3 m-85 -135.47 130.85 35.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.642 -0.661 . . . . 0.0 110.429 -176.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -89.56 151.38 21.97 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.716 -0.615 . . . . 0.0 110.076 174.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.4 -24.49 45.96 Favored Glycine 0 N--CA 1.5 2.929 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 86.5 p -76.82 -39.06 52.61 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.411 -1.052 . . . . 0.0 111.047 -177.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -82.04 -21.3 37.02 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.391 -0.818 . . . . 0.0 111.309 -173.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.788 HG21 ' HG ' ' A' ' 14' ' ' LEU . 45.1 mt -116.03 141.22 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.256 -0.902 . . . . 0.0 109.694 168.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -105.88 -14.3 15.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.86 -0.525 . . . . 0.0 111.87 -167.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -150.29 134.22 16.86 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 118.993 -1.083 . . . . 0.0 111.438 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.425 HD12 ' CD1' ' A' ' 14' ' ' LEU . 15.7 tt -132.04 140.63 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.94 -0.475 . . . . 0.0 109.826 176.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -147.05 138.04 23.85 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.624 -0.673 . . . . 0.0 110.344 178.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.9 t -87.2 146.1 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.573 -0.704 . . . . 0.0 109.656 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.3 t -93.63 132.71 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.52 -0.737 . . . . 0.0 109.788 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -118.63 144.99 45.79 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.774 -0.578 . . . . 0.0 110.035 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -94.46 109.79 21.63 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.713 -0.617 . . . . 0.0 110.213 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 47.4 p-80 -111.0 32.44 5.28 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.633 -0.667 . . . . 0.0 110.331 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.0 m -101.77 140.79 35.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.692 -0.63 . . . . 0.0 110.175 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 24.2 mt -110.72 162.63 19.83 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.649 -0.657 . . . . 0.0 110.204 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo . . . . . 0 N--CA 1.487 1.111 0 O-C-N 123.692 1.364 . . . . 0.0 110.373 179.97 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -104.49 144.76 31.23 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.685 -0.891 . . . . 0.0 110.118 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 88.2 mmm -96.51 97.93 9.81 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.679 -0.638 . . . . 0.0 110.219 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -105.9 135.46 47.3 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.678 -0.639 . . . . 0.0 110.067 178.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.3 mmm -131.44 153.35 49.81 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.666 -0.646 . . . . 0.0 110.231 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.6 t -121.73 143.47 49.35 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.619 -0.675 . . . . 0.0 110.054 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -136.63 -48.19 0.08 OUTLIER Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.55 -46.54 75.89 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 16.4 mt -80.96 145.93 58.18 Favored Pre-proline 0 N--CA 1.497 1.9 0 O-C-N 121.618 -0.93 . . . . 0.0 110.151 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -71.05 154.72 62.5 Favored 'Trans proline' 0 N--CA 1.486 1.055 0 O-C-N 123.551 1.29 . . . . 0.0 110.157 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -64.79 130.85 45.05 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.657 -0.652 . . . . 0.0 110.481 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.6 mt -64.79 145.96 55.51 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.681 -0.637 . . . . 0.0 110.652 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.67 -1.96 84.36 Favored Glycine 0 N--CA 1.497 2.72 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.794 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.0 m -62.18 139.86 58.46 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.079 -1.247 . . . . 0.0 110.445 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.572 ' HE3' HG11 ' A' ' 78' ' ' VAL . 35.8 pttt -81.87 127.27 32.83 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.71 -0.619 . . . . 0.0 110.35 179.015 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.404 HD12 ' HB2' ' A' ' 26' ' ' LEU . 92.8 mt -124.94 145.13 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.597 -0.689 . . . . 0.0 110.223 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.2 t -102.84 137.25 41.29 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.735 HD21 HD13 ' A' ' 72' ' ' ILE . 13.8 tp -131.88 125.69 32.35 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.814 -0.554 . . . . 0.0 110.198 -170.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 80.9 mt -107.5 118.65 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.522 -0.736 . . . . 0.0 109.692 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.9 m -93.57 157.72 16.05 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.039 0.447 . . . . 0.0 111.293 -177.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -53.29 -15.02 0.82 Allowed 'General case' 0 N--CA 1.508 2.473 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -172.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.568 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.29 20.55 3.73 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.099 -1.001 . . . . 0.0 110.405 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 54.35 33.51 18.63 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.435 -0.791 . . . . 0.0 109.874 -174.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.662 HG12 HG22 ' A' ' 46' ' ' THR . 65.7 mt -101.5 141.31 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -104.66 119.79 39.82 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.941 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -113.99 148.96 36.06 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 174.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.66 ' O ' HG23 ' A' ' 41' ' ' VAL . 42.8 tt0 -140.08 140.48 36.1 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.471 -0.768 . . . . 0.0 109.498 175.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.43 173.02 43.14 Favored Glycine 0 N--CA 1.496 2.683 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.665 -175.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 72.0 mtp85 -85.54 135.47 33.81 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.881 -0.776 . . . . 0.0 110.59 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.483 ' HA ' HD23 ' A' ' 38' ' ' LEU . 29.4 tp -66.16 119.53 11.63 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.668 -0.645 . . . . 0.0 110.679 176.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.44 ' O ' HG23 ' A' ' 28' ' ' THR . 26.4 t80 -99.57 -50.06 4.2 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.677 -0.64 . . . . 0.0 110.296 178.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 27' ' ' TYR . 16.5 p -153.79 154.97 34.99 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.671 -0.643 . . . . 0.0 110.295 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.895 HG23 HG22 ' A' ' 36' ' ' ILE . 13.6 p -142.26 145.7 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.648 -0.657 . . . . 0.0 110.11 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -128.64 98.3 25.51 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.591 -0.693 . . . . 0.0 109.554 177.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -59.42 -41.1 61.04 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 O-C-N 123.507 1.267 . . . . 0.0 110.924 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -80.66 -25.52 38.22 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.388 -0.82 . . . . 0.0 110.156 -171.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.728 ' O ' HG23 ' A' ' 35' ' ' THR . 54.6 mt-10 -87.46 2.19 51.28 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.463 -0.773 . . . . 0.0 111.254 173.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.8 m 49.73 38.79 16.23 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.122 -0.986 . . . . 0.0 111.254 -176.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.728 HG23 ' O ' ' A' ' 33' ' ' GLU . 22.3 p -136.6 152.71 50.76 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.336 -0.852 . . . . 0.0 110.391 -174.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.895 HG22 HG23 ' A' ' 29' ' ' VAL . 40.0 pt -142.38 162.03 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.687 -0.633 . . . . 0.0 110.167 177.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.518 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.3 127.81 28.67 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.571 -0.706 . . . . 0.0 109.666 175.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.483 HD23 ' HA ' ' A' ' 26' ' ' LEU . 85.9 mt -109.9 148.03 32.31 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -177.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 96.8 p -119.41 152.8 36.23 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -178.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.8 p 45.65 84.38 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 CA-C-O 121.565 0.698 . . . . 0.0 110.301 -172.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.695 HG11 HD12 ' A' ' 65' ' ' ILE . 14.6 p -134.55 149.86 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.914 -0.491 . . . . 0.0 109.786 -178.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.582 ' HB3' HD12 ' A' ' 61' ' ' ILE . 32.1 ptt180 -135.11 153.13 52.12 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.679 -0.638 . . . . 0.0 109.941 177.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.9 p -109.43 141.93 41.14 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.736 -0.603 . . . . 0.0 109.911 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -82.55 -38.36 23.84 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.591 -0.693 . . . . 0.0 110.678 -175.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.64 167.37 28.2 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 176.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.662 HG22 HG12 ' A' ' 20' ' ' ILE . 16.3 p -118.29 6.51 11.91 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.944 -0.739 . . . . 0.0 111.015 175.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -48.94 -25.89 2.19 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.582 -0.699 . . . . 0.0 112.784 -167.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -66.82 -59.21 3.74 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.287 -0.883 . . . . 0.0 110.417 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -94.39 10.21 35.24 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.633 -0.667 . . . . 0.0 111.225 176.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -58.32 174.07 0.32 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.232 -0.918 . . . . 0.0 111.552 -170.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.1 p -78.83 164.64 24.33 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 122.0 -0.438 . . . . 0.0 109.94 174.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -77.33 2.76 14.83 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.996 -0.681 . . . . 0.0 111.103 177.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -101.7 151.91 21.48 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.31 -0.869 . . . . 0.0 109.527 169.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -66.49 138.93 57.87 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.501 -0.749 . . . . 0.0 110.56 -174.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.7 mt -109.97 135.22 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.704 -0.622 . . . . 0.0 109.459 177.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -83.84 146.06 48.4 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.762 -0.587 . . . . 0.0 110.176 -178.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -68.44 156.96 63.79 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 O-C-N 123.522 1.275 . . . . 0.0 110.269 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -79.64 132.58 36.28 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.683 -0.636 . . . . 0.0 110.041 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.9 m -98.98 30.29 3.46 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.749 -0.594 . . . . 0.0 110.541 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -175.65 160.85 2.52 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.634 -0.666 . . . . 0.0 109.78 -177.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.582 HD12 ' HB3' ' A' ' 42' ' ' ARG . 51.0 mm -96.74 157.4 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.703 -0.623 . . . . 0.0 109.725 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -93.0 114.08 26.54 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.556 -0.715 . . . . 0.0 110.177 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -51.23 -42.34 60.94 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.9 -0.5 . . . . 0.0 111.711 178.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.518 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.9 t80 -152.72 129.95 11.23 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.685 -0.635 . . . . 0.0 110.292 -174.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.695 HD12 HG11 ' A' ' 41' ' ' VAL . 76.2 mt -129.6 129.14 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.652 -0.655 . . . . 0.0 109.85 172.249 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 24.8 tp -90.65 137.0 32.7 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.774 -0.579 . . . . 0.0 109.918 176.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.601 ' CD1' HD11 ' A' ' 72' ' ' ILE . 3.7 m-85 -135.59 129.44 32.91 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.67 -0.644 . . . . 0.0 110.635 -175.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 73.5 mtt85 -92.1 150.06 21.16 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.797 -0.565 . . . . 0.0 110.352 173.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.18 -24.43 61.0 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.9 m -66.57 -42.09 87.58 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.493 -1.004 . . . . 0.0 111.034 -176.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -83.16 -32.75 26.46 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.445 -0.785 . . . . 0.0 110.969 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.735 HD13 HD21 ' A' ' 14' ' ' LEU . 14.7 mt -101.38 138.61 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.395 -0.816 . . . . 0.0 110.174 177.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -106.37 -18.54 13.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.892 -0.505 . . . . 0.0 111.736 -167.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -150.0 131.25 14.56 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 119.001 -1.08 . . . . 0.0 111.242 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.538 HD12 ' CD1' ' A' ' 14' ' ' LEU . 17.6 tt -132.14 139.83 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 176.161 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -146.29 133.22 20.2 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.521 -0.737 . . . . 0.0 110.411 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.3 p -87.62 147.1 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.722 -0.611 . . . . 0.0 110.29 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.572 HG11 ' HE3' ' A' ' 11' ' ' LYS . 60.6 t -94.88 129.54 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.56 -0.712 . . . . 0.0 109.759 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -142.41 142.29 32.37 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.76 -0.588 . . . . 0.0 110.154 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -64.95 -33.97 77.29 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.659 -0.651 . . . . 0.0 110.3 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 46.7 p-80 -129.13 148.26 51.06 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.717 -0.614 . . . . 0.0 110.188 179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.3 p -122.38 161.49 23.34 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.682 -0.636 . . . . 0.0 110.182 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.7 mp -115.95 164.64 17.0 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.756 -0.59 . . . . 0.0 110.184 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo . . . . . 0 N--CA 1.488 1.195 0 O-C-N 123.596 1.314 . . . . 0.0 110.421 179.777 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -102.95 144.08 31.7 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.716 -0.873 . . . . 0.0 110.205 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 49.1 ttm -106.94 72.98 0.91 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.64 -0.663 . . . . 0.0 110.165 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -155.08 152.16 29.21 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.553 -0.717 . . . . 0.0 110.16 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.3 mtm -106.19 130.4 54.07 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.738 -0.601 . . . . 0.0 110.23 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 64.4 m -97.3 23.39 7.55 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.691 -0.631 . . . . 0.0 110.824 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -143.8 -56.96 0.03 OUTLIER Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.17 134.86 12.35 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.507 HD23 ' N ' ' A' ' 5' ' ' LEU . 0.7 OUTLIER -155.46 68.0 5.1 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.628 -0.925 . . . . 0.0 110.063 178.995 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -64.97 122.31 10.07 Favored 'Trans proline' 0 N--CA 1.489 1.24 0 O-C-N 123.387 1.204 . . . . 0.0 110.52 -178.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -64.84 152.03 43.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.718 -0.614 . . . . 0.0 110.445 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.4 mt -64.71 173.28 2.29 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.698 -0.626 . . . . 0.0 110.411 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.79 -1.73 85.4 Favored Glycine 0 N--CA 1.498 2.78 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.561 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 45.8 m -59.36 155.58 14.43 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.129 -1.218 . . . . 0.0 110.484 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -81.35 124.49 29.41 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.734 -0.604 . . . . 0.0 110.794 -177.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.417 HD12 ' HB2' ' A' ' 26' ' ' LEU . 91.5 mt -121.92 146.16 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.661 -0.649 . . . . 0.0 110.017 178.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.6 t -103.19 137.26 41.58 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 176.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.694 HD21 HD13 ' A' ' 72' ' ' ILE . 13.9 tp -132.47 126.31 32.71 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.75 -0.594 . . . . 0.0 110.252 -170.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.1 mt -107.05 118.79 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.515 -0.741 . . . . 0.0 109.66 -178.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.0 m -93.59 157.71 16.05 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.039 0.447 . . . . 0.0 111.301 -177.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.5 tttm -53.99 -13.63 0.83 Allowed 'General case' 0 N--CA 1.508 2.441 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -172.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.532 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.9 20.37 4.23 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.107 -0.996 . . . . 0.0 110.426 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 53.86 34.45 19.36 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.521 -0.737 . . . . 0.0 109.865 -173.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.791 HG12 HG22 ' A' ' 46' ' ' THR . 72.2 mt -102.27 140.96 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -104.67 119.8 39.85 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.009 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -113.84 150.3 33.75 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 175.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.653 ' O ' HG23 ' A' ' 41' ' ' VAL . 58.3 mt-10 -141.45 140.54 33.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.423 -0.798 . . . . 0.0 109.796 174.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.53 173.1 43.2 Favored Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.764 -1.207 . . . . 0.0 110.377 -176.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -85.04 135.83 33.84 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.849 -0.795 . . . . 0.0 110.588 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.479 ' HA ' HD23 ' A' ' 38' ' ' LEU . 24.7 tp -66.08 120.02 12.43 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.583 -0.698 . . . . 0.0 110.716 175.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.44 ' O ' HG23 ' A' ' 28' ' ' THR . 24.2 t80 -99.78 -50.11 4.14 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.655 -0.653 . . . . 0.0 110.394 178.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 27' ' ' TYR . 15.7 p -153.96 155.84 36.35 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.67 -0.644 . . . . 0.0 110.305 -178.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.894 HG23 HG22 ' A' ' 36' ' ' ILE . 13.4 p -142.22 145.81 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.697 -0.627 . . . . 0.0 110.081 -179.069 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -128.66 101.78 20.51 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.629 -0.669 . . . . 0.0 109.54 177.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.44 -41.93 30.35 Favored 'Trans proline' 0 N--CA 1.49 1.276 0 O-C-N 123.553 1.291 . . . . 0.0 110.746 -174.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -80.76 -23.56 39.28 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.384 -0.822 . . . . 0.0 110.212 -172.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.667 ' O ' HG23 ' A' ' 35' ' ' THR . 74.9 mm-40 -87.26 0.75 54.89 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.476 -0.765 . . . . 0.0 111.178 173.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.3 m 49.91 38.14 15.41 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.157 -0.964 . . . . 0.0 111.255 -176.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.667 HG23 ' O ' ' A' ' 33' ' ' GLU . 17.2 p -136.71 153.34 50.9 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.402 -0.811 . . . . 0.0 110.403 -174.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.894 HG22 HG23 ' A' ' 29' ' ' VAL . 39.9 pt -142.31 162.0 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.719 -0.613 . . . . 0.0 110.081 177.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.513 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -135.87 127.95 29.75 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.61 -0.681 . . . . 0.0 109.722 176.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.479 HD23 ' HA ' ' A' ' 26' ' ' LEU . 86.1 mt -109.88 147.73 32.84 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -177.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 95.7 p -118.51 151.42 37.87 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -178.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.7 p 45.8 84.05 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 CA-C-O 121.517 0.675 . . . . 0.0 110.341 -172.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.673 ' CG1' HD12 ' A' ' 65' ' ' ILE . 14.3 p -134.56 150.92 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.935 -0.478 . . . . 0.0 109.717 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -135.8 153.19 51.6 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.602 -0.686 . . . . 0.0 110.087 178.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.4 p -108.19 139.66 42.54 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.733 -0.604 . . . . 0.0 109.834 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -82.94 -38.33 22.93 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.657 -0.652 . . . . 0.0 111.056 -173.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.67 172.22 34.52 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 119.975 -1.107 . . . . 0.0 110.522 177.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.791 HG22 HG12 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -118.01 6.58 12.15 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.928 -0.748 . . . . 0.0 110.739 174.1 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -48.99 -25.2 1.84 Allowed 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.618 -0.676 . . . . 0.0 112.528 -169.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -64.42 -59.19 4.64 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.291 -0.881 . . . . 0.0 110.574 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -94.29 10.22 35.0 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.612 -0.68 . . . . 0.0 111.408 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.5 p-10 -61.4 174.19 0.77 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.279 -0.888 . . . . 0.0 111.244 -171.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.8 p -78.91 164.59 24.32 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.922 -0.486 . . . . 0.0 109.876 174.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -77.46 2.57 15.78 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.081 177.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -97.86 166.05 11.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.126 -0.984 . . . . 0.0 109.513 169.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -65.97 140.54 58.32 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.543 -0.723 . . . . 0.0 110.451 -175.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.466 ' N ' HD12 ' A' ' 55' ' ' ILE . 4.9 mp -111.95 141.91 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.702 -0.624 . . . . 0.0 109.705 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -92.06 109.87 40.34 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.65 -0.656 . . . . 0.0 110.178 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -66.79 146.96 80.18 Favored 'Trans proline' 0 N--CA 1.489 1.258 0 O-C-N 123.373 1.196 . . . . 0.0 110.428 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -96.81 117.24 30.63 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.678 -0.639 . . . . 0.0 110.165 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 86.8 p -88.29 -28.73 20.89 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.732 -0.605 . . . . 0.0 110.609 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -62.13 146.86 49.33 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.539 -0.726 . . . . 0.0 110.693 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.3 mm -96.77 144.72 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.695 -0.628 . . . . 0.0 109.708 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -94.97 114.54 26.37 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.586 -0.696 . . . . 0.0 110.285 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -51.08 -40.22 57.87 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.781 -0.575 . . . . 0.0 111.728 177.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.513 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.6 t80 -152.97 129.92 11.02 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.637 -0.664 . . . . 0.0 110.257 -174.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.673 HD12 ' CG1' ' A' ' 41' ' ' VAL . 74.3 mt -129.33 129.35 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.678 -0.639 . . . . 0.0 109.798 171.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.0 tp -90.38 137.06 32.66 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.87 -0.519 . . . . 0.0 109.865 176.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.602 ' CD1' HD11 ' A' ' 72' ' ' ILE . 3.2 m-85 -135.75 129.75 33.07 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.604 -0.685 . . . . 0.0 110.579 -175.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -92.08 150.18 21.1 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.748 -0.595 . . . . 0.0 110.325 173.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.29 -24.49 61.33 Favored Glycine 0 N--CA 1.498 2.818 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 177.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.5 m -66.59 -42.12 87.42 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.472 -1.016 . . . . 0.0 111.115 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -83.0 -32.94 26.68 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.415 -0.803 . . . . 0.0 110.905 -175.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.694 HD13 HD21 ' A' ' 14' ' ' LEU . 13.9 mt -100.77 139.89 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.418 -0.802 . . . . 0.0 110.124 177.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.0 tptm -106.27 -21.28 13.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.937 -0.477 . . . . 0.0 111.606 -166.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -150.63 135.28 17.32 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 119.037 -1.065 . . . . 0.0 111.353 -177.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.517 HD12 ' CD1' ' A' ' 14' ' ' LEU . 18.3 tt -133.2 142.13 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -146.44 139.02 25.24 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.535 -0.728 . . . . 0.0 110.411 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.0 t -87.2 144.48 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.621 -0.674 . . . . 0.0 109.638 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.8 t -95.5 132.32 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.492 -0.755 . . . . 0.0 109.831 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -148.62 38.38 0.85 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.761 -0.587 . . . . 0.0 110.155 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -97.28 133.27 42.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.596 -0.69 . . . . 0.0 110.272 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -124.54 146.21 49.13 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.704 -0.623 . . . . 0.0 110.214 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.5 m -119.6 138.79 53.0 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.633 -0.667 . . . . 0.0 110.128 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.9 mt -111.03 109.87 56.98 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.705 -0.622 . . . . 0.0 110.207 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo . . . . . 0 N--CA 1.49 1.272 0 O-C-N 123.398 1.209 . . . . 0.0 110.447 179.152 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -144.14 154.5 43.23 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.774 -0.839 . . . . 0.0 110.171 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 74.4 mtm -125.03 155.36 39.84 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.725 -0.61 . . . . 0.0 110.203 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -105.19 145.58 30.42 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.693 -0.629 . . . . 0.0 110.259 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.3 mtm -113.53 144.0 43.59 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.677 -0.639 . . . . 0.0 110.226 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.6 p -67.66 -31.9 72.21 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.744 -0.598 . . . . 0.0 110.348 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.56 62.46 0.29 Allowed Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.94 177.15 53.92 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 24.7 tp -80.44 145.25 58.91 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.717 -0.873 . . . . 0.0 109.985 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 5' ' ' LEU . 15.5 Cg_exo -64.92 153.88 75.91 Favored 'Trans proline' 0 N--CA 1.489 1.264 0 O-C-N 123.281 1.148 . . . . 0.0 110.343 177.112 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -64.81 123.35 19.15 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.727 -0.608 . . . . 0.0 110.55 -178.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.4 mt -64.85 160.12 21.09 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.711 -0.618 . . . . 0.0 110.594 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.73 -1.87 84.83 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.763 177.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 67.0 m -61.39 137.64 58.24 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.138 -1.213 . . . . 0.0 110.411 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -82.15 124.36 29.8 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.72 -0.612 . . . . 0.0 110.611 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.62 ' CD1' HD13 ' A' ' 26' ' ' LEU . 88.1 mt -121.16 145.12 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.644 -0.66 . . . . 0.0 110.17 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.8 t -103.44 137.27 41.77 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 175.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.709 HD21 HD13 ' A' ' 72' ' ' ILE . 13.8 tp -133.04 125.96 30.83 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.68 -0.638 . . . . 0.0 110.259 -169.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.0 mt -106.68 117.84 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.47 -0.769 . . . . 0.0 109.683 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.0 m -93.04 157.83 16.1 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.06 0.457 . . . . 0.0 111.254 -177.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -54.03 -13.9 0.92 Allowed 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -171.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.54 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -90.09 20.6 4.19 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.094 -1.004 . . . . 0.0 110.408 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 54.37 34.16 20.11 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.512 -0.743 . . . . 0.0 109.788 -174.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.808 HG12 HG22 ' A' ' 46' ' ' THR . 69.8 mt -102.47 141.82 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 36.8 ttp180 -104.85 119.86 40.01 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.973 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -114.0 150.3 34.08 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 174.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.655 ' O ' HG23 ' A' ' 41' ' ' VAL . 42.1 tt0 -140.7 140.47 34.92 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.535 -0.728 . . . . 0.0 109.515 175.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.58 172.69 43.13 Favored Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.657 -175.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -85.08 136.15 33.69 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.908 -0.76 . . . . 0.0 110.532 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.62 HD13 ' CD1' ' A' ' 12' ' ' ILE . 15.5 tp -66.14 118.83 10.44 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.62 -0.675 . . . . 0.0 110.716 175.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.449 ' O ' HG23 ' A' ' 28' ' ' THR . 24.9 t80 -100.03 -50.13 4.09 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.662 -0.649 . . . . 0.0 110.376 177.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 27' ' ' TYR . 14.8 p -154.09 153.74 32.41 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.701 -0.625 . . . . 0.0 110.284 -178.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.892 HG23 HG22 ' A' ' 36' ' ' ILE . 13.3 p -142.19 145.24 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.656 -0.652 . . . . 0.0 110.033 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -128.22 100.48 23.26 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.625 -0.672 . . . . 0.0 109.457 176.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.34 -42.79 26.09 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 O-C-N 123.496 1.261 . . . . 0.0 110.792 -174.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -80.2 -27.33 38.87 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.295 -0.878 . . . . 0.0 109.95 -172.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.597 ' O ' HG23 ' A' ' 35' ' ' THR . 74.9 mm-40 -89.24 12.04 17.12 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.62 -0.675 . . . . 0.0 111.268 172.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 6.3 p 47.48 33.62 2.94 Favored 'General case' 0 N--CA 1.507 2.411 0 O-C-N 121.783 -0.573 . . . . 0.0 112.034 173.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.597 HG23 ' O ' ' A' ' 33' ' ' GLU . 9.1 p -136.56 154.73 50.62 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.458 -0.776 . . . . 0.0 110.432 -173.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.892 HG22 HG23 ' A' ' 29' ' ' VAL . 40.0 pt -142.45 162.03 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.704 -0.622 . . . . 0.0 110.158 177.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.521 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -137.01 127.76 27.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.678 -0.639 . . . . 0.0 109.735 175.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.46 HD23 ' HA ' ' A' ' 26' ' ' LEU . 87.4 mt -109.91 148.04 32.29 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -177.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 95.8 p -119.44 152.93 36.05 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.5 p 45.79 84.29 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 CA-C-O 121.494 0.664 . . . . 0.0 110.271 -172.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.694 HG11 HD12 ' A' ' 65' ' ' ILE . 14.9 p -134.52 151.26 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -178.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -135.97 153.2 51.48 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.629 -0.669 . . . . 0.0 109.947 177.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 84.5 p -107.61 139.34 42.3 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.703 -0.623 . . . . 0.0 109.763 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -82.49 -38.36 23.99 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.626 -0.671 . . . . 0.0 110.941 -173.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.56 169.95 31.75 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 120.032 -1.08 . . . . 0.0 110.417 176.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.808 HG22 HG12 ' A' ' 20' ' ' ILE . 1.1 p -118.08 6.6 12.09 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.906 -0.761 . . . . 0.0 110.886 174.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -48.99 -26.03 2.3 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.649 -0.657 . . . . 0.0 112.504 -167.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -64.98 -59.23 4.39 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.267 -0.896 . . . . 0.0 110.555 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 82.5 mmt-85 -94.35 10.25 35.0 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.655 -0.653 . . . . 0.0 111.335 177.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.8 p-10 -60.15 173.46 0.64 Allowed 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.224 -0.923 . . . . 0.0 111.518 -169.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.3 m -78.92 164.45 24.42 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 173.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -77.33 3.34 13.31 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.596 -0.69 . . . . 0.0 111.309 -178.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -102.12 154.92 18.55 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.242 -0.911 . . . . 0.0 109.637 170.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -67.21 141.09 57.42 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.557 -0.714 . . . . 0.0 110.605 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 81.3 mt -114.91 137.04 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.658 -0.651 . . . . 0.0 109.596 177.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.07 109.97 53.98 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.746 -0.597 . . . . 0.0 110.143 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -67.14 151.19 81.84 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 O-C-N 123.355 1.187 . . . . 0.0 110.345 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -94.03 123.95 37.73 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.691 -0.63 . . . . 0.0 110.245 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.0 m -66.29 -31.5 72.35 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.741 -0.6 . . . . 0.0 110.519 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -61.69 148.49 42.54 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.561 -0.712 . . . . 0.0 110.687 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.2 mm -96.83 156.57 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.743 -0.598 . . . . 0.0 109.767 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -93.45 112.44 24.35 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.677 -0.64 . . . . 0.0 110.171 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -51.17 -43.03 61.2 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.807 -0.558 . . . . 0.0 111.669 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.521 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.7 t80 -152.88 130.27 11.35 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.659 -0.65 . . . . 0.0 110.284 -174.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.694 HD12 HG11 ' A' ' 41' ' ' VAL . 74.9 mt -128.93 128.6 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.66 -0.65 . . . . 0.0 109.859 172.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.0 tp -90.42 137.05 32.66 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.902 -0.498 . . . . 0.0 109.862 176.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.558 ' CD1' HD11 ' A' ' 72' ' ' ILE . 2.9 m-85 -135.45 129.65 33.54 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.645 -0.66 . . . . 0.0 110.546 -175.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -91.26 147.39 23.08 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.684 -0.635 . . . . 0.0 110.239 173.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.89 -26.38 60.56 Favored Glycine 0 N--CA 1.498 2.818 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.0 m -65.87 -39.65 90.91 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.476 -1.014 . . . . 0.0 110.947 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.68 -32.54 31.7 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.462 -0.774 . . . . 0.0 110.858 -174.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.709 HD13 HD21 ' A' ' 14' ' ' LEU . 8.1 mt -102.83 140.85 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.382 -0.824 . . . . 0.0 110.156 177.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -105.04 -21.82 13.21 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.522 -167.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -151.39 134.27 15.75 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 119.068 -1.053 . . . . 0.0 111.368 -177.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.536 HD12 ' CD1' ' A' ' 14' ' ' LEU . 17.6 tt -131.5 140.09 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.882 -0.511 . . . . 0.0 109.739 176.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -146.83 142.83 28.1 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.548 -0.72 . . . . 0.0 110.4 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.4 m -85.03 147.03 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.653 -0.654 . . . . 0.0 110.183 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.9 t -94.95 131.55 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.587 -0.695 . . . . 0.0 109.771 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -122.64 125.12 44.97 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.764 -0.585 . . . . 0.0 110.14 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -99.52 128.83 45.65 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.648 -0.658 . . . . 0.0 110.2 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -120.96 152.86 38.03 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.691 -0.631 . . . . 0.0 110.262 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.7 m -120.87 142.79 49.34 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.695 -0.628 . . . . 0.0 110.14 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.448 ' C ' HD23 ' A' ' 83' ' ' LEU . 5.7 tt -99.93 110.0 57.86 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.751 -0.593 . . . . 0.0 110.124 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo . . . . . 0 N--CA 1.487 1.112 0 O-C-N 123.393 1.207 . . . . 0.0 110.343 179.081 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -107.0 149.91 27.04 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.673 -0.898 . . . . 0.0 110.247 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 90.7 mtp -99.03 165.63 11.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.67 -0.643 . . . . 0.0 110.142 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -99.23 30.11 3.63 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.645 -0.66 . . . . 0.0 110.516 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -117.56 99.5 7.02 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.547 -0.72 . . . . 0.0 110.009 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 t -155.06 33.8 0.39 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.634 -0.666 . . . . 0.0 110.262 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -143.91 112.86 0.71 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.03 -48.32 0.95 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 5' ' ' LEU . 4.6 mm? -79.72 151.68 74.26 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.714 -0.874 . . . . 0.0 109.813 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -67.34 138.97 48.24 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 O-C-N 123.454 1.239 . . . . 0.0 110.361 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -64.88 113.51 3.88 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.695 -0.628 . . . . 0.0 110.503 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.5 mt -64.84 162.34 16.41 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.654 -0.654 . . . . 0.0 110.542 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.72 -1.8 85.02 Favored Glycine 0 N--CA 1.497 2.755 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.727 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.5 m -60.25 152.99 23.46 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.118 -1.225 . . . . 0.0 110.45 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.526 ' HE3' HG11 ' A' ' 78' ' ' VAL . 29.9 pttt -81.13 125.99 30.92 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.738 -0.601 . . . . 0.0 110.387 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.402 HD12 ' HB2' ' A' ' 26' ' ' LEU . 90.2 mt -124.3 143.79 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.547 -0.721 . . . . 0.0 110.129 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.5 t -101.66 137.25 40.22 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 174.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.64 HD21 HD13 ' A' ' 72' ' ' ILE . 15.2 tp -133.9 127.72 33.09 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.694 -0.629 . . . . 0.0 110.282 -169.005 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 81.9 mt -108.51 121.06 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.455 -0.778 . . . . 0.0 109.683 -178.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 18.3 m -94.51 157.62 15.92 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 120.981 0.42 . . . . 0.0 111.171 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -55.43 -11.5 0.85 Allowed 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -173.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.566 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -90.2 20.54 4.31 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.097 -1.002 . . . . 0.0 110.453 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 54.16 34.2 19.63 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.505 -0.747 . . . . 0.0 109.795 -174.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.803 HG12 HG22 ' A' ' 46' ' ' THR . 66.2 mt -102.6 141.91 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -105.84 119.83 40.16 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.007 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -114.4 148.82 37.12 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 173.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.648 ' O ' HG23 ' A' ' 41' ' ' VAL . 41.4 tt0 -140.09 140.5 36.1 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.37 -0.831 . . . . 0.0 109.504 175.05 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.53 173.5 43.22 Favored Glycine 0 N--CA 1.496 2.651 0 C-N-CA 119.636 -1.269 . . . . 0.0 110.617 -175.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 39.6 mmm-85 -84.83 134.19 34.3 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.926 -0.75 . . . . 0.0 110.439 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.481 ' HA ' HD23 ' A' ' 38' ' ' LEU . 25.7 tp -66.21 118.62 10.18 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.605 -0.684 . . . . 0.0 110.61 175.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.452 ' O ' HG23 ' A' ' 28' ' ' THR . 23.5 t80 -99.43 -50.19 4.18 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.567 -0.708 . . . . 0.0 110.413 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 27' ' ' TYR . 13.3 p -154.12 154.97 34.53 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.704 -0.622 . . . . 0.0 110.326 -178.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.893 HG23 HG22 ' A' ' 36' ' ' ILE . 13.2 p -142.34 144.95 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.737 -0.602 . . . . 0.0 110.055 -179.01 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -129.05 102.14 19.18 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.58 -0.7 . . . . 0.0 109.496 177.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.93 -38.04 50.08 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 O-C-N 123.652 1.343 . . . . 0.0 110.814 -174.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -80.42 -27.37 38.05 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.296 -0.878 . . . . 0.0 110.137 -170.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.577 ' O ' HG23 ' A' ' 35' ' ' THR . 49.5 mt-10 -87.85 2.51 51.26 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.512 -0.742 . . . . 0.0 111.28 173.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 55.5 m 49.3 40.02 17.33 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.077 -1.014 . . . . 0.0 111.326 -176.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.577 HG23 ' O ' ' A' ' 33' ' ' GLU . 9.6 p -135.92 153.13 51.53 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.357 -0.839 . . . . 0.0 110.411 -174.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.893 HG22 HG23 ' A' ' 29' ' ' VAL . 40.4 pt -142.63 162.01 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.685 -0.634 . . . . 0.0 110.082 178.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.518 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.42 128.22 29.15 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.655 -0.653 . . . . 0.0 109.741 175.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.481 HD23 ' HA ' ' A' ' 26' ' ' LEU . 88.7 mt -109.92 147.36 33.55 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 99.7 p -117.99 151.77 36.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.619 -0.676 . . . . 0.0 109.24 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.3 p 45.94 85.17 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 CA-C-O 121.574 0.702 . . . . 0.0 110.352 -172.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.697 HG11 HD12 ' A' ' 65' ' ' ILE . 14.3 p -134.66 150.55 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -178.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.508 ' HB3' HD12 ' A' ' 61' ' ' ILE . 14.0 ptm180 -133.38 153.09 51.89 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.6 -0.688 . . . . 0.0 109.941 178.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 84.0 p -110.14 140.01 44.68 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.656 -0.653 . . . . 0.0 109.875 178.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -82.89 -38.46 22.86 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.6 -0.688 . . . . 0.0 110.893 -174.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.59 168.65 30.05 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 176.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.803 HG22 HG12 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -118.13 6.48 12.04 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.863 -0.786 . . . . 0.0 111.03 174.687 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -49.06 -26.49 2.68 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.556 -0.715 . . . . 0.0 112.314 -168.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -66.34 -59.22 3.91 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.348 -0.845 . . . . 0.0 110.35 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -94.25 10.22 34.9 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.66 -0.65 . . . . 0.0 111.354 177.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 49.9 p-10 -58.71 172.91 0.46 Allowed 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.252 -0.905 . . . . 0.0 111.261 -170.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.8 m -78.99 164.44 24.39 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.942 -0.474 . . . . 0.0 109.743 175.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -77.39 2.89 14.61 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.646 -0.659 . . . . 0.0 111.246 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -98.58 165.08 11.98 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.332 -0.855 . . . . 0.0 109.551 170.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -67.88 135.52 52.62 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.51 -0.744 . . . . 0.0 110.439 -175.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 45.5 mm -114.1 132.82 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.726 -0.609 . . . . 0.0 109.58 177.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.03 137.28 29.69 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.717 -0.615 . . . . 0.0 110.136 -178.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -69.81 145.95 58.38 Favored 'Trans proline' 0 N--CA 1.488 1.155 0 O-C-N 123.463 1.244 . . . . 0.0 110.244 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -100.6 115.15 29.5 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.681 -0.637 . . . . 0.0 110.198 178.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 28.6 m -85.24 -33.01 22.3 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.7 -0.625 . . . . 0.0 110.329 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -62.37 143.93 56.4 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.687 -0.633 . . . . 0.0 110.567 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.508 HD12 ' HB3' ' A' ' 42' ' ' ARG . 49.4 mm -96.76 149.96 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.649 -0.657 . . . . 0.0 109.814 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -94.37 115.66 27.9 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.644 -0.66 . . . . 0.0 110.208 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -51.31 -40.97 60.16 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.769 -0.582 . . . . 0.0 111.804 178.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.518 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.8 t80 -153.38 130.51 11.13 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.686 -0.634 . . . . 0.0 110.316 -174.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.697 HD12 HG11 ' A' ' 41' ' ' VAL . 78.3 mt -129.88 129.61 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.659 -0.65 . . . . 0.0 109.895 172.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 24.5 tp -90.42 137.06 32.65 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.862 -0.524 . . . . 0.0 109.898 176.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.532 ' CD1' HD11 ' A' ' 72' ' ' ILE . 2.9 m-85 -135.53 130.29 34.36 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.701 -0.624 . . . . 0.0 110.45 -175.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -91.17 147.53 22.99 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.762 -0.586 . . . . 0.0 110.272 173.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.08 -25.63 60.03 Favored Glycine 0 N--CA 1.499 2.865 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.8 m -65.92 -39.36 90.48 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.46 -1.024 . . . . 0.0 110.898 -178.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -82.36 -32.5 29.23 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.541 -0.725 . . . . 0.0 111.055 -175.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.64 HD13 HD21 ' A' ' 14' ' ' LEU . 10.1 mt -104.84 141.35 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.412 -0.805 . . . . 0.0 110.209 177.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -106.98 -24.19 12.08 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.891 -0.505 . . . . 0.0 111.659 -166.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -150.62 139.15 20.55 Favored 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 119.013 -1.075 . . . . 0.0 111.359 -176.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.472 HD12 HD13 ' A' ' 14' ' ' LEU . 18.2 tt -134.16 143.85 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.996 -0.44 . . . . 0.0 110.023 178.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -143.03 127.19 17.52 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.65 -0.656 . . . . 0.0 110.052 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.5 p -87.7 145.77 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.56 -0.713 . . . . 0.0 110.434 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.526 HG11 ' HE3' ' A' ' 11' ' ' LYS . 60.9 t -97.43 133.45 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.629 -0.669 . . . . 0.0 109.78 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -123.4 122.67 38.86 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.622 -0.674 . . . . 0.0 110.203 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -65.49 -36.83 85.04 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.701 -0.624 . . . . 0.0 110.309 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -113.81 130.9 56.41 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.776 -0.578 . . . . 0.0 110.09 178.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.8 m -126.59 138.58 53.47 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.652 -0.655 . . . . 0.0 110.129 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 40.9 mt -127.78 159.53 65.8 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.724 -0.61 . . . . 0.0 110.199 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo . . . . . 0 N--CA 1.488 1.157 0 O-C-N 123.642 1.338 . . . . 0.0 110.303 179.835 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -67.51 -33.67 75.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.678 -0.896 . . . . 0.0 110.304 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 23.5 ttt -98.6 118.62 35.72 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.657 -0.652 . . . . 0.0 110.265 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -155.08 -60.04 0.11 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.683 -0.636 . . . . 0.0 110.148 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.2 ttp -135.7 152.18 50.91 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.708 -0.62 . . . . 0.0 110.156 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.2 t -109.55 130.0 55.54 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.664 -0.648 . . . . 0.0 110.202 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -155.09 -60.01 0.01 OUTLIER Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.21 36.62 4.2 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 11.9 tp -155.41 87.92 3.14 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.626 -0.926 . . . . 0.0 109.886 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -67.79 95.86 0.42 Allowed 'Trans proline' 0 N--CA 1.487 1.133 0 O-C-N 123.575 1.303 . . . . 0.0 110.407 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -64.81 146.8 54.33 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.552 -0.717 . . . . 0.0 110.473 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.9 mt -64.61 160.26 20.08 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.58 -0.7 . . . . 0.0 110.523 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.65 -1.88 84.59 Favored Glycine 0 N--CA 1.497 2.73 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.808 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.9 m -60.81 153.01 25.6 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 120.997 -1.296 . . . . 0.0 110.445 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.511 ' HE3' HG11 ' A' ' 78' ' ' VAL . 28.5 pttt -82.05 126.92 32.56 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.714 -0.616 . . . . 0.0 110.67 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.688 ' CD1' HD13 ' A' ' 26' ' ' LEU . 86.3 mt -118.6 142.39 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.581 -0.699 . . . . 0.0 109.941 179.031 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.6 t -103.67 137.34 41.85 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 175.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.815 HD21 HD13 ' A' ' 72' ' ' ILE . 13.7 tp -135.96 127.89 29.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.665 -0.647 . . . . 0.0 110.487 -169.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 79.5 mt -107.17 120.56 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.507 -0.746 . . . . 0.0 109.609 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.0 m -95.15 157.58 15.83 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.027 0.441 . . . . 0.0 111.134 -177.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -56.43 -11.44 1.26 Allowed 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -173.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.77 22.01 3.29 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.124 -0.985 . . . . 0.0 110.348 177.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 57.55 34.48 24.62 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.56 -0.713 . . . . 0.0 110.12 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.697 HG12 HG22 ' A' ' 46' ' ' THR . 42.8 mt -107.27 148.97 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.713 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -107.83 119.71 40.22 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.07 175.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -113.41 154.07 27.56 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 175.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.67 ' O ' HG23 ' A' ' 41' ' ' VAL . 42.3 tt0 -142.83 140.47 31.31 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.596 -0.69 . . . . 0.0 109.521 173.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -164.17 169.77 39.15 Favored Glycine 0 N--CA 1.496 2.657 0 C-N-CA 119.648 -1.263 . . . . 0.0 110.619 -176.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -84.61 137.43 33.29 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.911 -0.758 . . . . 0.0 110.525 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.688 HD13 ' CD1' ' A' ' 12' ' ' ILE . 15.8 tp -66.14 117.55 8.62 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.629 -0.669 . . . . 0.0 110.645 175.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.451 ' O ' HG23 ' A' ' 28' ' ' THR . 20.2 t80 -99.88 -50.15 4.11 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.585 -0.697 . . . . 0.0 110.309 177.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 27' ' ' TYR . 15.2 p -153.7 153.61 32.56 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.709 -0.619 . . . . 0.0 110.233 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.891 HG23 HG22 ' A' ' 36' ' ' ILE . 13.3 p -142.26 145.1 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.709 -0.619 . . . . 0.0 110.096 -178.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -129.04 102.2 19.16 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.669 -0.644 . . . . 0.0 109.477 176.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.71 -39.42 43.28 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 O-C-N 123.575 1.303 . . . . 0.0 110.863 -174.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -80.49 -26.4 38.23 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.339 -0.851 . . . . 0.0 110.152 -170.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.73 ' O ' HG23 ' A' ' 35' ' ' THR . 75.0 mm-40 -87.6 2.13 51.75 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.532 -0.73 . . . . 0.0 111.292 173.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.3 m 49.65 40.16 19.09 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 120.996 -1.065 . . . . 0.0 111.229 -176.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.73 HG23 ' O ' ' A' ' 33' ' ' GLU . 22.3 p -136.54 151.84 49.84 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.383 -0.823 . . . . 0.0 110.397 -174.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.891 HG22 HG23 ' A' ' 29' ' ' VAL . 40.1 pt -142.65 161.97 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.637 -0.664 . . . . 0.0 110.226 177.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.521 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -135.46 127.51 29.75 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.629 -0.669 . . . . 0.0 109.695 175.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 26' ' ' LEU . 83.9 mt -109.99 145.23 37.32 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -177.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.8 p -116.73 152.36 34.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.625 -0.672 . . . . 0.0 109.195 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 44.9 p 45.81 86.43 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.225 0 CA-C-O 121.502 0.668 . . . . 0.0 110.288 -172.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.707 HG11 HD12 ' A' ' 65' ' ' ILE . 12.9 p -134.65 147.73 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -178.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -129.1 153.03 48.05 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.748 -0.595 . . . . 0.0 109.754 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.5 p -107.51 121.81 45.37 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -83.09 -38.53 22.36 Favored 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.964 -169.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.4 -177.51 41.86 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.697 HG22 HG12 ' A' ' 20' ' ' ILE . 66.5 p -118.12 -2.41 11.22 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.794 -0.827 . . . . 0.0 110.645 172.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -54.41 -24.92 21.85 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.379 -0.825 . . . . 0.0 112.528 -162.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -77.07 -59.47 2.77 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.252 -0.905 . . . . 0.0 110.928 -174.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 70.7 mtp85 -94.51 6.15 49.66 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.631 -0.668 . . . . 0.0 112.098 -175.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.8 p-10 -89.32 174.45 7.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.092 -1.005 . . . . 0.0 111.295 -172.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.8 m -78.76 164.47 24.53 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.056 0.455 . . . . 0.0 110.013 178.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -77.66 9.24 3.55 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.743 -0.598 . . . . 0.0 111.71 -176.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -87.98 155.18 19.96 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.098 -1.001 . . . . 0.0 109.948 172.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -67.15 129.94 41.51 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.698 -0.627 . . . . 0.0 110.827 -172.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 82.4 mt -129.0 140.63 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.737 -0.602 . . . . 0.0 109.444 175.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.0 109.84 53.27 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.547 -0.72 . . . . 0.0 110.371 -178.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -77.63 157.07 32.03 Favored 'Trans proline' 0 N--CA 1.486 1.066 0 O-C-N 123.449 1.237 . . . . 0.0 110.432 176.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -114.67 131.22 56.81 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.656 -0.652 . . . . 0.0 110.14 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.6 m -97.06 12.41 32.71 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.69 -0.631 . . . . 0.0 111.333 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -63.62 145.07 56.42 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.308 -0.87 . . . . 0.0 110.564 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.81 128.94 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.613 -0.68 . . . . 0.0 109.863 178.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.512 ' CG ' HD11 ' A' ' 65' ' ' ILE . 22.0 m-85 -98.99 119.53 37.92 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.689 -0.632 . . . . 0.0 110.376 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -51.75 -41.22 61.43 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.715 -0.615 . . . . 0.0 111.252 173.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.521 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.7 t80 -153.98 128.82 9.46 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.686 -0.634 . . . . 0.0 110.103 -175.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.707 HD12 HG11 ' A' ' 41' ' ' VAL . 67.4 mt -126.31 130.33 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.639 -0.663 . . . . 0.0 109.879 172.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.5 tp -89.94 137.06 32.65 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.838 -0.539 . . . . 0.0 109.686 175.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.648 ' CD1' HD11 ' A' ' 72' ' ' ILE . 3.3 m-85 -133.8 126.5 30.71 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.706 -0.621 . . . . 0.0 110.55 -175.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -92.71 149.95 20.99 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.689 -0.632 . . . . 0.0 110.305 172.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.83 -24.01 57.02 Favored Glycine 0 N--CA 1.498 2.821 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 177.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.0 p -68.32 -42.05 79.94 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.409 -1.053 . . . . 0.0 111.115 -176.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -82.98 -29.38 29.04 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.331 -0.856 . . . . 0.0 111.028 -175.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.815 HD13 HD21 ' A' ' 14' ' ' LEU . 15.4 mt -103.74 140.7 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.416 -0.802 . . . . 0.0 110.255 176.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -105.74 -19.83 13.64 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.912 -0.492 . . . . 0.0 111.552 -168.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -149.98 131.55 14.86 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 119.046 -1.062 . . . . 0.0 111.319 -178.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.7 tt -129.88 138.81 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.979 -0.451 . . . . 0.0 109.809 176.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 90.6 mtt-85 -146.89 137.94 23.99 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.543 -0.723 . . . . 0.0 110.421 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.6 t -87.17 143.76 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.658 -0.652 . . . . 0.0 109.693 178.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.511 HG11 ' HE3' ' A' ' 11' ' ' LYS . 55.9 t -94.63 134.61 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.541 -0.724 . . . . 0.0 109.885 -178.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -121.16 156.94 31.27 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.706 -0.621 . . . . 0.0 110.134 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -96.75 135.42 38.72 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.733 -0.604 . . . . 0.0 110.225 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -124.92 148.2 48.46 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.695 -0.628 . . . . 0.0 110.191 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.2 p -121.23 161.18 22.36 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.671 -0.643 . . . . 0.0 110.271 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.519 ' N ' HD23 ' A' ' 83' ' ' LEU . 0.8 OUTLIER -146.41 159.81 43.88 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.695 -0.628 . . . . 0.0 110.351 -179.873 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo . . . . . 0 N--CA 1.488 1.177 0 O-C-N 123.623 1.328 . . . . 0.0 110.299 179.883 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -134.08 150.36 51.17 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.754 -0.851 . . . . 0.0 110.172 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 65.4 mtt -128.62 158.38 38.66 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.661 -0.649 . . . . 0.0 110.224 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -95.29 125.91 40.24 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.635 -0.666 . . . . 0.0 110.109 178.579 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 ttp -146.32 36.65 1.0 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.611 -0.681 . . . . 0.0 110.097 -179.359 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 97.8 p -112.95 151.97 29.91 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.625 -0.672 . . . . 0.0 110.201 -179.85 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -102.56 -48.22 1.32 Allowed Glycine 0 N--CA 1.495 2.586 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.678 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -131.42 158.68 22.86 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.439 HD13 ' HA ' ' A' ' 5' ' ' LEU . 3.5 mm? -78.6 -57.49 0.84 Allowed Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.674 -0.898 . . . . 0.0 110.695 -179.588 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -71.44 136.48 28.74 Favored 'Trans proline' 0 N--CA 1.488 1.161 0 O-C-N 123.23 1.121 . . . . 0.0 110.367 -176.329 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -64.78 126.31 27.54 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.676 -0.64 . . . . 0.0 110.519 179.174 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.78 136.48 56.95 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.689 -0.632 . . . . 0.0 110.902 -178.715 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.57 -2.37 82.78 Favored Glycine 0 N--CA 1.497 2.765 0 C-N-CA 120.699 -0.763 . . . . 0.0 111.944 175.196 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.1 m -64.29 150.62 45.71 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.168 -1.195 . . . . 0.0 110.389 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -81.42 127.84 33.22 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.623 -0.673 . . . . 0.0 110.052 175.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.636 ' CD1' HD13 ' A' ' 26' ' ' LEU . 88.4 mt -125.12 143.92 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.435 -0.791 . . . . 0.0 110.299 -178.317 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.6 t -102.19 137.28 40.66 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 173.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.467 ' CD1' HD12 ' A' ' 75' ' ' ILE . 12.6 tp -134.66 130.6 36.61 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.675 -0.641 . . . . 0.0 110.292 -170.183 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.2 mt -107.12 121.49 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.508 -0.745 . . . . 0.0 109.743 -178.699 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.6 m -93.95 157.86 15.91 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.033 0.444 . . . . 0.0 111.23 -178.129 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -53.35 -15.41 0.99 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -171.045 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.497 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -90.17 20.65 4.21 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.148 -0.97 . . . . 0.0 110.433 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 54.1 34.98 21.2 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.446 -0.784 . . . . 0.0 109.805 -174.511 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.864 HG12 HG22 ' A' ' 46' ' ' THR . 69.8 mt -102.89 143.1 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.21 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -103.77 119.83 39.72 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.159 -178.614 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -113.7 149.7 34.36 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 175.0 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.63 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.3 mt-10 -141.17 140.6 34.08 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.418 -0.801 . . . . 0.0 109.815 175.964 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.35 172.84 43.04 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 119.716 -1.231 . . . . 0.0 110.529 -175.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 80.8 mtt85 -86.0 135.91 33.46 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.888 -0.772 . . . . 0.0 110.62 179.05 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.636 HD13 ' CD1' ' A' ' 12' ' ' ILE . 13.6 tp -66.17 118.0 9.27 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.605 -0.684 . . . . 0.0 110.663 176.6 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.462 ' O ' HG23 ' A' ' 28' ' ' THR . 28.8 t80 -100.24 -50.14 4.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.627 -0.67 . . . . 0.0 110.55 179.093 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 27' ' ' TYR . 11.7 p -154.63 155.61 34.99 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.603 -0.686 . . . . 0.0 110.382 -178.024 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.842 HG23 HG22 ' A' ' 36' ' ' ILE . 13.2 p -142.31 145.92 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.744 -0.597 . . . . 0.0 110.009 -179.425 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -128.92 100.26 21.2 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.603 -0.686 . . . . 0.0 109.503 177.581 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.58 -37.16 60.09 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 O-C-N 123.599 1.315 . . . . 0.0 110.793 -175.17 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -80.07 -27.98 39.26 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.379 -0.826 . . . . 0.0 110.061 -171.251 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.577 ' O ' HG23 ' A' ' 35' ' ' THR . 77.8 mt-10 -88.23 2.6 51.92 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.545 -0.722 . . . . 0.0 111.235 174.011 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 39.0 m 49.44 40.66 19.41 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.007 -1.058 . . . . 0.0 111.198 -175.864 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.577 HG23 ' O ' ' A' ' 33' ' ' GLU . 11.2 p -135.73 154.49 51.23 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.436 -0.79 . . . . 0.0 110.381 -175.166 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.842 HG22 HG23 ' A' ' 29' ' ' VAL . 40.0 pt -141.94 162.03 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.718 -0.614 . . . . 0.0 110.142 177.675 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.514 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.9 128.37 28.43 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.695 -0.628 . . . . 0.0 109.802 175.482 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 26' ' ' LEU . 85.0 mt -109.81 147.01 34.06 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -178.536 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 87.6 p -115.71 150.12 37.33 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -177.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 52.5 p 45.73 85.36 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 121.504 0.668 . . . . 0.0 110.29 -172.657 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.709 ' CG1' HD12 ' A' ' 65' ' ' ILE . 15.0 p -134.64 152.33 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -178.787 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -136.39 153.09 51.2 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.503 -0.748 . . . . 0.0 110.236 179.037 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.6 p -109.69 136.3 49.25 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.764 -0.585 . . . . 0.0 109.637 176.576 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -83.04 -38.59 22.36 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.537 -0.727 . . . . 0.0 111.19 -172.533 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.4 174.94 36.93 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.912 -1.137 . . . . 0.0 110.515 176.195 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.864 HG22 HG12 ' A' ' 20' ' ' ILE . 7.4 p -116.75 6.53 13.26 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.834 -0.804 . . . . 0.0 110.528 169.645 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -52.35 -24.56 7.82 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.615 -0.678 . . . . 0.0 112.597 -166.451 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -64.14 -59.43 4.45 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.154 -0.966 . . . . 0.0 110.604 -176.635 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 39.6 mtp85 -94.54 10.2 35.61 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.55 -0.719 . . . . 0.0 111.393 176.512 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.5 p-10 -58.91 172.29 0.57 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.234 -0.916 . . . . 0.0 111.552 -169.161 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.8 m -85.0 164.49 18.23 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 174.717 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -77.47 3.81 12.55 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.642 -0.661 . . . . 0.0 111.287 -179.364 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -95.17 157.48 15.88 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.247 -0.908 . . . . 0.0 109.683 168.873 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -70.52 139.25 51.54 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.645 -0.659 . . . . 0.0 110.538 -176.004 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.7 mt -115.36 136.23 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.725 -0.61 . . . . 0.0 109.556 176.76 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.11 113.08 12.87 Favored Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 121.707 -0.621 . . . . 0.0 110.138 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -66.93 143.76 67.67 Favored 'Trans proline' 0 N--CA 1.488 1.188 0 O-C-N 123.389 1.205 . . . . 0.0 110.392 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -97.82 114.7 26.8 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.72 -0.612 . . . . 0.0 110.216 -179.79 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.6 t -101.54 -32.95 10.13 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.721 -0.612 . . . . 0.0 110.306 179.457 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -62.24 151.49 36.13 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.627 -0.671 . . . . 0.0 110.634 -178.807 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.2 mm -96.81 142.71 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.808 -0.557 . . . . 0.0 109.79 179.672 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -94.82 118.09 31.2 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.613 -0.679 . . . . 0.0 110.137 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -51.14 -42.36 60.7 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.859 -0.525 . . . . 0.0 111.732 178.618 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.514 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.0 t80 -152.7 130.88 11.95 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.609 -0.682 . . . . 0.0 110.182 -174.969 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.709 HD12 ' CG1' ' A' ' 41' ' ' VAL . 75.5 mt -129.73 127.45 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.625 -0.672 . . . . 0.0 109.859 172.148 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 23.9 tp -90.2 137.1 32.62 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.817 -0.552 . . . . 0.0 109.741 175.662 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.425 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 3.6 m-85 -136.57 131.16 33.43 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.629 -0.67 . . . . 0.0 110.6 -175.691 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -90.71 149.18 22.15 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.781 -0.575 . . . . 0.0 110.187 174.741 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.26 -25.06 59.69 Favored Glycine 0 N--CA 1.5 2.912 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 178.758 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.9 m -65.91 -40.55 91.6 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.412 -1.052 . . . . 0.0 110.885 -178.432 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.95 -34.42 29.8 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.631 -0.668 . . . . 0.0 110.929 -174.818 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.425 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 13.9 mt -105.94 140.26 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.429 -0.794 . . . . 0.0 110.11 177.617 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 47.8 tttm -107.27 -24.62 11.82 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.839 -164.589 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -149.12 140.78 23.5 Favored 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.548 -174.414 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.467 HD12 ' CD1' ' A' ' 14' ' ' LEU . 15.4 tt -134.09 147.81 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.939 -0.475 . . . . 0.0 110.106 179.567 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -147.02 129.75 16.1 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.597 -0.69 . . . . 0.0 110.287 176.59 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.41 HG22 HG12 ' A' ' 12' ' ' ILE . 51.4 t -87.4 146.05 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.657 -0.652 . . . . 0.0 109.83 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 50.2 t -93.4 125.38 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.573 -0.704 . . . . 0.0 109.711 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -154.96 -179.75 8.35 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.682 -0.636 . . . . 0.0 110.345 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -142.95 175.15 10.06 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.706 -0.621 . . . . 0.0 110.287 179.149 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 31.7 t60 -116.02 129.48 56.38 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.653 -0.654 . . . . 0.0 110.099 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.5 p -100.79 158.95 15.58 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.719 -0.613 . . . . 0.0 110.323 -178.531 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.9 tt -153.81 109.95 2.52 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.696 -0.627 . . . . 0.0 110.158 179.453 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo . . . . . 0 N--CA 1.487 1.117 0 O-C-N 123.445 1.234 . . . . 0.0 110.309 179.144 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -104.63 145.67 30.0 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.73 -0.865 . . . . 0.0 110.19 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 57.3 ttp -96.98 123.52 40.72 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.738 -0.601 . . . . 0.0 110.213 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -150.65 159.22 44.66 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.695 -0.628 . . . . 0.0 110.256 -179.652 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptm -125.15 159.23 31.99 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.675 -0.641 . . . . 0.0 110.222 179.6 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.4 t -111.63 139.79 46.78 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.682 -0.637 . . . . 0.0 110.223 -179.537 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -89.18 -176.22 46.31 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -147.33 59.26 0.47 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.777 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 28.7 mt -79.75 156.92 74.9 Favored Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 121.661 -0.905 . . . . 0.0 110.268 -179.499 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -66.95 155.69 69.68 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.711 1.374 . . . . 0.0 110.39 179.864 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -64.83 98.26 0.27 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.661 -0.649 . . . . 0.0 110.452 -179.729 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.5 mt -64.79 155.53 33.58 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.749 -0.594 . . . . 0.0 110.675 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.7 -1.96 84.46 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.826 177.287 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.7 m -61.99 136.34 57.92 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.13 -1.218 . . . . 0.0 110.405 179.283 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.485 ' HE3' HG11 ' A' ' 78' ' ' VAL . 31.3 pttt -81.83 126.4 31.82 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.655 -0.653 . . . . 0.0 110.475 179.761 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.409 HD12 ' HB2' ' A' ' 26' ' ' LEU . 92.7 mt -124.84 145.07 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.523 -0.736 . . . . 0.0 110.203 179.501 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.8 t -102.8 137.26 41.25 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.582 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.634 HD21 HD13 ' A' ' 72' ' ' ILE . 17.3 tp -134.9 126.76 29.36 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.788 -0.57 . . . . 0.0 110.282 -168.988 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 81.3 mt -108.74 120.91 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.557 -0.714 . . . . 0.0 109.697 -178.919 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.2 m -93.54 157.78 16.03 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.146 0.498 . . . . 0.0 111.216 -176.979 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -54.27 -13.77 0.97 Allowed 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -172.159 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.45 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.19 20.03 3.96 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.147 -0.97 . . . . 0.0 110.436 179.081 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 55.64 35.78 25.9 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.503 -0.748 . . . . 0.0 109.821 -176.241 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.828 HG12 HG22 ' A' ' 46' ' ' THR . 60.6 mt -105.81 145.63 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.929 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -105.4 119.82 40.05 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.25 -179.313 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -114.53 151.04 33.98 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 174.843 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.648 ' O ' HG23 ' A' ' 41' ' ' VAL . 65.1 mt-10 -142.29 140.64 32.25 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.35 -0.844 . . . . 0.0 109.818 174.354 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.22 173.08 43.01 Favored Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.526 -175.898 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 56.4 mtm180 -85.71 136.03 33.52 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.867 -0.784 . . . . 0.0 110.573 179.164 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.492 ' HA ' HD23 ' A' ' 38' ' ' LEU . 28.0 tp -66.17 119.99 12.43 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.62 -0.675 . . . . 0.0 110.738 175.343 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.439 ' O ' HG23 ' A' ' 28' ' ' THR . 27.4 t80 -99.68 -50.03 4.19 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.764 -0.585 . . . . 0.0 110.347 177.838 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 27' ' ' TYR . 16.2 p -153.98 155.58 35.85 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.642 -0.661 . . . . 0.0 110.233 -178.39 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.848 HG23 HG22 ' A' ' 36' ' ' ILE . 13.5 p -142.31 145.56 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.654 -0.654 . . . . 0.0 110.093 -178.967 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -127.33 98.62 29.04 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.65 -0.656 . . . . 0.0 109.602 177.645 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -59.3 -42.39 50.01 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 O-C-N 123.636 1.335 . . . . 0.0 111.03 -175.763 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -80.63 -25.14 38.55 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.405 -0.809 . . . . 0.0 110.199 -171.13 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.567 ' O ' HG23 ' A' ' 35' ' ' THR . 55.1 mt-10 -87.33 1.67 52.57 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.438 -0.789 . . . . 0.0 111.18 173.605 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 38.7 m 49.87 38.55 16.25 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 121.13 -0.981 . . . . 0.0 111.226 -177.009 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.567 HG23 ' O ' ' A' ' 33' ' ' GLU . 10.6 p -135.77 154.28 51.27 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.394 -0.816 . . . . 0.0 110.407 -175.128 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.848 HG22 HG23 ' A' ' 29' ' ' VAL . 39.9 pt -143.1 161.87 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.638 -0.664 . . . . 0.0 110.204 178.634 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.506 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.9 127.93 27.69 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.652 -0.655 . . . . 0.0 109.692 175.524 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 26' ' ' LEU . 87.4 mt -109.91 147.78 32.79 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -177.872 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 91.8 p -118.33 151.43 37.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.641 -0.662 . . . . 0.0 109.226 -177.888 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 44.1 p 45.63 83.66 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 121.543 0.687 . . . . 0.0 110.376 -172.197 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.692 ' CG1' HD12 ' A' ' 65' ' ' ILE . 14.3 p -134.63 150.53 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.406 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -136.36 153.19 51.19 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.638 -0.663 . . . . 0.0 110.128 178.554 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.0 p -108.4 137.16 46.83 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.736 -0.602 . . . . 0.0 109.546 177.307 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -83.01 -38.57 22.44 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 119.833 -0.747 . . . . 0.0 111.063 -172.017 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.32 167.55 28.16 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 175.614 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.828 HG22 HG12 ' A' ' 20' ' ' ILE . 50.2 p -118.3 -13.84 9.83 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.875 -0.779 . . . . 0.0 110.84 171.289 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -52.52 -24.59 8.38 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.398 -0.814 . . . . 0.0 112.482 -165.901 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -78.22 -59.36 2.81 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.287 -0.883 . . . . 0.0 110.836 -176.945 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -94.55 10.12 35.91 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.52 -0.738 . . . . 0.0 111.956 -174.668 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.9 p-10 -93.18 174.6 7.14 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.056 -1.028 . . . . 0.0 111.19 -174.584 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.4 m -78.48 164.58 24.62 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.967 -0.458 . . . . 0.0 109.783 177.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -77.49 11.78 1.87 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.662 -0.649 . . . . 0.0 111.671 -174.015 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -91.32 143.36 26.72 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.121 -0.987 . . . . 0.0 109.73 170.07 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -66.04 140.21 58.25 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.712 -0.618 . . . . 0.0 110.953 -171.013 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 83.9 mt -120.88 142.02 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 176.417 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.3 112.81 10.15 Favored Pre-proline 0 N--CA 1.501 2.084 0 O-C-N 121.628 -0.67 . . . . 0.0 110.204 -179.492 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -63.8 141.89 80.4 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 O-C-N 123.345 1.181 . . . . 0.0 110.614 -179.271 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -107.9 107.16 17.75 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.655 -0.653 . . . . 0.0 110.199 179.431 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.2 t -103.36 -34.87 8.6 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.713 -0.617 . . . . 0.0 110.2 179.47 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -62.84 157.45 21.37 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.674 -0.641 . . . . 0.0 110.611 -179.479 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.8 mm -96.75 136.98 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.698 -0.626 . . . . 0.0 109.686 179.071 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -96.05 117.2 30.21 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.62 -0.675 . . . . 0.0 110.356 -178.2 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -51.23 -40.46 58.84 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.827 -0.546 . . . . 0.0 111.629 177.229 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.506 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.6 t80 -152.33 130.2 11.71 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.615 -0.678 . . . . 0.0 110.35 -174.471 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.692 HD12 ' CG1' ' A' ' 41' ' ' VAL . 77.2 mt -129.66 126.68 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.671 -0.643 . . . . 0.0 109.798 171.527 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 19.2 tp -90.57 137.13 32.6 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.77 -0.581 . . . . 0.0 109.841 176.226 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.484 ' CD1' HD11 ' A' ' 72' ' ' ILE . 4.6 m-85 -137.07 132.58 34.35 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.653 -0.655 . . . . 0.0 110.585 -175.281 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -90.69 148.13 22.81 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.71 -0.619 . . . . 0.0 110.269 173.579 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.21 -25.65 60.35 Favored Glycine 0 N--CA 1.499 2.854 0 N-CA-C 110.521 -1.031 . . . . 0.0 110.521 179.363 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.4 p -67.41 -38.26 84.36 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.419 -1.048 . . . . 0.0 110.842 -177.45 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -82.48 -32.57 28.79 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.432 -0.792 . . . . 0.0 110.841 -175.394 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.634 HD13 HD21 ' A' ' 14' ' ' LEU . 10.6 mt -106.41 134.19 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.496 -0.752 . . . . 0.0 109.923 176.988 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.4 tttp -108.75 -10.98 15.11 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 120.485 -0.486 . . . . 0.0 112.077 -166.68 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -147.8 129.63 15.22 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.876 -1.14 . . . . 0.0 111.155 -179.641 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.48 HD12 ' CD1' ' A' ' 14' ' ' LEU . 18.1 tt -137.96 139.48 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.958 -0.464 . . . . 0.0 110.017 178.197 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 82.5 mtm-85 -147.12 136.86 23.04 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.54 -0.725 . . . . 0.0 110.51 176.912 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.3 p -87.13 147.04 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.688 -0.632 . . . . 0.0 110.1 177.781 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.485 HG11 ' HE3' ' A' ' 11' ' ' LYS . 61.4 t -94.76 131.69 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.624 -0.673 . . . . 0.0 109.772 -178.835 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -143.61 106.82 4.54 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.675 -0.641 . . . . 0.0 110.214 179.695 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -103.3 106.56 17.11 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.684 -0.635 . . . . 0.0 110.187 179.413 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -67.97 -47.94 67.21 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.699 -0.626 . . . . 0.0 110.239 -179.676 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.9 t -142.03 160.46 40.17 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.678 -0.639 . . . . 0.0 110.44 -179.486 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.2 tp -97.06 139.49 21.55 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.681 -0.637 . . . . 0.0 110.005 179.341 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo . . . . . 0 N--CA 1.489 1.236 0 O-C-N 123.452 1.238 . . . . 0.0 110.362 179.848 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -67.38 -34.46 77.32 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.642 -0.917 . . . . 0.0 110.298 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 57.7 ttp -101.3 114.78 29.07 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.776 -0.577 . . . . 0.0 110.205 179.737 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -109.12 139.29 44.21 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.617 -0.677 . . . . 0.0 110.204 179.574 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.2 mtm -110.94 28.78 8.38 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.733 -0.605 . . . . 0.0 110.514 179.594 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.3 m -105.44 29.62 6.35 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.487 -0.758 . . . . 0.0 110.57 -179.259 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -143.08 165.87 26.85 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.472 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -154.96 -178.78 29.59 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.617 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 35.4 mt -79.86 151.22 73.4 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.694 -0.886 . . . . 0.0 110.067 179.637 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -68.57 135.26 32.9 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 O-C-N 123.583 1.307 . . . . 0.0 110.345 -179.81 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -64.9 114.0 4.23 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.592 -0.693 . . . . 0.0 110.465 179.28 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.3 mt -64.82 144.46 57.24 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.644 -0.66 . . . . 0.0 110.683 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.71 -1.96 84.49 Favored Glycine 0 N--CA 1.496 2.682 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.809 177.712 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 74.8 m -62.38 142.73 57.68 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.09 -1.241 . . . . 0.0 110.477 179.679 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -82.03 126.81 32.42 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.693 -0.63 . . . . 0.0 110.386 178.289 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 90.5 mt -123.97 145.02 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.584 -0.697 . . . . 0.0 110.148 -179.725 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.6 t -103.33 137.29 41.65 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 176.12 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.663 HD21 HD13 ' A' ' 72' ' ' ILE . 14.5 tp -133.23 123.18 25.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.776 -0.578 . . . . 0.0 110.263 -169.662 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.604 ' O ' HG23 ' A' ' 72' ' ' ILE . 79.8 mt -106.31 116.87 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.427 -0.796 . . . . 0.0 109.711 -178.801 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.5 m -92.83 157.71 16.25 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 120.955 0.407 . . . . 0.0 111.231 -177.101 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -54.61 -11.81 0.63 Allowed 'General case' 0 N--CA 1.509 2.49 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -171.608 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.519 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -90.22 20.0 4.69 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.083 -1.01 . . . . 0.0 110.45 179.386 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 54.66 33.52 19.49 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.52 -0.738 . . . . 0.0 109.853 -174.285 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.857 HG12 HG22 ' A' ' 46' ' ' THR . 65.7 mt -102.52 140.93 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.441 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -104.83 119.77 39.8 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.994 -0.683 . . . . 0.0 109.939 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -114.25 149.43 35.87 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 174.403 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.669 ' O ' HG23 ' A' ' 41' ' ' VAL . 42.2 tt0 -140.34 140.46 35.6 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.584 -0.698 . . . . 0.0 109.54 175.154 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.4 172.65 42.4 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.624 -175.888 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -85.38 135.61 33.81 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.956 -0.732 . . . . 0.0 110.504 179.097 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.486 ' HA ' HD23 ' A' ' 38' ' ' LEU . 27.8 tp -66.14 120.82 13.87 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.597 -0.689 . . . . 0.0 110.663 176.13 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.433 ' O ' HG23 ' A' ' 28' ' ' THR . 21.6 t80 -99.19 -49.96 4.3 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.666 -0.646 . . . . 0.0 110.257 178.194 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 27' ' ' TYR . 17.0 p -153.38 156.77 38.9 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.742 -0.599 . . . . 0.0 110.068 -179.162 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.889 HG23 HG22 ' A' ' 36' ' ' ILE . 13.6 p -142.25 145.9 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.658 -0.651 . . . . 0.0 110.227 -177.795 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -128.26 101.49 21.96 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.609 -0.682 . . . . 0.0 109.507 177.022 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.38 -41.2 34.89 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 O-C-N 123.579 1.305 . . . . 0.0 110.839 -174.459 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -80.7 -24.57 38.75 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.283 -0.886 . . . . 0.0 110.203 -171.732 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.742 ' O ' HG23 ' A' ' 35' ' ' THR . 54.8 mt-10 -87.31 1.31 53.63 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.474 -0.767 . . . . 0.0 111.262 173.463 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.9 m 49.86 38.14 15.21 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.042 -1.036 . . . . 0.0 111.276 -176.698 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.742 HG23 ' O ' ' A' ' 33' ' ' GLU . 21.6 p -136.45 153.52 51.03 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.477 -0.764 . . . . 0.0 110.377 -174.27 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.889 HG22 HG23 ' A' ' 29' ' ' VAL . 39.8 pt -142.34 162.06 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.711 -0.618 . . . . 0.0 110.182 177.707 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.526 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -133.68 127.7 33.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.659 -0.651 . . . . 0.0 109.62 176.011 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 26' ' ' LEU . 88.7 mt -109.94 149.45 29.9 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -176.481 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 91.8 p -123.1 154.33 38.73 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.134 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.5 p 45.41 83.76 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 121.492 0.663 . . . . 0.0 110.375 -171.805 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.718 HG11 HD12 ' A' ' 65' ' ' ILE . 14.4 p -134.55 149.74 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -178.537 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -134.84 153.21 52.13 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.622 -0.674 . . . . 0.0 109.982 178.766 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.2 p -107.32 138.55 43.3 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.671 -0.643 . . . . 0.0 109.894 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -83.07 -38.28 22.73 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.648 -0.658 . . . . 0.0 110.905 -174.282 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.74 170.32 32.37 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 178.803 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.857 HG22 HG12 ' A' ' 20' ' ' ILE . 1.8 p -118.03 6.75 12.14 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.909 -0.759 . . . . 0.0 111.173 177.451 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -48.89 -23.87 1.26 Allowed 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.471 -0.768 . . . . 0.0 112.694 -169.552 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -54.3 -45.56 72.59 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.235 -0.915 . . . . 0.0 111.344 -179.396 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 75.4 mtp180 -94.14 -58.08 2.34 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.432 -0.792 . . . . 0.0 110.766 -179.788 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.45 ' OD1' HD11 ' A' ' 55' ' ' ILE . 2.9 p30 -67.35 174.88 3.01 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.727 -0.608 . . . . 0.0 110.378 -178.67 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.7 p -78.13 164.41 25.0 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.694 -0.629 . . . . 0.0 110.664 -170.664 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -77.52 1.68 18.65 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.413 -177.746 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -72.53 161.17 31.14 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.171 -0.956 . . . . 0.0 109.811 176.4 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -65.94 130.24 42.58 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.625 -0.672 . . . . 0.0 111.017 -168.179 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.45 HD11 ' OD1' ' A' ' 50' ' ' ASP . 82.2 mt -114.92 136.67 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 173.521 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.03 112.49 7.59 Favored Pre-proline 0 N--CA 1.501 2.122 0 O-C-N 121.581 -0.7 . . . . 0.0 110.54 -174.628 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -79.67 151.25 22.02 Favored 'Trans proline' 0 N--CA 1.485 1.021 0 O-C-N 123.403 1.212 . . . . 0.0 110.261 179.171 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -101.75 114.19 28.04 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.662 -0.649 . . . . 0.0 110.053 177.435 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.2 m -66.38 -32.65 74.17 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.698 -0.626 . . . . 0.0 110.492 -178.999 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -62.15 143.29 56.93 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.602 -0.686 . . . . 0.0 110.724 -178.238 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.9 mm -96.76 158.9 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.798 -0.564 . . . . 0.0 109.703 179.008 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -93.4 112.5 24.42 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.598 -0.689 . . . . 0.0 110.138 -178.798 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -51.57 -42.32 61.78 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.78 -0.575 . . . . 0.0 111.629 177.199 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.526 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.5 t80 -153.09 128.78 10.11 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.594 -0.691 . . . . 0.0 110.365 -174.018 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.718 HD12 HG11 ' A' ' 41' ' ' VAL . 71.1 mt -128.34 133.48 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.693 -0.63 . . . . 0.0 109.939 172.954 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 27.1 tp -90.35 137.06 32.66 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.866 -0.521 . . . . 0.0 109.971 176.107 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.919 ' CD1' HD11 ' A' ' 72' ' ' ILE . 2.2 m-85 -133.61 124.43 26.82 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.686 -0.634 . . . . 0.0 110.673 -176.622 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 73.6 mtt85 -92.96 145.98 23.97 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.696 -0.628 . . . . 0.0 110.358 172.358 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.73 -24.69 62.6 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 179.532 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.6 m -67.9 -42.24 81.47 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.413 -1.051 . . . . 0.0 111.199 -173.799 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -85.46 -24.19 27.52 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.328 -0.858 . . . . 0.0 111.128 -175.929 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.919 HD11 ' CD1' ' A' ' 67' ' ' PHE . 86.7 mt -96.65 143.03 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.236 -0.915 . . . . 0.0 110.165 173.556 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -104.02 -20.85 13.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.984 -0.447 . . . . 0.0 111.304 -170.412 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -152.87 131.88 12.59 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 119.147 -1.021 . . . . 0.0 111.297 -179.414 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.56 HD12 ' CD1' ' A' ' 14' ' ' LEU . 17.5 tt -131.53 138.53 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 175.292 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -146.81 131.28 17.68 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.663 -0.648 . . . . 0.0 110.423 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.2 p -87.99 147.08 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.61 -0.681 . . . . 0.0 110.171 177.686 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.2 t -94.84 133.85 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.57 -0.706 . . . . 0.0 109.737 -179.703 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -139.48 -41.75 0.45 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.658 -0.652 . . . . 0.0 111.0 -179.458 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -134.7 30.29 3.45 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.408 -0.808 . . . . 0.0 110.622 -178.249 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -153.16 157.06 39.75 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.592 -0.693 . . . . 0.0 110.311 179.099 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.4 p -125.03 163.17 22.94 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.608 -0.683 . . . . 0.0 110.223 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.3 tt -107.55 109.9 62.66 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.704 -0.622 . . . . 0.0 110.144 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo . . . . . 0 N--CA 1.489 1.222 0 O-C-N 123.405 1.213 . . . . 0.0 110.361 179.159 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -92.91 118.67 31.4 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.704 -0.88 . . . . 0.0 110.209 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 90.3 mtp -66.75 -37.77 85.3 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.586 -0.696 . . . . 0.0 110.266 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -154.5 155.71 35.37 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.711 -0.618 . . . . 0.0 110.241 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.2 ttp -147.71 -57.64 0.25 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.741 -0.6 . . . . 0.0 110.192 179.449 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.5 m -66.16 -34.27 77.67 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.705 -0.622 . . . . 0.0 110.347 -179.814 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.06 -40.85 93.12 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.215 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.18 152.1 20.75 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.847 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 12.0 tp -155.39 58.16 1.82 Allowed Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.709 -0.877 . . . . 0.0 110.035 179.682 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -68.77 127.83 16.0 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 O-C-N 123.477 1.251 . . . . 0.0 110.27 179.374 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -64.89 112.99 3.53 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.669 -0.645 . . . . 0.0 110.503 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.8 mt -64.87 147.35 53.47 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.628 -0.67 . . . . 0.0 110.529 178.75 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.58 -1.88 84.4 Favored Glycine 0 N--CA 1.497 2.741 0 C-N-CA 120.453 -0.88 . . . . 0.0 111.815 177.653 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 71.5 m -61.35 148.58 40.93 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.155 -1.203 . . . . 0.0 110.44 -179.086 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -82.21 127.45 33.19 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.491 179.588 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.683 ' CD1' HD13 ' A' ' 26' ' ' LEU . 89.1 mt -121.78 144.5 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.588 -0.695 . . . . 0.0 109.944 179.01 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.0 t -103.05 137.32 41.38 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 175.983 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.756 ' HG ' HG21 ' A' ' 72' ' ' ILE . 11.5 tp -133.32 123.3 25.2 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.792 -0.568 . . . . 0.0 110.002 -171.246 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.708 ' O ' HG23 ' A' ' 72' ' ' ILE . 82.2 mt -103.98 119.17 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.522 -0.736 . . . . 0.0 109.683 -177.707 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.1 m -94.32 157.93 15.81 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.137 0.494 . . . . 0.0 111.46 -175.525 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -53.72 -14.6 0.95 Allowed 'General case' 0 N--CA 1.507 2.385 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -171.363 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.462 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.68 20.39 4.07 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.221 -0.924 . . . . 0.0 110.459 179.475 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 55.53 35.42 25.11 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.486 -0.759 . . . . 0.0 109.93 -176.137 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.838 HG12 HG22 ' A' ' 46' ' ' THR . 60.9 mt -105.31 145.3 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.902 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 55.5 ttt85 -105.73 119.8 40.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.624 -0.673 . . . . 0.0 110.15 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -113.68 150.68 32.89 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.682 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.658 ' O ' HG23 ' A' ' 41' ' ' VAL . 36.1 mt-10 -141.36 140.55 33.76 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.437 -0.79 . . . . 0.0 109.776 174.883 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.61 172.49 41.12 Favored Glycine 0 N--CA 1.495 2.623 0 C-N-CA 119.875 -1.155 . . . . 0.0 110.451 -175.913 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -84.3 138.75 32.74 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.919 -0.753 . . . . 0.0 110.545 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.683 HD13 ' CD1' ' A' ' 12' ' ' ILE . 17.0 tp -66.15 117.68 8.8 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.628 -0.67 . . . . 0.0 110.685 175.888 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.457 ' O ' HG23 ' A' ' 28' ' ' THR . 28.7 t80 -100.09 -50.08 4.09 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.596 -0.69 . . . . 0.0 110.437 177.926 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 27' ' ' TYR . 15.2 p -154.19 154.83 34.18 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.648 -0.658 . . . . 0.0 110.317 -178.185 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.839 HG23 HG22 ' A' ' 36' ' ' ILE . 13.5 p -142.19 145.6 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.707 -0.62 . . . . 0.0 110.054 -179.347 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -129.02 98.19 24.56 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.643 -0.661 . . . . 0.0 109.504 177.355 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -59.64 -40.34 65.99 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 O-C-N 123.64 1.337 . . . . 0.0 110.973 -176.118 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -80.32 -27.39 38.42 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.308 -0.87 . . . . 0.0 110.118 -170.675 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.731 ' O ' HG23 ' A' ' 35' ' ' THR . 46.1 mt-10 -87.76 2.89 50.06 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.529 -0.732 . . . . 0.0 111.252 173.707 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 40.1 m 50.02 40.34 21.1 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.141 -0.974 . . . . 0.0 111.425 -177.768 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.731 HG23 ' O ' ' A' ' 33' ' ' GLU . 39.6 p -136.0 154.34 51.1 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.372 -0.83 . . . . 0.0 110.481 -176.81 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.839 HG22 HG23 ' A' ' 29' ' ' VAL . 40.0 pt -142.06 161.5 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.672 -0.643 . . . . 0.0 109.991 176.646 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.497 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.72 128.6 29.21 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.688 -0.633 . . . . 0.0 109.724 176.262 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 26' ' ' LEU . 83.8 mt -109.76 144.57 37.98 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -178.3 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.4 p -115.3 153.11 31.54 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -178.038 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.0 p 45.31 84.69 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 CA-C-O 121.506 0.669 . . . . 0.0 110.271 -171.672 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 23' ' ' GLU . 13.6 p -134.64 149.52 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -178.314 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.425 ' HB3' HD12 ' A' ' 61' ' ' ILE . 19.6 ptp180 -134.92 153.09 52.19 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.612 -0.68 . . . . 0.0 110.136 179.061 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.8 p -107.91 136.7 47.18 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.747 -0.596 . . . . 0.0 109.639 177.644 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -82.77 -38.45 23.18 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 119.864 -0.735 . . . . 0.0 111.115 -172.339 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.47 166.47 26.6 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 175.783 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.838 HG22 HG12 ' A' ' 20' ' ' ILE . 45.7 p -118.2 -19.77 8.87 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.846 -0.796 . . . . 0.0 110.909 172.786 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -53.3 -26.48 18.77 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.511 -0.743 . . . . 0.0 112.249 -167.54 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -70.49 -59.31 2.92 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.359 -0.838 . . . . 0.0 110.733 -176.025 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 63.1 mtp85 -94.42 -16.34 23.51 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.606 -0.684 . . . . 0.0 111.741 -175.739 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -63.7 174.57 1.34 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.239 -0.913 . . . . 0.0 111.245 -172.639 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.1 m -78.68 164.63 24.44 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 177.887 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -77.5 11.46 2.01 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.676 -0.64 . . . . 0.0 111.565 -174.805 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -92.93 164.48 13.29 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.2 -0.938 . . . . 0.0 109.683 169.519 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -66.05 138.17 57.58 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.584 -0.697 . . . . 0.0 110.726 -172.623 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.3 mm -118.39 139.54 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.773 -0.579 . . . . 0.0 109.595 177.383 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.58 113.63 18.48 Favored Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 121.69 -0.631 . . . . 0.0 110.288 -178.827 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -68.54 153.18 74.21 Favored 'Trans proline' 0 N--CA 1.487 1.123 0 O-C-N 123.365 1.192 . . . . 0.0 110.4 179.006 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -132.92 65.73 1.58 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.649 -0.657 . . . . 0.0 110.127 179.526 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.1 m -65.98 -33.4 75.72 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.515 -0.741 . . . . 0.0 110.401 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -62.0 155.35 24.05 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.616 -0.678 . . . . 0.0 110.621 -178.926 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.425 HD12 ' HB3' ' A' ' 42' ' ' ARG . 45.2 mm -96.71 138.34 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.656 -0.652 . . . . 0.0 109.741 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -97.85 118.8 35.24 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.664 -0.647 . . . . 0.0 110.471 -177.324 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -51.3 -39.95 57.95 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.721 -0.612 . . . . 0.0 111.428 175.27 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.497 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.8 t80 -152.95 130.4 11.4 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.75 -0.593 . . . . 0.0 110.254 -174.887 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.645 HD12 ' CG1' ' A' ' 41' ' ' VAL . 72.9 mt -128.97 127.33 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.65 -0.656 . . . . 0.0 109.901 171.445 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 24.0 tp -91.03 137.14 32.59 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.929 -0.482 . . . . 0.0 109.917 176.317 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.541 ' CD1' HD11 ' A' ' 72' ' ' ILE . 5.9 m-85 -137.18 128.61 28.29 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.65 -0.656 . . . . 0.0 110.531 -176.483 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -91.1 154.93 19.02 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.658 -0.651 . . . . 0.0 110.278 173.986 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.07 -23.96 57.87 Favored Glycine 0 N--CA 1.498 2.824 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 177.691 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.8 m -72.72 -42.09 64.52 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.46 -1.023 . . . . 0.0 111.28 -175.074 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -84.55 -26.63 27.89 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.345 -0.847 . . . . 0.0 111.144 -174.015 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.756 HG21 ' HG ' ' A' ' 14' ' ' LEU . 32.8 mt -106.27 140.73 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.316 -0.865 . . . . 0.0 109.91 171.089 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -105.19 -16.67 14.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.921 -0.487 . . . . 0.0 111.687 -167.691 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -149.94 133.45 16.61 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.92 -1.113 . . . . 0.0 111.409 -178.689 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.419 HD12 ' CD1' ' A' ' 14' ' ' LEU . 16.2 tt -131.13 137.92 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.048 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -144.89 135.18 24.16 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.613 -0.679 . . . . 0.0 110.164 179.633 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.2 p -86.85 147.04 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.589 -0.694 . . . . 0.0 110.163 178.546 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.4 t -93.87 136.96 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.572 -0.705 . . . . 0.0 109.79 -179.175 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 36.0 p-10 -100.42 165.71 11.31 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.706 -0.621 . . . . 0.0 110.389 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -103.92 32.54 3.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.725 -0.609 . . . . 0.0 110.298 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -112.4 134.3 54.02 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.57 -0.706 . . . . 0.0 110.173 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.7 m -120.1 141.98 49.31 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.712 -0.617 . . . . 0.0 110.109 -179.708 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.535 ' N ' HD12 ' A' ' 83' ' ' LEU . 6.8 mp -95.56 158.29 34.74 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.753 -0.592 . . . . 0.0 110.209 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo . . . . . 0 N--CA 1.487 1.11 0 O-C-N 123.684 1.36 . . . . 0.0 110.34 -179.985 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 N--CA 1.501 2.094 0 CA-C-O 121.003 0.43 . . . . 1.08 110.836 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.61 -1.95 84.25 Favored Glycine 0 N--CA 1.497 2.706 0 C-N-CA 120.708 -0.758 . . . . 0.45 111.798 176.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.3 m -63.29 145.11 56.23 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.039 -1.271 . . . . 0.35 110.445 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.46 ' HE3' HG11 ' A' ' 78' ' ' VAL . 30.9 pttt -82.18 125.15 30.57 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.73 -0.606 . . . . 1.62 110.269 176.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.619 ' CD1' HD13 ' A' ' 26' ' ' LEU . 87.1 mt -120.97 143.42 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.499 -0.751 . . . . 0.18 110.059 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.9 t -102.5 137.22 41.02 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.35 -0.611 . . . . 0.12 109.35 174.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.613 HD21 HD13 ' A' ' 72' ' ' ILE . 13.9 tp -133.8 127.1 31.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.673 -0.642 . . . . 0.17 110.268 -169.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.6 mt -107.05 118.19 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.55 -0.719 . . . . 0.13 109.732 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m -93.08 157.82 16.1 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.022 0.439 . . . . 0.12 111.212 -177.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -53.76 -13.91 0.81 Allowed 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 112.839 0.681 . . . . 2.52 112.839 -171.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.51 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -90.15 20.78 4.11 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.154 -0.966 . . . . 0.16 110.416 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 53.93 34.28 19.18 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.54 -0.725 . . . . 0.8 109.886 -174.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.833 HG12 HG22 ' A' ' 46' ' ' THR . 68.4 mt -102.59 141.88 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 109.128 -0.693 . . . . 0.23 109.128 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -104.74 119.87 40.02 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.999 -0.68 . . . . 2.34 109.927 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -114.28 149.53 35.79 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.086 -0.709 . . . . 0.15 109.086 174.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.651 ' O ' HG23 ' A' ' 41' ' ' VAL . 45.7 tt0 -140.52 140.53 35.26 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.498 -0.751 . . . . 1.44 109.628 175.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.68 173.37 43.3 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 119.801 -1.19 . . . . 0.06 110.541 -175.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -84.89 137.26 33.24 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.906 -0.761 . . . . 2.07 110.543 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.619 HD13 ' CD1' ' A' ' 12' ' ' ILE . 14.9 tp -66.09 117.66 8.73 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.589 -0.695 . . . . 0.24 110.6 175.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.454 ' O ' HG23 ' A' ' 28' ' ' THR . 31.1 t80 -100.05 -50.08 4.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.621 -0.675 . . . . 0.18 110.562 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 27' ' ' TYR . 14.8 p -154.44 156.95 37.71 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.696 -0.628 . . . . 0.1 110.293 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.813 HG23 HG22 ' A' ' 36' ' ' ILE . 13.7 p -142.27 146.32 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.755 -0.591 . . . . 0.15 110.085 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -128.12 100.95 22.92 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.716 -0.615 . . . . 0.91 109.507 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.31 -42.02 30.75 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 O-C-N 123.652 1.343 . . . . 0.48 110.734 -174.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -80.77 -23.88 39.03 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.379 -0.825 . . . . 2.16 110.148 -171.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.68 ' O ' HG23 ' A' ' 35' ' ' THR . 74.9 mm-40 -87.33 1.11 54.26 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.525 -0.734 . . . . 1.59 111.294 173.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 37.2 m 49.78 38.52 15.82 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.079 -1.013 . . . . 0.74 111.195 -176.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.68 HG23 ' O ' ' A' ' 33' ' ' GLU . 17.0 p -135.77 155.44 50.36 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.405 -0.81 . . . . 0.14 110.399 -174.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.813 HG22 HG23 ' A' ' 29' ' ' VAL . 39.7 pt -142.1 162.0 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.715 -0.616 . . . . 0.15 110.06 177.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.516 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.14 128.42 30.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.61 -0.681 . . . . 0.09 109.722 176.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 26' ' ' LEU . 84.2 mt -109.81 146.35 35.18 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.579 -0.526 . . . . 0.14 109.579 -178.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.3 p -118.29 152.54 35.57 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.12 -0.696 . . . . 0.08 109.12 -177.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.6 p 45.65 84.08 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 121.489 0.662 . . . . 0.07 110.238 -171.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.687 HG11 HD12 ' A' ' 65' ' ' ILE . 15.0 p -134.63 150.46 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 109.774 -0.454 . . . . 0.1 109.774 -178.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -135.72 153.23 51.65 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.697 -0.627 . . . . 2.7 109.967 178.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.8 p -106.57 139.21 41.38 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.686 -0.634 . . . . 0.24 109.788 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -82.74 -38.36 23.38 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.591 -0.693 . . . . 0.59 110.871 -173.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.63 170.48 32.48 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 120.024 -1.084 . . . . 0.51 110.447 177.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.833 HG22 HG12 ' A' ' 20' ' ' ILE . 1.4 p -118.08 6.58 12.09 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.952 -0.734 . . . . 1.13 110.737 174.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -48.94 -25.96 2.23 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.635 -0.666 . . . . 2.69 112.584 -166.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -64.87 -59.29 4.36 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.201 -0.937 . . . . 1.96 110.629 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 58.1 mtp85 -94.43 10.26 35.14 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.64 -0.662 . . . . 4.87 111.38 176.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.445 ' HB2' HD12 ' A' ' 55' ' ' ILE . 38.8 p-10 -59.74 174.02 0.51 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.237 -0.914 . . . . 2.14 111.466 -169.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.1 m -78.95 164.42 24.43 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.647 -0.501 . . . . 3.23 109.647 173.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -77.44 3.45 13.33 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.653 -0.654 . . . . 4.1 111.344 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -97.5 154.21 17.65 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.203 -0.936 . . . . 4.1 109.691 171.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -68.08 137.34 54.91 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.582 -0.699 . . . . 3.57 110.607 -175.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.445 HD12 ' HB2' ' A' ' 50' ' ' ASP . 78.9 mt -117.1 136.56 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.638 -0.664 . . . . 2.27 109.507 176.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . . . -85.35 138.89 36.15 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.693 -0.629 . . . . 2.49 110.124 -178.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 56' ' ' ALA . 17.3 Cg_exo -63.09 149.13 92.39 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 O-C-N 123.362 1.19 . . . . 2.03 110.543 178.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -96.49 115.0 26.71 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.641 -0.662 . . . . 2.72 110.097 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.9 m -85.66 -33.27 21.61 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.687 -0.633 . . . . 2.17 110.331 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -62.56 141.76 58.3 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.679 -0.638 . . . . 2.7 110.66 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.3 mm -96.86 147.36 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.761 -0.587 . . . . 0.5 109.719 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -93.93 114.98 27.3 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.614 -0.679 . . . . 0.73 110.192 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -51.12 -42.18 60.53 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.865 -0.522 . . . . 1.86 111.678 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.516 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.0 t80 -152.58 129.19 10.77 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.606 -0.684 . . . . 0.1 110.272 -174.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.687 HD12 HG11 ' A' ' 41' ' ' VAL . 78.3 mt -128.58 128.74 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.662 -0.649 . . . . 0.11 109.823 172.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.1 tp -90.79 137.08 32.64 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.893 -0.504 . . . . 0.17 109.932 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.538 ' CD1' HD11 ' A' ' 72' ' ' ILE . 3.2 m-85 -136.29 130.12 32.47 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.557 -0.714 . . . . 0.29 110.605 -175.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.7 mtm-85 -91.07 147.88 22.77 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.678 -0.639 . . . . 2.52 110.258 173.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.03 -26.46 61.02 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 110.558 -1.017 . . . . 0.13 110.558 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.3 m -65.7 -39.79 91.62 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.464 -1.021 . . . . 1.29 110.989 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.68 -32.95 31.52 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.395 -0.816 . . . . 1.09 110.859 -174.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.613 HD13 HD21 ' A' ' 14' ' ' LEU . 8.4 mt -103.07 139.35 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.472 -0.768 . . . . 0.27 110.101 177.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.5 tttp -106.26 -20.05 13.51 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 120.571 -0.452 . . . . 2.11 111.676 -166.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -150.92 136.38 17.84 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 118.996 -1.082 . . . . 1.03 111.342 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.525 HD12 ' CD1' ' A' ' 14' ' ' LEU . 17.5 tt -133.6 143.42 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.829 -0.434 . . . . 0.26 109.829 177.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -146.71 136.93 23.6 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.624 -0.672 . . . . 2.91 110.297 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.0 t -87.46 144.4 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.562 -0.711 . . . . 1.54 109.777 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.46 HG11 ' HE3' ' A' ' 11' ' ' LYS . 55.4 t . . . . . 0 N--CA 1.497 1.893 0 O-C-N 121.672 -0.643 . . . . 0.98 109.74 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 N--CA 1.501 2.094 0 CA-C-O 121.003 0.43 . . . . 1.08 110.836 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.61 -1.95 84.25 Favored Glycine 0 N--CA 1.497 2.706 0 C-N-CA 120.708 -0.758 . . . . 0.45 111.798 176.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.3 m -63.29 145.11 56.23 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.039 -1.271 . . . . 0.35 110.445 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.46 ' HE3' HG11 ' A' ' 78' ' ' VAL . 30.9 pttt -82.18 125.15 30.57 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.73 -0.606 . . . . 1.62 110.269 176.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.619 ' CD1' HD13 ' A' ' 26' ' ' LEU . 87.1 mt -120.97 143.42 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.499 -0.751 . . . . 0.18 110.059 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.9 t -102.5 137.22 41.02 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.35 -0.611 . . . . 0.12 109.35 174.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.613 HD21 HD13 ' A' ' 72' ' ' ILE . 13.9 tp -133.8 127.1 31.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.673 -0.642 . . . . 0.17 110.268 -169.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.6 mt -107.05 118.19 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.55 -0.719 . . . . 0.13 109.732 -178.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m -93.08 157.82 16.1 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.022 0.439 . . . . 0.12 111.212 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -53.76 -13.91 0.81 Allowed 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 112.839 0.681 . . . . 2.52 112.839 -171.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.51 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -90.15 20.78 4.11 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.154 -0.966 . . . . 0.16 110.416 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 53.93 34.28 19.18 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.54 -0.725 . . . . 0.8 109.886 -174.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.833 HG12 HG22 ' A' ' 46' ' ' THR . 68.4 mt -102.59 141.88 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 109.128 -0.693 . . . . 0.23 109.128 178.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -104.74 119.87 40.02 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.999 -0.68 . . . . 2.34 109.927 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -114.28 149.53 35.79 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.086 -0.709 . . . . 0.15 109.086 174.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.651 ' O ' HG23 ' A' ' 41' ' ' VAL . 45.7 tt0 -140.52 140.53 35.26 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.498 -0.751 . . . . 1.44 109.628 175.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.68 173.37 43.3 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 119.801 -1.19 . . . . 0.06 110.541 -175.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -84.89 137.26 33.24 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.906 -0.761 . . . . 2.07 110.543 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.619 HD13 ' CD1' ' A' ' 12' ' ' ILE . 14.9 tp -66.09 117.66 8.73 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.589 -0.695 . . . . 0.24 110.6 175.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.454 ' O ' HG23 ' A' ' 28' ' ' THR . 31.1 t80 -100.05 -50.08 4.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.621 -0.675 . . . . 0.18 110.562 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 27' ' ' TYR . 14.8 p -154.44 156.95 37.71 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.696 -0.628 . . . . 0.1 110.293 -177.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.813 HG23 HG22 ' A' ' 36' ' ' ILE . 13.7 p -142.27 146.32 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.755 -0.591 . . . . 0.15 110.085 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -128.12 100.95 22.92 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.716 -0.615 . . . . 0.91 109.507 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.31 -42.02 30.75 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 O-C-N 123.652 1.343 . . . . 0.48 110.734 -174.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -80.77 -23.88 39.03 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.379 -0.825 . . . . 2.16 110.148 -171.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.68 ' O ' HG23 ' A' ' 35' ' ' THR . 74.9 mm-40 -87.33 1.11 54.26 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.525 -0.734 . . . . 1.59 111.294 173.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 37.2 m 49.78 38.52 15.82 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.079 -1.013 . . . . 0.74 111.195 -176.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.68 HG23 ' O ' ' A' ' 33' ' ' GLU . 17.0 p -135.77 155.44 50.36 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.405 -0.81 . . . . 0.14 110.399 -174.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.813 HG22 HG23 ' A' ' 29' ' ' VAL . 39.7 pt -142.1 162.0 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.715 -0.616 . . . . 0.15 110.06 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.516 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.14 128.42 30.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.61 -0.681 . . . . 0.09 109.722 176.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 26' ' ' LEU . 84.2 mt -109.81 146.35 35.18 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.579 -0.526 . . . . 0.14 109.579 -178.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.3 p -118.29 152.54 35.57 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.12 -0.696 . . . . 0.08 109.12 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.6 p 45.65 84.08 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 121.489 0.662 . . . . 0.07 110.238 -171.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.687 HG11 HD12 ' A' ' 65' ' ' ILE . 15.0 p -134.63 150.46 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 109.774 -0.454 . . . . 0.1 109.774 -178.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -135.72 153.23 51.65 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.697 -0.627 . . . . 2.7 109.967 178.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.8 p -106.57 139.21 41.38 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.686 -0.634 . . . . 0.24 109.788 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -82.74 -38.36 23.38 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.591 -0.693 . . . . 0.59 110.871 -173.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.63 170.48 32.48 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 120.024 -1.084 . . . . 0.51 110.447 177.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.833 HG22 HG12 ' A' ' 20' ' ' ILE . 1.4 p -118.08 6.58 12.09 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.952 -0.734 . . . . 1.13 110.737 174.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -48.94 -25.96 2.23 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.635 -0.666 . . . . 2.69 112.584 -166.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -64.87 -59.29 4.36 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.201 -0.937 . . . . 1.96 110.629 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 58.1 mtp85 -94.43 10.26 35.14 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.64 -0.662 . . . . 4.87 111.38 176.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.445 ' HB2' HD12 ' A' ' 55' ' ' ILE . 38.8 p-10 -59.74 174.02 0.51 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.237 -0.914 . . . . 2.14 111.466 -169.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.1 m -78.95 164.42 24.43 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.647 -0.501 . . . . 3.23 109.647 173.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -77.44 3.45 13.33 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.653 -0.654 . . . . 4.1 111.344 -178.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -97.5 154.21 17.65 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.203 -0.936 . . . . 4.1 109.691 171.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -68.08 137.34 54.91 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.582 -0.699 . . . . 3.57 110.607 -175.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.445 HD12 ' HB2' ' A' ' 50' ' ' ASP . 78.9 mt -117.1 136.56 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.638 -0.664 . . . . 2.27 109.507 176.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . . . -85.35 138.89 36.15 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.693 -0.629 . . . . 2.49 110.124 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 56' ' ' ALA . 17.3 Cg_exo -63.09 149.13 92.39 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 O-C-N 123.362 1.19 . . . . 2.03 110.543 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -96.49 115.0 26.71 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.641 -0.662 . . . . 2.72 110.097 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.9 m -85.66 -33.27 21.61 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.687 -0.633 . . . . 2.17 110.331 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -62.56 141.76 58.3 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.679 -0.638 . . . . 2.7 110.66 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.3 mm -96.86 147.36 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.761 -0.587 . . . . 0.5 109.719 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -93.93 114.98 27.3 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.614 -0.679 . . . . 0.73 110.192 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -51.12 -42.18 60.53 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.865 -0.522 . . . . 1.86 111.678 178.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.516 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.0 t80 -152.58 129.19 10.77 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.606 -0.684 . . . . 0.1 110.272 -174.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.687 HD12 HG11 ' A' ' 41' ' ' VAL . 78.3 mt -128.58 128.74 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.662 -0.649 . . . . 0.11 109.823 172.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.1 tp -90.79 137.08 32.64 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.893 -0.504 . . . . 0.17 109.932 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.538 ' CD1' HD11 ' A' ' 72' ' ' ILE . 3.2 m-85 -136.29 130.12 32.47 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.557 -0.714 . . . . 0.29 110.605 -175.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.7 mtm-85 -91.07 147.88 22.77 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.678 -0.639 . . . . 2.52 110.258 173.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.03 -26.46 61.02 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 110.558 -1.017 . . . . 0.13 110.558 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.3 m -65.7 -39.79 91.62 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.464 -1.021 . . . . 1.29 110.989 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.68 -32.95 31.52 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.395 -0.816 . . . . 1.09 110.859 -174.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.613 HD13 HD21 ' A' ' 14' ' ' LEU . 8.4 mt -103.07 139.35 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.472 -0.768 . . . . 0.27 110.101 177.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.5 tttp -106.26 -20.05 13.51 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 120.571 -0.452 . . . . 2.11 111.676 -166.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -150.92 136.38 17.84 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 118.996 -1.082 . . . . 1.03 111.342 -177.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.525 HD12 ' CD1' ' A' ' 14' ' ' LEU . 17.5 tt -133.6 143.42 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.829 -0.434 . . . . 0.26 109.829 177.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -146.71 136.93 23.6 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.624 -0.672 . . . . 2.91 110.297 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.0 t -87.46 144.4 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.562 -0.711 . . . . 1.54 109.777 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.46 HG11 ' HE3' ' A' ' 11' ' ' LYS . 55.4 t . . . . . 0 N--CA 1.497 1.893 0 O-C-N 121.672 -0.643 . . . . 0.98 109.74 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.2 mt . . . . . 0 N--CA 1.501 2.109 0 CA-C-O 120.95 0.405 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.76 -1.85 84.96 Favored Glycine 0 N--CA 1.496 2.66 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.722 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.8 m -61.38 143.21 56.18 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.101 -1.235 . . . . 0.0 110.413 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -82.2 128.95 34.67 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.692 -0.63 . . . . 0.0 110.494 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.716 ' CD1' HD13 ' A' ' 26' ' ' LEU . 86.1 mt -122.0 142.92 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.581 -0.699 . . . . 0.0 110.076 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.5 t -103.15 137.23 41.59 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 174.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.77 HD21 HD13 ' A' ' 72' ' ' ILE . 13.7 tp -134.78 125.4 26.84 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.673 -0.642 . . . . 0.0 110.301 -169.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 81.5 mt -107.09 117.97 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.538 -0.727 . . . . 0.0 109.696 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.2 m -92.65 157.77 16.3 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.059 0.457 . . . . 0.0 111.267 -177.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -54.07 -13.66 0.87 Allowed 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -171.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.53 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -90.1 20.73 4.12 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.163 -0.961 . . . . 0.0 110.416 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 54.13 34.28 19.73 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.481 -0.762 . . . . 0.0 109.836 -174.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.844 HG12 HG22 ' A' ' 46' ' ' THR . 65.0 mt -102.94 141.3 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 55.1 ttt85 -104.61 119.84 39.92 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.997 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -114.79 149.65 36.64 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.666 ' O ' HG23 ' A' ' 41' ' ' VAL . 42.1 tt0 -140.42 140.49 35.45 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.556 -0.715 . . . . 0.0 109.478 175.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.3 172.01 41.48 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.688 -1.244 . . . . 0.0 110.681 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.3 mmt85 -84.85 138.51 32.51 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.919 -0.753 . . . . 0.0 110.522 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.716 HD13 ' CD1' ' A' ' 12' ' ' ILE . 16.8 tp -66.16 118.27 9.65 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.565 -0.709 . . . . 0.0 110.669 175.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.463 ' O ' HG23 ' A' ' 28' ' ' THR . 23.9 t80 -100.51 -50.14 4.0 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.623 -0.673 . . . . 0.0 110.385 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 27' ' ' TYR . 12.8 p -154.3 153.58 31.91 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.741 -0.599 . . . . 0.0 110.263 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.885 HG23 HG22 ' A' ' 36' ' ' ILE . 13.4 p -142.3 145.45 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.729 -0.607 . . . . 0.0 110.052 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -128.94 100.9 20.3 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.669 -0.644 . . . . 0.0 109.554 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.51 -39.44 45.2 Favored 'Trans proline' 0 N--CA 1.489 1.24 0 O-C-N 123.533 1.281 . . . . 0.0 110.796 -175.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -80.6 -25.74 38.27 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.369 -0.832 . . . . 0.0 110.066 -171.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.562 ' O ' HG23 ' A' ' 35' ' ' THR . 79.1 mt-10 -87.41 1.49 53.23 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.555 -0.715 . . . . 0.0 111.22 173.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 38.6 m 49.61 38.68 15.49 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.091 -1.006 . . . . 0.0 111.343 -176.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 33' ' ' GLU . 9.9 p -136.3 153.36 51.19 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.348 -0.845 . . . . 0.0 110.286 -174.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.885 HG22 HG23 ' A' ' 29' ' ' VAL . 39.9 pt -142.74 162.0 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.676 -0.64 . . . . 0.0 110.252 178.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.52 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.46 127.61 28.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.657 -0.652 . . . . 0.0 109.704 175.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 26' ' ' LEU . 83.2 mt -109.94 146.77 34.64 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -177.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 96.0 p -118.13 153.42 33.83 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.7 p 45.65 85.01 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 121.476 0.655 . . . . 0.0 110.364 -172.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.711 HG11 HD12 ' A' ' 65' ' ' ILE . 14.5 p -134.53 150.41 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.95 -0.469 . . . . 0.0 109.753 -178.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -135.21 153.18 52.03 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.634 -0.666 . . . . 0.0 109.952 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 82.5 p -108.19 138.83 43.79 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.656 -0.652 . . . . 0.0 109.866 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -83.02 -38.29 22.79 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.654 -0.654 . . . . 0.0 110.859 -174.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.64 168.1 29.29 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.844 HG22 HG12 ' A' ' 20' ' ' ILE . 17.6 p -118.15 6.6 12.03 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.925 -0.75 . . . . 0.0 110.908 175.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -49.87 -25.27 3.01 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.563 -0.711 . . . . 0.0 112.781 -166.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -64.92 -59.34 4.29 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.134 -0.978 . . . . 0.0 110.671 -177.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.1 mtp180 -94.45 10.16 35.59 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.502 -0.749 . . . . 0.0 111.524 176.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.593 ' HB2' HD12 ' A' ' 55' ' ' ILE . 39.5 p-10 -58.63 174.06 0.36 Allowed 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.204 -0.935 . . . . 0.0 111.448 -170.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.0 m -78.85 164.42 24.5 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.935 -0.478 . . . . 0.0 109.759 175.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -77.55 4.89 10.13 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.642 -0.661 . . . . 0.0 111.289 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -95.84 166.03 12.0 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.226 -0.921 . . . . 0.0 109.591 168.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -80.74 132.1 35.5 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.607 -0.683 . . . . 0.0 110.488 -175.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.593 HD12 ' HB2' ' A' ' 50' ' ' ASP . 78.5 mt -114.27 134.35 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.715 -0.615 . . . . 0.0 109.443 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.38 146.01 38.88 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.629 -0.669 . . . . 0.0 110.154 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -63.07 149.37 91.72 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 O-C-N 123.399 1.21 . . . . 0.0 110.539 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -96.28 121.62 38.26 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.647 -0.658 . . . . 0.0 110.107 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.0 t -91.66 -32.55 15.42 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.708 -0.62 . . . . 0.0 110.356 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -62.59 140.49 58.66 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.641 -0.662 . . . . 0.0 110.569 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.9 mm -96.89 148.12 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.744 -0.597 . . . . 0.0 109.683 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -94.2 114.27 26.35 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.62 -0.675 . . . . 0.0 110.195 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -51.38 -42.42 61.37 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.754 -0.591 . . . . 0.0 111.585 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.52 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.8 t80 -152.87 129.88 11.06 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.665 -0.647 . . . . 0.0 110.219 -174.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.711 HD12 HG11 ' A' ' 41' ' ' VAL . 72.8 mt -128.87 129.06 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.701 -0.625 . . . . 0.0 109.87 172.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.0 tp -90.34 137.05 32.66 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.802 -0.561 . . . . 0.0 109.84 176.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.609 ' CD1' HD11 ' A' ' 72' ' ' ILE . 2.8 m-85 -134.55 128.2 32.82 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.699 -0.626 . . . . 0.0 110.563 -175.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -91.61 146.81 23.47 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.686 -0.634 . . . . 0.0 110.213 172.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.81 -26.55 60.57 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.1 t -65.36 -40.11 93.15 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.467 -1.019 . . . . 0.0 111.004 -177.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -81.55 -32.31 32.3 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.431 -0.793 . . . . 0.0 110.857 -174.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.77 HD13 HD21 ' A' ' 14' ' ' LEU . 6.9 mt -101.15 140.48 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.456 -0.778 . . . . 0.0 110.149 177.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -104.63 -20.34 13.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.938 -0.476 . . . . 0.0 111.492 -168.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -151.56 133.69 15.17 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.034 -1.041 . . . . 0.0 111.233 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.539 HD12 ' CD1' ' A' ' 14' ' ' LEU . 17.0 tt -131.87 143.81 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.908 -0.495 . . . . 0.0 109.756 176.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -145.76 130.16 17.74 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.597 -0.689 . . . . 0.0 110.257 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.45 HG22 HG12 ' A' ' 12' ' ' ILE . 51.4 t -88.36 143.55 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.684 -0.635 . . . . 0.0 109.781 179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.9 t . . . . . 0 N--CA 1.497 1.901 0 O-C-N 121.567 -0.708 . . . . 0.0 109.674 179.471 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.0 mt . . . . . 0 N--CA 1.502 2.129 0 CA-C-O 120.985 0.421 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.6 -1.85 84.54 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.871 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 75.0 m -61.44 146.08 49.62 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.07 -1.253 . . . . 0.0 110.479 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.602 ' HE3' HG11 ' A' ' 78' ' ' VAL . 28.1 pttt -81.97 126.41 31.91 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.718 -0.613 . . . . 0.0 110.485 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.418 HG12 HG22 ' A' ' 77' ' ' VAL . 88.5 mt -123.91 143.96 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.605 -0.684 . . . . 0.0 110.177 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.6 t -102.65 137.26 41.11 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 175.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.629 HD21 HD13 ' A' ' 72' ' ' ILE . 13.8 tp -133.23 128.4 35.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.708 -0.62 . . . . 0.0 110.318 -170.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.1 mt -108.22 119.61 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.464 -0.772 . . . . 0.0 109.698 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.1 m -93.9 157.61 16.04 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.114 0.483 . . . . 0.0 111.222 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -54.12 -13.56 0.86 Allowed 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -172.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.552 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.84 20.41 4.16 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.148 -0.97 . . . . 0.0 110.485 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 53.91 34.04 18.6 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.38 -0.825 . . . . 0.0 109.804 -174.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.781 HG12 HG22 ' A' ' 46' ' ' THR . 67.3 mt -102.2 141.82 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -105.37 119.85 40.11 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.007 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -114.74 148.72 37.94 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 174.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.672 ' O ' HG23 ' A' ' 41' ' ' VAL . 41.9 tt0 -140.09 140.51 36.1 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.476 -0.765 . . . . 0.0 109.603 175.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.92 173.52 42.22 Favored Glycine 0 N--CA 1.495 2.597 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.48 -175.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -84.73 136.5 33.69 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.889 -0.771 . . . . 0.0 110.501 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' A' ' 38' ' ' LEU . 27.7 tp -66.14 116.33 7.1 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.548 -0.72 . . . . 0.0 110.537 175.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.413 ' C ' HG23 ' A' ' 28' ' ' THR . 25.8 t80 -99.14 -49.99 4.3 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.677 -0.639 . . . . 0.0 110.364 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.413 HG23 ' C ' ' A' ' 27' ' ' TYR . 25.1 p -152.97 154.87 35.86 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.655 -0.653 . . . . 0.0 110.25 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.829 HG23 HG22 ' A' ' 36' ' ' ILE . 13.6 p -142.23 145.61 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.686 -0.634 . . . . 0.0 110.104 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -127.83 101.54 23.26 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.627 -0.671 . . . . 0.0 109.506 177.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.44 -41.82 30.94 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 O-C-N 123.626 1.329 . . . . 0.0 110.868 -174.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -80.59 -24.55 39.08 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.301 -0.874 . . . . 0.0 110.214 -171.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.609 ' O ' HG23 ' A' ' 35' ' ' THR . 54.6 mt-10 -87.42 1.13 54.29 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.412 -0.805 . . . . 0.0 111.235 173.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 39.6 m 49.75 39.26 17.43 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.153 -0.967 . . . . 0.0 111.243 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.609 HG23 ' O ' ' A' ' 33' ' ' GLU . 11.8 p -135.82 153.79 51.4 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.407 -0.808 . . . . 0.0 110.38 -174.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.829 HG22 HG23 ' A' ' 29' ' ' VAL . 39.9 pt -142.62 162.02 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.708 -0.62 . . . . 0.0 110.193 177.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.51 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -135.61 129.54 33.02 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.63 -0.669 . . . . 0.0 109.82 175.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 26' ' ' LEU . 50.6 mt -109.84 144.23 38.59 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -178.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 99.9 p -116.24 151.41 35.83 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.8 p 46.1 87.43 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 CA-C-O 121.462 0.648 . . . . 0.0 110.267 -172.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.76 HG11 HD12 ' A' ' 65' ' ' ILE . 12.3 p -134.62 147.79 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.968 -0.458 . . . . 0.0 109.837 -178.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -127.33 153.08 46.63 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.821 -0.549 . . . . 0.0 109.703 178.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.8 p -109.39 136.74 48.33 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.697 -0.627 . . . . 0.0 109.824 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -82.93 -38.19 23.13 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.624 -0.672 . . . . 0.0 110.847 -174.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.58 167.13 27.8 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 176.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.781 HG22 HG12 ' A' ' 20' ' ' ILE . 6.9 p -118.16 6.6 12.03 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.976 -0.72 . . . . 0.0 110.977 175.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -48.99 -25.46 1.98 Allowed 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.498 -0.752 . . . . 0.0 112.417 -169.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -64.4 -59.2 4.63 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.225 -0.922 . . . . 0.0 110.622 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -94.34 10.23 35.07 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.628 -0.67 . . . . 0.0 111.373 177.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -61.08 174.02 0.72 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.241 -0.912 . . . . 0.0 111.279 -170.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.715 ' OG1' HD11 ' A' ' 55' ' ' ILE . 39.9 p -78.88 164.5 24.41 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.914 -0.491 . . . . 0.0 109.917 175.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -77.52 3.89 12.47 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.004 176.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -97.34 165.28 12.1 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.181 -0.95 . . . . 0.0 109.621 167.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -68.51 142.47 55.26 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.524 -0.735 . . . . 0.0 110.388 -177.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.715 HD11 ' OG1' ' A' ' 51' ' ' THR . 49.9 mm -112.67 134.95 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.704 -0.622 . . . . 0.0 109.675 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -97.96 109.91 53.48 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.731 -0.606 . . . . 0.0 110.201 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -67.49 147.16 76.54 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 O-C-N 123.379 1.199 . . . . 0.0 110.409 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -96.54 119.77 35.63 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.721 -0.612 . . . . 0.0 110.222 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.6 p -68.26 -30.65 69.74 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.707 -0.62 . . . . 0.0 110.422 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -62.4 145.78 53.07 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.551 -0.718 . . . . 0.0 110.595 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.87 154.71 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.745 -0.597 . . . . 0.0 109.699 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -94.13 113.68 25.68 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.667 -0.645 . . . . 0.0 110.17 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -51.54 -40.52 59.83 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.753 -0.592 . . . . 0.0 111.765 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.51 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.4 t80 -153.38 130.84 11.37 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.669 -0.644 . . . . 0.0 110.177 -175.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.76 HD12 HG11 ' A' ' 41' ' ' VAL . 76.2 mt -129.75 128.22 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.725 -0.609 . . . . 0.0 109.791 172.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.6 tp -90.46 136.99 32.71 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.851 -0.53 . . . . 0.0 109.805 176.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.589 ' CD1' HD11 ' A' ' 72' ' ' ILE . 3.3 m-85 -135.81 130.62 34.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.661 -0.649 . . . . 0.0 110.58 -175.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -91.68 149.66 21.52 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.678 -0.639 . . . . 0.0 110.343 173.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.05 -24.55 60.86 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.0 t -66.81 -42.14 86.39 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.481 -1.011 . . . . 0.0 111.056 -175.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -82.77 -33.04 27.49 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.396 -0.815 . . . . 0.0 110.879 -175.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.629 HD13 HD21 ' A' ' 14' ' ' LEU . 13.8 mt -100.72 138.4 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.423 -0.798 . . . . 0.0 110.143 177.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 50.3 tptt -108.0 -19.12 13.61 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.789 -166.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -149.71 135.86 18.89 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 118.935 -1.106 . . . . 0.0 111.319 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.5 HD12 ' CD1' ' A' ' 14' ' ' LEU . 18.2 tt -134.08 144.47 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.868 -0.52 . . . . 0.0 109.886 177.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -146.1 133.28 20.47 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.608 -0.682 . . . . 0.0 110.288 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.418 HG22 HG12 ' A' ' 12' ' ' ILE . 51.2 t -87.67 145.35 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.681 -0.637 . . . . 0.0 109.736 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.602 HG11 ' HE3' ' A' ' 11' ' ' LYS . 56.1 t . . . . . 0 N--CA 1.498 1.952 0 O-C-N 121.641 -0.662 . . . . 0.0 109.748 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.9 mt . . . . . 0 N--CA 1.501 2.121 0 CA-C-O 120.948 0.404 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.63 -1.79 84.83 Favored Glycine 0 N--CA 1.496 2.685 0 C-N-CA 120.49 -0.862 . . . . 0.0 111.73 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 58.5 m -60.88 153.66 24.18 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.119 -1.224 . . . . 0.0 110.541 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -81.56 123.58 28.78 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.715 -0.616 . . . . 0.0 110.583 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 89.0 mt -120.81 145.27 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.508 -0.745 . . . . 0.0 110.066 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.0 t -102.54 137.31 40.94 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 175.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.707 HD21 HD13 ' A' ' 72' ' ' ILE . 13.8 tp -131.71 125.6 32.44 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.707 -0.621 . . . . 0.0 110.146 -170.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.3 mt -106.03 119.05 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.552 -0.718 . . . . 0.0 109.632 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.3 m -94.33 157.72 15.9 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.068 0.461 . . . . 0.0 111.227 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -53.43 -14.73 0.84 Allowed 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -172.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.551 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.32 20.3 3.89 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.097 -1.002 . . . . 0.0 110.463 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 54.0 34.08 18.93 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.478 -0.764 . . . . 0.0 109.796 -174.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.794 HG12 HG22 ' A' ' 46' ' ' THR . 68.5 mt -102.0 141.41 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 63.8 ttt-85 -105.5 119.81 40.05 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.887 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -114.15 150.01 34.81 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.665 ' O ' HG23 ' A' ' 41' ' ' VAL . 34.4 tt0 -140.68 140.46 34.95 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.42 -0.8 . . . . 0.0 109.647 175.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.6 172.97 43.23 Favored Glycine 0 N--CA 1.495 2.611 0 C-N-CA 119.716 -1.231 . . . . 0.0 110.538 -175.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -84.96 135.53 34.0 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.893 -0.769 . . . . 0.0 110.576 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.461 ' HA ' HD23 ' A' ' 38' ' ' LEU . 25.0 tp -66.1 117.93 9.13 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.542 -0.724 . . . . 0.0 110.595 175.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.443 ' O ' HG23 ' A' ' 28' ' ' THR . 25.9 t80 -99.52 -50.13 4.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.573 -0.704 . . . . 0.0 110.481 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 27' ' ' TYR . 16.0 p -153.93 156.48 37.59 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.734 -0.604 . . . . 0.0 110.32 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.846 HG23 HG22 ' A' ' 36' ' ' ILE . 13.3 p -142.32 145.86 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.708 -0.62 . . . . 0.0 110.034 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -128.25 99.14 24.97 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.659 -0.651 . . . . 0.0 109.55 177.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -59.5 -40.86 62.54 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 O-C-N 123.553 1.291 . . . . 0.0 110.937 -175.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -80.58 -25.76 38.3 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.338 -0.852 . . . . 0.0 110.181 -171.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.626 ' O ' HG23 ' A' ' 35' ' ' THR . 79.4 mt-10 -87.43 1.87 52.14 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.538 -0.726 . . . . 0.0 111.167 173.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.3 m 49.54 38.41 14.61 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.079 -1.013 . . . . 0.0 111.197 -176.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.626 HG23 ' O ' ' A' ' 33' ' ' GLU . 11.5 p -135.71 154.76 51.16 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.415 -0.803 . . . . 0.0 110.438 -174.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.846 HG22 HG23 ' A' ' 29' ' ' VAL . 40.4 pt -142.26 162.02 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.732 -0.605 . . . . 0.0 110.131 177.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.515 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -135.82 128.28 30.46 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.592 -0.693 . . . . 0.0 109.765 176.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 26' ' ' LEU . 86.3 mt -109.86 146.37 35.2 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -178.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.9 p -117.68 151.58 36.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.623 -0.673 . . . . 0.0 109.234 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 46.8 p 45.98 86.71 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 121.472 0.653 . . . . 0.0 110.291 -172.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.745 HG11 HD12 ' A' ' 65' ' ' ILE . 12.8 p -134.58 147.76 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.939 -0.476 . . . . 0.0 109.873 -178.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -126.19 153.06 45.17 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.732 -0.605 . . . . 0.0 109.798 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.3 p -108.79 134.39 51.55 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.665 -0.647 . . . . 0.0 109.794 177.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -83.02 -38.28 22.8 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.623 -0.673 . . . . 0.0 111.011 -173.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.66 168.74 30.25 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.993 -1.099 . . . . 0.0 110.54 176.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.794 HG22 HG12 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -118.14 6.61 12.04 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 122.008 -0.701 . . . . 0.0 110.997 175.021 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.3 tp10 -48.95 -25.95 2.23 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.546 -0.721 . . . . 0.0 112.455 -168.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -65.76 -59.21 4.13 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.335 -0.853 . . . . 0.0 110.421 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.9 mmp_? -94.19 10.14 35.09 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.68 -0.638 . . . . 0.0 111.319 177.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.413 ' HB2' HD12 ' A' ' 55' ' ' ILE . 39.9 p-10 -59.47 166.18 2.49 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.243 -0.91 . . . . 0.0 111.418 -170.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.0 m -78.95 164.44 24.42 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.949 -0.47 . . . . 0.0 109.765 174.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -77.56 4.12 12.01 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.616 -0.678 . . . . 0.0 111.268 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -96.81 158.35 15.47 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.174 -0.954 . . . . 0.0 109.632 167.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -70.77 140.15 51.23 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.489 -0.757 . . . . 0.0 110.375 -176.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.413 HD12 ' HB2' ' A' ' 50' ' ' ASP . 81.1 mt -115.28 134.9 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.664 -0.647 . . . . 0.0 109.616 177.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.05 109.92 53.69 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.736 -0.603 . . . . 0.0 110.133 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -66.61 146.54 79.63 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 O-C-N 123.343 1.18 . . . . 0.0 110.379 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -95.59 124.01 39.42 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.667 -0.645 . . . . 0.0 110.232 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.5 p -67.67 -29.35 68.61 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.675 -0.641 . . . . 0.0 110.492 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -62.02 145.93 51.67 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.55 -0.719 . . . . 0.0 110.538 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.91 156.24 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.749 -0.594 . . . . 0.0 109.747 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -93.65 115.14 27.58 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.669 -0.644 . . . . 0.0 110.087 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -51.25 -42.98 61.4 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.767 -0.583 . . . . 0.0 111.697 178.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.515 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.8 t80 -152.73 129.1 10.59 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.624 -0.673 . . . . 0.0 110.244 -174.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.745 HD12 HG11 ' A' ' 41' ' ' VAL . 75.4 mt -128.0 129.24 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.665 -0.647 . . . . 0.0 109.871 172.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.0 tp -90.32 137.04 32.67 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.802 -0.562 . . . . 0.0 109.797 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.614 ' CD1' HD11 ' A' ' 72' ' ' ILE . 2.8 m-85 -135.19 130.33 35.15 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.647 -0.658 . . . . 0.0 110.544 -175.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.1 mtm-85 -91.47 148.26 22.43 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.713 -0.617 . . . . 0.0 110.322 173.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.69 -24.03 59.37 Favored Glycine 0 N--CA 1.498 2.816 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 178.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.0 p -67.82 -42.11 82.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.361 -1.082 . . . . 0.0 111.089 -175.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -82.49 -32.41 28.8 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.398 -0.814 . . . . 0.0 110.894 -175.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.707 HD13 HD21 ' A' ' 14' ' ' LEU . 14.8 mt -99.56 141.48 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.333 -0.854 . . . . 0.0 110.18 176.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -106.15 -24.61 12.3 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 120.554 -0.459 . . . . 0.0 111.447 -166.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -150.8 136.19 17.84 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 119.037 -1.065 . . . . 0.0 111.471 -176.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.49 HD12 ' CD1' ' A' ' 14' ' ' LEU . 18.4 tt -131.83 137.77 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 176.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -143.94 143.33 31.2 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.634 -0.666 . . . . 0.0 110.191 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.4 m -84.87 147.02 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.638 -0.664 . . . . 0.0 110.246 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.5 t . . . . . 0 N--CA 1.497 1.89 0 O-C-N 121.569 -0.707 . . . . 0.0 109.89 -178.97 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 80.6 mt . . . . . 0 N--CA 1.501 2.079 0 CA-C-O 120.999 0.428 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.62 -1.83 84.66 Favored Glycine 0 N--CA 1.497 2.708 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.679 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 58.2 m -60.86 155.5 19.48 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.074 -1.251 . . . . 0.0 110.579 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.19 122.25 27.66 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.805 -0.559 . . . . 0.0 110.366 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 90.3 mt -119.96 144.38 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.515 -0.741 . . . . 0.0 110.114 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.7 t -102.83 137.24 41.3 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 175.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.675 HD21 HD13 ' A' ' 72' ' ' ILE . 14.2 tp -133.33 125.47 29.28 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.789 -0.569 . . . . 0.0 110.183 -169.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.1 mt -106.52 117.97 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.561 -0.712 . . . . 0.0 109.654 -178.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m -93.35 157.74 16.08 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.078 0.466 . . . . 0.0 111.239 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -53.89 -13.95 0.87 Allowed 'General case' 0 N--CA 1.507 2.392 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -171.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.519 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -90.18 20.91 4.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.169 -0.957 . . . . 0.0 110.444 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 54.15 34.42 20.08 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.486 -0.759 . . . . 0.0 109.882 -174.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.834 HG12 HG22 ' A' ' 46' ' ' THR . 66.1 mt -102.86 141.24 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -104.85 119.73 39.71 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.905 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -114.47 148.29 38.04 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 174.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.66 ' O ' HG23 ' A' ' 41' ' ' VAL . 41.0 tt0 -139.05 140.51 38.1 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.573 -0.704 . . . . 0.0 109.592 175.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.54 173.11 43.21 Favored Glycine 0 N--CA 1.496 2.659 0 C-N-CA 119.794 -1.193 . . . . 0.0 110.386 -175.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 -85.95 136.16 33.38 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.814 -0.815 . . . . 0.0 110.604 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.466 ' HA ' HD23 ' A' ' 38' ' ' LEU . 25.3 tp -66.13 119.5 11.55 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.62 -0.675 . . . . 0.0 110.675 176.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.437 ' O ' HG23 ' A' ' 28' ' ' THR . 22.6 t80 -100.11 -50.01 4.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.693 -0.629 . . . . 0.0 110.446 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 27' ' ' TYR . 16.5 p -153.77 154.36 33.88 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.622 -0.674 . . . . 0.0 110.384 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.895 HG23 HG22 ' A' ' 36' ' ' ILE . 13.4 p -142.28 146.1 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.696 -0.627 . . . . 0.0 110.09 -178.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -129.03 101.26 19.76 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.61 -0.681 . . . . 0.0 109.574 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.42 -41.08 35.27 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 O-C-N 123.628 1.33 . . . . 0.0 110.785 -174.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -80.61 -23.98 39.42 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.396 -0.815 . . . . 0.0 110.187 -172.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.73 ' O ' HG23 ' A' ' 35' ' ' THR . 13.3 mm-40 -87.37 0.88 54.8 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.492 -0.755 . . . . 0.0 111.14 173.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.3 m 49.81 38.14 15.02 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.139 -0.976 . . . . 0.0 111.205 -176.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.73 HG23 ' O ' ' A' ' 33' ' ' GLU . 21.5 p -136.68 152.94 50.95 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.352 -0.842 . . . . 0.0 110.405 -174.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.895 HG22 HG23 ' A' ' 29' ' ' VAL . 39.8 pt -142.75 162.02 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.714 -0.616 . . . . 0.0 110.164 178.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.519 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.22 128.34 29.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.593 -0.692 . . . . 0.0 109.786 175.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 26' ' ' LEU . 86.7 mt -109.96 148.13 32.18 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 95.1 p -120.26 152.8 37.26 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.628 -0.67 . . . . 0.0 109.214 -177.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 53.0 p 44.94 87.34 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 CA-C-O 121.392 0.615 . . . . 0.0 110.385 -172.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.742 HG11 HD12 ' A' ' 65' ' ' ILE . 11.2 p -134.59 145.18 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 CA-C-O 121.155 0.503 . . . . 0.0 110.005 -177.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.837 ' HG2' HD12 ' A' ' 61' ' ' ILE . 90.8 mtt180 -120.46 153.11 37.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.688 -0.633 . . . . 0.0 109.755 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 86.3 p -111.27 133.44 53.6 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.629 -0.669 . . . . 0.0 109.856 177.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -83.05 -38.49 22.48 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.052 -173.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.53 171.98 34.14 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.993 -1.099 . . . . 0.0 110.445 177.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.834 HG22 HG12 ' A' ' 20' ' ' ILE . 2.2 p -117.97 6.48 12.18 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.797 -0.826 . . . . 0.0 110.915 173.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -51.06 -24.1 3.61 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.507 -0.746 . . . . 0.0 112.795 -167.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.08 -59.44 4.13 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.193 -0.942 . . . . 0.0 110.706 -176.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -94.5 10.21 35.49 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.575 -0.703 . . . . 0.0 111.444 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.559 ' HB2' HD12 ' A' ' 55' ' ' ILE . 40.2 p-10 -58.76 174.04 0.37 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.189 -0.944 . . . . 0.0 111.419 -170.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.0 m -78.92 164.48 24.4 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.957 -0.464 . . . . 0.0 109.774 175.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -77.5 4.71 10.48 Favored 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.277 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -95.98 166.07 11.95 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.176 -0.952 . . . . 0.0 109.622 168.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -80.6 133.19 35.72 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.594 -0.691 . . . . 0.0 110.399 -175.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.559 HD12 ' HB2' ' A' ' 50' ' ' ASP . 78.6 mt -113.9 135.35 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.625 -0.672 . . . . 0.0 109.54 177.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.88 146.11 38.09 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.642 -0.661 . . . . 0.0 110.138 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -68.78 149.37 72.86 Favored 'Trans proline' 0 N--CA 1.487 1.104 0 O-C-N 123.55 1.289 . . . . 0.0 110.307 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -92.71 107.4 19.19 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.631 -0.668 . . . . 0.0 110.074 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.9 m -68.01 -35.72 78.77 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.699 -0.625 . . . . 0.0 110.345 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -60.99 133.47 56.13 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.658 -0.651 . . . . 0.0 110.809 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.837 HD12 ' HG2' ' A' ' 42' ' ' ARG . 45.7 mm -96.97 153.73 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.659 -0.651 . . . . 0.0 109.606 178.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -96.76 112.47 24.21 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.598 -0.689 . . . . 0.0 110.446 -175.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -51.67 -41.02 61.09 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.678 -0.639 . . . . 0.0 111.496 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.519 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.7 t80 -153.02 130.31 11.28 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.604 -0.685 . . . . 0.0 110.124 -175.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.742 HD12 HG11 ' A' ' 41' ' ' VAL . 77.4 mt -127.96 128.34 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.644 -0.66 . . . . 0.0 109.804 172.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.2 tp -90.29 137.04 32.67 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.867 -0.52 . . . . 0.0 109.753 175.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.551 ' CD1' HD11 ' A' ' 72' ' ' ILE . 3.0 m-85 -137.03 130.54 31.54 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.663 -0.648 . . . . 0.0 110.6 -174.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -91.57 147.81 22.74 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.705 -0.622 . . . . 0.0 110.301 173.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.11 -26.8 61.66 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.4 m -65.56 -39.39 91.62 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.453 -1.028 . . . . 0.0 110.944 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.69 -32.54 31.67 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.445 -0.785 . . . . 0.0 110.807 -174.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.675 HD13 HD21 ' A' ' 14' ' ' LEU . 8.1 mt -102.97 140.23 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.422 -0.799 . . . . 0.0 110.157 177.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -106.34 -19.7 13.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.961 -0.462 . . . . 0.0 111.647 -167.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -150.41 133.61 16.25 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 119.008 -1.077 . . . . 0.0 111.379 -178.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.525 HD12 ' CD1' ' A' ' 14' ' ' LEU . 17.3 tt -132.44 138.77 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.931 -0.48 . . . . 0.0 109.799 176.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.1 mtm180 -147.07 145.95 29.81 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.598 -0.688 . . . . 0.0 110.422 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.8 m -84.83 147.1 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.664 -0.647 . . . . 0.0 110.328 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.499 1.996 0 O-C-N 121.559 -0.713 . . . . 0.0 110.172 -178.358 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.0 mt . . . . . 0 N--CA 1.501 2.114 0 CA-C-O 120.993 0.425 . . . . 0.0 110.602 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.72 -1.94 84.58 Favored Glycine 0 N--CA 1.496 2.659 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.793 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 74.1 m -61.13 148.1 41.74 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.097 -1.237 . . . . 0.0 110.46 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -81.59 125.18 30.22 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.716 -0.615 . . . . 0.0 110.536 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.61 ' CD1' HD13 ' A' ' 26' ' ' LEU . 90.0 mt -120.91 145.05 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.555 -0.716 . . . . 0.0 110.014 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.6 t -102.93 137.19 41.45 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.778 HD21 HD13 ' A' ' 72' ' ' ILE . 13.5 tp -133.12 124.86 28.32 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.875 -0.515 . . . . 0.0 110.211 -169.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.3 mt -105.75 118.49 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.633 -0.667 . . . . 0.0 109.661 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.1 m -93.1 157.8 16.1 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.112 0.482 . . . . 0.0 111.235 -176.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -53.8 -14.2 0.89 Allowed 'General case' 0 N--CA 1.51 2.525 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -171.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.516 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.63 20.08 4.23 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.207 -0.933 . . . . 0.0 110.412 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 54.38 35.07 22.18 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.448 -0.782 . . . . 0.0 109.817 -175.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.838 HG12 HG22 ' A' ' 46' ' ' THR . 65.2 mt -103.23 144.27 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 59.5 ttm-85 -105.06 119.87 40.09 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.073 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -114.2 150.12 34.75 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 174.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.647 ' O ' HG23 ' A' ' 41' ' ' VAL . 41.8 tt0 -141.48 140.52 33.55 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.484 -0.76 . . . . 0.0 109.648 175.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -169.28 172.86 43.6 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 119.607 -1.282 . . . . 0.0 110.575 -175.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -85.23 136.28 33.58 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.878 -0.778 . . . . 0.0 110.609 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.61 HD13 ' CD1' ' A' ' 12' ' ' ILE . 15.0 tp -66.3 119.53 11.71 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.634 -0.666 . . . . 0.0 110.694 175.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.453 ' O ' HG23 ' A' ' 28' ' ' THR . 26.2 t80 -100.13 -50.18 4.05 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.549 -0.719 . . . . 0.0 110.419 178.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 27' ' ' TYR . 13.5 p -154.4 156.01 36.04 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.636 -0.665 . . . . 0.0 110.283 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.874 HG23 HG22 ' A' ' 36' ' ' ILE . 13.6 p -142.26 145.63 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.612 -0.68 . . . . 0.0 110.068 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -127.5 98.74 28.24 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.627 -0.671 . . . . 0.0 109.565 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -59.38 -42.05 52.58 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 O-C-N 123.597 1.314 . . . . 0.0 111.044 -175.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -80.74 -24.59 38.6 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.372 -0.83 . . . . 0.0 110.169 -171.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.57 ' O ' HG23 ' A' ' 35' ' ' THR . 74.8 mm-40 -87.12 1.15 53.9 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.509 -0.745 . . . . 0.0 111.245 173.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.4 m 49.82 37.91 14.53 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.122 -0.986 . . . . 0.0 111.203 -176.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 33' ' ' GLU . 9.9 p -136.13 154.38 51.0 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.405 -0.809 . . . . 0.0 110.368 -174.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.874 HG22 HG23 ' A' ' 29' ' ' VAL . 39.9 pt -142.51 162.09 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.706 -0.621 . . . . 0.0 110.166 178.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.516 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.54 128.07 28.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.698 -0.627 . . . . 0.0 109.752 175.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.477 HD23 ' HA ' ' A' ' 26' ' ' LEU . 90.6 mt -109.92 148.95 30.63 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -177.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 96.6 p -119.65 152.18 37.52 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.6 p 45.58 83.46 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.226 0 CA-C-O 121.54 0.686 . . . . 0.0 110.382 -172.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.702 ' CG1' HD12 ' A' ' 65' ' ' ILE . 14.9 p -134.59 150.48 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -136.07 153.21 51.4 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.598 -0.689 . . . . 0.0 110.063 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 81.7 p -107.25 137.52 45.15 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.74 -0.6 . . . . 0.0 109.56 177.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -82.76 -38.47 23.18 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.92 -172.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.38 167.37 27.96 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 175.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.838 HG22 HG12 ' A' ' 20' ' ' ILE . 38.3 p -118.28 6.24 11.92 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.807 -0.819 . . . . 0.0 110.913 172.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -52.71 -26.22 13.36 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.49 -0.756 . . . . 0.0 112.095 -167.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -66.22 -59.16 4.0 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.393 -0.817 . . . . 0.0 110.273 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -94.28 10.18 35.15 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.736 -0.602 . . . . 0.0 111.342 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 52.9 p-10 -57.68 174.06 0.26 Allowed 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.29 -0.881 . . . . 0.0 111.499 -171.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.5 m -79.0 164.55 24.29 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -77.44 3.24 13.84 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.584 -0.698 . . . . 0.0 111.227 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -100.46 165.99 11.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.225 -0.922 . . . . 0.0 109.567 169.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -66.98 136.83 55.93 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.579 -0.7 . . . . 0.0 110.515 -175.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.2 mm -113.52 137.26 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.679 -0.638 . . . . 0.0 109.604 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -96.83 109.94 51.13 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.664 -0.648 . . . . 0.0 110.21 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -67.49 145.06 69.48 Favored 'Trans proline' 0 N--CA 1.488 1.16 0 O-C-N 123.395 1.208 . . . . 0.0 110.288 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -97.36 114.42 26.22 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.648 -0.657 . . . . 0.0 110.265 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 87.3 p -77.51 -29.18 52.34 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.655 -0.653 . . . . 0.0 110.478 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -62.13 151.24 36.31 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.601 -0.687 . . . . 0.0 110.669 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.5 mm -96.75 144.92 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.751 -0.593 . . . . 0.0 109.747 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -94.32 114.59 26.68 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.56 -0.712 . . . . 0.0 110.218 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -50.95 -40.51 57.64 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.824 -0.547 . . . . 0.0 111.812 178.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.516 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.8 t80 -152.57 130.12 11.47 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.714 -0.616 . . . . 0.0 110.289 -174.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.702 HD12 ' CG1' ' A' ' 41' ' ' VAL . 76.3 mt -130.09 129.53 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.641 -0.662 . . . . 0.0 109.793 172.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.2 tp -90.27 137.02 32.69 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.814 -0.554 . . . . 0.0 109.864 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.592 ' CD1' HD11 ' A' ' 72' ' ' ILE . 2.5 m-85 -135.17 129.28 33.56 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.658 -0.651 . . . . 0.0 110.562 -175.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 71.2 mtp85 -91.26 146.77 23.54 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.703 -0.623 . . . . 0.0 110.249 173.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.8 -26.52 60.49 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 110.539 -1.025 . . . . 0.0 110.539 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.2 m -65.84 -39.4 90.76 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.527 -0.984 . . . . 0.0 110.953 -177.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.67 -31.71 32.12 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.533 -0.73 . . . . 0.0 110.824 -174.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.778 HD13 HD21 ' A' ' 14' ' ' LEU . 7.9 mt -102.32 142.42 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.443 -0.786 . . . . 0.0 110.191 177.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -104.46 -23.67 13.13 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.378 -167.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -151.99 135.34 15.98 Favored 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 119.146 -1.022 . . . . 0.0 111.446 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.538 HD12 ' CD1' ' A' ' 14' ' ' LEU . 17.6 tt -131.81 140.8 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.906 -0.496 . . . . 0.0 109.775 176.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -146.91 141.56 26.66 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.519 -0.738 . . . . 0.0 110.349 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.5 t -86.85 145.75 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.679 -0.638 . . . . 0.0 109.711 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.3 t . . . . . 0 N--CA 1.497 1.904 0 O-C-N 121.583 -0.698 . . . . 0.0 109.758 -178.676 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.1 mt . . . . . 0 N--CA 1.5 2.068 0 CA-C-O 120.972 0.415 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.68 -1.92 84.55 Favored Glycine 0 N--CA 1.497 2.753 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.788 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 63.8 m -62.0 155.27 24.26 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.168 -1.195 . . . . 0.0 110.4 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.547 ' HE3' HG11 ' A' ' 78' ' ' VAL . 35.8 pttt -81.21 127.98 33.28 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 120.191 -0.604 . . . . 0.0 110.384 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.686 ' CD1' HD13 ' A' ' 26' ' ' LEU . 87.7 mt -121.62 142.95 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.563 -0.711 . . . . 0.0 110.03 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.0 t -102.99 137.29 41.38 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 175.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.885 HD21 HD13 ' A' ' 72' ' ' ILE . 13.9 tp -134.33 123.88 24.9 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.736 -0.602 . . . . 0.0 110.164 -169.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.5 mt -106.33 118.16 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.574 -0.704 . . . . 0.0 109.609 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 62.3 m -92.47 157.81 16.37 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 120.963 0.411 . . . . 0.0 111.245 -176.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -53.56 -13.98 0.75 Allowed 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 -172.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.571 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.96 20.58 4.13 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.115 -0.991 . . . . 0.0 110.412 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 53.43 34.37 18.02 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.395 -0.816 . . . . 0.0 109.813 -174.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.778 HG12 HG22 ' A' ' 46' ' ' THR . 73.1 mt -101.24 141.99 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -104.68 119.86 39.98 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.958 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -115.0 149.28 37.67 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 174.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.664 ' O ' HG23 ' A' ' 41' ' ' VAL . 71.2 mt-10 -140.95 140.52 34.44 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.377 -0.827 . . . . 0.0 109.706 174.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.35 172.17 41.56 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 119.814 -1.184 . . . . 0.0 110.559 -175.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -84.7 139.41 32.03 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.933 -0.745 . . . . 0.0 110.611 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.686 HD13 ' CD1' ' A' ' 12' ' ' ILE . 16.0 tp -66.11 117.9 9.09 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.718 -0.614 . . . . 0.0 110.7 175.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.446 ' O ' HG23 ' A' ' 28' ' ' THR . 21.8 t80 -100.11 -50.06 4.1 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.561 -0.712 . . . . 0.0 110.333 177.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 27' ' ' TYR . 16.9 p -153.81 156.05 36.94 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.684 -0.635 . . . . 0.0 110.271 -178.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.593 HG23 HG22 ' A' ' 36' ' ' ILE . 10.5 p -142.24 145.28 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.74 -0.6 . . . . 0.0 110.18 -178.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -129.03 101.88 19.38 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.675 -0.641 . . . . 0.0 109.434 176.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.83 -41.78 28.35 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 O-C-N 123.562 1.296 . . . . 0.0 110.919 -173.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -80.66 -24.97 38.57 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.332 -0.855 . . . . 0.0 110.227 -170.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.756 ' O ' HG23 ' A' ' 35' ' ' THR . 56.7 mt-10 -87.79 1.75 53.07 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.484 -0.76 . . . . 0.0 111.293 173.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 40.3 m 49.87 41.1 22.14 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.125 -0.984 . . . . 0.0 111.218 -176.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.756 HG23 ' O ' ' A' ' 33' ' ' GLU . 23.5 p -135.5 153.45 51.73 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.327 -0.858 . . . . 0.0 110.53 -174.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.593 HG22 HG23 ' A' ' 29' ' ' VAL . 40.4 pt -141.74 162.0 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.66 -0.65 . . . . 0.0 110.117 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.509 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.01 127.87 29.31 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.719 -0.613 . . . . 0.0 109.669 175.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 26' ' ' LEU . 51.5 mt -109.87 145.07 37.44 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 99.2 p -116.47 151.82 35.3 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.8 p 45.92 85.47 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 121.5 0.667 . . . . 0.0 110.356 -171.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.687 HG11 HD12 ' A' ' 65' ' ' ILE . 12.9 p -134.65 149.1 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -131.68 153.01 50.44 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.623 -0.673 . . . . 0.0 109.891 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 96.9 p -112.01 140.64 46.52 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.741 -0.599 . . . . 0.0 109.891 177.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -83.06 -38.5 22.44 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.613 -0.679 . . . . 0.0 111.175 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.58 171.91 34.1 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.993 -1.098 . . . . 0.0 110.417 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.778 HG22 HG12 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -118.16 6.5 12.02 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.829 -0.807 . . . . 0.0 110.884 173.56 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -50.3 -25.53 3.85 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.508 -0.745 . . . . 0.0 112.446 -168.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -66.06 -59.26 3.97 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.365 -0.834 . . . . 0.0 110.382 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -94.31 10.19 35.16 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.618 -0.676 . . . . 0.0 111.391 177.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 50.5 p-10 -58.15 171.98 0.49 Allowed 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.212 -0.93 . . . . 0.0 111.362 -171.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.7 m -78.98 164.41 24.41 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.908 -0.495 . . . . 0.0 109.873 176.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -77.6 4.22 11.88 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.662 -0.649 . . . . 0.0 111.198 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -95.54 164.75 12.66 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.25 -0.906 . . . . 0.0 109.608 167.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -68.55 135.38 51.44 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.507 -0.746 . . . . 0.0 110.453 -176.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.6 mm -114.17 134.39 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.734 -0.604 . . . . 0.0 109.615 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -96.22 109.88 49.49 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.703 -0.623 . . . . 0.0 110.181 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -67.33 135.02 35.34 Favored 'Trans proline' 0 N--CA 1.488 1.154 0 O-C-N 123.414 1.218 . . . . 0.0 110.308 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 18.8 mp0 -111.63 135.07 52.71 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.671 -0.643 . . . . 0.0 110.168 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 83.1 p -91.48 6.87 43.87 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.655 -0.653 . . . . 0.0 111.2 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -63.1 141.04 58.91 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.217 -0.927 . . . . 0.0 110.438 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.8 mm -96.86 137.7 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.655 -0.653 . . . . 0.0 109.844 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -94.14 119.03 32.39 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.715 -0.616 . . . . 0.0 110.177 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -51.35 -42.61 61.43 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.789 -0.569 . . . . 0.0 111.745 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.509 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.1 t80 -152.27 130.3 11.84 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.587 -0.695 . . . . 0.0 110.293 -174.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.687 HD12 HG11 ' A' ' 41' ' ' VAL . 75.2 mt -130.26 130.3 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.728 -0.608 . . . . 0.0 109.877 171.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 19.0 tp -90.25 137.01 32.69 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.823 -0.548 . . . . 0.0 109.934 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.647 ' CD1' HD11 ' A' ' 72' ' ' ILE . 2.3 m-85 -133.4 127.09 32.68 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.627 -0.67 . . . . 0.0 110.477 -176.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -92.12 145.98 24.08 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.592 -0.692 . . . . 0.0 110.31 173.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.88 -26.67 60.92 Favored Glycine 0 N--CA 1.499 2.843 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.2 m -65.02 -39.94 94.14 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.408 -1.054 . . . . 0.0 110.977 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.77 -32.24 31.51 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.445 -0.784 . . . . 0.0 110.826 -175.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.885 HD13 HD21 ' A' ' 14' ' ' LEU . 6.6 mt -99.34 141.75 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.53 -0.731 . . . . 0.0 110.264 177.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -104.35 -20.78 13.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.938 -0.476 . . . . 0.0 111.377 -169.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -151.79 131.95 13.56 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.238 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.536 HD12 ' CD1' ' A' ' 14' ' ' LEU . 17.1 tt -130.91 140.48 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.872 -0.517 . . . . 0.0 109.737 176.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -146.47 130.28 17.12 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.62 -0.675 . . . . 0.0 110.306 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.5 p -87.74 146.29 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.613 -0.679 . . . . 0.0 110.27 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.547 HG11 ' HE3' ' A' ' 11' ' ' LYS . 61.6 t . . . . . 0 N--CA 1.497 1.882 0 O-C-N 121.572 -0.705 . . . . 0.0 109.738 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 N--CA 1.501 2.114 0 CA-C-O 120.945 0.402 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.68 -1.92 84.53 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.841 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.6 m -61.72 142.22 57.37 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.113 -1.228 . . . . 0.0 110.457 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -82.36 123.38 29.04 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.748 -0.595 . . . . 0.0 110.559 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.621 ' CD1' HD13 ' A' ' 26' ' ' LEU . 91.0 mt -120.25 144.18 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.472 -0.768 . . . . 0.0 110.199 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.4 t -103.11 137.27 41.5 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 174.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.475 ' CD1' HD12 ' A' ' 75' ' ' ILE . 13.1 tp -133.49 127.84 34.11 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.712 -0.618 . . . . 0.0 110.339 -169.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.0 mt -107.59 119.98 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.593 -0.692 . . . . 0.0 109.738 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.3 m -94.35 157.81 15.86 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.049 0.452 . . . . 0.0 111.248 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.0 tptp -53.51 -15.18 1.0 Allowed 'General case' 0 N--CA 1.509 2.5 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -172.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.534 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.75 21.32 3.59 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.13 -0.982 . . . . 0.0 110.436 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 54.16 33.98 19.14 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.44 -0.788 . . . . 0.0 109.795 -174.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.804 HG12 HG22 ' A' ' 46' ' ' THR . 69.2 mt -101.81 142.72 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 36.7 ttp85 -105.19 119.8 39.94 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.941 -0.704 . . . . 0.0 109.887 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -113.79 149.24 35.21 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.662 ' O ' HG23 ' A' ' 41' ' ' VAL . 42.6 tt0 -140.61 140.53 35.09 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.546 -0.721 . . . . 0.0 109.696 176.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -169.13 173.24 43.57 Favored Glycine 0 N--CA 1.495 2.603 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.463 -175.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -85.11 136.44 33.55 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.881 -0.776 . . . . 0.0 110.495 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.621 HD13 ' CD1' ' A' ' 12' ' ' ILE . 15.3 tp -66.12 119.04 10.74 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.57 -0.706 . . . . 0.0 110.693 175.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.448 ' O ' HG23 ' A' ' 28' ' ' THR . 25.9 t80 -99.4 -50.09 4.22 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.666 -0.646 . . . . 0.0 110.292 178.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 27' ' ' TYR . 15.2 p -153.9 153.29 31.79 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.78 -0.575 . . . . 0.0 110.255 -178.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.882 HG23 HG22 ' A' ' 36' ' ' ILE . 13.5 p -142.31 144.86 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.643 -0.661 . . . . 0.0 110.102 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -128.99 101.53 19.68 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.531 -0.73 . . . . 0.0 109.528 177.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.68 -40.25 38.33 Favored 'Trans proline' 0 N--CA 1.489 1.243 0 O-C-N 123.515 1.271 . . . . 0.0 110.719 -175.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -80.68 -25.18 38.39 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.306 -0.871 . . . . 0.0 110.174 -171.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.723 ' O ' HG23 ' A' ' 35' ' ' THR . 79.2 mt-10 -87.44 1.46 53.36 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.516 -0.74 . . . . 0.0 111.256 173.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.0 m 49.84 39.51 18.38 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.105 -0.997 . . . . 0.0 111.284 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.723 HG23 ' O ' ' A' ' 33' ' ' GLU . 22.7 p -136.65 151.98 49.9 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.365 -0.834 . . . . 0.0 110.368 -175.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.882 HG22 HG23 ' A' ' 29' ' ' VAL . 39.7 pt -142.6 161.47 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.695 -0.628 . . . . 0.0 110.179 177.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.508 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.86 127.91 27.75 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.628 -0.67 . . . . 0.0 109.678 175.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 26' ' ' LEU . 85.6 mt -109.87 146.98 34.19 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -177.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 96.7 p -118.7 153.06 34.99 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -177.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.7 p 45.75 85.9 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 121.452 0.644 . . . . 0.0 110.318 -172.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.783 HG11 HD12 ' A' ' 65' ' ' ILE . 13.3 p -134.51 148.61 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.952 -0.468 . . . . 0.0 109.909 -177.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -126.41 153.12 45.43 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.699 -0.626 . . . . 0.0 109.829 177.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 96.6 p -108.24 134.93 50.39 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.703 -0.623 . . . . 0.0 109.726 175.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -83.01 -38.37 22.7 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.57 -0.706 . . . . 0.0 111.045 -173.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.61 169.29 30.96 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 120.027 -1.083 . . . . 0.0 110.602 176.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.804 HG22 HG12 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -118.19 6.58 12.0 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.97 -0.724 . . . . 0.0 110.837 174.309 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -49.16 -25.64 2.32 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.6 -0.688 . . . . 0.0 112.62 -168.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -65.04 -59.22 4.37 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.321 -0.862 . . . . 0.0 110.587 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -94.31 10.14 35.35 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.569 -0.707 . . . . 0.0 111.381 177.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.46 ' HB2' HD12 ' A' ' 55' ' ' ILE . 39.9 p-10 -59.44 165.86 2.61 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.251 -0.906 . . . . 0.0 111.438 -170.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.3 m -78.98 164.46 24.38 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.925 -0.484 . . . . 0.0 109.748 174.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -77.55 4.22 11.76 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.607 -0.683 . . . . 0.0 111.263 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -96.78 155.32 16.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.156 -0.965 . . . . 0.0 109.623 167.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -68.77 139.8 55.31 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.649 -0.657 . . . . 0.0 110.387 -175.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.46 HD12 ' HB2' ' A' ' 50' ' ' ASP . 81.5 mt -116.38 138.41 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.674 -0.641 . . . . 0.0 109.612 177.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -97.98 109.98 53.81 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.733 -0.605 . . . . 0.0 110.223 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -66.14 149.64 85.51 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 O-C-N 123.357 1.188 . . . . 0.0 110.335 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -93.22 112.64 24.64 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.667 -0.646 . . . . 0.0 110.301 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.7 t -67.18 -29.4 69.07 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.668 -0.645 . . . . 0.0 110.463 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -60.98 159.29 11.73 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.544 -0.723 . . . . 0.0 110.759 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.81 146.72 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.843 -0.536 . . . . 0.0 109.748 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -91.72 111.85 23.54 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.659 -0.651 . . . . 0.0 109.894 176.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -52.35 -43.21 64.5 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.786 -0.571 . . . . 0.0 111.707 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.508 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.7 t80 -154.55 130.28 10.02 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.742 -0.599 . . . . 0.0 110.264 -174.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.783 HD12 HG11 ' A' ' 41' ' ' VAL . 82.9 mt -129.07 127.44 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.663 -0.648 . . . . 0.0 109.989 171.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 24.0 tp -90.79 137.03 32.68 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.867 -0.521 . . . . 0.0 109.859 175.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.515 ' CZ ' HG21 ' A' ' 65' ' ' ILE . 4.5 m-85 -136.95 131.59 33.22 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.685 -0.634 . . . . 0.0 110.65 -175.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -91.78 151.57 20.55 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.736 -0.602 . . . . 0.0 110.452 174.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.96 -23.98 59.94 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.2 p -67.52 -41.99 83.51 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.45 -1.03 . . . . 0.0 111.032 -176.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -83.13 -32.87 26.45 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.354 -0.842 . . . . 0.0 110.914 -175.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.44 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 22.2 mt -105.94 136.25 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.459 -0.775 . . . . 0.0 110.013 177.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 59.4 tttt -109.1 -14.34 14.54 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 120.417 -0.513 . . . . 0.0 112.008 -165.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -147.88 131.41 16.75 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 118.901 -1.12 . . . . 0.0 111.433 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.475 HD12 ' CD1' ' A' ' 14' ' ' LEU . 15.8 tt -132.38 137.48 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.936 -0.478 . . . . 0.0 109.77 176.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.0 mtm180 -147.04 147.1 30.31 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.606 -0.684 . . . . 0.0 110.387 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.9 t -85.96 145.04 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.679 -0.638 . . . . 0.0 109.601 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.2 t . . . . . 0 N--CA 1.497 1.922 0 O-C-N 121.601 -0.687 . . . . 0.0 109.898 -177.194 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.5 mt . . . . . 0 N--CA 1.502 2.133 0 CA-C-O 120.999 0.428 . . . . 0.0 110.71 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.65 -1.97 84.29 Favored Glycine 0 N--CA 1.497 2.713 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.837 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.9 m -62.06 148.21 44.85 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.125 -1.221 . . . . 0.0 110.49 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -81.87 124.53 29.79 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.662 -0.649 . . . . 0.0 110.401 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.609 ' CD1' HD13 ' A' ' 26' ' ' LEU . 88.8 mt -120.64 144.54 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.565 -0.71 . . . . 0.0 110.122 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.6 t -102.91 137.33 41.25 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.766 HD21 HD13 ' A' ' 72' ' ' ILE . 13.6 tp -132.79 125.64 30.55 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.711 -0.618 . . . . 0.0 110.219 -169.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.0 mt -106.94 118.6 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.447 -0.783 . . . . 0.0 109.661 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.9 m -93.77 157.65 16.05 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 120.997 0.427 . . . . 0.0 111.3 -177.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -55.68 -11.17 0.85 Allowed 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -172.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.72 18.48 4.67 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.196 -0.94 . . . . 0.0 110.439 176.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 55.64 36.06 26.46 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.442 -0.786 . . . . 0.0 109.918 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.812 HG12 HG22 ' A' ' 46' ' ' THR . 57.6 mt -106.96 145.0 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -105.62 119.81 40.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.618 -0.676 . . . . 0.0 110.123 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -113.81 152.12 31.09 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.659 ' O ' HG23 ' A' ' 41' ' ' VAL . 46.4 tt0 -142.27 140.57 32.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.429 -0.795 . . . . 0.0 109.672 175.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.87 172.21 42.55 Favored Glycine 0 N--CA 1.496 2.634 0 C-N-CA 119.713 -1.232 . . . . 0.0 110.558 -175.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -85.08 136.16 33.68 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.864 -0.786 . . . . 0.0 110.517 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.609 HD13 ' CD1' ' A' ' 12' ' ' ILE . 15.1 tp -66.16 117.8 8.98 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.623 -0.673 . . . . 0.0 110.664 175.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.454 ' O ' HG23 ' A' ' 28' ' ' THR . 25.9 t80 -99.95 -50.1 4.11 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.657 -0.652 . . . . 0.0 110.455 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 27' ' ' TYR . 14.1 p -154.35 156.06 36.2 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.736 -0.603 . . . . 0.0 110.348 -178.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.828 HG23 HG22 ' A' ' 36' ' ' ILE . 13.3 p -142.31 146.25 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.771 -0.58 . . . . 0.0 110.007 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -128.48 100.8 21.97 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.582 -0.699 . . . . 0.0 109.536 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.59 -40.16 39.67 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 O-C-N 123.558 1.294 . . . . 0.0 110.71 -174.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -80.63 -25.27 38.47 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.365 -0.834 . . . . 0.0 110.202 -171.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.566 ' O ' HG23 ' A' ' 35' ' ' THR . 78.7 mt-10 -87.47 1.3 53.85 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.498 -0.751 . . . . 0.0 111.258 173.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 45.2 m 49.6 39.19 16.66 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.089 -1.007 . . . . 0.0 111.303 -176.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 33' ' ' GLU . 10.0 p -136.07 155.35 50.34 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.393 -0.817 . . . . 0.0 110.315 -174.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.828 HG22 HG23 ' A' ' 29' ' ' VAL . 39.8 pt -142.27 162.03 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.616 -0.677 . . . . 0.0 110.17 177.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.525 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.4 127.68 28.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.669 -0.644 . . . . 0.0 109.692 175.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' A' ' 26' ' ' LEU . 87.2 mt -109.87 147.12 33.94 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -178.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 96.8 p -118.22 152.43 35.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.674 -0.642 . . . . 0.0 109.27 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.3 p 45.5 84.79 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 CA-C-O 121.476 0.655 . . . . 0.0 110.358 -172.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.664 HG11 HD12 ' A' ' 65' ' ' ILE . 13.7 p -134.54 149.02 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.905 -0.497 . . . . 0.0 109.853 -178.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.4 ttm180 -131.71 153.05 50.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.68 -0.637 . . . . 0.0 109.799 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 85.1 p -107.93 133.89 51.63 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.741 -0.599 . . . . 0.0 109.476 175.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -82.68 -38.63 23.15 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.039 -171.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.23 167.08 27.38 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 175.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.812 HG22 HG12 ' A' ' 20' ' ' ILE . 53.0 p -118.23 -11.2 10.13 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.963 -0.728 . . . . 0.0 110.83 170.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -52.74 -24.99 9.81 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.462 -0.774 . . . . 0.0 112.492 -166.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -79.12 -59.3 2.83 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.261 -0.899 . . . . 0.0 110.894 -176.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -94.42 9.93 36.41 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.596 -0.69 . . . . 0.0 112.006 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -90.16 174.56 7.55 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.085 -1.009 . . . . 0.0 111.126 -175.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.0 m -78.43 164.66 24.58 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 122.016 -0.428 . . . . 0.0 109.854 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -77.45 12.07 1.72 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.726 -0.609 . . . . 0.0 111.616 -173.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -92.49 140.54 29.46 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.241 -0.912 . . . . 0.0 109.62 169.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -65.97 141.03 58.34 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.713 -0.617 . . . . 0.0 110.919 -170.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 82.5 mt -118.83 138.81 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.731 -0.606 . . . . 0.0 109.399 176.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.62 113.43 14.23 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.617 -0.677 . . . . 0.0 110.125 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -64.18 142.65 81.15 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 O-C-N 123.305 1.161 . . . . 0.0 110.465 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -104.02 107.11 17.85 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.713 -0.617 . . . . 0.0 110.27 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.6 p -93.4 -32.72 14.13 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.685 -0.634 . . . . 0.0 110.327 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -62.8 152.64 35.4 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.619 -0.675 . . . . 0.0 110.655 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.4 mm -96.8 141.08 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.705 -0.622 . . . . 0.0 109.592 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -96.36 113.16 24.72 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.64 -0.663 . . . . 0.0 110.37 -177.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -51.19 -39.93 57.55 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.738 -0.601 . . . . 0.0 111.416 175.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.525 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.7 t80 -152.73 129.19 10.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.627 -0.671 . . . . 0.0 110.201 -175.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.664 HD12 HG11 ' A' ' 41' ' ' VAL . 72.6 mt -127.55 129.14 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.566 -0.709 . . . . 0.0 109.798 172.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.9 tp -90.18 137.05 32.67 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.859 -0.526 . . . . 0.0 109.808 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.589 ' CD1' HD11 ' A' ' 72' ' ' ILE . 2.6 m-85 -135.56 129.21 32.62 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.751 -0.593 . . . . 0.0 110.559 -175.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -91.07 146.62 23.69 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.715 -0.615 . . . . 0.0 110.176 173.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.58 -25.86 58.94 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.1 p -67.75 -37.61 82.38 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.459 -1.024 . . . . 0.0 110.875 -177.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -82.46 -30.5 29.94 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.454 -0.779 . . . . 0.0 110.934 -175.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.766 HD13 HD21 ' A' ' 14' ' ' LEU . 8.6 mt -103.95 142.87 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.426 -0.796 . . . . 0.0 110.278 176.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -104.63 -24.73 12.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.932 -0.48 . . . . 0.0 111.381 -167.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -151.88 136.24 16.79 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.048 -1.033 . . . . 0.0 111.465 -177.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.53 HD12 ' CD1' ' A' ' 14' ' ' LEU . 17.7 tt -131.79 140.51 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.963 -0.461 . . . . 0.0 109.828 176.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -146.87 140.77 25.96 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.544 -0.723 . . . . 0.0 110.335 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.0 p -86.04 147.05 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.669 -0.644 . . . . 0.0 110.107 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.0 t . . . . . 0 N--CA 1.497 1.907 0 O-C-N 121.578 -0.701 . . . . 0.0 109.868 -178.79 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.6 mt . . . . . 0 N--CA 1.501 2.087 0 CA-C-O 121.001 0.429 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.57 -1.9 84.31 Favored Glycine 0 N--CA 1.496 2.663 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.85 176.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.4 m -62.71 138.94 58.63 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.126 -1.22 . . . . 0.0 110.355 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -82.13 126.98 32.67 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.624 -0.673 . . . . 0.0 110.415 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.679 ' CD1' HD13 ' A' ' 26' ' ' LEU . 86.5 mt -120.97 143.36 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.614 -0.679 . . . . 0.0 110.142 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.0 t -103.18 137.32 41.49 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.762 HD21 HD13 ' A' ' 72' ' ' ILE . 14.0 tp -134.8 125.9 27.8 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.687 -0.633 . . . . 0.0 110.337 -168.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.3 mt -106.85 118.11 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.614 -0.679 . . . . 0.0 109.665 -178.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.6 m -92.86 157.89 16.14 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 120.97 0.414 . . . . 0.0 111.303 -176.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -53.75 -14.43 0.93 Allowed 'General case' 0 N--CA 1.508 2.453 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -171.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.14 20.22 3.82 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.169 -0.957 . . . . 0.0 110.519 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 56.03 36.08 26.72 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.463 -0.773 . . . . 0.0 109.916 -177.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.788 HG12 HG22 ' A' ' 46' ' ' THR . 53.6 mt -107.05 146.58 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -105.39 119.81 40.03 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.13 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -113.41 152.39 30.11 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.656 ' O ' HG23 ' A' ' 41' ' ' VAL . 42.6 tt0 -142.36 140.45 32.08 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.491 -0.756 . . . . 0.0 109.583 175.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.95 171.41 41.77 Favored Glycine 0 N--CA 1.496 2.66 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.602 -175.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -85.45 137.27 33.02 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.836 -0.803 . . . . 0.0 110.607 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.679 HD13 ' CD1' ' A' ' 12' ' ' ILE . 16.2 tp -66.2 118.81 10.45 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.648 -0.657 . . . . 0.0 110.723 175.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.416 ' O ' HG23 ' A' ' 28' ' ' THR . 25.4 t80 -100.36 -50.06 4.05 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.611 -0.681 . . . . 0.0 110.351 176.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 27' ' ' TYR . 23.2 p -153.55 153.59 32.68 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.741 -0.599 . . . . 0.0 110.18 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.882 HG23 HG22 ' A' ' 36' ' ' ILE . 13.5 p -142.3 145.04 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.593 -0.692 . . . . 0.0 110.102 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -128.5 100.51 22.26 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.623 -0.673 . . . . 0.0 109.566 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.41 -39.69 44.47 Favored 'Trans proline' 0 N--CA 1.489 1.244 0 O-C-N 123.578 1.304 . . . . 0.0 110.726 -175.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -80.49 -25.83 38.56 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.406 -0.809 . . . . 0.0 110.157 -172.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.572 ' O ' HG23 ' A' ' 35' ' ' THR . 54.9 mt-10 -87.35 1.83 52.14 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.501 -0.75 . . . . 0.0 111.195 173.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 75.5 m 49.58 38.3 14.51 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.116 -0.99 . . . . 0.0 111.291 -176.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 33' ' ' GLU . 10.5 p -136.26 153.73 51.11 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.399 -0.813 . . . . 0.0 110.26 -174.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.882 HG22 HG23 ' A' ' 29' ' ' VAL . 39.9 pt -142.73 162.02 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.703 -0.623 . . . . 0.0 110.249 178.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.523 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.69 127.29 27.01 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.669 -0.644 . . . . 0.0 109.665 175.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 26' ' ' LEU . 83.8 mt -109.94 146.99 34.27 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -177.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 95.7 p -118.07 152.68 35.09 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.5 p 45.58 84.0 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 121.492 0.663 . . . . 0.0 110.336 -172.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.669 ' CG1' HD12 ' A' ' 65' ' ' ILE . 14.9 p -134.53 150.55 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.947 -0.47 . . . . 0.0 109.774 -178.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -136.4 153.09 51.19 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.64 -0.663 . . . . 0.0 110.168 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.5 p -107.2 133.03 52.39 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.71 -0.619 . . . . 0.0 109.506 176.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -83.09 -38.62 22.22 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.726 -0.79 . . . . 0.0 111.087 -170.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.27 171.73 33.65 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 176.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.788 HG22 HG12 ' A' ' 20' ' ' ILE . 69.6 p -118.22 6.1 11.95 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.789 -0.83 . . . . 0.0 110.467 169.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -57.26 -31.41 65.54 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.545 -0.722 . . . . 0.0 112.427 -161.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -66.69 -59.34 3.67 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.239 -0.913 . . . . 0.0 110.486 -174.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.0 mtt-85 -94.51 10.3 35.15 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.677 -0.639 . . . . 0.0 111.612 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.474 ' HB2' HD12 ' A' ' 55' ' ' ILE . 38.2 p30 -54.63 172.15 0.11 Allowed 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.166 -0.959 . . . . 0.0 111.894 -171.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.0 m -78.94 164.6 24.29 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 173.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -77.32 3.75 12.33 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.567 -0.708 . . . . 0.0 111.214 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -98.28 153.34 18.58 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.215 -0.928 . . . . 0.0 109.619 169.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -67.82 138.59 56.25 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.578 -0.701 . . . . 0.0 110.597 -174.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.474 HD12 ' HB2' ' A' ' 50' ' ' ASP . 79.2 mt -117.43 141.2 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.661 -0.65 . . . . 0.0 109.511 177.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -97.66 109.86 52.59 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.612 -0.68 . . . . 0.0 110.215 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -68.6 147.65 70.64 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 O-C-N 123.44 1.232 . . . . 0.0 110.325 178.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -101.38 121.44 41.93 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.64 -0.662 . . . . 0.0 110.206 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 86.6 p -81.25 -26.81 35.53 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.724 -0.61 . . . . 0.0 110.686 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -61.67 148.35 42.93 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.471 -0.768 . . . . 0.0 110.623 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.1 mm -96.85 145.64 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.712 -0.618 . . . . 0.0 109.747 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -95.75 114.34 26.06 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.659 -0.651 . . . . 0.0 110.347 -178.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -51.04 -41.09 59.64 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.709 -0.62 . . . . 0.0 111.527 176.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.523 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.7 t80 -152.63 129.51 10.97 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.727 -0.608 . . . . 0.0 110.226 -174.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.669 HD12 ' CG1' ' A' ' 41' ' ' VAL . 73.7 mt -128.23 128.34 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.683 -0.635 . . . . 0.0 109.794 172.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.8 tp -90.13 137.06 32.65 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.889 -0.507 . . . . 0.0 109.838 176.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.583 ' CD1' HD11 ' A' ' 72' ' ' ILE . 3.0 m-85 -135.35 128.84 32.43 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.572 -0.705 . . . . 0.0 110.603 -175.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -91.27 147.03 23.33 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.653 -0.654 . . . . 0.0 110.177 172.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.63 -25.62 58.76 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.2 p -67.83 -37.85 82.45 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.427 -1.043 . . . . 0.0 110.917 -177.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -82.43 -30.79 29.86 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.504 -0.748 . . . . 0.0 110.9 -175.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.762 HD13 HD21 ' A' ' 14' ' ' LEU . 8.5 mt -104.31 138.78 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.492 -0.755 . . . . 0.0 110.104 176.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -105.04 -18.07 14.28 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.92 -0.487 . . . . 0.0 111.58 -167.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -151.03 132.03 14.27 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 119.115 -1.034 . . . . 0.0 111.249 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.541 HD12 ' CD1' ' A' ' 14' ' ' LEU . 16.8 tt -132.2 141.97 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.887 -0.508 . . . . 0.0 109.806 176.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -146.4 135.13 22.28 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.659 -0.65 . . . . 0.0 110.361 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.406 HG22 HG12 ' A' ' 12' ' ' ILE . 52.4 t -87.59 143.74 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.682 -0.636 . . . . 0.0 109.775 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 N--CA 1.497 1.895 0 O-C-N 121.59 -0.694 . . . . 0.0 109.745 -179.777 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.3 mt . . . . . 0 N--CA 1.501 2.101 0 CA-C-O 121.01 0.433 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.68 -1.79 84.95 Favored Glycine 0 N--CA 1.497 2.707 0 C-N-CA 120.453 -0.879 . . . . 0.0 111.742 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.4 m -60.39 151.7 27.33 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.078 -1.248 . . . . 0.0 110.482 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.434 ' HE3' HG11 ' A' ' 78' ' ' VAL . 30.5 pttt -81.95 126.54 32.06 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.66 -0.65 . . . . 0.0 110.551 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.652 ' CD1' HD13 ' A' ' 26' ' ' LEU . 89.5 mt -120.8 143.76 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.57 -0.706 . . . . 0.0 109.988 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.4 t -102.42 137.27 40.89 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 175.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.668 HD21 HD13 ' A' ' 72' ' ' ILE . 14.7 tp -133.11 125.06 28.7 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.763 -0.586 . . . . 0.0 110.227 -169.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 81.7 mt -106.75 118.85 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.548 -0.72 . . . . 0.0 109.629 -178.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.7 m -93.69 157.66 16.06 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.064 0.459 . . . . 0.0 111.148 -178.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -54.21 -13.24 0.8 Allowed 'General case' 0 N--CA 1.507 2.416 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -172.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.556 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -90.0 20.4 4.27 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.142 -0.974 . . . . 0.0 110.475 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 53.96 33.98 18.6 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.485 -0.76 . . . . 0.0 109.749 -173.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.779 HG12 HG22 ' A' ' 46' ' ' THR . 68.8 mt -102.22 140.89 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -104.9 119.81 39.92 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.922 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -114.36 147.55 38.98 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 173.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.671 ' O ' HG23 ' A' ' 41' ' ' VAL . 41.5 tt0 -139.31 140.43 37.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.436 -0.79 . . . . 0.0 109.627 175.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.11 173.22 42.34 Favored Glycine 0 N--CA 1.496 2.678 0 C-N-CA 119.737 -1.22 . . . . 0.0 110.58 -175.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -84.28 137.57 33.39 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.907 -0.761 . . . . 0.0 110.546 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.652 HD13 ' CD1' ' A' ' 12' ' ' ILE . 16.0 tp -66.15 116.88 7.7 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.727 -0.608 . . . . 0.0 110.655 175.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.453 ' O ' HG23 ' A' ' 28' ' ' THR . 24.9 t80 -99.68 -50.18 4.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.659 -0.651 . . . . 0.0 110.421 178.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 27' ' ' TYR . 15.1 p -153.97 153.64 32.36 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.705 -0.622 . . . . 0.0 110.269 -178.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.885 HG23 HG22 ' A' ' 36' ' ' ILE . 13.7 p -142.24 145.19 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.696 -0.627 . . . . 0.0 110.092 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -127.88 98.73 27.01 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.631 -0.668 . . . . 0.0 109.611 177.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -59.44 -42.06 52.07 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 O-C-N 123.577 1.304 . . . . 0.0 110.984 -175.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -80.73 -24.82 38.49 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.413 -0.804 . . . . 0.0 110.181 -171.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.561 ' O ' HG23 ' A' ' 35' ' ' THR . 74.7 mm-40 -87.02 1.26 53.43 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.536 -0.728 . . . . 0.0 111.177 173.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 96.5 m 49.8 38.17 15.05 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.053 -1.029 . . . . 0.0 111.249 -176.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 33' ' ' GLU . 10.6 p -136.12 153.09 51.4 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.431 -0.793 . . . . 0.0 110.43 -174.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.885 HG22 HG23 ' A' ' 29' ' ' VAL . 39.9 pt -142.77 162.04 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.703 -0.623 . . . . 0.0 110.22 177.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.515 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.79 128.1 28.19 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.67 -0.644 . . . . 0.0 109.686 175.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 26' ' ' LEU . 83.6 mt -109.89 145.83 36.17 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -178.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.4 p -116.92 153.0 33.34 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -178.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 44.6 p 45.93 87.05 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 121.516 0.674 . . . . 0.0 110.317 -172.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.798 HG11 HD12 ' A' ' 65' ' ' ILE . 12.4 p -134.59 147.19 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.897 -0.502 . . . . 0.0 109.929 -177.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -123.84 153.17 41.45 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.767 -0.583 . . . . 0.0 109.881 177.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.3 p -108.54 136.69 47.72 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.716 -0.615 . . . . 0.0 109.707 176.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -82.93 -38.39 22.87 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.528 -0.733 . . . . 0.0 110.968 -174.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.57 167.62 28.51 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 120.024 -1.084 . . . . 0.0 110.578 176.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.779 HG22 HG12 ' A' ' 20' ' ' ILE . 0.8 OUTLIER -118.09 6.55 12.08 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.974 -0.721 . . . . 0.0 110.899 174.14 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -49.45 -25.16 2.39 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.544 -0.723 . . . . 0.0 112.624 -168.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -64.5 -59.22 4.57 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.191 -0.943 . . . . 0.0 110.607 -178.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 35.5 mtp180 -94.35 10.14 35.43 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.558 -0.714 . . . . 0.0 111.472 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 40.0 p-10 -60.27 173.97 0.6 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.3 -0.875 . . . . 0.0 111.297 -170.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.0 m -78.99 164.34 24.47 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.93 -0.481 . . . . 0.0 109.737 175.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -77.55 3.56 13.32 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.601 -0.687 . . . . 0.0 111.291 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -96.54 166.01 11.89 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.219 -0.926 . . . . 0.0 109.656 168.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -68.61 139.29 55.51 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.606 -0.684 . . . . 0.0 110.364 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 49.5 mm -114.18 134.76 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.745 -0.597 . . . . 0.0 109.697 178.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.01 109.94 53.68 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.649 -0.657 . . . . 0.0 110.236 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -66.86 146.57 78.48 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 O-C-N 123.331 1.174 . . . . 0.0 110.305 178.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -97.44 121.12 38.98 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.653 -0.654 . . . . 0.0 110.299 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 86.4 p -75.79 -22.07 56.74 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.705 -0.622 . . . . 0.0 110.828 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -61.16 156.59 17.96 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.376 -0.828 . . . . 0.0 110.693 -178.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.5 mm -96.87 145.9 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.754 -0.591 . . . . 0.0 109.853 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -92.1 111.87 23.58 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.553 -0.717 . . . . 0.0 109.87 175.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -52.35 -43.11 64.45 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.746 -0.596 . . . . 0.0 111.769 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.515 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.0 t80 -154.62 130.15 9.87 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.588 -0.695 . . . . 0.0 110.238 -174.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.798 HD12 HG11 ' A' ' 41' ' ' VAL . 80.4 mt -128.77 127.42 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.618 -0.676 . . . . 0.0 109.916 171.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 24.8 tp -90.32 137.09 32.63 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.779 -0.576 . . . . 0.0 109.755 175.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.57 ' CD1' HD11 ' A' ' 72' ' ' ILE . 3.5 m-85 -136.08 130.77 33.93 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.649 -0.657 . . . . 0.0 110.664 -175.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -91.6 149.57 21.59 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.663 -0.648 . . . . 0.0 110.339 173.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.31 -24.51 61.41 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 177.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.7 m -66.53 -42.04 87.83 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.366 -1.079 . . . . 0.0 111.077 -176.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -82.96 -33.41 26.69 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.423 -0.798 . . . . 0.0 110.919 -175.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.668 HD13 HD21 ' A' ' 14' ' ' LEU . 14.2 mt -101.02 138.15 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.404 -0.81 . . . . 0.0 110.11 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.0 tptp -107.32 -18.25 13.92 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 120.501 -0.479 . . . . 0.0 111.758 -166.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -148.93 131.14 15.49 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.897 -1.127 . . . . 0.0 111.354 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.499 HD12 ' CD1' ' A' ' 14' ' ' LEU . 18.0 tt -132.55 138.51 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.895 -0.503 . . . . 0.0 109.866 176.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.1 mtp180 -147.02 138.67 24.25 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.496 -0.753 . . . . 0.0 110.39 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.3 p -86.61 146.63 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.589 -0.694 . . . . 0.0 110.186 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.434 HG11 ' HE3' ' A' ' 11' ' ' LYS . 60.1 t . . . . . 0 N--CA 1.497 1.887 0 O-C-N 121.647 -0.658 . . . . 0.0 109.907 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.0 mt . . . . . 0 N--CA 1.501 2.088 0 CA-C-O 121.087 0.47 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.62 -1.91 84.42 Favored Glycine 0 N--CA 1.497 2.707 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.759 177.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.3 m -62.55 140.59 58.64 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.094 -1.239 . . . . 0.0 110.372 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -81.97 123.14 28.62 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.67 -0.644 . . . . 0.0 110.473 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.595 ' CD1' HD13 ' A' ' 26' ' ' LEU . 91.8 mt -121.17 145.35 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.492 -0.755 . . . . 0.0 110.222 -178.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.0 t -103.21 137.24 41.62 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 175.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.683 HD21 HD13 ' A' ' 72' ' ' ILE . 14.3 tp -132.02 126.14 33.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.741 -0.599 . . . . 0.0 110.261 -169.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 81.4 mt -107.04 119.03 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.594 -0.691 . . . . 0.0 109.622 -178.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.9 m -93.56 157.73 16.05 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.081 0.467 . . . . 0.0 111.187 -177.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.0 tptp -53.67 -14.78 0.97 Allowed 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -172.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.553 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.85 21.23 3.68 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.183 -0.948 . . . . 0.0 110.469 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 53.99 34.31 19.4 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.509 -0.745 . . . . 0.0 109.886 -174.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.836 HG12 HG22 ' A' ' 46' ' ' THR . 67.3 mt -102.1 141.55 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 54.0 ttt85 -104.51 119.84 39.89 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.891 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -113.86 149.24 35.36 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 174.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.653 ' O ' HG23 ' A' ' 41' ' ' VAL . 42.1 tt0 -140.69 140.49 34.94 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.499 -0.751 . . . . 0.0 109.494 175.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.64 173.09 43.27 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.666 -175.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -85.05 134.61 34.2 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.963 -0.728 . . . . 0.0 110.465 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.595 HD13 ' CD1' ' A' ' 12' ' ' ILE . 15.1 tp -66.2 119.87 12.24 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.61 -0.681 . . . . 0.0 110.735 176.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.443 ' O ' HG23 ' A' ' 28' ' ' THR . 24.0 t80 -99.43 -50.09 4.22 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.639 -0.663 . . . . 0.0 110.338 178.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 27' ' ' TYR . 15.4 p -153.83 154.29 33.69 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.693 -0.63 . . . . 0.0 110.229 -178.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.893 HG23 HG22 ' A' ' 36' ' ' ILE . 13.4 p -142.2 145.51 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.697 -0.627 . . . . 0.0 110.099 -178.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -129.04 98.25 24.37 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.583 -0.698 . . . . 0.0 109.502 177.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -59.45 -40.16 69.43 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 O-C-N 123.606 1.319 . . . . 0.0 111.037 -175.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -80.51 -27.12 37.77 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.319 -0.863 . . . . 0.0 110.21 -170.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.693 ' O ' HG23 ' A' ' 35' ' ' THR . 80.0 mt-10 -87.59 3.34 47.98 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.524 -0.735 . . . . 0.0 111.212 173.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 42.4 m 49.61 39.66 17.77 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.13 -0.981 . . . . 0.0 111.351 -177.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.693 HG23 ' O ' ' A' ' 33' ' ' GLU . 19.8 p -136.18 151.9 50.22 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.379 -0.826 . . . . 0.0 110.357 -175.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.893 HG22 HG23 ' A' ' 29' ' ' VAL . 40.0 pt -142.68 162.1 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.628 -0.67 . . . . 0.0 110.121 178.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.518 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -137.06 127.63 26.87 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.662 -0.648 . . . . 0.0 109.634 175.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 26' ' ' LEU . 88.6 mt -109.9 148.67 31.14 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -177.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.8 p -119.55 152.24 37.31 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.9 p 45.63 83.71 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 CA-C-O 121.457 0.646 . . . . 0.0 110.355 -172.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.674 ' CG1' HD12 ' A' ' 65' ' ' ILE . 14.6 p -134.54 150.33 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -178.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -136.07 153.19 51.41 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.658 -0.651 . . . . 0.0 110.043 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.9 p -108.41 139.89 42.5 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.753 -0.592 . . . . 0.0 109.839 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -83.0 -38.39 22.7 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.669 -0.644 . . . . 0.0 111.035 -173.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.62 171.93 34.15 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 177.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.836 HG22 HG12 ' A' ' 20' ' ' ILE . 2.3 p -118.09 6.51 12.08 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.925 -0.75 . . . . 0.0 110.986 174.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -50.99 -24.43 3.69 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.555 -0.716 . . . . 0.0 112.749 -167.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -65.95 -59.35 3.92 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.191 -0.943 . . . . 0.0 110.583 -177.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 -94.5 10.24 35.36 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.567 -0.708 . . . . 0.0 111.474 176.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 41.4 p-10 -58.22 174.08 0.31 Allowed 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.168 -0.958 . . . . 0.0 111.283 -171.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.0 m -79.03 164.37 24.41 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.905 -0.497 . . . . 0.0 109.794 176.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -77.53 4.09 12.02 Favored 'General case' 0 N--CA 1.502 2.135 0 C-N-CA 120.046 -0.662 . . . . 0.0 111.235 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -96.2 164.91 12.47 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.169 -0.957 . . . . 0.0 109.597 168.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -68.81 137.0 53.61 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.62 -0.675 . . . . 0.0 110.47 -176.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.3 mm -114.43 135.96 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.705 -0.622 . . . . 0.0 109.591 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -96.1 109.85 49.09 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.621 -0.675 . . . . 0.0 110.195 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -69.29 140.74 45.21 Favored 'Trans proline' 0 N--CA 1.487 1.091 0 O-C-N 123.469 1.247 . . . . 0.0 110.269 177.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -115.21 136.35 53.2 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.626 -0.671 . . . . 0.0 110.174 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.5 m -91.45 11.86 22.58 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.693 -0.63 . . . . 0.0 111.234 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -63.38 138.52 58.55 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.279 -0.888 . . . . 0.0 110.449 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.0 mm -96.92 135.35 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.715 -0.616 . . . . 0.0 109.758 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -95.28 117.72 30.79 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.605 -0.684 . . . . 0.0 110.191 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -51.02 -42.41 60.43 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.817 -0.552 . . . . 0.0 111.634 177.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.518 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.6 t80 -152.68 130.38 11.58 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.614 -0.679 . . . . 0.0 110.3 -174.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.674 HD12 ' CG1' ' A' ' 41' ' ' VAL . 77.0 mt -129.4 128.43 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.664 -0.647 . . . . 0.0 109.854 172.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.2 tp -90.47 137.1 32.62 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.821 -0.549 . . . . 0.0 109.817 176.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.57 ' CD1' HD11 ' A' ' 72' ' ' ILE . 3.4 m-85 -136.53 130.81 33.01 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.636 -0.665 . . . . 0.0 110.606 -175.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.9 mtm-85 -92.21 150.68 20.76 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.725 -0.609 . . . . 0.0 110.367 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.31 -23.99 60.74 Favored Glycine 0 N--CA 1.498 2.804 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.3 p -67.11 -42.04 85.19 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.408 -1.054 . . . . 0.0 110.979 -176.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -82.92 -33.22 26.87 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.471 -0.768 . . . . 0.0 110.942 -175.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.683 HD13 HD21 ' A' ' 14' ' ' LEU . 14.9 mt -102.32 138.26 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.393 -0.817 . . . . 0.0 110.142 177.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -107.22 -18.45 13.88 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.797 -166.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -149.64 131.31 14.97 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 118.936 -1.106 . . . . 0.0 111.231 -178.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.509 HD12 ' CD1' ' A' ' 14' ' ' LEU . 18.1 tt -132.01 138.27 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.937 -0.477 . . . . 0.0 109.783 176.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -146.92 144.12 29.0 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.584 -0.698 . . . . 0.0 110.429 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.465 HG12 HG12 ' A' ' 12' ' ' ILE . 35.5 m -84.87 147.0 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.585 -0.697 . . . . 0.0 110.203 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.6 t . . . . . 0 N--CA 1.496 1.866 0 O-C-N 121.636 -0.665 . . . . 0.0 109.868 -178.727 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.5 mt . . . . . 0 N--CA 1.501 2.122 0 CA-C-O 120.961 0.41 . . . . 0.0 110.673 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.62 -1.88 84.5 Favored Glycine 0 N--CA 1.497 2.728 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.783 177.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.6 m -62.17 147.37 47.91 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.047 -1.266 . . . . 0.0 110.446 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.562 ' HE3' HG11 ' A' ' 78' ' ' VAL . 28.6 pttt -81.77 126.0 31.31 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.716 -0.615 . . . . 0.0 110.371 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.628 ' CD1' HD13 ' A' ' 26' ' ' LEU . 89.1 mt -122.49 144.15 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.543 -0.723 . . . . 0.0 110.107 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.3 t -102.68 137.3 41.08 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.476 ' CD1' HD12 ' A' ' 75' ' ' ILE . 13.4 tp -135.41 128.33 31.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.742 -0.599 . . . . 0.0 110.28 -169.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.3 mt -108.38 121.88 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.558 -0.714 . . . . 0.0 109.668 -178.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.1 m -93.2 157.85 16.06 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.042 0.449 . . . . 0.0 111.151 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -53.95 -13.78 0.85 Allowed 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -172.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.515 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.52 20.07 4.17 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.2 -0.938 . . . . 0.0 110.394 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 54.16 34.81 20.98 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.411 -0.806 . . . . 0.0 109.829 -175.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.828 HG12 HG22 ' A' ' 46' ' ' THR . 64.4 mt -102.35 143.44 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -104.31 119.67 39.48 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.058 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -114.22 149.28 36.04 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.649 ' O ' HG23 ' A' ' 41' ' ' VAL . 63.4 mt-10 -141.13 140.5 34.12 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.417 -0.802 . . . . 0.0 109.7 175.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.27 173.23 43.04 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 119.721 -1.228 . . . . 0.0 110.527 -175.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -85.29 136.81 33.34 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.872 -0.781 . . . . 0.0 110.581 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.628 HD13 ' CD1' ' A' ' 12' ' ' ILE . 15.5 tp -66.23 119.22 11.12 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.57 -0.706 . . . . 0.0 110.66 175.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.443 ' O ' HG23 ' A' ' 28' ' ' THR . 25.2 t80 -100.07 -50.16 4.07 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.641 -0.662 . . . . 0.0 110.445 178.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 27' ' ' TYR . 16.6 p -153.94 156.18 37.01 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.708 -0.62 . . . . 0.0 110.34 -177.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.598 HG23 HG22 ' A' ' 36' ' ' ILE . 10.6 p -142.18 145.37 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.758 -0.589 . . . . 0.0 110.093 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -128.83 98.46 24.52 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.678 -0.639 . . . . 0.0 109.539 177.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -59.4 -43.29 41.45 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 O-C-N 123.595 1.313 . . . . 0.0 110.993 -175.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -80.88 -23.88 38.7 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.335 -0.853 . . . . 0.0 110.237 -171.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.74 ' O ' HG23 ' A' ' 35' ' ' THR . 74.7 mm-40 -87.18 0.99 54.46 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.473 -0.767 . . . . 0.0 111.188 173.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.0 m 50.03 39.8 19.84 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.101 -0.999 . . . . 0.0 111.172 -176.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.74 HG23 ' O ' ' A' ' 33' ' ' GLU . 23.1 p -136.06 154.36 51.05 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.452 -0.78 . . . . 0.0 110.476 -174.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.598 HG22 HG23 ' A' ' 29' ' ' VAL . 40.3 pt -141.66 160.61 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.816 -0.553 . . . . 0.0 110.031 177.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.512 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.52 126.94 26.71 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.698 -0.626 . . . . 0.0 109.648 175.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 26' ' ' LEU . 88.0 mt -109.89 146.6 34.86 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -178.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 99.9 p -117.65 152.24 35.6 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.1 p 45.65 83.62 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 121.491 0.662 . . . . 0.0 110.311 -172.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.666 ' CG1' HD12 ' A' ' 65' ' ' ILE . 14.9 p -134.58 151.06 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.938 -0.476 . . . . 0.0 109.733 -179.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -136.6 153.19 51.03 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.596 -0.69 . . . . 0.0 110.137 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.3 p -109.6 137.7 47.04 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.806 -0.559 . . . . 0.0 109.664 177.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -83.06 -38.57 22.34 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.194 -172.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.31 169.4 30.83 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 175.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.828 HG22 HG12 ' A' ' 20' ' ' ILE . 41.0 p -118.17 6.21 12.0 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.865 -0.785 . . . . 0.0 110.818 170.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -54.29 -24.3 18.48 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.48 -0.762 . . . . 0.0 112.257 -167.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -65.79 -59.21 4.12 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.281 -0.887 . . . . 0.0 110.387 -177.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 82.0 mmt-85 -94.52 10.26 35.34 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.619 -0.676 . . . . 0.0 111.417 177.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.448 ' HB2' HD12 ' A' ' 55' ' ' ILE . 53.2 p-10 -57.42 170.02 0.57 Allowed 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.211 -0.93 . . . . 0.0 111.52 -170.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.7 m -79.01 164.54 24.29 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 175.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -77.42 4.21 11.48 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.092 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -97.53 148.16 23.53 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.312 -0.867 . . . . 0.0 109.394 166.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -65.98 142.2 57.93 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.578 -0.701 . . . . 0.0 110.81 -174.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.448 HD12 ' HB2' ' A' ' 50' ' ' ASP . 79.8 mt -115.75 135.7 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.678 -0.639 . . . . 0.0 109.439 177.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.35 132.52 89.66 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.626 -0.671 . . . . 0.0 110.025 -178.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -69.48 144.07 54.28 Favored 'Trans proline' 0 N--CA 1.487 1.117 0 O-C-N 123.389 1.205 . . . . 0.0 110.253 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -98.93 110.1 22.76 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.668 -0.645 . . . . 0.0 110.111 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.4 t -99.18 -33.17 10.88 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.748 -0.595 . . . . 0.0 110.364 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -62.52 148.64 45.24 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.592 -0.692 . . . . 0.0 110.668 -179.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.4 mm -96.83 143.75 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.681 -0.637 . . . . 0.0 109.667 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -94.75 114.77 26.72 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.711 -0.618 . . . . 0.0 110.322 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.19 -41.39 60.18 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 121.812 -0.555 . . . . 0.0 111.56 177.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.512 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.0 t80 -152.59 130.6 11.82 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.632 -0.668 . . . . 0.0 110.262 -175.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.666 HD12 ' CG1' ' A' ' 41' ' ' VAL . 76.2 mt -129.34 127.27 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.586 -0.696 . . . . 0.0 109.792 171.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.2 tp -90.58 137.07 32.64 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.833 -0.542 . . . . 0.0 109.858 176.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.457 ' CZ ' HG21 ' A' ' 65' ' ' ILE . 3.9 m-85 -137.93 131.89 31.57 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.685 -0.634 . . . . 0.0 110.67 -175.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -91.59 151.91 20.51 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.752 -0.592 . . . . 0.0 110.313 174.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.93 -24.75 60.82 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.6 t -66.83 -42.15 86.27 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.451 -1.029 . . . . 0.0 111.066 -176.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -82.89 -33.17 27.02 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.527 -0.733 . . . . 0.0 110.93 -175.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.435 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 24.5 mt -105.17 135.1 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.336 -0.853 . . . . 0.0 109.962 176.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -110.18 -12.59 14.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.941 -0.474 . . . . 0.0 112.111 -165.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -147.4 130.65 16.52 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.809 -1.182 . . . . 0.0 111.298 -178.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.476 HD12 ' CD1' ' A' ' 14' ' ' LEU . 14.6 tt -132.27 141.25 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.92 -0.488 . . . . 0.0 109.87 176.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -145.96 134.4 21.95 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.498 -0.751 . . . . 0.0 110.307 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.3 t -87.14 144.45 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.612 -0.68 . . . . 0.0 109.611 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.562 HG11 ' HE3' ' A' ' 11' ' ' LYS . 57.8 t . . . . . 0 N--CA 1.497 1.905 0 O-C-N 121.603 -0.686 . . . . 0.0 109.749 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.5 mt . . . . . 0 N--CA 1.501 2.083 0 CA-C-O 120.932 0.396 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.66 -1.75 85.01 Favored Glycine 0 N--CA 1.497 2.721 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.608 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 42.6 m -60.01 159.54 9.22 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.151 -1.206 . . . . 0.0 110.437 -177.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -81.27 126.58 31.72 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.747 -0.596 . . . . 0.0 110.534 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.686 ' CD1' HD13 ' A' ' 26' ' ' LEU . 88.1 mt -120.83 144.66 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.555 -0.716 . . . . 0.0 109.907 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.8 t -102.97 137.27 41.39 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 175.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.788 ' HG ' HG21 ' A' ' 72' ' ' ILE . 11.9 tp -134.15 123.88 25.12 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.723 -0.611 . . . . 0.0 110.057 -170.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.721 ' O ' HG23 ' A' ' 72' ' ' ILE . 82.0 mt -103.99 119.45 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.528 -0.732 . . . . 0.0 109.643 -177.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.7 m -94.96 157.89 15.7 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.166 0.507 . . . . 0.0 111.59 -175.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -53.64 -15.19 1.08 Allowed 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -171.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.6 21.15 3.58 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.157 -0.964 . . . . 0.0 110.449 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 56.69 35.57 26.37 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.49 -0.756 . . . . 0.0 110.031 -178.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.747 HG12 HG22 ' A' ' 46' ' ' THR . 53.1 mt -107.05 148.79 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.0 ttt-85 -106.66 119.83 40.36 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.167 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -112.87 152.37 29.34 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 175.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.655 ' O ' HG23 ' A' ' 41' ' ' VAL . 42.3 tt0 -141.88 140.55 32.89 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.452 -0.78 . . . . 0.0 109.68 175.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.57 171.8 41.61 Favored Glycine 0 N--CA 1.496 2.65 0 C-N-CA 119.753 -1.213 . . . . 0.0 110.464 -176.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 43.1 mmm-85 -84.35 138.97 32.59 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.843 -0.798 . . . . 0.0 110.538 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.686 HD13 ' CD1' ' A' ' 12' ' ' ILE . 16.5 tp -66.17 116.5 7.31 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.605 -0.684 . . . . 0.0 110.618 175.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.461 ' O ' HG23 ' A' ' 28' ' ' THR . 32.1 t80 -100.35 -50.13 4.03 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.609 -0.682 . . . . 0.0 110.553 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 27' ' ' TYR . 14.5 p -154.58 155.33 34.56 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.718 -0.614 . . . . 0.0 110.359 -177.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.836 HG23 HG22 ' A' ' 36' ' ' ILE . 13.4 p -142.23 145.94 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.746 -0.597 . . . . 0.0 110.062 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -128.5 99.01 24.27 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.579 -0.7 . . . . 0.0 109.649 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -59.61 -41.67 54.17 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 O-C-N 123.654 1.344 . . . . 0.0 111.038 -175.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -80.59 -25.51 38.43 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.384 -0.823 . . . . 0.0 110.252 -170.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.581 ' O ' HG23 ' A' ' 35' ' ' THR . 79.3 mt-10 -87.58 1.97 52.12 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.437 -0.79 . . . . 0.0 111.236 173.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 97.7 m 49.66 39.97 18.7 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.093 -1.004 . . . . 0.0 111.199 -176.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 33' ' ' GLU . 11.0 p -135.86 154.32 51.2 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.415 -0.803 . . . . 0.0 110.379 -175.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.836 HG22 HG23 ' A' ' 29' ' ' VAL . 39.9 pt -142.0 160.94 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.675 -0.641 . . . . 0.0 109.969 176.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.505 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -137.06 128.99 29.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.572 -0.705 . . . . 0.0 109.828 176.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 26' ' ' LEU . 84.1 mt -109.87 144.82 37.8 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -178.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 97.6 p -114.95 152.66 31.97 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.1 p 45.55 84.94 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 121.454 0.645 . . . . 0.0 110.214 -171.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.1 p -134.55 149.97 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.967 -0.458 . . . . 0.0 109.766 -178.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -136.07 153.2 51.4 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.635 -0.665 . . . . 0.0 110.068 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.2 p -105.61 129.79 53.78 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.757 -0.589 . . . . 0.0 109.463 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -83.07 -38.49 22.44 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.112 -170.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.22 175.45 37.25 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 178.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.747 HG22 HG12 ' A' ' 20' ' ' ILE . 65.3 p -118.11 2.68 12.05 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.81 -0.817 . . . . 0.0 110.489 169.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -57.33 -33.83 68.12 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.541 -0.725 . . . . 0.0 112.134 -163.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -63.36 -59.06 5.19 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.332 -0.855 . . . . 0.0 110.435 -175.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -94.32 10.49 34.01 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.753 -0.592 . . . . 0.0 111.289 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 51.2 p30 -49.82 157.78 0.55 Allowed 'General case' 0 N--CA 1.51 2.556 0 O-C-N 121.413 -0.804 . . . . 0.0 112.41 -169.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.421 ' H ' HD11 ' A' ' 55' ' ' ILE . 21.1 m -79.2 164.49 24.16 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 172.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -77.51 4.53 10.92 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.236 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -96.83 166.05 11.82 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.236 -0.915 . . . . 0.0 109.645 167.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -76.58 133.98 39.52 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.544 -0.722 . . . . 0.0 110.52 -176.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.421 HD11 ' H ' ' A' ' 51' ' ' THR . 69.8 mt -119.35 139.48 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.805 -0.56 . . . . 0.0 109.531 177.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.04 109.89 53.56 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.613 -0.679 . . . . 0.0 110.249 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -68.77 152.06 74.17 Favored 'Trans proline' 0 N--CA 1.488 1.153 0 O-C-N 123.414 1.218 . . . . 0.0 110.387 178.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -99.0 127.8 45.0 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.755 -0.59 . . . . 0.0 110.187 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.2 m -94.63 -31.63 13.76 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.721 -0.612 . . . . 0.0 110.468 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -61.76 151.45 34.04 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.633 -0.667 . . . . 0.0 110.613 -178.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.2 mm -96.81 140.01 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.67 -0.643 . . . . 0.0 109.758 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -97.3 116.19 29.05 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.603 -0.686 . . . . 0.0 110.297 -177.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -50.96 -40.35 57.34 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.701 -0.625 . . . . 0.0 111.562 176.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.505 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.3 t80 -152.97 129.76 10.9 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.656 -0.652 . . . . 0.0 110.217 -174.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.651 HD12 ' CG1' ' A' ' 41' ' ' VAL . 71.2 mt -128.32 126.68 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.713 -0.617 . . . . 0.0 109.893 171.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.4 HD12 ' HB2' ' A' ' 37' ' ' ALA . 22.4 tp -91.42 137.12 32.62 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.87 -0.519 . . . . 0.0 109.9 176.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.469 ' CD1' HD11 ' A' ' 72' ' ' ILE . 7.3 m-85 -135.47 130.85 35.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.642 -0.661 . . . . 0.0 110.429 -176.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -89.56 151.38 21.97 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.716 -0.615 . . . . 0.0 110.076 174.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.4 -24.49 45.96 Favored Glycine 0 N--CA 1.5 2.929 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 86.5 p -76.82 -39.06 52.61 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.411 -1.052 . . . . 0.0 111.047 -177.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -82.04 -21.3 37.02 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.391 -0.818 . . . . 0.0 111.309 -173.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.788 HG21 ' HG ' ' A' ' 14' ' ' LEU . 45.1 mt -116.03 141.22 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.256 -0.902 . . . . 0.0 109.694 168.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -105.88 -14.3 15.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.86 -0.525 . . . . 0.0 111.87 -167.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -150.29 134.22 16.86 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 118.993 -1.083 . . . . 0.0 111.438 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.425 HD12 ' CD1' ' A' ' 14' ' ' LEU . 15.7 tt -132.04 140.63 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.94 -0.475 . . . . 0.0 109.826 176.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -147.05 138.04 23.85 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.624 -0.673 . . . . 0.0 110.344 178.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.9 t -87.2 146.1 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.573 -0.704 . . . . 0.0 109.656 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.3 t . . . . . 0 N--CA 1.498 1.932 0 O-C-N 121.52 -0.737 . . . . 0.0 109.788 -178.638 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.6 mt . . . . . 0 N--CA 1.501 2.085 0 CA-C-O 121.041 0.448 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.67 -1.96 84.36 Favored Glycine 0 N--CA 1.497 2.72 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.794 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.0 m -62.18 139.86 58.46 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.079 -1.247 . . . . 0.0 110.445 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.572 ' HE3' HG11 ' A' ' 78' ' ' VAL . 35.8 pttt -81.87 127.27 32.83 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.71 -0.619 . . . . 0.0 110.35 179.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.404 HD12 ' HB2' ' A' ' 26' ' ' LEU . 92.8 mt -124.94 145.13 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.597 -0.689 . . . . 0.0 110.223 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.2 t -102.84 137.25 41.29 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.735 HD21 HD13 ' A' ' 72' ' ' ILE . 13.8 tp -131.88 125.69 32.35 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.814 -0.554 . . . . 0.0 110.198 -170.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 80.9 mt -107.5 118.65 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.522 -0.736 . . . . 0.0 109.692 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.9 m -93.57 157.72 16.05 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.039 0.447 . . . . 0.0 111.293 -177.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -53.29 -15.02 0.82 Allowed 'General case' 0 N--CA 1.508 2.473 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -172.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.568 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.29 20.55 3.73 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.099 -1.001 . . . . 0.0 110.405 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 54.35 33.51 18.63 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.435 -0.791 . . . . 0.0 109.874 -174.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.662 HG12 HG22 ' A' ' 46' ' ' THR . 65.7 mt -101.5 141.31 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -104.66 119.79 39.82 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.941 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -113.99 148.96 36.06 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 174.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.66 ' O ' HG23 ' A' ' 41' ' ' VAL . 42.8 tt0 -140.08 140.48 36.1 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.471 -0.768 . . . . 0.0 109.498 175.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.43 173.02 43.14 Favored Glycine 0 N--CA 1.496 2.683 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.665 -175.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 72.0 mtp85 -85.54 135.47 33.81 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.881 -0.776 . . . . 0.0 110.59 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.483 ' HA ' HD23 ' A' ' 38' ' ' LEU . 29.4 tp -66.16 119.53 11.63 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.668 -0.645 . . . . 0.0 110.679 176.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.44 ' O ' HG23 ' A' ' 28' ' ' THR . 26.4 t80 -99.57 -50.06 4.2 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.677 -0.64 . . . . 0.0 110.296 178.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 27' ' ' TYR . 16.5 p -153.79 154.97 34.99 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.671 -0.643 . . . . 0.0 110.295 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.895 HG23 HG22 ' A' ' 36' ' ' ILE . 13.6 p -142.26 145.7 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.648 -0.657 . . . . 0.0 110.11 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -128.64 98.3 25.51 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.591 -0.693 . . . . 0.0 109.554 177.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -59.42 -41.1 61.04 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 O-C-N 123.507 1.267 . . . . 0.0 110.924 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -80.66 -25.52 38.22 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.388 -0.82 . . . . 0.0 110.156 -171.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.728 ' O ' HG23 ' A' ' 35' ' ' THR . 54.6 mt-10 -87.46 2.19 51.28 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.463 -0.773 . . . . 0.0 111.254 173.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.8 m 49.73 38.79 16.23 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.122 -0.986 . . . . 0.0 111.254 -176.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.728 HG23 ' O ' ' A' ' 33' ' ' GLU . 22.3 p -136.6 152.71 50.76 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.336 -0.852 . . . . 0.0 110.391 -174.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.895 HG22 HG23 ' A' ' 29' ' ' VAL . 40.0 pt -142.38 162.03 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.687 -0.633 . . . . 0.0 110.167 177.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.518 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.3 127.81 28.67 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.571 -0.706 . . . . 0.0 109.666 175.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.483 HD23 ' HA ' ' A' ' 26' ' ' LEU . 85.9 mt -109.9 148.03 32.31 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -177.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 96.8 p -119.41 152.8 36.23 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -178.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.8 p 45.65 84.38 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 CA-C-O 121.565 0.698 . . . . 0.0 110.301 -172.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.695 HG11 HD12 ' A' ' 65' ' ' ILE . 14.6 p -134.55 149.86 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.914 -0.491 . . . . 0.0 109.786 -178.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.582 ' HB3' HD12 ' A' ' 61' ' ' ILE . 32.1 ptt180 -135.11 153.13 52.12 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.679 -0.638 . . . . 0.0 109.941 177.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.9 p -109.43 141.93 41.14 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.736 -0.603 . . . . 0.0 109.911 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -82.55 -38.36 23.84 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.591 -0.693 . . . . 0.0 110.678 -175.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.64 167.37 28.2 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 176.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.662 HG22 HG12 ' A' ' 20' ' ' ILE . 16.3 p -118.29 6.51 11.91 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.944 -0.739 . . . . 0.0 111.015 175.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -48.94 -25.89 2.19 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.582 -0.699 . . . . 0.0 112.784 -167.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -66.82 -59.21 3.74 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.287 -0.883 . . . . 0.0 110.417 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -94.39 10.21 35.24 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.633 -0.667 . . . . 0.0 111.225 176.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -58.32 174.07 0.32 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.232 -0.918 . . . . 0.0 111.552 -170.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.1 p -78.83 164.64 24.33 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 122.0 -0.438 . . . . 0.0 109.94 174.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -77.33 2.76 14.83 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.996 -0.681 . . . . 0.0 111.103 177.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -101.7 151.91 21.48 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.31 -0.869 . . . . 0.0 109.527 169.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -66.49 138.93 57.87 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.501 -0.749 . . . . 0.0 110.56 -174.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.7 mt -109.97 135.22 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.704 -0.622 . . . . 0.0 109.459 177.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -83.84 146.06 48.4 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.762 -0.587 . . . . 0.0 110.176 -178.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -68.44 156.96 63.79 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 O-C-N 123.522 1.275 . . . . 0.0 110.269 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -79.64 132.58 36.28 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.683 -0.636 . . . . 0.0 110.041 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.9 m -98.98 30.29 3.46 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.749 -0.594 . . . . 0.0 110.541 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -175.65 160.85 2.52 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.634 -0.666 . . . . 0.0 109.78 -177.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.582 HD12 ' HB3' ' A' ' 42' ' ' ARG . 51.0 mm -96.74 157.4 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.703 -0.623 . . . . 0.0 109.725 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -93.0 114.08 26.54 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.556 -0.715 . . . . 0.0 110.177 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -51.23 -42.34 60.94 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.9 -0.5 . . . . 0.0 111.711 178.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.518 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.9 t80 -152.72 129.95 11.23 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.685 -0.635 . . . . 0.0 110.292 -174.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.695 HD12 HG11 ' A' ' 41' ' ' VAL . 76.2 mt -129.6 129.14 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.652 -0.655 . . . . 0.0 109.85 172.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 24.8 tp -90.65 137.0 32.7 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.774 -0.579 . . . . 0.0 109.918 176.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.601 ' CD1' HD11 ' A' ' 72' ' ' ILE . 3.7 m-85 -135.59 129.44 32.91 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.67 -0.644 . . . . 0.0 110.635 -175.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 73.5 mtt85 -92.1 150.06 21.16 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.797 -0.565 . . . . 0.0 110.352 173.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.18 -24.43 61.0 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.9 m -66.57 -42.09 87.58 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.493 -1.004 . . . . 0.0 111.034 -176.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -83.16 -32.75 26.46 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.445 -0.785 . . . . 0.0 110.969 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.735 HD13 HD21 ' A' ' 14' ' ' LEU . 14.7 mt -101.38 138.61 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.395 -0.816 . . . . 0.0 110.174 177.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -106.37 -18.54 13.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.892 -0.505 . . . . 0.0 111.736 -167.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -150.0 131.25 14.56 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 119.001 -1.08 . . . . 0.0 111.242 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.538 HD12 ' CD1' ' A' ' 14' ' ' LEU . 17.6 tt -132.14 139.83 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 176.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -146.29 133.22 20.2 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.521 -0.737 . . . . 0.0 110.411 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.3 p -87.62 147.1 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.722 -0.611 . . . . 0.0 110.29 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.572 HG11 ' HE3' ' A' ' 11' ' ' LYS . 60.6 t . . . . . 0 N--CA 1.497 1.895 0 O-C-N 121.56 -0.712 . . . . 0.0 109.759 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.4 mt . . . . . 0 N--CA 1.501 2.118 0 CA-C-O 120.915 0.388 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.79 -1.73 85.4 Favored Glycine 0 N--CA 1.498 2.78 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.561 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 45.8 m -59.36 155.58 14.43 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.129 -1.218 . . . . 0.0 110.484 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -81.35 124.49 29.41 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.734 -0.604 . . . . 0.0 110.794 -177.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.417 HD12 ' HB2' ' A' ' 26' ' ' LEU . 91.5 mt -121.92 146.16 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.661 -0.649 . . . . 0.0 110.017 178.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.6 t -103.19 137.26 41.58 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 176.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.694 HD21 HD13 ' A' ' 72' ' ' ILE . 13.9 tp -132.47 126.31 32.71 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.75 -0.594 . . . . 0.0 110.252 -170.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.1 mt -107.05 118.79 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.515 -0.741 . . . . 0.0 109.66 -178.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.0 m -93.59 157.71 16.05 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.039 0.447 . . . . 0.0 111.301 -177.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.5 tttm -53.99 -13.63 0.83 Allowed 'General case' 0 N--CA 1.508 2.441 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -172.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.532 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.9 20.37 4.23 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.107 -0.996 . . . . 0.0 110.426 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 53.86 34.45 19.36 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.521 -0.737 . . . . 0.0 109.865 -173.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.791 HG12 HG22 ' A' ' 46' ' ' THR . 72.2 mt -102.27 140.96 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -104.67 119.8 39.85 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.009 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -113.84 150.3 33.75 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 175.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.653 ' O ' HG23 ' A' ' 41' ' ' VAL . 58.3 mt-10 -141.45 140.54 33.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.423 -0.798 . . . . 0.0 109.796 174.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.53 173.1 43.2 Favored Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.764 -1.207 . . . . 0.0 110.377 -176.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -85.04 135.83 33.84 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.849 -0.795 . . . . 0.0 110.588 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.479 ' HA ' HD23 ' A' ' 38' ' ' LEU . 24.7 tp -66.08 120.02 12.43 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.583 -0.698 . . . . 0.0 110.716 175.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.44 ' O ' HG23 ' A' ' 28' ' ' THR . 24.2 t80 -99.78 -50.11 4.14 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.655 -0.653 . . . . 0.0 110.394 178.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 27' ' ' TYR . 15.7 p -153.96 155.84 36.35 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.67 -0.644 . . . . 0.0 110.305 -178.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.894 HG23 HG22 ' A' ' 36' ' ' ILE . 13.4 p -142.22 145.81 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.697 -0.627 . . . . 0.0 110.081 -179.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -128.66 101.78 20.51 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.629 -0.669 . . . . 0.0 109.54 177.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.44 -41.93 30.35 Favored 'Trans proline' 0 N--CA 1.49 1.276 0 O-C-N 123.553 1.291 . . . . 0.0 110.746 -174.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -80.76 -23.56 39.28 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.384 -0.822 . . . . 0.0 110.212 -172.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.667 ' O ' HG23 ' A' ' 35' ' ' THR . 74.9 mm-40 -87.26 0.75 54.89 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.476 -0.765 . . . . 0.0 111.178 173.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.3 m 49.91 38.14 15.41 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.157 -0.964 . . . . 0.0 111.255 -176.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.667 HG23 ' O ' ' A' ' 33' ' ' GLU . 17.2 p -136.71 153.34 50.9 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.402 -0.811 . . . . 0.0 110.403 -174.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.894 HG22 HG23 ' A' ' 29' ' ' VAL . 39.9 pt -142.31 162.0 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.719 -0.613 . . . . 0.0 110.081 177.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.513 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -135.87 127.95 29.75 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.61 -0.681 . . . . 0.0 109.722 176.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.479 HD23 ' HA ' ' A' ' 26' ' ' LEU . 86.1 mt -109.88 147.73 32.84 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -177.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 95.7 p -118.51 151.42 37.87 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -178.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.7 p 45.8 84.05 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 CA-C-O 121.517 0.675 . . . . 0.0 110.341 -172.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.673 ' CG1' HD12 ' A' ' 65' ' ' ILE . 14.3 p -134.56 150.92 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.935 -0.478 . . . . 0.0 109.717 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -135.8 153.19 51.6 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.602 -0.686 . . . . 0.0 110.087 178.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.4 p -108.19 139.66 42.54 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.733 -0.604 . . . . 0.0 109.834 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -82.94 -38.33 22.93 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.657 -0.652 . . . . 0.0 111.056 -173.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.67 172.22 34.52 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 119.975 -1.107 . . . . 0.0 110.522 177.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.791 HG22 HG12 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -118.01 6.58 12.15 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.928 -0.748 . . . . 0.0 110.739 174.1 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -48.99 -25.2 1.84 Allowed 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.618 -0.676 . . . . 0.0 112.528 -169.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -64.42 -59.19 4.64 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.291 -0.881 . . . . 0.0 110.574 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -94.29 10.22 35.0 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.612 -0.68 . . . . 0.0 111.408 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.5 p-10 -61.4 174.19 0.77 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.279 -0.888 . . . . 0.0 111.244 -171.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.8 p -78.91 164.59 24.32 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.922 -0.486 . . . . 0.0 109.876 174.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -77.46 2.57 15.78 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.081 177.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -97.86 166.05 11.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.126 -0.984 . . . . 0.0 109.513 169.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -65.97 140.54 58.32 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.543 -0.723 . . . . 0.0 110.451 -175.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.466 ' N ' HD12 ' A' ' 55' ' ' ILE . 4.9 mp -111.95 141.91 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.702 -0.624 . . . . 0.0 109.705 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -92.06 109.87 40.34 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.65 -0.656 . . . . 0.0 110.178 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -66.79 146.96 80.18 Favored 'Trans proline' 0 N--CA 1.489 1.258 0 O-C-N 123.373 1.196 . . . . 0.0 110.428 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -96.81 117.24 30.63 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.678 -0.639 . . . . 0.0 110.165 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 86.8 p -88.29 -28.73 20.89 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.732 -0.605 . . . . 0.0 110.609 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -62.13 146.86 49.33 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.539 -0.726 . . . . 0.0 110.693 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.3 mm -96.77 144.72 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.695 -0.628 . . . . 0.0 109.708 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -94.97 114.54 26.37 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.586 -0.696 . . . . 0.0 110.285 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -51.08 -40.22 57.87 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.781 -0.575 . . . . 0.0 111.728 177.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.513 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.6 t80 -152.97 129.92 11.02 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.637 -0.664 . . . . 0.0 110.257 -174.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.673 HD12 ' CG1' ' A' ' 41' ' ' VAL . 74.3 mt -129.33 129.35 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.678 -0.639 . . . . 0.0 109.798 171.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.0 tp -90.38 137.06 32.66 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.87 -0.519 . . . . 0.0 109.865 176.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.602 ' CD1' HD11 ' A' ' 72' ' ' ILE . 3.2 m-85 -135.75 129.75 33.07 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.604 -0.685 . . . . 0.0 110.579 -175.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -92.08 150.18 21.1 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.748 -0.595 . . . . 0.0 110.325 173.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.29 -24.49 61.33 Favored Glycine 0 N--CA 1.498 2.818 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 177.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.5 m -66.59 -42.12 87.42 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.472 -1.016 . . . . 0.0 111.115 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -83.0 -32.94 26.68 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.415 -0.803 . . . . 0.0 110.905 -175.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.694 HD13 HD21 ' A' ' 14' ' ' LEU . 13.9 mt -100.77 139.89 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.418 -0.802 . . . . 0.0 110.124 177.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.0 tptm -106.27 -21.28 13.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.937 -0.477 . . . . 0.0 111.606 -166.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -150.63 135.28 17.32 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 119.037 -1.065 . . . . 0.0 111.353 -177.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.517 HD12 ' CD1' ' A' ' 14' ' ' LEU . 18.3 tt -133.2 142.13 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -146.44 139.02 25.24 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.535 -0.728 . . . . 0.0 110.411 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.0 t -87.2 144.48 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.621 -0.674 . . . . 0.0 109.638 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.8 t . . . . . 0 N--CA 1.496 1.863 0 O-C-N 121.492 -0.755 . . . . 0.0 109.831 -178.391 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.4 mt . . . . . 0 N--CA 1.501 2.096 0 CA-C-O 121.031 0.443 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.73 -1.87 84.83 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.763 177.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 67.0 m -61.39 137.64 58.24 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.138 -1.213 . . . . 0.0 110.411 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -82.15 124.36 29.8 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.72 -0.612 . . . . 0.0 110.611 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.62 ' CD1' HD13 ' A' ' 26' ' ' LEU . 88.1 mt -121.16 145.12 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.644 -0.66 . . . . 0.0 110.17 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.8 t -103.44 137.27 41.77 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 175.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.709 HD21 HD13 ' A' ' 72' ' ' ILE . 13.8 tp -133.04 125.96 30.83 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.68 -0.638 . . . . 0.0 110.259 -169.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.0 mt -106.68 117.84 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.47 -0.769 . . . . 0.0 109.683 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.0 m -93.04 157.83 16.1 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.06 0.457 . . . . 0.0 111.254 -177.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -54.03 -13.9 0.92 Allowed 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -171.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.54 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -90.09 20.6 4.19 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.094 -1.004 . . . . 0.0 110.408 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 54.37 34.16 20.11 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.512 -0.743 . . . . 0.0 109.788 -174.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.808 HG12 HG22 ' A' ' 46' ' ' THR . 69.8 mt -102.47 141.82 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 36.8 ttp180 -104.85 119.86 40.01 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.973 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -114.0 150.3 34.08 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 174.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.655 ' O ' HG23 ' A' ' 41' ' ' VAL . 42.1 tt0 -140.7 140.47 34.92 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.535 -0.728 . . . . 0.0 109.515 175.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.58 172.69 43.13 Favored Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.657 -175.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -85.08 136.15 33.69 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.908 -0.76 . . . . 0.0 110.532 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.62 HD13 ' CD1' ' A' ' 12' ' ' ILE . 15.5 tp -66.14 118.83 10.44 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.62 -0.675 . . . . 0.0 110.716 175.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.449 ' O ' HG23 ' A' ' 28' ' ' THR . 24.9 t80 -100.03 -50.13 4.09 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.662 -0.649 . . . . 0.0 110.376 177.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 27' ' ' TYR . 14.8 p -154.09 153.74 32.41 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.701 -0.625 . . . . 0.0 110.284 -178.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.892 HG23 HG22 ' A' ' 36' ' ' ILE . 13.3 p -142.19 145.24 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.656 -0.652 . . . . 0.0 110.033 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -128.22 100.48 23.26 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.625 -0.672 . . . . 0.0 109.457 176.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.34 -42.79 26.09 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 O-C-N 123.496 1.261 . . . . 0.0 110.792 -174.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -80.2 -27.33 38.87 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.295 -0.878 . . . . 0.0 109.95 -172.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.597 ' O ' HG23 ' A' ' 35' ' ' THR . 74.9 mm-40 -89.24 12.04 17.12 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.62 -0.675 . . . . 0.0 111.268 172.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 6.3 p 47.48 33.62 2.94 Favored 'General case' 0 N--CA 1.507 2.411 0 O-C-N 121.783 -0.573 . . . . 0.0 112.034 173.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.597 HG23 ' O ' ' A' ' 33' ' ' GLU . 9.1 p -136.56 154.73 50.62 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.458 -0.776 . . . . 0.0 110.432 -173.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.892 HG22 HG23 ' A' ' 29' ' ' VAL . 40.0 pt -142.45 162.03 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.704 -0.622 . . . . 0.0 110.158 177.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.521 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -137.01 127.76 27.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.678 -0.639 . . . . 0.0 109.735 175.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.46 HD23 ' HA ' ' A' ' 26' ' ' LEU . 87.4 mt -109.91 148.04 32.29 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -177.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 95.8 p -119.44 152.93 36.05 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.5 p 45.79 84.29 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 CA-C-O 121.494 0.664 . . . . 0.0 110.271 -172.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.694 HG11 HD12 ' A' ' 65' ' ' ILE . 14.9 p -134.52 151.26 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -178.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -135.97 153.2 51.48 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.629 -0.669 . . . . 0.0 109.947 177.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 84.5 p -107.61 139.34 42.3 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.703 -0.623 . . . . 0.0 109.763 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -82.49 -38.36 23.99 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.626 -0.671 . . . . 0.0 110.941 -173.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.56 169.95 31.75 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 120.032 -1.08 . . . . 0.0 110.417 176.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.808 HG22 HG12 ' A' ' 20' ' ' ILE . 1.1 p -118.08 6.6 12.09 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.906 -0.761 . . . . 0.0 110.886 174.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -48.99 -26.03 2.3 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.649 -0.657 . . . . 0.0 112.504 -167.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -64.98 -59.23 4.39 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.267 -0.896 . . . . 0.0 110.555 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 82.5 mmt-85 -94.35 10.25 35.0 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.655 -0.653 . . . . 0.0 111.335 177.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.8 p-10 -60.15 173.46 0.64 Allowed 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.224 -0.923 . . . . 0.0 111.518 -169.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.3 m -78.92 164.45 24.42 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 173.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -77.33 3.34 13.31 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.596 -0.69 . . . . 0.0 111.309 -178.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -102.12 154.92 18.55 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.242 -0.911 . . . . 0.0 109.637 170.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -67.21 141.09 57.42 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.557 -0.714 . . . . 0.0 110.605 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 81.3 mt -114.91 137.04 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.658 -0.651 . . . . 0.0 109.596 177.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.07 109.97 53.98 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.746 -0.597 . . . . 0.0 110.143 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -67.14 151.19 81.84 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 O-C-N 123.355 1.187 . . . . 0.0 110.345 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -94.03 123.95 37.73 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.691 -0.63 . . . . 0.0 110.245 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.0 m -66.29 -31.5 72.35 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.741 -0.6 . . . . 0.0 110.519 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -61.69 148.49 42.54 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.561 -0.712 . . . . 0.0 110.687 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.2 mm -96.83 156.57 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.743 -0.598 . . . . 0.0 109.767 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -93.45 112.44 24.35 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.677 -0.64 . . . . 0.0 110.171 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -51.17 -43.03 61.2 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.807 -0.558 . . . . 0.0 111.669 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.521 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.7 t80 -152.88 130.27 11.35 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.659 -0.65 . . . . 0.0 110.284 -174.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.694 HD12 HG11 ' A' ' 41' ' ' VAL . 74.9 mt -128.93 128.6 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.66 -0.65 . . . . 0.0 109.859 172.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.0 tp -90.42 137.05 32.66 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.902 -0.498 . . . . 0.0 109.862 176.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.558 ' CD1' HD11 ' A' ' 72' ' ' ILE . 2.9 m-85 -135.45 129.65 33.54 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.645 -0.66 . . . . 0.0 110.546 -175.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -91.26 147.39 23.08 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.684 -0.635 . . . . 0.0 110.239 173.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.89 -26.38 60.56 Favored Glycine 0 N--CA 1.498 2.818 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.0 m -65.87 -39.65 90.91 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.476 -1.014 . . . . 0.0 110.947 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.68 -32.54 31.7 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.462 -0.774 . . . . 0.0 110.858 -174.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.709 HD13 HD21 ' A' ' 14' ' ' LEU . 8.1 mt -102.83 140.85 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.382 -0.824 . . . . 0.0 110.156 177.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -105.04 -21.82 13.21 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.522 -167.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -151.39 134.27 15.75 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 119.068 -1.053 . . . . 0.0 111.368 -177.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.536 HD12 ' CD1' ' A' ' 14' ' ' LEU . 17.6 tt -131.5 140.09 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.882 -0.511 . . . . 0.0 109.739 176.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -146.83 142.83 28.1 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.548 -0.72 . . . . 0.0 110.4 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.4 m -85.03 147.03 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.653 -0.654 . . . . 0.0 110.183 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.9 t . . . . . 0 N--CA 1.497 1.904 0 O-C-N 121.587 -0.695 . . . . 0.0 109.771 -179.586 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.5 mt . . . . . 0 N--CA 1.501 2.109 0 CA-C-O 120.961 0.41 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.72 -1.8 85.02 Favored Glycine 0 N--CA 1.497 2.755 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.727 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.5 m -60.25 152.99 23.46 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.118 -1.225 . . . . 0.0 110.45 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.526 ' HE3' HG11 ' A' ' 78' ' ' VAL . 29.9 pttt -81.13 125.99 30.92 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.738 -0.601 . . . . 0.0 110.387 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.402 HD12 ' HB2' ' A' ' 26' ' ' LEU . 90.2 mt -124.3 143.79 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.547 -0.721 . . . . 0.0 110.129 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.5 t -101.66 137.25 40.22 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 174.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.64 HD21 HD13 ' A' ' 72' ' ' ILE . 15.2 tp -133.9 127.72 33.09 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.694 -0.629 . . . . 0.0 110.282 -169.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 81.9 mt -108.51 121.06 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.455 -0.778 . . . . 0.0 109.683 -178.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 18.3 m -94.51 157.62 15.92 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 120.981 0.42 . . . . 0.0 111.171 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -55.43 -11.5 0.85 Allowed 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -173.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.566 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -90.2 20.54 4.31 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.097 -1.002 . . . . 0.0 110.453 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 54.16 34.2 19.63 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.505 -0.747 . . . . 0.0 109.795 -174.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.803 HG12 HG22 ' A' ' 46' ' ' THR . 66.2 mt -102.6 141.91 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -105.84 119.83 40.16 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.007 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -114.4 148.82 37.12 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 173.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.648 ' O ' HG23 ' A' ' 41' ' ' VAL . 41.4 tt0 -140.09 140.5 36.1 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.37 -0.831 . . . . 0.0 109.504 175.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.53 173.5 43.22 Favored Glycine 0 N--CA 1.496 2.651 0 C-N-CA 119.636 -1.269 . . . . 0.0 110.617 -175.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 39.6 mmm-85 -84.83 134.19 34.3 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.926 -0.75 . . . . 0.0 110.439 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.481 ' HA ' HD23 ' A' ' 38' ' ' LEU . 25.7 tp -66.21 118.62 10.18 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.605 -0.684 . . . . 0.0 110.61 175.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.452 ' O ' HG23 ' A' ' 28' ' ' THR . 23.5 t80 -99.43 -50.19 4.18 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.567 -0.708 . . . . 0.0 110.413 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 27' ' ' TYR . 13.3 p -154.12 154.97 34.53 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.704 -0.622 . . . . 0.0 110.326 -178.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.893 HG23 HG22 ' A' ' 36' ' ' ILE . 13.2 p -142.34 144.95 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.737 -0.602 . . . . 0.0 110.055 -179.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -129.05 102.14 19.18 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.58 -0.7 . . . . 0.0 109.496 177.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.93 -38.04 50.08 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 O-C-N 123.652 1.343 . . . . 0.0 110.814 -174.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -80.42 -27.37 38.05 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.296 -0.878 . . . . 0.0 110.137 -170.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.577 ' O ' HG23 ' A' ' 35' ' ' THR . 49.5 mt-10 -87.85 2.51 51.26 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.512 -0.742 . . . . 0.0 111.28 173.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 55.5 m 49.3 40.02 17.33 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.077 -1.014 . . . . 0.0 111.326 -176.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.577 HG23 ' O ' ' A' ' 33' ' ' GLU . 9.6 p -135.92 153.13 51.53 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.357 -0.839 . . . . 0.0 110.411 -174.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.893 HG22 HG23 ' A' ' 29' ' ' VAL . 40.4 pt -142.63 162.01 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.685 -0.634 . . . . 0.0 110.082 178.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.518 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.42 128.22 29.15 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.655 -0.653 . . . . 0.0 109.741 175.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.481 HD23 ' HA ' ' A' ' 26' ' ' LEU . 88.7 mt -109.92 147.36 33.55 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 99.7 p -117.99 151.77 36.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.619 -0.676 . . . . 0.0 109.24 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.3 p 45.94 85.17 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 CA-C-O 121.574 0.702 . . . . 0.0 110.352 -172.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.697 HG11 HD12 ' A' ' 65' ' ' ILE . 14.3 p -134.66 150.55 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -178.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.508 ' HB3' HD12 ' A' ' 61' ' ' ILE . 14.0 ptm180 -133.38 153.09 51.89 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.6 -0.688 . . . . 0.0 109.941 178.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 84.0 p -110.14 140.01 44.68 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.656 -0.653 . . . . 0.0 109.875 178.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -82.89 -38.46 22.86 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.6 -0.688 . . . . 0.0 110.893 -174.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.59 168.65 30.05 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 176.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.803 HG22 HG12 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -118.13 6.48 12.04 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.863 -0.786 . . . . 0.0 111.03 174.687 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -49.06 -26.49 2.68 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.556 -0.715 . . . . 0.0 112.314 -168.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -66.34 -59.22 3.91 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.348 -0.845 . . . . 0.0 110.35 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -94.25 10.22 34.9 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.66 -0.65 . . . . 0.0 111.354 177.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 49.9 p-10 -58.71 172.91 0.46 Allowed 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.252 -0.905 . . . . 0.0 111.261 -170.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.8 m -78.99 164.44 24.39 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.942 -0.474 . . . . 0.0 109.743 175.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -77.39 2.89 14.61 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.646 -0.659 . . . . 0.0 111.246 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -98.58 165.08 11.98 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.332 -0.855 . . . . 0.0 109.551 170.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -67.88 135.52 52.62 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.51 -0.744 . . . . 0.0 110.439 -175.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 45.5 mm -114.1 132.82 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.726 -0.609 . . . . 0.0 109.58 177.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.03 137.28 29.69 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.717 -0.615 . . . . 0.0 110.136 -178.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -69.81 145.95 58.38 Favored 'Trans proline' 0 N--CA 1.488 1.155 0 O-C-N 123.463 1.244 . . . . 0.0 110.244 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -100.6 115.15 29.5 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.681 -0.637 . . . . 0.0 110.198 178.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 28.6 m -85.24 -33.01 22.3 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.7 -0.625 . . . . 0.0 110.329 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -62.37 143.93 56.4 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.687 -0.633 . . . . 0.0 110.567 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.508 HD12 ' HB3' ' A' ' 42' ' ' ARG . 49.4 mm -96.76 149.96 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.649 -0.657 . . . . 0.0 109.814 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -94.37 115.66 27.9 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.644 -0.66 . . . . 0.0 110.208 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -51.31 -40.97 60.16 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.769 -0.582 . . . . 0.0 111.804 178.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.518 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.8 t80 -153.38 130.51 11.13 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.686 -0.634 . . . . 0.0 110.316 -174.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.697 HD12 HG11 ' A' ' 41' ' ' VAL . 78.3 mt -129.88 129.61 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.659 -0.65 . . . . 0.0 109.895 172.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 24.5 tp -90.42 137.06 32.65 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.862 -0.524 . . . . 0.0 109.898 176.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.532 ' CD1' HD11 ' A' ' 72' ' ' ILE . 2.9 m-85 -135.53 130.29 34.36 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.701 -0.624 . . . . 0.0 110.45 -175.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -91.17 147.53 22.99 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.762 -0.586 . . . . 0.0 110.272 173.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.08 -25.63 60.03 Favored Glycine 0 N--CA 1.499 2.865 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.8 m -65.92 -39.36 90.48 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.46 -1.024 . . . . 0.0 110.898 -178.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -82.36 -32.5 29.23 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.541 -0.725 . . . . 0.0 111.055 -175.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.64 HD13 HD21 ' A' ' 14' ' ' LEU . 10.1 mt -104.84 141.35 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.412 -0.805 . . . . 0.0 110.209 177.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -106.98 -24.19 12.08 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.891 -0.505 . . . . 0.0 111.659 -166.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -150.62 139.15 20.55 Favored 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 119.013 -1.075 . . . . 0.0 111.359 -176.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.472 HD12 HD13 ' A' ' 14' ' ' LEU . 18.2 tt -134.16 143.85 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.996 -0.44 . . . . 0.0 110.023 178.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -143.03 127.19 17.52 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.65 -0.656 . . . . 0.0 110.052 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.5 p -87.7 145.77 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.56 -0.713 . . . . 0.0 110.434 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.526 HG11 ' HE3' ' A' ' 11' ' ' LYS . 60.9 t . . . . . 0 N--CA 1.497 1.898 0 O-C-N 121.629 -0.669 . . . . 0.0 109.78 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.9 mt . . . . . 0 N--CA 1.5 2.055 0 CA-C-O 120.948 0.404 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.65 -1.88 84.59 Favored Glycine 0 N--CA 1.497 2.73 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.808 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.9 m -60.81 153.01 25.6 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 120.997 -1.296 . . . . 0.0 110.445 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.511 ' HE3' HG11 ' A' ' 78' ' ' VAL . 28.5 pttt -82.05 126.92 32.56 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.714 -0.616 . . . . 0.0 110.67 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.688 ' CD1' HD13 ' A' ' 26' ' ' LEU . 86.3 mt -118.6 142.39 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.581 -0.699 . . . . 0.0 109.941 179.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.6 t -103.67 137.34 41.85 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 175.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.815 HD21 HD13 ' A' ' 72' ' ' ILE . 13.7 tp -135.96 127.89 29.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.665 -0.647 . . . . 0.0 110.487 -169.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 79.5 mt -107.17 120.56 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.507 -0.746 . . . . 0.0 109.609 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.0 m -95.15 157.58 15.83 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.027 0.441 . . . . 0.0 111.134 -177.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -56.43 -11.44 1.26 Allowed 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -173.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.77 22.01 3.29 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.124 -0.985 . . . . 0.0 110.348 177.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 57.55 34.48 24.62 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.56 -0.713 . . . . 0.0 110.12 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.697 HG12 HG22 ' A' ' 46' ' ' THR . 42.8 mt -107.27 148.97 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.713 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -107.83 119.71 40.22 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.07 175.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -113.41 154.07 27.56 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 175.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.67 ' O ' HG23 ' A' ' 41' ' ' VAL . 42.3 tt0 -142.83 140.47 31.31 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.596 -0.69 . . . . 0.0 109.521 173.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -164.17 169.77 39.15 Favored Glycine 0 N--CA 1.496 2.657 0 C-N-CA 119.648 -1.263 . . . . 0.0 110.619 -176.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -84.61 137.43 33.29 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.911 -0.758 . . . . 0.0 110.525 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.688 HD13 ' CD1' ' A' ' 12' ' ' ILE . 15.8 tp -66.14 117.55 8.62 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.629 -0.669 . . . . 0.0 110.645 175.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.451 ' O ' HG23 ' A' ' 28' ' ' THR . 20.2 t80 -99.88 -50.15 4.11 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.585 -0.697 . . . . 0.0 110.309 177.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 27' ' ' TYR . 15.2 p -153.7 153.61 32.56 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.709 -0.619 . . . . 0.0 110.233 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.891 HG23 HG22 ' A' ' 36' ' ' ILE . 13.3 p -142.26 145.1 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.709 -0.619 . . . . 0.0 110.096 -178.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -129.04 102.2 19.16 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.669 -0.644 . . . . 0.0 109.477 176.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.71 -39.42 43.28 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 O-C-N 123.575 1.303 . . . . 0.0 110.863 -174.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -80.49 -26.4 38.23 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.339 -0.851 . . . . 0.0 110.152 -170.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.73 ' O ' HG23 ' A' ' 35' ' ' THR . 75.0 mm-40 -87.6 2.13 51.75 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.532 -0.73 . . . . 0.0 111.292 173.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.3 m 49.65 40.16 19.09 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 120.996 -1.065 . . . . 0.0 111.229 -176.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.73 HG23 ' O ' ' A' ' 33' ' ' GLU . 22.3 p -136.54 151.84 49.84 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.383 -0.823 . . . . 0.0 110.397 -174.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.891 HG22 HG23 ' A' ' 29' ' ' VAL . 40.1 pt -142.65 161.97 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.637 -0.664 . . . . 0.0 110.226 177.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.521 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -135.46 127.51 29.75 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.629 -0.669 . . . . 0.0 109.695 175.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 26' ' ' LEU . 83.9 mt -109.99 145.23 37.32 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -177.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.8 p -116.73 152.36 34.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.625 -0.672 . . . . 0.0 109.195 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 44.9 p 45.81 86.43 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.225 0 CA-C-O 121.502 0.668 . . . . 0.0 110.288 -172.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.707 HG11 HD12 ' A' ' 65' ' ' ILE . 12.9 p -134.65 147.73 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -178.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -129.1 153.03 48.05 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.748 -0.595 . . . . 0.0 109.754 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.5 p -107.51 121.81 45.37 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -83.09 -38.53 22.36 Favored 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.964 -169.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.4 -177.51 41.86 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.697 HG22 HG12 ' A' ' 20' ' ' ILE . 66.5 p -118.12 -2.41 11.22 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.794 -0.827 . . . . 0.0 110.645 172.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -54.41 -24.92 21.85 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.379 -0.825 . . . . 0.0 112.528 -162.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -77.07 -59.47 2.77 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.252 -0.905 . . . . 0.0 110.928 -174.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 70.7 mtp85 -94.51 6.15 49.66 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.631 -0.668 . . . . 0.0 112.098 -175.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.8 p-10 -89.32 174.45 7.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.092 -1.005 . . . . 0.0 111.295 -172.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.8 m -78.76 164.47 24.53 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.056 0.455 . . . . 0.0 110.013 178.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -77.66 9.24 3.55 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.743 -0.598 . . . . 0.0 111.71 -176.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -87.98 155.18 19.96 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.098 -1.001 . . . . 0.0 109.948 172.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -67.15 129.94 41.51 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.698 -0.627 . . . . 0.0 110.827 -172.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 82.4 mt -129.0 140.63 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.737 -0.602 . . . . 0.0 109.444 175.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.0 109.84 53.27 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.547 -0.72 . . . . 0.0 110.371 -178.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -77.63 157.07 32.03 Favored 'Trans proline' 0 N--CA 1.486 1.066 0 O-C-N 123.449 1.237 . . . . 0.0 110.432 176.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -114.67 131.22 56.81 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.656 -0.652 . . . . 0.0 110.14 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.6 m -97.06 12.41 32.71 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.69 -0.631 . . . . 0.0 111.333 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -63.62 145.07 56.42 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.308 -0.87 . . . . 0.0 110.564 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.81 128.94 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.613 -0.68 . . . . 0.0 109.863 178.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.512 ' CG ' HD11 ' A' ' 65' ' ' ILE . 22.0 m-85 -98.99 119.53 37.92 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.689 -0.632 . . . . 0.0 110.376 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -51.75 -41.22 61.43 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.715 -0.615 . . . . 0.0 111.252 173.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.521 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.7 t80 -153.98 128.82 9.46 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.686 -0.634 . . . . 0.0 110.103 -175.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.707 HD12 HG11 ' A' ' 41' ' ' VAL . 67.4 mt -126.31 130.33 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.639 -0.663 . . . . 0.0 109.879 172.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.5 tp -89.94 137.06 32.65 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.838 -0.539 . . . . 0.0 109.686 175.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.648 ' CD1' HD11 ' A' ' 72' ' ' ILE . 3.3 m-85 -133.8 126.5 30.71 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.706 -0.621 . . . . 0.0 110.55 -175.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -92.71 149.95 20.99 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.689 -0.632 . . . . 0.0 110.305 172.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.83 -24.01 57.02 Favored Glycine 0 N--CA 1.498 2.821 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 177.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.0 p -68.32 -42.05 79.94 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.409 -1.053 . . . . 0.0 111.115 -176.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -82.98 -29.38 29.04 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.331 -0.856 . . . . 0.0 111.028 -175.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.815 HD13 HD21 ' A' ' 14' ' ' LEU . 15.4 mt -103.74 140.7 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.416 -0.802 . . . . 0.0 110.255 176.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -105.74 -19.83 13.64 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.912 -0.492 . . . . 0.0 111.552 -168.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -149.98 131.55 14.86 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 119.046 -1.062 . . . . 0.0 111.319 -178.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.7 tt -129.88 138.81 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.979 -0.451 . . . . 0.0 109.809 176.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 90.6 mtt-85 -146.89 137.94 23.99 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.543 -0.723 . . . . 0.0 110.421 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.6 t -87.17 143.76 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.658 -0.652 . . . . 0.0 109.693 178.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.511 HG11 ' HE3' ' A' ' 11' ' ' LYS . 55.9 t . . . . . 0 N--CA 1.496 1.872 0 O-C-N 121.541 -0.724 . . . . 0.0 109.885 -178.5 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.1 mt . . . . . 0 N--CA 1.502 2.159 0 CA-C-O 121.05 0.452 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.57 -2.37 82.78 Favored Glycine 0 N--CA 1.497 2.765 0 C-N-CA 120.699 -0.763 . . . . 0.0 111.944 175.196 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.1 m -64.29 150.62 45.71 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.168 -1.195 . . . . 0.0 110.389 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -81.42 127.84 33.22 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.623 -0.673 . . . . 0.0 110.052 175.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.636 ' CD1' HD13 ' A' ' 26' ' ' LEU . 88.4 mt -125.12 143.92 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.435 -0.791 . . . . 0.0 110.299 -178.317 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.6 t -102.19 137.28 40.66 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 173.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.467 ' CD1' HD12 ' A' ' 75' ' ' ILE . 12.6 tp -134.66 130.6 36.61 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.675 -0.641 . . . . 0.0 110.292 -170.183 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.2 mt -107.12 121.49 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.508 -0.745 . . . . 0.0 109.743 -178.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.6 m -93.95 157.86 15.91 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.033 0.444 . . . . 0.0 111.23 -178.129 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -53.35 -15.41 0.99 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -171.045 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.497 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -90.17 20.65 4.21 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.148 -0.97 . . . . 0.0 110.433 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 54.1 34.98 21.2 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.446 -0.784 . . . . 0.0 109.805 -174.511 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.864 HG12 HG22 ' A' ' 46' ' ' THR . 69.8 mt -102.89 143.1 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.21 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -103.77 119.83 39.72 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.159 -178.614 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -113.7 149.7 34.36 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 175.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.63 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.3 mt-10 -141.17 140.6 34.08 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.418 -0.801 . . . . 0.0 109.815 175.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.35 172.84 43.04 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 119.716 -1.231 . . . . 0.0 110.529 -175.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 80.8 mtt85 -86.0 135.91 33.46 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.888 -0.772 . . . . 0.0 110.62 179.05 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.636 HD13 ' CD1' ' A' ' 12' ' ' ILE . 13.6 tp -66.17 118.0 9.27 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.605 -0.684 . . . . 0.0 110.663 176.6 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.462 ' O ' HG23 ' A' ' 28' ' ' THR . 28.8 t80 -100.24 -50.14 4.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.627 -0.67 . . . . 0.0 110.55 179.093 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 27' ' ' TYR . 11.7 p -154.63 155.61 34.99 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.603 -0.686 . . . . 0.0 110.382 -178.024 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.842 HG23 HG22 ' A' ' 36' ' ' ILE . 13.2 p -142.31 145.92 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.744 -0.597 . . . . 0.0 110.009 -179.425 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -128.92 100.26 21.2 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.603 -0.686 . . . . 0.0 109.503 177.581 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.58 -37.16 60.09 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 O-C-N 123.599 1.315 . . . . 0.0 110.793 -175.17 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -80.07 -27.98 39.26 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.379 -0.826 . . . . 0.0 110.061 -171.251 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.577 ' O ' HG23 ' A' ' 35' ' ' THR . 77.8 mt-10 -88.23 2.6 51.92 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.545 -0.722 . . . . 0.0 111.235 174.011 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 39.0 m 49.44 40.66 19.41 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.007 -1.058 . . . . 0.0 111.198 -175.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.577 HG23 ' O ' ' A' ' 33' ' ' GLU . 11.2 p -135.73 154.49 51.23 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.436 -0.79 . . . . 0.0 110.381 -175.166 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.842 HG22 HG23 ' A' ' 29' ' ' VAL . 40.0 pt -141.94 162.03 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.718 -0.614 . . . . 0.0 110.142 177.675 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.514 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.9 128.37 28.43 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.695 -0.628 . . . . 0.0 109.802 175.482 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 26' ' ' LEU . 85.0 mt -109.81 147.01 34.06 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -178.536 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 87.6 p -115.71 150.12 37.33 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -177.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 52.5 p 45.73 85.36 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 121.504 0.668 . . . . 0.0 110.29 -172.657 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.709 ' CG1' HD12 ' A' ' 65' ' ' ILE . 15.0 p -134.64 152.33 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -178.787 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -136.39 153.09 51.2 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.503 -0.748 . . . . 0.0 110.236 179.037 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.6 p -109.69 136.3 49.25 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.764 -0.585 . . . . 0.0 109.637 176.576 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -83.04 -38.59 22.36 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.537 -0.727 . . . . 0.0 111.19 -172.533 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.4 174.94 36.93 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.912 -1.137 . . . . 0.0 110.515 176.195 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.864 HG22 HG12 ' A' ' 20' ' ' ILE . 7.4 p -116.75 6.53 13.26 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.834 -0.804 . . . . 0.0 110.528 169.645 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -52.35 -24.56 7.82 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.615 -0.678 . . . . 0.0 112.597 -166.451 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -64.14 -59.43 4.45 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.154 -0.966 . . . . 0.0 110.604 -176.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 39.6 mtp85 -94.54 10.2 35.61 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.55 -0.719 . . . . 0.0 111.393 176.512 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.5 p-10 -58.91 172.29 0.57 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.234 -0.916 . . . . 0.0 111.552 -169.161 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.8 m -85.0 164.49 18.23 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 174.717 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -77.47 3.81 12.55 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.642 -0.661 . . . . 0.0 111.287 -179.364 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -95.17 157.48 15.88 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.247 -0.908 . . . . 0.0 109.683 168.873 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -70.52 139.25 51.54 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.645 -0.659 . . . . 0.0 110.538 -176.004 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.7 mt -115.36 136.23 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.725 -0.61 . . . . 0.0 109.556 176.76 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.11 113.08 12.87 Favored Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 121.707 -0.621 . . . . 0.0 110.138 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -66.93 143.76 67.67 Favored 'Trans proline' 0 N--CA 1.488 1.188 0 O-C-N 123.389 1.205 . . . . 0.0 110.392 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -97.82 114.7 26.8 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.72 -0.612 . . . . 0.0 110.216 -179.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.6 t -101.54 -32.95 10.13 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.721 -0.612 . . . . 0.0 110.306 179.457 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -62.24 151.49 36.13 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.627 -0.671 . . . . 0.0 110.634 -178.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.2 mm -96.81 142.71 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.808 -0.557 . . . . 0.0 109.79 179.672 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -94.82 118.09 31.2 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.613 -0.679 . . . . 0.0 110.137 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -51.14 -42.36 60.7 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.859 -0.525 . . . . 0.0 111.732 178.618 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.514 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.0 t80 -152.7 130.88 11.95 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.609 -0.682 . . . . 0.0 110.182 -174.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.709 HD12 ' CG1' ' A' ' 41' ' ' VAL . 75.5 mt -129.73 127.45 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.625 -0.672 . . . . 0.0 109.859 172.148 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 23.9 tp -90.2 137.1 32.62 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.817 -0.552 . . . . 0.0 109.741 175.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.425 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 3.6 m-85 -136.57 131.16 33.43 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.629 -0.67 . . . . 0.0 110.6 -175.691 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -90.71 149.18 22.15 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.781 -0.575 . . . . 0.0 110.187 174.741 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.26 -25.06 59.69 Favored Glycine 0 N--CA 1.5 2.912 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 178.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.9 m -65.91 -40.55 91.6 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.412 -1.052 . . . . 0.0 110.885 -178.432 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.95 -34.42 29.8 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.631 -0.668 . . . . 0.0 110.929 -174.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.425 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 13.9 mt -105.94 140.26 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.429 -0.794 . . . . 0.0 110.11 177.617 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 47.8 tttm -107.27 -24.62 11.82 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.839 -164.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -149.12 140.78 23.5 Favored 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.548 -174.414 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.467 HD12 ' CD1' ' A' ' 14' ' ' LEU . 15.4 tt -134.09 147.81 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.939 -0.475 . . . . 0.0 110.106 179.567 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -147.02 129.75 16.1 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.597 -0.69 . . . . 0.0 110.287 176.59 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.41 HG22 HG12 ' A' ' 12' ' ' ILE . 51.4 t -87.4 146.05 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.657 -0.652 . . . . 0.0 109.83 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 50.2 t . . . . . 0 N--CA 1.498 1.957 0 O-C-N 121.573 -0.704 . . . . 0.0 109.711 179.99 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.5 mt . . . . . 0 N--CA 1.5 2.064 0 CA-C-O 121.002 0.43 . . . . 0.0 110.675 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.7 -1.96 84.46 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.826 177.287 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.7 m -61.99 136.34 57.92 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.13 -1.218 . . . . 0.0 110.405 179.283 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.485 ' HE3' HG11 ' A' ' 78' ' ' VAL . 31.3 pttt -81.83 126.4 31.82 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.655 -0.653 . . . . 0.0 110.475 179.761 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.409 HD12 ' HB2' ' A' ' 26' ' ' LEU . 92.7 mt -124.84 145.07 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.523 -0.736 . . . . 0.0 110.203 179.501 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.8 t -102.8 137.26 41.25 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.582 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.634 HD21 HD13 ' A' ' 72' ' ' ILE . 17.3 tp -134.9 126.76 29.36 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.788 -0.57 . . . . 0.0 110.282 -168.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 81.3 mt -108.74 120.91 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.557 -0.714 . . . . 0.0 109.697 -178.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.2 m -93.54 157.78 16.03 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.146 0.498 . . . . 0.0 111.216 -176.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -54.27 -13.77 0.97 Allowed 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -172.159 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.45 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.19 20.03 3.96 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.147 -0.97 . . . . 0.0 110.436 179.081 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 55.64 35.78 25.9 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.503 -0.748 . . . . 0.0 109.821 -176.241 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.828 HG12 HG22 ' A' ' 46' ' ' THR . 60.6 mt -105.81 145.63 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -105.4 119.82 40.05 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.25 -179.313 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -114.53 151.04 33.98 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 174.843 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.648 ' O ' HG23 ' A' ' 41' ' ' VAL . 65.1 mt-10 -142.29 140.64 32.25 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.35 -0.844 . . . . 0.0 109.818 174.354 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.22 173.08 43.01 Favored Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.526 -175.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 56.4 mtm180 -85.71 136.03 33.52 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.867 -0.784 . . . . 0.0 110.573 179.164 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.492 ' HA ' HD23 ' A' ' 38' ' ' LEU . 28.0 tp -66.17 119.99 12.43 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.62 -0.675 . . . . 0.0 110.738 175.343 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.439 ' O ' HG23 ' A' ' 28' ' ' THR . 27.4 t80 -99.68 -50.03 4.19 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.764 -0.585 . . . . 0.0 110.347 177.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 27' ' ' TYR . 16.2 p -153.98 155.58 35.85 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.642 -0.661 . . . . 0.0 110.233 -178.39 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.848 HG23 HG22 ' A' ' 36' ' ' ILE . 13.5 p -142.31 145.56 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.654 -0.654 . . . . 0.0 110.093 -178.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -127.33 98.62 29.04 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.65 -0.656 . . . . 0.0 109.602 177.645 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -59.3 -42.39 50.01 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 O-C-N 123.636 1.335 . . . . 0.0 111.03 -175.763 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -80.63 -25.14 38.55 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.405 -0.809 . . . . 0.0 110.199 -171.13 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.567 ' O ' HG23 ' A' ' 35' ' ' THR . 55.1 mt-10 -87.33 1.67 52.57 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.438 -0.789 . . . . 0.0 111.18 173.605 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 38.7 m 49.87 38.55 16.25 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 121.13 -0.981 . . . . 0.0 111.226 -177.009 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.567 HG23 ' O ' ' A' ' 33' ' ' GLU . 10.6 p -135.77 154.28 51.27 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.394 -0.816 . . . . 0.0 110.407 -175.128 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.848 HG22 HG23 ' A' ' 29' ' ' VAL . 39.9 pt -143.1 161.87 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.638 -0.664 . . . . 0.0 110.204 178.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.506 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.9 127.93 27.69 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.652 -0.655 . . . . 0.0 109.692 175.524 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 26' ' ' LEU . 87.4 mt -109.91 147.78 32.79 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -177.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 91.8 p -118.33 151.43 37.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.641 -0.662 . . . . 0.0 109.226 -177.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 44.1 p 45.63 83.66 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 121.543 0.687 . . . . 0.0 110.376 -172.197 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.692 ' CG1' HD12 ' A' ' 65' ' ' ILE . 14.3 p -134.63 150.53 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.406 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -136.36 153.19 51.19 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.638 -0.663 . . . . 0.0 110.128 178.554 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.0 p -108.4 137.16 46.83 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.736 -0.602 . . . . 0.0 109.546 177.307 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -83.01 -38.57 22.44 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 119.833 -0.747 . . . . 0.0 111.063 -172.017 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.32 167.55 28.16 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 175.614 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.828 HG22 HG12 ' A' ' 20' ' ' ILE . 50.2 p -118.3 -13.84 9.83 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.875 -0.779 . . . . 0.0 110.84 171.289 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -52.52 -24.59 8.38 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.398 -0.814 . . . . 0.0 112.482 -165.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -78.22 -59.36 2.81 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.287 -0.883 . . . . 0.0 110.836 -176.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -94.55 10.12 35.91 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.52 -0.738 . . . . 0.0 111.956 -174.668 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.9 p-10 -93.18 174.6 7.14 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.056 -1.028 . . . . 0.0 111.19 -174.584 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.4 m -78.48 164.58 24.62 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.967 -0.458 . . . . 0.0 109.783 177.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -77.49 11.78 1.87 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.662 -0.649 . . . . 0.0 111.671 -174.015 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -91.32 143.36 26.72 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.121 -0.987 . . . . 0.0 109.73 170.07 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -66.04 140.21 58.25 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.712 -0.618 . . . . 0.0 110.953 -171.013 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 83.9 mt -120.88 142.02 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 176.417 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.3 112.81 10.15 Favored Pre-proline 0 N--CA 1.501 2.084 0 O-C-N 121.628 -0.67 . . . . 0.0 110.204 -179.492 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -63.8 141.89 80.4 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 O-C-N 123.345 1.181 . . . . 0.0 110.614 -179.271 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -107.9 107.16 17.75 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.655 -0.653 . . . . 0.0 110.199 179.431 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.2 t -103.36 -34.87 8.6 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.713 -0.617 . . . . 0.0 110.2 179.47 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -62.84 157.45 21.37 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.674 -0.641 . . . . 0.0 110.611 -179.479 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.8 mm -96.75 136.98 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.698 -0.626 . . . . 0.0 109.686 179.071 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -96.05 117.2 30.21 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.62 -0.675 . . . . 0.0 110.356 -178.2 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -51.23 -40.46 58.84 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.827 -0.546 . . . . 0.0 111.629 177.229 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.506 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.6 t80 -152.33 130.2 11.71 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.615 -0.678 . . . . 0.0 110.35 -174.471 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.692 HD12 ' CG1' ' A' ' 41' ' ' VAL . 77.2 mt -129.66 126.68 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.671 -0.643 . . . . 0.0 109.798 171.527 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 19.2 tp -90.57 137.13 32.6 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.77 -0.581 . . . . 0.0 109.841 176.226 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.484 ' CD1' HD11 ' A' ' 72' ' ' ILE . 4.6 m-85 -137.07 132.58 34.35 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.653 -0.655 . . . . 0.0 110.585 -175.281 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -90.69 148.13 22.81 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.71 -0.619 . . . . 0.0 110.269 173.579 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.21 -25.65 60.35 Favored Glycine 0 N--CA 1.499 2.854 0 N-CA-C 110.521 -1.031 . . . . 0.0 110.521 179.363 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.4 p -67.41 -38.26 84.36 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.419 -1.048 . . . . 0.0 110.842 -177.45 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -82.48 -32.57 28.79 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.432 -0.792 . . . . 0.0 110.841 -175.394 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.634 HD13 HD21 ' A' ' 14' ' ' LEU . 10.6 mt -106.41 134.19 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.496 -0.752 . . . . 0.0 109.923 176.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.4 tttp -108.75 -10.98 15.11 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 120.485 -0.486 . . . . 0.0 112.077 -166.68 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -147.8 129.63 15.22 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.876 -1.14 . . . . 0.0 111.155 -179.641 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.48 HD12 ' CD1' ' A' ' 14' ' ' LEU . 18.1 tt -137.96 139.48 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.958 -0.464 . . . . 0.0 110.017 178.197 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 82.5 mtm-85 -147.12 136.86 23.04 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.54 -0.725 . . . . 0.0 110.51 176.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.3 p -87.13 147.04 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.688 -0.632 . . . . 0.0 110.1 177.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.485 HG11 ' HE3' ' A' ' 11' ' ' LYS . 61.4 t . . . . . 0 N--CA 1.498 1.953 0 O-C-N 121.624 -0.673 . . . . 0.0 109.772 -178.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.3 mt . . . . . 0 N--CA 1.502 2.14 0 CA-C-O 121.055 0.455 . . . . 0.0 110.683 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.71 -1.96 84.49 Favored Glycine 0 N--CA 1.496 2.682 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.809 177.712 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 74.8 m -62.38 142.73 57.68 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.09 -1.241 . . . . 0.0 110.477 179.679 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -82.03 126.81 32.42 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.693 -0.63 . . . . 0.0 110.386 178.289 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 90.5 mt -123.97 145.02 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.584 -0.697 . . . . 0.0 110.148 -179.725 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.6 t -103.33 137.29 41.65 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 176.12 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.663 HD21 HD13 ' A' ' 72' ' ' ILE . 14.5 tp -133.23 123.18 25.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.776 -0.578 . . . . 0.0 110.263 -169.662 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.604 ' O ' HG23 ' A' ' 72' ' ' ILE . 79.8 mt -106.31 116.87 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.427 -0.796 . . . . 0.0 109.711 -178.801 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.5 m -92.83 157.71 16.25 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 120.955 0.407 . . . . 0.0 111.231 -177.101 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -54.61 -11.81 0.63 Allowed 'General case' 0 N--CA 1.509 2.49 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -171.608 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.519 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -90.22 20.0 4.69 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.083 -1.01 . . . . 0.0 110.45 179.386 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 54.66 33.52 19.49 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.52 -0.738 . . . . 0.0 109.853 -174.285 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.857 HG12 HG22 ' A' ' 46' ' ' THR . 65.7 mt -102.52 140.93 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.441 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -104.83 119.77 39.8 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.994 -0.683 . . . . 0.0 109.939 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -114.25 149.43 35.87 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 174.403 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.669 ' O ' HG23 ' A' ' 41' ' ' VAL . 42.2 tt0 -140.34 140.46 35.6 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.584 -0.698 . . . . 0.0 109.54 175.154 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.4 172.65 42.4 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.624 -175.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -85.38 135.61 33.81 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.956 -0.732 . . . . 0.0 110.504 179.097 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.486 ' HA ' HD23 ' A' ' 38' ' ' LEU . 27.8 tp -66.14 120.82 13.87 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.597 -0.689 . . . . 0.0 110.663 176.13 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.433 ' O ' HG23 ' A' ' 28' ' ' THR . 21.6 t80 -99.19 -49.96 4.3 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.666 -0.646 . . . . 0.0 110.257 178.194 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 27' ' ' TYR . 17.0 p -153.38 156.77 38.9 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.742 -0.599 . . . . 0.0 110.068 -179.162 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.889 HG23 HG22 ' A' ' 36' ' ' ILE . 13.6 p -142.25 145.9 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.658 -0.651 . . . . 0.0 110.227 -177.795 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -128.26 101.49 21.96 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.609 -0.682 . . . . 0.0 109.507 177.022 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.38 -41.2 34.89 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 O-C-N 123.579 1.305 . . . . 0.0 110.839 -174.459 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -80.7 -24.57 38.75 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.283 -0.886 . . . . 0.0 110.203 -171.732 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.742 ' O ' HG23 ' A' ' 35' ' ' THR . 54.8 mt-10 -87.31 1.31 53.63 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.474 -0.767 . . . . 0.0 111.262 173.463 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.9 m 49.86 38.14 15.21 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.042 -1.036 . . . . 0.0 111.276 -176.698 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.742 HG23 ' O ' ' A' ' 33' ' ' GLU . 21.6 p -136.45 153.52 51.03 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.477 -0.764 . . . . 0.0 110.377 -174.27 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.889 HG22 HG23 ' A' ' 29' ' ' VAL . 39.8 pt -142.34 162.06 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.711 -0.618 . . . . 0.0 110.182 177.707 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.526 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -133.68 127.7 33.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.659 -0.651 . . . . 0.0 109.62 176.011 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 26' ' ' LEU . 88.7 mt -109.94 149.45 29.9 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -176.481 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 91.8 p -123.1 154.33 38.73 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.134 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.5 p 45.41 83.76 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 121.492 0.663 . . . . 0.0 110.375 -171.805 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.718 HG11 HD12 ' A' ' 65' ' ' ILE . 14.4 p -134.55 149.74 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -178.537 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -134.84 153.21 52.13 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.622 -0.674 . . . . 0.0 109.982 178.766 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.2 p -107.32 138.55 43.3 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.671 -0.643 . . . . 0.0 109.894 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -83.07 -38.28 22.73 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.648 -0.658 . . . . 0.0 110.905 -174.282 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.74 170.32 32.37 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 178.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.857 HG22 HG12 ' A' ' 20' ' ' ILE . 1.8 p -118.03 6.75 12.14 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.909 -0.759 . . . . 0.0 111.173 177.451 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -48.89 -23.87 1.26 Allowed 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.471 -0.768 . . . . 0.0 112.694 -169.552 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -54.3 -45.56 72.59 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.235 -0.915 . . . . 0.0 111.344 -179.396 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 75.4 mtp180 -94.14 -58.08 2.34 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.432 -0.792 . . . . 0.0 110.766 -179.788 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.45 ' OD1' HD11 ' A' ' 55' ' ' ILE . 2.9 p30 -67.35 174.88 3.01 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.727 -0.608 . . . . 0.0 110.378 -178.67 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.7 p -78.13 164.41 25.0 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.694 -0.629 . . . . 0.0 110.664 -170.664 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -77.52 1.68 18.65 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.413 -177.746 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -72.53 161.17 31.14 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.171 -0.956 . . . . 0.0 109.811 176.4 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -65.94 130.24 42.58 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.625 -0.672 . . . . 0.0 111.017 -168.179 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.45 HD11 ' OD1' ' A' ' 50' ' ' ASP . 82.2 mt -114.92 136.67 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 173.521 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.03 112.49 7.59 Favored Pre-proline 0 N--CA 1.501 2.122 0 O-C-N 121.581 -0.7 . . . . 0.0 110.54 -174.628 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -79.67 151.25 22.02 Favored 'Trans proline' 0 N--CA 1.485 1.021 0 O-C-N 123.403 1.212 . . . . 0.0 110.261 179.171 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -101.75 114.19 28.04 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.662 -0.649 . . . . 0.0 110.053 177.435 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.2 m -66.38 -32.65 74.17 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.698 -0.626 . . . . 0.0 110.492 -178.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -62.15 143.29 56.93 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.602 -0.686 . . . . 0.0 110.724 -178.238 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.9 mm -96.76 158.9 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.798 -0.564 . . . . 0.0 109.703 179.008 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -93.4 112.5 24.42 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.598 -0.689 . . . . 0.0 110.138 -178.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -51.57 -42.32 61.78 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.78 -0.575 . . . . 0.0 111.629 177.199 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.526 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.5 t80 -153.09 128.78 10.11 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.594 -0.691 . . . . 0.0 110.365 -174.018 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.718 HD12 HG11 ' A' ' 41' ' ' VAL . 71.1 mt -128.34 133.48 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.693 -0.63 . . . . 0.0 109.939 172.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 27.1 tp -90.35 137.06 32.66 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.866 -0.521 . . . . 0.0 109.971 176.107 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.919 ' CD1' HD11 ' A' ' 72' ' ' ILE . 2.2 m-85 -133.61 124.43 26.82 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.686 -0.634 . . . . 0.0 110.673 -176.622 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 73.6 mtt85 -92.96 145.98 23.97 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.696 -0.628 . . . . 0.0 110.358 172.358 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.73 -24.69 62.6 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 179.532 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.6 m -67.9 -42.24 81.47 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.413 -1.051 . . . . 0.0 111.199 -173.799 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -85.46 -24.19 27.52 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.328 -0.858 . . . . 0.0 111.128 -175.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.919 HD11 ' CD1' ' A' ' 67' ' ' PHE . 86.7 mt -96.65 143.03 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.236 -0.915 . . . . 0.0 110.165 173.556 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -104.02 -20.85 13.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.984 -0.447 . . . . 0.0 111.304 -170.412 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -152.87 131.88 12.59 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 119.147 -1.021 . . . . 0.0 111.297 -179.414 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.56 HD12 ' CD1' ' A' ' 14' ' ' LEU . 17.5 tt -131.53 138.53 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 175.292 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -146.81 131.28 17.68 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.663 -0.648 . . . . 0.0 110.423 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.2 p -87.99 147.08 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.61 -0.681 . . . . 0.0 110.171 177.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.2 t . . . . . 0 N--CA 1.497 1.906 0 O-C-N 121.57 -0.706 . . . . 0.0 109.737 -179.703 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.8 mt . . . . . 0 N--CA 1.501 2.102 0 CA-C-O 121.035 0.445 . . . . 0.0 110.529 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.58 -1.88 84.4 Favored Glycine 0 N--CA 1.497 2.741 0 C-N-CA 120.453 -0.88 . . . . 0.0 111.815 177.653 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 71.5 m -61.35 148.58 40.93 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.155 -1.203 . . . . 0.0 110.44 -179.086 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -82.21 127.45 33.19 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.491 179.588 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.683 ' CD1' HD13 ' A' ' 26' ' ' LEU . 89.1 mt -121.78 144.5 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.588 -0.695 . . . . 0.0 109.944 179.01 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.0 t -103.05 137.32 41.38 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 175.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.756 ' HG ' HG21 ' A' ' 72' ' ' ILE . 11.5 tp -133.32 123.3 25.2 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.792 -0.568 . . . . 0.0 110.002 -171.246 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.708 ' O ' HG23 ' A' ' 72' ' ' ILE . 82.2 mt -103.98 119.17 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.522 -0.736 . . . . 0.0 109.683 -177.707 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.1 m -94.32 157.93 15.81 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.137 0.494 . . . . 0.0 111.46 -175.525 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -53.72 -14.6 0.95 Allowed 'General case' 0 N--CA 1.507 2.385 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -171.363 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.462 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.68 20.39 4.07 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.221 -0.924 . . . . 0.0 110.459 179.475 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 55.53 35.42 25.11 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.486 -0.759 . . . . 0.0 109.93 -176.137 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.838 HG12 HG22 ' A' ' 46' ' ' THR . 60.9 mt -105.31 145.3 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 55.5 ttt85 -105.73 119.8 40.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.624 -0.673 . . . . 0.0 110.15 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -113.68 150.68 32.89 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.682 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.658 ' O ' HG23 ' A' ' 41' ' ' VAL . 36.1 mt-10 -141.36 140.55 33.76 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.437 -0.79 . . . . 0.0 109.776 174.883 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.61 172.49 41.12 Favored Glycine 0 N--CA 1.495 2.623 0 C-N-CA 119.875 -1.155 . . . . 0.0 110.451 -175.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -84.3 138.75 32.74 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.919 -0.753 . . . . 0.0 110.545 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.683 HD13 ' CD1' ' A' ' 12' ' ' ILE . 17.0 tp -66.15 117.68 8.8 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.628 -0.67 . . . . 0.0 110.685 175.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.457 ' O ' HG23 ' A' ' 28' ' ' THR . 28.7 t80 -100.09 -50.08 4.09 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.596 -0.69 . . . . 0.0 110.437 177.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 27' ' ' TYR . 15.2 p -154.19 154.83 34.18 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.648 -0.658 . . . . 0.0 110.317 -178.185 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.839 HG23 HG22 ' A' ' 36' ' ' ILE . 13.5 p -142.19 145.6 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.707 -0.62 . . . . 0.0 110.054 -179.347 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -129.02 98.19 24.56 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.643 -0.661 . . . . 0.0 109.504 177.355 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -59.64 -40.34 65.99 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 O-C-N 123.64 1.337 . . . . 0.0 110.973 -176.118 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -80.32 -27.39 38.42 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.308 -0.87 . . . . 0.0 110.118 -170.675 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.731 ' O ' HG23 ' A' ' 35' ' ' THR . 46.1 mt-10 -87.76 2.89 50.06 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.529 -0.732 . . . . 0.0 111.252 173.707 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 40.1 m 50.02 40.34 21.1 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.141 -0.974 . . . . 0.0 111.425 -177.768 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.731 HG23 ' O ' ' A' ' 33' ' ' GLU . 39.6 p -136.0 154.34 51.1 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.372 -0.83 . . . . 0.0 110.481 -176.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.839 HG22 HG23 ' A' ' 29' ' ' VAL . 40.0 pt -142.06 161.5 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.672 -0.643 . . . . 0.0 109.991 176.646 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.497 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.72 128.6 29.21 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.688 -0.633 . . . . 0.0 109.724 176.262 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 26' ' ' LEU . 83.8 mt -109.76 144.57 37.98 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -178.3 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.4 p -115.3 153.11 31.54 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -178.038 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.0 p 45.31 84.69 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 CA-C-O 121.506 0.669 . . . . 0.0 110.271 -171.672 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 23' ' ' GLU . 13.6 p -134.64 149.52 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -178.314 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.425 ' HB3' HD12 ' A' ' 61' ' ' ILE . 19.6 ptp180 -134.92 153.09 52.19 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.612 -0.68 . . . . 0.0 110.136 179.061 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.8 p -107.91 136.7 47.18 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.747 -0.596 . . . . 0.0 109.639 177.644 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -82.77 -38.45 23.18 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 119.864 -0.735 . . . . 0.0 111.115 -172.339 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.47 166.47 26.6 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 175.783 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.838 HG22 HG12 ' A' ' 20' ' ' ILE . 45.7 p -118.2 -19.77 8.87 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.846 -0.796 . . . . 0.0 110.909 172.786 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -53.3 -26.48 18.77 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.511 -0.743 . . . . 0.0 112.249 -167.54 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -70.49 -59.31 2.92 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.359 -0.838 . . . . 0.0 110.733 -176.025 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 63.1 mtp85 -94.42 -16.34 23.51 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.606 -0.684 . . . . 0.0 111.741 -175.739 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -63.7 174.57 1.34 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.239 -0.913 . . . . 0.0 111.245 -172.639 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.1 m -78.68 164.63 24.44 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 177.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -77.5 11.46 2.01 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.676 -0.64 . . . . 0.0 111.565 -174.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -92.93 164.48 13.29 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.2 -0.938 . . . . 0.0 109.683 169.519 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -66.05 138.17 57.58 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.584 -0.697 . . . . 0.0 110.726 -172.623 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.3 mm -118.39 139.54 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.773 -0.579 . . . . 0.0 109.595 177.383 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.58 113.63 18.48 Favored Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 121.69 -0.631 . . . . 0.0 110.288 -178.827 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -68.54 153.18 74.21 Favored 'Trans proline' 0 N--CA 1.487 1.123 0 O-C-N 123.365 1.192 . . . . 0.0 110.4 179.006 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -132.92 65.73 1.58 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.649 -0.657 . . . . 0.0 110.127 179.526 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.1 m -65.98 -33.4 75.72 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.515 -0.741 . . . . 0.0 110.401 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -62.0 155.35 24.05 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.616 -0.678 . . . . 0.0 110.621 -178.926 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.425 HD12 ' HB3' ' A' ' 42' ' ' ARG . 45.2 mm -96.71 138.34 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.656 -0.652 . . . . 0.0 109.741 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -97.85 118.8 35.24 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.664 -0.647 . . . . 0.0 110.471 -177.324 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -51.3 -39.95 57.95 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.721 -0.612 . . . . 0.0 111.428 175.27 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.497 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.8 t80 -152.95 130.4 11.4 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.75 -0.593 . . . . 0.0 110.254 -174.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.645 HD12 ' CG1' ' A' ' 41' ' ' VAL . 72.9 mt -128.97 127.33 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.65 -0.656 . . . . 0.0 109.901 171.445 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 24.0 tp -91.03 137.14 32.59 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.929 -0.482 . . . . 0.0 109.917 176.317 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.541 ' CD1' HD11 ' A' ' 72' ' ' ILE . 5.9 m-85 -137.18 128.61 28.29 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.65 -0.656 . . . . 0.0 110.531 -176.483 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -91.1 154.93 19.02 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.658 -0.651 . . . . 0.0 110.278 173.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.07 -23.96 57.87 Favored Glycine 0 N--CA 1.498 2.824 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 177.691 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.8 m -72.72 -42.09 64.52 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.46 -1.023 . . . . 0.0 111.28 -175.074 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -84.55 -26.63 27.89 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.345 -0.847 . . . . 0.0 111.144 -174.015 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.756 HG21 ' HG ' ' A' ' 14' ' ' LEU . 32.8 mt -106.27 140.73 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.316 -0.865 . . . . 0.0 109.91 171.089 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -105.19 -16.67 14.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.921 -0.487 . . . . 0.0 111.687 -167.691 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -149.94 133.45 16.61 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.92 -1.113 . . . . 0.0 111.409 -178.689 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.419 HD12 ' CD1' ' A' ' 14' ' ' LEU . 16.2 tt -131.13 137.92 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.048 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -144.89 135.18 24.16 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.613 -0.679 . . . . 0.0 110.164 179.633 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.2 p -86.85 147.04 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.589 -0.694 . . . . 0.0 110.163 178.546 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.4 t . . . . . 0 N--CA 1.499 2.003 0 O-C-N 121.572 -0.705 . . . . 0.0 109.79 -179.175 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.391 0 N-CA-C 109.476 -1.45 . . . . 16.81 109.476 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -67.28 -33.19 74.79 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.653 -0.91 . . . . 14.72 110.342 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 74.2 mtm -99.14 138.57 36.06 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.717 -0.614 . . . . 13.59 110.263 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -68.19 -33.65 74.82 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.701 -0.624 . . . . 11.44 110.259 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.2 mmt -120.83 151.91 39.03 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.69 -0.631 . . . . 10.45 110.267 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.7 p -131.31 155.9 46.39 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.677 -0.64 . . . . 7.87 110.127 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -126.93 -46.86 0.2 Allowed Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.511 -1.436 . . . . 6.13 109.511 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -67.85 -45.28 75.54 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.756 -1.338 . . . . 4.64 109.756 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 11.7 tp -81.98 114.83 53.51 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.721 -0.87 . . . . 5.14 110.291 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -67.11 138.26 46.85 Favored 'Trans proline' 0 N--CA 1.488 1.161 0 O-C-N 123.339 1.178 . . . . 2.91 110.292 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -64.87 131.72 47.48 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.682 -0.636 . . . . 2.67 110.437 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.9 mt -64.75 142.89 58.27 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.686 -0.633 . . . . 1.08 110.836 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.61 -1.95 84.25 Favored Glycine 0 N--CA 1.497 2.706 0 C-N-CA 120.708 -0.758 . . . . 0.45 111.798 176.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.3 m -63.29 145.11 56.23 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.039 -1.271 . . . . 0.35 110.445 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.46 ' HE3' HG11 ' A' ' 78' ' ' VAL . 30.9 pttt -82.18 125.15 30.57 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.73 -0.606 . . . . 1.62 110.269 176.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.619 ' CD1' HD13 ' A' ' 26' ' ' LEU . 87.1 mt -120.97 143.42 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.499 -0.751 . . . . 0.18 110.059 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.9 t -102.5 137.22 41.02 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.35 -0.611 . . . . 0.12 109.35 174.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.613 HD21 HD13 ' A' ' 72' ' ' ILE . 13.9 tp -133.8 127.1 31.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.673 -0.642 . . . . 0.17 110.268 -169.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.6 mt -107.05 118.19 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.55 -0.719 . . . . 0.13 109.732 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m -93.08 157.82 16.1 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.022 0.439 . . . . 0.12 111.212 -177.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -53.76 -13.91 0.81 Allowed 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 112.839 0.681 . . . . 2.52 112.839 -171.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.51 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -90.15 20.78 4.11 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.154 -0.966 . . . . 0.16 110.416 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 53.93 34.28 19.18 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.54 -0.725 . . . . 0.8 109.886 -174.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.833 HG12 HG22 ' A' ' 46' ' ' THR . 68.4 mt -102.59 141.88 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 109.128 -0.693 . . . . 0.23 109.128 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -104.74 119.87 40.02 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.999 -0.68 . . . . 2.34 109.927 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -114.28 149.53 35.79 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.086 -0.709 . . . . 0.15 109.086 174.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.651 ' O ' HG23 ' A' ' 41' ' ' VAL . 45.7 tt0 -140.52 140.53 35.26 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.498 -0.751 . . . . 1.44 109.628 175.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.68 173.37 43.3 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 119.801 -1.19 . . . . 0.06 110.541 -175.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -84.89 137.26 33.24 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.906 -0.761 . . . . 2.07 110.543 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.619 HD13 ' CD1' ' A' ' 12' ' ' ILE . 14.9 tp -66.09 117.66 8.73 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.589 -0.695 . . . . 0.24 110.6 175.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.454 ' O ' HG23 ' A' ' 28' ' ' THR . 31.1 t80 -100.05 -50.08 4.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.621 -0.675 . . . . 0.18 110.562 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 27' ' ' TYR . 14.8 p -154.44 156.95 37.71 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.696 -0.628 . . . . 0.1 110.293 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.813 HG23 HG22 ' A' ' 36' ' ' ILE . 13.7 p -142.27 146.32 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.755 -0.591 . . . . 0.15 110.085 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -128.12 100.95 22.92 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.716 -0.615 . . . . 0.91 109.507 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.31 -42.02 30.75 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 O-C-N 123.652 1.343 . . . . 0.48 110.734 -174.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -80.77 -23.88 39.03 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.379 -0.825 . . . . 2.16 110.148 -171.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.68 ' O ' HG23 ' A' ' 35' ' ' THR . 74.9 mm-40 -87.33 1.11 54.26 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.525 -0.734 . . . . 1.59 111.294 173.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 37.2 m 49.78 38.52 15.82 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.079 -1.013 . . . . 0.74 111.195 -176.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.68 HG23 ' O ' ' A' ' 33' ' ' GLU . 17.0 p -135.77 155.44 50.36 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.405 -0.81 . . . . 0.14 110.399 -174.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.813 HG22 HG23 ' A' ' 29' ' ' VAL . 39.7 pt -142.1 162.0 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.715 -0.616 . . . . 0.15 110.06 177.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.516 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.14 128.42 30.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.61 -0.681 . . . . 0.09 109.722 176.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 26' ' ' LEU . 84.2 mt -109.81 146.35 35.18 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.579 -0.526 . . . . 0.14 109.579 -178.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.3 p -118.29 152.54 35.57 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.12 -0.696 . . . . 0.08 109.12 -177.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.6 p 45.65 84.08 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 121.489 0.662 . . . . 0.07 110.238 -171.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.687 HG11 HD12 ' A' ' 65' ' ' ILE . 15.0 p -134.63 150.46 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 109.774 -0.454 . . . . 0.1 109.774 -178.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -135.72 153.23 51.65 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.697 -0.627 . . . . 2.7 109.967 178.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.8 p -106.57 139.21 41.38 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.686 -0.634 . . . . 0.24 109.788 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -82.74 -38.36 23.38 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.591 -0.693 . . . . 0.59 110.871 -173.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.63 170.48 32.48 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 120.024 -1.084 . . . . 0.51 110.447 177.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.833 HG22 HG12 ' A' ' 20' ' ' ILE . 1.4 p -118.08 6.58 12.09 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.952 -0.734 . . . . 1.13 110.737 174.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -48.94 -25.96 2.23 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.635 -0.666 . . . . 2.69 112.584 -166.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -64.87 -59.29 4.36 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.201 -0.937 . . . . 1.96 110.629 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 58.1 mtp85 -94.43 10.26 35.14 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.64 -0.662 . . . . 4.87 111.38 176.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.445 ' HB2' HD12 ' A' ' 55' ' ' ILE . 38.8 p-10 -59.74 174.02 0.51 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.237 -0.914 . . . . 2.14 111.466 -169.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.1 m -78.95 164.42 24.43 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.647 -0.501 . . . . 3.23 109.647 173.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -77.44 3.45 13.33 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.653 -0.654 . . . . 4.1 111.344 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -97.5 154.21 17.65 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.203 -0.936 . . . . 4.1 109.691 171.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -68.08 137.34 54.91 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.582 -0.699 . . . . 3.57 110.607 -175.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.445 HD12 ' HB2' ' A' ' 50' ' ' ASP . 78.9 mt -117.1 136.56 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.638 -0.664 . . . . 2.27 109.507 176.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . . . -85.35 138.89 36.15 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.693 -0.629 . . . . 2.49 110.124 -178.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 56' ' ' ALA . 17.3 Cg_exo -63.09 149.13 92.39 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 O-C-N 123.362 1.19 . . . . 2.03 110.543 178.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -96.49 115.0 26.71 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.641 -0.662 . . . . 2.72 110.097 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.9 m -85.66 -33.27 21.61 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.687 -0.633 . . . . 2.17 110.331 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -62.56 141.76 58.3 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.679 -0.638 . . . . 2.7 110.66 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.3 mm -96.86 147.36 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.761 -0.587 . . . . 0.5 109.719 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -93.93 114.98 27.3 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.614 -0.679 . . . . 0.73 110.192 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -51.12 -42.18 60.53 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.865 -0.522 . . . . 1.86 111.678 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.516 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.0 t80 -152.58 129.19 10.77 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.606 -0.684 . . . . 0.1 110.272 -174.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.687 HD12 HG11 ' A' ' 41' ' ' VAL . 78.3 mt -128.58 128.74 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.662 -0.649 . . . . 0.11 109.823 172.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.1 tp -90.79 137.08 32.64 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.893 -0.504 . . . . 0.17 109.932 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.538 ' CD1' HD11 ' A' ' 72' ' ' ILE . 3.2 m-85 -136.29 130.12 32.47 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.557 -0.714 . . . . 0.29 110.605 -175.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.7 mtm-85 -91.07 147.88 22.77 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.678 -0.639 . . . . 2.52 110.258 173.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.03 -26.46 61.02 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 110.558 -1.017 . . . . 0.13 110.558 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.3 m -65.7 -39.79 91.62 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.464 -1.021 . . . . 1.29 110.989 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.68 -32.95 31.52 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.395 -0.816 . . . . 1.09 110.859 -174.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.613 HD13 HD21 ' A' ' 14' ' ' LEU . 8.4 mt -103.07 139.35 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.472 -0.768 . . . . 0.27 110.101 177.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.5 tttp -106.26 -20.05 13.51 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 120.571 -0.452 . . . . 2.11 111.676 -166.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -150.92 136.38 17.84 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 118.996 -1.082 . . . . 1.03 111.342 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.525 HD12 ' CD1' ' A' ' 14' ' ' LEU . 17.5 tt -133.6 143.42 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.829 -0.434 . . . . 0.26 109.829 177.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -146.71 136.93 23.6 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.624 -0.672 . . . . 2.91 110.297 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.0 t -87.46 144.4 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.562 -0.711 . . . . 1.54 109.777 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.46 HG11 ' HE3' ' A' ' 11' ' ' LYS . 55.4 t -93.99 133.89 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.672 -0.643 . . . . 0.98 109.74 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -107.41 121.82 45.37 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.755 -0.591 . . . . 2.85 110.318 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -116.19 104.12 11.21 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.644 -0.66 . . . . 4.24 110.116 178.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -136.56 171.95 13.73 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.609 -0.682 . . . . 6.85 110.228 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.2 p -116.44 162.42 17.58 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.657 -0.652 . . . . 6.82 110.171 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.5 mt -117.19 164.21 20.0 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.703 -0.623 . . . . 10.11 110.165 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo . . . . . 0 N--CA 1.486 1.083 0 O-C-N 123.686 1.361 . . . . 12.05 110.362 179.906 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.391 0 N-CA-C 109.476 -1.45 . . . . 16.81 109.476 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -67.28 -33.19 74.79 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.653 -0.91 . . . . 14.72 110.342 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 74.2 mtm -99.14 138.57 36.06 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.717 -0.614 . . . . 13.59 110.263 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -68.19 -33.65 74.82 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.701 -0.624 . . . . 11.44 110.259 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.2 mmt -120.83 151.91 39.03 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.69 -0.631 . . . . 10.45 110.267 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.7 p -131.31 155.9 46.39 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.677 -0.64 . . . . 7.87 110.127 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -126.93 -46.86 0.2 Allowed Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.511 -1.436 . . . . 6.13 109.511 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -67.85 -45.28 75.54 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.756 -1.338 . . . . 4.64 109.756 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 11.7 tp -81.98 114.83 53.51 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.721 -0.87 . . . . 5.14 110.291 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -67.11 138.26 46.85 Favored 'Trans proline' 0 N--CA 1.488 1.161 0 O-C-N 123.339 1.178 . . . . 2.91 110.292 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -64.87 131.72 47.48 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.682 -0.636 . . . . 2.67 110.437 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.9 mt -64.75 142.89 58.27 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.686 -0.633 . . . . 1.08 110.836 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.61 -1.95 84.25 Favored Glycine 0 N--CA 1.497 2.706 0 C-N-CA 120.708 -0.758 . . . . 0.45 111.798 176.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.3 m -63.29 145.11 56.23 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.039 -1.271 . . . . 0.35 110.445 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.46 ' HE3' HG11 ' A' ' 78' ' ' VAL . 30.9 pttt -82.18 125.15 30.57 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.73 -0.606 . . . . 1.62 110.269 176.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.619 ' CD1' HD13 ' A' ' 26' ' ' LEU . 87.1 mt -120.97 143.42 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.499 -0.751 . . . . 0.18 110.059 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.9 t -102.5 137.22 41.02 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.35 -0.611 . . . . 0.12 109.35 174.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.613 HD21 HD13 ' A' ' 72' ' ' ILE . 13.9 tp -133.8 127.1 31.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.673 -0.642 . . . . 0.17 110.268 -169.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.6 mt -107.05 118.19 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.55 -0.719 . . . . 0.13 109.732 -178.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m -93.08 157.82 16.1 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.022 0.439 . . . . 0.12 111.212 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -53.76 -13.91 0.81 Allowed 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 112.839 0.681 . . . . 2.52 112.839 -171.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.51 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -90.15 20.78 4.11 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.154 -0.966 . . . . 0.16 110.416 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 53.93 34.28 19.18 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.54 -0.725 . . . . 0.8 109.886 -174.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.833 HG12 HG22 ' A' ' 46' ' ' THR . 68.4 mt -102.59 141.88 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 109.128 -0.693 . . . . 0.23 109.128 178.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -104.74 119.87 40.02 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.999 -0.68 . . . . 2.34 109.927 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -114.28 149.53 35.79 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.086 -0.709 . . . . 0.15 109.086 174.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.651 ' O ' HG23 ' A' ' 41' ' ' VAL . 45.7 tt0 -140.52 140.53 35.26 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.498 -0.751 . . . . 1.44 109.628 175.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.68 173.37 43.3 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 119.801 -1.19 . . . . 0.06 110.541 -175.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -84.89 137.26 33.24 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.906 -0.761 . . . . 2.07 110.543 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.619 HD13 ' CD1' ' A' ' 12' ' ' ILE . 14.9 tp -66.09 117.66 8.73 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.589 -0.695 . . . . 0.24 110.6 175.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.454 ' O ' HG23 ' A' ' 28' ' ' THR . 31.1 t80 -100.05 -50.08 4.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.621 -0.675 . . . . 0.18 110.562 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 27' ' ' TYR . 14.8 p -154.44 156.95 37.71 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.696 -0.628 . . . . 0.1 110.293 -177.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.813 HG23 HG22 ' A' ' 36' ' ' ILE . 13.7 p -142.27 146.32 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.755 -0.591 . . . . 0.15 110.085 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -128.12 100.95 22.92 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.716 -0.615 . . . . 0.91 109.507 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.31 -42.02 30.75 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 O-C-N 123.652 1.343 . . . . 0.48 110.734 -174.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -80.77 -23.88 39.03 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.379 -0.825 . . . . 2.16 110.148 -171.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.68 ' O ' HG23 ' A' ' 35' ' ' THR . 74.9 mm-40 -87.33 1.11 54.26 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.525 -0.734 . . . . 1.59 111.294 173.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 37.2 m 49.78 38.52 15.82 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.079 -1.013 . . . . 0.74 111.195 -176.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.68 HG23 ' O ' ' A' ' 33' ' ' GLU . 17.0 p -135.77 155.44 50.36 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.405 -0.81 . . . . 0.14 110.399 -174.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.813 HG22 HG23 ' A' ' 29' ' ' VAL . 39.7 pt -142.1 162.0 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.715 -0.616 . . . . 0.15 110.06 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.516 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.14 128.42 30.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.61 -0.681 . . . . 0.09 109.722 176.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 26' ' ' LEU . 84.2 mt -109.81 146.35 35.18 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.579 -0.526 . . . . 0.14 109.579 -178.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.3 p -118.29 152.54 35.57 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.12 -0.696 . . . . 0.08 109.12 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.6 p 45.65 84.08 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 121.489 0.662 . . . . 0.07 110.238 -171.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.687 HG11 HD12 ' A' ' 65' ' ' ILE . 15.0 p -134.63 150.46 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 109.774 -0.454 . . . . 0.1 109.774 -178.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -135.72 153.23 51.65 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.697 -0.627 . . . . 2.7 109.967 178.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.8 p -106.57 139.21 41.38 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.686 -0.634 . . . . 0.24 109.788 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -82.74 -38.36 23.38 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.591 -0.693 . . . . 0.59 110.871 -173.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.63 170.48 32.48 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 120.024 -1.084 . . . . 0.51 110.447 177.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.833 HG22 HG12 ' A' ' 20' ' ' ILE . 1.4 p -118.08 6.58 12.09 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.952 -0.734 . . . . 1.13 110.737 174.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -48.94 -25.96 2.23 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.635 -0.666 . . . . 2.69 112.584 -166.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -64.87 -59.29 4.36 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.201 -0.937 . . . . 1.96 110.629 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 58.1 mtp85 -94.43 10.26 35.14 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.64 -0.662 . . . . 4.87 111.38 176.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.445 ' HB2' HD12 ' A' ' 55' ' ' ILE . 38.8 p-10 -59.74 174.02 0.51 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.237 -0.914 . . . . 2.14 111.466 -169.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.1 m -78.95 164.42 24.43 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.647 -0.501 . . . . 3.23 109.647 173.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -77.44 3.45 13.33 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.653 -0.654 . . . . 4.1 111.344 -178.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -97.5 154.21 17.65 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.203 -0.936 . . . . 4.1 109.691 171.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -68.08 137.34 54.91 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.582 -0.699 . . . . 3.57 110.607 -175.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.445 HD12 ' HB2' ' A' ' 50' ' ' ASP . 78.9 mt -117.1 136.56 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.638 -0.664 . . . . 2.27 109.507 176.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . . . -85.35 138.89 36.15 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.693 -0.629 . . . . 2.49 110.124 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 56' ' ' ALA . 17.3 Cg_exo -63.09 149.13 92.39 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 O-C-N 123.362 1.19 . . . . 2.03 110.543 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -96.49 115.0 26.71 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.641 -0.662 . . . . 2.72 110.097 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.9 m -85.66 -33.27 21.61 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.687 -0.633 . . . . 2.17 110.331 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -62.56 141.76 58.3 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.679 -0.638 . . . . 2.7 110.66 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.3 mm -96.86 147.36 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.761 -0.587 . . . . 0.5 109.719 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -93.93 114.98 27.3 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.614 -0.679 . . . . 0.73 110.192 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -51.12 -42.18 60.53 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.865 -0.522 . . . . 1.86 111.678 178.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.516 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.0 t80 -152.58 129.19 10.77 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.606 -0.684 . . . . 0.1 110.272 -174.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.687 HD12 HG11 ' A' ' 41' ' ' VAL . 78.3 mt -128.58 128.74 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.662 -0.649 . . . . 0.11 109.823 172.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.1 tp -90.79 137.08 32.64 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.893 -0.504 . . . . 0.17 109.932 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.538 ' CD1' HD11 ' A' ' 72' ' ' ILE . 3.2 m-85 -136.29 130.12 32.47 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.557 -0.714 . . . . 0.29 110.605 -175.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.7 mtm-85 -91.07 147.88 22.77 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.678 -0.639 . . . . 2.52 110.258 173.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.03 -26.46 61.02 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 110.558 -1.017 . . . . 0.13 110.558 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.3 m -65.7 -39.79 91.62 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.464 -1.021 . . . . 1.29 110.989 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.68 -32.95 31.52 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.395 -0.816 . . . . 1.09 110.859 -174.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.613 HD13 HD21 ' A' ' 14' ' ' LEU . 8.4 mt -103.07 139.35 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.472 -0.768 . . . . 0.27 110.101 177.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.5 tttp -106.26 -20.05 13.51 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 120.571 -0.452 . . . . 2.11 111.676 -166.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -150.92 136.38 17.84 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 118.996 -1.082 . . . . 1.03 111.342 -177.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.525 HD12 ' CD1' ' A' ' 14' ' ' LEU . 17.5 tt -133.6 143.42 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.829 -0.434 . . . . 0.26 109.829 177.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -146.71 136.93 23.6 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.624 -0.672 . . . . 2.91 110.297 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.0 t -87.46 144.4 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.562 -0.711 . . . . 1.54 109.777 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.46 HG11 ' HE3' ' A' ' 11' ' ' LYS . 55.4 t -93.99 133.89 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.672 -0.643 . . . . 0.98 109.74 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -107.41 121.82 45.37 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.755 -0.591 . . . . 2.85 110.318 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -116.19 104.12 11.21 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.644 -0.66 . . . . 4.24 110.116 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -136.56 171.95 13.73 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.609 -0.682 . . . . 6.85 110.228 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.2 p -116.44 162.42 17.58 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.657 -0.652 . . . . 6.82 110.171 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.5 mt -117.19 164.21 20.0 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.703 -0.623 . . . . 10.11 110.165 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo . . . . . 0 N--CA 1.486 1.083 0 O-C-N 123.686 1.361 . . . . 12.05 110.362 179.906 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -144.53 156.7 44.28 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.761 -0.846 . . . . 0.0 110.206 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 89.1 mmm -96.91 138.31 34.64 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.698 -0.626 . . . . 0.0 110.171 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -67.89 -33.46 74.77 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.739 -0.601 . . . . 0.0 110.289 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt -118.22 151.63 37.26 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.628 -0.67 . . . . 0.0 110.213 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.4 m -65.2 -35.19 80.3 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.661 -0.649 . . . . 0.0 110.36 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -148.04 173.39 28.09 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.61 178.09 47.14 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.5 tp -155.43 87.8 3.15 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.74 -0.859 . . . . 0.0 109.953 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -67.52 106.55 1.27 Allowed 'Trans proline' 0 N--CA 1.488 1.183 0 O-C-N 123.509 1.268 . . . . 0.0 110.343 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -64.86 139.26 58.74 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.686 -0.634 . . . . 0.0 110.544 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.2 mt -64.76 -172.67 0.09 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.674 -0.642 . . . . 0.0 110.498 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.76 -1.85 84.96 Favored Glycine 0 N--CA 1.496 2.66 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.722 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.8 m -61.38 143.21 56.18 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.101 -1.235 . . . . 0.0 110.413 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -82.2 128.95 34.67 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.692 -0.63 . . . . 0.0 110.494 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.716 ' CD1' HD13 ' A' ' 26' ' ' LEU . 86.1 mt -122.0 142.92 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.581 -0.699 . . . . 0.0 110.076 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.5 t -103.15 137.23 41.59 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 174.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.77 HD21 HD13 ' A' ' 72' ' ' ILE . 13.7 tp -134.78 125.4 26.84 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.673 -0.642 . . . . 0.0 110.301 -169.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 81.5 mt -107.09 117.97 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.538 -0.727 . . . . 0.0 109.696 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.2 m -92.65 157.77 16.3 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.059 0.457 . . . . 0.0 111.267 -177.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -54.07 -13.66 0.87 Allowed 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -171.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.53 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -90.1 20.73 4.12 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.163 -0.961 . . . . 0.0 110.416 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 54.13 34.28 19.73 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.481 -0.762 . . . . 0.0 109.836 -174.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.844 HG12 HG22 ' A' ' 46' ' ' THR . 65.0 mt -102.94 141.3 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 55.1 ttt85 -104.61 119.84 39.92 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.997 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -114.79 149.65 36.64 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.666 ' O ' HG23 ' A' ' 41' ' ' VAL . 42.1 tt0 -140.42 140.49 35.45 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.556 -0.715 . . . . 0.0 109.478 175.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.3 172.01 41.48 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.688 -1.244 . . . . 0.0 110.681 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.3 mmt85 -84.85 138.51 32.51 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.919 -0.753 . . . . 0.0 110.522 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.716 HD13 ' CD1' ' A' ' 12' ' ' ILE . 16.8 tp -66.16 118.27 9.65 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.565 -0.709 . . . . 0.0 110.669 175.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.463 ' O ' HG23 ' A' ' 28' ' ' THR . 23.9 t80 -100.51 -50.14 4.0 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.623 -0.673 . . . . 0.0 110.385 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 27' ' ' TYR . 12.8 p -154.3 153.58 31.91 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.741 -0.599 . . . . 0.0 110.263 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.885 HG23 HG22 ' A' ' 36' ' ' ILE . 13.4 p -142.3 145.45 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.729 -0.607 . . . . 0.0 110.052 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -128.94 100.9 20.3 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.669 -0.644 . . . . 0.0 109.554 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.51 -39.44 45.2 Favored 'Trans proline' 0 N--CA 1.489 1.24 0 O-C-N 123.533 1.281 . . . . 0.0 110.796 -175.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -80.6 -25.74 38.27 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.369 -0.832 . . . . 0.0 110.066 -171.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.562 ' O ' HG23 ' A' ' 35' ' ' THR . 79.1 mt-10 -87.41 1.49 53.23 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.555 -0.715 . . . . 0.0 111.22 173.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 38.6 m 49.61 38.68 15.49 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.091 -1.006 . . . . 0.0 111.343 -176.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 33' ' ' GLU . 9.9 p -136.3 153.36 51.19 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.348 -0.845 . . . . 0.0 110.286 -174.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.885 HG22 HG23 ' A' ' 29' ' ' VAL . 39.9 pt -142.74 162.0 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.676 -0.64 . . . . 0.0 110.252 178.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.52 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.46 127.61 28.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.657 -0.652 . . . . 0.0 109.704 175.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 26' ' ' LEU . 83.2 mt -109.94 146.77 34.64 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -177.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 96.0 p -118.13 153.42 33.83 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.7 p 45.65 85.01 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 121.476 0.655 . . . . 0.0 110.364 -172.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.711 HG11 HD12 ' A' ' 65' ' ' ILE . 14.5 p -134.53 150.41 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.95 -0.469 . . . . 0.0 109.753 -178.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -135.21 153.18 52.03 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.634 -0.666 . . . . 0.0 109.952 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 82.5 p -108.19 138.83 43.79 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.656 -0.652 . . . . 0.0 109.866 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -83.02 -38.29 22.79 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.654 -0.654 . . . . 0.0 110.859 -174.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.64 168.1 29.29 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.844 HG22 HG12 ' A' ' 20' ' ' ILE . 17.6 p -118.15 6.6 12.03 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.925 -0.75 . . . . 0.0 110.908 175.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -49.87 -25.27 3.01 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.563 -0.711 . . . . 0.0 112.781 -166.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -64.92 -59.34 4.29 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.134 -0.978 . . . . 0.0 110.671 -177.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.1 mtp180 -94.45 10.16 35.59 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.502 -0.749 . . . . 0.0 111.524 176.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.593 ' HB2' HD12 ' A' ' 55' ' ' ILE . 39.5 p-10 -58.63 174.06 0.36 Allowed 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.204 -0.935 . . . . 0.0 111.448 -170.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.0 m -78.85 164.42 24.5 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.935 -0.478 . . . . 0.0 109.759 175.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -77.55 4.89 10.13 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.642 -0.661 . . . . 0.0 111.289 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -95.84 166.03 12.0 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.226 -0.921 . . . . 0.0 109.591 168.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -80.74 132.1 35.5 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.607 -0.683 . . . . 0.0 110.488 -175.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.593 HD12 ' HB2' ' A' ' 50' ' ' ASP . 78.5 mt -114.27 134.35 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.715 -0.615 . . . . 0.0 109.443 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.38 146.01 38.88 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.629 -0.669 . . . . 0.0 110.154 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -63.07 149.37 91.72 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 O-C-N 123.399 1.21 . . . . 0.0 110.539 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -96.28 121.62 38.26 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.647 -0.658 . . . . 0.0 110.107 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.0 t -91.66 -32.55 15.42 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.708 -0.62 . . . . 0.0 110.356 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -62.59 140.49 58.66 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.641 -0.662 . . . . 0.0 110.569 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.9 mm -96.89 148.12 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.744 -0.597 . . . . 0.0 109.683 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -94.2 114.27 26.35 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.62 -0.675 . . . . 0.0 110.195 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -51.38 -42.42 61.37 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.754 -0.591 . . . . 0.0 111.585 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.52 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.8 t80 -152.87 129.88 11.06 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.665 -0.647 . . . . 0.0 110.219 -174.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.711 HD12 HG11 ' A' ' 41' ' ' VAL . 72.8 mt -128.87 129.06 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.701 -0.625 . . . . 0.0 109.87 172.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.0 tp -90.34 137.05 32.66 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.802 -0.561 . . . . 0.0 109.84 176.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.609 ' CD1' HD11 ' A' ' 72' ' ' ILE . 2.8 m-85 -134.55 128.2 32.82 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.699 -0.626 . . . . 0.0 110.563 -175.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -91.61 146.81 23.47 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.686 -0.634 . . . . 0.0 110.213 172.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.81 -26.55 60.57 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.1 t -65.36 -40.11 93.15 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.467 -1.019 . . . . 0.0 111.004 -177.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -81.55 -32.31 32.3 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.431 -0.793 . . . . 0.0 110.857 -174.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.77 HD13 HD21 ' A' ' 14' ' ' LEU . 6.9 mt -101.15 140.48 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.456 -0.778 . . . . 0.0 110.149 177.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -104.63 -20.34 13.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.938 -0.476 . . . . 0.0 111.492 -168.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -151.56 133.69 15.17 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.034 -1.041 . . . . 0.0 111.233 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.539 HD12 ' CD1' ' A' ' 14' ' ' LEU . 17.0 tt -131.87 143.81 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.908 -0.495 . . . . 0.0 109.756 176.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -145.76 130.16 17.74 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.597 -0.689 . . . . 0.0 110.257 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.45 HG22 HG12 ' A' ' 12' ' ' ILE . 51.4 t -88.36 143.55 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.684 -0.635 . . . . 0.0 109.781 179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.9 t -93.7 129.87 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.567 -0.708 . . . . 0.0 109.674 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -117.5 140.25 49.86 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.667 -0.646 . . . . 0.0 110.259 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -106.11 131.88 52.84 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.677 -0.64 . . . . 0.0 110.125 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -119.77 140.34 50.89 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.672 -0.643 . . . . 0.0 110.215 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.7 m -122.27 138.74 54.39 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.666 -0.646 . . . . 0.0 110.127 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.0 tt -111.49 109.93 55.79 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.716 -0.615 . . . . 0.0 110.167 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo . . . . . 0 N--CA 1.49 1.279 0 O-C-N 123.369 1.194 . . . . 0.0 110.451 179.073 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -95.16 127.8 41.49 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.745 -0.856 . . . . 0.0 110.173 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.36 -34.38 70.41 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.699 -0.626 . . . . 0.0 110.234 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -90.9 115.35 27.87 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.636 -0.665 . . . . 0.0 110.169 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.9 mtp -67.26 -34.4 77.35 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.74 -0.6 . . . . 0.0 110.326 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.4 t -112.48 146.95 37.55 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.724 -0.61 . . . . 0.0 110.376 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -133.32 177.59 18.86 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -142.95 173.31 24.15 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.539 HD23 ' N ' ' A' ' 5' ' ' LEU . 0.9 OUTLIER -155.33 157.06 31.62 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.594 -0.945 . . . . 0.0 110.135 179.632 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -67.55 111.69 2.41 Favored 'Trans proline' 0 N--CA 1.488 1.149 0 O-C-N 123.612 1.322 . . . . 0.0 110.369 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.79 130.29 42.96 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.712 -0.617 . . . . 0.0 110.609 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.0 mt -64.83 149.67 49.01 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.714 -0.616 . . . . 0.0 110.626 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.6 -1.85 84.54 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.871 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 75.0 m -61.44 146.08 49.62 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.07 -1.253 . . . . 0.0 110.479 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.602 ' HE3' HG11 ' A' ' 78' ' ' VAL . 28.1 pttt -81.97 126.41 31.91 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.718 -0.613 . . . . 0.0 110.485 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.418 HG12 HG22 ' A' ' 77' ' ' VAL . 88.5 mt -123.91 143.96 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.605 -0.684 . . . . 0.0 110.177 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.6 t -102.65 137.26 41.11 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 175.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.629 HD21 HD13 ' A' ' 72' ' ' ILE . 13.8 tp -133.23 128.4 35.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.708 -0.62 . . . . 0.0 110.318 -170.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.1 mt -108.22 119.61 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.464 -0.772 . . . . 0.0 109.698 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.1 m -93.9 157.61 16.04 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.114 0.483 . . . . 0.0 111.222 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -54.12 -13.56 0.86 Allowed 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -172.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.552 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.84 20.41 4.16 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.148 -0.97 . . . . 0.0 110.485 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 53.91 34.04 18.6 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.38 -0.825 . . . . 0.0 109.804 -174.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.781 HG12 HG22 ' A' ' 46' ' ' THR . 67.3 mt -102.2 141.82 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -105.37 119.85 40.11 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.007 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -114.74 148.72 37.94 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 174.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.672 ' O ' HG23 ' A' ' 41' ' ' VAL . 41.9 tt0 -140.09 140.51 36.1 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.476 -0.765 . . . . 0.0 109.603 175.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.92 173.52 42.22 Favored Glycine 0 N--CA 1.495 2.597 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.48 -175.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -84.73 136.5 33.69 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.889 -0.771 . . . . 0.0 110.501 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' A' ' 38' ' ' LEU . 27.7 tp -66.14 116.33 7.1 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.548 -0.72 . . . . 0.0 110.537 175.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.413 ' C ' HG23 ' A' ' 28' ' ' THR . 25.8 t80 -99.14 -49.99 4.3 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.677 -0.639 . . . . 0.0 110.364 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.413 HG23 ' C ' ' A' ' 27' ' ' TYR . 25.1 p -152.97 154.87 35.86 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.655 -0.653 . . . . 0.0 110.25 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.829 HG23 HG22 ' A' ' 36' ' ' ILE . 13.6 p -142.23 145.61 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.686 -0.634 . . . . 0.0 110.104 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -127.83 101.54 23.26 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.627 -0.671 . . . . 0.0 109.506 177.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.44 -41.82 30.94 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 O-C-N 123.626 1.329 . . . . 0.0 110.868 -174.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -80.59 -24.55 39.08 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.301 -0.874 . . . . 0.0 110.214 -171.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.609 ' O ' HG23 ' A' ' 35' ' ' THR . 54.6 mt-10 -87.42 1.13 54.29 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.412 -0.805 . . . . 0.0 111.235 173.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 39.6 m 49.75 39.26 17.43 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.153 -0.967 . . . . 0.0 111.243 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.609 HG23 ' O ' ' A' ' 33' ' ' GLU . 11.8 p -135.82 153.79 51.4 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.407 -0.808 . . . . 0.0 110.38 -174.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.829 HG22 HG23 ' A' ' 29' ' ' VAL . 39.9 pt -142.62 162.02 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.708 -0.62 . . . . 0.0 110.193 177.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.51 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -135.61 129.54 33.02 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.63 -0.669 . . . . 0.0 109.82 175.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 26' ' ' LEU . 50.6 mt -109.84 144.23 38.59 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -178.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 99.9 p -116.24 151.41 35.83 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.8 p 46.1 87.43 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 CA-C-O 121.462 0.648 . . . . 0.0 110.267 -172.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.76 HG11 HD12 ' A' ' 65' ' ' ILE . 12.3 p -134.62 147.79 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.968 -0.458 . . . . 0.0 109.837 -178.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -127.33 153.08 46.63 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.821 -0.549 . . . . 0.0 109.703 178.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.8 p -109.39 136.74 48.33 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.697 -0.627 . . . . 0.0 109.824 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -82.93 -38.19 23.13 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.624 -0.672 . . . . 0.0 110.847 -174.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.58 167.13 27.8 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 176.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.781 HG22 HG12 ' A' ' 20' ' ' ILE . 6.9 p -118.16 6.6 12.03 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.976 -0.72 . . . . 0.0 110.977 175.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -48.99 -25.46 1.98 Allowed 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.498 -0.752 . . . . 0.0 112.417 -169.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -64.4 -59.2 4.63 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.225 -0.922 . . . . 0.0 110.622 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -94.34 10.23 35.07 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.628 -0.67 . . . . 0.0 111.373 177.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -61.08 174.02 0.72 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.241 -0.912 . . . . 0.0 111.279 -170.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.715 ' OG1' HD11 ' A' ' 55' ' ' ILE . 39.9 p -78.88 164.5 24.41 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.914 -0.491 . . . . 0.0 109.917 175.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -77.52 3.89 12.47 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.004 176.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -97.34 165.28 12.1 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.181 -0.95 . . . . 0.0 109.621 167.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -68.51 142.47 55.26 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.524 -0.735 . . . . 0.0 110.388 -177.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.715 HD11 ' OG1' ' A' ' 51' ' ' THR . 49.9 mm -112.67 134.95 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.704 -0.622 . . . . 0.0 109.675 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -97.96 109.91 53.48 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.731 -0.606 . . . . 0.0 110.201 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -67.49 147.16 76.54 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 O-C-N 123.379 1.199 . . . . 0.0 110.409 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -96.54 119.77 35.63 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.721 -0.612 . . . . 0.0 110.222 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.6 p -68.26 -30.65 69.74 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.707 -0.62 . . . . 0.0 110.422 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -62.4 145.78 53.07 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.551 -0.718 . . . . 0.0 110.595 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.87 154.71 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.745 -0.597 . . . . 0.0 109.699 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -94.13 113.68 25.68 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.667 -0.645 . . . . 0.0 110.17 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -51.54 -40.52 59.83 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.753 -0.592 . . . . 0.0 111.765 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.51 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.4 t80 -153.38 130.84 11.37 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.669 -0.644 . . . . 0.0 110.177 -175.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.76 HD12 HG11 ' A' ' 41' ' ' VAL . 76.2 mt -129.75 128.22 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.725 -0.609 . . . . 0.0 109.791 172.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.6 tp -90.46 136.99 32.71 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.851 -0.53 . . . . 0.0 109.805 176.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.589 ' CD1' HD11 ' A' ' 72' ' ' ILE . 3.3 m-85 -135.81 130.62 34.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.661 -0.649 . . . . 0.0 110.58 -175.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -91.68 149.66 21.52 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.678 -0.639 . . . . 0.0 110.343 173.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.05 -24.55 60.86 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.0 t -66.81 -42.14 86.39 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.481 -1.011 . . . . 0.0 111.056 -175.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -82.77 -33.04 27.49 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.396 -0.815 . . . . 0.0 110.879 -175.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.629 HD13 HD21 ' A' ' 14' ' ' LEU . 13.8 mt -100.72 138.4 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.423 -0.798 . . . . 0.0 110.143 177.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 50.3 tptt -108.0 -19.12 13.61 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.789 -166.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -149.71 135.86 18.89 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 118.935 -1.106 . . . . 0.0 111.319 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.5 HD12 ' CD1' ' A' ' 14' ' ' LEU . 18.2 tt -134.08 144.47 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.868 -0.52 . . . . 0.0 109.886 177.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -146.1 133.28 20.47 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.608 -0.682 . . . . 0.0 110.288 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.418 HG22 HG12 ' A' ' 12' ' ' ILE . 51.2 t -87.67 145.35 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.681 -0.637 . . . . 0.0 109.736 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.602 HG11 ' HE3' ' A' ' 11' ' ' LYS . 56.1 t -93.74 135.27 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.641 -0.662 . . . . 0.0 109.748 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -123.41 173.52 7.94 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.716 -0.615 . . . . 0.0 110.201 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -75.77 168.43 20.04 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.672 -0.642 . . . . 0.0 110.117 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -65.09 -34.82 79.31 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.724 -0.61 . . . . 0.0 110.335 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.6 m -121.23 141.09 51.2 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.674 -0.641 . . . . 0.0 110.097 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.493 ' N ' HD12 ' A' ' 83' ' ' LEU . 6.5 mp -109.47 161.84 22.48 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.758 -0.589 . . . . 0.0 110.241 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo . . . . . 0 N--CA 1.488 1.178 0 O-C-N 123.689 1.362 . . . . 0.0 110.324 -179.868 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -143.83 155.43 44.12 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.684 -0.892 . . . . 0.0 110.255 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 89.0 mmm -120.41 153.98 35.79 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.711 -0.618 . . . . 0.0 110.157 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -145.62 155.47 43.05 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.689 -0.632 . . . . 0.0 110.225 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.1 mtp -108.11 146.68 32.3 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.796 -0.565 . . . . 0.0 110.203 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 94.4 p -131.69 155.88 46.86 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.667 -0.646 . . . . 0.0 110.223 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -148.3 37.62 1.06 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -129.84 44.02 1.25 Allowed Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 15.6 tp -79.94 138.9 53.37 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.682 -0.893 . . . . 0.0 109.946 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -68.31 108.99 1.9 Allowed 'Trans proline' 0 N--CA 1.488 1.18 0 O-C-N 123.35 1.184 . . . . 0.0 110.324 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -64.93 137.78 57.96 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.711 -0.618 . . . . 0.0 110.491 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.9 mt -64.84 152.17 43.56 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.675 -0.641 . . . . 0.0 110.559 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.63 -1.79 84.83 Favored Glycine 0 N--CA 1.496 2.685 0 C-N-CA 120.49 -0.862 . . . . 0.0 111.73 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 58.5 m -60.88 153.66 24.18 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.119 -1.224 . . . . 0.0 110.541 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -81.56 123.58 28.78 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.715 -0.616 . . . . 0.0 110.583 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 89.0 mt -120.81 145.27 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.508 -0.745 . . . . 0.0 110.066 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.0 t -102.54 137.31 40.94 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 175.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.707 HD21 HD13 ' A' ' 72' ' ' ILE . 13.8 tp -131.71 125.6 32.44 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.707 -0.621 . . . . 0.0 110.146 -170.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.3 mt -106.03 119.05 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.552 -0.718 . . . . 0.0 109.632 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.3 m -94.33 157.72 15.9 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.068 0.461 . . . . 0.0 111.227 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -53.43 -14.73 0.84 Allowed 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -172.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.551 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.32 20.3 3.89 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.097 -1.002 . . . . 0.0 110.463 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 54.0 34.08 18.93 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.478 -0.764 . . . . 0.0 109.796 -174.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.794 HG12 HG22 ' A' ' 46' ' ' THR . 68.5 mt -102.0 141.41 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 63.8 ttt-85 -105.5 119.81 40.05 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.887 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -114.15 150.01 34.81 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.665 ' O ' HG23 ' A' ' 41' ' ' VAL . 34.4 tt0 -140.68 140.46 34.95 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.42 -0.8 . . . . 0.0 109.647 175.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.6 172.97 43.23 Favored Glycine 0 N--CA 1.495 2.611 0 C-N-CA 119.716 -1.231 . . . . 0.0 110.538 -175.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -84.96 135.53 34.0 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.893 -0.769 . . . . 0.0 110.576 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.461 ' HA ' HD23 ' A' ' 38' ' ' LEU . 25.0 tp -66.1 117.93 9.13 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.542 -0.724 . . . . 0.0 110.595 175.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.443 ' O ' HG23 ' A' ' 28' ' ' THR . 25.9 t80 -99.52 -50.13 4.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.573 -0.704 . . . . 0.0 110.481 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 27' ' ' TYR . 16.0 p -153.93 156.48 37.59 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.734 -0.604 . . . . 0.0 110.32 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.846 HG23 HG22 ' A' ' 36' ' ' ILE . 13.3 p -142.32 145.86 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.708 -0.62 . . . . 0.0 110.034 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -128.25 99.14 24.97 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.659 -0.651 . . . . 0.0 109.55 177.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -59.5 -40.86 62.54 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 O-C-N 123.553 1.291 . . . . 0.0 110.937 -175.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -80.58 -25.76 38.3 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.338 -0.852 . . . . 0.0 110.181 -171.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.626 ' O ' HG23 ' A' ' 35' ' ' THR . 79.4 mt-10 -87.43 1.87 52.14 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.538 -0.726 . . . . 0.0 111.167 173.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.3 m 49.54 38.41 14.61 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.079 -1.013 . . . . 0.0 111.197 -176.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.626 HG23 ' O ' ' A' ' 33' ' ' GLU . 11.5 p -135.71 154.76 51.16 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.415 -0.803 . . . . 0.0 110.438 -174.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.846 HG22 HG23 ' A' ' 29' ' ' VAL . 40.4 pt -142.26 162.02 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.732 -0.605 . . . . 0.0 110.131 177.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.515 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -135.82 128.28 30.46 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.592 -0.693 . . . . 0.0 109.765 176.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 26' ' ' LEU . 86.3 mt -109.86 146.37 35.2 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -178.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.9 p -117.68 151.58 36.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.623 -0.673 . . . . 0.0 109.234 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 46.8 p 45.98 86.71 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 121.472 0.653 . . . . 0.0 110.291 -172.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.745 HG11 HD12 ' A' ' 65' ' ' ILE . 12.8 p -134.58 147.76 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.939 -0.476 . . . . 0.0 109.873 -178.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -126.19 153.06 45.17 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.732 -0.605 . . . . 0.0 109.798 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.3 p -108.79 134.39 51.55 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.665 -0.647 . . . . 0.0 109.794 177.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -83.02 -38.28 22.8 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.623 -0.673 . . . . 0.0 111.011 -173.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.66 168.74 30.25 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.993 -1.099 . . . . 0.0 110.54 176.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.794 HG22 HG12 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -118.14 6.61 12.04 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 122.008 -0.701 . . . . 0.0 110.997 175.021 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.3 tp10 -48.95 -25.95 2.23 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.546 -0.721 . . . . 0.0 112.455 -168.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -65.76 -59.21 4.13 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.335 -0.853 . . . . 0.0 110.421 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.9 mmp_? -94.19 10.14 35.09 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.68 -0.638 . . . . 0.0 111.319 177.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.413 ' HB2' HD12 ' A' ' 55' ' ' ILE . 39.9 p-10 -59.47 166.18 2.49 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.243 -0.91 . . . . 0.0 111.418 -170.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.0 m -78.95 164.44 24.42 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.949 -0.47 . . . . 0.0 109.765 174.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -77.56 4.12 12.01 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.616 -0.678 . . . . 0.0 111.268 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -96.81 158.35 15.47 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.174 -0.954 . . . . 0.0 109.632 167.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -70.77 140.15 51.23 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.489 -0.757 . . . . 0.0 110.375 -176.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.413 HD12 ' HB2' ' A' ' 50' ' ' ASP . 81.1 mt -115.28 134.9 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.664 -0.647 . . . . 0.0 109.616 177.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.05 109.92 53.69 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.736 -0.603 . . . . 0.0 110.133 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -66.61 146.54 79.63 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 O-C-N 123.343 1.18 . . . . 0.0 110.379 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -95.59 124.01 39.42 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.667 -0.645 . . . . 0.0 110.232 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.5 p -67.67 -29.35 68.61 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.675 -0.641 . . . . 0.0 110.492 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -62.02 145.93 51.67 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.55 -0.719 . . . . 0.0 110.538 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.91 156.24 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.749 -0.594 . . . . 0.0 109.747 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -93.65 115.14 27.58 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.669 -0.644 . . . . 0.0 110.087 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -51.25 -42.98 61.4 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.767 -0.583 . . . . 0.0 111.697 178.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.515 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.8 t80 -152.73 129.1 10.59 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.624 -0.673 . . . . 0.0 110.244 -174.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.745 HD12 HG11 ' A' ' 41' ' ' VAL . 75.4 mt -128.0 129.24 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.665 -0.647 . . . . 0.0 109.871 172.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.0 tp -90.32 137.04 32.67 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.802 -0.562 . . . . 0.0 109.797 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.614 ' CD1' HD11 ' A' ' 72' ' ' ILE . 2.8 m-85 -135.19 130.33 35.15 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.647 -0.658 . . . . 0.0 110.544 -175.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.1 mtm-85 -91.47 148.26 22.43 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.713 -0.617 . . . . 0.0 110.322 173.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.69 -24.03 59.37 Favored Glycine 0 N--CA 1.498 2.816 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 178.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.0 p -67.82 -42.11 82.03 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.361 -1.082 . . . . 0.0 111.089 -175.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -82.49 -32.41 28.8 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.398 -0.814 . . . . 0.0 110.894 -175.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.707 HD13 HD21 ' A' ' 14' ' ' LEU . 14.8 mt -99.56 141.48 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.333 -0.854 . . . . 0.0 110.18 176.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -106.15 -24.61 12.3 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 120.554 -0.459 . . . . 0.0 111.447 -166.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -150.8 136.19 17.84 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 119.037 -1.065 . . . . 0.0 111.471 -176.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.49 HD12 ' CD1' ' A' ' 14' ' ' LEU . 18.4 tt -131.83 137.77 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 176.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -143.94 143.33 31.2 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.634 -0.666 . . . . 0.0 110.191 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.4 m -84.87 147.02 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.638 -0.664 . . . . 0.0 110.246 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.5 t -96.91 132.74 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.569 -0.707 . . . . 0.0 109.89 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -114.67 122.41 46.36 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.729 -0.607 . . . . 0.0 110.135 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -132.4 -46.47 0.9 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.714 -0.616 . . . . 0.0 110.325 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -124.73 141.25 52.24 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.704 -0.622 . . . . 0.0 110.183 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 25.1 m -119.42 141.65 48.93 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.658 -0.651 . . . . 0.0 110.105 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.1 tp -102.7 109.87 61.94 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.691 -0.63 . . . . 0.0 110.24 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo . . . . . 0 N--CA 1.488 1.199 0 O-C-N 123.328 1.172 . . . . 0.0 110.509 179.094 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -67.79 -33.69 75.31 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.702 -0.881 . . . . 0.0 110.407 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 89.4 mtp -65.86 -36.59 83.88 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.669 -0.644 . . . . 0.0 110.549 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -107.67 155.96 19.59 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.646 -0.659 . . . . 0.0 110.306 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.4 mtm -86.84 120.75 28.45 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.644 -0.66 . . . . 0.0 110.085 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -66.24 -35.42 80.37 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.69 -0.631 . . . . 0.0 110.366 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -101.34 34.26 5.79 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.74 -60.13 0.66 Allowed Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.509 HD12 ' N ' ' A' ' 5' ' ' LEU . 7.7 mp -81.35 152.23 70.22 Favored Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 121.69 -0.888 . . . . 0.0 110.115 178.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -68.61 129.56 19.1 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 O-C-N 123.659 1.347 . . . . 0.0 110.309 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -64.88 129.51 40.01 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.62 -0.675 . . . . 0.0 110.441 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 80.6 mt -64.81 145.25 56.53 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.778 -0.576 . . . . 0.0 110.614 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.62 -1.83 84.66 Favored Glycine 0 N--CA 1.497 2.708 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.679 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 58.2 m -60.86 155.5 19.48 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.074 -1.251 . . . . 0.0 110.579 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.19 122.25 27.66 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.805 -0.559 . . . . 0.0 110.366 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 90.3 mt -119.96 144.38 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.515 -0.741 . . . . 0.0 110.114 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.7 t -102.83 137.24 41.3 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 175.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.675 HD21 HD13 ' A' ' 72' ' ' ILE . 14.2 tp -133.33 125.47 29.28 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.789 -0.569 . . . . 0.0 110.183 -169.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.1 mt -106.52 117.97 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.561 -0.712 . . . . 0.0 109.654 -178.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m -93.35 157.74 16.08 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.078 0.466 . . . . 0.0 111.239 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -53.89 -13.95 0.87 Allowed 'General case' 0 N--CA 1.507 2.392 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -171.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.519 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -90.18 20.91 4.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.169 -0.957 . . . . 0.0 110.444 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 54.15 34.42 20.08 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.486 -0.759 . . . . 0.0 109.882 -174.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.834 HG12 HG22 ' A' ' 46' ' ' THR . 66.1 mt -102.86 141.24 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -104.85 119.73 39.71 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.905 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -114.47 148.29 38.04 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 174.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.66 ' O ' HG23 ' A' ' 41' ' ' VAL . 41.0 tt0 -139.05 140.51 38.1 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.573 -0.704 . . . . 0.0 109.592 175.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.54 173.11 43.21 Favored Glycine 0 N--CA 1.496 2.659 0 C-N-CA 119.794 -1.193 . . . . 0.0 110.386 -175.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 -85.95 136.16 33.38 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.814 -0.815 . . . . 0.0 110.604 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.466 ' HA ' HD23 ' A' ' 38' ' ' LEU . 25.3 tp -66.13 119.5 11.55 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.62 -0.675 . . . . 0.0 110.675 176.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.437 ' O ' HG23 ' A' ' 28' ' ' THR . 22.6 t80 -100.11 -50.01 4.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.693 -0.629 . . . . 0.0 110.446 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 27' ' ' TYR . 16.5 p -153.77 154.36 33.88 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.622 -0.674 . . . . 0.0 110.384 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.895 HG23 HG22 ' A' ' 36' ' ' ILE . 13.4 p -142.28 146.1 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.696 -0.627 . . . . 0.0 110.09 -178.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -129.03 101.26 19.76 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.61 -0.681 . . . . 0.0 109.574 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.42 -41.08 35.27 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 O-C-N 123.628 1.33 . . . . 0.0 110.785 -174.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -80.61 -23.98 39.42 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.396 -0.815 . . . . 0.0 110.187 -172.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.73 ' O ' HG23 ' A' ' 35' ' ' THR . 13.3 mm-40 -87.37 0.88 54.8 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.492 -0.755 . . . . 0.0 111.14 173.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.3 m 49.81 38.14 15.02 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.139 -0.976 . . . . 0.0 111.205 -176.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.73 HG23 ' O ' ' A' ' 33' ' ' GLU . 21.5 p -136.68 152.94 50.95 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.352 -0.842 . . . . 0.0 110.405 -174.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.895 HG22 HG23 ' A' ' 29' ' ' VAL . 39.8 pt -142.75 162.02 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.714 -0.616 . . . . 0.0 110.164 178.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.519 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.22 128.34 29.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.593 -0.692 . . . . 0.0 109.786 175.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 26' ' ' LEU . 86.7 mt -109.96 148.13 32.18 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 95.1 p -120.26 152.8 37.26 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.628 -0.67 . . . . 0.0 109.214 -177.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 53.0 p 44.94 87.34 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 CA-C-O 121.392 0.615 . . . . 0.0 110.385 -172.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.742 HG11 HD12 ' A' ' 65' ' ' ILE . 11.2 p -134.59 145.18 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 CA-C-O 121.155 0.503 . . . . 0.0 110.005 -177.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.837 ' HG2' HD12 ' A' ' 61' ' ' ILE . 90.8 mtt180 -120.46 153.11 37.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.688 -0.633 . . . . 0.0 109.755 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 86.3 p -111.27 133.44 53.6 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.629 -0.669 . . . . 0.0 109.856 177.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -83.05 -38.49 22.48 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.052 -173.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.53 171.98 34.14 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.993 -1.099 . . . . 0.0 110.445 177.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.834 HG22 HG12 ' A' ' 20' ' ' ILE . 2.2 p -117.97 6.48 12.18 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.797 -0.826 . . . . 0.0 110.915 173.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -51.06 -24.1 3.61 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.507 -0.746 . . . . 0.0 112.795 -167.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.08 -59.44 4.13 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.193 -0.942 . . . . 0.0 110.706 -176.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -94.5 10.21 35.49 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.575 -0.703 . . . . 0.0 111.444 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.559 ' HB2' HD12 ' A' ' 55' ' ' ILE . 40.2 p-10 -58.76 174.04 0.37 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.189 -0.944 . . . . 0.0 111.419 -170.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.0 m -78.92 164.48 24.4 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.957 -0.464 . . . . 0.0 109.774 175.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -77.5 4.71 10.48 Favored 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.277 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -95.98 166.07 11.95 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.176 -0.952 . . . . 0.0 109.622 168.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -80.6 133.19 35.72 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.594 -0.691 . . . . 0.0 110.399 -175.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.559 HD12 ' HB2' ' A' ' 50' ' ' ASP . 78.6 mt -113.9 135.35 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.625 -0.672 . . . . 0.0 109.54 177.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.88 146.11 38.09 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.642 -0.661 . . . . 0.0 110.138 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -68.78 149.37 72.86 Favored 'Trans proline' 0 N--CA 1.487 1.104 0 O-C-N 123.55 1.289 . . . . 0.0 110.307 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -92.71 107.4 19.19 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.631 -0.668 . . . . 0.0 110.074 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.9 m -68.01 -35.72 78.77 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.699 -0.625 . . . . 0.0 110.345 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -60.99 133.47 56.13 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.658 -0.651 . . . . 0.0 110.809 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.837 HD12 ' HG2' ' A' ' 42' ' ' ARG . 45.7 mm -96.97 153.73 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.659 -0.651 . . . . 0.0 109.606 178.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -96.76 112.47 24.21 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.598 -0.689 . . . . 0.0 110.446 -175.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -51.67 -41.02 61.09 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.678 -0.639 . . . . 0.0 111.496 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.519 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.7 t80 -153.02 130.31 11.28 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.604 -0.685 . . . . 0.0 110.124 -175.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.742 HD12 HG11 ' A' ' 41' ' ' VAL . 77.4 mt -127.96 128.34 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.644 -0.66 . . . . 0.0 109.804 172.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.2 tp -90.29 137.04 32.67 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.867 -0.52 . . . . 0.0 109.753 175.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.551 ' CD1' HD11 ' A' ' 72' ' ' ILE . 3.0 m-85 -137.03 130.54 31.54 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.663 -0.648 . . . . 0.0 110.6 -174.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -91.57 147.81 22.74 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.705 -0.622 . . . . 0.0 110.301 173.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.11 -26.8 61.66 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.4 m -65.56 -39.39 91.62 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.453 -1.028 . . . . 0.0 110.944 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.69 -32.54 31.67 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.445 -0.785 . . . . 0.0 110.807 -174.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.675 HD13 HD21 ' A' ' 14' ' ' LEU . 8.1 mt -102.97 140.23 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.422 -0.799 . . . . 0.0 110.157 177.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -106.34 -19.7 13.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.961 -0.462 . . . . 0.0 111.647 -167.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -150.41 133.61 16.25 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 119.008 -1.077 . . . . 0.0 111.379 -178.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.525 HD12 ' CD1' ' A' ' 14' ' ' LEU . 17.3 tt -132.44 138.77 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.931 -0.48 . . . . 0.0 109.799 176.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.1 mtm180 -147.07 145.95 29.81 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.598 -0.688 . . . . 0.0 110.422 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.8 m -84.83 147.1 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.664 -0.647 . . . . 0.0 110.328 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.7 m -139.15 147.09 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.559 -0.713 . . . . 0.0 110.172 -178.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -101.63 147.08 26.84 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.697 -0.627 . . . . 0.0 110.164 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -64.94 -31.79 73.19 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.618 -0.676 . . . . 0.0 110.531 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -95.11 109.22 21.31 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.68 -0.638 . . . . 0.0 110.127 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 39.3 p -131.85 166.47 21.53 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.743 -0.598 . . . . 0.0 110.194 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 83' ' ' LEU . 6.3 mp -71.56 155.26 92.75 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 121.669 -0.645 . . . . 0.0 110.129 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo . . . . . 0 N--CA 1.487 1.137 0 O-C-N 123.699 1.368 . . . . 0.0 110.365 -179.636 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -102.31 141.59 34.9 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.659 -0.907 . . . . 0.0 110.192 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 90.2 mtp -65.98 -37.65 86.5 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.712 -0.617 . . . . 0.0 110.322 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -154.98 150.08 26.97 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.771 -0.581 . . . . 0.0 110.238 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.9 ttm -119.95 123.03 42.53 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.658 -0.651 . . . . 0.0 110.16 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.8 m -125.52 142.93 51.24 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.701 -0.625 . . . . 0.0 110.155 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -155.05 110.29 0.44 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.87 -60.1 0.89 Allowed Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 5' ' ' LEU . 6.6 mp -80.76 156.37 72.77 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.64 -0.918 . . . . 0.0 110.158 178.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -66.98 132.92 29.48 Favored 'Trans proline' 0 N--CA 1.488 1.151 0 O-C-N 123.659 1.347 . . . . 0.0 110.329 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -64.91 127.49 31.79 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.626 -0.671 . . . . 0.0 110.525 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.0 mt -64.89 150.52 47.63 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.765 -0.584 . . . . 0.0 110.602 178.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.72 -1.94 84.58 Favored Glycine 0 N--CA 1.496 2.659 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.793 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 74.1 m -61.13 148.1 41.74 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.097 -1.237 . . . . 0.0 110.46 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -81.59 125.18 30.22 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.716 -0.615 . . . . 0.0 110.536 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.61 ' CD1' HD13 ' A' ' 26' ' ' LEU . 90.0 mt -120.91 145.05 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.555 -0.716 . . . . 0.0 110.014 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.6 t -102.93 137.19 41.45 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.778 HD21 HD13 ' A' ' 72' ' ' ILE . 13.5 tp -133.12 124.86 28.32 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.875 -0.515 . . . . 0.0 110.211 -169.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.3 mt -105.75 118.49 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.633 -0.667 . . . . 0.0 109.661 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.1 m -93.1 157.8 16.1 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.112 0.482 . . . . 0.0 111.235 -176.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -53.8 -14.2 0.89 Allowed 'General case' 0 N--CA 1.51 2.525 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -171.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.516 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.63 20.08 4.23 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.207 -0.933 . . . . 0.0 110.412 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 54.38 35.07 22.18 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.448 -0.782 . . . . 0.0 109.817 -175.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.838 HG12 HG22 ' A' ' 46' ' ' THR . 65.2 mt -103.23 144.27 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 59.5 ttm-85 -105.06 119.87 40.09 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.073 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -114.2 150.12 34.75 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 174.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.647 ' O ' HG23 ' A' ' 41' ' ' VAL . 41.8 tt0 -141.48 140.52 33.55 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.484 -0.76 . . . . 0.0 109.648 175.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -169.28 172.86 43.6 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 119.607 -1.282 . . . . 0.0 110.575 -175.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -85.23 136.28 33.58 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.878 -0.778 . . . . 0.0 110.609 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.61 HD13 ' CD1' ' A' ' 12' ' ' ILE . 15.0 tp -66.3 119.53 11.71 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.634 -0.666 . . . . 0.0 110.694 175.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.453 ' O ' HG23 ' A' ' 28' ' ' THR . 26.2 t80 -100.13 -50.18 4.05 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.549 -0.719 . . . . 0.0 110.419 178.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 27' ' ' TYR . 13.5 p -154.4 156.01 36.04 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.636 -0.665 . . . . 0.0 110.283 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.874 HG23 HG22 ' A' ' 36' ' ' ILE . 13.6 p -142.26 145.63 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.612 -0.68 . . . . 0.0 110.068 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -127.5 98.74 28.24 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.627 -0.671 . . . . 0.0 109.565 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -59.38 -42.05 52.58 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 O-C-N 123.597 1.314 . . . . 0.0 111.044 -175.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -80.74 -24.59 38.6 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.372 -0.83 . . . . 0.0 110.169 -171.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.57 ' O ' HG23 ' A' ' 35' ' ' THR . 74.8 mm-40 -87.12 1.15 53.9 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.509 -0.745 . . . . 0.0 111.245 173.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.4 m 49.82 37.91 14.53 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.122 -0.986 . . . . 0.0 111.203 -176.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 33' ' ' GLU . 9.9 p -136.13 154.38 51.0 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.405 -0.809 . . . . 0.0 110.368 -174.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.874 HG22 HG23 ' A' ' 29' ' ' VAL . 39.9 pt -142.51 162.09 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.706 -0.621 . . . . 0.0 110.166 178.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.516 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.54 128.07 28.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.698 -0.627 . . . . 0.0 109.752 175.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.477 HD23 ' HA ' ' A' ' 26' ' ' LEU . 90.6 mt -109.92 148.95 30.63 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -177.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 96.6 p -119.65 152.18 37.52 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.6 p 45.58 83.46 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.226 0 CA-C-O 121.54 0.686 . . . . 0.0 110.382 -172.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.702 ' CG1' HD12 ' A' ' 65' ' ' ILE . 14.9 p -134.59 150.48 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -136.07 153.21 51.4 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.598 -0.689 . . . . 0.0 110.063 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 81.7 p -107.25 137.52 45.15 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.74 -0.6 . . . . 0.0 109.56 177.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -82.76 -38.47 23.18 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.92 -172.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.38 167.37 27.96 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 175.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.838 HG22 HG12 ' A' ' 20' ' ' ILE . 38.3 p -118.28 6.24 11.92 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.807 -0.819 . . . . 0.0 110.913 172.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -52.71 -26.22 13.36 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.49 -0.756 . . . . 0.0 112.095 -167.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -66.22 -59.16 4.0 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.393 -0.817 . . . . 0.0 110.273 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -94.28 10.18 35.15 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.736 -0.602 . . . . 0.0 111.342 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 52.9 p-10 -57.68 174.06 0.26 Allowed 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.29 -0.881 . . . . 0.0 111.499 -171.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.5 m -79.0 164.55 24.29 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -77.44 3.24 13.84 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.584 -0.698 . . . . 0.0 111.227 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -100.46 165.99 11.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.225 -0.922 . . . . 0.0 109.567 169.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -66.98 136.83 55.93 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.579 -0.7 . . . . 0.0 110.515 -175.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.2 mm -113.52 137.26 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.679 -0.638 . . . . 0.0 109.604 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -96.83 109.94 51.13 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.664 -0.648 . . . . 0.0 110.21 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -67.49 145.06 69.48 Favored 'Trans proline' 0 N--CA 1.488 1.16 0 O-C-N 123.395 1.208 . . . . 0.0 110.288 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -97.36 114.42 26.22 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.648 -0.657 . . . . 0.0 110.265 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 87.3 p -77.51 -29.18 52.34 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.655 -0.653 . . . . 0.0 110.478 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -62.13 151.24 36.31 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.601 -0.687 . . . . 0.0 110.669 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.5 mm -96.75 144.92 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.751 -0.593 . . . . 0.0 109.747 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -94.32 114.59 26.68 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.56 -0.712 . . . . 0.0 110.218 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -50.95 -40.51 57.64 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.824 -0.547 . . . . 0.0 111.812 178.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.516 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.8 t80 -152.57 130.12 11.47 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.714 -0.616 . . . . 0.0 110.289 -174.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.702 HD12 ' CG1' ' A' ' 41' ' ' VAL . 76.3 mt -130.09 129.53 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.641 -0.662 . . . . 0.0 109.793 172.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.2 tp -90.27 137.02 32.69 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.814 -0.554 . . . . 0.0 109.864 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.592 ' CD1' HD11 ' A' ' 72' ' ' ILE . 2.5 m-85 -135.17 129.28 33.56 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.658 -0.651 . . . . 0.0 110.562 -175.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 71.2 mtp85 -91.26 146.77 23.54 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.703 -0.623 . . . . 0.0 110.249 173.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.8 -26.52 60.49 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 110.539 -1.025 . . . . 0.0 110.539 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.2 m -65.84 -39.4 90.76 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.527 -0.984 . . . . 0.0 110.953 -177.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.67 -31.71 32.12 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.533 -0.73 . . . . 0.0 110.824 -174.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.778 HD13 HD21 ' A' ' 14' ' ' LEU . 7.9 mt -102.32 142.42 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.443 -0.786 . . . . 0.0 110.191 177.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -104.46 -23.67 13.13 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.378 -167.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -151.99 135.34 15.98 Favored 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 119.146 -1.022 . . . . 0.0 111.446 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.538 HD12 ' CD1' ' A' ' 14' ' ' LEU . 17.6 tt -131.81 140.8 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.906 -0.496 . . . . 0.0 109.775 176.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -146.91 141.56 26.66 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.519 -0.738 . . . . 0.0 110.349 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.5 t -86.85 145.75 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.679 -0.638 . . . . 0.0 109.711 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.3 t -139.2 135.92 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.583 -0.698 . . . . 0.0 109.758 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -142.35 100.36 3.69 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.65 -0.656 . . . . 0.0 110.167 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -125.0 105.87 9.52 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.708 -0.62 . . . . 0.0 110.255 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.584 ' CE1' HG23 ' A' ' 82' ' ' THR . 19.0 p80 -110.59 -26.29 9.53 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.658 -0.651 . . . . 0.0 110.677 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.584 HG23 ' CE1' ' A' ' 81' ' ' HIS . 56.4 p -77.09 161.46 28.25 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.446 -0.784 . . . . 0.0 110.097 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.2 tp -109.1 109.91 60.71 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.65 -0.656 . . . . 0.0 110.128 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo . . . . . 0 N--CA 1.488 1.182 0 O-C-N 123.394 1.207 . . . . 0.0 110.295 179.178 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -103.82 144.76 31.07 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.613 -0.934 . . . . 0.0 110.196 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 88.8 mmm -119.01 148.34 43.11 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.734 -0.604 . . . . 0.0 110.148 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -95.18 111.38 23.23 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.684 -0.635 . . . . 0.0 110.147 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.6 mtp -134.71 158.27 44.54 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.666 -0.646 . . . . 0.0 110.241 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.3 t -120.81 141.24 50.72 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.695 -0.628 . . . . 0.0 110.142 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -127.66 104.72 0.7 Allowed Glycine 0 N--CA 1.496 2.691 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.24 -179.58 48.39 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.91 -56.81 1.04 Allowed Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.643 -0.916 . . . . 0.0 110.591 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -71.93 137.43 29.39 Favored 'Trans proline' 0 N--CA 1.487 1.104 0 O-C-N 123.244 1.128 . . . . 0.0 110.377 -178.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -64.79 141.03 58.92 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.707 -0.621 . . . . 0.0 110.499 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.1 mt -64.76 152.05 43.63 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.623 -0.673 . . . . 0.0 110.622 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.68 -1.92 84.55 Favored Glycine 0 N--CA 1.497 2.753 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.788 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 63.8 m -62.0 155.27 24.26 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.168 -1.195 . . . . 0.0 110.4 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.547 ' HE3' HG11 ' A' ' 78' ' ' VAL . 35.8 pttt -81.21 127.98 33.28 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 120.191 -0.604 . . . . 0.0 110.384 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.686 ' CD1' HD13 ' A' ' 26' ' ' LEU . 87.7 mt -121.62 142.95 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.563 -0.711 . . . . 0.0 110.03 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.0 t -102.99 137.29 41.38 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 175.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.885 HD21 HD13 ' A' ' 72' ' ' ILE . 13.9 tp -134.33 123.88 24.9 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.736 -0.602 . . . . 0.0 110.164 -169.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.5 mt -106.33 118.16 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.574 -0.704 . . . . 0.0 109.609 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 62.3 m -92.47 157.81 16.37 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 120.963 0.411 . . . . 0.0 111.245 -176.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -53.56 -13.98 0.75 Allowed 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 -172.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.571 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.96 20.58 4.13 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.115 -0.991 . . . . 0.0 110.412 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 53.43 34.37 18.02 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.395 -0.816 . . . . 0.0 109.813 -174.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.778 HG12 HG22 ' A' ' 46' ' ' THR . 73.1 mt -101.24 141.99 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -104.68 119.86 39.98 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.958 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -115.0 149.28 37.67 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 174.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.664 ' O ' HG23 ' A' ' 41' ' ' VAL . 71.2 mt-10 -140.95 140.52 34.44 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.377 -0.827 . . . . 0.0 109.706 174.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.35 172.17 41.56 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 119.814 -1.184 . . . . 0.0 110.559 -175.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -84.7 139.41 32.03 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.933 -0.745 . . . . 0.0 110.611 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.686 HD13 ' CD1' ' A' ' 12' ' ' ILE . 16.0 tp -66.11 117.9 9.09 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.718 -0.614 . . . . 0.0 110.7 175.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.446 ' O ' HG23 ' A' ' 28' ' ' THR . 21.8 t80 -100.11 -50.06 4.1 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.561 -0.712 . . . . 0.0 110.333 177.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 27' ' ' TYR . 16.9 p -153.81 156.05 36.94 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.684 -0.635 . . . . 0.0 110.271 -178.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.593 HG23 HG22 ' A' ' 36' ' ' ILE . 10.5 p -142.24 145.28 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.74 -0.6 . . . . 0.0 110.18 -178.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -129.03 101.88 19.38 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.675 -0.641 . . . . 0.0 109.434 176.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.83 -41.78 28.35 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 O-C-N 123.562 1.296 . . . . 0.0 110.919 -173.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -80.66 -24.97 38.57 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.332 -0.855 . . . . 0.0 110.227 -170.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.756 ' O ' HG23 ' A' ' 35' ' ' THR . 56.7 mt-10 -87.79 1.75 53.07 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.484 -0.76 . . . . 0.0 111.293 173.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 40.3 m 49.87 41.1 22.14 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.125 -0.984 . . . . 0.0 111.218 -176.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.756 HG23 ' O ' ' A' ' 33' ' ' GLU . 23.5 p -135.5 153.45 51.73 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.327 -0.858 . . . . 0.0 110.53 -174.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.593 HG22 HG23 ' A' ' 29' ' ' VAL . 40.4 pt -141.74 162.0 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.66 -0.65 . . . . 0.0 110.117 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.509 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.01 127.87 29.31 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.719 -0.613 . . . . 0.0 109.669 175.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 26' ' ' LEU . 51.5 mt -109.87 145.07 37.44 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 99.2 p -116.47 151.82 35.3 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.8 p 45.92 85.47 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 121.5 0.667 . . . . 0.0 110.356 -171.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.687 HG11 HD12 ' A' ' 65' ' ' ILE . 12.9 p -134.65 149.1 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -131.68 153.01 50.44 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.623 -0.673 . . . . 0.0 109.891 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 96.9 p -112.01 140.64 46.52 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.741 -0.599 . . . . 0.0 109.891 177.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -83.06 -38.5 22.44 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.613 -0.679 . . . . 0.0 111.175 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.58 171.91 34.1 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.993 -1.098 . . . . 0.0 110.417 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.778 HG22 HG12 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -118.16 6.5 12.02 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.829 -0.807 . . . . 0.0 110.884 173.56 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -50.3 -25.53 3.85 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.508 -0.745 . . . . 0.0 112.446 -168.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -66.06 -59.26 3.97 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.365 -0.834 . . . . 0.0 110.382 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -94.31 10.19 35.16 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.618 -0.676 . . . . 0.0 111.391 177.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 50.5 p-10 -58.15 171.98 0.49 Allowed 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.212 -0.93 . . . . 0.0 111.362 -171.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.7 m -78.98 164.41 24.41 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.908 -0.495 . . . . 0.0 109.873 176.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -77.6 4.22 11.88 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.662 -0.649 . . . . 0.0 111.198 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -95.54 164.75 12.66 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.25 -0.906 . . . . 0.0 109.608 167.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -68.55 135.38 51.44 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.507 -0.746 . . . . 0.0 110.453 -176.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.6 mm -114.17 134.39 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.734 -0.604 . . . . 0.0 109.615 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -96.22 109.88 49.49 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.703 -0.623 . . . . 0.0 110.181 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -67.33 135.02 35.34 Favored 'Trans proline' 0 N--CA 1.488 1.154 0 O-C-N 123.414 1.218 . . . . 0.0 110.308 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 18.8 mp0 -111.63 135.07 52.71 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.671 -0.643 . . . . 0.0 110.168 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 83.1 p -91.48 6.87 43.87 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.655 -0.653 . . . . 0.0 111.2 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -63.1 141.04 58.91 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.217 -0.927 . . . . 0.0 110.438 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.8 mm -96.86 137.7 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.655 -0.653 . . . . 0.0 109.844 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -94.14 119.03 32.39 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.715 -0.616 . . . . 0.0 110.177 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -51.35 -42.61 61.43 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.789 -0.569 . . . . 0.0 111.745 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.509 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.1 t80 -152.27 130.3 11.84 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.587 -0.695 . . . . 0.0 110.293 -174.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.687 HD12 HG11 ' A' ' 41' ' ' VAL . 75.2 mt -130.26 130.3 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.728 -0.608 . . . . 0.0 109.877 171.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 19.0 tp -90.25 137.01 32.69 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.823 -0.548 . . . . 0.0 109.934 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.647 ' CD1' HD11 ' A' ' 72' ' ' ILE . 2.3 m-85 -133.4 127.09 32.68 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.627 -0.67 . . . . 0.0 110.477 -176.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -92.12 145.98 24.08 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.592 -0.692 . . . . 0.0 110.31 173.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.88 -26.67 60.92 Favored Glycine 0 N--CA 1.499 2.843 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.2 m -65.02 -39.94 94.14 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.408 -1.054 . . . . 0.0 110.977 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.77 -32.24 31.51 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.445 -0.784 . . . . 0.0 110.826 -175.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.885 HD13 HD21 ' A' ' 14' ' ' LEU . 6.6 mt -99.34 141.75 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.53 -0.731 . . . . 0.0 110.264 177.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -104.35 -20.78 13.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.938 -0.476 . . . . 0.0 111.377 -169.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -151.79 131.95 13.56 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.238 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.536 HD12 ' CD1' ' A' ' 14' ' ' LEU . 17.1 tt -130.91 140.48 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.872 -0.517 . . . . 0.0 109.737 176.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -146.47 130.28 17.12 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.62 -0.675 . . . . 0.0 110.306 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.5 p -87.74 146.29 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.613 -0.679 . . . . 0.0 110.27 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.547 HG11 ' HE3' ' A' ' 11' ' ' LYS . 61.6 t -96.05 133.48 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.572 -0.705 . . . . 0.0 109.738 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -125.42 -60.06 1.35 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.619 -0.676 . . . . 0.0 110.155 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -114.69 117.71 31.59 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.7 -0.625 . . . . 0.0 110.169 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -121.66 120.13 33.85 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.64 -0.662 . . . . 0.0 110.155 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.0 t -138.78 160.52 39.49 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.582 -0.699 . . . . 0.0 110.352 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.1 mp -113.36 165.19 13.85 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.614 -0.679 . . . . 0.0 110.19 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo . . . . . 0 N--CA 1.489 1.235 0 O-C-N 123.664 1.349 . . . . 0.0 110.481 179.964 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -144.74 156.65 44.17 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.662 -0.905 . . . . 0.0 110.203 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 74.4 mtm -118.52 159.0 24.3 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.81 -0.556 . . . . 0.0 110.151 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -141.3 156.74 45.83 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.763 -0.586 . . . . 0.0 110.147 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.6 mtm -110.39 151.71 27.14 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.729 -0.607 . . . . 0.0 110.209 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.6 t -117.36 143.87 45.52 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.687 -0.633 . . . . 0.0 110.225 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.33 -34.84 89.16 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -146.3 83.73 0.19 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.562 HD21 HD11 ' A' ' 8' ' ' LEU . 14.9 tp -80.26 139.63 52.45 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.724 -0.868 . . . . 0.0 110.032 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -66.28 153.18 79.03 Favored 'Trans proline' 0 N--CA 1.489 1.224 0 O-C-N 123.392 1.206 . . . . 0.0 110.415 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -64.91 96.05 0.18 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.67 -0.644 . . . . 0.0 110.473 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.562 HD11 HD21 ' A' ' 5' ' ' LEU . 84.0 mt -64.81 174.09 2.0 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.693 -0.629 . . . . 0.0 110.722 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.68 -1.92 84.53 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.841 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.6 m -61.72 142.22 57.37 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.113 -1.228 . . . . 0.0 110.457 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -82.36 123.38 29.04 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.748 -0.595 . . . . 0.0 110.559 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.621 ' CD1' HD13 ' A' ' 26' ' ' LEU . 91.0 mt -120.25 144.18 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.472 -0.768 . . . . 0.0 110.199 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.4 t -103.11 137.27 41.5 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 174.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.475 ' CD1' HD12 ' A' ' 75' ' ' ILE . 13.1 tp -133.49 127.84 34.11 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.712 -0.618 . . . . 0.0 110.339 -169.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.0 mt -107.59 119.98 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.593 -0.692 . . . . 0.0 109.738 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.3 m -94.35 157.81 15.86 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.049 0.452 . . . . 0.0 111.248 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.0 tptp -53.51 -15.18 1.0 Allowed 'General case' 0 N--CA 1.509 2.5 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -172.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.534 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.75 21.32 3.59 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.13 -0.982 . . . . 0.0 110.436 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 54.16 33.98 19.14 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.44 -0.788 . . . . 0.0 109.795 -174.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.804 HG12 HG22 ' A' ' 46' ' ' THR . 69.2 mt -101.81 142.72 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 36.7 ttp85 -105.19 119.8 39.94 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.941 -0.704 . . . . 0.0 109.887 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -113.79 149.24 35.21 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.662 ' O ' HG23 ' A' ' 41' ' ' VAL . 42.6 tt0 -140.61 140.53 35.09 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.546 -0.721 . . . . 0.0 109.696 176.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -169.13 173.24 43.57 Favored Glycine 0 N--CA 1.495 2.603 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.463 -175.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -85.11 136.44 33.55 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.881 -0.776 . . . . 0.0 110.495 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.621 HD13 ' CD1' ' A' ' 12' ' ' ILE . 15.3 tp -66.12 119.04 10.74 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.57 -0.706 . . . . 0.0 110.693 175.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.448 ' O ' HG23 ' A' ' 28' ' ' THR . 25.9 t80 -99.4 -50.09 4.22 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.666 -0.646 . . . . 0.0 110.292 178.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 27' ' ' TYR . 15.2 p -153.9 153.29 31.79 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.78 -0.575 . . . . 0.0 110.255 -178.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.882 HG23 HG22 ' A' ' 36' ' ' ILE . 13.5 p -142.31 144.86 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.643 -0.661 . . . . 0.0 110.102 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -128.99 101.53 19.68 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.531 -0.73 . . . . 0.0 109.528 177.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.68 -40.25 38.33 Favored 'Trans proline' 0 N--CA 1.489 1.243 0 O-C-N 123.515 1.271 . . . . 0.0 110.719 -175.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -80.68 -25.18 38.39 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.306 -0.871 . . . . 0.0 110.174 -171.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.723 ' O ' HG23 ' A' ' 35' ' ' THR . 79.2 mt-10 -87.44 1.46 53.36 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.516 -0.74 . . . . 0.0 111.256 173.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.0 m 49.84 39.51 18.38 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.105 -0.997 . . . . 0.0 111.284 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.723 HG23 ' O ' ' A' ' 33' ' ' GLU . 22.7 p -136.65 151.98 49.9 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.365 -0.834 . . . . 0.0 110.368 -175.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.882 HG22 HG23 ' A' ' 29' ' ' VAL . 39.7 pt -142.6 161.47 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.695 -0.628 . . . . 0.0 110.179 177.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.508 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.86 127.91 27.75 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.628 -0.67 . . . . 0.0 109.678 175.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 26' ' ' LEU . 85.6 mt -109.87 146.98 34.19 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -177.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 96.7 p -118.7 153.06 34.99 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -177.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.7 p 45.75 85.9 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 121.452 0.644 . . . . 0.0 110.318 -172.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.783 HG11 HD12 ' A' ' 65' ' ' ILE . 13.3 p -134.51 148.61 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.952 -0.468 . . . . 0.0 109.909 -177.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -126.41 153.12 45.43 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.699 -0.626 . . . . 0.0 109.829 177.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 96.6 p -108.24 134.93 50.39 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.703 -0.623 . . . . 0.0 109.726 175.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -83.01 -38.37 22.7 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.57 -0.706 . . . . 0.0 111.045 -173.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.61 169.29 30.96 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 120.027 -1.083 . . . . 0.0 110.602 176.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.804 HG22 HG12 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -118.19 6.58 12.0 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.97 -0.724 . . . . 0.0 110.837 174.309 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -49.16 -25.64 2.32 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.6 -0.688 . . . . 0.0 112.62 -168.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -65.04 -59.22 4.37 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.321 -0.862 . . . . 0.0 110.587 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -94.31 10.14 35.35 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.569 -0.707 . . . . 0.0 111.381 177.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.46 ' HB2' HD12 ' A' ' 55' ' ' ILE . 39.9 p-10 -59.44 165.86 2.61 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.251 -0.906 . . . . 0.0 111.438 -170.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.3 m -78.98 164.46 24.38 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.925 -0.484 . . . . 0.0 109.748 174.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -77.55 4.22 11.76 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.607 -0.683 . . . . 0.0 111.263 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -96.78 155.32 16.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.156 -0.965 . . . . 0.0 109.623 167.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -68.77 139.8 55.31 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.649 -0.657 . . . . 0.0 110.387 -175.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.46 HD12 ' HB2' ' A' ' 50' ' ' ASP . 81.5 mt -116.38 138.41 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.674 -0.641 . . . . 0.0 109.612 177.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -97.98 109.98 53.81 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.733 -0.605 . . . . 0.0 110.223 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -66.14 149.64 85.51 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 O-C-N 123.357 1.188 . . . . 0.0 110.335 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -93.22 112.64 24.64 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.667 -0.646 . . . . 0.0 110.301 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.7 t -67.18 -29.4 69.07 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.668 -0.645 . . . . 0.0 110.463 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -60.98 159.29 11.73 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.544 -0.723 . . . . 0.0 110.759 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.81 146.72 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.843 -0.536 . . . . 0.0 109.748 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -91.72 111.85 23.54 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.659 -0.651 . . . . 0.0 109.894 176.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -52.35 -43.21 64.5 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.786 -0.571 . . . . 0.0 111.707 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.508 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.7 t80 -154.55 130.28 10.02 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.742 -0.599 . . . . 0.0 110.264 -174.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.783 HD12 HG11 ' A' ' 41' ' ' VAL . 82.9 mt -129.07 127.44 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.663 -0.648 . . . . 0.0 109.989 171.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 24.0 tp -90.79 137.03 32.68 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.867 -0.521 . . . . 0.0 109.859 175.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.515 ' CZ ' HG21 ' A' ' 65' ' ' ILE . 4.5 m-85 -136.95 131.59 33.22 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.685 -0.634 . . . . 0.0 110.65 -175.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -91.78 151.57 20.55 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.736 -0.602 . . . . 0.0 110.452 174.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.96 -23.98 59.94 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.2 p -67.52 -41.99 83.51 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.45 -1.03 . . . . 0.0 111.032 -176.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -83.13 -32.87 26.45 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.354 -0.842 . . . . 0.0 110.914 -175.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.44 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 22.2 mt -105.94 136.25 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.459 -0.775 . . . . 0.0 110.013 177.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 59.4 tttt -109.1 -14.34 14.54 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 120.417 -0.513 . . . . 0.0 112.008 -165.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -147.88 131.41 16.75 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 118.901 -1.12 . . . . 0.0 111.433 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.475 HD12 ' CD1' ' A' ' 14' ' ' LEU . 15.8 tt -132.38 137.48 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.936 -0.478 . . . . 0.0 109.77 176.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.0 mtm180 -147.04 147.1 30.31 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.606 -0.684 . . . . 0.0 110.387 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.9 t -85.96 145.04 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.679 -0.638 . . . . 0.0 109.601 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.2 t -94.68 134.89 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.601 -0.687 . . . . 0.0 109.898 -177.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -105.14 126.27 51.9 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.704 -0.623 . . . . 0.0 110.096 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -99.96 150.24 22.62 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.683 -0.636 . . . . 0.0 110.263 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -121.74 163.58 18.84 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.74 -0.6 . . . . 0.0 110.104 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.8 p -87.5 160.49 18.24 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.717 -0.615 . . . . 0.0 110.214 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.7 mt -126.35 163.56 39.53 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.682 -0.636 . . . . 0.0 110.112 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo . . . . . 0 N--CA 1.487 1.11 0 O-C-N 123.728 1.383 . . . . 0.0 110.323 179.932 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.361 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . 0.457 ' HB1' ' O ' ' A' ' 1' ' ' MET . . . -102.96 144.81 30.76 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.678 -0.895 . . . . 0.0 110.27 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 9.3 tpt -66.48 -35.59 80.65 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.651 -0.656 . . . . 0.0 110.263 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -140.1 -59.78 0.54 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.765 -0.584 . . . . 0.0 110.176 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.457 ' O ' ' HB1' ' A' ' -2' ' ' ALA . 90.5 mtp -109.64 134.8 51.53 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.673 -0.642 . . . . 0.0 110.115 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 86.4 p -108.35 28.77 7.99 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.67 -0.644 . . . . 0.0 110.585 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -153.31 37.34 0.74 Allowed Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.89 -60.06 1.16 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 27.5 mt -80.29 152.95 74.01 Favored Pre-proline 0 N--CA 1.497 1.919 0 O-C-N 121.63 -0.924 . . . . 0.0 110.262 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -69.16 155.76 66.94 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 O-C-N 123.685 1.361 . . . . 0.0 110.279 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -64.82 103.87 0.77 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.644 -0.66 . . . . 0.0 110.407 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.5 mt -64.8 149.95 48.41 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.736 -0.603 . . . . 0.0 110.71 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.65 -1.97 84.29 Favored Glycine 0 N--CA 1.497 2.713 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.837 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.9 m -62.06 148.21 44.85 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.125 -1.221 . . . . 0.0 110.49 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -81.87 124.53 29.79 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.662 -0.649 . . . . 0.0 110.401 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.609 ' CD1' HD13 ' A' ' 26' ' ' LEU . 88.8 mt -120.64 144.54 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.565 -0.71 . . . . 0.0 110.122 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.6 t -102.91 137.33 41.25 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.766 HD21 HD13 ' A' ' 72' ' ' ILE . 13.6 tp -132.79 125.64 30.55 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.711 -0.618 . . . . 0.0 110.219 -169.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.0 mt -106.94 118.6 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.447 -0.783 . . . . 0.0 109.661 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.9 m -93.77 157.65 16.05 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 120.997 0.427 . . . . 0.0 111.3 -177.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -55.68 -11.17 0.85 Allowed 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -172.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.72 18.48 4.67 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.196 -0.94 . . . . 0.0 110.439 176.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 55.64 36.06 26.46 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.442 -0.786 . . . . 0.0 109.918 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.812 HG12 HG22 ' A' ' 46' ' ' THR . 57.6 mt -106.96 145.0 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -105.62 119.81 40.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.618 -0.676 . . . . 0.0 110.123 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -113.81 152.12 31.09 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.659 ' O ' HG23 ' A' ' 41' ' ' VAL . 46.4 tt0 -142.27 140.57 32.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.429 -0.795 . . . . 0.0 109.672 175.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.87 172.21 42.55 Favored Glycine 0 N--CA 1.496 2.634 0 C-N-CA 119.713 -1.232 . . . . 0.0 110.558 -175.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -85.08 136.16 33.68 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.864 -0.786 . . . . 0.0 110.517 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.609 HD13 ' CD1' ' A' ' 12' ' ' ILE . 15.1 tp -66.16 117.8 8.98 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.623 -0.673 . . . . 0.0 110.664 175.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.454 ' O ' HG23 ' A' ' 28' ' ' THR . 25.9 t80 -99.95 -50.1 4.11 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.657 -0.652 . . . . 0.0 110.455 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 27' ' ' TYR . 14.1 p -154.35 156.06 36.2 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.736 -0.603 . . . . 0.0 110.348 -178.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.828 HG23 HG22 ' A' ' 36' ' ' ILE . 13.3 p -142.31 146.25 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.771 -0.58 . . . . 0.0 110.007 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -128.48 100.8 21.97 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.582 -0.699 . . . . 0.0 109.536 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.59 -40.16 39.67 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 O-C-N 123.558 1.294 . . . . 0.0 110.71 -174.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -80.63 -25.27 38.47 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.365 -0.834 . . . . 0.0 110.202 -171.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.566 ' O ' HG23 ' A' ' 35' ' ' THR . 78.7 mt-10 -87.47 1.3 53.85 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.498 -0.751 . . . . 0.0 111.258 173.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 45.2 m 49.6 39.19 16.66 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.089 -1.007 . . . . 0.0 111.303 -176.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 33' ' ' GLU . 10.0 p -136.07 155.35 50.34 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.393 -0.817 . . . . 0.0 110.315 -174.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.828 HG22 HG23 ' A' ' 29' ' ' VAL . 39.8 pt -142.27 162.03 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.616 -0.677 . . . . 0.0 110.17 177.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.525 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.4 127.68 28.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.669 -0.644 . . . . 0.0 109.692 175.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' A' ' 26' ' ' LEU . 87.2 mt -109.87 147.12 33.94 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -178.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 96.8 p -118.22 152.43 35.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.674 -0.642 . . . . 0.0 109.27 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.3 p 45.5 84.79 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 CA-C-O 121.476 0.655 . . . . 0.0 110.358 -172.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.664 HG11 HD12 ' A' ' 65' ' ' ILE . 13.7 p -134.54 149.02 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.905 -0.497 . . . . 0.0 109.853 -178.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.4 ttm180 -131.71 153.05 50.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.68 -0.637 . . . . 0.0 109.799 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 85.1 p -107.93 133.89 51.63 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.741 -0.599 . . . . 0.0 109.476 175.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -82.68 -38.63 23.15 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.039 -171.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.23 167.08 27.38 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 175.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.812 HG22 HG12 ' A' ' 20' ' ' ILE . 53.0 p -118.23 -11.2 10.13 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.963 -0.728 . . . . 0.0 110.83 170.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -52.74 -24.99 9.81 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.462 -0.774 . . . . 0.0 112.492 -166.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -79.12 -59.3 2.83 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.261 -0.899 . . . . 0.0 110.894 -176.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -94.42 9.93 36.41 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.596 -0.69 . . . . 0.0 112.006 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -90.16 174.56 7.55 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.085 -1.009 . . . . 0.0 111.126 -175.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.0 m -78.43 164.66 24.58 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 122.016 -0.428 . . . . 0.0 109.854 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -77.45 12.07 1.72 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.726 -0.609 . . . . 0.0 111.616 -173.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -92.49 140.54 29.46 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.241 -0.912 . . . . 0.0 109.62 169.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -65.97 141.03 58.34 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.713 -0.617 . . . . 0.0 110.919 -170.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 82.5 mt -118.83 138.81 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.731 -0.606 . . . . 0.0 109.399 176.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.62 113.43 14.23 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.617 -0.677 . . . . 0.0 110.125 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -64.18 142.65 81.15 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 O-C-N 123.305 1.161 . . . . 0.0 110.465 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -104.02 107.11 17.85 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.713 -0.617 . . . . 0.0 110.27 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.6 p -93.4 -32.72 14.13 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.685 -0.634 . . . . 0.0 110.327 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -62.8 152.64 35.4 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.619 -0.675 . . . . 0.0 110.655 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.4 mm -96.8 141.08 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.705 -0.622 . . . . 0.0 109.592 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -96.36 113.16 24.72 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.64 -0.663 . . . . 0.0 110.37 -177.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -51.19 -39.93 57.55 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.738 -0.601 . . . . 0.0 111.416 175.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.525 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.7 t80 -152.73 129.19 10.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.627 -0.671 . . . . 0.0 110.201 -175.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.664 HD12 HG11 ' A' ' 41' ' ' VAL . 72.6 mt -127.55 129.14 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.566 -0.709 . . . . 0.0 109.798 172.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.9 tp -90.18 137.05 32.67 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.859 -0.526 . . . . 0.0 109.808 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.589 ' CD1' HD11 ' A' ' 72' ' ' ILE . 2.6 m-85 -135.56 129.21 32.62 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.751 -0.593 . . . . 0.0 110.559 -175.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -91.07 146.62 23.69 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.715 -0.615 . . . . 0.0 110.176 173.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.58 -25.86 58.94 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.1 p -67.75 -37.61 82.38 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.459 -1.024 . . . . 0.0 110.875 -177.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -82.46 -30.5 29.94 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.454 -0.779 . . . . 0.0 110.934 -175.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.766 HD13 HD21 ' A' ' 14' ' ' LEU . 8.6 mt -103.95 142.87 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.426 -0.796 . . . . 0.0 110.278 176.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -104.63 -24.73 12.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.932 -0.48 . . . . 0.0 111.381 -167.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -151.88 136.24 16.79 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.048 -1.033 . . . . 0.0 111.465 -177.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.53 HD12 ' CD1' ' A' ' 14' ' ' LEU . 17.7 tt -131.79 140.51 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.963 -0.461 . . . . 0.0 109.828 176.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -146.87 140.77 25.96 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.544 -0.723 . . . . 0.0 110.335 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.0 p -86.04 147.05 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.669 -0.644 . . . . 0.0 110.107 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.0 t -93.98 134.76 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.578 -0.701 . . . . 0.0 109.868 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -120.82 157.31 30.03 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.712 -0.617 . . . . 0.0 110.195 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -98.81 134.2 42.03 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.707 -0.621 . . . . 0.0 110.111 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -116.85 139.49 50.56 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.656 -0.652 . . . . 0.0 110.184 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.8 t -133.46 156.96 46.77 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.705 -0.622 . . . . 0.0 110.397 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.1 tp -145.06 139.74 15.44 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.719 -0.613 . . . . 0.0 110.059 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo . . . . . 0 N--CA 1.488 1.193 0 O-C-N 123.346 1.182 . . . . 0.0 110.295 179.534 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -143.76 151.32 39.84 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.663 -0.904 . . . . 0.0 110.219 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 66.0 mtt -104.24 29.33 6.08 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.668 -0.645 . . . . 0.0 110.406 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -69.06 -34.68 75.56 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.577 -0.702 . . . . 0.0 110.254 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.7 mtp -129.18 165.47 21.26 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.667 -0.645 . . . . 0.0 110.313 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.5 m -117.41 151.9 36.08 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.715 -0.615 . . . . 0.0 110.102 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.35 34.53 5.47 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -115.44 37.51 3.44 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.534 HD12 ' O ' ' A' ' 6' ' ' PRO . 4.0 pp -77.64 152.59 80.75 Favored Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 121.687 -0.89 . . . . 0.0 110.499 -179.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.534 ' O ' HD12 ' A' ' 5' ' ' LEU . 31.4 Cg_endo -68.52 155.4 69.16 Favored 'Trans proline' 0 N--CA 1.487 1.127 0 O-C-N 123.624 1.328 . . . . 0.0 110.382 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -64.82 127.0 29.73 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.652 -0.655 . . . . 0.0 110.445 -178.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.6 mt -64.85 145.82 55.74 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.748 -0.595 . . . . 0.0 110.737 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.57 -1.9 84.31 Favored Glycine 0 N--CA 1.496 2.663 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.85 176.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.4 m -62.71 138.94 58.63 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.126 -1.22 . . . . 0.0 110.355 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -82.13 126.98 32.67 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.624 -0.673 . . . . 0.0 110.415 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.679 ' CD1' HD13 ' A' ' 26' ' ' LEU . 86.5 mt -120.97 143.36 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.614 -0.679 . . . . 0.0 110.142 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.0 t -103.18 137.32 41.49 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.762 HD21 HD13 ' A' ' 72' ' ' ILE . 14.0 tp -134.8 125.9 27.8 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.687 -0.633 . . . . 0.0 110.337 -168.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.3 mt -106.85 118.11 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.614 -0.679 . . . . 0.0 109.665 -178.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.6 m -92.86 157.89 16.14 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 120.97 0.414 . . . . 0.0 111.303 -176.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -53.75 -14.43 0.93 Allowed 'General case' 0 N--CA 1.508 2.453 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -171.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.14 20.22 3.82 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.169 -0.957 . . . . 0.0 110.519 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 56.03 36.08 26.72 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.463 -0.773 . . . . 0.0 109.916 -177.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.788 HG12 HG22 ' A' ' 46' ' ' THR . 53.6 mt -107.05 146.58 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -105.39 119.81 40.03 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.13 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -113.41 152.39 30.11 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.656 ' O ' HG23 ' A' ' 41' ' ' VAL . 42.6 tt0 -142.36 140.45 32.08 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.491 -0.756 . . . . 0.0 109.583 175.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.95 171.41 41.77 Favored Glycine 0 N--CA 1.496 2.66 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.602 -175.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -85.45 137.27 33.02 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.836 -0.803 . . . . 0.0 110.607 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.679 HD13 ' CD1' ' A' ' 12' ' ' ILE . 16.2 tp -66.2 118.81 10.45 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.648 -0.657 . . . . 0.0 110.723 175.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.416 ' O ' HG23 ' A' ' 28' ' ' THR . 25.4 t80 -100.36 -50.06 4.05 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.611 -0.681 . . . . 0.0 110.351 176.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 27' ' ' TYR . 23.2 p -153.55 153.59 32.68 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.741 -0.599 . . . . 0.0 110.18 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.882 HG23 HG22 ' A' ' 36' ' ' ILE . 13.5 p -142.3 145.04 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.593 -0.692 . . . . 0.0 110.102 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -128.5 100.51 22.26 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.623 -0.673 . . . . 0.0 109.566 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.41 -39.69 44.47 Favored 'Trans proline' 0 N--CA 1.489 1.244 0 O-C-N 123.578 1.304 . . . . 0.0 110.726 -175.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -80.49 -25.83 38.56 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.406 -0.809 . . . . 0.0 110.157 -172.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.572 ' O ' HG23 ' A' ' 35' ' ' THR . 54.9 mt-10 -87.35 1.83 52.14 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.501 -0.75 . . . . 0.0 111.195 173.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 75.5 m 49.58 38.3 14.51 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.116 -0.99 . . . . 0.0 111.291 -176.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 33' ' ' GLU . 10.5 p -136.26 153.73 51.11 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.399 -0.813 . . . . 0.0 110.26 -174.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.882 HG22 HG23 ' A' ' 29' ' ' VAL . 39.9 pt -142.73 162.02 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.703 -0.623 . . . . 0.0 110.249 178.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.523 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.69 127.29 27.01 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.669 -0.644 . . . . 0.0 109.665 175.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 26' ' ' LEU . 83.8 mt -109.94 146.99 34.27 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -177.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 95.7 p -118.07 152.68 35.09 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.5 p 45.58 84.0 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 121.492 0.663 . . . . 0.0 110.336 -172.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.669 ' CG1' HD12 ' A' ' 65' ' ' ILE . 14.9 p -134.53 150.55 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.947 -0.47 . . . . 0.0 109.774 -178.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -136.4 153.09 51.19 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.64 -0.663 . . . . 0.0 110.168 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.5 p -107.2 133.03 52.39 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.71 -0.619 . . . . 0.0 109.506 176.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -83.09 -38.62 22.22 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.726 -0.79 . . . . 0.0 111.087 -170.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.27 171.73 33.65 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 176.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.788 HG22 HG12 ' A' ' 20' ' ' ILE . 69.6 p -118.22 6.1 11.95 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.789 -0.83 . . . . 0.0 110.467 169.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -57.26 -31.41 65.54 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.545 -0.722 . . . . 0.0 112.427 -161.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -66.69 -59.34 3.67 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.239 -0.913 . . . . 0.0 110.486 -174.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.0 mtt-85 -94.51 10.3 35.15 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.677 -0.639 . . . . 0.0 111.612 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.474 ' HB2' HD12 ' A' ' 55' ' ' ILE . 38.2 p30 -54.63 172.15 0.11 Allowed 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.166 -0.959 . . . . 0.0 111.894 -171.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.0 m -78.94 164.6 24.29 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 173.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -77.32 3.75 12.33 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.567 -0.708 . . . . 0.0 111.214 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -98.28 153.34 18.58 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.215 -0.928 . . . . 0.0 109.619 169.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -67.82 138.59 56.25 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.578 -0.701 . . . . 0.0 110.597 -174.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.474 HD12 ' HB2' ' A' ' 50' ' ' ASP . 79.2 mt -117.43 141.2 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.661 -0.65 . . . . 0.0 109.511 177.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -97.66 109.86 52.59 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.612 -0.68 . . . . 0.0 110.215 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -68.6 147.65 70.64 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 O-C-N 123.44 1.232 . . . . 0.0 110.325 178.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -101.38 121.44 41.93 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.64 -0.662 . . . . 0.0 110.206 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 86.6 p -81.25 -26.81 35.53 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.724 -0.61 . . . . 0.0 110.686 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -61.67 148.35 42.93 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.471 -0.768 . . . . 0.0 110.623 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.1 mm -96.85 145.64 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.712 -0.618 . . . . 0.0 109.747 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -95.75 114.34 26.06 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.659 -0.651 . . . . 0.0 110.347 -178.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -51.04 -41.09 59.64 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.709 -0.62 . . . . 0.0 111.527 176.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.523 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.7 t80 -152.63 129.51 10.97 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.727 -0.608 . . . . 0.0 110.226 -174.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.669 HD12 ' CG1' ' A' ' 41' ' ' VAL . 73.7 mt -128.23 128.34 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.683 -0.635 . . . . 0.0 109.794 172.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.8 tp -90.13 137.06 32.65 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.889 -0.507 . . . . 0.0 109.838 176.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.583 ' CD1' HD11 ' A' ' 72' ' ' ILE . 3.0 m-85 -135.35 128.84 32.43 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.572 -0.705 . . . . 0.0 110.603 -175.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -91.27 147.03 23.33 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.653 -0.654 . . . . 0.0 110.177 172.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.63 -25.62 58.76 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.2 p -67.83 -37.85 82.45 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.427 -1.043 . . . . 0.0 110.917 -177.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -82.43 -30.79 29.86 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.504 -0.748 . . . . 0.0 110.9 -175.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.762 HD13 HD21 ' A' ' 14' ' ' LEU . 8.5 mt -104.31 138.78 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.492 -0.755 . . . . 0.0 110.104 176.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -105.04 -18.07 14.28 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.92 -0.487 . . . . 0.0 111.58 -167.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -151.03 132.03 14.27 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 119.115 -1.034 . . . . 0.0 111.249 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.541 HD12 ' CD1' ' A' ' 14' ' ' LEU . 16.8 tt -132.2 141.97 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.887 -0.508 . . . . 0.0 109.806 176.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -146.4 135.13 22.28 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.659 -0.65 . . . . 0.0 110.361 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.406 HG22 HG12 ' A' ' 12' ' ' ILE . 52.4 t -87.59 143.74 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.682 -0.636 . . . . 0.0 109.775 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.3 t -93.82 134.81 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.59 -0.694 . . . . 0.0 109.745 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -113.28 165.46 12.4 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.736 -0.603 . . . . 0.0 110.227 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -90.35 132.1 35.77 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.763 -0.586 . . . . 0.0 110.107 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -118.9 160.32 22.16 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.599 -0.688 . . . . 0.0 110.203 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.6 m -113.18 142.39 45.84 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.706 -0.621 . . . . 0.0 110.135 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.33 162.22 63.04 Favored Pre-proline 0 N--CA 1.5 2.049 0 O-C-N 121.646 -0.659 . . . . 0.0 110.244 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo . . . . . 0 N--CA 1.488 1.175 0 O-C-N 123.561 1.296 . . . . 0.0 110.47 179.796 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -103.83 31.7 4.33 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.686 -0.89 . . . . 0.0 110.376 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 22.5 ttt -111.71 138.67 47.97 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.607 -0.683 . . . . 0.0 110.174 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -102.06 141.68 34.52 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.791 -0.568 . . . . 0.0 110.216 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.88 -35.36 79.85 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.703 -0.623 . . . . 0.0 110.301 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.2 t -124.25 140.62 52.78 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.706 -0.622 . . . . 0.0 110.217 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -106.25 -50.08 0.89 Allowed Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.32 137.66 23.13 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 11.6 tp -81.28 112.03 29.75 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.665 -0.903 . . . . 0.0 110.111 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -65.82 136.59 46.03 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 O-C-N 123.349 1.184 . . . . 0.0 110.383 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -64.83 131.56 47.09 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.653 -0.654 . . . . 0.0 110.583 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.3 mt -64.76 165.56 10.29 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.664 -0.647 . . . . 0.0 110.469 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.68 -1.79 84.95 Favored Glycine 0 N--CA 1.497 2.707 0 C-N-CA 120.453 -0.879 . . . . 0.0 111.742 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.4 m -60.39 151.7 27.33 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.078 -1.248 . . . . 0.0 110.482 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.434 ' HE3' HG11 ' A' ' 78' ' ' VAL . 30.5 pttt -81.95 126.54 32.06 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.66 -0.65 . . . . 0.0 110.551 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.652 ' CD1' HD13 ' A' ' 26' ' ' LEU . 89.5 mt -120.8 143.76 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.57 -0.706 . . . . 0.0 109.988 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.4 t -102.42 137.27 40.89 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 175.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.668 HD21 HD13 ' A' ' 72' ' ' ILE . 14.7 tp -133.11 125.06 28.7 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.763 -0.586 . . . . 0.0 110.227 -169.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 81.7 mt -106.75 118.85 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.548 -0.72 . . . . 0.0 109.629 -178.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.7 m -93.69 157.66 16.06 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.064 0.459 . . . . 0.0 111.148 -178.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -54.21 -13.24 0.8 Allowed 'General case' 0 N--CA 1.507 2.416 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -172.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.556 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -90.0 20.4 4.27 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.142 -0.974 . . . . 0.0 110.475 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 53.96 33.98 18.6 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.485 -0.76 . . . . 0.0 109.749 -173.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.779 HG12 HG22 ' A' ' 46' ' ' THR . 68.8 mt -102.22 140.89 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -104.9 119.81 39.92 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.922 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -114.36 147.55 38.98 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 173.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.671 ' O ' HG23 ' A' ' 41' ' ' VAL . 41.5 tt0 -139.31 140.43 37.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.436 -0.79 . . . . 0.0 109.627 175.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.11 173.22 42.34 Favored Glycine 0 N--CA 1.496 2.678 0 C-N-CA 119.737 -1.22 . . . . 0.0 110.58 -175.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -84.28 137.57 33.39 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.907 -0.761 . . . . 0.0 110.546 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.652 HD13 ' CD1' ' A' ' 12' ' ' ILE . 16.0 tp -66.15 116.88 7.7 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.727 -0.608 . . . . 0.0 110.655 175.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.453 ' O ' HG23 ' A' ' 28' ' ' THR . 24.9 t80 -99.68 -50.18 4.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.659 -0.651 . . . . 0.0 110.421 178.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 27' ' ' TYR . 15.1 p -153.97 153.64 32.36 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.705 -0.622 . . . . 0.0 110.269 -178.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.885 HG23 HG22 ' A' ' 36' ' ' ILE . 13.7 p -142.24 145.19 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.696 -0.627 . . . . 0.0 110.092 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -127.88 98.73 27.01 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.631 -0.668 . . . . 0.0 109.611 177.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -59.44 -42.06 52.07 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 O-C-N 123.577 1.304 . . . . 0.0 110.984 -175.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -80.73 -24.82 38.49 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.413 -0.804 . . . . 0.0 110.181 -171.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.561 ' O ' HG23 ' A' ' 35' ' ' THR . 74.7 mm-40 -87.02 1.26 53.43 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.536 -0.728 . . . . 0.0 111.177 173.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 96.5 m 49.8 38.17 15.05 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.053 -1.029 . . . . 0.0 111.249 -176.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 33' ' ' GLU . 10.6 p -136.12 153.09 51.4 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.431 -0.793 . . . . 0.0 110.43 -174.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.885 HG22 HG23 ' A' ' 29' ' ' VAL . 39.9 pt -142.77 162.04 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.703 -0.623 . . . . 0.0 110.22 177.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.515 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.79 128.1 28.19 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.67 -0.644 . . . . 0.0 109.686 175.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 26' ' ' LEU . 83.6 mt -109.89 145.83 36.17 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -178.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.4 p -116.92 153.0 33.34 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -178.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 44.6 p 45.93 87.05 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 121.516 0.674 . . . . 0.0 110.317 -172.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.798 HG11 HD12 ' A' ' 65' ' ' ILE . 12.4 p -134.59 147.19 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.897 -0.502 . . . . 0.0 109.929 -177.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -123.84 153.17 41.45 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.767 -0.583 . . . . 0.0 109.881 177.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.3 p -108.54 136.69 47.72 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.716 -0.615 . . . . 0.0 109.707 176.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -82.93 -38.39 22.87 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.528 -0.733 . . . . 0.0 110.968 -174.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.57 167.62 28.51 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 120.024 -1.084 . . . . 0.0 110.578 176.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.779 HG22 HG12 ' A' ' 20' ' ' ILE . 0.8 OUTLIER -118.09 6.55 12.08 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.974 -0.721 . . . . 0.0 110.899 174.14 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -49.45 -25.16 2.39 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.544 -0.723 . . . . 0.0 112.624 -168.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -64.5 -59.22 4.57 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.191 -0.943 . . . . 0.0 110.607 -178.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 35.5 mtp180 -94.35 10.14 35.43 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.558 -0.714 . . . . 0.0 111.472 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 40.0 p-10 -60.27 173.97 0.6 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.3 -0.875 . . . . 0.0 111.297 -170.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.0 m -78.99 164.34 24.47 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.93 -0.481 . . . . 0.0 109.737 175.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -77.55 3.56 13.32 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.601 -0.687 . . . . 0.0 111.291 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -96.54 166.01 11.89 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.219 -0.926 . . . . 0.0 109.656 168.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -68.61 139.29 55.51 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.606 -0.684 . . . . 0.0 110.364 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 49.5 mm -114.18 134.76 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.745 -0.597 . . . . 0.0 109.697 178.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.01 109.94 53.68 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.649 -0.657 . . . . 0.0 110.236 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -66.86 146.57 78.48 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 O-C-N 123.331 1.174 . . . . 0.0 110.305 178.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -97.44 121.12 38.98 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.653 -0.654 . . . . 0.0 110.299 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 86.4 p -75.79 -22.07 56.74 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.705 -0.622 . . . . 0.0 110.828 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -61.16 156.59 17.96 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.376 -0.828 . . . . 0.0 110.693 -178.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.5 mm -96.87 145.9 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.754 -0.591 . . . . 0.0 109.853 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -92.1 111.87 23.58 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.553 -0.717 . . . . 0.0 109.87 175.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -52.35 -43.11 64.45 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.746 -0.596 . . . . 0.0 111.769 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.515 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.0 t80 -154.62 130.15 9.87 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.588 -0.695 . . . . 0.0 110.238 -174.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.798 HD12 HG11 ' A' ' 41' ' ' VAL . 80.4 mt -128.77 127.42 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.618 -0.676 . . . . 0.0 109.916 171.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 24.8 tp -90.32 137.09 32.63 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.779 -0.576 . . . . 0.0 109.755 175.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.57 ' CD1' HD11 ' A' ' 72' ' ' ILE . 3.5 m-85 -136.08 130.77 33.93 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.649 -0.657 . . . . 0.0 110.664 -175.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -91.6 149.57 21.59 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.663 -0.648 . . . . 0.0 110.339 173.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.31 -24.51 61.41 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 177.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.7 m -66.53 -42.04 87.83 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.366 -1.079 . . . . 0.0 111.077 -176.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -82.96 -33.41 26.69 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.423 -0.798 . . . . 0.0 110.919 -175.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.668 HD13 HD21 ' A' ' 14' ' ' LEU . 14.2 mt -101.02 138.15 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.404 -0.81 . . . . 0.0 110.11 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.0 tptp -107.32 -18.25 13.92 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 120.501 -0.479 . . . . 0.0 111.758 -166.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -148.93 131.14 15.49 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.897 -1.127 . . . . 0.0 111.354 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.499 HD12 ' CD1' ' A' ' 14' ' ' LEU . 18.0 tt -132.55 138.51 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.895 -0.503 . . . . 0.0 109.866 176.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.1 mtp180 -147.02 138.67 24.25 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.496 -0.753 . . . . 0.0 110.39 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.3 p -86.61 146.63 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.589 -0.694 . . . . 0.0 110.186 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.434 HG11 ' HE3' ' A' ' 11' ' ' LYS . 60.1 t -97.31 133.95 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.647 -0.658 . . . . 0.0 109.907 -179.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -120.84 93.89 4.18 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.724 -0.61 . . . . 0.0 110.158 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -97.3 -60.0 1.67 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.679 -0.638 . . . . 0.0 110.331 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -139.42 157.69 45.42 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.706 -0.621 . . . . 0.0 110.239 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.1 t -133.69 156.84 47.2 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.66 -0.65 . . . . 0.0 110.317 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.532 ' N ' HD23 ' A' ' 83' ' ' LEU . 0.8 OUTLIER -146.86 159.63 42.9 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.622 -0.674 . . . . 0.0 110.406 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo . . . . . 0 N--CA 1.488 1.198 0 O-C-N 123.662 1.348 . . . . 0.0 110.342 179.972 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -143.59 153.22 42.32 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.654 -0.909 . . . . 0.0 110.203 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 89.5 mtp -125.72 150.63 47.53 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.711 -0.618 . . . . 0.0 110.154 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -154.98 -47.1 0.08 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.705 -0.622 . . . . 0.0 110.232 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.5 mtp -128.88 167.79 16.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.66 -0.65 . . . . 0.0 110.194 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.1 m -113.36 147.92 36.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.653 -0.655 . . . . 0.0 110.205 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -113.25 -49.62 0.56 Allowed Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -119.22 -44.52 0.48 Allowed Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 41.8 mt -79.43 154.39 76.59 Favored Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.635 -0.921 . . . . 0.0 110.319 -178.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -68.4 160.12 50.48 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 O-C-N 123.718 1.378 . . . . 0.0 110.327 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -64.76 108.3 1.69 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.724 -0.61 . . . . 0.0 110.407 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.0 mt -64.89 143.19 58.11 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.718 -0.614 . . . . 0.0 110.663 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.62 -1.91 84.42 Favored Glycine 0 N--CA 1.497 2.707 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.759 177.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.3 m -62.55 140.59 58.64 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.094 -1.239 . . . . 0.0 110.372 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -81.97 123.14 28.62 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.67 -0.644 . . . . 0.0 110.473 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.595 ' CD1' HD13 ' A' ' 26' ' ' LEU . 91.8 mt -121.17 145.35 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.492 -0.755 . . . . 0.0 110.222 -178.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.0 t -103.21 137.24 41.62 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 175.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.683 HD21 HD13 ' A' ' 72' ' ' ILE . 14.3 tp -132.02 126.14 33.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.741 -0.599 . . . . 0.0 110.261 -169.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 81.4 mt -107.04 119.03 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.594 -0.691 . . . . 0.0 109.622 -178.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.9 m -93.56 157.73 16.05 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.081 0.467 . . . . 0.0 111.187 -177.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.0 tptp -53.67 -14.78 0.97 Allowed 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -172.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.553 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.85 21.23 3.68 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.183 -0.948 . . . . 0.0 110.469 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 53.99 34.31 19.4 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.509 -0.745 . . . . 0.0 109.886 -174.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.836 HG12 HG22 ' A' ' 46' ' ' THR . 67.3 mt -102.1 141.55 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 54.0 ttt85 -104.51 119.84 39.89 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.891 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -113.86 149.24 35.36 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 174.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.653 ' O ' HG23 ' A' ' 41' ' ' VAL . 42.1 tt0 -140.69 140.49 34.94 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.499 -0.751 . . . . 0.0 109.494 175.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.64 173.09 43.27 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.666 -175.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -85.05 134.61 34.2 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.963 -0.728 . . . . 0.0 110.465 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.595 HD13 ' CD1' ' A' ' 12' ' ' ILE . 15.1 tp -66.2 119.87 12.24 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.61 -0.681 . . . . 0.0 110.735 176.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.443 ' O ' HG23 ' A' ' 28' ' ' THR . 24.0 t80 -99.43 -50.09 4.22 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.639 -0.663 . . . . 0.0 110.338 178.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 27' ' ' TYR . 15.4 p -153.83 154.29 33.69 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.693 -0.63 . . . . 0.0 110.229 -178.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.893 HG23 HG22 ' A' ' 36' ' ' ILE . 13.4 p -142.2 145.51 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.697 -0.627 . . . . 0.0 110.099 -178.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -129.04 98.25 24.37 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.583 -0.698 . . . . 0.0 109.502 177.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -59.45 -40.16 69.43 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 O-C-N 123.606 1.319 . . . . 0.0 111.037 -175.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -80.51 -27.12 37.77 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.319 -0.863 . . . . 0.0 110.21 -170.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.693 ' O ' HG23 ' A' ' 35' ' ' THR . 80.0 mt-10 -87.59 3.34 47.98 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.524 -0.735 . . . . 0.0 111.212 173.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 42.4 m 49.61 39.66 17.77 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.13 -0.981 . . . . 0.0 111.351 -177.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.693 HG23 ' O ' ' A' ' 33' ' ' GLU . 19.8 p -136.18 151.9 50.22 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.379 -0.826 . . . . 0.0 110.357 -175.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.893 HG22 HG23 ' A' ' 29' ' ' VAL . 40.0 pt -142.68 162.1 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.628 -0.67 . . . . 0.0 110.121 178.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.518 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -137.06 127.63 26.87 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.662 -0.648 . . . . 0.0 109.634 175.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 26' ' ' LEU . 88.6 mt -109.9 148.67 31.14 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -177.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.8 p -119.55 152.24 37.31 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.9 p 45.63 83.71 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 CA-C-O 121.457 0.646 . . . . 0.0 110.355 -172.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.674 ' CG1' HD12 ' A' ' 65' ' ' ILE . 14.6 p -134.54 150.33 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -178.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -136.07 153.19 51.41 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.658 -0.651 . . . . 0.0 110.043 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.9 p -108.41 139.89 42.5 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.753 -0.592 . . . . 0.0 109.839 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -83.0 -38.39 22.7 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.669 -0.644 . . . . 0.0 111.035 -173.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.62 171.93 34.15 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 177.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.836 HG22 HG12 ' A' ' 20' ' ' ILE . 2.3 p -118.09 6.51 12.08 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.925 -0.75 . . . . 0.0 110.986 174.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -50.99 -24.43 3.69 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.555 -0.716 . . . . 0.0 112.749 -167.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -65.95 -59.35 3.92 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.191 -0.943 . . . . 0.0 110.583 -177.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 -94.5 10.24 35.36 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.567 -0.708 . . . . 0.0 111.474 176.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 41.4 p-10 -58.22 174.08 0.31 Allowed 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.168 -0.958 . . . . 0.0 111.283 -171.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.0 m -79.03 164.37 24.41 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.905 -0.497 . . . . 0.0 109.794 176.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -77.53 4.09 12.02 Favored 'General case' 0 N--CA 1.502 2.135 0 C-N-CA 120.046 -0.662 . . . . 0.0 111.235 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -96.2 164.91 12.47 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.169 -0.957 . . . . 0.0 109.597 168.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -68.81 137.0 53.61 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.62 -0.675 . . . . 0.0 110.47 -176.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.3 mm -114.43 135.96 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.705 -0.622 . . . . 0.0 109.591 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -96.1 109.85 49.09 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.621 -0.675 . . . . 0.0 110.195 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -69.29 140.74 45.21 Favored 'Trans proline' 0 N--CA 1.487 1.091 0 O-C-N 123.469 1.247 . . . . 0.0 110.269 177.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -115.21 136.35 53.2 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.626 -0.671 . . . . 0.0 110.174 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.5 m -91.45 11.86 22.58 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.693 -0.63 . . . . 0.0 111.234 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -63.38 138.52 58.55 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.279 -0.888 . . . . 0.0 110.449 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.0 mm -96.92 135.35 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.715 -0.616 . . . . 0.0 109.758 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -95.28 117.72 30.79 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.605 -0.684 . . . . 0.0 110.191 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -51.02 -42.41 60.43 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.817 -0.552 . . . . 0.0 111.634 177.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.518 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.6 t80 -152.68 130.38 11.58 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.614 -0.679 . . . . 0.0 110.3 -174.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.674 HD12 ' CG1' ' A' ' 41' ' ' VAL . 77.0 mt -129.4 128.43 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.664 -0.647 . . . . 0.0 109.854 172.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.2 tp -90.47 137.1 32.62 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.821 -0.549 . . . . 0.0 109.817 176.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.57 ' CD1' HD11 ' A' ' 72' ' ' ILE . 3.4 m-85 -136.53 130.81 33.01 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.636 -0.665 . . . . 0.0 110.606 -175.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.9 mtm-85 -92.21 150.68 20.76 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.725 -0.609 . . . . 0.0 110.367 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.31 -23.99 60.74 Favored Glycine 0 N--CA 1.498 2.804 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.3 p -67.11 -42.04 85.19 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.408 -1.054 . . . . 0.0 110.979 -176.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -82.92 -33.22 26.87 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.471 -0.768 . . . . 0.0 110.942 -175.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.683 HD13 HD21 ' A' ' 14' ' ' LEU . 14.9 mt -102.32 138.26 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.393 -0.817 . . . . 0.0 110.142 177.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -107.22 -18.45 13.88 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.797 -166.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -149.64 131.31 14.97 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 118.936 -1.106 . . . . 0.0 111.231 -178.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.509 HD12 ' CD1' ' A' ' 14' ' ' LEU . 18.1 tt -132.01 138.27 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.937 -0.477 . . . . 0.0 109.783 176.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -146.92 144.12 29.0 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.584 -0.698 . . . . 0.0 110.429 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.465 HG12 HG12 ' A' ' 12' ' ' ILE . 35.5 m -84.87 147.0 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.585 -0.697 . . . . 0.0 110.203 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.6 t -96.12 129.03 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.636 -0.665 . . . . 0.0 109.868 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -107.09 -36.06 6.69 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.747 -0.596 . . . . 0.0 110.194 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -104.68 136.79 43.55 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.687 -0.633 . . . . 0.0 110.238 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -111.27 138.69 47.41 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.759 -0.588 . . . . 0.0 110.159 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.1 m -109.62 141.23 42.45 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.702 -0.624 . . . . 0.0 110.157 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.6 mt -115.06 161.72 27.9 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.679 -0.638 . . . . 0.0 110.181 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo . . . . . 0 N--CA 1.487 1.141 0 O-C-N 123.707 1.372 . . . . 0.0 110.302 179.987 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -102.16 144.31 30.88 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.718 -0.872 . . . . 0.0 110.18 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 8.5 tpt -101.09 129.47 46.97 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.755 -0.59 . . . . 0.0 110.187 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -154.66 32.74 0.41 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.742 -0.599 . . . . 0.0 110.285 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.5 mtm -126.31 148.62 49.5 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.638 -0.664 . . . . 0.0 110.169 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 86.2 p -108.54 29.54 7.31 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.697 -0.627 . . . . 0.0 110.595 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -142.72 39.85 1.31 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.69 -50.2 1.21 Allowed Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 5' ' ' LEU . 7.5 mp -80.11 158.66 72.0 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.737 -0.86 . . . . 0.0 110.202 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -64.91 147.61 89.38 Favored 'Trans proline' 0 N--CA 1.489 1.261 0 O-C-N 123.605 1.318 . . . . 0.0 110.383 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -64.86 132.09 48.49 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.71 -0.619 . . . . 0.0 110.463 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.5 mt -64.84 148.62 50.96 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.646 -0.659 . . . . 0.0 110.673 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.62 -1.88 84.5 Favored Glycine 0 N--CA 1.497 2.728 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.783 177.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.6 m -62.17 147.37 47.91 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.047 -1.266 . . . . 0.0 110.446 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.562 ' HE3' HG11 ' A' ' 78' ' ' VAL . 28.6 pttt -81.77 126.0 31.31 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.716 -0.615 . . . . 0.0 110.371 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.628 ' CD1' HD13 ' A' ' 26' ' ' LEU . 89.1 mt -122.49 144.15 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.543 -0.723 . . . . 0.0 110.107 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.3 t -102.68 137.3 41.08 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.476 ' CD1' HD12 ' A' ' 75' ' ' ILE . 13.4 tp -135.41 128.33 31.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.742 -0.599 . . . . 0.0 110.28 -169.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.3 mt -108.38 121.88 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.558 -0.714 . . . . 0.0 109.668 -178.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.1 m -93.2 157.85 16.06 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.042 0.449 . . . . 0.0 111.151 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -53.95 -13.78 0.85 Allowed 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -172.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.515 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.52 20.07 4.17 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.2 -0.938 . . . . 0.0 110.394 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 54.16 34.81 20.98 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.411 -0.806 . . . . 0.0 109.829 -175.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.828 HG12 HG22 ' A' ' 46' ' ' THR . 64.4 mt -102.35 143.44 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -104.31 119.67 39.48 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.058 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -114.22 149.28 36.04 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.649 ' O ' HG23 ' A' ' 41' ' ' VAL . 63.4 mt-10 -141.13 140.5 34.12 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.417 -0.802 . . . . 0.0 109.7 175.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.27 173.23 43.04 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 119.721 -1.228 . . . . 0.0 110.527 -175.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -85.29 136.81 33.34 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.872 -0.781 . . . . 0.0 110.581 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.628 HD13 ' CD1' ' A' ' 12' ' ' ILE . 15.5 tp -66.23 119.22 11.12 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.57 -0.706 . . . . 0.0 110.66 175.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.443 ' O ' HG23 ' A' ' 28' ' ' THR . 25.2 t80 -100.07 -50.16 4.07 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.641 -0.662 . . . . 0.0 110.445 178.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 27' ' ' TYR . 16.6 p -153.94 156.18 37.01 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.708 -0.62 . . . . 0.0 110.34 -177.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.598 HG23 HG22 ' A' ' 36' ' ' ILE . 10.6 p -142.18 145.37 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.758 -0.589 . . . . 0.0 110.093 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -128.83 98.46 24.52 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.678 -0.639 . . . . 0.0 109.539 177.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -59.4 -43.29 41.45 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 O-C-N 123.595 1.313 . . . . 0.0 110.993 -175.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -80.88 -23.88 38.7 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.335 -0.853 . . . . 0.0 110.237 -171.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.74 ' O ' HG23 ' A' ' 35' ' ' THR . 74.7 mm-40 -87.18 0.99 54.46 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.473 -0.767 . . . . 0.0 111.188 173.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.0 m 50.03 39.8 19.84 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.101 -0.999 . . . . 0.0 111.172 -176.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.74 HG23 ' O ' ' A' ' 33' ' ' GLU . 23.1 p -136.06 154.36 51.05 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.452 -0.78 . . . . 0.0 110.476 -174.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.598 HG22 HG23 ' A' ' 29' ' ' VAL . 40.3 pt -141.66 160.61 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.816 -0.553 . . . . 0.0 110.031 177.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.512 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.52 126.94 26.71 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.698 -0.626 . . . . 0.0 109.648 175.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 26' ' ' LEU . 88.0 mt -109.89 146.6 34.86 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -178.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 99.9 p -117.65 152.24 35.6 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.1 p 45.65 83.62 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 121.491 0.662 . . . . 0.0 110.311 -172.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.666 ' CG1' HD12 ' A' ' 65' ' ' ILE . 14.9 p -134.58 151.06 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.938 -0.476 . . . . 0.0 109.733 -179.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -136.6 153.19 51.03 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.596 -0.69 . . . . 0.0 110.137 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.3 p -109.6 137.7 47.04 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.806 -0.559 . . . . 0.0 109.664 177.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -83.06 -38.57 22.34 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.194 -172.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.31 169.4 30.83 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 175.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.828 HG22 HG12 ' A' ' 20' ' ' ILE . 41.0 p -118.17 6.21 12.0 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.865 -0.785 . . . . 0.0 110.818 170.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -54.29 -24.3 18.48 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.48 -0.762 . . . . 0.0 112.257 -167.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -65.79 -59.21 4.12 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.281 -0.887 . . . . 0.0 110.387 -177.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 82.0 mmt-85 -94.52 10.26 35.34 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.619 -0.676 . . . . 0.0 111.417 177.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.448 ' HB2' HD12 ' A' ' 55' ' ' ILE . 53.2 p-10 -57.42 170.02 0.57 Allowed 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.211 -0.93 . . . . 0.0 111.52 -170.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.7 m -79.01 164.54 24.29 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 175.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -77.42 4.21 11.48 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.092 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -97.53 148.16 23.53 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.312 -0.867 . . . . 0.0 109.394 166.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -65.98 142.2 57.93 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.578 -0.701 . . . . 0.0 110.81 -174.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.448 HD12 ' HB2' ' A' ' 50' ' ' ASP . 79.8 mt -115.75 135.7 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.678 -0.639 . . . . 0.0 109.439 177.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.35 132.52 89.66 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.626 -0.671 . . . . 0.0 110.025 -178.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -69.48 144.07 54.28 Favored 'Trans proline' 0 N--CA 1.487 1.117 0 O-C-N 123.389 1.205 . . . . 0.0 110.253 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -98.93 110.1 22.76 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.668 -0.645 . . . . 0.0 110.111 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.4 t -99.18 -33.17 10.88 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.748 -0.595 . . . . 0.0 110.364 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -62.52 148.64 45.24 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.592 -0.692 . . . . 0.0 110.668 -179.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.4 mm -96.83 143.75 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.681 -0.637 . . . . 0.0 109.667 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -94.75 114.77 26.72 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.711 -0.618 . . . . 0.0 110.322 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.19 -41.39 60.18 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 121.812 -0.555 . . . . 0.0 111.56 177.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.512 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.0 t80 -152.59 130.6 11.82 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.632 -0.668 . . . . 0.0 110.262 -175.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.666 HD12 ' CG1' ' A' ' 41' ' ' VAL . 76.2 mt -129.34 127.27 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.586 -0.696 . . . . 0.0 109.792 171.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.2 tp -90.58 137.07 32.64 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.833 -0.542 . . . . 0.0 109.858 176.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.457 ' CZ ' HG21 ' A' ' 65' ' ' ILE . 3.9 m-85 -137.93 131.89 31.57 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.685 -0.634 . . . . 0.0 110.67 -175.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -91.59 151.91 20.51 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.752 -0.592 . . . . 0.0 110.313 174.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.93 -24.75 60.82 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.6 t -66.83 -42.15 86.27 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.451 -1.029 . . . . 0.0 111.066 -176.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -82.89 -33.17 27.02 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.527 -0.733 . . . . 0.0 110.93 -175.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.435 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 24.5 mt -105.17 135.1 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.336 -0.853 . . . . 0.0 109.962 176.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -110.18 -12.59 14.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.941 -0.474 . . . . 0.0 112.111 -165.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -147.4 130.65 16.52 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.809 -1.182 . . . . 0.0 111.298 -178.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.476 HD12 ' CD1' ' A' ' 14' ' ' LEU . 14.6 tt -132.27 141.25 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.92 -0.488 . . . . 0.0 109.87 176.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -145.96 134.4 21.95 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.498 -0.751 . . . . 0.0 110.307 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.3 t -87.14 144.45 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.612 -0.68 . . . . 0.0 109.611 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.562 HG11 ' HE3' ' A' ' 11' ' ' LYS . 57.8 t -93.71 127.09 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.603 -0.686 . . . . 0.0 109.749 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -149.55 -176.4 5.39 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.863 -0.523 . . . . 0.0 110.186 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -87.0 172.35 10.06 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.69 -0.631 . . . . 0.0 110.112 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -98.42 132.35 43.95 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.671 -0.643 . . . . 0.0 110.269 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.8 t -138.46 164.76 28.55 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.74 -0.6 . . . . 0.0 110.286 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.434 ' C ' HD23 ' A' ' 83' ' ' LEU . 5.0 tt -97.32 109.87 51.9 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.666 -0.646 . . . . 0.0 110.147 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo . . . . . 0 N--CA 1.489 1.234 0 O-C-N 123.422 1.222 . . . . 0.0 110.411 179.102 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -67.56 -33.66 75.48 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.69 -0.888 . . . . 0.0 110.319 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 65.7 mtt -122.22 148.41 45.01 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.659 -0.65 . . . . 0.0 110.198 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -113.36 32.92 5.43 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.715 -0.616 . . . . 0.0 110.269 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.1 mmm -95.88 135.89 37.02 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.631 -0.668 . . . . 0.0 110.175 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 89.3 p -67.83 -31.85 71.98 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.692 -0.63 . . . . 0.0 110.424 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -144.05 174.2 24.49 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.59 -41.76 1.31 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 29.1 mt -79.9 160.17 69.51 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.63 -0.924 . . . . 0.0 110.14 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -64.98 131.09 27.67 Favored 'Trans proline' 0 N--CA 1.489 1.246 0 O-C-N 123.652 1.343 . . . . 0.0 110.456 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -64.89 143.0 58.24 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.697 -0.627 . . . . 0.0 110.503 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.5 mt -64.64 174.38 1.8 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.635 -0.666 . . . . 0.0 110.496 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.66 -1.75 85.01 Favored Glycine 0 N--CA 1.497 2.721 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.608 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 42.6 m -60.01 159.54 9.22 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.151 -1.206 . . . . 0.0 110.437 -177.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -81.27 126.58 31.72 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.747 -0.596 . . . . 0.0 110.534 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.686 ' CD1' HD13 ' A' ' 26' ' ' LEU . 88.1 mt -120.83 144.66 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.555 -0.716 . . . . 0.0 109.907 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.8 t -102.97 137.27 41.39 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 175.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.788 ' HG ' HG21 ' A' ' 72' ' ' ILE . 11.9 tp -134.15 123.88 25.12 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.723 -0.611 . . . . 0.0 110.057 -170.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.721 ' O ' HG23 ' A' ' 72' ' ' ILE . 82.0 mt -103.99 119.45 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.528 -0.732 . . . . 0.0 109.643 -177.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.7 m -94.96 157.89 15.7 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.166 0.507 . . . . 0.0 111.59 -175.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -53.64 -15.19 1.08 Allowed 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -171.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.6 21.15 3.58 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.157 -0.964 . . . . 0.0 110.449 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 56.69 35.57 26.37 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.49 -0.756 . . . . 0.0 110.031 -178.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.747 HG12 HG22 ' A' ' 46' ' ' THR . 53.1 mt -107.05 148.79 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.0 ttt-85 -106.66 119.83 40.36 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.167 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -112.87 152.37 29.34 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 175.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.655 ' O ' HG23 ' A' ' 41' ' ' VAL . 42.3 tt0 -141.88 140.55 32.89 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.452 -0.78 . . . . 0.0 109.68 175.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.57 171.8 41.61 Favored Glycine 0 N--CA 1.496 2.65 0 C-N-CA 119.753 -1.213 . . . . 0.0 110.464 -176.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 43.1 mmm-85 -84.35 138.97 32.59 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.843 -0.798 . . . . 0.0 110.538 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.686 HD13 ' CD1' ' A' ' 12' ' ' ILE . 16.5 tp -66.17 116.5 7.31 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.605 -0.684 . . . . 0.0 110.618 175.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.461 ' O ' HG23 ' A' ' 28' ' ' THR . 32.1 t80 -100.35 -50.13 4.03 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.609 -0.682 . . . . 0.0 110.553 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 27' ' ' TYR . 14.5 p -154.58 155.33 34.56 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.718 -0.614 . . . . 0.0 110.359 -177.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.836 HG23 HG22 ' A' ' 36' ' ' ILE . 13.4 p -142.23 145.94 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.746 -0.597 . . . . 0.0 110.062 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -128.5 99.01 24.27 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.579 -0.7 . . . . 0.0 109.649 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -59.61 -41.67 54.17 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 O-C-N 123.654 1.344 . . . . 0.0 111.038 -175.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -80.59 -25.51 38.43 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.384 -0.823 . . . . 0.0 110.252 -170.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.581 ' O ' HG23 ' A' ' 35' ' ' THR . 79.3 mt-10 -87.58 1.97 52.12 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.437 -0.79 . . . . 0.0 111.236 173.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 97.7 m 49.66 39.97 18.7 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.093 -1.004 . . . . 0.0 111.199 -176.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 33' ' ' GLU . 11.0 p -135.86 154.32 51.2 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.415 -0.803 . . . . 0.0 110.379 -175.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.836 HG22 HG23 ' A' ' 29' ' ' VAL . 39.9 pt -142.0 160.94 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.675 -0.641 . . . . 0.0 109.969 176.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.505 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -137.06 128.99 29.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.572 -0.705 . . . . 0.0 109.828 176.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 26' ' ' LEU . 84.1 mt -109.87 144.82 37.8 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -178.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 97.6 p -114.95 152.66 31.97 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.1 p 45.55 84.94 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 121.454 0.645 . . . . 0.0 110.214 -171.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.1 p -134.55 149.97 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.967 -0.458 . . . . 0.0 109.766 -178.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -136.07 153.2 51.4 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.635 -0.665 . . . . 0.0 110.068 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.2 p -105.61 129.79 53.78 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.757 -0.589 . . . . 0.0 109.463 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -83.07 -38.49 22.44 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.112 -170.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.22 175.45 37.25 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 178.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.747 HG22 HG12 ' A' ' 20' ' ' ILE . 65.3 p -118.11 2.68 12.05 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.81 -0.817 . . . . 0.0 110.489 169.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -57.33 -33.83 68.12 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.541 -0.725 . . . . 0.0 112.134 -163.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -63.36 -59.06 5.19 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.332 -0.855 . . . . 0.0 110.435 -175.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -94.32 10.49 34.01 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.753 -0.592 . . . . 0.0 111.289 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 51.2 p30 -49.82 157.78 0.55 Allowed 'General case' 0 N--CA 1.51 2.556 0 O-C-N 121.413 -0.804 . . . . 0.0 112.41 -169.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.421 ' H ' HD11 ' A' ' 55' ' ' ILE . 21.1 m -79.2 164.49 24.16 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 172.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -77.51 4.53 10.92 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.236 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -96.83 166.05 11.82 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.236 -0.915 . . . . 0.0 109.645 167.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -76.58 133.98 39.52 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.544 -0.722 . . . . 0.0 110.52 -176.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.421 HD11 ' H ' ' A' ' 51' ' ' THR . 69.8 mt -119.35 139.48 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.805 -0.56 . . . . 0.0 109.531 177.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.04 109.89 53.56 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.613 -0.679 . . . . 0.0 110.249 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -68.77 152.06 74.17 Favored 'Trans proline' 0 N--CA 1.488 1.153 0 O-C-N 123.414 1.218 . . . . 0.0 110.387 178.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -99.0 127.8 45.0 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.755 -0.59 . . . . 0.0 110.187 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.2 m -94.63 -31.63 13.76 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.721 -0.612 . . . . 0.0 110.468 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -61.76 151.45 34.04 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.633 -0.667 . . . . 0.0 110.613 -178.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.2 mm -96.81 140.01 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.67 -0.643 . . . . 0.0 109.758 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -97.3 116.19 29.05 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.603 -0.686 . . . . 0.0 110.297 -177.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -50.96 -40.35 57.34 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.701 -0.625 . . . . 0.0 111.562 176.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.505 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.3 t80 -152.97 129.76 10.9 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.656 -0.652 . . . . 0.0 110.217 -174.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.651 HD12 ' CG1' ' A' ' 41' ' ' VAL . 71.2 mt -128.32 126.68 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.713 -0.617 . . . . 0.0 109.893 171.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.4 HD12 ' HB2' ' A' ' 37' ' ' ALA . 22.4 tp -91.42 137.12 32.62 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.87 -0.519 . . . . 0.0 109.9 176.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.469 ' CD1' HD11 ' A' ' 72' ' ' ILE . 7.3 m-85 -135.47 130.85 35.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.642 -0.661 . . . . 0.0 110.429 -176.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -89.56 151.38 21.97 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.716 -0.615 . . . . 0.0 110.076 174.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.4 -24.49 45.96 Favored Glycine 0 N--CA 1.5 2.929 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 86.5 p -76.82 -39.06 52.61 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.411 -1.052 . . . . 0.0 111.047 -177.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -82.04 -21.3 37.02 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.391 -0.818 . . . . 0.0 111.309 -173.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.788 HG21 ' HG ' ' A' ' 14' ' ' LEU . 45.1 mt -116.03 141.22 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.256 -0.902 . . . . 0.0 109.694 168.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -105.88 -14.3 15.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.86 -0.525 . . . . 0.0 111.87 -167.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -150.29 134.22 16.86 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 118.993 -1.083 . . . . 0.0 111.438 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.425 HD12 ' CD1' ' A' ' 14' ' ' LEU . 15.7 tt -132.04 140.63 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.94 -0.475 . . . . 0.0 109.826 176.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -147.05 138.04 23.85 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.624 -0.673 . . . . 0.0 110.344 178.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.9 t -87.2 146.1 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.573 -0.704 . . . . 0.0 109.656 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.3 t -93.63 132.71 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.52 -0.737 . . . . 0.0 109.788 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -118.63 144.99 45.79 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.774 -0.578 . . . . 0.0 110.035 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -94.46 109.79 21.63 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.713 -0.617 . . . . 0.0 110.213 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 47.4 p-80 -111.0 32.44 5.28 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.633 -0.667 . . . . 0.0 110.331 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.0 m -101.77 140.79 35.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.692 -0.63 . . . . 0.0 110.175 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 24.2 mt -110.72 162.63 19.83 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.649 -0.657 . . . . 0.0 110.204 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo . . . . . 0 N--CA 1.487 1.111 0 O-C-N 123.692 1.364 . . . . 0.0 110.373 179.97 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -104.49 144.76 31.23 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.685 -0.891 . . . . 0.0 110.118 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 88.2 mmm -96.51 97.93 9.81 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.679 -0.638 . . . . 0.0 110.219 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -105.9 135.46 47.3 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.678 -0.639 . . . . 0.0 110.067 178.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.3 mmm -131.44 153.35 49.81 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.666 -0.646 . . . . 0.0 110.231 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.6 t -121.73 143.47 49.35 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.619 -0.675 . . . . 0.0 110.054 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -136.63 -48.19 0.08 OUTLIER Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.55 -46.54 75.89 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 16.4 mt -80.96 145.93 58.18 Favored Pre-proline 0 N--CA 1.497 1.9 0 O-C-N 121.618 -0.93 . . . . 0.0 110.151 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -71.05 154.72 62.5 Favored 'Trans proline' 0 N--CA 1.486 1.055 0 O-C-N 123.551 1.29 . . . . 0.0 110.157 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -64.79 130.85 45.05 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.657 -0.652 . . . . 0.0 110.481 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.6 mt -64.79 145.96 55.51 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.681 -0.637 . . . . 0.0 110.652 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.67 -1.96 84.36 Favored Glycine 0 N--CA 1.497 2.72 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.794 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.0 m -62.18 139.86 58.46 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.079 -1.247 . . . . 0.0 110.445 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.572 ' HE3' HG11 ' A' ' 78' ' ' VAL . 35.8 pttt -81.87 127.27 32.83 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.71 -0.619 . . . . 0.0 110.35 179.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.404 HD12 ' HB2' ' A' ' 26' ' ' LEU . 92.8 mt -124.94 145.13 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.597 -0.689 . . . . 0.0 110.223 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.2 t -102.84 137.25 41.29 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.735 HD21 HD13 ' A' ' 72' ' ' ILE . 13.8 tp -131.88 125.69 32.35 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.814 -0.554 . . . . 0.0 110.198 -170.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 80.9 mt -107.5 118.65 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.522 -0.736 . . . . 0.0 109.692 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.9 m -93.57 157.72 16.05 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.039 0.447 . . . . 0.0 111.293 -177.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -53.29 -15.02 0.82 Allowed 'General case' 0 N--CA 1.508 2.473 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -172.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.568 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.29 20.55 3.73 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.099 -1.001 . . . . 0.0 110.405 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 54.35 33.51 18.63 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.435 -0.791 . . . . 0.0 109.874 -174.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.662 HG12 HG22 ' A' ' 46' ' ' THR . 65.7 mt -101.5 141.31 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -104.66 119.79 39.82 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.941 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -113.99 148.96 36.06 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 174.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.66 ' O ' HG23 ' A' ' 41' ' ' VAL . 42.8 tt0 -140.08 140.48 36.1 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.471 -0.768 . . . . 0.0 109.498 175.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.43 173.02 43.14 Favored Glycine 0 N--CA 1.496 2.683 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.665 -175.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 72.0 mtp85 -85.54 135.47 33.81 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.881 -0.776 . . . . 0.0 110.59 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.483 ' HA ' HD23 ' A' ' 38' ' ' LEU . 29.4 tp -66.16 119.53 11.63 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.668 -0.645 . . . . 0.0 110.679 176.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.44 ' O ' HG23 ' A' ' 28' ' ' THR . 26.4 t80 -99.57 -50.06 4.2 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.677 -0.64 . . . . 0.0 110.296 178.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 27' ' ' TYR . 16.5 p -153.79 154.97 34.99 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.671 -0.643 . . . . 0.0 110.295 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.895 HG23 HG22 ' A' ' 36' ' ' ILE . 13.6 p -142.26 145.7 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.648 -0.657 . . . . 0.0 110.11 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -128.64 98.3 25.51 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.591 -0.693 . . . . 0.0 109.554 177.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -59.42 -41.1 61.04 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 O-C-N 123.507 1.267 . . . . 0.0 110.924 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -80.66 -25.52 38.22 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.388 -0.82 . . . . 0.0 110.156 -171.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.728 ' O ' HG23 ' A' ' 35' ' ' THR . 54.6 mt-10 -87.46 2.19 51.28 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.463 -0.773 . . . . 0.0 111.254 173.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.8 m 49.73 38.79 16.23 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.122 -0.986 . . . . 0.0 111.254 -176.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.728 HG23 ' O ' ' A' ' 33' ' ' GLU . 22.3 p -136.6 152.71 50.76 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.336 -0.852 . . . . 0.0 110.391 -174.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.895 HG22 HG23 ' A' ' 29' ' ' VAL . 40.0 pt -142.38 162.03 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.687 -0.633 . . . . 0.0 110.167 177.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.518 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.3 127.81 28.67 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.571 -0.706 . . . . 0.0 109.666 175.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.483 HD23 ' HA ' ' A' ' 26' ' ' LEU . 85.9 mt -109.9 148.03 32.31 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -177.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 96.8 p -119.41 152.8 36.23 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -178.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.8 p 45.65 84.38 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 CA-C-O 121.565 0.698 . . . . 0.0 110.301 -172.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.695 HG11 HD12 ' A' ' 65' ' ' ILE . 14.6 p -134.55 149.86 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.914 -0.491 . . . . 0.0 109.786 -178.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.582 ' HB3' HD12 ' A' ' 61' ' ' ILE . 32.1 ptt180 -135.11 153.13 52.12 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.679 -0.638 . . . . 0.0 109.941 177.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.9 p -109.43 141.93 41.14 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.736 -0.603 . . . . 0.0 109.911 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -82.55 -38.36 23.84 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.591 -0.693 . . . . 0.0 110.678 -175.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.64 167.37 28.2 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 176.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.662 HG22 HG12 ' A' ' 20' ' ' ILE . 16.3 p -118.29 6.51 11.91 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.944 -0.739 . . . . 0.0 111.015 175.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -48.94 -25.89 2.19 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.582 -0.699 . . . . 0.0 112.784 -167.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -66.82 -59.21 3.74 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.287 -0.883 . . . . 0.0 110.417 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -94.39 10.21 35.24 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.633 -0.667 . . . . 0.0 111.225 176.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -58.32 174.07 0.32 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.232 -0.918 . . . . 0.0 111.552 -170.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.1 p -78.83 164.64 24.33 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 122.0 -0.438 . . . . 0.0 109.94 174.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -77.33 2.76 14.83 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.996 -0.681 . . . . 0.0 111.103 177.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -101.7 151.91 21.48 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.31 -0.869 . . . . 0.0 109.527 169.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -66.49 138.93 57.87 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.501 -0.749 . . . . 0.0 110.56 -174.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.7 mt -109.97 135.22 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.704 -0.622 . . . . 0.0 109.459 177.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -83.84 146.06 48.4 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.762 -0.587 . . . . 0.0 110.176 -178.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -68.44 156.96 63.79 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 O-C-N 123.522 1.275 . . . . 0.0 110.269 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -79.64 132.58 36.28 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.683 -0.636 . . . . 0.0 110.041 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.9 m -98.98 30.29 3.46 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.749 -0.594 . . . . 0.0 110.541 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -175.65 160.85 2.52 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.634 -0.666 . . . . 0.0 109.78 -177.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.582 HD12 ' HB3' ' A' ' 42' ' ' ARG . 51.0 mm -96.74 157.4 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.703 -0.623 . . . . 0.0 109.725 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -93.0 114.08 26.54 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.556 -0.715 . . . . 0.0 110.177 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -51.23 -42.34 60.94 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.9 -0.5 . . . . 0.0 111.711 178.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.518 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.9 t80 -152.72 129.95 11.23 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.685 -0.635 . . . . 0.0 110.292 -174.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.695 HD12 HG11 ' A' ' 41' ' ' VAL . 76.2 mt -129.6 129.14 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.652 -0.655 . . . . 0.0 109.85 172.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 24.8 tp -90.65 137.0 32.7 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.774 -0.579 . . . . 0.0 109.918 176.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.601 ' CD1' HD11 ' A' ' 72' ' ' ILE . 3.7 m-85 -135.59 129.44 32.91 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.67 -0.644 . . . . 0.0 110.635 -175.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 73.5 mtt85 -92.1 150.06 21.16 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.797 -0.565 . . . . 0.0 110.352 173.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.18 -24.43 61.0 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.9 m -66.57 -42.09 87.58 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.493 -1.004 . . . . 0.0 111.034 -176.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -83.16 -32.75 26.46 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.445 -0.785 . . . . 0.0 110.969 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.735 HD13 HD21 ' A' ' 14' ' ' LEU . 14.7 mt -101.38 138.61 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.395 -0.816 . . . . 0.0 110.174 177.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -106.37 -18.54 13.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.892 -0.505 . . . . 0.0 111.736 -167.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -150.0 131.25 14.56 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 119.001 -1.08 . . . . 0.0 111.242 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.538 HD12 ' CD1' ' A' ' 14' ' ' LEU . 17.6 tt -132.14 139.83 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 176.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -146.29 133.22 20.2 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.521 -0.737 . . . . 0.0 110.411 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.3 p -87.62 147.1 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.722 -0.611 . . . . 0.0 110.29 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.572 HG11 ' HE3' ' A' ' 11' ' ' LYS . 60.6 t -94.88 129.54 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.56 -0.712 . . . . 0.0 109.759 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -142.41 142.29 32.37 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.76 -0.588 . . . . 0.0 110.154 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -64.95 -33.97 77.29 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.659 -0.651 . . . . 0.0 110.3 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 46.7 p-80 -129.13 148.26 51.06 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.717 -0.614 . . . . 0.0 110.188 179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.3 p -122.38 161.49 23.34 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.682 -0.636 . . . . 0.0 110.182 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.7 mp -115.95 164.64 17.0 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.756 -0.59 . . . . 0.0 110.184 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo . . . . . 0 N--CA 1.488 1.195 0 O-C-N 123.596 1.314 . . . . 0.0 110.421 179.777 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -102.95 144.08 31.7 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.716 -0.873 . . . . 0.0 110.205 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 49.1 ttm -106.94 72.98 0.91 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.64 -0.663 . . . . 0.0 110.165 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -155.08 152.16 29.21 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.553 -0.717 . . . . 0.0 110.16 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.3 mtm -106.19 130.4 54.07 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.738 -0.601 . . . . 0.0 110.23 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 64.4 m -97.3 23.39 7.55 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.691 -0.631 . . . . 0.0 110.824 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -143.8 -56.96 0.03 OUTLIER Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.17 134.86 12.35 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.507 HD23 ' N ' ' A' ' 5' ' ' LEU . 0.7 OUTLIER -155.46 68.0 5.1 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.628 -0.925 . . . . 0.0 110.063 178.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -64.97 122.31 10.07 Favored 'Trans proline' 0 N--CA 1.489 1.24 0 O-C-N 123.387 1.204 . . . . 0.0 110.52 -178.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -64.84 152.03 43.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.718 -0.614 . . . . 0.0 110.445 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.4 mt -64.71 173.28 2.29 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.698 -0.626 . . . . 0.0 110.411 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.79 -1.73 85.4 Favored Glycine 0 N--CA 1.498 2.78 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.561 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 45.8 m -59.36 155.58 14.43 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.129 -1.218 . . . . 0.0 110.484 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -81.35 124.49 29.41 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.734 -0.604 . . . . 0.0 110.794 -177.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.417 HD12 ' HB2' ' A' ' 26' ' ' LEU . 91.5 mt -121.92 146.16 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.661 -0.649 . . . . 0.0 110.017 178.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.6 t -103.19 137.26 41.58 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 176.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.694 HD21 HD13 ' A' ' 72' ' ' ILE . 13.9 tp -132.47 126.31 32.71 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.75 -0.594 . . . . 0.0 110.252 -170.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.1 mt -107.05 118.79 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.515 -0.741 . . . . 0.0 109.66 -178.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.0 m -93.59 157.71 16.05 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.039 0.447 . . . . 0.0 111.301 -177.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.5 tttm -53.99 -13.63 0.83 Allowed 'General case' 0 N--CA 1.508 2.441 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -172.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.532 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.9 20.37 4.23 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.107 -0.996 . . . . 0.0 110.426 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 53.86 34.45 19.36 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.521 -0.737 . . . . 0.0 109.865 -173.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.791 HG12 HG22 ' A' ' 46' ' ' THR . 72.2 mt -102.27 140.96 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -104.67 119.8 39.85 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.009 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -113.84 150.3 33.75 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 175.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.653 ' O ' HG23 ' A' ' 41' ' ' VAL . 58.3 mt-10 -141.45 140.54 33.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.423 -0.798 . . . . 0.0 109.796 174.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.53 173.1 43.2 Favored Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.764 -1.207 . . . . 0.0 110.377 -176.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -85.04 135.83 33.84 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.849 -0.795 . . . . 0.0 110.588 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.479 ' HA ' HD23 ' A' ' 38' ' ' LEU . 24.7 tp -66.08 120.02 12.43 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.583 -0.698 . . . . 0.0 110.716 175.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.44 ' O ' HG23 ' A' ' 28' ' ' THR . 24.2 t80 -99.78 -50.11 4.14 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.655 -0.653 . . . . 0.0 110.394 178.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 27' ' ' TYR . 15.7 p -153.96 155.84 36.35 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.67 -0.644 . . . . 0.0 110.305 -178.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.894 HG23 HG22 ' A' ' 36' ' ' ILE . 13.4 p -142.22 145.81 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.697 -0.627 . . . . 0.0 110.081 -179.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -128.66 101.78 20.51 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.629 -0.669 . . . . 0.0 109.54 177.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.44 -41.93 30.35 Favored 'Trans proline' 0 N--CA 1.49 1.276 0 O-C-N 123.553 1.291 . . . . 0.0 110.746 -174.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -80.76 -23.56 39.28 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.384 -0.822 . . . . 0.0 110.212 -172.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.667 ' O ' HG23 ' A' ' 35' ' ' THR . 74.9 mm-40 -87.26 0.75 54.89 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.476 -0.765 . . . . 0.0 111.178 173.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.3 m 49.91 38.14 15.41 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.157 -0.964 . . . . 0.0 111.255 -176.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.667 HG23 ' O ' ' A' ' 33' ' ' GLU . 17.2 p -136.71 153.34 50.9 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.402 -0.811 . . . . 0.0 110.403 -174.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.894 HG22 HG23 ' A' ' 29' ' ' VAL . 39.9 pt -142.31 162.0 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.719 -0.613 . . . . 0.0 110.081 177.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.513 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -135.87 127.95 29.75 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.61 -0.681 . . . . 0.0 109.722 176.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.479 HD23 ' HA ' ' A' ' 26' ' ' LEU . 86.1 mt -109.88 147.73 32.84 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -177.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 95.7 p -118.51 151.42 37.87 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -178.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.7 p 45.8 84.05 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 CA-C-O 121.517 0.675 . . . . 0.0 110.341 -172.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.673 ' CG1' HD12 ' A' ' 65' ' ' ILE . 14.3 p -134.56 150.92 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.935 -0.478 . . . . 0.0 109.717 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -135.8 153.19 51.6 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.602 -0.686 . . . . 0.0 110.087 178.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.4 p -108.19 139.66 42.54 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.733 -0.604 . . . . 0.0 109.834 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -82.94 -38.33 22.93 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.657 -0.652 . . . . 0.0 111.056 -173.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.67 172.22 34.52 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 119.975 -1.107 . . . . 0.0 110.522 177.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.791 HG22 HG12 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -118.01 6.58 12.15 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.928 -0.748 . . . . 0.0 110.739 174.1 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -48.99 -25.2 1.84 Allowed 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.618 -0.676 . . . . 0.0 112.528 -169.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -64.42 -59.19 4.64 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.291 -0.881 . . . . 0.0 110.574 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -94.29 10.22 35.0 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.612 -0.68 . . . . 0.0 111.408 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.5 p-10 -61.4 174.19 0.77 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.279 -0.888 . . . . 0.0 111.244 -171.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.8 p -78.91 164.59 24.32 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.922 -0.486 . . . . 0.0 109.876 174.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -77.46 2.57 15.78 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.081 177.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -97.86 166.05 11.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.126 -0.984 . . . . 0.0 109.513 169.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -65.97 140.54 58.32 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.543 -0.723 . . . . 0.0 110.451 -175.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.466 ' N ' HD12 ' A' ' 55' ' ' ILE . 4.9 mp -111.95 141.91 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.702 -0.624 . . . . 0.0 109.705 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -92.06 109.87 40.34 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.65 -0.656 . . . . 0.0 110.178 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -66.79 146.96 80.18 Favored 'Trans proline' 0 N--CA 1.489 1.258 0 O-C-N 123.373 1.196 . . . . 0.0 110.428 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -96.81 117.24 30.63 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.678 -0.639 . . . . 0.0 110.165 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 86.8 p -88.29 -28.73 20.89 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.732 -0.605 . . . . 0.0 110.609 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -62.13 146.86 49.33 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.539 -0.726 . . . . 0.0 110.693 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.3 mm -96.77 144.72 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.695 -0.628 . . . . 0.0 109.708 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -94.97 114.54 26.37 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.586 -0.696 . . . . 0.0 110.285 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -51.08 -40.22 57.87 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.781 -0.575 . . . . 0.0 111.728 177.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.513 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.6 t80 -152.97 129.92 11.02 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.637 -0.664 . . . . 0.0 110.257 -174.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.673 HD12 ' CG1' ' A' ' 41' ' ' VAL . 74.3 mt -129.33 129.35 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.678 -0.639 . . . . 0.0 109.798 171.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.0 tp -90.38 137.06 32.66 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.87 -0.519 . . . . 0.0 109.865 176.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.602 ' CD1' HD11 ' A' ' 72' ' ' ILE . 3.2 m-85 -135.75 129.75 33.07 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.604 -0.685 . . . . 0.0 110.579 -175.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -92.08 150.18 21.1 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.748 -0.595 . . . . 0.0 110.325 173.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.29 -24.49 61.33 Favored Glycine 0 N--CA 1.498 2.818 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 177.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.5 m -66.59 -42.12 87.42 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.472 -1.016 . . . . 0.0 111.115 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -83.0 -32.94 26.68 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.415 -0.803 . . . . 0.0 110.905 -175.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.694 HD13 HD21 ' A' ' 14' ' ' LEU . 13.9 mt -100.77 139.89 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.418 -0.802 . . . . 0.0 110.124 177.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.0 tptm -106.27 -21.28 13.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.937 -0.477 . . . . 0.0 111.606 -166.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -150.63 135.28 17.32 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 119.037 -1.065 . . . . 0.0 111.353 -177.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.517 HD12 ' CD1' ' A' ' 14' ' ' LEU . 18.3 tt -133.2 142.13 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -146.44 139.02 25.24 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.535 -0.728 . . . . 0.0 110.411 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.0 t -87.2 144.48 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.621 -0.674 . . . . 0.0 109.638 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.8 t -95.5 132.32 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.492 -0.755 . . . . 0.0 109.831 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -148.62 38.38 0.85 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.761 -0.587 . . . . 0.0 110.155 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -97.28 133.27 42.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.596 -0.69 . . . . 0.0 110.272 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -124.54 146.21 49.13 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.704 -0.623 . . . . 0.0 110.214 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.5 m -119.6 138.79 53.0 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.633 -0.667 . . . . 0.0 110.128 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.9 mt -111.03 109.87 56.98 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.705 -0.622 . . . . 0.0 110.207 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo . . . . . 0 N--CA 1.49 1.272 0 O-C-N 123.398 1.209 . . . . 0.0 110.447 179.152 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -144.14 154.5 43.23 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.774 -0.839 . . . . 0.0 110.171 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 74.4 mtm -125.03 155.36 39.84 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.725 -0.61 . . . . 0.0 110.203 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -105.19 145.58 30.42 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.693 -0.629 . . . . 0.0 110.259 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.3 mtm -113.53 144.0 43.59 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.677 -0.639 . . . . 0.0 110.226 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.6 p -67.66 -31.9 72.21 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.744 -0.598 . . . . 0.0 110.348 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.56 62.46 0.29 Allowed Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.94 177.15 53.92 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 24.7 tp -80.44 145.25 58.91 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.717 -0.873 . . . . 0.0 109.985 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 5' ' ' LEU . 15.5 Cg_exo -64.92 153.88 75.91 Favored 'Trans proline' 0 N--CA 1.489 1.264 0 O-C-N 123.281 1.148 . . . . 0.0 110.343 177.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -64.81 123.35 19.15 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.727 -0.608 . . . . 0.0 110.55 -178.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.4 mt -64.85 160.12 21.09 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.711 -0.618 . . . . 0.0 110.594 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.73 -1.87 84.83 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.763 177.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 67.0 m -61.39 137.64 58.24 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.138 -1.213 . . . . 0.0 110.411 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -82.15 124.36 29.8 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.72 -0.612 . . . . 0.0 110.611 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.62 ' CD1' HD13 ' A' ' 26' ' ' LEU . 88.1 mt -121.16 145.12 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.644 -0.66 . . . . 0.0 110.17 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.8 t -103.44 137.27 41.77 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 175.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.709 HD21 HD13 ' A' ' 72' ' ' ILE . 13.8 tp -133.04 125.96 30.83 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.68 -0.638 . . . . 0.0 110.259 -169.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.0 mt -106.68 117.84 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.47 -0.769 . . . . 0.0 109.683 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.0 m -93.04 157.83 16.1 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.06 0.457 . . . . 0.0 111.254 -177.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -54.03 -13.9 0.92 Allowed 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -171.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.54 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -90.09 20.6 4.19 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.094 -1.004 . . . . 0.0 110.408 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 54.37 34.16 20.11 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.512 -0.743 . . . . 0.0 109.788 -174.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.808 HG12 HG22 ' A' ' 46' ' ' THR . 69.8 mt -102.47 141.82 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 36.8 ttp180 -104.85 119.86 40.01 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.973 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -114.0 150.3 34.08 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 174.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.655 ' O ' HG23 ' A' ' 41' ' ' VAL . 42.1 tt0 -140.7 140.47 34.92 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.535 -0.728 . . . . 0.0 109.515 175.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.58 172.69 43.13 Favored Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.657 -175.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -85.08 136.15 33.69 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.908 -0.76 . . . . 0.0 110.532 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.62 HD13 ' CD1' ' A' ' 12' ' ' ILE . 15.5 tp -66.14 118.83 10.44 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.62 -0.675 . . . . 0.0 110.716 175.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.449 ' O ' HG23 ' A' ' 28' ' ' THR . 24.9 t80 -100.03 -50.13 4.09 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.662 -0.649 . . . . 0.0 110.376 177.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 27' ' ' TYR . 14.8 p -154.09 153.74 32.41 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.701 -0.625 . . . . 0.0 110.284 -178.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.892 HG23 HG22 ' A' ' 36' ' ' ILE . 13.3 p -142.19 145.24 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.656 -0.652 . . . . 0.0 110.033 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -128.22 100.48 23.26 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.625 -0.672 . . . . 0.0 109.457 176.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.34 -42.79 26.09 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 O-C-N 123.496 1.261 . . . . 0.0 110.792 -174.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -80.2 -27.33 38.87 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.295 -0.878 . . . . 0.0 109.95 -172.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.597 ' O ' HG23 ' A' ' 35' ' ' THR . 74.9 mm-40 -89.24 12.04 17.12 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.62 -0.675 . . . . 0.0 111.268 172.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 6.3 p 47.48 33.62 2.94 Favored 'General case' 0 N--CA 1.507 2.411 0 O-C-N 121.783 -0.573 . . . . 0.0 112.034 173.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.597 HG23 ' O ' ' A' ' 33' ' ' GLU . 9.1 p -136.56 154.73 50.62 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.458 -0.776 . . . . 0.0 110.432 -173.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.892 HG22 HG23 ' A' ' 29' ' ' VAL . 40.0 pt -142.45 162.03 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.704 -0.622 . . . . 0.0 110.158 177.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.521 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -137.01 127.76 27.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.678 -0.639 . . . . 0.0 109.735 175.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.46 HD23 ' HA ' ' A' ' 26' ' ' LEU . 87.4 mt -109.91 148.04 32.29 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -177.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 95.8 p -119.44 152.93 36.05 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.5 p 45.79 84.29 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 CA-C-O 121.494 0.664 . . . . 0.0 110.271 -172.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.694 HG11 HD12 ' A' ' 65' ' ' ILE . 14.9 p -134.52 151.26 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -178.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -135.97 153.2 51.48 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.629 -0.669 . . . . 0.0 109.947 177.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 84.5 p -107.61 139.34 42.3 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.703 -0.623 . . . . 0.0 109.763 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -82.49 -38.36 23.99 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.626 -0.671 . . . . 0.0 110.941 -173.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.56 169.95 31.75 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 120.032 -1.08 . . . . 0.0 110.417 176.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.808 HG22 HG12 ' A' ' 20' ' ' ILE . 1.1 p -118.08 6.6 12.09 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.906 -0.761 . . . . 0.0 110.886 174.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -48.99 -26.03 2.3 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.649 -0.657 . . . . 0.0 112.504 -167.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -64.98 -59.23 4.39 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.267 -0.896 . . . . 0.0 110.555 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 82.5 mmt-85 -94.35 10.25 35.0 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.655 -0.653 . . . . 0.0 111.335 177.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.8 p-10 -60.15 173.46 0.64 Allowed 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.224 -0.923 . . . . 0.0 111.518 -169.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.3 m -78.92 164.45 24.42 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 173.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -77.33 3.34 13.31 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.596 -0.69 . . . . 0.0 111.309 -178.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -102.12 154.92 18.55 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.242 -0.911 . . . . 0.0 109.637 170.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -67.21 141.09 57.42 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.557 -0.714 . . . . 0.0 110.605 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 81.3 mt -114.91 137.04 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.658 -0.651 . . . . 0.0 109.596 177.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.07 109.97 53.98 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.746 -0.597 . . . . 0.0 110.143 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -67.14 151.19 81.84 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 O-C-N 123.355 1.187 . . . . 0.0 110.345 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -94.03 123.95 37.73 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.691 -0.63 . . . . 0.0 110.245 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.0 m -66.29 -31.5 72.35 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.741 -0.6 . . . . 0.0 110.519 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -61.69 148.49 42.54 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.561 -0.712 . . . . 0.0 110.687 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.2 mm -96.83 156.57 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.743 -0.598 . . . . 0.0 109.767 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -93.45 112.44 24.35 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.677 -0.64 . . . . 0.0 110.171 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -51.17 -43.03 61.2 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.807 -0.558 . . . . 0.0 111.669 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.521 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.7 t80 -152.88 130.27 11.35 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.659 -0.65 . . . . 0.0 110.284 -174.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.694 HD12 HG11 ' A' ' 41' ' ' VAL . 74.9 mt -128.93 128.6 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.66 -0.65 . . . . 0.0 109.859 172.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.0 tp -90.42 137.05 32.66 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.902 -0.498 . . . . 0.0 109.862 176.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.558 ' CD1' HD11 ' A' ' 72' ' ' ILE . 2.9 m-85 -135.45 129.65 33.54 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.645 -0.66 . . . . 0.0 110.546 -175.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -91.26 147.39 23.08 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.684 -0.635 . . . . 0.0 110.239 173.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.89 -26.38 60.56 Favored Glycine 0 N--CA 1.498 2.818 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.0 m -65.87 -39.65 90.91 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.476 -1.014 . . . . 0.0 110.947 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.68 -32.54 31.7 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.462 -0.774 . . . . 0.0 110.858 -174.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.709 HD13 HD21 ' A' ' 14' ' ' LEU . 8.1 mt -102.83 140.85 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.382 -0.824 . . . . 0.0 110.156 177.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -105.04 -21.82 13.21 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.522 -167.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -151.39 134.27 15.75 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 119.068 -1.053 . . . . 0.0 111.368 -177.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.536 HD12 ' CD1' ' A' ' 14' ' ' LEU . 17.6 tt -131.5 140.09 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.882 -0.511 . . . . 0.0 109.739 176.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -146.83 142.83 28.1 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.548 -0.72 . . . . 0.0 110.4 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.4 m -85.03 147.03 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.653 -0.654 . . . . 0.0 110.183 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.9 t -94.95 131.55 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.587 -0.695 . . . . 0.0 109.771 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -122.64 125.12 44.97 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.764 -0.585 . . . . 0.0 110.14 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -99.52 128.83 45.65 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.648 -0.658 . . . . 0.0 110.2 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -120.96 152.86 38.03 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.691 -0.631 . . . . 0.0 110.262 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.7 m -120.87 142.79 49.34 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.695 -0.628 . . . . 0.0 110.14 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.448 ' C ' HD23 ' A' ' 83' ' ' LEU . 5.7 tt -99.93 110.0 57.86 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.751 -0.593 . . . . 0.0 110.124 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo . . . . . 0 N--CA 1.487 1.112 0 O-C-N 123.393 1.207 . . . . 0.0 110.343 179.081 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -107.0 149.91 27.04 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.673 -0.898 . . . . 0.0 110.247 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 90.7 mtp -99.03 165.63 11.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.67 -0.643 . . . . 0.0 110.142 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -99.23 30.11 3.63 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.645 -0.66 . . . . 0.0 110.516 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -117.56 99.5 7.02 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.547 -0.72 . . . . 0.0 110.009 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 t -155.06 33.8 0.39 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.634 -0.666 . . . . 0.0 110.262 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -143.91 112.86 0.71 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.03 -48.32 0.95 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 5' ' ' LEU . 4.6 mm? -79.72 151.68 74.26 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.714 -0.874 . . . . 0.0 109.813 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -67.34 138.97 48.24 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 O-C-N 123.454 1.239 . . . . 0.0 110.361 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -64.88 113.51 3.88 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.695 -0.628 . . . . 0.0 110.503 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.5 mt -64.84 162.34 16.41 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.654 -0.654 . . . . 0.0 110.542 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.72 -1.8 85.02 Favored Glycine 0 N--CA 1.497 2.755 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.727 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.5 m -60.25 152.99 23.46 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.118 -1.225 . . . . 0.0 110.45 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.526 ' HE3' HG11 ' A' ' 78' ' ' VAL . 29.9 pttt -81.13 125.99 30.92 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.738 -0.601 . . . . 0.0 110.387 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.402 HD12 ' HB2' ' A' ' 26' ' ' LEU . 90.2 mt -124.3 143.79 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.547 -0.721 . . . . 0.0 110.129 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.5 t -101.66 137.25 40.22 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 174.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.64 HD21 HD13 ' A' ' 72' ' ' ILE . 15.2 tp -133.9 127.72 33.09 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.694 -0.629 . . . . 0.0 110.282 -169.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 81.9 mt -108.51 121.06 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.455 -0.778 . . . . 0.0 109.683 -178.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 18.3 m -94.51 157.62 15.92 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 120.981 0.42 . . . . 0.0 111.171 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -55.43 -11.5 0.85 Allowed 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -173.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.566 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -90.2 20.54 4.31 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.097 -1.002 . . . . 0.0 110.453 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 54.16 34.2 19.63 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.505 -0.747 . . . . 0.0 109.795 -174.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.803 HG12 HG22 ' A' ' 46' ' ' THR . 66.2 mt -102.6 141.91 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -105.84 119.83 40.16 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.007 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -114.4 148.82 37.12 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 173.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.648 ' O ' HG23 ' A' ' 41' ' ' VAL . 41.4 tt0 -140.09 140.5 36.1 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.37 -0.831 . . . . 0.0 109.504 175.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.53 173.5 43.22 Favored Glycine 0 N--CA 1.496 2.651 0 C-N-CA 119.636 -1.269 . . . . 0.0 110.617 -175.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 39.6 mmm-85 -84.83 134.19 34.3 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.926 -0.75 . . . . 0.0 110.439 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.481 ' HA ' HD23 ' A' ' 38' ' ' LEU . 25.7 tp -66.21 118.62 10.18 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.605 -0.684 . . . . 0.0 110.61 175.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.452 ' O ' HG23 ' A' ' 28' ' ' THR . 23.5 t80 -99.43 -50.19 4.18 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.567 -0.708 . . . . 0.0 110.413 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 27' ' ' TYR . 13.3 p -154.12 154.97 34.53 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.704 -0.622 . . . . 0.0 110.326 -178.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.893 HG23 HG22 ' A' ' 36' ' ' ILE . 13.2 p -142.34 144.95 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.737 -0.602 . . . . 0.0 110.055 -179.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -129.05 102.14 19.18 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.58 -0.7 . . . . 0.0 109.496 177.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.93 -38.04 50.08 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 O-C-N 123.652 1.343 . . . . 0.0 110.814 -174.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -80.42 -27.37 38.05 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.296 -0.878 . . . . 0.0 110.137 -170.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.577 ' O ' HG23 ' A' ' 35' ' ' THR . 49.5 mt-10 -87.85 2.51 51.26 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.512 -0.742 . . . . 0.0 111.28 173.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 55.5 m 49.3 40.02 17.33 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.077 -1.014 . . . . 0.0 111.326 -176.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.577 HG23 ' O ' ' A' ' 33' ' ' GLU . 9.6 p -135.92 153.13 51.53 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.357 -0.839 . . . . 0.0 110.411 -174.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.893 HG22 HG23 ' A' ' 29' ' ' VAL . 40.4 pt -142.63 162.01 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.685 -0.634 . . . . 0.0 110.082 178.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.518 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.42 128.22 29.15 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.655 -0.653 . . . . 0.0 109.741 175.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.481 HD23 ' HA ' ' A' ' 26' ' ' LEU . 88.7 mt -109.92 147.36 33.55 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 99.7 p -117.99 151.77 36.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.619 -0.676 . . . . 0.0 109.24 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.3 p 45.94 85.17 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 CA-C-O 121.574 0.702 . . . . 0.0 110.352 -172.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.697 HG11 HD12 ' A' ' 65' ' ' ILE . 14.3 p -134.66 150.55 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -178.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.508 ' HB3' HD12 ' A' ' 61' ' ' ILE . 14.0 ptm180 -133.38 153.09 51.89 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.6 -0.688 . . . . 0.0 109.941 178.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 84.0 p -110.14 140.01 44.68 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.656 -0.653 . . . . 0.0 109.875 178.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -82.89 -38.46 22.86 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.6 -0.688 . . . . 0.0 110.893 -174.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.59 168.65 30.05 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 176.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.803 HG22 HG12 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -118.13 6.48 12.04 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.863 -0.786 . . . . 0.0 111.03 174.687 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -49.06 -26.49 2.68 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.556 -0.715 . . . . 0.0 112.314 -168.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -66.34 -59.22 3.91 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.348 -0.845 . . . . 0.0 110.35 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -94.25 10.22 34.9 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.66 -0.65 . . . . 0.0 111.354 177.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 49.9 p-10 -58.71 172.91 0.46 Allowed 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.252 -0.905 . . . . 0.0 111.261 -170.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.8 m -78.99 164.44 24.39 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.942 -0.474 . . . . 0.0 109.743 175.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -77.39 2.89 14.61 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.646 -0.659 . . . . 0.0 111.246 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -98.58 165.08 11.98 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.332 -0.855 . . . . 0.0 109.551 170.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -67.88 135.52 52.62 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.51 -0.744 . . . . 0.0 110.439 -175.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 45.5 mm -114.1 132.82 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.726 -0.609 . . . . 0.0 109.58 177.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.03 137.28 29.69 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.717 -0.615 . . . . 0.0 110.136 -178.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -69.81 145.95 58.38 Favored 'Trans proline' 0 N--CA 1.488 1.155 0 O-C-N 123.463 1.244 . . . . 0.0 110.244 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -100.6 115.15 29.5 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.681 -0.637 . . . . 0.0 110.198 178.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 28.6 m -85.24 -33.01 22.3 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.7 -0.625 . . . . 0.0 110.329 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -62.37 143.93 56.4 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.687 -0.633 . . . . 0.0 110.567 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.508 HD12 ' HB3' ' A' ' 42' ' ' ARG . 49.4 mm -96.76 149.96 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.649 -0.657 . . . . 0.0 109.814 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -94.37 115.66 27.9 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.644 -0.66 . . . . 0.0 110.208 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -51.31 -40.97 60.16 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.769 -0.582 . . . . 0.0 111.804 178.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.518 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.8 t80 -153.38 130.51 11.13 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.686 -0.634 . . . . 0.0 110.316 -174.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.697 HD12 HG11 ' A' ' 41' ' ' VAL . 78.3 mt -129.88 129.61 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.659 -0.65 . . . . 0.0 109.895 172.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 24.5 tp -90.42 137.06 32.65 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.862 -0.524 . . . . 0.0 109.898 176.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.532 ' CD1' HD11 ' A' ' 72' ' ' ILE . 2.9 m-85 -135.53 130.29 34.36 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.701 -0.624 . . . . 0.0 110.45 -175.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -91.17 147.53 22.99 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.762 -0.586 . . . . 0.0 110.272 173.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.08 -25.63 60.03 Favored Glycine 0 N--CA 1.499 2.865 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.8 m -65.92 -39.36 90.48 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.46 -1.024 . . . . 0.0 110.898 -178.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -82.36 -32.5 29.23 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.541 -0.725 . . . . 0.0 111.055 -175.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.64 HD13 HD21 ' A' ' 14' ' ' LEU . 10.1 mt -104.84 141.35 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.412 -0.805 . . . . 0.0 110.209 177.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -106.98 -24.19 12.08 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.891 -0.505 . . . . 0.0 111.659 -166.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -150.62 139.15 20.55 Favored 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 119.013 -1.075 . . . . 0.0 111.359 -176.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.472 HD12 HD13 ' A' ' 14' ' ' LEU . 18.2 tt -134.16 143.85 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.996 -0.44 . . . . 0.0 110.023 178.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -143.03 127.19 17.52 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.65 -0.656 . . . . 0.0 110.052 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.5 p -87.7 145.77 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.56 -0.713 . . . . 0.0 110.434 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.526 HG11 ' HE3' ' A' ' 11' ' ' LYS . 60.9 t -97.43 133.45 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.629 -0.669 . . . . 0.0 109.78 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -123.4 122.67 38.86 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.622 -0.674 . . . . 0.0 110.203 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -65.49 -36.83 85.04 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.701 -0.624 . . . . 0.0 110.309 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -113.81 130.9 56.41 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.776 -0.578 . . . . 0.0 110.09 178.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.8 m -126.59 138.58 53.47 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.652 -0.655 . . . . 0.0 110.129 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 40.9 mt -127.78 159.53 65.8 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.724 -0.61 . . . . 0.0 110.199 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo . . . . . 0 N--CA 1.488 1.157 0 O-C-N 123.642 1.338 . . . . 0.0 110.303 179.835 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -67.51 -33.67 75.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.678 -0.896 . . . . 0.0 110.304 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 23.5 ttt -98.6 118.62 35.72 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.657 -0.652 . . . . 0.0 110.265 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -155.08 -60.04 0.11 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.683 -0.636 . . . . 0.0 110.148 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.2 ttp -135.7 152.18 50.91 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.708 -0.62 . . . . 0.0 110.156 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.2 t -109.55 130.0 55.54 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.664 -0.648 . . . . 0.0 110.202 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -155.09 -60.01 0.01 OUTLIER Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.21 36.62 4.2 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 11.9 tp -155.41 87.92 3.14 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.626 -0.926 . . . . 0.0 109.886 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -67.79 95.86 0.42 Allowed 'Trans proline' 0 N--CA 1.487 1.133 0 O-C-N 123.575 1.303 . . . . 0.0 110.407 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -64.81 146.8 54.33 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.552 -0.717 . . . . 0.0 110.473 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.9 mt -64.61 160.26 20.08 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.58 -0.7 . . . . 0.0 110.523 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.65 -1.88 84.59 Favored Glycine 0 N--CA 1.497 2.73 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.808 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.9 m -60.81 153.01 25.6 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 120.997 -1.296 . . . . 0.0 110.445 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.511 ' HE3' HG11 ' A' ' 78' ' ' VAL . 28.5 pttt -82.05 126.92 32.56 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.714 -0.616 . . . . 0.0 110.67 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.688 ' CD1' HD13 ' A' ' 26' ' ' LEU . 86.3 mt -118.6 142.39 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.581 -0.699 . . . . 0.0 109.941 179.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.6 t -103.67 137.34 41.85 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 175.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.815 HD21 HD13 ' A' ' 72' ' ' ILE . 13.7 tp -135.96 127.89 29.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.665 -0.647 . . . . 0.0 110.487 -169.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 79.5 mt -107.17 120.56 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.507 -0.746 . . . . 0.0 109.609 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.0 m -95.15 157.58 15.83 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.027 0.441 . . . . 0.0 111.134 -177.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -56.43 -11.44 1.26 Allowed 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -173.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.77 22.01 3.29 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.124 -0.985 . . . . 0.0 110.348 177.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 57.55 34.48 24.62 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.56 -0.713 . . . . 0.0 110.12 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.697 HG12 HG22 ' A' ' 46' ' ' THR . 42.8 mt -107.27 148.97 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.713 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -107.83 119.71 40.22 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.07 175.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -113.41 154.07 27.56 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 175.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.67 ' O ' HG23 ' A' ' 41' ' ' VAL . 42.3 tt0 -142.83 140.47 31.31 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.596 -0.69 . . . . 0.0 109.521 173.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -164.17 169.77 39.15 Favored Glycine 0 N--CA 1.496 2.657 0 C-N-CA 119.648 -1.263 . . . . 0.0 110.619 -176.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -84.61 137.43 33.29 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.911 -0.758 . . . . 0.0 110.525 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.688 HD13 ' CD1' ' A' ' 12' ' ' ILE . 15.8 tp -66.14 117.55 8.62 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.629 -0.669 . . . . 0.0 110.645 175.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.451 ' O ' HG23 ' A' ' 28' ' ' THR . 20.2 t80 -99.88 -50.15 4.11 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.585 -0.697 . . . . 0.0 110.309 177.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 27' ' ' TYR . 15.2 p -153.7 153.61 32.56 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.709 -0.619 . . . . 0.0 110.233 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.891 HG23 HG22 ' A' ' 36' ' ' ILE . 13.3 p -142.26 145.1 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.709 -0.619 . . . . 0.0 110.096 -178.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -129.04 102.2 19.16 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.669 -0.644 . . . . 0.0 109.477 176.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.71 -39.42 43.28 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 O-C-N 123.575 1.303 . . . . 0.0 110.863 -174.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -80.49 -26.4 38.23 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.339 -0.851 . . . . 0.0 110.152 -170.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.73 ' O ' HG23 ' A' ' 35' ' ' THR . 75.0 mm-40 -87.6 2.13 51.75 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.532 -0.73 . . . . 0.0 111.292 173.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.3 m 49.65 40.16 19.09 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 120.996 -1.065 . . . . 0.0 111.229 -176.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.73 HG23 ' O ' ' A' ' 33' ' ' GLU . 22.3 p -136.54 151.84 49.84 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.383 -0.823 . . . . 0.0 110.397 -174.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.891 HG22 HG23 ' A' ' 29' ' ' VAL . 40.1 pt -142.65 161.97 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.637 -0.664 . . . . 0.0 110.226 177.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.521 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -135.46 127.51 29.75 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.629 -0.669 . . . . 0.0 109.695 175.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 26' ' ' LEU . 83.9 mt -109.99 145.23 37.32 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -177.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.8 p -116.73 152.36 34.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.625 -0.672 . . . . 0.0 109.195 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 44.9 p 45.81 86.43 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.225 0 CA-C-O 121.502 0.668 . . . . 0.0 110.288 -172.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.707 HG11 HD12 ' A' ' 65' ' ' ILE . 12.9 p -134.65 147.73 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -178.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -129.1 153.03 48.05 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.748 -0.595 . . . . 0.0 109.754 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.5 p -107.51 121.81 45.37 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -83.09 -38.53 22.36 Favored 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.964 -169.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.4 -177.51 41.86 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.697 HG22 HG12 ' A' ' 20' ' ' ILE . 66.5 p -118.12 -2.41 11.22 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.794 -0.827 . . . . 0.0 110.645 172.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -54.41 -24.92 21.85 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.379 -0.825 . . . . 0.0 112.528 -162.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -77.07 -59.47 2.77 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.252 -0.905 . . . . 0.0 110.928 -174.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 70.7 mtp85 -94.51 6.15 49.66 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.631 -0.668 . . . . 0.0 112.098 -175.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.8 p-10 -89.32 174.45 7.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.092 -1.005 . . . . 0.0 111.295 -172.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.8 m -78.76 164.47 24.53 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.056 0.455 . . . . 0.0 110.013 178.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -77.66 9.24 3.55 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.743 -0.598 . . . . 0.0 111.71 -176.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -87.98 155.18 19.96 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.098 -1.001 . . . . 0.0 109.948 172.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -67.15 129.94 41.51 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.698 -0.627 . . . . 0.0 110.827 -172.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 82.4 mt -129.0 140.63 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.737 -0.602 . . . . 0.0 109.444 175.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.0 109.84 53.27 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.547 -0.72 . . . . 0.0 110.371 -178.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -77.63 157.07 32.03 Favored 'Trans proline' 0 N--CA 1.486 1.066 0 O-C-N 123.449 1.237 . . . . 0.0 110.432 176.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -114.67 131.22 56.81 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.656 -0.652 . . . . 0.0 110.14 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.6 m -97.06 12.41 32.71 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.69 -0.631 . . . . 0.0 111.333 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -63.62 145.07 56.42 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.308 -0.87 . . . . 0.0 110.564 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.81 128.94 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.613 -0.68 . . . . 0.0 109.863 178.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.512 ' CG ' HD11 ' A' ' 65' ' ' ILE . 22.0 m-85 -98.99 119.53 37.92 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.689 -0.632 . . . . 0.0 110.376 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -51.75 -41.22 61.43 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.715 -0.615 . . . . 0.0 111.252 173.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.521 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.7 t80 -153.98 128.82 9.46 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.686 -0.634 . . . . 0.0 110.103 -175.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.707 HD12 HG11 ' A' ' 41' ' ' VAL . 67.4 mt -126.31 130.33 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.639 -0.663 . . . . 0.0 109.879 172.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.5 tp -89.94 137.06 32.65 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.838 -0.539 . . . . 0.0 109.686 175.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.648 ' CD1' HD11 ' A' ' 72' ' ' ILE . 3.3 m-85 -133.8 126.5 30.71 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.706 -0.621 . . . . 0.0 110.55 -175.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -92.71 149.95 20.99 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.689 -0.632 . . . . 0.0 110.305 172.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.83 -24.01 57.02 Favored Glycine 0 N--CA 1.498 2.821 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 177.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.0 p -68.32 -42.05 79.94 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.409 -1.053 . . . . 0.0 111.115 -176.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -82.98 -29.38 29.04 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.331 -0.856 . . . . 0.0 111.028 -175.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.815 HD13 HD21 ' A' ' 14' ' ' LEU . 15.4 mt -103.74 140.7 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.416 -0.802 . . . . 0.0 110.255 176.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -105.74 -19.83 13.64 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.912 -0.492 . . . . 0.0 111.552 -168.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -149.98 131.55 14.86 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 119.046 -1.062 . . . . 0.0 111.319 -178.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.7 tt -129.88 138.81 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.979 -0.451 . . . . 0.0 109.809 176.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 90.6 mtt-85 -146.89 137.94 23.99 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.543 -0.723 . . . . 0.0 110.421 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.6 t -87.17 143.76 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.658 -0.652 . . . . 0.0 109.693 178.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.511 HG11 ' HE3' ' A' ' 11' ' ' LYS . 55.9 t -94.63 134.61 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.541 -0.724 . . . . 0.0 109.885 -178.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -121.16 156.94 31.27 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.706 -0.621 . . . . 0.0 110.134 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -96.75 135.42 38.72 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.733 -0.604 . . . . 0.0 110.225 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -124.92 148.2 48.46 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.695 -0.628 . . . . 0.0 110.191 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.2 p -121.23 161.18 22.36 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.671 -0.643 . . . . 0.0 110.271 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.519 ' N ' HD23 ' A' ' 83' ' ' LEU . 0.8 OUTLIER -146.41 159.81 43.88 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.695 -0.628 . . . . 0.0 110.351 -179.873 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo . . . . . 0 N--CA 1.488 1.177 0 O-C-N 123.623 1.328 . . . . 0.0 110.299 179.883 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -134.08 150.36 51.17 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.754 -0.851 . . . . 0.0 110.172 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 65.4 mtt -128.62 158.38 38.66 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.661 -0.649 . . . . 0.0 110.224 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -95.29 125.91 40.24 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.635 -0.666 . . . . 0.0 110.109 178.579 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 ttp -146.32 36.65 1.0 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.611 -0.681 . . . . 0.0 110.097 -179.359 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 97.8 p -112.95 151.97 29.91 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.625 -0.672 . . . . 0.0 110.201 -179.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -102.56 -48.22 1.32 Allowed Glycine 0 N--CA 1.495 2.586 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.678 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -131.42 158.68 22.86 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.439 HD13 ' HA ' ' A' ' 5' ' ' LEU . 3.5 mm? -78.6 -57.49 0.84 Allowed Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.674 -0.898 . . . . 0.0 110.695 -179.588 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -71.44 136.48 28.74 Favored 'Trans proline' 0 N--CA 1.488 1.161 0 O-C-N 123.23 1.121 . . . . 0.0 110.367 -176.329 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -64.78 126.31 27.54 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.676 -0.64 . . . . 0.0 110.519 179.174 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.78 136.48 56.95 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.689 -0.632 . . . . 0.0 110.902 -178.715 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.57 -2.37 82.78 Favored Glycine 0 N--CA 1.497 2.765 0 C-N-CA 120.699 -0.763 . . . . 0.0 111.944 175.196 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.1 m -64.29 150.62 45.71 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.168 -1.195 . . . . 0.0 110.389 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -81.42 127.84 33.22 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.623 -0.673 . . . . 0.0 110.052 175.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.636 ' CD1' HD13 ' A' ' 26' ' ' LEU . 88.4 mt -125.12 143.92 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.435 -0.791 . . . . 0.0 110.299 -178.317 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.6 t -102.19 137.28 40.66 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 173.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.467 ' CD1' HD12 ' A' ' 75' ' ' ILE . 12.6 tp -134.66 130.6 36.61 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.675 -0.641 . . . . 0.0 110.292 -170.183 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.2 mt -107.12 121.49 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.508 -0.745 . . . . 0.0 109.743 -178.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.6 m -93.95 157.86 15.91 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.033 0.444 . . . . 0.0 111.23 -178.129 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -53.35 -15.41 0.99 Allowed 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -171.045 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.497 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -90.17 20.65 4.21 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.148 -0.97 . . . . 0.0 110.433 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 54.1 34.98 21.2 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.446 -0.784 . . . . 0.0 109.805 -174.511 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.864 HG12 HG22 ' A' ' 46' ' ' THR . 69.8 mt -102.89 143.1 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.21 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -103.77 119.83 39.72 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.159 -178.614 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -113.7 149.7 34.36 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 175.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.63 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.3 mt-10 -141.17 140.6 34.08 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.418 -0.801 . . . . 0.0 109.815 175.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.35 172.84 43.04 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 119.716 -1.231 . . . . 0.0 110.529 -175.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 80.8 mtt85 -86.0 135.91 33.46 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.888 -0.772 . . . . 0.0 110.62 179.05 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.636 HD13 ' CD1' ' A' ' 12' ' ' ILE . 13.6 tp -66.17 118.0 9.27 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.605 -0.684 . . . . 0.0 110.663 176.6 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.462 ' O ' HG23 ' A' ' 28' ' ' THR . 28.8 t80 -100.24 -50.14 4.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.627 -0.67 . . . . 0.0 110.55 179.093 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 27' ' ' TYR . 11.7 p -154.63 155.61 34.99 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.603 -0.686 . . . . 0.0 110.382 -178.024 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.842 HG23 HG22 ' A' ' 36' ' ' ILE . 13.2 p -142.31 145.92 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.744 -0.597 . . . . 0.0 110.009 -179.425 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -128.92 100.26 21.2 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.603 -0.686 . . . . 0.0 109.503 177.581 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.58 -37.16 60.09 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 O-C-N 123.599 1.315 . . . . 0.0 110.793 -175.17 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -80.07 -27.98 39.26 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.379 -0.826 . . . . 0.0 110.061 -171.251 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.577 ' O ' HG23 ' A' ' 35' ' ' THR . 77.8 mt-10 -88.23 2.6 51.92 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.545 -0.722 . . . . 0.0 111.235 174.011 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 39.0 m 49.44 40.66 19.41 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.007 -1.058 . . . . 0.0 111.198 -175.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.577 HG23 ' O ' ' A' ' 33' ' ' GLU . 11.2 p -135.73 154.49 51.23 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.436 -0.79 . . . . 0.0 110.381 -175.166 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.842 HG22 HG23 ' A' ' 29' ' ' VAL . 40.0 pt -141.94 162.03 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.718 -0.614 . . . . 0.0 110.142 177.675 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.514 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.9 128.37 28.43 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.695 -0.628 . . . . 0.0 109.802 175.482 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 26' ' ' LEU . 85.0 mt -109.81 147.01 34.06 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -178.536 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 87.6 p -115.71 150.12 37.33 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -177.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 52.5 p 45.73 85.36 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 121.504 0.668 . . . . 0.0 110.29 -172.657 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.709 ' CG1' HD12 ' A' ' 65' ' ' ILE . 15.0 p -134.64 152.33 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -178.787 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -136.39 153.09 51.2 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.503 -0.748 . . . . 0.0 110.236 179.037 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.6 p -109.69 136.3 49.25 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.764 -0.585 . . . . 0.0 109.637 176.576 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -83.04 -38.59 22.36 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.537 -0.727 . . . . 0.0 111.19 -172.533 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.4 174.94 36.93 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.912 -1.137 . . . . 0.0 110.515 176.195 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.864 HG22 HG12 ' A' ' 20' ' ' ILE . 7.4 p -116.75 6.53 13.26 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.834 -0.804 . . . . 0.0 110.528 169.645 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -52.35 -24.56 7.82 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.615 -0.678 . . . . 0.0 112.597 -166.451 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -64.14 -59.43 4.45 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.154 -0.966 . . . . 0.0 110.604 -176.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 39.6 mtp85 -94.54 10.2 35.61 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.55 -0.719 . . . . 0.0 111.393 176.512 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.5 p-10 -58.91 172.29 0.57 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.234 -0.916 . . . . 0.0 111.552 -169.161 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.8 m -85.0 164.49 18.23 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 174.717 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -77.47 3.81 12.55 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.642 -0.661 . . . . 0.0 111.287 -179.364 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -95.17 157.48 15.88 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.247 -0.908 . . . . 0.0 109.683 168.873 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -70.52 139.25 51.54 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.645 -0.659 . . . . 0.0 110.538 -176.004 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.7 mt -115.36 136.23 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.725 -0.61 . . . . 0.0 109.556 176.76 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.11 113.08 12.87 Favored Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 121.707 -0.621 . . . . 0.0 110.138 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -66.93 143.76 67.67 Favored 'Trans proline' 0 N--CA 1.488 1.188 0 O-C-N 123.389 1.205 . . . . 0.0 110.392 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -97.82 114.7 26.8 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.72 -0.612 . . . . 0.0 110.216 -179.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.6 t -101.54 -32.95 10.13 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.721 -0.612 . . . . 0.0 110.306 179.457 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -62.24 151.49 36.13 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.627 -0.671 . . . . 0.0 110.634 -178.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.2 mm -96.81 142.71 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.808 -0.557 . . . . 0.0 109.79 179.672 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -94.82 118.09 31.2 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.613 -0.679 . . . . 0.0 110.137 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -51.14 -42.36 60.7 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.859 -0.525 . . . . 0.0 111.732 178.618 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.514 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.0 t80 -152.7 130.88 11.95 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.609 -0.682 . . . . 0.0 110.182 -174.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.709 HD12 ' CG1' ' A' ' 41' ' ' VAL . 75.5 mt -129.73 127.45 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.625 -0.672 . . . . 0.0 109.859 172.148 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 23.9 tp -90.2 137.1 32.62 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.817 -0.552 . . . . 0.0 109.741 175.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.425 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 3.6 m-85 -136.57 131.16 33.43 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.629 -0.67 . . . . 0.0 110.6 -175.691 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -90.71 149.18 22.15 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.781 -0.575 . . . . 0.0 110.187 174.741 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.26 -25.06 59.69 Favored Glycine 0 N--CA 1.5 2.912 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 178.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.9 m -65.91 -40.55 91.6 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.412 -1.052 . . . . 0.0 110.885 -178.432 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.95 -34.42 29.8 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.631 -0.668 . . . . 0.0 110.929 -174.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.425 ' CD1' ' CD1' ' A' ' 67' ' ' PHE . 13.9 mt -105.94 140.26 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.429 -0.794 . . . . 0.0 110.11 177.617 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 47.8 tttm -107.27 -24.62 11.82 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.839 -164.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -149.12 140.78 23.5 Favored 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.548 -174.414 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.467 HD12 ' CD1' ' A' ' 14' ' ' LEU . 15.4 tt -134.09 147.81 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.939 -0.475 . . . . 0.0 110.106 179.567 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -147.02 129.75 16.1 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.597 -0.69 . . . . 0.0 110.287 176.59 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.41 HG22 HG12 ' A' ' 12' ' ' ILE . 51.4 t -87.4 146.05 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.657 -0.652 . . . . 0.0 109.83 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 50.2 t -93.4 125.38 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.573 -0.704 . . . . 0.0 109.711 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -154.96 -179.75 8.35 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.682 -0.636 . . . . 0.0 110.345 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -142.95 175.15 10.06 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.706 -0.621 . . . . 0.0 110.287 179.149 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 31.7 t60 -116.02 129.48 56.38 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.653 -0.654 . . . . 0.0 110.099 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.5 p -100.79 158.95 15.58 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.719 -0.613 . . . . 0.0 110.323 -178.531 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.9 tt -153.81 109.95 2.52 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.696 -0.627 . . . . 0.0 110.158 179.453 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo . . . . . 0 N--CA 1.487 1.117 0 O-C-N 123.445 1.234 . . . . 0.0 110.309 179.144 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -104.63 145.67 30.0 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.73 -0.865 . . . . 0.0 110.19 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 57.3 ttp -96.98 123.52 40.72 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.738 -0.601 . . . . 0.0 110.213 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -150.65 159.22 44.66 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.695 -0.628 . . . . 0.0 110.256 -179.652 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptm -125.15 159.23 31.99 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.675 -0.641 . . . . 0.0 110.222 179.6 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.4 t -111.63 139.79 46.78 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.682 -0.637 . . . . 0.0 110.223 -179.537 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -89.18 -176.22 46.31 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -147.33 59.26 0.47 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.777 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 28.7 mt -79.75 156.92 74.9 Favored Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 121.661 -0.905 . . . . 0.0 110.268 -179.499 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -66.95 155.69 69.68 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.711 1.374 . . . . 0.0 110.39 179.864 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -64.83 98.26 0.27 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.661 -0.649 . . . . 0.0 110.452 -179.729 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.5 mt -64.79 155.53 33.58 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.749 -0.594 . . . . 0.0 110.675 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.7 -1.96 84.46 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.826 177.287 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.7 m -61.99 136.34 57.92 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.13 -1.218 . . . . 0.0 110.405 179.283 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.485 ' HE3' HG11 ' A' ' 78' ' ' VAL . 31.3 pttt -81.83 126.4 31.82 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.655 -0.653 . . . . 0.0 110.475 179.761 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.409 HD12 ' HB2' ' A' ' 26' ' ' LEU . 92.7 mt -124.84 145.07 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.523 -0.736 . . . . 0.0 110.203 179.501 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.8 t -102.8 137.26 41.25 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.582 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.634 HD21 HD13 ' A' ' 72' ' ' ILE . 17.3 tp -134.9 126.76 29.36 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.788 -0.57 . . . . 0.0 110.282 -168.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 81.3 mt -108.74 120.91 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.557 -0.714 . . . . 0.0 109.697 -178.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.2 m -93.54 157.78 16.03 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.146 0.498 . . . . 0.0 111.216 -176.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -54.27 -13.77 0.97 Allowed 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -172.159 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.45 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.19 20.03 3.96 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.147 -0.97 . . . . 0.0 110.436 179.081 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 55.64 35.78 25.9 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.503 -0.748 . . . . 0.0 109.821 -176.241 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.828 HG12 HG22 ' A' ' 46' ' ' THR . 60.6 mt -105.81 145.63 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -105.4 119.82 40.05 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.25 -179.313 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -114.53 151.04 33.98 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 174.843 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.648 ' O ' HG23 ' A' ' 41' ' ' VAL . 65.1 mt-10 -142.29 140.64 32.25 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.35 -0.844 . . . . 0.0 109.818 174.354 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.22 173.08 43.01 Favored Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.526 -175.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 56.4 mtm180 -85.71 136.03 33.52 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.867 -0.784 . . . . 0.0 110.573 179.164 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.492 ' HA ' HD23 ' A' ' 38' ' ' LEU . 28.0 tp -66.17 119.99 12.43 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.62 -0.675 . . . . 0.0 110.738 175.343 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.439 ' O ' HG23 ' A' ' 28' ' ' THR . 27.4 t80 -99.68 -50.03 4.19 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.764 -0.585 . . . . 0.0 110.347 177.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 27' ' ' TYR . 16.2 p -153.98 155.58 35.85 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.642 -0.661 . . . . 0.0 110.233 -178.39 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.848 HG23 HG22 ' A' ' 36' ' ' ILE . 13.5 p -142.31 145.56 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.654 -0.654 . . . . 0.0 110.093 -178.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -127.33 98.62 29.04 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.65 -0.656 . . . . 0.0 109.602 177.645 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -59.3 -42.39 50.01 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 O-C-N 123.636 1.335 . . . . 0.0 111.03 -175.763 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -80.63 -25.14 38.55 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.405 -0.809 . . . . 0.0 110.199 -171.13 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.567 ' O ' HG23 ' A' ' 35' ' ' THR . 55.1 mt-10 -87.33 1.67 52.57 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.438 -0.789 . . . . 0.0 111.18 173.605 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 38.7 m 49.87 38.55 16.25 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 121.13 -0.981 . . . . 0.0 111.226 -177.009 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.567 HG23 ' O ' ' A' ' 33' ' ' GLU . 10.6 p -135.77 154.28 51.27 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.394 -0.816 . . . . 0.0 110.407 -175.128 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.848 HG22 HG23 ' A' ' 29' ' ' VAL . 39.9 pt -143.1 161.87 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.638 -0.664 . . . . 0.0 110.204 178.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.506 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.9 127.93 27.69 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.652 -0.655 . . . . 0.0 109.692 175.524 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 26' ' ' LEU . 87.4 mt -109.91 147.78 32.79 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -177.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 91.8 p -118.33 151.43 37.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.641 -0.662 . . . . 0.0 109.226 -177.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 44.1 p 45.63 83.66 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 121.543 0.687 . . . . 0.0 110.376 -172.197 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.692 ' CG1' HD12 ' A' ' 65' ' ' ILE . 14.3 p -134.63 150.53 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.406 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -136.36 153.19 51.19 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.638 -0.663 . . . . 0.0 110.128 178.554 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.0 p -108.4 137.16 46.83 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.736 -0.602 . . . . 0.0 109.546 177.307 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -83.01 -38.57 22.44 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 119.833 -0.747 . . . . 0.0 111.063 -172.017 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.32 167.55 28.16 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 175.614 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.828 HG22 HG12 ' A' ' 20' ' ' ILE . 50.2 p -118.3 -13.84 9.83 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.875 -0.779 . . . . 0.0 110.84 171.289 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -52.52 -24.59 8.38 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.398 -0.814 . . . . 0.0 112.482 -165.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -78.22 -59.36 2.81 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.287 -0.883 . . . . 0.0 110.836 -176.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -94.55 10.12 35.91 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.52 -0.738 . . . . 0.0 111.956 -174.668 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.9 p-10 -93.18 174.6 7.14 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.056 -1.028 . . . . 0.0 111.19 -174.584 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.4 m -78.48 164.58 24.62 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.967 -0.458 . . . . 0.0 109.783 177.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -77.49 11.78 1.87 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.662 -0.649 . . . . 0.0 111.671 -174.015 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -91.32 143.36 26.72 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.121 -0.987 . . . . 0.0 109.73 170.07 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -66.04 140.21 58.25 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.712 -0.618 . . . . 0.0 110.953 -171.013 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 83.9 mt -120.88 142.02 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 176.417 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.3 112.81 10.15 Favored Pre-proline 0 N--CA 1.501 2.084 0 O-C-N 121.628 -0.67 . . . . 0.0 110.204 -179.492 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -63.8 141.89 80.4 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 O-C-N 123.345 1.181 . . . . 0.0 110.614 -179.271 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -107.9 107.16 17.75 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.655 -0.653 . . . . 0.0 110.199 179.431 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.2 t -103.36 -34.87 8.6 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.713 -0.617 . . . . 0.0 110.2 179.47 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -62.84 157.45 21.37 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.674 -0.641 . . . . 0.0 110.611 -179.479 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.8 mm -96.75 136.98 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.698 -0.626 . . . . 0.0 109.686 179.071 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -96.05 117.2 30.21 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.62 -0.675 . . . . 0.0 110.356 -178.2 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -51.23 -40.46 58.84 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.827 -0.546 . . . . 0.0 111.629 177.229 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.506 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.6 t80 -152.33 130.2 11.71 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.615 -0.678 . . . . 0.0 110.35 -174.471 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.692 HD12 ' CG1' ' A' ' 41' ' ' VAL . 77.2 mt -129.66 126.68 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.671 -0.643 . . . . 0.0 109.798 171.527 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 19.2 tp -90.57 137.13 32.6 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.77 -0.581 . . . . 0.0 109.841 176.226 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.484 ' CD1' HD11 ' A' ' 72' ' ' ILE . 4.6 m-85 -137.07 132.58 34.35 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.653 -0.655 . . . . 0.0 110.585 -175.281 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -90.69 148.13 22.81 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.71 -0.619 . . . . 0.0 110.269 173.579 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.21 -25.65 60.35 Favored Glycine 0 N--CA 1.499 2.854 0 N-CA-C 110.521 -1.031 . . . . 0.0 110.521 179.363 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.4 p -67.41 -38.26 84.36 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.419 -1.048 . . . . 0.0 110.842 -177.45 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -82.48 -32.57 28.79 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.432 -0.792 . . . . 0.0 110.841 -175.394 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.634 HD13 HD21 ' A' ' 14' ' ' LEU . 10.6 mt -106.41 134.19 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.496 -0.752 . . . . 0.0 109.923 176.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.4 tttp -108.75 -10.98 15.11 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 120.485 -0.486 . . . . 0.0 112.077 -166.68 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -147.8 129.63 15.22 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.876 -1.14 . . . . 0.0 111.155 -179.641 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.48 HD12 ' CD1' ' A' ' 14' ' ' LEU . 18.1 tt -137.96 139.48 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.958 -0.464 . . . . 0.0 110.017 178.197 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 82.5 mtm-85 -147.12 136.86 23.04 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.54 -0.725 . . . . 0.0 110.51 176.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.3 p -87.13 147.04 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.688 -0.632 . . . . 0.0 110.1 177.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.485 HG11 ' HE3' ' A' ' 11' ' ' LYS . 61.4 t -94.76 131.69 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.624 -0.673 . . . . 0.0 109.772 -178.835 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -143.61 106.82 4.54 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.675 -0.641 . . . . 0.0 110.214 179.695 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -103.3 106.56 17.11 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.684 -0.635 . . . . 0.0 110.187 179.413 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -67.97 -47.94 67.21 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.699 -0.626 . . . . 0.0 110.239 -179.676 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.9 t -142.03 160.46 40.17 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.678 -0.639 . . . . 0.0 110.44 -179.486 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.2 tp -97.06 139.49 21.55 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.681 -0.637 . . . . 0.0 110.005 179.341 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo . . . . . 0 N--CA 1.489 1.236 0 O-C-N 123.452 1.238 . . . . 0.0 110.362 179.848 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -67.38 -34.46 77.32 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.642 -0.917 . . . . 0.0 110.298 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 57.7 ttp -101.3 114.78 29.07 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.776 -0.577 . . . . 0.0 110.205 179.737 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -109.12 139.29 44.21 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.617 -0.677 . . . . 0.0 110.204 179.574 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.2 mtm -110.94 28.78 8.38 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.733 -0.605 . . . . 0.0 110.514 179.594 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.3 m -105.44 29.62 6.35 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.487 -0.758 . . . . 0.0 110.57 -179.259 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -143.08 165.87 26.85 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.472 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -154.96 -178.78 29.59 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.617 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 35.4 mt -79.86 151.22 73.4 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.694 -0.886 . . . . 0.0 110.067 179.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -68.57 135.26 32.9 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 O-C-N 123.583 1.307 . . . . 0.0 110.345 -179.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -64.9 114.0 4.23 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.592 -0.693 . . . . 0.0 110.465 179.28 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.3 mt -64.82 144.46 57.24 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.644 -0.66 . . . . 0.0 110.683 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.71 -1.96 84.49 Favored Glycine 0 N--CA 1.496 2.682 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.809 177.712 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 74.8 m -62.38 142.73 57.68 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.09 -1.241 . . . . 0.0 110.477 179.679 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -82.03 126.81 32.42 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.693 -0.63 . . . . 0.0 110.386 178.289 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 90.5 mt -123.97 145.02 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.584 -0.697 . . . . 0.0 110.148 -179.725 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.6 t -103.33 137.29 41.65 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 176.12 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.663 HD21 HD13 ' A' ' 72' ' ' ILE . 14.5 tp -133.23 123.18 25.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.776 -0.578 . . . . 0.0 110.263 -169.662 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.604 ' O ' HG23 ' A' ' 72' ' ' ILE . 79.8 mt -106.31 116.87 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.427 -0.796 . . . . 0.0 109.711 -178.801 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.5 m -92.83 157.71 16.25 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 120.955 0.407 . . . . 0.0 111.231 -177.101 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -54.61 -11.81 0.63 Allowed 'General case' 0 N--CA 1.509 2.49 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -171.608 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.519 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -90.22 20.0 4.69 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.083 -1.01 . . . . 0.0 110.45 179.386 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 54.66 33.52 19.49 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.52 -0.738 . . . . 0.0 109.853 -174.285 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.857 HG12 HG22 ' A' ' 46' ' ' THR . 65.7 mt -102.52 140.93 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.441 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -104.83 119.77 39.8 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.994 -0.683 . . . . 0.0 109.939 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -114.25 149.43 35.87 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 174.403 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.669 ' O ' HG23 ' A' ' 41' ' ' VAL . 42.2 tt0 -140.34 140.46 35.6 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.584 -0.698 . . . . 0.0 109.54 175.154 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.4 172.65 42.4 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.624 -175.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -85.38 135.61 33.81 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.956 -0.732 . . . . 0.0 110.504 179.097 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.486 ' HA ' HD23 ' A' ' 38' ' ' LEU . 27.8 tp -66.14 120.82 13.87 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.597 -0.689 . . . . 0.0 110.663 176.13 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.433 ' O ' HG23 ' A' ' 28' ' ' THR . 21.6 t80 -99.19 -49.96 4.3 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.666 -0.646 . . . . 0.0 110.257 178.194 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 27' ' ' TYR . 17.0 p -153.38 156.77 38.9 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.742 -0.599 . . . . 0.0 110.068 -179.162 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.889 HG23 HG22 ' A' ' 36' ' ' ILE . 13.6 p -142.25 145.9 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.658 -0.651 . . . . 0.0 110.227 -177.795 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -128.26 101.49 21.96 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.609 -0.682 . . . . 0.0 109.507 177.022 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.38 -41.2 34.89 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 O-C-N 123.579 1.305 . . . . 0.0 110.839 -174.459 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -80.7 -24.57 38.75 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.283 -0.886 . . . . 0.0 110.203 -171.732 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.742 ' O ' HG23 ' A' ' 35' ' ' THR . 54.8 mt-10 -87.31 1.31 53.63 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.474 -0.767 . . . . 0.0 111.262 173.463 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.9 m 49.86 38.14 15.21 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.042 -1.036 . . . . 0.0 111.276 -176.698 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.742 HG23 ' O ' ' A' ' 33' ' ' GLU . 21.6 p -136.45 153.52 51.03 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.477 -0.764 . . . . 0.0 110.377 -174.27 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.889 HG22 HG23 ' A' ' 29' ' ' VAL . 39.8 pt -142.34 162.06 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.711 -0.618 . . . . 0.0 110.182 177.707 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.526 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -133.68 127.7 33.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.659 -0.651 . . . . 0.0 109.62 176.011 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 26' ' ' LEU . 88.7 mt -109.94 149.45 29.9 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -176.481 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 91.8 p -123.1 154.33 38.73 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.134 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.5 p 45.41 83.76 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 121.492 0.663 . . . . 0.0 110.375 -171.805 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.718 HG11 HD12 ' A' ' 65' ' ' ILE . 14.4 p -134.55 149.74 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -178.537 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -134.84 153.21 52.13 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.622 -0.674 . . . . 0.0 109.982 178.766 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.2 p -107.32 138.55 43.3 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.671 -0.643 . . . . 0.0 109.894 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -83.07 -38.28 22.73 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.648 -0.658 . . . . 0.0 110.905 -174.282 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.74 170.32 32.37 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 178.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.857 HG22 HG12 ' A' ' 20' ' ' ILE . 1.8 p -118.03 6.75 12.14 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.909 -0.759 . . . . 0.0 111.173 177.451 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -48.89 -23.87 1.26 Allowed 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.471 -0.768 . . . . 0.0 112.694 -169.552 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -54.3 -45.56 72.59 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.235 -0.915 . . . . 0.0 111.344 -179.396 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 75.4 mtp180 -94.14 -58.08 2.34 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.432 -0.792 . . . . 0.0 110.766 -179.788 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.45 ' OD1' HD11 ' A' ' 55' ' ' ILE . 2.9 p30 -67.35 174.88 3.01 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.727 -0.608 . . . . 0.0 110.378 -178.67 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.7 p -78.13 164.41 25.0 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.694 -0.629 . . . . 0.0 110.664 -170.664 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -77.52 1.68 18.65 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.413 -177.746 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -72.53 161.17 31.14 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.171 -0.956 . . . . 0.0 109.811 176.4 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -65.94 130.24 42.58 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.625 -0.672 . . . . 0.0 111.017 -168.179 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.45 HD11 ' OD1' ' A' ' 50' ' ' ASP . 82.2 mt -114.92 136.67 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 173.521 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.03 112.49 7.59 Favored Pre-proline 0 N--CA 1.501 2.122 0 O-C-N 121.581 -0.7 . . . . 0.0 110.54 -174.628 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -79.67 151.25 22.02 Favored 'Trans proline' 0 N--CA 1.485 1.021 0 O-C-N 123.403 1.212 . . . . 0.0 110.261 179.171 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -101.75 114.19 28.04 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.662 -0.649 . . . . 0.0 110.053 177.435 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.2 m -66.38 -32.65 74.17 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.698 -0.626 . . . . 0.0 110.492 -178.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -62.15 143.29 56.93 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.602 -0.686 . . . . 0.0 110.724 -178.238 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.9 mm -96.76 158.9 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.798 -0.564 . . . . 0.0 109.703 179.008 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -93.4 112.5 24.42 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.598 -0.689 . . . . 0.0 110.138 -178.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -51.57 -42.32 61.78 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.78 -0.575 . . . . 0.0 111.629 177.199 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.526 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.5 t80 -153.09 128.78 10.11 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.594 -0.691 . . . . 0.0 110.365 -174.018 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.718 HD12 HG11 ' A' ' 41' ' ' VAL . 71.1 mt -128.34 133.48 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.693 -0.63 . . . . 0.0 109.939 172.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 27.1 tp -90.35 137.06 32.66 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.866 -0.521 . . . . 0.0 109.971 176.107 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.919 ' CD1' HD11 ' A' ' 72' ' ' ILE . 2.2 m-85 -133.61 124.43 26.82 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.686 -0.634 . . . . 0.0 110.673 -176.622 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 73.6 mtt85 -92.96 145.98 23.97 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.696 -0.628 . . . . 0.0 110.358 172.358 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.73 -24.69 62.6 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 179.532 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.6 m -67.9 -42.24 81.47 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.413 -1.051 . . . . 0.0 111.199 -173.799 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -85.46 -24.19 27.52 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.328 -0.858 . . . . 0.0 111.128 -175.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.919 HD11 ' CD1' ' A' ' 67' ' ' PHE . 86.7 mt -96.65 143.03 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.236 -0.915 . . . . 0.0 110.165 173.556 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -104.02 -20.85 13.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.984 -0.447 . . . . 0.0 111.304 -170.412 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -152.87 131.88 12.59 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 119.147 -1.021 . . . . 0.0 111.297 -179.414 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.56 HD12 ' CD1' ' A' ' 14' ' ' LEU . 17.5 tt -131.53 138.53 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 175.292 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -146.81 131.28 17.68 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.663 -0.648 . . . . 0.0 110.423 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.2 p -87.99 147.08 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.61 -0.681 . . . . 0.0 110.171 177.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.2 t -94.84 133.85 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.57 -0.706 . . . . 0.0 109.737 -179.703 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -139.48 -41.75 0.45 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.658 -0.652 . . . . 0.0 111.0 -179.458 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -134.7 30.29 3.45 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.408 -0.808 . . . . 0.0 110.622 -178.249 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -153.16 157.06 39.75 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.592 -0.693 . . . . 0.0 110.311 179.099 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.4 p -125.03 163.17 22.94 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.608 -0.683 . . . . 0.0 110.223 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.3 tt -107.55 109.9 62.66 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.704 -0.622 . . . . 0.0 110.144 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo . . . . . 0 N--CA 1.489 1.222 0 O-C-N 123.405 1.213 . . . . 0.0 110.361 179.159 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -92.91 118.67 31.4 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.704 -0.88 . . . . 0.0 110.209 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 90.3 mtp -66.75 -37.77 85.3 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.586 -0.696 . . . . 0.0 110.266 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -154.5 155.71 35.37 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.711 -0.618 . . . . 0.0 110.241 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.2 ttp -147.71 -57.64 0.25 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.741 -0.6 . . . . 0.0 110.192 179.449 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.5 m -66.16 -34.27 77.67 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.705 -0.622 . . . . 0.0 110.347 -179.814 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.06 -40.85 93.12 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.215 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.18 152.1 20.75 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.847 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 12.0 tp -155.39 58.16 1.82 Allowed Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.709 -0.877 . . . . 0.0 110.035 179.682 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -68.77 127.83 16.0 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 O-C-N 123.477 1.251 . . . . 0.0 110.27 179.374 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -64.89 112.99 3.53 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.669 -0.645 . . . . 0.0 110.503 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.8 mt -64.87 147.35 53.47 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.628 -0.67 . . . . 0.0 110.529 178.75 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.58 -1.88 84.4 Favored Glycine 0 N--CA 1.497 2.741 0 C-N-CA 120.453 -0.88 . . . . 0.0 111.815 177.653 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 71.5 m -61.35 148.58 40.93 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.155 -1.203 . . . . 0.0 110.44 -179.086 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -82.21 127.45 33.19 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.491 179.588 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.683 ' CD1' HD13 ' A' ' 26' ' ' LEU . 89.1 mt -121.78 144.5 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.588 -0.695 . . . . 0.0 109.944 179.01 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.0 t -103.05 137.32 41.38 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 175.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.756 ' HG ' HG21 ' A' ' 72' ' ' ILE . 11.5 tp -133.32 123.3 25.2 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.792 -0.568 . . . . 0.0 110.002 -171.246 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.708 ' O ' HG23 ' A' ' 72' ' ' ILE . 82.2 mt -103.98 119.17 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.522 -0.736 . . . . 0.0 109.683 -177.707 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.1 m -94.32 157.93 15.81 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.137 0.494 . . . . 0.0 111.46 -175.525 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -53.72 -14.6 0.95 Allowed 'General case' 0 N--CA 1.507 2.385 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -171.363 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.462 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -89.68 20.39 4.07 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.221 -0.924 . . . . 0.0 110.459 179.475 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 55.53 35.42 25.11 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.486 -0.759 . . . . 0.0 109.93 -176.137 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.838 HG12 HG22 ' A' ' 46' ' ' THR . 60.9 mt -105.31 145.3 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 55.5 ttt85 -105.73 119.8 40.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.624 -0.673 . . . . 0.0 110.15 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -113.68 150.68 32.89 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.682 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.658 ' O ' HG23 ' A' ' 41' ' ' VAL . 36.1 mt-10 -141.36 140.55 33.76 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.437 -0.79 . . . . 0.0 109.776 174.883 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.61 172.49 41.12 Favored Glycine 0 N--CA 1.495 2.623 0 C-N-CA 119.875 -1.155 . . . . 0.0 110.451 -175.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -84.3 138.75 32.74 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.919 -0.753 . . . . 0.0 110.545 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.683 HD13 ' CD1' ' A' ' 12' ' ' ILE . 17.0 tp -66.15 117.68 8.8 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.628 -0.67 . . . . 0.0 110.685 175.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.457 ' O ' HG23 ' A' ' 28' ' ' THR . 28.7 t80 -100.09 -50.08 4.09 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.596 -0.69 . . . . 0.0 110.437 177.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 27' ' ' TYR . 15.2 p -154.19 154.83 34.18 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.648 -0.658 . . . . 0.0 110.317 -178.185 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.839 HG23 HG22 ' A' ' 36' ' ' ILE . 13.5 p -142.19 145.6 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.707 -0.62 . . . . 0.0 110.054 -179.347 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -129.02 98.19 24.56 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.643 -0.661 . . . . 0.0 109.504 177.355 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -59.64 -40.34 65.99 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 O-C-N 123.64 1.337 . . . . 0.0 110.973 -176.118 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -80.32 -27.39 38.42 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.308 -0.87 . . . . 0.0 110.118 -170.675 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.731 ' O ' HG23 ' A' ' 35' ' ' THR . 46.1 mt-10 -87.76 2.89 50.06 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.529 -0.732 . . . . 0.0 111.252 173.707 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 40.1 m 50.02 40.34 21.1 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.141 -0.974 . . . . 0.0 111.425 -177.768 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.731 HG23 ' O ' ' A' ' 33' ' ' GLU . 39.6 p -136.0 154.34 51.1 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.372 -0.83 . . . . 0.0 110.481 -176.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.839 HG22 HG23 ' A' ' 29' ' ' VAL . 40.0 pt -142.06 161.5 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.672 -0.643 . . . . 0.0 109.991 176.646 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.497 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -136.72 128.6 29.21 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.688 -0.633 . . . . 0.0 109.724 176.262 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 26' ' ' LEU . 83.8 mt -109.76 144.57 37.98 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -178.3 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.4 p -115.3 153.11 31.54 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -178.038 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.0 p 45.31 84.69 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 CA-C-O 121.506 0.669 . . . . 0.0 110.271 -171.672 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 23' ' ' GLU . 13.6 p -134.64 149.52 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -178.314 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.425 ' HB3' HD12 ' A' ' 61' ' ' ILE . 19.6 ptp180 -134.92 153.09 52.19 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.612 -0.68 . . . . 0.0 110.136 179.061 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.8 p -107.91 136.7 47.18 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.747 -0.596 . . . . 0.0 109.639 177.644 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -82.77 -38.45 23.18 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 119.864 -0.735 . . . . 0.0 111.115 -172.339 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.47 166.47 26.6 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 175.783 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.838 HG22 HG12 ' A' ' 20' ' ' ILE . 45.7 p -118.2 -19.77 8.87 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.846 -0.796 . . . . 0.0 110.909 172.786 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -53.3 -26.48 18.77 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.511 -0.743 . . . . 0.0 112.249 -167.54 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -70.49 -59.31 2.92 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.359 -0.838 . . . . 0.0 110.733 -176.025 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 63.1 mtp85 -94.42 -16.34 23.51 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.606 -0.684 . . . . 0.0 111.741 -175.739 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -63.7 174.57 1.34 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.239 -0.913 . . . . 0.0 111.245 -172.639 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.1 m -78.68 164.63 24.44 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 177.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -77.5 11.46 2.01 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.676 -0.64 . . . . 0.0 111.565 -174.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -92.93 164.48 13.29 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.2 -0.938 . . . . 0.0 109.683 169.519 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -66.05 138.17 57.58 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.584 -0.697 . . . . 0.0 110.726 -172.623 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.3 mm -118.39 139.54 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.773 -0.579 . . . . 0.0 109.595 177.383 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.58 113.63 18.48 Favored Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 121.69 -0.631 . . . . 0.0 110.288 -178.827 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -68.54 153.18 74.21 Favored 'Trans proline' 0 N--CA 1.487 1.123 0 O-C-N 123.365 1.192 . . . . 0.0 110.4 179.006 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -132.92 65.73 1.58 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.649 -0.657 . . . . 0.0 110.127 179.526 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.1 m -65.98 -33.4 75.72 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.515 -0.741 . . . . 0.0 110.401 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -62.0 155.35 24.05 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.616 -0.678 . . . . 0.0 110.621 -178.926 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.425 HD12 ' HB3' ' A' ' 42' ' ' ARG . 45.2 mm -96.71 138.34 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.656 -0.652 . . . . 0.0 109.741 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -97.85 118.8 35.24 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.664 -0.647 . . . . 0.0 110.471 -177.324 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -51.3 -39.95 57.95 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.721 -0.612 . . . . 0.0 111.428 175.27 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.497 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.8 t80 -152.95 130.4 11.4 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.75 -0.593 . . . . 0.0 110.254 -174.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.645 HD12 ' CG1' ' A' ' 41' ' ' VAL . 72.9 mt -128.97 127.33 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.65 -0.656 . . . . 0.0 109.901 171.445 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 24.0 tp -91.03 137.14 32.59 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.929 -0.482 . . . . 0.0 109.917 176.317 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.541 ' CD1' HD11 ' A' ' 72' ' ' ILE . 5.9 m-85 -137.18 128.61 28.29 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.65 -0.656 . . . . 0.0 110.531 -176.483 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -91.1 154.93 19.02 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.658 -0.651 . . . . 0.0 110.278 173.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.07 -23.96 57.87 Favored Glycine 0 N--CA 1.498 2.824 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 177.691 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.8 m -72.72 -42.09 64.52 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.46 -1.023 . . . . 0.0 111.28 -175.074 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -84.55 -26.63 27.89 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.345 -0.847 . . . . 0.0 111.144 -174.015 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.756 HG21 ' HG ' ' A' ' 14' ' ' LEU . 32.8 mt -106.27 140.73 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.316 -0.865 . . . . 0.0 109.91 171.089 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -105.19 -16.67 14.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.921 -0.487 . . . . 0.0 111.687 -167.691 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -149.94 133.45 16.61 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.92 -1.113 . . . . 0.0 111.409 -178.689 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.419 HD12 ' CD1' ' A' ' 14' ' ' LEU . 16.2 tt -131.13 137.92 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.048 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -144.89 135.18 24.16 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.613 -0.679 . . . . 0.0 110.164 179.633 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.2 p -86.85 147.04 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.589 -0.694 . . . . 0.0 110.163 178.546 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.4 t -93.87 136.96 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.572 -0.705 . . . . 0.0 109.79 -179.175 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 36.0 p-10 -100.42 165.71 11.31 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.706 -0.621 . . . . 0.0 110.389 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -103.92 32.54 3.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.725 -0.609 . . . . 0.0 110.298 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -112.4 134.3 54.02 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.57 -0.706 . . . . 0.0 110.173 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.7 m -120.1 141.98 49.31 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.712 -0.617 . . . . 0.0 110.109 -179.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.535 ' N ' HD12 ' A' ' 83' ' ' LEU . 6.8 mp -95.56 158.29 34.74 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.753 -0.592 . . . . 0.0 110.209 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo . . . . . 0 N--CA 1.487 1.11 0 O-C-N 123.684 1.36 . . . . 0.0 110.34 -179.985 . . . . . . . . 0 0 . 1 stop_ save_